*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 5 7nn9_c01 NEURAMINIDASE N9 user 1 5 # 1 151 ASP A 440 ASP^? 18.54 C1 EDO B 603 220 ARG B 425 ARG^? 24.19 C2 EDO B 603 277 GLU A 342 GLU^? 20.93 C1 EDO B 603 371 ARG A 412 ARG.? 27.85 C1 EDO B 603 412 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo 25.08 13.39 65.77 24.68 15.22 66.73 8.21 11.09 12.88 6.30 10.30 13.36 coo 41.51 8.52 57.30 41.41 5.60 58.24 13.19 26.25 26.41 10.66 27.96 25.98 coo 24.99 20.41 57.94 24.48 20.83 59.94 16.70 11.35 13.94 16.42 9.25 14.14 coo 19.75 24.53 67.21 22.06 22.76 66.23 12.54 -0.59 17.25 14.66 0.99 15.65 coo 7.28 20.59 43.64 6.35 19.17 42.40 33.51 7.96 1.59 32.78 7.85 -0.37 7nn9_c01 source 7nn9 NEURAMINIDASE N9 : 1 hits 7nn9_c01 naa= 5 ULMN 4 13pk_c00 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 A 39 ARG A 397 ARG~? 24.94 O2 GOL D 601 A 219 LYS A 403 LYS^? 8.85 O1 EDO B 603 A 376 GLY C 429 GLY.? 21.29 O2 GOL D 601 A 399 GLY C 399 GLY.? 18.04 O1 EDO B 603 coo -12.38 76.96 90.60 -12.31 75.41 87.97 31.00 11.06 -6.51 32.72 12.02 -4.11 coo -15.03 67.62 79.35 -16.01 71.68 83.38 17.56 13.24 -3.73 14.59 17.27 -0.83 coo -9.88 73.08 89.49 -9.40 72.65 89.00 30.74 14.63 -9.51 31.39 15.13 -9.63 coo -11.12 75.93 79.79 -10.82 76.54 80.30 22.21 18.06 -10.13 21.51 18.50 -10.08 ULMN 4 13pk_c00 3-PHOSPHOGLYCERATE KINASE user 2 4 # 2 A 39 ARG C 397 ARG~? 23.93 O1 EDO B 603 A 219 LYS C 403 LYS^? 9.83 O1 GOL D 601 A 376 GLY A 429 GLY.? 20.67 O1 EDO B 603 A 399 GLY A 399 GLY.? 18.69 O2 GOL D 601 coo -12.38 76.96 90.60 -12.31 75.41 87.97 25.49 26.02 -11.91 27.94 26.82 -13.64 coo -15.03 67.62 79.35 -16.01 71.68 83.38 19.56 15.05 -18.65 18.30 10.78 -20.22 coo -9.88 73.08 89.49 -9.40 72.65 89.00 27.23 22.60 -8.91 27.96 22.71 -8.54 coo -11.12 75.93 79.79 -10.82 76.54 80.30 24.04 14.08 -10.54 23.93 13.28 -10.73 13pk_c00 source 13pk 3-PHOSPHOGLYCERATE KINASE : 2 hits 13pk_c00 naa= 4 ULMN 4 13pk_c01 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 B 39 ARG A 397 ARG~? 24.94 O2 GOL D 601 B 219 LYS A 403 LYS^? 8.85 O1 EDO B 603 B 376 GLY C 429 GLY.? 21.29 O2 GOL D 601 B 399 GLY C 399 GLY.? 18.04 O1 EDO B 603 coo -2.66 39.94 47.71 -4.08 39.67 44.99 31.00 11.06 -6.51 32.72 12.02 -4.11 coo -12.62 42.34 36.27 -8.73 43.54 40.31 17.56 13.24 -3.73 14.59 17.27 -0.83 coo -6.85 37.45 46.42 -7.20 36.92 45.92 30.74 14.63 -9.51 31.39 15.13 -9.63 coo -4.26 38.64 36.66 -3.61 38.69 37.17 22.21 18.06 -10.13 21.51 18.50 -10.08 ULMN 4 13pk_c01 3-PHOSPHOGLYCERATE KINASE user 2 4 # 2 B 39 ARG A 397 ARG~? 24.94 O2 GOL D 601 B 219 LYS C 403 LYS^? 9.83 O1 GOL D 601 B 376 GLY C 429 GLY.? 21.29 O2 GOL D 601 B 399 GLY C 399 GLY.? 18.04 O1 EDO B 603 coo -2.66 39.94 47.71 -4.08 39.67 44.99 31.00 11.06 -6.51 32.72 12.02 -4.11 coo -12.62 42.34 36.27 -8.73 43.54 40.31 19.56 15.05 -18.65 18.30 10.78 -20.22 coo -6.85 37.45 46.42 -7.20 36.92 45.92 30.74 14.63 -9.51 31.39 15.13 -9.63 coo -4.26 38.64 36.66 -3.61 38.69 37.17 22.21 18.06 -10.13 21.51 18.50 -10.08 ULMN 4 13pk_c01 3-PHOSPHOGLYCERATE KINASE user 3 4 # 3 B 39 ARG C 397 ARG~? 23.93 O1 EDO B 603 B 219 LYS A 403 LYS^? 8.85 O1 EDO B 603 B 376 GLY A 429 GLY.? 20.67 O1 EDO B 603 B 399 GLY A 399 GLY.? 18.69 O2 GOL D 601 coo -2.66 39.94 47.71 -4.08 39.67 44.99 25.49 26.02 -11.91 27.94 26.82 -13.64 coo -12.62 42.34 36.27 -8.73 43.54 40.31 17.56 13.24 -3.73 14.59 17.27 -0.83 coo -6.85 37.45 46.42 -7.20 36.92 45.92 27.23 22.60 -8.91 27.96 22.71 -8.54 coo -4.26 38.64 36.66 -3.61 38.69 37.17 24.04 14.08 -10.54 23.93 13.28 -10.73 ULMN 4 13pk_c01 3-PHOSPHOGLYCERATE KINASE user 4 4 # 4 B 39 ARG C 397 ARG~? 23.93 O1 EDO B 603 B 219 LYS C 403 LYS^? 9.83 O1 GOL D 601 B 376 GLY A 429 GLY.? 20.67 O1 EDO B 603 B 399 GLY A 399 GLY.? 18.69 O2 GOL D 601 coo -2.66 39.94 47.71 -4.08 39.67 44.99 25.49 26.02 -11.91 27.94 26.82 -13.64 coo -12.62 42.34 36.27 -8.73 43.54 40.31 19.56 15.05 -18.65 18.30 10.78 -20.22 coo -6.85 37.45 46.42 -7.20 36.92 45.92 27.23 22.60 -8.91 27.96 22.71 -8.54 coo -4.26 38.64 36.66 -3.61 38.69 37.17 24.04 14.08 -10.54 23.93 13.28 -10.73 13pk_c01 source 13pk 3-PHOSPHOGLYCERATE KINASE : 4 hits 13pk_c01 naa= 4 ULMN 4 13pk_c02 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 C 39 ARG A 397 ARG~? 24.94 O2 GOL D 601 C 219 LYS A 403 LYS^? 8.85 O1 EDO B 603 C 376 GLY C 429 GLY.? 21.29 O2 GOL D 601 C 399 GLY C 399 GLY.? 18.04 O1 EDO B 603 coo -3.47 26.80 67.67 -1.24 26.00 69.62 31.00 11.06 -6.51 32.72 12.02 -4.11 coo 5.22 26.79 80.32 0.48 26.84 77.06 17.56 13.24 -3.73 14.59 17.27 -0.83 coo 1.35 28.76 68.50 2.09 28.66 68.61 30.74 14.63 -9.51 31.39 15.13 -9.63 coo 2.85 20.10 73.72 2.25 20.01 73.15 22.21 18.06 -10.13 21.51 18.50 -10.08 ULMN 4 13pk_c02 3-PHOSPHOGLYCERATE KINASE user 2 4 # 2 C 39 ARG A 397 ARG~? 24.94 O2 GOL D 601 C 219 LYS C 403 LYS^? 9.83 O1 GOL D 601 C 376 GLY C 429 GLY.? 21.29 O2 GOL D 601 C 399 GLY C 399 GLY.? 18.04 O1 EDO B 603 coo -3.47 26.80 67.67 -1.24 26.00 69.62 31.00 11.06 -6.51 32.72 12.02 -4.11 coo 5.22 26.79 80.32 0.48 26.84 77.06 19.56 15.05 -18.65 18.30 10.78 -20.22 coo 1.35 28.76 68.50 2.09 28.66 68.61 30.74 14.63 -9.51 31.39 15.13 -9.63 coo 2.85 20.10 73.72 2.25 20.01 73.15 22.21 18.06 -10.13 21.51 18.50 -10.08 ULMN 4 13pk_c02 3-PHOSPHOGLYCERATE KINASE user 3 4 # 3 C 39 ARG C 397 ARG~? 23.93 O1 EDO B 603 C 219 LYS A 403 LYS^? 8.85 O1 EDO B 603 C 376 GLY A 429 GLY.? 20.67 O1 EDO B 603 C 399 GLY A 399 GLY.? 18.69 O2 GOL D 601 coo -3.47 26.80 67.67 -1.24 26.00 69.62 25.49 26.02 -11.91 27.94 26.82 -13.64 coo 5.22 26.79 80.32 0.48 26.84 77.06 17.56 13.24 -3.73 14.59 17.27 -0.83 coo 1.35 28.76 68.50 2.09 28.66 68.61 27.23 22.60 -8.91 27.96 22.71 -8.54 coo 2.85 20.10 73.72 2.25 20.01 73.15 24.04 14.08 -10.54 23.93 13.28 -10.73 ULMN 4 13pk_c02 3-PHOSPHOGLYCERATE KINASE user 4 4 # 4 C 39 ARG C 397 ARG~? 23.93 O1 EDO B 603 C 219 LYS C 403 LYS^? 9.83 O1 GOL D 601 C 376 GLY A 429 GLY.? 20.67 O1 EDO B 603 C 399 GLY A 399 GLY.? 18.69 O2 GOL D 601 coo -3.47 26.80 67.67 -1.24 26.00 69.62 25.49 26.02 -11.91 27.94 26.82 -13.64 coo 5.22 26.79 80.32 0.48 26.84 77.06 19.56 15.05 -18.65 18.30 10.78 -20.22 coo 1.35 28.76 68.50 2.09 28.66 68.61 27.23 22.60 -8.91 27.96 22.71 -8.54 coo 2.85 20.10 73.72 2.25 20.01 73.15 24.04 14.08 -10.54 23.93 13.28 -10.73 13pk_c02 source 13pk 3-PHOSPHOGLYCERATE KINASE : 4 hits 13pk_c02 naa= 4 ULMN 4 13pk_c03 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 D 39 ARG A 397 ARG~? 24.94 O2 GOL D 601 D 219 LYS A 403 LYS^? 8.85 O1 EDO B 603 D 376 GLY C 429 GLY.? 21.29 O2 GOL D 601 D 399 GLY C 399 GLY.? 18.04 O1 EDO B 603 coo 0.59 75.69 110.95 1.51 77.84 112.93 31.00 11.06 -6.51 32.72 12.02 -4.11 coo 1.28 85.37 123.16 0.84 80.41 120.28 17.56 13.24 -3.73 14.59 17.27 -0.83 coo -1.06 80.88 111.45 -0.91 81.65 111.55 30.74 14.63 -9.51 31.39 15.13 -9.63 coo 7.52 81.86 116.81 7.49 81.18 116.34 22.21 18.06 -10.13 21.51 18.50 -10.08 ULMN 4 13pk_c03 3-PHOSPHOGLYCERATE KINASE user 2 4 # 2 D 39 ARG A 397 ARG~? 24.94 O2 GOL D 601 D 219 LYS C 403 LYS^? 9.83 O1 GOL D 601 D 376 GLY C 429 GLY.? 21.29 O2 GOL D 601 D 399 GLY C 399 GLY.? 18.04 O1 EDO B 603 coo 0.59 75.69 110.95 1.51 77.84 112.93 31.00 11.06 -6.51 32.72 12.02 -4.11 coo 1.28 85.37 123.16 0.84 80.41 120.28 19.56 15.05 -18.65 18.30 10.78 -20.22 coo -1.06 80.88 111.45 -0.91 81.65 111.55 30.74 14.63 -9.51 31.39 15.13 -9.63 coo 7.52 81.86 116.81 7.49 81.18 116.34 22.21 18.06 -10.13 21.51 18.50 -10.08 ULMN 4 13pk_c03 3-PHOSPHOGLYCERATE KINASE user 3 4 # 3 D 39 ARG C 397 ARG~? 23.93 O1 EDO B 603 D 219 LYS A 403 LYS^? 8.85 O1 EDO B 603 D 376 GLY A 429 GLY.? 20.67 O1 EDO B 603 D 399 GLY A 399 GLY.? 18.69 O2 GOL D 601 coo 0.59 75.69 110.95 1.51 77.84 112.93 25.49 26.02 -11.91 27.94 26.82 -13.64 coo 1.28 85.37 123.16 0.84 80.41 120.28 17.56 13.24 -3.73 14.59 17.27 -0.83 coo -1.06 80.88 111.45 -0.91 81.65 111.55 27.23 22.60 -8.91 27.96 22.71 -8.54 coo 7.52 81.86 116.81 7.49 81.18 116.34 24.04 14.08 -10.54 23.93 13.28 -10.73 ULMN 4 13pk_c03 3-PHOSPHOGLYCERATE KINASE user 4 4 # 4 D 39 ARG C 397 ARG~? 23.93 O1 EDO B 603 D 219 LYS C 403 LYS^? 9.83 O1 GOL D 601 D 376 GLY A 429 GLY.? 20.67 O1 EDO B 603 D 399 GLY A 399 GLY.? 18.69 O2 GOL D 601 coo 0.59 75.69 110.95 1.51 77.84 112.93 25.49 26.02 -11.91 27.94 26.82 -13.64 coo 1.28 85.37 123.16 0.84 80.41 120.28 19.56 15.05 -18.65 18.30 10.78 -20.22 coo -1.06 80.88 111.45 -0.91 81.65 111.55 27.23 22.60 -8.91 27.96 22.71 -8.54 coo 7.52 81.86 116.81 7.49 81.18 116.34 24.04 14.08 -10.54 23.93 13.28 -10.73 13pk_c03 source 13pk 3-PHOSPHOGLYCERATE KINASE : 4 hits 13pk_c03 naa= 4 ULMN 4 1di1_c00 ARISTOLOCHENE SYNTHASE user 1 4 # 1 A 92 TYR C 418 TYR^? 10.50 O1 GOL D 601 A 112 PHE C 444 PHE~? 9.55 O1 GOL D 601 A 178 PHE D 416 PHE^? 11.70 C3 GOL D 601 A 333 TRP C 407 TRP^? 15.00 C2 EDO C 602 coo 36.26 31.30 22.39 35.67 33.02 24.49 15.25 12.39 -28.72 15.00 11.49 -26.08 coo 45.52 35.08 26.96 42.72 35.07 26.70 16.05 5.22 -34.74 18.74 5.99 -34.45 coo 43.67 42.67 22.02 43.98 41.21 24.38 15.40 -2.83 -31.27 15.07 -3.80 -33.86 coo 37.80 27.73 29.78 38.27 31.62 30.15 8.62 13.87 -28.54 9.69 13.09 -24.84 1di1_c00 source 1di1 ARISTOLOCHENE SYNTHASE : 1 hits 1di1_c00 naa= 4 ULMN 4 1di1_c01 ARISTOLOCHENE SYNTHASE user 1 4 # 1 B 92 TYR A 418 TYR^? 12.62 O1 EDO B 603 B 112 PHE A 444 PHE~? 11.79 C1 EDO B 603 B 178 PHE B 416 PHE^? 11.67 C2 EDO B 603 B 333 TRP A 407 TRP^? 17.84 O1 EDO B 603 coo 99.56 54.98 23.15 101.17 54.32 25.32 9.59 11.03 3.92 9.74 11.89 1.25 coo 95.53 46.26 28.54 97.54 48.18 28.09 2.91 15.92 8.56 5.14 17.37 9.33 coo 102.10 41.65 23.98 100.86 42.71 26.26 -1.62 21.04 3.18 -3.66 21.32 5.09 coo 96.01 57.16 30.39 98.35 54.06 31.01 6.49 5.24 2.04 7.76 7.03 -1.22 ULMN 4 1di1_c01 ARISTOLOCHENE SYNTHASE user 2 4 # 2 B 92 TYR B 418 TYR^? 11.01 C2 EDO B 603 B 112 PHE B 444 PHE~? 10.27 O1 EDO B 603 B 178 PHE A 416 PHE^? 19.67 O1 EDO B 603 B 333 TRP B 407 TRP^? 14.83 C2 EDO B 603 coo 99.56 54.98 23.15 101.17 54.32 25.32 3.01 21.54 9.44 2.74 20.74 12.09 coo 95.53 46.26 28.54 97.54 48.18 28.09 5.02 14.17 3.93 7.63 15.10 4.40 coo 102.10 41.65 23.98 100.86 42.71 26.26 4.63 6.30 7.93 4.64 5.09 5.42 coo 96.01 57.16 30.39 98.35 54.06 31.01 -3.73 22.30 9.20 -2.79 21.98 13.01 ULMN 4 1di1_c01 ARISTOLOCHENE SYNTHASE user 3 4 # 3 B 92 TYR C 418 TYR^? 10.50 O1 GOL D 601 B 112 PHE C 444 PHE~? 9.55 O1 GOL D 601 B 178 PHE D 416 PHE^? 11.70 C3 GOL D 601 B 333 TRP C 407 TRP^? 15.00 C2 EDO C 602 coo 99.56 54.98 23.15 101.17 54.32 25.32 15.25 12.39 -28.72 15.00 11.49 -26.08 coo 95.53 46.26 28.54 97.54 48.18 28.09 16.05 5.22 -34.74 18.74 5.99 -34.45 coo 102.10 41.65 23.98 100.86 42.71 26.26 15.40 -2.83 -31.27 15.07 -3.80 -33.86 coo 96.01 57.16 30.39 98.35 54.06 31.01 8.62 13.87 -28.54 9.69 13.09 -24.84 1di1_c01 source 1di1 ARISTOLOCHENE SYNTHASE : 3 hits 1di1_c01 naa= 4 ULMN 4 1k32_c00 TRICORN PROTEASE user 1 4 # 1 A 746 HIS A 338 HIS~? 19.64 C1 EDO B 603 A 918 GLY B 323 GLY.? 23.84 C1 EDO B 603 A 965 SER A 358 SER.? 19.71 C1 EDO B 603 A 966 ASP A 357 ASP.? 25.14 C1 EDO B 603 coo -30.53 -25.10 -22.20 -29.14 -23.81 -23.10 16.13 23.68 19.02 16.84 23.99 20.97 coo -25.40 -17.26 -19.44 -25.62 -17.20 -20.29 26.13 18.22 17.28 26.94 18.27 17.39 coo -26.14 -21.10 -25.40 -27.47 -21.37 -23.37 17.92 16.03 18.01 17.94 14.38 16.23 coo -25.61 -16.60 -23.52 -25.94 -14.50 -23.79 22.54 16.74 19.72 22.05 16.00 21.61 ULMN 4 1k32_c00 TRICORN PROTEASE user 2 4 # 2 A 746 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 918 GLY A 323 GLY.? 15.38 C1 EDO B 603 A 965 SER B 358 SER.? 7.25 C1 EDO B 603 A 966 ASP B 357 ASP.? 13.04 C1 EDO B 603 coo -30.53 -25.10 -22.20 -29.14 -23.81 -23.10 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -25.40 -17.26 -19.44 -25.62 -17.20 -20.29 22.31 31.99 4.41 22.84 32.64 4.56 coo -26.14 -21.10 -25.40 -27.47 -21.37 -23.37 16.90 26.63 0.02 16.29 24.39 0.69 coo -25.61 -16.60 -23.52 -25.94 -14.50 -23.79 19.95 30.44 0.55 20.02 30.85 -1.53 ULMN 4 1k32_c00 TRICORN PROTEASE user 3 4 # 3 A 746 HIS C 338 HIS~? 12.91 O1 EDO C 602 A 918 GLY D 323 GLY.? 15.22 C1 EDO C 602 A 965 SER C 358 SER.? 6.66 O1 EDO C 602 A 966 ASP C 357 ASP.? 12.50 O2 EDO C 602 coo -30.53 -25.10 -22.20 -29.14 -23.81 -23.10 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -25.40 -17.26 -19.44 -25.62 -17.20 -20.29 34.88 21.72 -34.87 35.47 22.28 -34.67 coo -26.14 -21.10 -25.40 -27.47 -21.37 -23.37 28.49 17.26 -38.81 27.76 14.99 -38.31 coo -25.61 -16.60 -23.52 -25.94 -14.50 -23.79 32.02 20.63 -38.57 31.77 21.72 -40.39 ULMN 4 1k32_c00 TRICORN PROTEASE user 4 4 # 4 A 746 HIS D 338 HIS~? 13.70 C1 GOL D 601 A 918 GLY C 323 GLY.? 15.53 C2 GOL D 601 A 965 SER D 358 SER.? 6.75 C2 GOL D 601 A 966 ASP D 357 ASP.? 12.64 O3 GOL D 601 coo -30.53 -25.10 -22.20 -29.14 -23.81 -23.10 29.23 12.85 -20.11 30.06 13.12 -18.20 coo -25.40 -17.26 -19.44 -25.62 -17.20 -20.29 38.52 6.83 -23.34 39.38 6.77 -23.23 coo -26.14 -21.10 -25.40 -27.47 -21.37 -23.37 29.79 5.62 -21.71 27.82 6.72 -22.45 coo -25.61 -16.60 -23.52 -25.94 -14.50 -23.79 34.52 5.19 -20.65 34.58 3.94 -18.98 1k32_c00 source 1k32 TRICORN PROTEASE : 4 hits 1k32_c00 naa= 4 ULMN 4 1k32_c01 TRICORN PROTEASE user 1 4 # 1 B 746 HIS A 338 HIS~? 19.64 C1 EDO B 603 B 918 GLY B 323 GLY.? 23.84 C1 EDO B 603 B 965 SER A 358 SER.? 19.71 C1 EDO B 603 B 966 ASP A 357 ASP.? 25.14 C1 EDO B 603 coo -17.40 24.94 -22.27 -18.74 23.62 -23.18 16.13 23.68 19.02 16.84 23.99 20.97 coo -22.53 17.09 -19.52 -22.29 17.04 -20.35 26.13 18.22 17.28 26.94 18.27 17.39 coo -21.72 20.93 -25.41 -20.40 21.13 -23.36 17.92 16.03 18.01 17.94 14.38 16.23 coo -22.32 16.41 -23.56 -21.95 14.31 -23.78 22.54 16.74 19.72 22.05 16.00 21.61 ULMN 4 1k32_c01 TRICORN PROTEASE user 2 4 # 2 B 746 HIS B 338 HIS.? 13.66 O1 EDO B 603 B 918 GLY A 323 GLY.? 15.38 C1 EDO B 603 B 965 SER B 358 SER.? 7.25 C1 EDO B 603 B 966 ASP B 357 ASP.? 13.04 C1 EDO B 603 coo -17.40 24.94 -22.27 -18.74 23.62 -23.18 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -22.53 17.09 -19.52 -22.29 17.04 -20.35 22.31 31.99 4.41 22.84 32.64 4.56 coo -21.72 20.93 -25.41 -20.40 21.13 -23.36 16.90 26.63 0.02 16.29 24.39 0.69 coo -22.32 16.41 -23.56 -21.95 14.31 -23.78 19.95 30.44 0.55 20.02 30.85 -1.53 ULMN 4 1k32_c01 TRICORN PROTEASE user 3 4 # 3 B 746 HIS C 338 HIS~? 12.91 O1 EDO C 602 B 918 GLY D 323 GLY.? 15.22 C1 EDO C 602 B 965 SER C 358 SER.? 6.66 O1 EDO C 602 B 966 ASP C 357 ASP.? 12.50 O2 EDO C 602 coo -17.40 24.94 -22.27 -18.74 23.62 -23.18 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -22.53 17.09 -19.52 -22.29 17.04 -20.35 34.88 21.72 -34.87 35.47 22.28 -34.67 coo -21.72 20.93 -25.41 -20.40 21.13 -23.36 28.49 17.26 -38.81 27.76 14.99 -38.31 coo -22.32 16.41 -23.56 -21.95 14.31 -23.78 32.02 20.63 -38.57 31.77 21.72 -40.39 ULMN 4 1k32_c01 TRICORN PROTEASE user 4 4 # 4 B 746 HIS D 338 HIS~? 13.70 C1 GOL D 601 B 918 GLY C 323 GLY.? 15.53 C2 GOL D 601 B 965 SER D 358 SER.? 6.75 C2 GOL D 601 B 966 ASP D 357 ASP.? 12.64 O3 GOL D 601 coo -17.40 24.94 -22.27 -18.74 23.62 -23.18 29.23 12.85 -20.11 30.06 13.12 -18.20 coo -22.53 17.09 -19.52 -22.29 17.04 -20.35 38.52 6.83 -23.34 39.38 6.77 -23.23 coo -21.72 20.93 -25.41 -20.40 21.13 -23.36 29.79 5.62 -21.71 27.82 6.72 -22.45 coo -22.32 16.41 -23.56 -21.95 14.31 -23.78 34.52 5.19 -20.65 34.58 3.94 -18.98 1k32_c01 source 1k32 TRICORN PROTEASE : 4 hits 1k32_c01 naa= 4 ULMN 4 1k32_c02 TRICORN PROTEASE user 1 4 # 1 C 746 HIS A 338 HIS~? 19.64 C1 EDO B 603 C 918 GLY B 323 GLY.? 23.84 C1 EDO B 603 C 965 SER A 358 SER.? 19.71 C1 EDO B 603 C 966 ASP A 357 ASP.? 25.14 C1 EDO B 603 coo -29.83 -34.35 79.54 -28.31 -35.67 78.96 16.13 23.68 19.02 16.84 23.99 20.97 coo -24.11 -35.42 71.64 -24.35 -36.18 72.01 26.13 18.22 17.28 26.94 18.27 17.39 coo -24.94 -38.70 77.86 -26.35 -37.06 76.80 17.92 16.03 18.01 17.94 14.38 16.23 coo -24.06 -39.23 73.09 -24.19 -40.48 71.39 22.54 16.74 19.72 22.05 16.00 21.61 ULMN 4 1k32_c02 TRICORN PROTEASE user 2 4 # 2 C 746 HIS B 338 HIS.? 13.66 O1 EDO B 603 C 918 GLY A 323 GLY.? 15.38 C1 EDO B 603 C 965 SER B 358 SER.? 7.25 C1 EDO B 603 C 966 ASP B 357 ASP.? 13.04 C1 EDO B 603 coo -29.83 -34.35 79.54 -28.31 -35.67 78.96 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -24.11 -35.42 71.64 -24.35 -36.18 72.01 22.31 31.99 4.41 22.84 32.64 4.56 coo -24.94 -38.70 77.86 -26.35 -37.06 76.80 16.90 26.63 0.02 16.29 24.39 0.69 coo -24.06 -39.23 73.09 -24.19 -40.48 71.39 19.95 30.44 0.55 20.02 30.85 -1.53 ULMN 4 1k32_c02 TRICORN PROTEASE user 3 4 # 3 C 746 HIS C 338 HIS~? 12.91 O1 EDO C 602 C 918 GLY D 323 GLY.? 15.22 C1 EDO C 602 C 965 SER C 358 SER.? 6.66 O1 EDO C 602 C 966 ASP C 357 ASP.? 12.50 O2 EDO C 602 coo -29.83 -34.35 79.54 -28.31 -35.67 78.96 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -24.11 -35.42 71.64 -24.35 -36.18 72.01 34.88 21.72 -34.87 35.47 22.28 -34.67 coo -24.94 -38.70 77.86 -26.35 -37.06 76.80 28.49 17.26 -38.81 27.76 14.99 -38.31 coo -24.06 -39.23 73.09 -24.19 -40.48 71.39 32.02 20.63 -38.57 31.77 21.72 -40.39 ULMN 4 1k32_c02 TRICORN PROTEASE user 4 4 # 4 C 746 HIS D 338 HIS~? 13.70 C1 GOL D 601 C 918 GLY C 323 GLY.? 15.53 C2 GOL D 601 C 965 SER D 358 SER.? 6.75 C2 GOL D 601 C 966 ASP D 357 ASP.? 12.64 O3 GOL D 601 coo -29.83 -34.35 79.54 -28.31 -35.67 78.96 29.23 12.85 -20.11 30.06 13.12 -18.20 coo -24.11 -35.42 71.64 -24.35 -36.18 72.01 38.52 6.83 -23.34 39.38 6.77 -23.23 coo -24.94 -38.70 77.86 -26.35 -37.06 76.80 29.79 5.62 -21.71 27.82 6.72 -22.45 coo -24.06 -39.23 73.09 -24.19 -40.48 71.39 34.52 5.19 -20.65 34.58 3.94 -18.98 1k32_c02 source 1k32 TRICORN PROTEASE : 4 hits 1k32_c02 naa= 4 ULMN 4 1k32_c03 TRICORN PROTEASE user 1 4 # 1 D 746 HIS A 338 HIS~? 19.64 C1 EDO B 603 D 918 GLY B 323 GLY.? 23.84 C1 EDO B 603 D 965 SER A 358 SER.? 19.71 C1 EDO B 603 D 966 ASP A 357 ASP.? 25.14 C1 EDO B 603 coo -12.39 -58.08 36.98 -13.82 -58.32 38.50 16.13 23.68 19.02 16.84 23.99 20.97 coo -18.39 -52.23 42.26 -18.11 -52.90 42.72 26.13 18.22 17.28 26.94 18.27 17.39 coo -16.96 -59.28 41.74 -15.86 -57.26 40.98 17.92 16.03 18.01 17.94 14.38 16.23 coo -17.84 -55.46 44.68 -17.84 -54.60 46.60 22.54 16.74 19.72 22.05 16.00 21.61 ULMN 4 1k32_c03 TRICORN PROTEASE user 2 4 # 2 D 746 HIS B 338 HIS.? 13.66 O1 EDO B 603 D 918 GLY A 323 GLY.? 15.38 C1 EDO B 603 D 965 SER B 358 SER.? 7.25 C1 EDO B 603 D 966 ASP B 357 ASP.? 13.04 C1 EDO B 603 coo -12.39 -58.08 36.98 -13.82 -58.32 38.50 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -18.39 -52.23 42.26 -18.11 -52.90 42.72 22.31 31.99 4.41 22.84 32.64 4.56 coo -16.96 -59.28 41.74 -15.86 -57.26 40.98 16.90 26.63 0.02 16.29 24.39 0.69 coo -17.84 -55.46 44.68 -17.84 -54.60 46.60 19.95 30.44 0.55 20.02 30.85 -1.53 ULMN 4 1k32_c03 TRICORN PROTEASE user 3 4 # 3 D 746 HIS C 338 HIS~? 12.91 O1 EDO C 602 D 918 GLY D 323 GLY.? 15.22 C1 EDO C 602 D 965 SER C 358 SER.? 6.66 O1 EDO C 602 D 966 ASP C 357 ASP.? 12.50 O2 EDO C 602 coo -12.39 -58.08 36.98 -13.82 -58.32 38.50 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -18.39 -52.23 42.26 -18.11 -52.90 42.72 34.88 21.72 -34.87 35.47 22.28 -34.67 coo -16.96 -59.28 41.74 -15.86 -57.26 40.98 28.49 17.26 -38.81 27.76 14.99 -38.31 coo -17.84 -55.46 44.68 -17.84 -54.60 46.60 32.02 20.63 -38.57 31.77 21.72 -40.39 ULMN 4 1k32_c03 TRICORN PROTEASE user 4 4 # 4 D 746 HIS D 338 HIS~? 13.70 C1 GOL D 601 D 918 GLY C 323 GLY.? 15.53 C2 GOL D 601 D 965 SER D 358 SER.? 6.75 C2 GOL D 601 D 966 ASP D 357 ASP.? 12.64 O3 GOL D 601 coo -12.39 -58.08 36.98 -13.82 -58.32 38.50 29.23 12.85 -20.11 30.06 13.12 -18.20 coo -18.39 -52.23 42.26 -18.11 -52.90 42.72 38.52 6.83 -23.34 39.38 6.77 -23.23 coo -16.96 -59.28 41.74 -15.86 -57.26 40.98 29.79 5.62 -21.71 27.82 6.72 -22.45 coo -17.84 -55.46 44.68 -17.84 -54.60 46.60 34.52 5.19 -20.65 34.58 3.94 -18.98 1k32_c03 source 1k32 TRICORN PROTEASE : 4 hits 1k32_c03 naa= 4 ULMN 4 1k32_c04 TRICORN PROTEASE user 1 4 # 1 E 746 HIS A 338 HIS~? 19.64 C1 EDO B 603 E 918 GLY B 323 GLY.? 23.84 C1 EDO B 603 E 965 SER A 358 SER.? 19.71 C1 EDO B 603 E 966 ASP A 357 ASP.? 25.14 C1 EDO B 603 coo -35.64 58.00 36.79 -34.24 58.25 38.33 16.13 23.68 19.02 16.84 23.99 20.97 coo -29.67 52.09 42.06 -29.97 52.76 42.50 26.13 18.22 17.28 26.94 18.27 17.39 coo -31.07 59.20 41.64 -32.20 57.20 40.88 17.92 16.03 18.01 17.94 14.38 16.23 coo -30.15 55.39 44.56 -30.23 54.51 46.49 22.54 16.74 19.72 22.05 16.00 21.61 ULMN 4 1k32_c04 TRICORN PROTEASE user 2 4 # 2 E 746 HIS B 338 HIS.? 13.66 O1 EDO B 603 E 918 GLY A 323 GLY.? 15.38 C1 EDO B 603 E 965 SER B 358 SER.? 7.25 C1 EDO B 603 E 966 ASP B 357 ASP.? 13.04 C1 EDO B 603 coo -35.64 58.00 36.79 -34.24 58.25 38.33 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -29.67 52.09 42.06 -29.97 52.76 42.50 22.31 31.99 4.41 22.84 32.64 4.56 coo -31.07 59.20 41.64 -32.20 57.20 40.88 16.90 26.63 0.02 16.29 24.39 0.69 coo -30.15 55.39 44.56 -30.23 54.51 46.49 19.95 30.44 0.55 20.02 30.85 -1.53 ULMN 4 1k32_c04 TRICORN PROTEASE user 3 4 # 3 E 746 HIS C 338 HIS~? 12.91 O1 EDO C 602 E 918 GLY D 323 GLY.? 15.22 C1 EDO C 602 E 965 SER C 358 SER.? 6.66 O1 EDO C 602 E 966 ASP C 357 ASP.? 12.50 O2 EDO C 602 coo -35.64 58.00 36.79 -34.24 58.25 38.33 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -29.67 52.09 42.06 -29.97 52.76 42.50 34.88 21.72 -34.87 35.47 22.28 -34.67 coo -31.07 59.20 41.64 -32.20 57.20 40.88 28.49 17.26 -38.81 27.76 14.99 -38.31 coo -30.15 55.39 44.56 -30.23 54.51 46.49 32.02 20.63 -38.57 31.77 21.72 -40.39 ULMN 4 1k32_c04 TRICORN PROTEASE user 4 4 # 4 E 746 HIS D 338 HIS~? 13.70 C1 GOL D 601 E 918 GLY C 323 GLY.? 15.53 C2 GOL D 601 E 965 SER D 358 SER.? 6.75 C2 GOL D 601 E 966 ASP D 357 ASP.? 12.64 O3 GOL D 601 coo -35.64 58.00 36.79 -34.24 58.25 38.33 29.23 12.85 -20.11 30.06 13.12 -18.20 coo -29.67 52.09 42.06 -29.97 52.76 42.50 38.52 6.83 -23.34 39.38 6.77 -23.23 coo -31.07 59.20 41.64 -32.20 57.20 40.88 29.79 5.62 -21.71 27.82 6.72 -22.45 coo -30.15 55.39 44.56 -30.23 54.51 46.49 34.52 5.19 -20.65 34.58 3.94 -18.98 1k32_c04 source 1k32 TRICORN PROTEASE : 4 hits 1k32_c04 naa= 4 ULMN 4 1k32_c05 TRICORN PROTEASE user 1 4 # 1 F 746 HIS A 338 HIS~? 19.64 C1 EDO B 603 F 918 GLY B 323 GLY.? 23.84 C1 EDO B 603 F 965 SER A 358 SER.? 19.71 C1 EDO B 603 F 966 ASP A 357 ASP.? 25.14 C1 EDO B 603 coo -18.39 34.44 79.46 -19.89 35.78 78.84 16.13 23.68 19.02 16.84 23.99 20.97 coo -24.07 35.50 71.61 -23.86 36.27 71.94 26.13 18.22 17.28 26.94 18.27 17.39 coo -23.27 38.87 77.92 -21.94 37.18 76.84 17.92 16.03 18.01 17.94 14.38 16.23 coo -24.16 39.29 73.08 -24.04 40.55 71.37 22.54 16.74 19.72 22.05 16.00 21.61 ULMN 4 1k32_c05 TRICORN PROTEASE user 2 4 # 2 F 746 HIS B 338 HIS.? 13.66 O1 EDO B 603 F 918 GLY A 323 GLY.? 15.38 C1 EDO B 603 F 965 SER B 358 SER.? 7.25 C1 EDO B 603 F 966 ASP B 357 ASP.? 13.04 C1 EDO B 603 coo -18.39 34.44 79.46 -19.89 35.78 78.84 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -24.07 35.50 71.61 -23.86 36.27 71.94 22.31 31.99 4.41 22.84 32.64 4.56 coo -23.27 38.87 77.92 -21.94 37.18 76.84 16.90 26.63 0.02 16.29 24.39 0.69 coo -24.16 39.29 73.08 -24.04 40.55 71.37 19.95 30.44 0.55 20.02 30.85 -1.53 ULMN 4 1k32_c05 TRICORN PROTEASE user 3 4 # 3 F 746 HIS C 338 HIS~? 12.91 O1 EDO C 602 F 918 GLY D 323 GLY.? 15.22 C1 EDO C 602 F 965 SER C 358 SER.? 6.66 O1 EDO C 602 F 966 ASP C 357 ASP.? 12.50 O2 EDO C 602 coo -18.39 34.44 79.46 -19.89 35.78 78.84 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -24.07 35.50 71.61 -23.86 36.27 71.94 34.88 21.72 -34.87 35.47 22.28 -34.67 coo -23.27 38.87 77.92 -21.94 37.18 76.84 28.49 17.26 -38.81 27.76 14.99 -38.31 coo -24.16 39.29 73.08 -24.04 40.55 71.37 32.02 20.63 -38.57 31.77 21.72 -40.39 ULMN 4 1k32_c05 TRICORN PROTEASE user 4 4 # 4 F 746 HIS D 338 HIS~? 13.70 C1 GOL D 601 F 918 GLY C 323 GLY.? 15.53 C2 GOL D 601 F 965 SER D 358 SER.? 6.75 C2 GOL D 601 F 966 ASP D 357 ASP.? 12.64 O3 GOL D 601 coo -18.39 34.44 79.46 -19.89 35.78 78.84 29.23 12.85 -20.11 30.06 13.12 -18.20 coo -24.07 35.50 71.61 -23.86 36.27 71.94 38.52 6.83 -23.34 39.38 6.77 -23.23 coo -23.27 38.87 77.92 -21.94 37.18 76.84 29.79 5.62 -21.71 27.82 6.72 -22.45 coo -24.16 39.29 73.08 -24.04 40.55 71.37 34.52 5.19 -20.65 34.58 3.94 -18.98 1k32_c05 source 1k32 TRICORN PROTEASE : 4 hits 1k32_c05 naa= 4 ULMN 4 1l7d_c00 NICOTINAMIDE NUCLEOTIDE TRANSHYDROGEuser 1 4 # 1 A 127 ARG A 316 ARG.? 27.22 C1 EDO B 603 A 132 GLN A 320 GLN^? 25.36 C1 EDO B 603 A 135 ASP B 315 ASP.? 32.42 C1 EDO B 603 A 138 SER A 313 SER.? 36.10 C1 EDO B 603 coo -5.87 -32.14 16.05 -5.08 -34.04 18.31 32.66 26.75 19.60 30.80 24.65 18.26 coo 0.32 -23.63 17.28 -0.45 -21.67 17.61 29.74 33.26 11.08 31.47 32.04 11.15 coo 2.58 -27.93 13.18 1.12 -28.64 11.82 37.58 31.51 9.95 39.21 32.46 10.92 coo 1.28 -26.11 8.70 -0.28 -25.96 10.56 39.91 33.41 13.35 41.22 34.11 15.24 1l7d_c00 source 1l7d NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE, SUBU: 1 hits 1l7d_c00 naa= 4 ULMN 4 1l7d_c02 NICOTINAMIDE NUCLEOTIDE TRANSHYDROGEuser 1 4 # 1 C 927 ARG B 316 ARG.? 22.40 C1 EDO B 603 C 932 GLN B 320 GLN^? 27.80 C1 EDO B 603 C 935 ASP B 315 ASP.? 32.42 C1 EDO B 603 C 938 SER A 313 SER.? 36.10 C1 EDO B 603 coo 1.74 -6.46 15.39 2.55 -4.22 13.45 32.74 31.58 5.20 30.84 29.65 3.70 coo 2.39 -8.41 25.36 1.15 -9.40 26.79 34.66 25.17 13.76 33.95 27.13 14.05 coo 4.51 -3.25 22.25 3.50 -2.74 20.47 37.58 31.51 9.95 39.21 32.46 10.92 coo 0.91 -0.11 23.31 0.17 -1.93 24.76 39.91 33.41 13.35 41.22 34.11 15.24 1l7d_c02 source 1l7d NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE, SUBU: 1 hits 1l7d_c02 naa= 4 ULMN 4 1l7d_c03 NICOTINAMIDE NUCLEOTIDE TRANSHYDROGEuser 1 4 # 1 D1327 ARG B 316 ARG.? 22.40 C1 EDO B 603 D1332 GLN B 320 GLN^? 27.80 C1 EDO B 603 D1335 ASP B 315 ASP.? 32.42 C1 EDO B 603 D1338 SER A 313 SER.? 36.10 C1 EDO B 603 coo -22.62 30.03 57.43 -19.58 30.46 57.46 32.74 31.58 5.20 30.84 29.65 3.70 coo -27.46 22.07 54.10 -27.67 20.09 54.90 34.66 25.17 13.76 33.95 27.13 14.05 coo -25.80 27.06 50.51 -24.16 28.17 51.26 37.58 31.51 9.95 39.21 32.46 10.92 coo -21.87 25.29 48.40 -22.55 24.92 50.69 39.91 33.41 13.35 41.22 34.11 15.24 1l7d_c03 source 1l7d NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE, SUBU: 1 hits 1l7d_c03 naa= 4 ULMN 4 1ltq_c00 POLYNUCLEOTIDE KINASE user 1 4 # 1 A 15 LYS C 403 LYS^? 9.83 O1 GOL D 601 A 35 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 126 ARG C 425 ARG^? 21.48 O1 GOL D 601 A 165 ASP C 315 ASP.? 32.88 C1 EDO C 602 coo 25.71 11.82 52.50 25.05 7.88 50.17 19.56 15.05 -18.65 18.30 10.78 -20.22 coo 23.50 1.36 54.56 23.86 1.61 52.50 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 33.89 4.42 51.79 30.99 5.09 51.05 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 42.34 11.15 22.32 43.58 12.11 23.75 51.14 17.66 -30.05 53.19 17.33 -29.52 1ltq_c00 source 1ltq POLYNUCLEOTIDE KINASE : 1 hits 1ltq_c00 naa= 4 ULMN 4 1oh9_c00 ACETYLGLUTAMATE KINASE user 1 4 # 1 A 8 LYS A 403 LYS^? 8.85 O1 EDO B 603 A 11 GLY A 399 GLY.? 18.69 O2 GOL D 601 A 45 GLY C 429 GLY.? 21.29 O2 GOL D 601 A 217 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo 23.95 20.41 42.64 25.99 15.22 44.13 17.56 13.24 -3.73 14.59 17.27 -0.83 coo 21.78 10.35 42.81 21.85 10.58 42.04 24.04 14.08 -10.54 23.93 13.28 -10.73 coo 27.49 8.11 39.28 26.75 8.17 38.90 30.74 14.63 -9.51 31.39 15.13 -9.63 coo 29.45 15.15 50.79 25.80 14.13 47.92 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 4 1oh9_c00 ACETYLGLUTAMATE KINASE user 2 4 # 2 A 8 LYS C 403 LYS^? 9.83 O1 GOL D 601 A 11 GLY C 399 GLY.? 18.04 O1 EDO B 603 A 45 GLY A 429 GLY.? 20.67 O1 EDO B 603 A 217 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 23.95 20.41 42.64 25.99 15.22 44.13 19.56 15.05 -18.65 18.30 10.78 -20.22 coo 21.78 10.35 42.81 21.85 10.58 42.04 22.21 18.06 -10.13 21.51 18.50 -10.08 coo 27.49 8.11 39.28 26.75 8.17 38.90 27.23 22.60 -8.91 27.96 22.71 -8.54 coo 29.45 15.15 50.79 25.80 14.13 47.92 15.56 26.67 -15.99 9.90 23.87 -16.19 1oh9_c00 source 1oh9 ACETYLGLUTAMATE KINASE : 2 hits 1oh9_c00 naa= 4 ULMN 4 1p4n_c00 UDP-MURNAC-PENTAPEPTIDE user 1 4 # 1 A 36 LYS C 403 LYS^? 9.83 O1 GOL D 601 A 108 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 211 ARG C 425 ARG^? 21.48 O1 GOL D 601 A 319 GLU C 378 GLU~? 24.96 O2 EDO B 603 coo 26.40 -0.07 5.65 25.70 1.89 10.82 19.56 15.05 -18.65 18.30 10.78 -20.22 coo 13.95 1.15 16.48 15.65 1.17 15.18 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 30.30 5.19 11.85 28.49 2.83 12.64 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 15.01 -1.52 19.72 16.83 -2.42 20.27 22.14 33.77 -19.82 21.71 34.90 -18.09 1p4n_c00 source 1p4n UDP-MURNAC-PENTAPEPTIDE : 1 hits 1p4n_c00 naa= 4 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 1 3 # 1 A 46 ASP A 315 ASP.? 32.31 C1 EDO B 603 A 100 ARG A 316 ARG.? 27.22 C1 EDO B 603 A 116 GLN B 320 GLN^? 27.80 C1 EDO B 603 coo 32.24 20.09 5.34 30.38 19.04 5.27 35.16 33.09 19.50 33.98 34.83 19.67 coo 26.40 25.34 6.28 26.15 22.33 7.25 32.66 26.75 19.60 30.80 24.65 18.26 coo 26.74 21.94 13.78 27.57 20.97 12.08 34.66 25.17 13.76 33.95 27.13 14.05 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 2 3 # 2 A 46 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 100 ARG A 401 ARG.? 15.99 O2 GOL D 601 A 116 GLN A 400 GLN.? 13.34 O2 GOL D 601 coo 32.24 20.09 5.34 30.38 19.04 5.27 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 26.40 25.34 6.28 26.15 22.33 7.25 17.05 9.37 -8.73 16.66 7.27 -10.98 coo 26.74 21.94 13.78 27.57 20.97 12.08 22.76 9.60 -12.72 23.33 7.54 -12.60 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 3 3 # 3 A 46 ASP A 430 ASP.? 25.41 O1 EDO B 603 A 100 ARG C 397 ARG~? 23.93 O1 EDO B 603 A 116 GLN A 427 GLN.? 20.08 O1 EDO B 603 coo 32.24 20.09 5.34 30.38 19.04 5.27 31.59 21.51 -7.17 32.38 22.31 -9.00 coo 26.40 25.34 6.28 26.15 22.33 7.25 25.49 26.02 -11.91 27.94 26.82 -13.64 coo 26.74 21.94 13.78 27.57 20.97 12.08 25.85 29.74 -6.76 26.03 31.82 -6.25 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 4 3 # 4 A 46 ASP A 430 ASP.? 25.41 O1 EDO B 603 A 100 ARG C 425 ARG^? 21.48 O1 GOL D 601 A 116 GLN C 432 GLN^? 23.55 C1 GOL D 601 coo 32.24 20.09 5.34 30.38 19.04 5.27 31.59 21.51 -7.17 32.38 22.31 -9.00 coo 26.40 25.34 6.28 26.15 22.33 7.25 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 26.74 21.94 13.78 27.57 20.97 12.08 33.54 18.76 -15.71 34.79 19.97 -14.45 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 5 3 # 5 A 46 ASP B 402 ASP.? 23.46 C2 EDO B 603 A 100 ARG B 401 ARG.? 20.08 C2 EDO B 603 A 116 GLN B 400 GLN.? 28.52 C2 EDO B 603 coo 32.24 20.09 5.34 30.38 19.04 5.27 8.17 23.01 23.39 8.93 22.69 25.33 coo 26.40 25.34 6.28 26.15 22.33 7.25 1.75 25.80 23.58 1.16 24.37 20.91 coo 26.74 21.94 13.78 27.57 20.97 12.08 2.84 29.43 29.50 2.03 31.39 29.32 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 6 3 # 6 A 46 ASP C 315 ASP.? 32.88 C1 EDO C 602 A 100 ARG C 316 ARG.? 22.36 C1 EDO C 602 A 116 GLN D 320 GLN^? 25.85 C1 EDO C 602 coo 32.24 20.09 5.34 30.38 19.04 5.27 51.14 17.66 -30.05 53.19 17.33 -29.52 coo 26.40 25.34 6.28 26.15 22.33 7.25 45.68 20.68 -34.53 42.70 20.67 -33.83 coo 26.74 21.94 13.78 27.57 20.97 12.08 44.13 21.88 -28.02 45.21 20.13 -28.45 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 7 3 # 7 A 46 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 100 ARG C 397 ARG~? 23.93 O1 EDO B 603 A 116 GLN A 427 GLN.? 20.08 O1 EDO B 603 coo 32.24 20.09 5.34 30.38 19.04 5.27 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 26.40 25.34 6.28 26.15 22.33 7.25 25.49 26.02 -11.91 27.94 26.82 -13.64 coo 26.74 21.94 13.78 27.57 20.97 12.08 25.85 29.74 -6.76 26.03 31.82 -6.25 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 8 3 # 8 A 46 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 100 ARG C 401 ARG.? 15.33 O1 EDO B 603 A 116 GLN C 400 GLN.? 12.85 O1 EDO B 603 coo 32.24 20.09 5.34 30.38 19.04 5.27 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 26.40 25.34 6.28 26.15 22.33 7.25 15.13 16.06 -14.86 13.60 17.63 -12.63 coo 26.74 21.94 13.78 27.57 20.97 12.08 17.76 19.88 -9.09 16.75 21.72 -9.38 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 9 3 # 9 A 46 ASP C 430 ASP.? 26.01 O2 GOL D 601 A 100 ARG A 397 ARG~? 24.94 O2 GOL D 601 A 116 GLN C 427 GLN.? 21.67 C2 GOL D 601 coo 32.24 20.09 5.34 30.38 19.04 5.27 33.23 18.77 -9.92 33.78 18.54 -7.88 coo 26.40 25.34 6.28 26.15 22.33 7.25 31.00 11.06 -6.51 32.72 12.02 -4.11 coo 26.74 21.94 13.78 27.57 20.97 12.08 35.58 9.46 -10.57 37.38 8.54 -9.94 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 10 3 # 10 A 46 ASP C 430 ASP.? 26.01 O2 GOL D 601 A 100 ARG A 425 ARG^? 21.19 O1 EDO B 603 A 116 GLN A 432 GLN^? 23.55 O1 EDO B 603 coo 32.24 20.09 5.34 30.38 19.04 5.27 33.23 18.77 -9.92 33.78 18.54 -7.88 coo 26.40 25.34 6.28 26.15 22.33 7.25 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 26.74 21.94 13.78 27.57 20.97 12.08 30.06 20.95 -1.70 32.12 21.19 -2.22 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 11 3 # 11 A 46 ASP D 315 ASP.? 31.69 C1 GOL D 601 A 100 ARG D 316 ARG.? 22.70 C2 GOL D 601 A 116 GLN C 320 GLN^? 25.79 C1 GOL D 601 coo 32.24 20.09 5.34 30.38 19.04 5.27 48.83 21.16 -21.57 48.15 21.79 -19.66 coo 26.40 25.34 6.28 26.15 22.33 7.25 45.13 14.38 -20.32 42.13 14.31 -19.52 coo 26.74 21.94 13.78 27.57 20.97 12.08 46.21 12.60 -26.90 46.51 14.66 -26.40 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 12 3 # 12 A 46 ASP D 402 ASP.? 14.20 O1 EDO C 602 A 100 ARG D 401 ARG.? 17.46 O1 EDO C 602 A 116 GLN D 400 GLN.? 25.00 O1 EDO C 602 coo 32.24 20.09 5.34 30.38 19.04 5.27 28.53 7.95 -46.44 29.10 9.08 -48.14 coo 26.40 25.34 6.28 26.15 22.33 7.25 26.50 1.94 -49.52 24.85 0.58 -47.31 coo 26.74 21.94 13.78 27.57 20.97 12.08 31.74 1.70 -54.05 32.37 -0.33 -54.30 12as_c00 source 12as ASPARAGINE SYNTHETASE : 12 hits 12as_c00 naa= 3 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 1 3 # 1 B 46 ASP A 315 ASP.? 32.31 C1 EDO B 603 B 100 ARG A 316 ARG.? 27.22 C1 EDO B 603 B 116 GLN B 320 GLN^? 27.80 C1 EDO B 603 coo 32.18 48.37 12.48 33.96 49.46 12.97 35.16 33.09 19.50 33.98 34.83 19.67 coo 39.04 43.25 11.37 38.30 45.35 13.56 32.66 26.75 19.60 30.80 24.65 18.26 coo 37.43 42.63 19.41 36.76 44.08 17.97 34.66 25.17 13.76 33.95 27.13 14.05 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 2 3 # 2 B 46 ASP A 402 ASP.? 12.59 O1 EDO B 603 B 100 ARG A 401 ARG.? 15.99 O2 GOL D 601 B 116 GLN A 400 GLN.? 13.34 O2 GOL D 601 coo 32.18 48.37 12.48 33.96 49.46 12.97 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 39.04 43.25 11.37 38.30 45.35 13.56 17.05 9.37 -8.73 16.66 7.27 -10.98 coo 37.43 42.63 19.41 36.76 44.08 17.97 22.76 9.60 -12.72 23.33 7.54 -12.60 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 3 3 # 3 B 46 ASP A 402 ASP.? 12.59 O1 EDO B 603 B 100 ARG C 425 ARG^? 21.48 O1 GOL D 601 B 116 GLN A 400 GLN.? 13.34 O2 GOL D 601 coo 32.18 48.37 12.48 33.96 49.46 12.97 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 39.04 43.25 11.37 38.30 45.35 13.56 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 37.43 42.63 19.41 36.76 44.08 17.97 22.76 9.60 -12.72 23.33 7.54 -12.60 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 4 3 # 4 B 46 ASP A 430 ASP.? 25.41 O1 EDO B 603 B 100 ARG C 397 ARG~? 23.93 O1 EDO B 603 B 116 GLN A 427 GLN.? 20.08 O1 EDO B 603 coo 32.18 48.37 12.48 33.96 49.46 12.97 31.59 21.51 -7.17 32.38 22.31 -9.00 coo 39.04 43.25 11.37 38.30 45.35 13.56 25.49 26.02 -11.91 27.94 26.82 -13.64 coo 37.43 42.63 19.41 36.76 44.08 17.97 25.85 29.74 -6.76 26.03 31.82 -6.25 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 5 3 # 5 B 46 ASP A 430 ASP.? 25.41 O1 EDO B 603 B 100 ARG C 425 ARG^? 21.48 O1 GOL D 601 B 116 GLN C 432 GLN^? 23.55 C1 GOL D 601 coo 32.18 48.37 12.48 33.96 49.46 12.97 31.59 21.51 -7.17 32.38 22.31 -9.00 coo 39.04 43.25 11.37 38.30 45.35 13.56 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 37.43 42.63 19.41 36.76 44.08 17.97 33.54 18.76 -15.71 34.79 19.97 -14.45 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 6 3 # 6 B 46 ASP B 402 ASP.? 23.46 C2 EDO B 603 B 100 ARG B 401 ARG.? 20.08 C2 EDO B 603 B 116 GLN B 400 GLN.? 28.52 C2 EDO B 603 coo 32.18 48.37 12.48 33.96 49.46 12.97 8.17 23.01 23.39 8.93 22.69 25.33 coo 39.04 43.25 11.37 38.30 45.35 13.56 1.75 25.80 23.58 1.16 24.37 20.91 coo 37.43 42.63 19.41 36.76 44.08 17.97 2.84 29.43 29.50 2.03 31.39 29.32 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 7 3 # 7 B 46 ASP C 315 ASP.? 32.88 C1 EDO C 602 B 100 ARG C 316 ARG.? 22.36 C1 EDO C 602 B 116 GLN D 320 GLN^? 25.85 C1 EDO C 602 coo 32.18 48.37 12.48 33.96 49.46 12.97 51.14 17.66 -30.05 53.19 17.33 -29.52 coo 39.04 43.25 11.37 38.30 45.35 13.56 45.68 20.68 -34.53 42.70 20.67 -33.83 coo 37.43 42.63 19.41 36.76 44.08 17.97 44.13 21.88 -28.02 45.21 20.13 -28.45 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 8 3 # 8 B 46 ASP C 350 ASP.? 24.48 C2 EDO C 602 B 100 ARG C 397 ARG~? 23.93 O1 EDO B 603 B 116 GLN A 427 GLN.? 20.08 O1 EDO B 603 coo 32.18 48.37 12.48 33.96 49.46 12.97 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 39.04 43.25 11.37 38.30 45.35 13.56 25.49 26.02 -11.91 27.94 26.82 -13.64 coo 37.43 42.63 19.41 36.76 44.08 17.97 25.85 29.74 -6.76 26.03 31.82 -6.25 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 9 3 # 9 B 46 ASP C 402 ASP.? 12.78 O1 GOL D 601 B 100 ARG A 425 ARG^? 21.19 O1 EDO B 603 B 116 GLN C 400 GLN.? 12.85 O1 EDO B 603 coo 32.18 48.37 12.48 33.96 49.46 12.97 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 39.04 43.25 11.37 38.30 45.35 13.56 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 37.43 42.63 19.41 36.76 44.08 17.97 17.76 19.88 -9.09 16.75 21.72 -9.38 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 10 3 # 10 B 46 ASP C 402 ASP.? 12.78 O1 GOL D 601 B 100 ARG C 401 ARG.? 15.33 O1 EDO B 603 B 116 GLN C 400 GLN.? 12.85 O1 EDO B 603 coo 32.18 48.37 12.48 33.96 49.46 12.97 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 39.04 43.25 11.37 38.30 45.35 13.56 15.13 16.06 -14.86 13.60 17.63 -12.63 coo 37.43 42.63 19.41 36.76 44.08 17.97 17.76 19.88 -9.09 16.75 21.72 -9.38 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 11 3 # 11 B 46 ASP C 430 ASP.? 26.01 O2 GOL D 601 B 100 ARG A 397 ARG~? 24.94 O2 GOL D 601 B 116 GLN C 427 GLN.? 21.67 C2 GOL D 601 coo 32.18 48.37 12.48 33.96 49.46 12.97 33.23 18.77 -9.92 33.78 18.54 -7.88 coo 39.04 43.25 11.37 38.30 45.35 13.56 31.00 11.06 -6.51 32.72 12.02 -4.11 coo 37.43 42.63 19.41 36.76 44.08 17.97 35.58 9.46 -10.57 37.38 8.54 -9.94 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 12 3 # 12 B 46 ASP C 430 ASP.? 26.01 O2 GOL D 601 B 100 ARG A 425 ARG^? 21.19 O1 EDO B 603 B 116 GLN A 432 GLN^? 23.55 O1 EDO B 603 coo 32.18 48.37 12.48 33.96 49.46 12.97 33.23 18.77 -9.92 33.78 18.54 -7.88 coo 39.04 43.25 11.37 38.30 45.35 13.56 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 37.43 42.63 19.41 36.76 44.08 17.97 30.06 20.95 -1.70 32.12 21.19 -2.22 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 13 3 # 13 B 46 ASP D 315 ASP.? 31.69 C1 GOL D 601 B 100 ARG D 316 ARG.? 22.70 C2 GOL D 601 B 116 GLN C 320 GLN^? 25.79 C1 GOL D 601 coo 32.18 48.37 12.48 33.96 49.46 12.97 48.83 21.16 -21.57 48.15 21.79 -19.66 coo 39.04 43.25 11.37 38.30 45.35 13.56 45.13 14.38 -20.32 42.13 14.31 -19.52 coo 37.43 42.63 19.41 36.76 44.08 17.97 46.21 12.60 -26.90 46.51 14.66 -26.40 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 14 3 # 14 B 46 ASP D 402 ASP.? 14.20 O1 EDO C 602 B 100 ARG D 401 ARG.? 17.46 O1 EDO C 602 B 116 GLN D 400 GLN.? 25.00 O1 EDO C 602 coo 32.18 48.37 12.48 33.96 49.46 12.97 28.53 7.95 -46.44 29.10 9.08 -48.14 coo 39.04 43.25 11.37 38.30 45.35 13.56 26.50 1.94 -49.52 24.85 0.58 -47.31 coo 37.43 42.63 19.41 36.76 44.08 17.97 31.74 1.70 -54.05 32.37 -0.33 -54.30 12as_c01 source 12as ASPARAGINE SYNTHETASE : 14 hits 12as_c01 naa= 3 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 140 TYR B 421 TYR^? 13.58 C2 EDO B 603 B 190 LYS B 390 LYS~? 27.12 C2 EDO B 603 B 222 ASP B 350 ASP.? 23.89 C2 EDO B 603 coo 7.17 16.59 41.26 8.01 19.20 40.73 6.36 30.57 15.08 5.68 32.41 13.09 coo 13.38 20.00 35.06 11.43 22.49 39.53 3.52 38.72 20.17 3.15 45.06 20.21 coo 9.76 26.58 38.10 11.63 25.78 38.76 12.16 40.72 19.41 11.14 39.74 20.98 1a05_c00 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 1 hits 1a05_c00 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS B 390 LYS~? 27.12 C2 EDO B 603 A 222 ASP B 350 ASP.? 23.89 C2 EDO B 603 B 140 TYR B 421 TYR^? 13.58 C2 EDO B 603 coo -4.61 20.12 30.34 -2.74 22.65 25.95 3.52 38.72 20.17 3.15 45.06 20.21 coo -1.04 26.60 27.37 -2.94 25.93 26.69 12.16 40.72 19.41 11.14 39.74 20.98 coo 1.51 16.60 24.17 0.82 19.23 24.79 6.36 30.57 15.08 5.68 32.41 13.09 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 1 hits 1a05_c01 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 375 ARG.? 36.99 C1 EDO B 603 265 HIS A 381 HIS.? 27.31 O1 EDO B 603 274 TYR A 354 TYR^? 20.91 C1 EDO B 603 coo -15.18 55.46 8.55 -14.82 52.98 10.38 34.50 3.88 12.57 36.52 3.36 14.83 coo -14.48 45.59 11.18 -14.02 47.49 10.42 25.64 1.98 6.69 25.07 4.00 6.65 coo 0.94 52.26 9.16 1.95 54.78 9.91 27.10 16.84 11.56 24.90 18.34 12.50 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG B 368 ARG.? 11.04 O2 EDO B 603 265 HIS B 381 HIS.? 15.29 C2 EDO B 603 274 TYR B 418 TYR^? 11.01 C2 EDO B 603 coo -15.18 55.46 8.55 -14.82 52.98 10.38 11.09 36.07 6.20 8.36 35.36 7.43 coo -14.48 45.59 11.18 -14.02 47.49 10.42 4.86 38.27 11.07 6.17 36.67 11.45 coo 0.94 52.26 9.16 1.95 54.78 9.91 3.01 21.54 9.44 2.74 20.74 12.09 ULMN 3 1a41_c01 TOPOISOMERASE I user 3 3 # 3 223 ARG C 368 ARG.? 10.85 O2 EDO C 602 265 HIS C 381 HIS~? 16.26 O2 EDO C 602 274 TYR C 418 TYR^? 10.50 O1 GOL D 601 coo -15.18 55.46 8.55 -14.82 52.98 10.38 24.45 26.16 -32.00 21.85 25.58 -30.53 coo -14.48 45.59 11.18 -14.02 47.49 10.42 19.26 30.57 -26.59 20.09 28.69 -27.02 coo 0.94 52.26 9.16 1.95 54.78 9.91 15.25 12.39 -28.72 15.00 11.49 -26.08 ULMN 3 1a41_c01 TOPOISOMERASE I user 4 3 # 4 223 ARG C 375 ARG.? 20.99 O2 EDO C 602 265 HIS C 381 HIS~? 16.26 O2 EDO C 602 274 TYR C 354 TYR^? 14.37 C1 EDO C 602 coo -15.18 55.46 8.55 -14.82 52.98 10.38 27.90 36.71 -28.33 26.60 36.43 -31.10 coo -14.48 45.59 11.18 -14.02 47.49 10.42 19.26 30.57 -26.59 20.09 28.69 -27.02 coo 0.94 52.26 9.16 1.95 54.78 9.91 32.76 22.10 -29.37 32.74 19.75 -30.93 ULMN 3 1a41_c01 TOPOISOMERASE I user 5 3 # 5 223 ARG D 375 ARG.? 23.45 O3 GOL D 601 265 HIS D 381 HIS.? 16.49 O3 GOL D 601 274 TYR D 354 TYR^? 14.76 C3 GOL D 601 coo -15.18 55.46 8.55 -14.82 52.98 10.38 45.57 -7.61 -30.32 45.87 -9.61 -28.01 coo -14.48 45.59 11.18 -14.02 47.49 10.42 36.03 -8.97 -35.15 35.55 -7.12 -34.29 coo 0.94 52.26 9.16 1.95 54.78 9.91 38.74 5.77 -29.00 36.83 7.38 -27.74 1a41_c01 source 1a41 TOPOISOMERASE I : 5 hits 1a41_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 436 GLU^? 20.55 O1 EDO B 603 A 60 ASP A 440 ASP^? 18.54 C1 EDO B 603 A 175 TYR A 437 TYR^? 11.45 C1 EDO B 603 coo 46.10 28.27 19.27 45.48 26.99 20.84 19.93 9.98 5.88 20.55 8.03 6.42 coo 56.42 28.06 12.93 55.01 27.92 14.50 8.21 11.09 12.88 6.30 10.30 13.36 coo 45.02 22.04 15.38 46.16 24.00 13.76 16.79 15.50 5.48 15.91 16.43 3.01 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU B 436 GLU^? 10.42 C2 EDO B 603 A 60 ASP B 440 ASP^? 5.62 O1 EDO B 603 A 175 TYR B 437 TYR^? 10.72 C1 EDO B 603 coo 46.10 28.27 19.27 45.48 26.99 20.84 8.55 30.19 11.17 7.66 31.90 10.29 coo 56.42 28.06 12.93 55.01 27.92 14.50 5.66 21.79 0.79 4.10 21.14 -0.54 coo 45.02 22.04 15.38 46.16 24.00 13.76 10.92 24.41 11.32 10.27 22.67 13.43 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 3 3 # 3 A 49 GLU C 436 GLU^? 10.62 C2 EDO C 602 A 60 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 175 TYR C 437 TYR^? 9.81 O1 GOL D 601 coo 46.10 28.27 19.27 45.48 26.99 20.84 21.74 20.63 -27.21 21.00 22.48 -27.90 coo 56.42 28.06 12.93 55.01 27.92 14.50 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 45.02 22.04 15.38 46.16 24.00 13.76 23.51 14.66 -27.39 22.94 13.02 -25.21 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 4 3 # 4 A 49 GLU C 436 GLU^? 10.62 C2 EDO C 602 A 60 ASP C 440 ASP^? 5.97 O1 EDO C 602 A 175 TYR C 437 TYR^? 9.81 O1 GOL D 601 coo 46.10 28.27 19.27 45.48 26.99 20.84 21.74 20.63 -27.21 21.00 22.48 -27.90 coo 56.42 28.06 12.93 55.01 27.92 14.50 17.33 13.03 -37.56 15.74 12.38 -38.82 coo 45.02 22.04 15.38 46.16 24.00 13.76 23.51 14.66 -27.39 22.94 13.02 -25.21 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 5 3 # 5 A 49 GLU D 436 GLU^? 11.06 C3 GOL D 601 A 60 ASP D 440 ASP^? -5.34 O2 GOL D 601s A 175 TYR D 437 TYR^? 9.97 C1 GOL D 601 coo 46.10 28.27 19.27 45.48 26.99 20.84 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 56.42 28.06 12.93 55.01 27.92 14.50 19.76 1.27 -26.39 17.89 0.46 -25.75 coo 45.02 22.04 15.38 46.16 24.00 13.76 27.83 5.60 -34.20 26.72 6.80 -36.49 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 5 hits 1a50_c03 naa= 3 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 1 3 # 1 A 115 TYR B 421 TYR^? 13.58 C2 EDO B 603 A 125 HIS B 381 HIS.? 15.29 C2 EDO B 603 A 156 LYS B 388 LYS~? 19.48 C2 EDO B 603 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 6.36 30.57 15.08 5.68 32.41 13.09 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 4.86 38.27 11.07 6.17 36.67 11.45 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -0.92 37.13 17.34 -4.46 33.66 14.61 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 2 3 # 2 A 115 TYR B 421 TYR^? 13.58 C2 EDO B 603 A 125 HIS B 381 HIS.? 15.29 C2 EDO B 603 A 156 LYS B 390 LYS~? 27.12 C2 EDO B 603 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 6.36 30.57 15.08 5.68 32.41 13.09 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 4.86 38.27 11.07 6.17 36.67 11.45 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 3.52 38.72 20.17 3.15 45.06 20.21 1a79_c00 source 1a79 TRNA ENDONUCLEASE : 2 hits 1a79_c00 naa= 3 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 1 3 # 1 B 115 TYR A 437 TYR^? 11.45 C1 EDO B 603 B 125 HIS B 338 HIS.? 13.66 O1 EDO B 603 B 156 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 16.79 15.50 5.48 15.91 16.43 3.01 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 2 3 # 2 B 115 TYR B 421 TYR^? 13.58 C2 EDO B 603 B 125 HIS B 381 HIS.? 15.29 C2 EDO B 603 B 156 LYS B 388 LYS~? 19.48 C2 EDO B 603 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 6.36 30.57 15.08 5.68 32.41 13.09 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 4.86 38.27 11.07 6.17 36.67 11.45 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -0.92 37.13 17.34 -4.46 33.66 14.61 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 3 3 # 3 B 115 TYR B 421 TYR^? 13.58 C2 EDO B 603 B 125 HIS B 381 HIS.? 15.29 C2 EDO B 603 B 156 LYS B 390 LYS~? 27.12 C2 EDO B 603 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 6.36 30.57 15.08 5.68 32.41 13.09 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 4.86 38.27 11.07 6.17 36.67 11.45 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 3.52 38.72 20.17 3.15 45.06 20.21 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 4 3 # 4 B 115 TYR B 421 TYR^? 13.58 C2 EDO B 603 B 125 HIS B 381 HIS.? 15.29 C2 EDO B 603 B 156 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 6.36 30.57 15.08 5.68 32.41 13.09 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 4.86 38.27 11.07 6.17 36.67 11.45 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 5 3 # 5 B 115 TYR B 437 TYR^? 10.72 C1 EDO B 603 B 125 HIS A 338 HIS~? 19.64 C1 EDO B 603 B 156 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 10.92 24.41 11.32 10.27 22.67 13.43 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 16.13 23.68 19.02 16.84 23.99 20.97 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 6 3 # 6 B 115 TYR C 437 TYR^? 9.81 O1 GOL D 601 B 125 HIS D 338 HIS~? 13.70 C1 GOL D 601 B 156 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 23.51 14.66 -27.39 22.94 13.02 -25.21 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 7 3 # 7 B 115 TYR D 437 TYR^? 9.97 C1 GOL D 601 B 125 HIS C 338 HIS~? 12.91 O1 EDO C 602 B 156 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 27.83 5.60 -34.20 26.72 6.80 -36.49 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 27.51 4.47 -43.69 23.30 8.13 -41.81 1a79_c01 source 1a79 TRNA ENDONUCLEASE : 7 hits 1a79_c01 naa= 3 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 1 3 # 1 C 115 TYR B 421 TYR^? 13.58 C2 EDO B 603 C 125 HIS B 381 HIS.? 15.29 C2 EDO B 603 C 156 LYS B 388 LYS~? 19.48 C2 EDO B 603 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 6.36 30.57 15.08 5.68 32.41 13.09 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 4.86 38.27 11.07 6.17 36.67 11.45 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -0.92 37.13 17.34 -4.46 33.66 14.61 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 2 3 # 2 C 115 TYR B 421 TYR^? 13.58 C2 EDO B 603 C 125 HIS B 381 HIS.? 15.29 C2 EDO B 603 C 156 LYS B 390 LYS~? 27.12 C2 EDO B 603 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 6.36 30.57 15.08 5.68 32.41 13.09 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 4.86 38.27 11.07 6.17 36.67 11.45 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 3.52 38.72 20.17 3.15 45.06 20.21 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 3 3 # 3 C 115 TYR C 421 TYR^? 13.35 C2 EDO C 602 C 125 HIS C 381 HIS~? 16.26 O2 EDO C 602 C 156 LYS C 388 LYS~? 20.15 C2 EDO C 602 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 19.38 20.76 -23.26 18.18 22.24 -25.31 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 19.26 30.57 -26.59 20.09 28.69 -27.02 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 13.46 28.58 -20.25 9.42 25.73 -22.18 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 4 3 # 4 C 115 TYR C 421 TYR^? 13.35 C2 EDO C 602 C 125 HIS C 381 HIS~? 16.26 O2 EDO C 602 C 156 LYS C 390 LYS~? 21.48 O2 EDO B 603 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 19.38 20.76 -23.26 18.18 22.24 -25.31 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 19.26 30.57 -26.59 20.09 28.69 -27.02 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 17.95 29.37 -17.21 18.11 35.53 -15.65 1a79_c02 source 1a79 TRNA ENDONUCLEASE : 4 hits 1a79_c02 naa= 3 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 1 3 # 1 D 115 TYR A 437 TYR^? 11.45 C1 EDO B 603 D 125 HIS B 338 HIS.? 13.66 O1 EDO B 603 D 156 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 54.10 1.42 85.16 54.14 4.17 85.62 16.79 15.50 5.48 15.91 16.43 3.01 coo 61.27 5.43 85.32 62.73 6.38 86.49 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 60.28 4.62 76.00 58.35 6.41 80.65 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 2 3 # 2 D 115 TYR B 421 TYR^? 13.58 C2 EDO B 603 D 125 HIS B 381 HIS.? 15.29 C2 EDO B 603 D 156 LYS B 388 LYS~? 19.48 C2 EDO B 603 coo 54.10 1.42 85.16 54.14 4.17 85.62 6.36 30.57 15.08 5.68 32.41 13.09 coo 61.27 5.43 85.32 62.73 6.38 86.49 4.86 38.27 11.07 6.17 36.67 11.45 coo 60.28 4.62 76.00 58.35 6.41 80.65 -0.92 37.13 17.34 -4.46 33.66 14.61 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 3 3 # 3 D 115 TYR B 421 TYR^? 13.58 C2 EDO B 603 D 125 HIS B 381 HIS.? 15.29 C2 EDO B 603 D 156 LYS B 390 LYS~? 27.12 C2 EDO B 603 coo 54.10 1.42 85.16 54.14 4.17 85.62 6.36 30.57 15.08 5.68 32.41 13.09 coo 61.27 5.43 85.32 62.73 6.38 86.49 4.86 38.27 11.07 6.17 36.67 11.45 coo 60.28 4.62 76.00 58.35 6.41 80.65 3.52 38.72 20.17 3.15 45.06 20.21 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 4 3 # 4 D 115 TYR B 437 TYR^? 10.72 C1 EDO B 603 D 125 HIS A 338 HIS~? 19.64 C1 EDO B 603 D 156 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo 54.10 1.42 85.16 54.14 4.17 85.62 10.92 24.41 11.32 10.27 22.67 13.43 coo 61.27 5.43 85.32 62.73 6.38 86.49 16.13 23.68 19.02 16.84 23.99 20.97 coo 60.28 4.62 76.00 58.35 6.41 80.65 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 5 3 # 5 D 115 TYR C 437 TYR^? 9.81 O1 GOL D 601 D 125 HIS D 338 HIS~? 13.70 C1 GOL D 601 D 156 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 54.10 1.42 85.16 54.14 4.17 85.62 23.51 14.66 -27.39 22.94 13.02 -25.21 coo 61.27 5.43 85.32 62.73 6.38 86.49 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 60.28 4.62 76.00 58.35 6.41 80.65 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 6 3 # 6 D 115 TYR D 437 TYR^? 9.97 C1 GOL D 601 D 125 HIS C 338 HIS~? 12.91 O1 EDO C 602 D 156 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 54.10 1.42 85.16 54.14 4.17 85.62 27.83 5.60 -34.20 26.72 6.80 -36.49 coo 61.27 5.43 85.32 62.73 6.38 86.49 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 60.28 4.62 76.00 58.35 6.41 80.65 27.51 4.47 -43.69 23.30 8.13 -41.81 1a79_c03 source 1a79 TRNA ENDONUCLEASE : 6 hits 1a79_c03 naa= 3 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 1 3 # 1 142 TRP A 407 TRP^? 17.84 O1 EDO B 603 223 ASP B 448 ASP.? 21.29 O1 EDO B 603 258 LYS A 442 LYS~? 23.27 C1 EDO B 603 coo 127.19 33.46 26.14 126.78 36.79 28.15 6.49 5.24 2.04 7.76 7.03 -1.22 coo 126.95 41.66 23.38 128.48 40.72 24.51 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo 138.83 37.95 25.17 133.50 36.37 26.52 2.76 10.16 11.03 0.96 5.43 12.32 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 2 3 # 2 142 TRP A 407 TRP^? 17.84 O1 EDO B 603 223 ASP B 448 ASP.? 21.29 O1 EDO B 603 258 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 127.19 33.46 26.14 126.78 36.79 28.15 6.49 5.24 2.04 7.76 7.03 -1.22 coo 126.95 41.66 23.38 128.48 40.72 24.51 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo 138.83 37.95 25.17 133.50 36.37 26.52 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 3 3 # 3 142 TRP B 407 TRP^? 14.83 C2 EDO B 603 223 ASP A 448 ASP~? 19.70 O1 EDO B 603 258 LYS A 442 LYS~? 23.27 C1 EDO B 603 coo 127.19 33.46 26.14 126.78 36.79 28.15 -3.73 22.30 9.20 -2.79 21.98 13.01 coo 126.95 41.66 23.38 128.48 40.72 24.51 -6.12 13.55 5.97 -7.03 12.86 4.20 coo 138.83 37.95 25.17 133.50 36.37 26.52 2.76 10.16 11.03 0.96 5.43 12.32 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 4 3 # 4 142 TRP C 407 TRP^? 15.00 C2 EDO C 602 223 ASP D 448 ASP.? 19.66 C2 EDO C 602 258 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 127.19 33.46 26.14 126.78 36.79 28.15 8.62 13.87 -28.54 9.69 13.09 -24.84 coo 126.95 41.66 23.38 128.48 40.72 24.51 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 138.83 37.95 25.17 133.50 36.37 26.52 12.96 9.36 -37.91 9.04 10.02 -41.38 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 5 3 # 5 142 TRP C 407 TRP^? 15.00 C2 EDO C 602 223 ASP D 448 ASP.? 19.66 C2 EDO C 602 258 LYS D 442 LYS~? 12.65 O2 GOL D 601 coo 127.19 33.46 26.14 126.78 36.79 28.15 8.62 13.87 -28.54 9.69 13.09 -24.84 coo 126.95 41.66 23.38 128.48 40.72 24.51 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 138.83 37.95 25.17 133.50 36.37 26.52 14.14 0.83 -27.84 11.41 -3.18 -25.91 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 6 3 # 6 142 TRP D 407 TRP^? 14.97 C3 GOL D 601 223 ASP C 448 ASP.? 19.32 O1 GOL D 601 258 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 127.19 33.46 26.14 126.78 36.79 28.15 16.64 -3.51 -37.62 17.68 -1.39 -40.78 coo 126.95 41.66 23.38 128.48 40.72 24.51 9.52 -2.93 -40.85 10.47 -4.20 -39.42 coo 138.83 37.95 25.17 133.50 36.37 26.52 12.96 9.36 -37.91 9.04 10.02 -41.38 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 7 3 # 7 142 TRP D 407 TRP^? 14.97 C3 GOL D 601 223 ASP C 448 ASP.? 19.32 O1 GOL D 601 258 LYS D 442 LYS~? 12.65 O2 GOL D 601 coo 127.19 33.46 26.14 126.78 36.79 28.15 16.64 -3.51 -37.62 17.68 -1.39 -40.78 coo 126.95 41.66 23.38 128.48 40.72 24.51 9.52 -2.93 -40.85 10.47 -4.20 -39.42 coo 138.83 37.95 25.17 133.50 36.37 26.52 14.14 0.83 -27.84 11.41 -3.18 -25.91 1aam_c01 source 1aam ASPARTATE AMINOTRANSFERASE : 7 hits 1aam_c01 naa= 3 ULMN 3 1ab4_c00 GYRASE A user 1 3 # 1 32 ARG A 425 ARG^? 21.19 O1 EDO B 603 78 HIS B 338 HIS.? 13.66 O1 EDO B 603 122 TYR B 418 TYR^? 11.01 C2 EDO B 603 coo 48.32 72.26 30.89 48.69 69.28 31.53 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 53.63 68.24 34.99 53.08 69.10 33.16 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 75.01 61.87 32.93 75.34 59.26 31.96 3.01 21.54 9.44 2.74 20.74 12.09 ULMN 3 1ab4_c00 GYRASE A user 2 3 # 2 32 ARG B 425 ARG^? 24.19 C2 EDO B 603 78 HIS A 338 HIS~? 19.64 C1 EDO B 603 122 TYR A 418 TYR^? 12.62 O1 EDO B 603 coo 48.32 72.26 30.89 48.69 69.28 31.53 13.19 26.25 26.41 10.66 27.96 25.98 coo 53.63 68.24 34.99 53.08 69.10 33.16 16.13 23.68 19.02 16.84 23.99 20.97 coo 75.01 61.87 32.93 75.34 59.26 31.96 9.59 11.03 3.92 9.74 11.89 1.25 ULMN 3 1ab4_c00 GYRASE A user 3 3 # 3 32 ARG C 425 ARG^? 21.48 O1 GOL D 601 78 HIS D 338 HIS~? 13.70 C1 GOL D 601 122 TYR D 418 TYR^? 10.77 C1 GOL D 601 coo 48.32 72.26 30.89 48.69 69.28 31.53 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 53.63 68.24 34.99 53.08 69.10 33.16 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 75.01 61.87 32.93 75.34 59.26 31.96 20.16 1.85 -35.57 20.10 2.87 -38.19 ULMN 3 1ab4_c00 GYRASE A user 4 3 # 4 32 ARG D 425 ARG^? 16.89 O1 EDO C 602 78 HIS C 338 HIS~? 12.91 O1 EDO C 602 122 TYR C 418 TYR^? 10.50 O1 GOL D 601 coo 48.32 72.26 30.89 48.69 69.28 31.53 35.18 9.71 -47.18 32.90 7.74 -47.72 coo 53.63 68.24 34.99 53.08 69.10 33.16 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 75.01 61.87 32.93 75.34 59.26 31.96 15.25 12.39 -28.72 15.00 11.49 -26.08 1ab4_c00 source 1ab4 GYRASE A : 4 hits 1ab4_c00 naa= 3 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 1 3 # 1 22 ASN A 398 ASN~? 16.47 O2 GOL D 601 63 ARG A 397 ARG~? 24.94 O2 GOL D 601 255 ARG A 425 ARG^? 21.19 O1 EDO B 603 coo 42.10 13.02 11.14 41.85 11.12 10.23 26.81 10.21 -11.17 28.62 9.13 -11.03 coo 44.36 11.24 3.39 41.81 12.78 4.00 31.00 11.06 -6.51 32.72 12.02 -4.11 coo 38.40 3.83 10.26 40.02 6.30 9.25 25.04 18.93 -7.11 26.86 16.62 -8.01 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 2 3 # 2 22 ASN A 398 ASN~? 16.47 O2 GOL D 601 63 ARG A 401 ARG.? 15.99 O2 GOL D 601 255 ARG A 425 ARG^? 21.19 O1 EDO B 603 coo 42.10 13.02 11.14 41.85 11.12 10.23 26.81 10.21 -11.17 28.62 9.13 -11.03 coo 44.36 11.24 3.39 41.81 12.78 4.00 17.05 9.37 -8.73 16.66 7.27 -10.98 coo 38.40 3.83 10.26 40.02 6.30 9.25 25.04 18.93 -7.11 26.86 16.62 -8.01 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 3 3 # 3 22 ASN A 398 ASN~? 16.47 O2 GOL D 601 63 ARG A 425 ARG^? 21.19 O1 EDO B 603 255 ARG A 401 ARG.? 15.99 O2 GOL D 601 coo 42.10 13.02 11.14 41.85 11.12 10.23 26.81 10.21 -11.17 28.62 9.13 -11.03 coo 44.36 11.24 3.39 41.81 12.78 4.00 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 38.40 3.83 10.26 40.02 6.30 9.25 17.05 9.37 -8.73 16.66 7.27 -10.98 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 4 3 # 4 22 ASN B 398 ASN~? 28.43 C2 EDO B 603 63 ARG B 397 ARG~? 26.01 C2 EDO B 603 255 ARG B 425 ARG^? 24.19 C2 EDO B 603 coo 42.10 13.02 11.14 41.85 11.12 10.23 6.35 32.55 29.26 6.04 34.62 28.91 coo 44.36 11.24 3.39 41.81 12.78 4.00 10.79 36.41 26.32 12.94 37.68 24.51 coo 38.40 3.83 10.26 40.02 6.30 9.25 13.19 26.25 26.41 10.66 27.96 25.98 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 5 3 # 5 22 ASN B 398 ASN~? 28.43 C2 EDO B 603 63 ARG B 401 ARG.? 20.08 C2 EDO B 603 255 ARG B 425 ARG^? 24.19 C2 EDO B 603 coo 42.10 13.02 11.14 41.85 11.12 10.23 6.35 32.55 29.26 6.04 34.62 28.91 coo 44.36 11.24 3.39 41.81 12.78 4.00 1.75 25.80 23.58 1.16 24.37 20.91 coo 38.40 3.83 10.26 40.02 6.30 9.25 13.19 26.25 26.41 10.66 27.96 25.98 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 6 3 # 6 22 ASN B 398 ASN~? 28.43 C2 EDO B 603 63 ARG B 425 ARG^? 24.19 C2 EDO B 603 255 ARG B 401 ARG.? 20.08 C2 EDO B 603 coo 42.10 13.02 11.14 41.85 11.12 10.23 6.35 32.55 29.26 6.04 34.62 28.91 coo 44.36 11.24 3.39 41.81 12.78 4.00 13.19 26.25 26.41 10.66 27.96 25.98 coo 38.40 3.83 10.26 40.02 6.30 9.25 1.75 25.80 23.58 1.16 24.37 20.91 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 7 3 # 7 22 ASN C 398 ASN~? 15.53 O1 EDO B 603 63 ARG C 397 ARG~? 23.93 O1 EDO B 603 255 ARG C 425 ARG^? 21.48 O1 GOL D 601 coo 42.10 13.02 11.14 41.85 11.12 10.23 21.01 22.53 -8.94 21.24 24.62 -8.84 coo 44.36 11.24 3.39 41.81 12.78 4.00 25.49 26.02 -11.91 27.94 26.82 -13.64 coo 38.40 3.83 10.26 40.02 6.30 9.25 27.32 15.93 -12.34 26.51 18.69 -11.26 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 8 3 # 8 22 ASN C 398 ASN~? 15.53 O1 EDO B 603 63 ARG C 425 ARG^? 21.48 O1 GOL D 601 255 ARG C 401 ARG.? 15.33 O1 EDO B 603 coo 42.10 13.02 11.14 41.85 11.12 10.23 21.01 22.53 -8.94 21.24 24.62 -8.84 coo 44.36 11.24 3.39 41.81 12.78 4.00 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 38.40 3.83 10.26 40.02 6.30 9.25 15.13 16.06 -14.86 13.60 17.63 -12.63 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 9 3 # 9 22 ASN D 398 ASN~? 25.80 O1 EDO C 602 63 ARG D 397 ARG~? 26.17 C3 GOL D 601 255 ARG D 425 ARG^? 16.89 O1 EDO C 602 coo 42.10 13.02 11.14 41.85 11.12 10.23 35.65 1.59 -52.48 36.44 -0.37 -52.06 coo 44.36 11.24 3.39 41.81 12.78 4.00 40.54 0.77 -47.66 42.41 1.45 -45.29 coo 38.40 3.83 10.26 40.02 6.30 9.25 35.18 9.71 -47.18 32.90 7.74 -47.72 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 10 3 # 10 22 ASN D 398 ASN~? 25.80 O1 EDO C 602 63 ARG D 401 ARG.? 17.46 O1 EDO C 602 255 ARG D 425 ARG^? 16.89 O1 EDO C 602 coo 42.10 13.02 11.14 41.85 11.12 10.23 35.65 1.59 -52.48 36.44 -0.37 -52.06 coo 44.36 11.24 3.39 41.81 12.78 4.00 26.50 1.94 -49.52 24.85 0.58 -47.31 coo 38.40 3.83 10.26 40.02 6.30 9.25 35.18 9.71 -47.18 32.90 7.74 -47.72 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 11 3 # 11 22 ASN D 398 ASN~? 25.80 O1 EDO C 602 63 ARG D 425 ARG^? 16.89 O1 EDO C 602 255 ARG D 401 ARG.? 17.46 O1 EDO C 602 coo 42.10 13.02 11.14 41.85 11.12 10.23 35.65 1.59 -52.48 36.44 -0.37 -52.06 coo 44.36 11.24 3.39 41.81 12.78 4.00 35.18 9.71 -47.18 32.90 7.74 -47.72 coo 38.40 3.83 10.26 40.02 6.30 9.25 26.50 1.94 -49.52 24.85 0.58 -47.31 1aj0_c00 source 1aj0 DIHYDROPTEROATE SYNTHASE : 11 hits 1aj0_c00 naa= 3 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 1 3 # 1 252 THR A 369 THR~? 31.64 C1 EDO B 603 350 PHE A 352 PHE^? 25.89 C1 EDO B 603 357 CYH A 380 CYH~? 29.74 C1 EDO B 603 coo 17.85 20.47 14.62 16.85 19.84 12.80 27.07 6.63 18.00 27.23 4.49 18.30 coo 7.92 21.96 13.27 8.57 20.30 15.42 29.09 9.19 9.94 27.10 9.67 11.86 coo 8.82 20.77 7.90 10.59 19.75 9.80 29.01 2.63 9.50 30.23 5.08 9.65 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 2 3 # 2 252 THR C 369 THR~? 15.84 O2 EDO C 602 350 PHE C 352 PHE^? 15.48 O2 EDO C 602 357 CYH C 380 CYH~? 18.52 O2 EDO C 602 coo 17.85 20.47 14.62 16.85 19.84 12.80 27.27 30.44 -36.03 26.03 32.19 -36.25 coo 7.92 21.96 13.27 8.57 20.30 15.42 27.97 28.62 -27.76 27.73 27.28 -30.22 coo 8.82 20.77 7.90 10.59 19.75 9.80 22.88 33.08 -27.72 25.47 32.05 -27.37 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 3 3 # 3 252 THR D 369 THR~? 16.21 O3 GOL D 601 350 PHE D 352 PHE^? 15.53 O3 GOL D 601 357 CYH D 380 CYH~? 19.05 O3 GOL D 601 coo 17.85 20.47 14.62 16.85 19.84 12.80 38.48 -5.77 -24.43 38.79 -7.85 -25.06 coo 7.92 21.96 13.27 8.57 20.30 15.42 40.13 -1.84 -31.50 38.47 -1.47 -29.25 coo 8.82 20.77 7.90 10.59 19.75 9.80 39.90 -9.16 -33.04 41.11 -6.65 -32.46 1akd_c01 source 1akd CYTOCHROME P450CAM : 3 hits 1akd_c01 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 350 ASP.? 26.92 O2 GOL D 601 187 GLU A 394 GLU~? 15.90 O2 GOL D 601 229 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo -52.57 56.60 47.75 -51.52 54.87 46.95 33.51 7.96 1.59 32.78 7.85 -0.37 coo -45.08 48.37 46.81 -46.53 49.74 45.96 27.33 5.77 -8.72 27.90 4.03 -9.75 coo -47.40 44.36 48.48 -50.80 49.18 46.20 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP A 402 ASP.? 12.59 O1 EDO B 603 187 GLU C 394 GLU~? 16.86 O1 EDO B 603 229 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo -52.57 56.60 47.75 -51.52 54.87 46.95 18.87 16.83 -6.49 16.77 17.04 -6.49 coo -45.08 48.37 46.81 -46.53 49.74 45.96 19.77 27.90 -12.93 18.57 29.44 -12.10 coo -47.40 44.36 48.48 -50.80 49.18 46.20 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP B 350 ASP.? 23.89 C2 EDO B 603 187 GLU B 394 GLU~? 28.21 C2 EDO B 603 229 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo -52.57 56.60 47.75 -51.52 54.87 46.95 12.16 40.72 19.41 11.14 39.74 20.98 coo -45.08 48.37 46.81 -46.53 49.74 45.96 4.47 36.77 26.38 2.63 37.63 26.96 coo -47.40 44.36 48.48 -50.80 49.18 46.20 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 4 3 # 4 33 ASP C 349 ASP.? 28.09 C1 EDO C 602 187 GLU C 378 GLU~? 24.96 O2 EDO B 603 229 LYS C 390 LYS~? 21.48 O2 EDO B 603 coo -52.57 56.60 47.75 -51.52 54.87 46.95 32.59 30.21 -17.31 34.23 29.55 -16.13 coo -45.08 48.37 46.81 -46.53 49.74 45.96 22.14 33.77 -19.82 21.71 34.90 -18.09 coo -47.40 44.36 48.48 -50.80 49.18 46.20 17.95 29.37 -17.21 18.11 35.53 -15.65 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 5 3 # 5 33 ASP C 350 ASP.? 24.48 C2 EDO C 602 187 GLU C 394 GLU~? 16.86 O1 EDO B 603 229 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo -52.57 56.60 47.75 -51.52 54.87 46.95 27.03 30.18 -18.47 26.26 29.33 -16.72 coo -45.08 48.37 46.81 -46.53 49.74 45.96 19.77 27.90 -12.93 18.57 29.44 -12.10 coo -47.40 44.36 48.48 -50.80 49.18 46.20 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 6 3 # 6 33 ASP C 402 ASP.? 12.78 O1 GOL D 601 187 GLU A 394 GLU~? 15.90 O2 GOL D 601 229 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo -52.57 56.60 47.75 -51.52 54.87 46.95 22.26 13.02 -15.38 21.01 11.37 -15.92 coo -45.08 48.37 46.81 -46.53 49.74 45.96 27.33 5.77 -8.72 27.90 4.03 -9.75 coo -47.40 44.36 48.48 -50.80 49.18 46.20 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 7 3 # 7 33 ASP D 350 ASP.? 24.09 C3 GOL D 601 187 GLU D 394 GLU~? 26.98 C3 GOL D 601 229 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo -52.57 56.60 47.75 -51.52 54.87 46.95 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo -45.08 48.37 46.81 -46.53 49.74 45.96 35.24 -3.52 -50.42 34.05 -5.26 -50.80 coo -47.40 44.36 48.48 -50.80 49.18 46.20 32.90 -6.30 -46.84 30.42 -11.34 -47.14 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 7 hits 1ald_c00 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 315 ASP.? 32.31 C1 EDO B 603 214 ASP A 350 ASP.? 26.92 O2 GOL D 601 289 ASP B 315 ASP.? 32.42 C1 EDO B 603 coo -0.62 65.95 29.97 0.31 67.47 31.05 35.16 33.09 19.50 33.98 34.83 19.67 coo 26.86 59.76 46.36 25.42 58.23 45.92 33.51 7.96 1.59 32.78 7.85 -0.37 coo 9.42 68.07 30.27 7.35 68.27 30.10 37.58 31.51 9.95 39.21 32.46 10.92 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 315 ASP.? 32.31 C1 EDO B 603 214 ASP C 430 ASP.? 26.01 O2 GOL D 601 289 ASP B 315 ASP.? 32.42 C1 EDO B 603 coo -0.62 65.95 29.97 0.31 67.47 31.05 35.16 33.09 19.50 33.98 34.83 19.67 coo 26.86 59.76 46.36 25.42 58.23 45.92 33.23 18.77 -9.92 33.78 18.54 -7.88 coo 9.42 68.07 30.27 7.35 68.27 30.10 37.58 31.51 9.95 39.21 32.46 10.92 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 402 ASP.? 12.59 O1 EDO B 603 214 ASP D 448 ASP.? 19.66 C2 EDO C 602 289 ASP C 402 ASP.? 12.78 O1 GOL D 601 coo -0.62 65.95 29.97 0.31 67.47 31.05 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 26.86 59.76 46.36 25.42 58.23 45.92 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 9.42 68.07 30.27 7.35 68.27 30.10 22.26 13.02 -15.38 21.01 11.37 -15.92 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 426 ASP.? 22.31 O1 EDO B 603 214 ASP B 349 ASP.? 28.06 C2 EDO B 603 289 ASP B 357 ASP.? 13.04 C1 EDO B 603 coo -0.62 65.95 29.97 0.31 67.47 31.05 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 26.86 59.76 46.36 25.42 58.23 45.92 17.36 41.29 21.17 18.85 41.14 22.68 coo 9.42 68.07 30.27 7.35 68.27 30.10 19.95 30.44 0.55 20.02 30.85 -1.53 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP A 426 ASP.? 22.31 O1 EDO B 603 214 ASP B 402 ASP.? 23.46 C2 EDO B 603 289 ASP B 357 ASP.? 13.04 C1 EDO B 603 coo -0.62 65.95 29.97 0.31 67.47 31.05 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 26.86 59.76 46.36 25.42 58.23 45.92 8.17 23.01 23.39 8.93 22.69 25.33 coo 9.42 68.07 30.27 7.35 68.27 30.10 19.95 30.44 0.55 20.02 30.85 -1.53 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP A 426 ASP.? 22.31 O1 EDO B 603 214 ASP B 426 ASP.? 28.68 C1 EDO B 603 289 ASP B 357 ASP.? 13.04 C1 EDO B 603 coo -0.62 65.95 29.97 0.31 67.47 31.05 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 26.86 59.76 46.36 25.42 58.23 45.92 21.11 26.70 26.04 20.61 27.63 27.90 coo 9.42 68.07 30.27 7.35 68.27 30.10 19.95 30.44 0.55 20.02 30.85 -1.53 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP A 430 ASP.? 25.41 O1 EDO B 603 214 ASP C 357 ASP.? 12.50 O2 EDO C 602 289 ASP C 426 ASP.? 22.72 C2 GOL D 601 coo -0.62 65.95 29.97 0.31 67.47 31.05 31.59 21.51 -7.17 32.38 22.31 -9.00 coo 26.86 59.76 46.36 25.42 58.23 45.92 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 9.42 68.07 30.27 7.35 68.27 30.10 35.09 15.28 -13.55 34.97 16.40 -11.75 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP B 426 ASP.? 28.68 C1 EDO B 603 214 ASP A 349 ASP.? 30.68 C1 EDO B 603 289 ASP A 357 ASP.? 25.14 C1 EDO B 603 coo -0.62 65.95 29.97 0.31 67.47 31.05 21.11 26.70 26.04 20.61 27.63 27.90 coo 26.86 59.76 46.36 25.42 58.23 45.92 36.99 12.23 1.79 37.88 13.87 0.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 22.54 16.74 19.72 22.05 16.00 21.61 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP B 426 ASP.? 28.68 C1 EDO B 603 214 ASP A 402 ASP.? 12.59 O1 EDO B 603 289 ASP A 357 ASP.? 25.14 C1 EDO B 603 coo -0.62 65.95 29.97 0.31 67.47 31.05 21.11 26.70 26.04 20.61 27.63 27.90 coo 26.86 59.76 46.36 25.42 58.23 45.92 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 9.42 68.07 30.27 7.35 68.27 30.10 22.54 16.74 19.72 22.05 16.00 21.61 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP B 426 ASP.? 28.68 C1 EDO B 603 214 ASP A 426 ASP.? 22.31 O1 EDO B 603 289 ASP A 357 ASP.? 25.14 C1 EDO B 603 coo -0.62 65.95 29.97 0.31 67.47 31.05 21.11 26.70 26.04 20.61 27.63 27.90 coo 26.86 59.76 46.36 25.42 58.23 45.92 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 9.42 68.07 30.27 7.35 68.27 30.10 22.54 16.74 19.72 22.05 16.00 21.61 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP C 430 ASP.? 26.01 O2 GOL D 601 214 ASP A 315 ASP.? 32.31 C1 EDO B 603 289 ASP A 426 ASP.? 22.31 O1 EDO B 603 coo -0.62 65.95 29.97 0.31 67.47 31.05 33.23 18.77 -9.92 33.78 18.54 -7.88 coo 26.86 59.76 46.36 25.42 58.23 45.92 35.16 33.09 19.50 33.98 34.83 19.67 coo 9.42 68.07 30.27 7.35 68.27 30.10 29.17 24.78 -3.72 30.40 24.16 -5.34 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP C 430 ASP.? 26.01 O2 GOL D 601 214 ASP A 357 ASP.? 25.14 C1 EDO B 603 289 ASP A 426 ASP.? 22.31 O1 EDO B 603 coo -0.62 65.95 29.97 0.31 67.47 31.05 33.23 18.77 -9.92 33.78 18.54 -7.88 coo 26.86 59.76 46.36 25.42 58.23 45.92 22.54 16.74 19.72 22.05 16.00 21.61 coo 9.42 68.07 30.27 7.35 68.27 30.10 29.17 24.78 -3.72 30.40 24.16 -5.34 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP D 315 ASP.? 31.69 C1 GOL D 601 214 ASP D 350 ASP.? 24.09 C3 GOL D 601 289 ASP C 315 ASP.? 32.88 C1 EDO C 602 coo -0.62 65.95 29.97 0.31 67.47 31.05 48.83 21.16 -21.57 48.15 21.79 -19.66 coo 26.86 59.76 46.36 25.42 58.23 45.92 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 51.14 17.66 -30.05 53.19 17.33 -29.52 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP D 426 ASP.? 21.84 O1 EDO C 602 214 ASP C 349 ASP.? 28.09 C1 EDO C 602 289 ASP C 357 ASP.? 12.50 O2 EDO C 602 coo -0.62 65.95 29.97 0.31 67.47 31.05 40.54 14.64 -43.98 41.47 13.99 -45.77 coo 26.86 59.76 46.36 25.42 58.23 45.92 32.59 30.21 -17.31 34.23 29.55 -16.13 coo 9.42 68.07 30.27 7.35 68.27 30.10 32.02 20.63 -38.57 31.77 21.72 -40.39 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 15 3 # 15 179 ASP D 426 ASP.? 21.84 O1 EDO C 602 214 ASP C 402 ASP.? 12.78 O1 GOL D 601 289 ASP C 357 ASP.? 12.50 O2 EDO C 602 coo -0.62 65.95 29.97 0.31 67.47 31.05 40.54 14.64 -43.98 41.47 13.99 -45.77 coo 26.86 59.76 46.36 25.42 58.23 45.92 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 9.42 68.07 30.27 7.35 68.27 30.10 32.02 20.63 -38.57 31.77 21.72 -40.39 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 16 3 # 16 179 ASP D 426 ASP.? 21.84 O1 EDO C 602 214 ASP C 426 ASP.? 22.72 C2 GOL D 601 289 ASP C 357 ASP.? 12.50 O2 EDO C 602 coo -0.62 65.95 29.97 0.31 67.47 31.05 40.54 14.64 -43.98 41.47 13.99 -45.77 coo 26.86 59.76 46.36 25.42 58.23 45.92 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 9.42 68.07 30.27 7.35 68.27 30.10 32.02 20.63 -38.57 31.77 21.72 -40.39 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 16 hits 1amy_c01 naa= 3 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 1 3 # 1 232 HIS B 338 HIS.? 13.66 O1 EDO B 603 254 LYS A 403 LYS^? 8.85 O1 EDO B 603 333 ARG C 425 ARG^? 21.48 O1 GOL D 601 coo 28.11 -1.15 8.51 29.21 0.63 8.34 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 26.09 4.87 14.60 27.89 3.33 10.26 17.56 13.24 -3.73 14.59 17.27 -0.83 coo 37.35 7.47 11.84 34.90 6.11 10.60 27.32 15.93 -12.34 26.51 18.69 -11.26 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 2 3 # 2 232 HIS B 381 HIS.? 15.29 C2 EDO B 603 254 LYS B 367 LYS.? 8.96 O2 EDO B 603 333 ARG B 375 ARG.? 22.49 O2 EDO B 603 coo 28.11 -1.15 8.51 29.21 0.63 8.34 4.86 38.27 11.07 6.17 36.67 11.45 coo 26.09 4.87 14.60 27.89 3.33 10.26 8.46 36.63 1.57 6.31 34.95 -1.21 coo 37.35 7.47 11.84 34.90 6.11 10.60 13.81 46.43 8.85 13.44 47.64 6.03 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 3 3 # 3 232 HIS D 338 HIS~? 13.70 C1 GOL D 601 254 LYS C 403 LYS^? 9.83 O1 GOL D 601 333 ARG A 425 ARG^? 21.19 O1 EDO B 603 coo 28.11 -1.15 8.51 29.21 0.63 8.34 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 26.09 4.87 14.60 27.89 3.33 10.26 19.56 15.05 -18.65 18.30 10.78 -20.22 coo 37.35 7.47 11.84 34.90 6.11 10.60 25.04 18.93 -7.11 26.86 16.62 -8.01 1aq2_c00 source 1aq2 PHOSPHOENOLPYRUVATE CARBOXYKINASE : 3 hits 1aq2_c00 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER B 410 SER^? 8.36 O2 EDO B 603 A 292 ASP B 448 ASP.? 21.29 O1 EDO B 603 A 322 HIS B 381 HIS.? 15.29 C2 EDO B 603 coo 36.34 32.23 39.60 36.43 34.62 39.93 -1.48 27.73 -0.43 0.38 29.00 -1.36 coo 19.73 19.18 41.39 21.50 18.65 40.34 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo 41.69 45.14 46.60 41.78 47.19 46.18 4.86 38.27 11.07 6.17 36.67 11.45 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 1 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER B 410 SER^? 8.36 O2 EDO B 603 B 292 ASP B 448 ASP.? 21.29 O1 EDO B 603 B 322 HIS B 381 HIS.? 15.29 C2 EDO B 603 coo 35.42 71.28 22.94 36.24 69.06 22.37 -1.48 27.73 -0.43 0.38 29.00 -1.36 coo 24.74 78.07 5.59 24.32 79.03 7.46 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo 48.81 64.16 26.34 49.30 62.16 26.73 4.86 38.27 11.07 6.17 36.67 11.45 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 1 hits 1aql_c03 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 375 ARG.? 36.99 C1 EDO B 603 B 342 ASP A 350 ASP.? 26.92 O2 GOL D 601 B 531 ARG A 368 ARG.? 24.16 C1 EDO B 603 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 34.50 3.88 12.57 36.52 3.36 14.83 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 33.51 7.96 1.59 32.78 7.85 -0.37 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 23.91 7.22 12.24 22.49 6.03 9.76 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG A 397 ARG~? 24.94 O2 GOL D 601 B 342 ASP A 349 ASP.? 30.68 C1 EDO B 603 B 531 ARG A 425 ARG^? 21.19 O1 EDO B 603 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 31.00 11.06 -6.51 32.72 12.02 -4.11 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 36.99 12.23 1.79 37.88 13.87 0.83 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 25.04 18.93 -7.11 26.86 16.62 -8.01 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 B 325 ARG B 375 ARG.? 22.49 O2 EDO B 603 B 342 ASP B 350 ASP.? 23.89 C2 EDO B 603 B 531 ARG B 368 ARG.? 11.04 O2 EDO B 603 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 13.81 46.43 8.85 13.44 47.64 6.03 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 12.16 40.72 19.41 11.14 39.74 20.98 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 11.09 36.07 6.20 8.36 35.36 7.43 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 B 325 ARG C 375 ARG.? 20.99 O2 EDO C 602 B 342 ASP C 350 ASP.? 24.48 C2 EDO C 602 B 531 ARG C 368 ARG.? 10.85 O2 EDO C 602 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 27.90 36.71 -28.33 26.60 36.43 -31.10 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 24.45 26.16 -32.00 21.85 25.58 -30.53 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 B 325 ARG C 397 ARG~? 23.93 O1 EDO B 603 B 342 ASP C 349 ASP.? 28.09 C1 EDO C 602 B 531 ARG C 425 ARG^? 21.48 O1 GOL D 601 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 25.49 26.02 -11.91 27.94 26.82 -13.64 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 32.59 30.21 -17.31 34.23 29.55 -16.13 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 27.32 15.93 -12.34 26.51 18.69 -11.26 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 B 325 ARG D 375 ARG.? 23.45 O3 GOL D 601 B 342 ASP D 350 ASP.? 24.09 C3 GOL D 601 B 531 ARG D 368 ARG.? 11.23 O3 GOL D 601 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 45.57 -7.61 -30.32 45.87 -9.61 -28.01 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 34.63 -3.42 -28.94 33.31 -3.73 -31.69 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 6 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG A 375 ARG.? 36.99 C1 EDO B 603 A 342 ASP A 350 ASP.? 26.92 O2 GOL D 601 A 531 ARG A 368 ARG.? 24.16 C1 EDO B 603 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 34.50 3.88 12.57 36.52 3.36 14.83 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 33.51 7.96 1.59 32.78 7.85 -0.37 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 23.91 7.22 12.24 22.49 6.03 9.76 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 A 325 ARG B 375 ARG.? 22.49 O2 EDO B 603 A 342 ASP B 350 ASP.? 23.89 C2 EDO B 603 A 531 ARG B 368 ARG.? 11.04 O2 EDO B 603 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 13.81 46.43 8.85 13.44 47.64 6.03 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 12.16 40.72 19.41 11.14 39.74 20.98 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 11.09 36.07 6.20 8.36 35.36 7.43 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 A 325 ARG C 375 ARG.? 20.99 O2 EDO C 602 A 342 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 531 ARG C 368 ARG.? 10.85 O2 EDO C 602 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 27.90 36.71 -28.33 26.60 36.43 -31.10 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 24.45 26.16 -32.00 21.85 25.58 -30.53 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 A 325 ARG D 375 ARG.? 23.45 O3 GOL D 601 A 342 ASP D 350 ASP.? 24.09 C3 GOL D 601 A 531 ARG D 368 ARG.? 11.23 O3 GOL D 601 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 45.57 -7.61 -30.32 45.87 -9.61 -28.01 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 34.63 -3.42 -28.94 33.31 -3.73 -31.69 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 4 hits 1asy_c01 naa= 3 ULMN 3 1avf_c04 GASTRICSIN user 1 3 # 1 A 32 ASP B 315 ASP.? 32.42 C1 EDO B 603 A 35 SER A 313 SER.? 36.10 C1 EDO B 603 A 217 ASP A 315 ASP.? 32.31 C1 EDO B 603 coo -10.06 2.54 49.69 -8.83 3.73 50.96 37.58 31.51 9.95 39.21 32.46 10.92 coo -11.96 5.74 52.90 -10.55 6.74 51.22 39.91 33.41 13.35 41.22 34.11 15.24 coo -5.22 1.43 56.08 -5.36 2.84 54.49 35.16 33.09 19.50 33.98 34.83 19.67 1avf_c04 source 1avf GASTRICSIN : 1 hits 1avf_c04 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 322 PHE^? 19.75 C1 EDO B 603 A 223 ASP B 357 ASP.? 13.04 C1 EDO B 603 A 265 LYS B 367 LYS.? 8.96 O2 EDO B 603 coo 39.74 52.86 65.74 41.15 55.14 66.52 25.53 30.74 9.03 27.34 28.99 10.32 coo 30.70 47.50 67.53 29.83 49.47 67.39 19.95 30.44 0.55 20.02 30.85 -1.53 coo 19.99 54.53 64.11 20.55 58.78 68.33 8.46 36.63 1.57 6.31 34.95 -1.21 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE A 345 PHE^? 20.97 C1 EDO B 603 A 223 ASP A 350 ASP.? 26.92 O2 GOL D 601 A 265 LYS A 388 LYS~? 27.25 O2 GOL D 601 coo 39.74 52.86 65.74 41.15 55.14 66.52 27.58 16.29 6.01 29.18 17.39 3.97 coo 30.70 47.50 67.53 29.83 49.47 67.39 33.51 7.96 1.59 32.78 7.85 -0.37 coo 19.99 54.53 64.11 20.55 58.78 68.33 22.21 -0.11 -1.07 17.85 -4.01 1.39 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE A 431 PHE^? 22.59 O1 EDO B 603 A 223 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 265 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 39.74 52.86 65.74 41.15 55.14 66.52 29.40 15.33 -4.65 28.40 13.37 -2.94 coo 30.70 47.50 67.53 29.83 49.47 67.39 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 19.99 54.53 64.11 20.55 58.78 68.33 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1ax4_c04 TRYPTOPHANASE user 4 3 # 4 A 130 PHE B 322 PHE^? 22.61 C1 EDO B 603 A 223 ASP A 357 ASP.? 25.14 C1 EDO B 603 A 265 LYS A 367 LYS.? 27.79 C1 EDO B 603 coo 39.74 52.86 65.74 41.15 55.14 66.52 28.50 22.31 13.84 28.57 24.95 12.91 coo 30.70 47.50 67.53 29.83 49.47 67.39 22.54 16.74 19.72 22.05 16.00 21.61 coo 19.99 54.53 64.11 20.55 58.78 68.33 21.09 4.68 15.64 17.32 4.21 18.91 ULMN 3 1ax4_c04 TRYPTOPHANASE user 5 3 # 5 A 130 PHE B 345 PHE^? 18.52 C2 EDO B 603 A 223 ASP B 350 ASP.? 23.89 C2 EDO B 603 A 265 LYS B 388 LYS~? 19.48 C2 EDO B 603 coo 39.74 52.86 65.74 41.15 55.14 66.52 17.53 32.29 14.73 18.42 32.57 17.36 coo 30.70 47.50 67.53 29.83 49.47 67.39 12.16 40.72 19.41 11.14 39.74 20.98 coo 19.99 54.53 64.11 20.55 58.78 68.33 -0.92 37.13 17.34 -4.46 33.66 14.61 ULMN 3 1ax4_c04 TRYPTOPHANASE user 6 3 # 6 A 130 PHE B 345 PHE^? 18.52 C2 EDO B 603 A 223 ASP B 350 ASP.? 23.89 C2 EDO B 603 A 265 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo 39.74 52.86 65.74 41.15 55.14 66.52 17.53 32.29 14.73 18.42 32.57 17.36 coo 30.70 47.50 67.53 29.83 49.47 67.39 12.16 40.72 19.41 11.14 39.74 20.98 coo 19.99 54.53 64.11 20.55 58.78 68.33 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 1ax4_c04 TRYPTOPHANASE user 7 3 # 7 A 130 PHE C 322 PHE^? 19.87 C1 GOL D 601 A 223 ASP D 357 ASP.? 12.64 O3 GOL D 601 A 265 LYS D 367 LYS.? 8.67 O3 GOL D 601 coo 39.74 52.86 65.74 41.15 55.14 66.52 41.03 10.86 -26.53 41.21 13.56 -27.25 coo 30.70 47.50 67.53 29.83 49.47 67.39 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 19.99 54.53 64.11 20.55 58.78 68.33 32.17 -6.41 -25.63 28.00 -7.23 -22.20 ULMN 3 1ax4_c04 TRYPTOPHANASE user 8 3 # 8 A 130 PHE C 345 PHE^? 18.39 C1 EDO C 602 A 223 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 265 LYS C 388 LYS~? 20.15 C2 EDO C 602 coo 39.74 52.86 65.74 41.15 55.14 66.52 30.97 21.80 -24.09 32.10 21.77 -21.54 coo 30.70 47.50 67.53 29.83 49.47 67.39 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 19.99 54.53 64.11 20.55 58.78 68.33 13.46 28.58 -20.25 9.42 25.73 -22.18 ULMN 3 1ax4_c04 TRYPTOPHANASE user 9 3 # 9 A 130 PHE C 345 PHE^? 18.39 C1 EDO C 602 A 223 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 265 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 39.74 52.86 65.74 41.15 55.14 66.52 30.97 21.80 -24.09 32.10 21.77 -21.54 coo 30.70 47.50 67.53 29.83 49.47 67.39 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 19.99 54.53 64.11 20.55 58.78 68.33 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1ax4_c04 TRYPTOPHANASE user 10 3 # 10 A 130 PHE C 431 PHE^? 22.21 O1 GOL D 601 A 223 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 265 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo 39.74 52.86 65.74 41.15 55.14 66.52 28.24 21.80 -13.63 26.64 22.64 -15.77 coo 30.70 47.50 67.53 29.83 49.47 67.39 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 19.99 54.53 64.11 20.55 58.78 68.33 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 1ax4_c04 TRYPTOPHANASE user 11 3 # 11 A 130 PHE C 444 PHE~? 9.55 O1 GOL D 601 A 223 ASP D 440 ASP^? -5.34 O2 GOL D 601s A 265 LYS D 367 LYS.? 8.67 O3 GOL D 601 coo 39.74 52.86 65.74 41.15 55.14 66.52 16.05 5.22 -34.74 18.74 5.99 -34.45 coo 30.70 47.50 67.53 29.83 49.47 67.39 19.76 1.27 -26.39 17.89 0.46 -25.75 coo 19.99 54.53 64.11 20.55 58.78 68.33 32.17 -6.41 -25.63 28.00 -7.23 -22.20 ULMN 3 1ax4_c04 TRYPTOPHANASE user 12 3 # 12 A 130 PHE C 445 PHE~? 14.33 C2 EDO C 602 A 223 ASP C 440 ASP^? 5.97 O1 EDO C 602 A 265 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 39.74 52.86 65.74 41.15 55.14 66.52 9.78 6.26 -35.53 9.91 7.07 -32.85 coo 30.70 47.50 67.53 29.83 49.47 67.39 17.33 13.03 -37.56 15.74 12.38 -38.82 coo 19.99 54.53 64.11 20.55 58.78 68.33 27.51 4.47 -43.69 23.30 8.13 -41.81 ULMN 3 1ax4_c04 TRYPTOPHANASE user 13 3 # 13 A 130 PHE C 451 PHE.? 26.22 O1 EDO C 602 A 223 ASP C 448 ASP.? 19.32 O1 GOL D 601 A 265 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 39.74 52.86 65.74 41.15 55.14 66.52 6.71 0.00 -51.87 4.28 -1.15 -52.64 coo 30.70 47.50 67.53 29.83 49.47 67.39 9.52 -2.93 -40.85 10.47 -4.20 -39.42 coo 19.99 54.53 64.11 20.55 58.78 68.33 12.96 9.36 -37.91 9.04 10.02 -41.38 ULMN 3 1ax4_c04 TRYPTOPHANASE user 14 3 # 14 A 130 PHE D 322 PHE^? 19.43 C1 EDO C 602 A 223 ASP C 357 ASP.? 12.50 O2 EDO C 602 A 265 LYS C 367 LYS.? 10.18 O2 EDO C 602 coo 39.74 52.86 65.74 41.15 55.14 66.52 38.30 19.76 -30.55 39.98 17.72 -29.59 coo 30.70 47.50 67.53 29.83 49.47 67.39 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 19.99 54.53 64.11 20.55 58.78 68.33 21.41 26.99 -36.15 19.64 26.87 -41.36 ULMN 3 1ax4_c04 TRYPTOPHANASE user 15 3 # 15 A 130 PHE D 345 PHE^? 18.57 C3 GOL D 601 A 223 ASP D 350 ASP.? 24.09 C3 GOL D 601 A 265 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo 39.74 52.86 65.74 41.15 55.14 66.52 38.63 5.82 -34.75 40.11 6.86 -36.92 coo 30.70 47.50 67.53 29.83 49.47 67.39 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 19.99 54.53 64.11 20.55 58.78 68.33 31.25 -9.34 -42.79 29.68 -12.48 -44.35 ULMN 3 1ax4_c04 TRYPTOPHANASE user 16 3 # 16 A 130 PHE D 345 PHE^? 18.57 C3 GOL D 601 A 223 ASP D 350 ASP.? 24.09 C3 GOL D 601 A 265 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo 39.74 52.86 65.74 41.15 55.14 66.52 38.63 5.82 -34.75 40.11 6.86 -36.92 coo 30.70 47.50 67.53 29.83 49.47 67.39 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 19.99 54.53 64.11 20.55 58.78 68.33 32.90 -6.30 -46.84 30.42 -11.34 -47.14 ULMN 3 1ax4_c04 TRYPTOPHANASE user 17 3 # 17 A 130 PHE D 444 PHE~? 7.80 O1 GOL D 601 A 223 ASP C 440 ASP^? 5.97 O1 EDO C 602 A 265 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 39.74 52.86 65.74 41.15 55.14 66.52 14.59 6.86 -29.80 16.94 8.25 -29.13 coo 30.70 47.50 67.53 29.83 49.47 67.39 17.33 13.03 -37.56 15.74 12.38 -38.82 coo 19.99 54.53 64.11 20.55 58.78 68.33 27.51 4.47 -43.69 23.30 8.13 -41.81 1ax4_c04 source 1ax4 TRYPTOPHANASE : 17 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 322 PHE^? 19.75 C1 EDO B 603 B 223 ASP B 357 ASP.? 13.04 C1 EDO B 603 B 265 LYS B 367 LYS.? 8.96 O2 EDO B 603 coo 7.48 54.94 99.62 7.67 52.27 100.42 25.53 30.74 9.03 27.34 28.99 10.32 coo 10.43 61.66 91.81 9.80 60.04 90.61 19.95 30.44 0.55 20.02 30.85 -1.53 coo 5.43 58.06 80.08 8.57 53.00 79.37 8.46 36.63 1.57 6.31 34.95 -1.21 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE A 345 PHE^? 20.97 C1 EDO B 603 B 223 ASP A 350 ASP.? 26.92 O2 GOL D 601 B 265 LYS A 388 LYS~? 27.25 O2 GOL D 601 coo 7.48 54.94 99.62 7.67 52.27 100.42 27.58 16.29 6.01 29.18 17.39 3.97 coo 10.43 61.66 91.81 9.80 60.04 90.61 33.51 7.96 1.59 32.78 7.85 -0.37 coo 5.43 58.06 80.08 8.57 53.00 79.37 22.21 -0.11 -1.07 17.85 -4.01 1.39 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE A 431 PHE^? 22.59 O1 EDO B 603 B 223 ASP A 402 ASP.? 12.59 O1 EDO B 603 B 265 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 7.48 54.94 99.62 7.67 52.27 100.42 29.40 15.33 -4.65 28.40 13.37 -2.94 coo 10.43 61.66 91.81 9.80 60.04 90.61 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 5.43 58.06 80.08 8.57 53.00 79.37 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1ax4_c05 TRYPTOPHANASE user 4 3 # 4 B 130 PHE B 322 PHE^? 22.61 C1 EDO B 603 B 223 ASP A 357 ASP.? 25.14 C1 EDO B 603 B 265 LYS A 367 LYS.? 27.79 C1 EDO B 603 coo 7.48 54.94 99.62 7.67 52.27 100.42 28.50 22.31 13.84 28.57 24.95 12.91 coo 10.43 61.66 91.81 9.80 60.04 90.61 22.54 16.74 19.72 22.05 16.00 21.61 coo 5.43 58.06 80.08 8.57 53.00 79.37 21.09 4.68 15.64 17.32 4.21 18.91 ULMN 3 1ax4_c05 TRYPTOPHANASE user 5 3 # 5 B 130 PHE B 345 PHE^? 18.52 C2 EDO B 603 B 223 ASP B 350 ASP.? 23.89 C2 EDO B 603 B 265 LYS B 388 LYS~? 19.48 C2 EDO B 603 coo 7.48 54.94 99.62 7.67 52.27 100.42 17.53 32.29 14.73 18.42 32.57 17.36 coo 10.43 61.66 91.81 9.80 60.04 90.61 12.16 40.72 19.41 11.14 39.74 20.98 coo 5.43 58.06 80.08 8.57 53.00 79.37 -0.92 37.13 17.34 -4.46 33.66 14.61 ULMN 3 1ax4_c05 TRYPTOPHANASE user 6 3 # 6 B 130 PHE B 345 PHE^? 18.52 C2 EDO B 603 B 223 ASP B 350 ASP.? 23.89 C2 EDO B 603 B 265 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo 7.48 54.94 99.62 7.67 52.27 100.42 17.53 32.29 14.73 18.42 32.57 17.36 coo 10.43 61.66 91.81 9.80 60.04 90.61 12.16 40.72 19.41 11.14 39.74 20.98 coo 5.43 58.06 80.08 8.57 53.00 79.37 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 1ax4_c05 TRYPTOPHANASE user 7 3 # 7 B 130 PHE C 322 PHE^? 19.87 C1 GOL D 601 B 223 ASP D 357 ASP.? 12.64 O3 GOL D 601 B 265 LYS D 367 LYS.? 8.67 O3 GOL D 601 coo 7.48 54.94 99.62 7.67 52.27 100.42 41.03 10.86 -26.53 41.21 13.56 -27.25 coo 10.43 61.66 91.81 9.80 60.04 90.61 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 5.43 58.06 80.08 8.57 53.00 79.37 32.17 -6.41 -25.63 28.00 -7.23 -22.20 ULMN 3 1ax4_c05 TRYPTOPHANASE user 8 3 # 8 B 130 PHE C 345 PHE^? 18.39 C1 EDO C 602 B 223 ASP C 350 ASP.? 24.48 C2 EDO C 602 B 265 LYS C 388 LYS~? 20.15 C2 EDO C 602 coo 7.48 54.94 99.62 7.67 52.27 100.42 30.97 21.80 -24.09 32.10 21.77 -21.54 coo 10.43 61.66 91.81 9.80 60.04 90.61 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 5.43 58.06 80.08 8.57 53.00 79.37 13.46 28.58 -20.25 9.42 25.73 -22.18 ULMN 3 1ax4_c05 TRYPTOPHANASE user 9 3 # 9 B 130 PHE C 345 PHE^? 18.39 C1 EDO C 602 B 223 ASP C 350 ASP.? 24.48 C2 EDO C 602 B 265 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 7.48 54.94 99.62 7.67 52.27 100.42 30.97 21.80 -24.09 32.10 21.77 -21.54 coo 10.43 61.66 91.81 9.80 60.04 90.61 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 5.43 58.06 80.08 8.57 53.00 79.37 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1ax4_c05 TRYPTOPHANASE user 10 3 # 10 B 130 PHE C 431 PHE^? 22.21 O1 GOL D 601 B 223 ASP C 402 ASP.? 12.78 O1 GOL D 601 B 265 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo 7.48 54.94 99.62 7.67 52.27 100.42 28.24 21.80 -13.63 26.64 22.64 -15.77 coo 10.43 61.66 91.81 9.80 60.04 90.61 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 5.43 58.06 80.08 8.57 53.00 79.37 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 1ax4_c05 TRYPTOPHANASE user 11 3 # 11 B 130 PHE C 444 PHE~? 9.55 O1 GOL D 601 B 223 ASP D 440 ASP^? -5.34 O2 GOL D 601s B 265 LYS D 367 LYS.? 8.67 O3 GOL D 601 coo 7.48 54.94 99.62 7.67 52.27 100.42 16.05 5.22 -34.74 18.74 5.99 -34.45 coo 10.43 61.66 91.81 9.80 60.04 90.61 19.76 1.27 -26.39 17.89 0.46 -25.75 coo 5.43 58.06 80.08 8.57 53.00 79.37 32.17 -6.41 -25.63 28.00 -7.23 -22.20 ULMN 3 1ax4_c05 TRYPTOPHANASE user 12 3 # 12 B 130 PHE C 445 PHE~? 14.33 C2 EDO C 602 B 223 ASP C 440 ASP^? 5.97 O1 EDO C 602 B 265 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 7.48 54.94 99.62 7.67 52.27 100.42 9.78 6.26 -35.53 9.91 7.07 -32.85 coo 10.43 61.66 91.81 9.80 60.04 90.61 17.33 13.03 -37.56 15.74 12.38 -38.82 coo 5.43 58.06 80.08 8.57 53.00 79.37 27.51 4.47 -43.69 23.30 8.13 -41.81 ULMN 3 1ax4_c05 TRYPTOPHANASE user 13 3 # 13 B 130 PHE C 451 PHE.? 26.22 O1 EDO C 602 B 223 ASP C 448 ASP.? 19.32 O1 GOL D 601 B 265 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 7.48 54.94 99.62 7.67 52.27 100.42 6.71 0.00 -51.87 4.28 -1.15 -52.64 coo 10.43 61.66 91.81 9.80 60.04 90.61 9.52 -2.93 -40.85 10.47 -4.20 -39.42 coo 5.43 58.06 80.08 8.57 53.00 79.37 12.96 9.36 -37.91 9.04 10.02 -41.38 ULMN 3 1ax4_c05 TRYPTOPHANASE user 14 3 # 14 B 130 PHE D 322 PHE^? 19.43 C1 EDO C 602 B 223 ASP C 357 ASP.? 12.50 O2 EDO C 602 B 265 LYS C 367 LYS.? 10.18 O2 EDO C 602 coo 7.48 54.94 99.62 7.67 52.27 100.42 38.30 19.76 -30.55 39.98 17.72 -29.59 coo 10.43 61.66 91.81 9.80 60.04 90.61 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 5.43 58.06 80.08 8.57 53.00 79.37 21.41 26.99 -36.15 19.64 26.87 -41.36 ULMN 3 1ax4_c05 TRYPTOPHANASE user 15 3 # 15 B 130 PHE D 345 PHE^? 18.57 C3 GOL D 601 B 223 ASP D 350 ASP.? 24.09 C3 GOL D 601 B 265 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo 7.48 54.94 99.62 7.67 52.27 100.42 38.63 5.82 -34.75 40.11 6.86 -36.92 coo 10.43 61.66 91.81 9.80 60.04 90.61 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 5.43 58.06 80.08 8.57 53.00 79.37 31.25 -9.34 -42.79 29.68 -12.48 -44.35 ULMN 3 1ax4_c05 TRYPTOPHANASE user 16 3 # 16 B 130 PHE D 345 PHE^? 18.57 C3 GOL D 601 B 223 ASP D 350 ASP.? 24.09 C3 GOL D 601 B 265 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo 7.48 54.94 99.62 7.67 52.27 100.42 38.63 5.82 -34.75 40.11 6.86 -36.92 coo 10.43 61.66 91.81 9.80 60.04 90.61 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 5.43 58.06 80.08 8.57 53.00 79.37 32.90 -6.30 -46.84 30.42 -11.34 -47.14 ULMN 3 1ax4_c05 TRYPTOPHANASE user 17 3 # 17 B 130 PHE D 444 PHE~? 7.80 O1 GOL D 601 B 223 ASP C 440 ASP^? 5.97 O1 EDO C 602 B 265 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 7.48 54.94 99.62 7.67 52.27 100.42 14.59 6.86 -29.80 16.94 8.25 -29.13 coo 10.43 61.66 91.81 9.80 60.04 90.61 17.33 13.03 -37.56 15.74 12.38 -38.82 coo 5.43 58.06 80.08 8.57 53.00 79.37 27.51 4.47 -43.69 23.30 8.13 -41.81 1ax4_c05 source 1ax4 TRYPTOPHANASE : 17 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 322 PHE^? 19.75 C1 EDO B 603 C 223 ASP B 357 ASP.? 13.04 C1 EDO B 603 C 265 LYS B 367 LYS.? 8.96 O2 EDO B 603 coo -6.55 73.45 23.60 -6.77 71.48 21.66 25.53 30.74 9.03 27.34 28.99 10.32 coo -9.52 75.74 33.62 -8.85 73.74 33.93 19.95 30.44 0.55 20.02 30.85 -1.53 coo -4.44 67.20 42.32 -7.50 62.41 40.49 8.46 36.63 1.57 6.31 34.95 -1.21 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE A 345 PHE^? 20.97 C1 EDO B 603 C 223 ASP A 350 ASP.? 26.92 O2 GOL D 601 C 265 LYS A 388 LYS~? 27.25 O2 GOL D 601 coo -6.55 73.45 23.60 -6.77 71.48 21.66 27.58 16.29 6.01 29.18 17.39 3.97 coo -9.52 75.74 33.62 -8.85 73.74 33.93 33.51 7.96 1.59 32.78 7.85 -0.37 coo -4.44 67.20 42.32 -7.50 62.41 40.49 22.21 -0.11 -1.07 17.85 -4.01 1.39 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE A 431 PHE^? 22.59 O1 EDO B 603 C 223 ASP A 402 ASP.? 12.59 O1 EDO B 603 C 265 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo -6.55 73.45 23.60 -6.77 71.48 21.66 29.40 15.33 -4.65 28.40 13.37 -2.94 coo -9.52 75.74 33.62 -8.85 73.74 33.93 18.87 16.83 -6.49 16.77 17.04 -6.49 coo -4.44 67.20 42.32 -7.50 62.41 40.49 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1ax4_c06 TRYPTOPHANASE user 4 3 # 4 C 130 PHE B 322 PHE^? 22.61 C1 EDO B 603 C 223 ASP A 357 ASP.? 25.14 C1 EDO B 603 C 265 LYS A 367 LYS.? 27.79 C1 EDO B 603 coo -6.55 73.45 23.60 -6.77 71.48 21.66 28.50 22.31 13.84 28.57 24.95 12.91 coo -9.52 75.74 33.62 -8.85 73.74 33.93 22.54 16.74 19.72 22.05 16.00 21.61 coo -4.44 67.20 42.32 -7.50 62.41 40.49 21.09 4.68 15.64 17.32 4.21 18.91 ULMN 3 1ax4_c06 TRYPTOPHANASE user 5 3 # 5 C 130 PHE B 345 PHE^? 18.52 C2 EDO B 603 C 223 ASP B 350 ASP.? 23.89 C2 EDO B 603 C 265 LYS B 388 LYS~? 19.48 C2 EDO B 603 coo -6.55 73.45 23.60 -6.77 71.48 21.66 17.53 32.29 14.73 18.42 32.57 17.36 coo -9.52 75.74 33.62 -8.85 73.74 33.93 12.16 40.72 19.41 11.14 39.74 20.98 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -0.92 37.13 17.34 -4.46 33.66 14.61 ULMN 3 1ax4_c06 TRYPTOPHANASE user 6 3 # 6 C 130 PHE B 345 PHE^? 18.52 C2 EDO B 603 C 223 ASP B 350 ASP.? 23.89 C2 EDO B 603 C 265 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo -6.55 73.45 23.60 -6.77 71.48 21.66 17.53 32.29 14.73 18.42 32.57 17.36 coo -9.52 75.74 33.62 -8.85 73.74 33.93 12.16 40.72 19.41 11.14 39.74 20.98 coo -4.44 67.20 42.32 -7.50 62.41 40.49 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 1ax4_c06 TRYPTOPHANASE user 7 3 # 7 C 130 PHE C 322 PHE^? 19.87 C1 GOL D 601 C 223 ASP D 357 ASP.? 12.64 O3 GOL D 601 C 265 LYS D 367 LYS.? 8.67 O3 GOL D 601 coo -6.55 73.45 23.60 -6.77 71.48 21.66 41.03 10.86 -26.53 41.21 13.56 -27.25 coo -9.52 75.74 33.62 -8.85 73.74 33.93 34.52 5.19 -20.65 34.58 3.94 -18.98 coo -4.44 67.20 42.32 -7.50 62.41 40.49 32.17 -6.41 -25.63 28.00 -7.23 -22.20 ULMN 3 1ax4_c06 TRYPTOPHANASE user 8 3 # 8 C 130 PHE C 345 PHE^? 18.39 C1 EDO C 602 C 223 ASP C 350 ASP.? 24.48 C2 EDO C 602 C 265 LYS C 388 LYS~? 20.15 C2 EDO C 602 coo -6.55 73.45 23.60 -6.77 71.48 21.66 30.97 21.80 -24.09 32.10 21.77 -21.54 coo -9.52 75.74 33.62 -8.85 73.74 33.93 27.03 30.18 -18.47 26.26 29.33 -16.72 coo -4.44 67.20 42.32 -7.50 62.41 40.49 13.46 28.58 -20.25 9.42 25.73 -22.18 ULMN 3 1ax4_c06 TRYPTOPHANASE user 9 3 # 9 C 130 PHE C 345 PHE^? 18.39 C1 EDO C 602 C 223 ASP C 350 ASP.? 24.48 C2 EDO C 602 C 265 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo -6.55 73.45 23.60 -6.77 71.48 21.66 30.97 21.80 -24.09 32.10 21.77 -21.54 coo -9.52 75.74 33.62 -8.85 73.74 33.93 27.03 30.18 -18.47 26.26 29.33 -16.72 coo -4.44 67.20 42.32 -7.50 62.41 40.49 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1ax4_c06 TRYPTOPHANASE user 10 3 # 10 C 130 PHE C 431 PHE^? 22.21 O1 GOL D 601 C 223 ASP C 402 ASP.? 12.78 O1 GOL D 601 C 265 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo -6.55 73.45 23.60 -6.77 71.48 21.66 28.24 21.80 -13.63 26.64 22.64 -15.77 coo -9.52 75.74 33.62 -8.85 73.74 33.93 22.26 13.02 -15.38 21.01 11.37 -15.92 coo -4.44 67.20 42.32 -7.50 62.41 40.49 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 1ax4_c06 TRYPTOPHANASE user 11 3 # 11 C 130 PHE C 445 PHE~? 14.33 C2 EDO C 602 C 223 ASP C 440 ASP^? 5.97 O1 EDO C 602 C 265 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo -6.55 73.45 23.60 -6.77 71.48 21.66 9.78 6.26 -35.53 9.91 7.07 -32.85 coo -9.52 75.74 33.62 -8.85 73.74 33.93 17.33 13.03 -37.56 15.74 12.38 -38.82 coo -4.44 67.20 42.32 -7.50 62.41 40.49 27.51 4.47 -43.69 23.30 8.13 -41.81 ULMN 3 1ax4_c06 TRYPTOPHANASE user 12 3 # 12 C 130 PHE C 451 PHE.? 26.22 O1 EDO C 602 C 223 ASP C 448 ASP.? 19.32 O1 GOL D 601 C 265 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo -6.55 73.45 23.60 -6.77 71.48 21.66 6.71 0.00 -51.87 4.28 -1.15 -52.64 coo -9.52 75.74 33.62 -8.85 73.74 33.93 9.52 -2.93 -40.85 10.47 -4.20 -39.42 coo -4.44 67.20 42.32 -7.50 62.41 40.49 12.96 9.36 -37.91 9.04 10.02 -41.38 ULMN 3 1ax4_c06 TRYPTOPHANASE user 13 3 # 13 C 130 PHE D 322 PHE^? 19.43 C1 EDO C 602 C 223 ASP C 357 ASP.? 12.50 O2 EDO C 602 C 265 LYS C 367 LYS.? 10.18 O2 EDO C 602 coo -6.55 73.45 23.60 -6.77 71.48 21.66 38.30 19.76 -30.55 39.98 17.72 -29.59 coo -9.52 75.74 33.62 -8.85 73.74 33.93 32.02 20.63 -38.57 31.77 21.72 -40.39 coo -4.44 67.20 42.32 -7.50 62.41 40.49 21.41 26.99 -36.15 19.64 26.87 -41.36 ULMN 3 1ax4_c06 TRYPTOPHANASE user 14 3 # 14 C 130 PHE D 345 PHE^? 18.57 C3 GOL D 601 C 223 ASP D 350 ASP.? 24.09 C3 GOL D 601 C 265 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo -6.55 73.45 23.60 -6.77 71.48 21.66 38.63 5.82 -34.75 40.11 6.86 -36.92 coo -9.52 75.74 33.62 -8.85 73.74 33.93 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo -4.44 67.20 42.32 -7.50 62.41 40.49 31.25 -9.34 -42.79 29.68 -12.48 -44.35 ULMN 3 1ax4_c06 TRYPTOPHANASE user 15 3 # 15 C 130 PHE D 345 PHE^? 18.57 C3 GOL D 601 C 223 ASP D 350 ASP.? 24.09 C3 GOL D 601 C 265 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo -6.55 73.45 23.60 -6.77 71.48 21.66 38.63 5.82 -34.75 40.11 6.86 -36.92 coo -9.52 75.74 33.62 -8.85 73.74 33.93 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo -4.44 67.20 42.32 -7.50 62.41 40.49 32.90 -6.30 -46.84 30.42 -11.34 -47.14 ULMN 3 1ax4_c06 TRYPTOPHANASE user 16 3 # 16 C 130 PHE D 444 PHE~? 7.80 O1 GOL D 601 C 223 ASP C 440 ASP^? 5.97 O1 EDO C 602 C 265 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo -6.55 73.45 23.60 -6.77 71.48 21.66 14.59 6.86 -29.80 16.94 8.25 -29.13 coo -9.52 75.74 33.62 -8.85 73.74 33.93 17.33 13.03 -37.56 15.74 12.38 -38.82 coo -4.44 67.20 42.32 -7.50 62.41 40.49 27.51 4.47 -43.69 23.30 8.13 -41.81 1ax4_c06 source 1ax4 TRYPTOPHANASE : 16 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 322 PHE^? 19.75 C1 EDO B 603 D 223 ASP B 357 ASP.? 13.04 C1 EDO B 603 D 265 LYS B 367 LYS.? 8.96 O2 EDO B 603 coo -38.60 55.38 52.70 -40.06 57.72 53.04 25.53 30.74 9.03 27.34 28.99 10.32 coo -29.46 51.67 48.51 -28.63 53.31 49.56 19.95 30.44 0.55 20.02 30.85 -1.53 coo -18.87 56.53 54.79 -19.47 62.22 53.03 8.46 36.63 1.57 6.31 34.95 -1.21 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE A 345 PHE^? 20.97 C1 EDO B 603 D 223 ASP A 350 ASP.? 26.92 O2 GOL D 601 D 265 LYS A 388 LYS~? 27.25 O2 GOL D 601 coo -38.60 55.38 52.70 -40.06 57.72 53.04 27.58 16.29 6.01 29.18 17.39 3.97 coo -29.46 51.67 48.51 -28.63 53.31 49.56 33.51 7.96 1.59 32.78 7.85 -0.37 coo -18.87 56.53 54.79 -19.47 62.22 53.03 22.21 -0.11 -1.07 17.85 -4.01 1.39 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE A 431 PHE^? 22.59 O1 EDO B 603 D 223 ASP A 402 ASP.? 12.59 O1 EDO B 603 D 265 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo -38.60 55.38 52.70 -40.06 57.72 53.04 29.40 15.33 -4.65 28.40 13.37 -2.94 coo -29.46 51.67 48.51 -28.63 53.31 49.56 18.87 16.83 -6.49 16.77 17.04 -6.49 coo -18.87 56.53 54.79 -19.47 62.22 53.03 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1ax4_c07 TRYPTOPHANASE user 4 3 # 4 D 130 PHE B 322 PHE^? 22.61 C1 EDO B 603 D 223 ASP A 357 ASP.? 25.14 C1 EDO B 603 D 265 LYS A 367 LYS.? 27.79 C1 EDO B 603 coo -38.60 55.38 52.70 -40.06 57.72 53.04 28.50 22.31 13.84 28.57 24.95 12.91 coo -29.46 51.67 48.51 -28.63 53.31 49.56 22.54 16.74 19.72 22.05 16.00 21.61 coo -18.87 56.53 54.79 -19.47 62.22 53.03 21.09 4.68 15.64 17.32 4.21 18.91 ULMN 3 1ax4_c07 TRYPTOPHANASE user 5 3 # 5 D 130 PHE B 345 PHE^? 18.52 C2 EDO B 603 D 223 ASP B 350 ASP.? 23.89 C2 EDO B 603 D 265 LYS B 388 LYS~? 19.48 C2 EDO B 603 coo -38.60 55.38 52.70 -40.06 57.72 53.04 17.53 32.29 14.73 18.42 32.57 17.36 coo -29.46 51.67 48.51 -28.63 53.31 49.56 12.16 40.72 19.41 11.14 39.74 20.98 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -0.92 37.13 17.34 -4.46 33.66 14.61 ULMN 3 1ax4_c07 TRYPTOPHANASE user 6 3 # 6 D 130 PHE B 345 PHE^? 18.52 C2 EDO B 603 D 223 ASP B 350 ASP.? 23.89 C2 EDO B 603 D 265 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo -38.60 55.38 52.70 -40.06 57.72 53.04 17.53 32.29 14.73 18.42 32.57 17.36 coo -29.46 51.67 48.51 -28.63 53.31 49.56 12.16 40.72 19.41 11.14 39.74 20.98 coo -18.87 56.53 54.79 -19.47 62.22 53.03 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 1ax4_c07 TRYPTOPHANASE user 7 3 # 7 D 130 PHE C 322 PHE^? 19.87 C1 GOL D 601 D 223 ASP D 357 ASP.? 12.64 O3 GOL D 601 D 265 LYS D 367 LYS.? 8.67 O3 GOL D 601 coo -38.60 55.38 52.70 -40.06 57.72 53.04 41.03 10.86 -26.53 41.21 13.56 -27.25 coo -29.46 51.67 48.51 -28.63 53.31 49.56 34.52 5.19 -20.65 34.58 3.94 -18.98 coo -18.87 56.53 54.79 -19.47 62.22 53.03 32.17 -6.41 -25.63 28.00 -7.23 -22.20 ULMN 3 1ax4_c07 TRYPTOPHANASE user 8 3 # 8 D 130 PHE C 345 PHE^? 18.39 C1 EDO C 602 D 223 ASP C 350 ASP.? 24.48 C2 EDO C 602 D 265 LYS C 388 LYS~? 20.15 C2 EDO C 602 coo -38.60 55.38 52.70 -40.06 57.72 53.04 30.97 21.80 -24.09 32.10 21.77 -21.54 coo -29.46 51.67 48.51 -28.63 53.31 49.56 27.03 30.18 -18.47 26.26 29.33 -16.72 coo -18.87 56.53 54.79 -19.47 62.22 53.03 13.46 28.58 -20.25 9.42 25.73 -22.18 ULMN 3 1ax4_c07 TRYPTOPHANASE user 9 3 # 9 D 130 PHE C 345 PHE^? 18.39 C1 EDO C 602 D 223 ASP C 350 ASP.? 24.48 C2 EDO C 602 D 265 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo -38.60 55.38 52.70 -40.06 57.72 53.04 30.97 21.80 -24.09 32.10 21.77 -21.54 coo -29.46 51.67 48.51 -28.63 53.31 49.56 27.03 30.18 -18.47 26.26 29.33 -16.72 coo -18.87 56.53 54.79 -19.47 62.22 53.03 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1ax4_c07 TRYPTOPHANASE user 10 3 # 10 D 130 PHE C 431 PHE^? 22.21 O1 GOL D 601 D 223 ASP C 402 ASP.? 12.78 O1 GOL D 601 D 265 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo -38.60 55.38 52.70 -40.06 57.72 53.04 28.24 21.80 -13.63 26.64 22.64 -15.77 coo -29.46 51.67 48.51 -28.63 53.31 49.56 22.26 13.02 -15.38 21.01 11.37 -15.92 coo -18.87 56.53 54.79 -19.47 62.22 53.03 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 1ax4_c07 TRYPTOPHANASE user 11 3 # 11 D 130 PHE C 444 PHE~? 9.55 O1 GOL D 601 D 223 ASP D 440 ASP^? -5.34 O2 GOL D 601s D 265 LYS D 367 LYS.? 8.67 O3 GOL D 601 coo -38.60 55.38 52.70 -40.06 57.72 53.04 16.05 5.22 -34.74 18.74 5.99 -34.45 coo -29.46 51.67 48.51 -28.63 53.31 49.56 19.76 1.27 -26.39 17.89 0.46 -25.75 coo -18.87 56.53 54.79 -19.47 62.22 53.03 32.17 -6.41 -25.63 28.00 -7.23 -22.20 ULMN 3 1ax4_c07 TRYPTOPHANASE user 12 3 # 12 D 130 PHE C 445 PHE~? 14.33 C2 EDO C 602 D 223 ASP C 440 ASP^? 5.97 O1 EDO C 602 D 265 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo -38.60 55.38 52.70 -40.06 57.72 53.04 9.78 6.26 -35.53 9.91 7.07 -32.85 coo -29.46 51.67 48.51 -28.63 53.31 49.56 17.33 13.03 -37.56 15.74 12.38 -38.82 coo -18.87 56.53 54.79 -19.47 62.22 53.03 27.51 4.47 -43.69 23.30 8.13 -41.81 ULMN 3 1ax4_c07 TRYPTOPHANASE user 13 3 # 13 D 130 PHE C 451 PHE.? 26.22 O1 EDO C 602 D 223 ASP C 448 ASP.? 19.32 O1 GOL D 601 D 265 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo -38.60 55.38 52.70 -40.06 57.72 53.04 6.71 0.00 -51.87 4.28 -1.15 -52.64 coo -29.46 51.67 48.51 -28.63 53.31 49.56 9.52 -2.93 -40.85 10.47 -4.20 -39.42 coo -18.87 56.53 54.79 -19.47 62.22 53.03 12.96 9.36 -37.91 9.04 10.02 -41.38 ULMN 3 1ax4_c07 TRYPTOPHANASE user 14 3 # 14 D 130 PHE D 322 PHE^? 19.43 C1 EDO C 602 D 223 ASP C 357 ASP.? 12.50 O2 EDO C 602 D 265 LYS C 367 LYS.? 10.18 O2 EDO C 602 coo -38.60 55.38 52.70 -40.06 57.72 53.04 38.30 19.76 -30.55 39.98 17.72 -29.59 coo -29.46 51.67 48.51 -28.63 53.31 49.56 32.02 20.63 -38.57 31.77 21.72 -40.39 coo -18.87 56.53 54.79 -19.47 62.22 53.03 21.41 26.99 -36.15 19.64 26.87 -41.36 ULMN 3 1ax4_c07 TRYPTOPHANASE user 15 3 # 15 D 130 PHE D 345 PHE^? 18.57 C3 GOL D 601 D 223 ASP D 350 ASP.? 24.09 C3 GOL D 601 D 265 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo -38.60 55.38 52.70 -40.06 57.72 53.04 38.63 5.82 -34.75 40.11 6.86 -36.92 coo -29.46 51.67 48.51 -28.63 53.31 49.56 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo -18.87 56.53 54.79 -19.47 62.22 53.03 31.25 -9.34 -42.79 29.68 -12.48 -44.35 ULMN 3 1ax4_c07 TRYPTOPHANASE user 16 3 # 16 D 130 PHE D 345 PHE^? 18.57 C3 GOL D 601 D 223 ASP D 350 ASP.? 24.09 C3 GOL D 601 D 265 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo -38.60 55.38 52.70 -40.06 57.72 53.04 38.63 5.82 -34.75 40.11 6.86 -36.92 coo -29.46 51.67 48.51 -28.63 53.31 49.56 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo -18.87 56.53 54.79 -19.47 62.22 53.03 32.90 -6.30 -46.84 30.42 -11.34 -47.14 ULMN 3 1ax4_c07 TRYPTOPHANASE user 17 3 # 17 D 130 PHE D 444 PHE~? 7.80 O1 GOL D 601 D 223 ASP C 440 ASP^? 5.97 O1 EDO C 602 D 265 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo -38.60 55.38 52.70 -40.06 57.72 53.04 14.59 6.86 -29.80 16.94 8.25 -29.13 coo -29.46 51.67 48.51 -28.63 53.31 49.56 17.33 13.03 -37.56 15.74 12.38 -38.82 coo -18.87 56.53 54.79 -19.47 62.22 53.03 27.51 4.47 -43.69 23.30 8.13 -41.81 1ax4_c07 source 1ax4 TRYPTOPHANASE : 17 hits 1ax4_c07 naa= 3 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 A 140 TRP A 407 TRP^? 17.84 O1 EDO B 603 A 222 ASP B 448 ASP.? 21.29 O1 EDO B 603 A 258 LYS A 442 LYS~? 23.27 C1 EDO B 603 coo 89.83 15.40 0.01 90.61 18.86 1.71 6.49 5.24 2.04 7.76 7.03 -1.22 coo 82.92 20.43 2.47 84.82 20.45 1.55 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 2.76 10.16 11.03 0.96 5.43 12.32 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 A 140 TRP A 407 TRP^? 17.84 O1 EDO B 603 A 222 ASP B 448 ASP.? 21.29 O1 EDO B 603 A 258 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 89.83 15.40 0.01 90.61 18.86 1.71 6.49 5.24 2.04 7.76 7.03 -1.22 coo 82.92 20.43 2.47 84.82 20.45 1.55 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 3 3 # 3 A 140 TRP B 407 TRP^? 14.83 C2 EDO B 603 A 222 ASP A 448 ASP~? 19.70 O1 EDO B 603 A 258 LYS B 415 LYS^? -2.82 O2 EDO B 603s coo 89.83 15.40 0.01 90.61 18.86 1.71 -3.73 22.30 9.20 -2.79 21.98 13.01 coo 82.92 20.43 2.47 84.82 20.45 1.55 -6.12 13.55 5.97 -7.03 12.86 4.20 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 1.57 23.62 -1.31 7.49 26.02 -1.78 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 4 3 # 4 A 140 TRP C 407 TRP^? 15.00 C2 EDO C 602 A 222 ASP D 448 ASP.? 19.66 C2 EDO C 602 A 258 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 89.83 15.40 0.01 90.61 18.86 1.71 8.62 13.87 -28.54 9.69 13.09 -24.84 coo 82.92 20.43 2.47 84.82 20.45 1.55 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 12.96 9.36 -37.91 9.04 10.02 -41.38 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 5 3 # 5 A 140 TRP C 407 TRP^? 15.00 C2 EDO C 602 A 222 ASP D 448 ASP.? 19.66 C2 EDO C 602 A 258 LYS D 442 LYS~? 12.65 O2 GOL D 601 coo 89.83 15.40 0.01 90.61 18.86 1.71 8.62 13.87 -28.54 9.69 13.09 -24.84 coo 82.92 20.43 2.47 84.82 20.45 1.55 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 14.14 0.83 -27.84 11.41 -3.18 -25.91 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 6 3 # 6 A 140 TRP D 407 TRP^? 14.97 C3 GOL D 601 A 222 ASP C 448 ASP.? 19.32 O1 GOL D 601 A 258 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 89.83 15.40 0.01 90.61 18.86 1.71 16.64 -3.51 -37.62 17.68 -1.39 -40.78 coo 82.92 20.43 2.47 84.82 20.45 1.55 9.52 -2.93 -40.85 10.47 -4.20 -39.42 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 12.96 9.36 -37.91 9.04 10.02 -41.38 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 7 3 # 7 A 140 TRP D 407 TRP^? 14.97 C3 GOL D 601 A 222 ASP C 448 ASP.? 19.32 O1 GOL D 601 A 258 LYS D 442 LYS~? 12.65 O2 GOL D 601 coo 89.83 15.40 0.01 90.61 18.86 1.71 16.64 -3.51 -37.62 17.68 -1.39 -40.78 coo 82.92 20.43 2.47 84.82 20.45 1.55 9.52 -2.93 -40.85 10.47 -4.20 -39.42 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 14.14 0.83 -27.84 11.41 -3.18 -25.91 1ay4_c02 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 7 hits 1ay4_c02 naa= 3 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 B 140 TRP A 407 TRP^? 17.84 O1 EDO B 603 B 222 ASP B 448 ASP.? 21.29 O1 EDO B 603 B 258 LYS A 442 LYS~? 23.27 C1 EDO B 603 coo 103.45 44.39 16.20 102.66 41.02 14.32 6.49 5.24 2.04 7.76 7.03 -1.22 coo 110.10 38.66 15.58 108.40 39.41 14.53 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo 107.51 45.54 4.76 105.41 44.51 10.25 2.76 10.16 11.03 0.96 5.43 12.32 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 B 140 TRP A 407 TRP^? 17.84 O1 EDO B 603 B 222 ASP B 448 ASP.? 21.29 O1 EDO B 603 B 258 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 103.45 44.39 16.20 102.66 41.02 14.32 6.49 5.24 2.04 7.76 7.03 -1.22 coo 110.10 38.66 15.58 108.40 39.41 14.53 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo 107.51 45.54 4.76 105.41 44.51 10.25 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 3 3 # 3 B 140 TRP B 407 TRP^? 14.83 C2 EDO B 603 B 222 ASP A 448 ASP~? 19.70 O1 EDO B 603 B 258 LYS B 415 LYS^? -2.82 O2 EDO B 603s coo 103.45 44.39 16.20 102.66 41.02 14.32 -3.73 22.30 9.20 -2.79 21.98 13.01 coo 110.10 38.66 15.58 108.40 39.41 14.53 -6.12 13.55 5.97 -7.03 12.86 4.20 coo 107.51 45.54 4.76 105.41 44.51 10.25 1.57 23.62 -1.31 7.49 26.02 -1.78 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 4 3 # 4 B 140 TRP C 407 TRP^? 15.00 C2 EDO C 602 B 222 ASP D 448 ASP.? 19.66 C2 EDO C 602 B 258 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 103.45 44.39 16.20 102.66 41.02 14.32 8.62 13.87 -28.54 9.69 13.09 -24.84 coo 110.10 38.66 15.58 108.40 39.41 14.53 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 107.51 45.54 4.76 105.41 44.51 10.25 12.96 9.36 -37.91 9.04 10.02 -41.38 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 5 3 # 5 B 140 TRP C 407 TRP^? 15.00 C2 EDO C 602 B 222 ASP D 448 ASP.? 19.66 C2 EDO C 602 B 258 LYS D 442 LYS~? 12.65 O2 GOL D 601 coo 103.45 44.39 16.20 102.66 41.02 14.32 8.62 13.87 -28.54 9.69 13.09 -24.84 coo 110.10 38.66 15.58 108.40 39.41 14.53 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 107.51 45.54 4.76 105.41 44.51 10.25 14.14 0.83 -27.84 11.41 -3.18 -25.91 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 6 3 # 6 B 140 TRP D 407 TRP^? 14.97 C3 GOL D 601 B 222 ASP C 448 ASP.? 19.32 O1 GOL D 601 B 258 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 103.45 44.39 16.20 102.66 41.02 14.32 16.64 -3.51 -37.62 17.68 -1.39 -40.78 coo 110.10 38.66 15.58 108.40 39.41 14.53 9.52 -2.93 -40.85 10.47 -4.20 -39.42 coo 107.51 45.54 4.76 105.41 44.51 10.25 12.96 9.36 -37.91 9.04 10.02 -41.38 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 7 3 # 7 B 140 TRP D 407 TRP^? 14.97 C3 GOL D 601 B 222 ASP C 448 ASP.? 19.32 O1 GOL D 601 B 258 LYS D 442 LYS~? 12.65 O2 GOL D 601 coo 103.45 44.39 16.20 102.66 41.02 14.32 16.64 -3.51 -37.62 17.68 -1.39 -40.78 coo 110.10 38.66 15.58 108.40 39.41 14.53 9.52 -2.93 -40.85 10.47 -4.20 -39.42 coo 107.51 45.54 4.76 105.41 44.51 10.25 14.14 0.83 -27.84 11.41 -3.18 -25.91 1ay4_c03 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 7 hits 1ay4_c03 naa= 3 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 1 3 # 1 A 85 HIS A 338 HIS~? 19.64 C1 EDO B 603 A 171 ARG B 397 ARG~? 26.01 C2 EDO B 603 A 190 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo 22.59 2.26 43.22 21.17 3.47 42.27 16.13 23.68 19.02 16.84 23.99 20.97 coo 13.63 3.81 28.83 14.49 2.91 31.59 10.79 36.41 26.32 12.94 37.68 24.51 coo 24.97 7.47 37.69 21.24 10.69 35.89 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 2 3 # 2 A 85 HIS A 381 HIS.? 27.31 O1 EDO B 603 A 171 ARG A 397 ARG~? 24.94 O2 GOL D 601 A 190 LYS A 388 LYS~? 27.25 O2 GOL D 601 coo 22.59 2.26 43.22 21.17 3.47 42.27 25.64 1.98 6.69 25.07 4.00 6.65 coo 13.63 3.81 28.83 14.49 2.91 31.59 31.00 11.06 -6.51 32.72 12.02 -4.11 coo 24.97 7.47 37.69 21.24 10.69 35.89 22.21 -0.11 -1.07 17.85 -4.01 1.39 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 3 3 # 3 A 85 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 171 ARG A 397 ARG~? 24.94 O2 GOL D 601 A 190 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 22.59 2.26 43.22 21.17 3.47 42.27 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 13.63 3.81 28.83 14.49 2.91 31.59 31.00 11.06 -6.51 32.72 12.02 -4.11 coo 24.97 7.47 37.69 21.24 10.69 35.89 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 4 3 # 4 A 85 HIS B 381 HIS.? 15.29 C2 EDO B 603 A 171 ARG B 397 ARG~? 26.01 C2 EDO B 603 A 190 LYS B 388 LYS~? 19.48 C2 EDO B 603 coo 22.59 2.26 43.22 21.17 3.47 42.27 4.86 38.27 11.07 6.17 36.67 11.45 coo 13.63 3.81 28.83 14.49 2.91 31.59 10.79 36.41 26.32 12.94 37.68 24.51 coo 24.97 7.47 37.69 21.24 10.69 35.89 -0.92 37.13 17.34 -4.46 33.66 14.61 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 5 3 # 5 A 85 HIS B 381 HIS.? 15.29 C2 EDO B 603 A 171 ARG B 401 ARG.? 20.08 C2 EDO B 603 A 190 LYS B 388 LYS~? 19.48 C2 EDO B 603 coo 22.59 2.26 43.22 21.17 3.47 42.27 4.86 38.27 11.07 6.17 36.67 11.45 coo 13.63 3.81 28.83 14.49 2.91 31.59 1.75 25.80 23.58 1.16 24.37 20.91 coo 24.97 7.47 37.69 21.24 10.69 35.89 -0.92 37.13 17.34 -4.46 33.66 14.61 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 6 3 # 6 A 85 HIS B 381 HIS.? 15.29 C2 EDO B 603 A 171 ARG B 401 ARG.? 20.08 C2 EDO B 603 A 190 LYS B 390 LYS~? 27.12 C2 EDO B 603 coo 22.59 2.26 43.22 21.17 3.47 42.27 4.86 38.27 11.07 6.17 36.67 11.45 coo 13.63 3.81 28.83 14.49 2.91 31.59 1.75 25.80 23.58 1.16 24.37 20.91 coo 24.97 7.47 37.69 21.24 10.69 35.89 3.52 38.72 20.17 3.15 45.06 20.21 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 7 3 # 7 A 85 HIS C 338 HIS~? 12.91 O1 EDO C 602 A 171 ARG D 397 ARG~? 26.17 C3 GOL D 601 A 190 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 22.59 2.26 43.22 21.17 3.47 42.27 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 13.63 3.81 28.83 14.49 2.91 31.59 40.54 0.77 -47.66 42.41 1.45 -45.29 coo 24.97 7.47 37.69 21.24 10.69 35.89 27.51 4.47 -43.69 23.30 8.13 -41.81 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 8 3 # 8 A 85 HIS C 381 HIS~? 16.26 O2 EDO C 602 A 171 ARG C 397 ARG~? 23.93 O1 EDO B 603 A 190 LYS C 388 LYS~? 20.15 C2 EDO C 602 coo 22.59 2.26 43.22 21.17 3.47 42.27 19.26 30.57 -26.59 20.09 28.69 -27.02 coo 13.63 3.81 28.83 14.49 2.91 31.59 25.49 26.02 -11.91 27.94 26.82 -13.64 coo 24.97 7.47 37.69 21.24 10.69 35.89 13.46 28.58 -20.25 9.42 25.73 -22.18 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 9 3 # 9 A 85 HIS D 381 HIS.? 16.49 O3 GOL D 601 A 171 ARG D 397 ARG~? 26.17 C3 GOL D 601 A 190 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo 22.59 2.26 43.22 21.17 3.47 42.27 36.03 -8.97 -35.15 35.55 -7.12 -34.29 coo 13.63 3.81 28.83 14.49 2.91 31.59 40.54 0.77 -47.66 42.41 1.45 -45.29 coo 24.97 7.47 37.69 21.24 10.69 35.89 31.25 -9.34 -42.79 29.68 -12.48 -44.35 1azy_c00 source 1azy THYMIDINE PHOSPHORYLASE : 9 hits 1azy_c00 naa= 3 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 1 3 # 1 B 85 HIS A 338 HIS~? 19.64 C1 EDO B 603 B 171 ARG B 397 ARG~? 26.01 C2 EDO B 603 B 190 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 16.13 23.68 19.02 16.84 23.99 20.97 coo 2.83 4.83 10.84 1.96 4.32 7.97 10.79 36.41 26.32 12.94 37.68 24.51 coo -8.96 9.04 2.88 -5.39 12.11 5.08 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 2 3 # 2 B 85 HIS A 381 HIS.? 27.31 O1 EDO B 603 B 171 ARG A 397 ARG~? 24.94 O2 GOL D 601 B 190 LYS A 388 LYS~? 27.25 O2 GOL D 601 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 25.64 1.98 6.69 25.07 4.00 6.65 coo 2.83 4.83 10.84 1.96 4.32 7.97 31.00 11.06 -6.51 32.72 12.02 -4.11 coo -8.96 9.04 2.88 -5.39 12.11 5.08 22.21 -0.11 -1.07 17.85 -4.01 1.39 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 3 3 # 3 B 85 HIS B 338 HIS.? 13.66 O1 EDO B 603 B 171 ARG A 397 ARG~? 24.94 O2 GOL D 601 B 190 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 2.83 4.83 10.84 1.96 4.32 7.97 31.00 11.06 -6.51 32.72 12.02 -4.11 coo -8.96 9.04 2.88 -5.39 12.11 5.08 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 4 3 # 4 B 85 HIS B 381 HIS.? 15.29 C2 EDO B 603 B 171 ARG B 397 ARG~? 26.01 C2 EDO B 603 B 190 LYS B 388 LYS~? 19.48 C2 EDO B 603 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 4.86 38.27 11.07 6.17 36.67 11.45 coo 2.83 4.83 10.84 1.96 4.32 7.97 10.79 36.41 26.32 12.94 37.68 24.51 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -0.92 37.13 17.34 -4.46 33.66 14.61 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 5 3 # 5 B 85 HIS B 381 HIS.? 15.29 C2 EDO B 603 B 171 ARG B 401 ARG.? 20.08 C2 EDO B 603 B 190 LYS B 388 LYS~? 19.48 C2 EDO B 603 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 4.86 38.27 11.07 6.17 36.67 11.45 coo 2.83 4.83 10.84 1.96 4.32 7.97 1.75 25.80 23.58 1.16 24.37 20.91 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -0.92 37.13 17.34 -4.46 33.66 14.61 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 6 3 # 6 B 85 HIS B 381 HIS.? 15.29 C2 EDO B 603 B 171 ARG B 401 ARG.? 20.08 C2 EDO B 603 B 190 LYS B 390 LYS~? 27.12 C2 EDO B 603 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 4.86 38.27 11.07 6.17 36.67 11.45 coo 2.83 4.83 10.84 1.96 4.32 7.97 1.75 25.80 23.58 1.16 24.37 20.91 coo -8.96 9.04 2.88 -5.39 12.11 5.08 3.52 38.72 20.17 3.15 45.06 20.21 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 7 3 # 7 B 85 HIS C 338 HIS~? 12.91 O1 EDO C 602 B 171 ARG D 397 ARG~? 26.17 C3 GOL D 601 B 190 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 2.83 4.83 10.84 1.96 4.32 7.97 40.54 0.77 -47.66 42.41 1.45 -45.29 coo -8.96 9.04 2.88 -5.39 12.11 5.08 27.51 4.47 -43.69 23.30 8.13 -41.81 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 8 3 # 8 B 85 HIS C 381 HIS~? 16.26 O2 EDO C 602 B 171 ARG C 397 ARG~? 23.93 O1 EDO B 603 B 190 LYS C 388 LYS~? 20.15 C2 EDO C 602 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 19.26 30.57 -26.59 20.09 28.69 -27.02 coo 2.83 4.83 10.84 1.96 4.32 7.97 25.49 26.02 -11.91 27.94 26.82 -13.64 coo -8.96 9.04 2.88 -5.39 12.11 5.08 13.46 28.58 -20.25 9.42 25.73 -22.18 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 9 3 # 9 B 85 HIS D 381 HIS.? 16.49 O3 GOL D 601 B 171 ARG D 397 ARG~? 26.17 C3 GOL D 601 B 190 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 36.03 -8.97 -35.15 35.55 -7.12 -34.29 coo 2.83 4.83 10.84 1.96 4.32 7.97 40.54 0.77 -47.66 42.41 1.45 -45.29 coo -8.96 9.04 2.88 -5.39 12.11 5.08 31.25 -9.34 -42.79 29.68 -12.48 -44.35 1azy_c01 source 1azy THYMIDINE PHOSPHORYLASE : 9 hits 1azy_c01 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP A 357 ASP.? 25.14 C1 EDO B 603 A 182 GLU A 342 GLU^? 20.93 C1 EDO B 603 A 286 ASN B 324 ASN.? 26.30 C1 EDO B 603 coo 26.03 44.66 108.90 25.67 42.61 108.82 22.54 16.74 19.72 22.05 16.00 21.61 coo 18.06 44.02 105.38 18.08 45.37 107.03 16.70 11.35 13.94 16.42 9.25 14.14 coo 25.47 38.28 112.06 27.26 39.30 111.54 26.83 13.52 17.81 25.43 13.66 19.36 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 A 109 ASP B 357 ASP.? 13.04 C1 EDO B 603 A 182 GLU B 342 GLU^? -3.54 O2 EDO B 603s A 286 ASN A 324 ASN.? 13.71 O2 EDO B 603 coo 26.03 44.66 108.90 25.67 42.61 108.82 19.95 30.44 0.55 20.02 30.85 -1.53 coo 18.06 44.02 105.38 18.08 45.37 107.03 10.25 28.44 3.00 8.52 29.59 2.44 coo 25.47 38.28 112.06 27.26 39.30 111.54 19.23 35.37 3.15 19.16 34.35 1.29 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 A 109 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 182 GLU C 394 GLU~? 16.86 O1 EDO B 603 A 286 ASN C 376 ASN~? 24.86 O2 EDO C 602 coo 26.03 44.66 108.90 25.67 42.61 108.82 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 18.06 44.02 105.38 18.08 45.37 107.03 19.77 27.90 -12.93 18.57 29.44 -12.10 coo 25.47 38.28 112.06 27.26 39.30 111.54 27.15 34.69 -21.55 26.19 33.87 -19.83 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 A 109 ASP C 357 ASP.? 12.50 O2 EDO C 602 A 182 GLU C 342 GLU^? -3.52 O2 EDO C 602s A 286 ASN D 324 ASN.? 13.50 O2 EDO C 602 coo 26.03 44.66 108.90 25.67 42.61 108.82 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 18.06 44.02 105.38 18.08 45.37 107.03 22.61 19.18 -35.41 20.92 20.43 -35.77 coo 25.47 38.28 112.06 27.26 39.30 111.54 32.08 25.49 -35.40 31.73 24.73 -37.32 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 5 3 # 5 A 109 ASP D 349 ASP.? 28.27 C3 GOL D 601 A 182 GLU D 378 GLU~? 27.27 O3 GOL D 601 A 286 ASN D 347 ASN^? 23.69 C3 GOL D 601 coo 26.03 44.66 108.90 25.67 42.61 108.82 47.11 1.34 -40.59 48.04 2.96 -41.60 coo 18.06 44.02 105.38 18.08 45.37 107.03 43.18 -8.44 -40.40 44.74 -9.12 -41.62 coo 25.47 38.28 112.06 27.26 39.30 111.54 43.61 4.31 -37.61 45.14 2.83 -37.46 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 6 3 # 6 A 109 ASP D 357 ASP.? 12.64 O3 GOL D 601 A 182 GLU D 342 GLU^? -3.57 O3 GOL D 601s A 286 ASN C 324 ASN.? 13.62 O3 GOL D 601 coo 26.03 44.66 108.90 25.67 42.61 108.82 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 18.06 44.02 105.38 18.08 45.37 107.03 28.06 0.59 -26.56 27.66 -1.50 -26.76 coo 25.47 38.28 112.06 27.26 39.30 111.54 38.59 2.13 -22.95 37.27 2.55 -21.34 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 6 hits 1b57_c00 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP A 357 ASP.? 25.14 C1 EDO B 603 B 182 GLU A 342 GLU^? 20.93 C1 EDO B 603 B 286 ASN B 324 ASN.? 26.30 C1 EDO B 603 coo 13.82 69.26 132.27 11.87 70.14 132.51 22.54 16.74 19.72 22.05 16.00 21.61 coo 8.74 63.05 136.42 9.87 62.19 134.79 16.70 11.35 13.94 16.42 9.25 14.14 coo 8.26 72.60 129.22 10.14 73.45 129.80 26.83 13.52 17.81 25.43 13.66 19.36 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 B 109 ASP B 350 ASP.? 23.89 C2 EDO B 603 B 182 GLU B 378 GLU~? 25.07 O2 EDO B 603 B 286 ASN B 347 ASN^? 23.37 C2 EDO B 603 coo 13.82 69.26 132.27 11.87 70.14 132.51 12.16 40.72 19.41 11.14 39.74 20.98 coo 8.74 63.05 136.42 9.87 62.19 134.79 7.63 44.96 15.04 7.63 45.65 17.05 coo 8.26 72.60 129.22 10.14 73.45 129.80 18.47 36.73 18.25 18.44 38.86 18.15 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 B 109 ASP B 357 ASP.? 13.04 C1 EDO B 603 B 182 GLU B 342 GLU^? -3.54 O2 EDO B 603s B 286 ASN A 324 ASN.? 13.71 O2 EDO B 603 coo 13.82 69.26 132.27 11.87 70.14 132.51 19.95 30.44 0.55 20.02 30.85 -1.53 coo 8.74 63.05 136.42 9.87 62.19 134.79 10.25 28.44 3.00 8.52 29.59 2.44 coo 8.26 72.60 129.22 10.14 73.45 129.80 19.23 35.37 3.15 19.16 34.35 1.29 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 B 109 ASP C 350 ASP.? 24.48 C2 EDO C 602 B 182 GLU C 394 GLU~? 16.86 O1 EDO B 603 B 286 ASN C 376 ASN~? 24.86 O2 EDO C 602 coo 13.82 69.26 132.27 11.87 70.14 132.51 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 8.74 63.05 136.42 9.87 62.19 134.79 19.77 27.90 -12.93 18.57 29.44 -12.10 coo 8.26 72.60 129.22 10.14 73.45 129.80 27.15 34.69 -21.55 26.19 33.87 -19.83 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 5 3 # 5 B 109 ASP C 357 ASP.? 12.50 O2 EDO C 602 B 182 GLU C 342 GLU^? -3.52 O2 EDO C 602s B 286 ASN D 324 ASN.? 13.50 O2 EDO C 602 coo 13.82 69.26 132.27 11.87 70.14 132.51 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 8.74 63.05 136.42 9.87 62.19 134.79 22.61 19.18 -35.41 20.92 20.43 -35.77 coo 8.26 72.60 129.22 10.14 73.45 129.80 32.08 25.49 -35.40 31.73 24.73 -37.32 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 6 3 # 6 B 109 ASP D 349 ASP.? 28.27 C3 GOL D 601 B 182 GLU D 378 GLU~? 27.27 O3 GOL D 601 B 286 ASN D 347 ASN^? 23.69 C3 GOL D 601 coo 13.82 69.26 132.27 11.87 70.14 132.51 47.11 1.34 -40.59 48.04 2.96 -41.60 coo 8.74 63.05 136.42 9.87 62.19 134.79 43.18 -8.44 -40.40 44.74 -9.12 -41.62 coo 8.26 72.60 129.22 10.14 73.45 129.80 43.61 4.31 -37.61 45.14 2.83 -37.46 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 7 3 # 7 B 109 ASP D 357 ASP.? 12.64 O3 GOL D 601 B 182 GLU D 342 GLU^? -3.57 O3 GOL D 601s B 286 ASN C 324 ASN.? 13.62 O3 GOL D 601 coo 13.82 69.26 132.27 11.87 70.14 132.51 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 8.74 63.05 136.42 9.87 62.19 134.79 28.06 0.59 -26.56 27.66 -1.50 -26.76 coo 8.26 72.60 129.22 10.14 73.45 129.80 38.59 2.13 -22.95 37.27 2.55 -21.34 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 7 hits 1b57_c01 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 431 PHE^? 22.59 O1 EDO B 603 A 159 ASP A 349 ASP.? 30.68 C1 EDO B 603 A 188 LYS A 390 LYS~? 25.88 O2 GOL D 601 coo 13.91 34.58 14.67 12.95 36.00 12.47 29.40 15.33 -4.65 28.40 13.37 -2.94 coo 20.97 28.40 16.26 20.19 30.15 15.34 36.99 12.23 1.79 37.88 13.87 0.83 coo 22.55 41.65 15.60 18.92 37.20 14.63 26.64 2.81 -1.98 30.91 -1.55 -0.35 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE A 444 PHE~? 11.79 C1 EDO B 603 A 159 ASP A 448 ASP~? 19.70 O1 EDO B 603 A 188 LYS B 415 LYS^? -2.82 O2 EDO B 603s coo 13.91 34.58 14.67 12.95 36.00 12.47 2.91 15.92 8.56 5.14 17.37 9.33 coo 20.97 28.40 16.26 20.19 30.15 15.34 -6.12 13.55 5.97 -7.03 12.86 4.20 coo 22.55 41.65 15.60 18.92 37.20 14.63 1.57 23.62 -1.31 7.49 26.02 -1.78 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE A 445 PHE~? 17.72 O1 EDO B 603 A 159 ASP B 448 ASP.? 21.29 O1 EDO B 603 A 188 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 13.91 34.58 14.67 12.95 36.00 12.47 -0.28 10.05 7.85 1.97 9.05 6.47 coo 20.97 28.40 16.26 20.19 30.15 15.34 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo 22.55 41.65 15.60 18.92 37.20 14.63 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE B 431 PHE^? 23.47 C2 EDO B 603 A 159 ASP B 349 ASP.? 28.06 C2 EDO B 603 A 188 LYS B 390 LYS~? 27.12 C2 EDO B 603 coo 13.91 34.58 14.67 12.95 36.00 12.47 13.65 32.28 24.99 12.40 33.20 22.64 coo 20.97 28.40 16.26 20.19 30.15 15.34 17.36 41.29 21.17 18.85 41.14 22.68 coo 22.55 41.65 15.60 18.92 37.20 14.63 3.52 38.72 20.17 3.15 45.06 20.21 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 5 3 # 5 A 88 PHE B 444 PHE~? 10.27 O1 EDO B 603 A 159 ASP A 448 ASP~? 19.70 O1 EDO B 603 A 188 LYS B 415 LYS^? -2.82 O2 EDO B 603s coo 13.91 34.58 14.67 12.95 36.00 12.47 5.02 14.17 3.93 7.63 15.10 4.40 coo 20.97 28.40 16.26 20.19 30.15 15.34 -6.12 13.55 5.97 -7.03 12.86 4.20 coo 22.55 41.65 15.60 18.92 37.20 14.63 1.57 23.62 -1.31 7.49 26.02 -1.78 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 6 3 # 6 A 88 PHE B 445 PHE~? 13.78 O1 EDO B 603 A 159 ASP B 448 ASP.? 21.29 O1 EDO B 603 A 188 LYS A 442 LYS~? 23.27 C1 EDO B 603 coo 13.91 34.58 14.67 12.95 36.00 12.47 -1.25 14.50 2.62 -1.24 15.79 5.10 coo 20.97 28.40 16.26 20.19 30.15 15.34 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo 22.55 41.65 15.60 18.92 37.20 14.63 2.76 10.16 11.03 0.96 5.43 12.32 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 7 3 # 7 A 88 PHE C 445 PHE~? 14.33 C2 EDO C 602 A 159 ASP C 448 ASP.? 19.32 O1 GOL D 601 A 188 LYS D 442 LYS~? 12.65 O2 GOL D 601 coo 13.91 34.58 14.67 12.95 36.00 12.47 9.78 6.26 -35.53 9.91 7.07 -32.85 coo 20.97 28.40 16.26 20.19 30.15 15.34 9.52 -2.93 -40.85 10.47 -4.20 -39.42 coo 22.55 41.65 15.60 18.92 37.20 14.63 14.14 0.83 -27.84 11.41 -3.18 -25.91 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 8 3 # 8 A 88 PHE C 445 PHE~? 14.33 C2 EDO C 602 A 159 ASP D 448 ASP.? 19.66 C2 EDO C 602 A 188 LYS D 442 LYS~? 12.65 O2 GOL D 601 coo 13.91 34.58 14.67 12.95 36.00 12.47 9.78 6.26 -35.53 9.91 7.07 -32.85 coo 20.97 28.40 16.26 20.19 30.15 15.34 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 22.55 41.65 15.60 18.92 37.20 14.63 14.14 0.83 -27.84 11.41 -3.18 -25.91 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 9 3 # 9 A 88 PHE D 431 PHE^? 21.51 O1 EDO C 602 A 159 ASP D 349 ASP.? 28.27 C3 GOL D 601 A 188 LYS D 390 LYS~? 25.65 O3 GOL D 601 coo 13.91 34.58 14.67 12.95 36.00 12.47 39.18 5.51 -45.56 38.23 3.44 -43.92 coo 20.97 28.40 16.26 20.19 30.15 15.34 47.11 1.34 -40.59 48.04 2.96 -41.60 coo 22.55 41.65 15.60 18.92 37.20 14.63 35.81 -6.92 -44.49 39.58 -10.95 -43.36 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 10 3 # 10 A 88 PHE D 445 PHE~? 11.88 O1 GOL D 601 A 159 ASP C 448 ASP.? 19.32 O1 GOL D 601 A 188 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 13.91 34.58 14.67 12.95 36.00 12.47 10.86 1.23 -30.60 12.85 0.20 -32.29 coo 20.97 28.40 16.26 20.19 30.15 15.34 9.52 -2.93 -40.85 10.47 -4.20 -39.42 coo 22.55 41.65 15.60 18.92 37.20 14.63 12.96 9.36 -37.91 9.04 10.02 -41.38 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 11 3 # 11 A 88 PHE D 445 PHE~? 11.88 O1 GOL D 601 A 159 ASP D 448 ASP.? 19.66 C2 EDO C 602 A 188 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 13.91 34.58 14.67 12.95 36.00 12.47 10.86 1.23 -30.60 12.85 0.20 -32.29 coo 20.97 28.40 16.26 20.19 30.15 15.34 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 22.55 41.65 15.60 18.92 37.20 14.63 12.96 9.36 -37.91 9.04 10.02 -41.38 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 11 hits 1b9h_c02 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 316 ARG.? 27.22 C1 EDO B 603 A 141 THR A 318 THR.? 30.43 C1 EDO B 603 A 235 ASP A 357 ASP.? 25.14 C1 EDO B 603 coo 6.21 93.81 36.58 4.58 96.33 37.17 32.66 26.75 19.60 30.80 24.65 18.26 coo 6.80 92.87 28.33 4.91 92.74 27.40 30.31 35.91 17.26 32.03 37.29 17.23 coo 12.98 90.36 47.57 11.26 89.62 46.62 22.54 16.74 19.72 22.05 16.00 21.61 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG A 375 ARG.? 36.99 C1 EDO B 603 A 141 THR A 369 THR~? 31.64 C1 EDO B 603 A 235 ASP A 349 ASP.? 30.68 C1 EDO B 603 coo 6.21 93.81 36.58 4.58 96.33 37.17 34.50 3.88 12.57 36.52 3.36 14.83 coo 6.80 92.87 28.33 4.91 92.74 27.40 27.07 6.63 18.00 27.23 4.49 18.30 coo 12.98 90.36 47.57 11.26 89.62 46.62 36.99 12.23 1.79 37.88 13.87 0.83 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 A 137 ARG B 316 ARG.? 22.40 C1 EDO B 603 A 141 THR B 318 THR.? 31.71 C1 EDO B 603 A 235 ASP B 357 ASP.? 13.04 C1 EDO B 603 coo 6.21 93.81 36.58 4.58 96.33 37.17 32.74 31.58 5.20 30.84 29.65 3.70 coo 6.80 92.87 28.33 4.91 92.74 27.40 38.06 24.71 9.55 39.51 25.67 10.82 coo 12.98 90.36 47.57 11.26 89.62 46.62 19.95 30.44 0.55 20.02 30.85 -1.53 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 A 137 ARG B 375 ARG.? 22.49 O2 EDO B 603 A 141 THR B 369 THR~? 15.82 O2 EDO B 603 A 235 ASP B 349 ASP.? 28.06 C2 EDO B 603 coo 6.21 93.81 36.58 4.58 96.33 37.17 13.81 46.43 8.85 13.44 47.64 6.03 coo 6.80 92.87 28.33 4.91 92.74 27.40 14.08 40.07 2.07 12.56 41.55 1.60 coo 12.98 90.36 47.57 11.26 89.62 46.62 17.36 41.29 21.17 18.85 41.14 22.68 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 A 137 ARG C 316 ARG.? 22.36 C1 EDO C 602 A 141 THR C 318 THR.? 30.49 C2 GOL D 601 A 235 ASP C 357 ASP.? 12.50 O2 EDO C 602 coo 6.21 93.81 36.58 4.58 96.33 37.17 45.68 20.68 -34.53 42.70 20.67 -33.83 coo 6.80 92.87 28.33 4.91 92.74 27.40 50.21 12.77 -31.72 51.79 13.54 -30.47 coo 12.98 90.36 47.57 11.26 89.62 46.62 32.02 20.63 -38.57 31.77 21.72 -40.39 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 A 137 ARG C 375 ARG.? 20.99 O2 EDO C 602 A 141 THR C 369 THR~? 15.84 O2 EDO C 602 A 235 ASP C 349 ASP.? 28.09 C1 EDO C 602 coo 6.21 93.81 36.58 4.58 96.33 37.17 27.90 36.71 -28.33 26.60 36.43 -31.10 coo 6.80 92.87 28.33 4.91 92.74 27.40 27.27 30.44 -36.03 26.03 32.19 -36.25 coo 12.98 90.36 47.57 11.26 89.62 46.62 32.59 30.21 -17.31 34.23 29.55 -16.13 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 A 137 ARG D 316 ARG.? 22.70 C2 GOL D 601 A 141 THR D 318 THR.? 30.09 C1 EDO C 602 A 235 ASP D 357 ASP.? 12.64 O3 GOL D 601 coo 6.21 93.81 36.58 4.58 96.33 37.17 45.13 14.38 -20.32 42.13 14.31 -19.52 coo 6.80 92.87 28.33 4.91 92.74 27.40 44.56 23.70 -22.81 46.55 24.41 -23.21 coo 12.98 90.36 47.57 11.26 89.62 46.62 34.52 5.19 -20.65 34.58 3.94 -18.98 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 A 137 ARG D 375 ARG.? 23.45 O3 GOL D 601 A 141 THR D 369 THR~? 16.21 O3 GOL D 601 A 235 ASP D 349 ASP.? 28.27 C3 GOL D 601 coo 6.21 93.81 36.58 4.58 96.33 37.17 45.57 -7.61 -30.32 45.87 -9.61 -28.01 coo 6.80 92.87 28.33 4.91 92.74 27.40 38.48 -5.77 -24.43 38.79 -7.85 -25.06 coo 12.98 90.36 47.57 11.26 89.62 46.62 47.11 1.34 -40.59 48.04 2.96 -41.60 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 8 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 316 ARG.? 27.22 C1 EDO B 603 D 141 THR A 318 THR.? 30.43 C1 EDO B 603 D 235 ASP A 357 ASP.? 25.14 C1 EDO B 603 coo -8.33 92.80 100.06 -7.71 95.33 98.44 32.66 26.75 19.60 30.80 24.65 18.26 coo -9.24 93.49 108.77 -7.37 94.21 109.61 30.31 35.91 17.26 32.03 37.29 17.23 coo -14.64 87.74 89.51 -12.89 87.43 90.65 22.54 16.74 19.72 22.05 16.00 21.61 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG A 375 ARG.? 36.99 C1 EDO B 603 D 141 THR A 369 THR~? 31.64 C1 EDO B 603 D 235 ASP A 349 ASP.? 30.68 C1 EDO B 603 coo -8.33 92.80 100.06 -7.71 95.33 98.44 34.50 3.88 12.57 36.52 3.36 14.83 coo -9.24 93.49 108.77 -7.37 94.21 109.61 27.07 6.63 18.00 27.23 4.49 18.30 coo -14.64 87.74 89.51 -12.89 87.43 90.65 36.99 12.23 1.79 37.88 13.87 0.83 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 D 137 ARG B 316 ARG.? 22.40 C1 EDO B 603 D 141 THR B 318 THR.? 31.71 C1 EDO B 603 D 235 ASP B 357 ASP.? 13.04 C1 EDO B 603 coo -8.33 92.80 100.06 -7.71 95.33 98.44 32.74 31.58 5.20 30.84 29.65 3.70 coo -9.24 93.49 108.77 -7.37 94.21 109.61 38.06 24.71 9.55 39.51 25.67 10.82 coo -14.64 87.74 89.51 -12.89 87.43 90.65 19.95 30.44 0.55 20.02 30.85 -1.53 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 D 137 ARG B 375 ARG.? 22.49 O2 EDO B 603 D 141 THR B 369 THR~? 15.82 O2 EDO B 603 D 235 ASP B 349 ASP.? 28.06 C2 EDO B 603 coo -8.33 92.80 100.06 -7.71 95.33 98.44 13.81 46.43 8.85 13.44 47.64 6.03 coo -9.24 93.49 108.77 -7.37 94.21 109.61 14.08 40.07 2.07 12.56 41.55 1.60 coo -14.64 87.74 89.51 -12.89 87.43 90.65 17.36 41.29 21.17 18.85 41.14 22.68 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 D 137 ARG C 316 ARG.? 22.36 C1 EDO C 602 D 141 THR C 318 THR.? 30.49 C2 GOL D 601 D 235 ASP C 357 ASP.? 12.50 O2 EDO C 602 coo -8.33 92.80 100.06 -7.71 95.33 98.44 45.68 20.68 -34.53 42.70 20.67 -33.83 coo -9.24 93.49 108.77 -7.37 94.21 109.61 50.21 12.77 -31.72 51.79 13.54 -30.47 coo -14.64 87.74 89.51 -12.89 87.43 90.65 32.02 20.63 -38.57 31.77 21.72 -40.39 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 D 137 ARG C 375 ARG.? 20.99 O2 EDO C 602 D 141 THR C 369 THR~? 15.84 O2 EDO C 602 D 235 ASP C 349 ASP.? 28.09 C1 EDO C 602 coo -8.33 92.80 100.06 -7.71 95.33 98.44 27.90 36.71 -28.33 26.60 36.43 -31.10 coo -9.24 93.49 108.77 -7.37 94.21 109.61 27.27 30.44 -36.03 26.03 32.19 -36.25 coo -14.64 87.74 89.51 -12.89 87.43 90.65 32.59 30.21 -17.31 34.23 29.55 -16.13 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 D 137 ARG D 316 ARG.? 22.70 C2 GOL D 601 D 141 THR D 318 THR.? 30.09 C1 EDO C 602 D 235 ASP D 357 ASP.? 12.64 O3 GOL D 601 coo -8.33 92.80 100.06 -7.71 95.33 98.44 45.13 14.38 -20.32 42.13 14.31 -19.52 coo -9.24 93.49 108.77 -7.37 94.21 109.61 44.56 23.70 -22.81 46.55 24.41 -23.21 coo -14.64 87.74 89.51 -12.89 87.43 90.65 34.52 5.19 -20.65 34.58 3.94 -18.98 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 D 137 ARG D 375 ARG.? 23.45 O3 GOL D 601 D 141 THR D 369 THR~? 16.21 O3 GOL D 601 D 235 ASP D 349 ASP.? 28.27 C3 GOL D 601 coo -8.33 92.80 100.06 -7.71 95.33 98.44 45.57 -7.61 -30.32 45.87 -9.61 -28.01 coo -9.24 93.49 108.77 -7.37 94.21 109.61 38.48 -5.77 -24.43 38.79 -7.85 -25.06 coo -14.64 87.74 89.51 -12.89 87.43 90.65 47.11 1.34 -40.59 48.04 2.96 -41.60 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 8 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 316 ARG.? 27.22 C1 EDO B 603 C 141 THR A 318 THR.? 30.43 C1 EDO B 603 C 235 ASP A 357 ASP.? 25.14 C1 EDO B 603 coo -5.79 67.26 36.83 -4.57 64.58 37.74 32.66 26.75 19.60 30.80 24.65 18.26 coo -6.81 68.31 28.28 -4.82 68.47 27.57 30.31 35.91 17.26 32.03 37.29 17.23 coo -13.01 70.96 47.58 -11.44 71.65 46.34 22.54 16.74 19.72 22.05 16.00 21.61 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG A 375 ARG.? 36.99 C1 EDO B 603 C 141 THR A 369 THR~? 31.64 C1 EDO B 603 C 235 ASP A 349 ASP.? 30.68 C1 EDO B 603 coo -5.79 67.26 36.83 -4.57 64.58 37.74 34.50 3.88 12.57 36.52 3.36 14.83 coo -6.81 68.31 28.28 -4.82 68.47 27.57 27.07 6.63 18.00 27.23 4.49 18.30 coo -13.01 70.96 47.58 -11.44 71.65 46.34 36.99 12.23 1.79 37.88 13.87 0.83 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 C 137 ARG B 316 ARG.? 22.40 C1 EDO B 603 C 141 THR B 318 THR.? 31.71 C1 EDO B 603 C 235 ASP B 357 ASP.? 13.04 C1 EDO B 603 coo -5.79 67.26 36.83 -4.57 64.58 37.74 32.74 31.58 5.20 30.84 29.65 3.70 coo -6.81 68.31 28.28 -4.82 68.47 27.57 38.06 24.71 9.55 39.51 25.67 10.82 coo -13.01 70.96 47.58 -11.44 71.65 46.34 19.95 30.44 0.55 20.02 30.85 -1.53 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 C 137 ARG B 375 ARG.? 22.49 O2 EDO B 603 C 141 THR B 369 THR~? 15.82 O2 EDO B 603 C 235 ASP B 349 ASP.? 28.06 C2 EDO B 603 coo -5.79 67.26 36.83 -4.57 64.58 37.74 13.81 46.43 8.85 13.44 47.64 6.03 coo -6.81 68.31 28.28 -4.82 68.47 27.57 14.08 40.07 2.07 12.56 41.55 1.60 coo -13.01 70.96 47.58 -11.44 71.65 46.34 17.36 41.29 21.17 18.85 41.14 22.68 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 C 137 ARG C 316 ARG.? 22.36 C1 EDO C 602 C 141 THR C 318 THR.? 30.49 C2 GOL D 601 C 235 ASP C 357 ASP.? 12.50 O2 EDO C 602 coo -5.79 67.26 36.83 -4.57 64.58 37.74 45.68 20.68 -34.53 42.70 20.67 -33.83 coo -6.81 68.31 28.28 -4.82 68.47 27.57 50.21 12.77 -31.72 51.79 13.54 -30.47 coo -13.01 70.96 47.58 -11.44 71.65 46.34 32.02 20.63 -38.57 31.77 21.72 -40.39 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 C 137 ARG C 375 ARG.? 20.99 O2 EDO C 602 C 141 THR C 369 THR~? 15.84 O2 EDO C 602 C 235 ASP C 349 ASP.? 28.09 C1 EDO C 602 coo -5.79 67.26 36.83 -4.57 64.58 37.74 27.90 36.71 -28.33 26.60 36.43 -31.10 coo -6.81 68.31 28.28 -4.82 68.47 27.57 27.27 30.44 -36.03 26.03 32.19 -36.25 coo -13.01 70.96 47.58 -11.44 71.65 46.34 32.59 30.21 -17.31 34.23 29.55 -16.13 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 C 137 ARG D 316 ARG.? 22.70 C2 GOL D 601 C 141 THR D 318 THR.? 30.09 C1 EDO C 602 C 235 ASP D 357 ASP.? 12.64 O3 GOL D 601 coo -5.79 67.26 36.83 -4.57 64.58 37.74 45.13 14.38 -20.32 42.13 14.31 -19.52 coo -6.81 68.31 28.28 -4.82 68.47 27.57 44.56 23.70 -22.81 46.55 24.41 -23.21 coo -13.01 70.96 47.58 -11.44 71.65 46.34 34.52 5.19 -20.65 34.58 3.94 -18.98 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 C 137 ARG D 375 ARG.? 23.45 O3 GOL D 601 C 141 THR D 369 THR~? 16.21 O3 GOL D 601 C 235 ASP D 349 ASP.? 28.27 C3 GOL D 601 coo -5.79 67.26 36.83 -4.57 64.58 37.74 45.57 -7.61 -30.32 45.87 -9.61 -28.01 coo -6.81 68.31 28.28 -4.82 68.47 27.57 38.48 -5.77 -24.43 38.79 -7.85 -25.06 coo -13.01 70.96 47.58 -11.44 71.65 46.34 47.11 1.34 -40.59 48.04 2.96 -41.60 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 8 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 316 ARG.? 27.22 C1 EDO B 603 B 141 THR A 318 THR.? 30.43 C1 EDO B 603 B 235 ASP A 357 ASP.? 25.14 C1 EDO B 603 coo 8.13 67.41 100.27 7.18 68.35 97.45 32.66 26.75 19.60 30.80 24.65 18.26 coo 8.28 67.78 108.81 6.22 67.65 109.43 30.31 35.91 17.26 32.03 37.29 17.23 coo 14.55 73.52 89.47 12.81 73.95 90.56 22.54 16.74 19.72 22.05 16.00 21.61 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG A 375 ARG.? 36.99 C1 EDO B 603 B 141 THR A 369 THR~? 31.64 C1 EDO B 603 B 235 ASP A 349 ASP.? 30.68 C1 EDO B 603 coo 8.13 67.41 100.27 7.18 68.35 97.45 34.50 3.88 12.57 36.52 3.36 14.83 coo 8.28 67.78 108.81 6.22 67.65 109.43 27.07 6.63 18.00 27.23 4.49 18.30 coo 14.55 73.52 89.47 12.81 73.95 90.56 36.99 12.23 1.79 37.88 13.87 0.83 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 B 137 ARG B 316 ARG.? 22.40 C1 EDO B 603 B 141 THR B 318 THR.? 31.71 C1 EDO B 603 B 235 ASP B 357 ASP.? 13.04 C1 EDO B 603 coo 8.13 67.41 100.27 7.18 68.35 97.45 32.74 31.58 5.20 30.84 29.65 3.70 coo 8.28 67.78 108.81 6.22 67.65 109.43 38.06 24.71 9.55 39.51 25.67 10.82 coo 14.55 73.52 89.47 12.81 73.95 90.56 19.95 30.44 0.55 20.02 30.85 -1.53 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 B 137 ARG B 375 ARG.? 22.49 O2 EDO B 603 B 141 THR B 369 THR~? 15.82 O2 EDO B 603 B 235 ASP B 349 ASP.? 28.06 C2 EDO B 603 coo 8.13 67.41 100.27 7.18 68.35 97.45 13.81 46.43 8.85 13.44 47.64 6.03 coo 8.28 67.78 108.81 6.22 67.65 109.43 14.08 40.07 2.07 12.56 41.55 1.60 coo 14.55 73.52 89.47 12.81 73.95 90.56 17.36 41.29 21.17 18.85 41.14 22.68 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 B 137 ARG C 316 ARG.? 22.36 C1 EDO C 602 B 141 THR C 318 THR.? 30.49 C2 GOL D 601 B 235 ASP C 357 ASP.? 12.50 O2 EDO C 602 coo 8.13 67.41 100.27 7.18 68.35 97.45 45.68 20.68 -34.53 42.70 20.67 -33.83 coo 8.28 67.78 108.81 6.22 67.65 109.43 50.21 12.77 -31.72 51.79 13.54 -30.47 coo 14.55 73.52 89.47 12.81 73.95 90.56 32.02 20.63 -38.57 31.77 21.72 -40.39 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 B 137 ARG C 368 ARG.? 10.85 O2 EDO C 602 B 141 THR C 369 THR~? 15.84 O2 EDO C 602 B 235 ASP C 440 ASP^? 5.97 O1 EDO C 602 coo 8.13 67.41 100.27 7.18 68.35 97.45 24.45 26.16 -32.00 21.85 25.58 -30.53 coo 8.28 67.78 108.81 6.22 67.65 109.43 27.27 30.44 -36.03 26.03 32.19 -36.25 coo 14.55 73.52 89.47 12.81 73.95 90.56 17.33 13.03 -37.56 15.74 12.38 -38.82 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 B 137 ARG C 375 ARG.? 20.99 O2 EDO C 602 B 141 THR C 369 THR~? 15.84 O2 EDO C 602 B 235 ASP C 349 ASP.? 28.09 C1 EDO C 602 coo 8.13 67.41 100.27 7.18 68.35 97.45 27.90 36.71 -28.33 26.60 36.43 -31.10 coo 8.28 67.78 108.81 6.22 67.65 109.43 27.27 30.44 -36.03 26.03 32.19 -36.25 coo 14.55 73.52 89.47 12.81 73.95 90.56 32.59 30.21 -17.31 34.23 29.55 -16.13 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 B 137 ARG D 316 ARG.? 22.70 C2 GOL D 601 B 141 THR D 318 THR.? 30.09 C1 EDO C 602 B 235 ASP D 357 ASP.? 12.64 O3 GOL D 601 coo 8.13 67.41 100.27 7.18 68.35 97.45 45.13 14.38 -20.32 42.13 14.31 -19.52 coo 8.28 67.78 108.81 6.22 67.65 109.43 44.56 23.70 -22.81 46.55 24.41 -23.21 coo 14.55 73.52 89.47 12.81 73.95 90.56 34.52 5.19 -20.65 34.58 3.94 -18.98 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 B 137 ARG D 375 ARG.? 23.45 O3 GOL D 601 B 141 THR D 369 THR~? 16.21 O3 GOL D 601 B 235 ASP D 349 ASP.? 28.27 C3 GOL D 601 coo 8.13 67.41 100.27 7.18 68.35 97.45 45.57 -7.61 -30.32 45.87 -9.61 -28.01 coo 8.28 67.78 108.81 6.22 67.65 109.43 38.48 -5.77 -24.43 38.79 -7.85 -25.06 coo 14.55 73.52 89.47 12.81 73.95 90.56 47.11 1.34 -40.59 48.04 2.96 -41.60 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 9 hits 1bd3_c03 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU A 342 GLU^? 20.93 C1 EDO B 603 A 503 TYR A 437 TYR^? 11.45 C1 EDO B 603 A 537 GLU A 436 GLU^? 20.55 O1 EDO B 603 coo 24.06 146.21 11.09 22.89 146.18 9.36 16.70 11.35 13.94 16.42 9.25 14.14 coo 15.91 140.69 8.32 15.71 143.39 9.13 16.79 15.50 5.48 15.91 16.43 3.01 coo 16.65 144.44 13.24 18.34 145.22 12.33 19.93 9.98 5.88 20.55 8.03 6.42 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 2 3 # 2 A 461 GLU B 342 GLU^? -3.54 O2 EDO B 603s A 503 TYR B 437 TYR^? 10.72 C1 EDO B 603 A 537 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo 24.06 146.21 11.09 22.89 146.18 9.36 10.25 28.44 3.00 8.52 29.59 2.44 coo 15.91 140.69 8.32 15.71 143.39 9.13 10.92 24.41 11.32 10.27 22.67 13.43 coo 16.65 144.44 13.24 18.34 145.22 12.33 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 3 3 # 3 A 461 GLU C 342 GLU^? -3.52 O2 EDO C 602s A 503 TYR C 437 TYR^? 9.81 O1 GOL D 601 A 537 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 24.06 146.21 11.09 22.89 146.18 9.36 22.61 19.18 -35.41 20.92 20.43 -35.77 coo 15.91 140.69 8.32 15.71 143.39 9.13 23.51 14.66 -27.39 22.94 13.02 -25.21 coo 16.65 144.44 13.24 18.34 145.22 12.33 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 4 3 # 4 A 461 GLU D 342 GLU^? -3.57 O3 GOL D 601s A 503 TYR D 437 TYR^? 9.97 C1 GOL D 601 A 537 GLU D 436 GLU^? 11.06 C3 GOL D 601 coo 24.06 146.21 11.09 22.89 146.18 9.36 28.06 0.59 -26.56 27.66 -1.50 -26.76 coo 15.91 140.69 8.32 15.71 143.39 9.13 27.83 5.60 -34.20 26.72 6.80 -36.49 coo 16.65 144.44 13.24 18.34 145.22 12.33 30.72 -0.04 -34.79 31.42 -2.01 -34.30 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 4 hits 1bgl_c08 naa= 3 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 1 3 # 1 A 451 GLU A 342 GLU^? 20.93 C1 EDO B 603 A 504 TYR A 437 TYR^? 11.45 C1 EDO B 603 A 540 GLU A 436 GLU^? 20.55 O1 EDO B 603 coo 81.34 87.29 87.22 82.36 86.09 88.61 16.70 11.35 13.94 16.42 9.25 14.14 coo 80.85 81.34 94.77 81.70 80.16 92.41 16.79 15.50 5.48 15.91 16.43 3.01 coo 79.94 80.46 88.84 81.11 81.36 87.27 19.93 9.98 5.88 20.55 8.03 6.42 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 2 3 # 2 A 451 GLU B 342 GLU^? -3.54 O2 EDO B 603s A 504 TYR B 437 TYR^? 10.72 C1 EDO B 603 A 540 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo 81.34 87.29 87.22 82.36 86.09 88.61 10.25 28.44 3.00 8.52 29.59 2.44 coo 80.85 81.34 94.77 81.70 80.16 92.41 10.92 24.41 11.32 10.27 22.67 13.43 coo 79.94 80.46 88.84 81.11 81.36 87.27 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 3 3 # 3 A 451 GLU C 342 GLU^? -3.52 O2 EDO C 602s A 504 TYR C 437 TYR^? 9.81 O1 GOL D 601 A 540 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 81.34 87.29 87.22 82.36 86.09 88.61 22.61 19.18 -35.41 20.92 20.43 -35.77 coo 80.85 81.34 94.77 81.70 80.16 92.41 23.51 14.66 -27.39 22.94 13.02 -25.21 coo 79.94 80.46 88.84 81.11 81.36 87.27 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 4 3 # 4 A 451 GLU D 342 GLU^? -3.57 O3 GOL D 601s A 504 TYR D 437 TYR^? 9.97 C1 GOL D 601 A 540 GLU D 436 GLU^? 11.06 C3 GOL D 601 coo 81.34 87.29 87.22 82.36 86.09 88.61 28.06 0.59 -26.56 27.66 -1.50 -26.76 coo 80.85 81.34 94.77 81.70 80.16 92.41 27.83 5.60 -34.20 26.72 6.80 -36.49 coo 79.94 80.46 88.84 81.11 81.36 87.27 30.72 -0.04 -34.79 31.42 -2.01 -34.30 1bhg_c02 source 1bhg BETA-GLUCURONIDASE : 4 hits 1bhg_c02 naa= 3 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 1 3 # 1 B 451 GLU B 342 GLU^? -3.54 O2 EDO B 603s B 504 TYR B 437 TYR^? 10.72 C1 EDO B 603 B 540 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo 86.52 35.28 112.74 87.08 36.38 110.99 10.25 28.44 3.00 8.52 29.59 2.44 coo 84.93 40.21 105.31 85.72 41.45 107.72 10.92 24.41 11.32 10.27 22.67 13.43 coo 83.38 41.19 112.55 85.47 40.59 112.72 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 2 3 # 2 B 451 GLU B 436 GLU^? 10.42 C2 EDO B 603 B 504 TYR B 355 TYR^? 12.60 O2 EDO B 603 B 540 GLU B 342 GLU^? -3.54 O2 EDO B 603s coo 86.52 35.28 112.74 87.08 36.38 110.99 8.55 30.19 11.17 7.66 31.90 10.29 coo 84.93 40.21 105.31 85.72 41.45 107.72 15.82 34.63 5.10 16.14 36.63 3.16 coo 83.38 41.19 112.55 85.47 40.59 112.72 10.25 28.44 3.00 8.52 29.59 2.44 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 3 3 # 3 B 451 GLU C 342 GLU^? -3.52 O2 EDO C 602s B 504 TYR C 437 TYR^? 9.81 O1 GOL D 601 B 540 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 86.52 35.28 112.74 87.08 36.38 110.99 22.61 19.18 -35.41 20.92 20.43 -35.77 coo 84.93 40.21 105.31 85.72 41.45 107.72 23.51 14.66 -27.39 22.94 13.02 -25.21 coo 83.38 41.19 112.55 85.47 40.59 112.72 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 4 3 # 4 B 451 GLU C 436 GLU^? 10.62 C2 EDO C 602 B 504 TYR C 355 TYR^? 12.28 O2 EDO C 602 B 540 GLU C 342 GLU^? -3.52 O2 EDO C 602s coo 86.52 35.28 112.74 87.08 36.38 110.99 21.74 20.63 -27.21 21.00 22.48 -27.90 coo 84.93 40.21 105.31 85.72 41.45 107.72 28.68 24.77 -33.28 28.94 26.73 -35.28 coo 83.38 41.19 112.55 85.47 40.59 112.72 22.61 19.18 -35.41 20.92 20.43 -35.77 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 5 3 # 5 B 451 GLU D 342 GLU^? -3.57 O3 GOL D 601s B 504 TYR D 437 TYR^? 9.97 C1 GOL D 601 B 540 GLU D 436 GLU^? 11.06 C3 GOL D 601 coo 86.52 35.28 112.74 87.08 36.38 110.99 28.06 0.59 -26.56 27.66 -1.50 -26.76 coo 84.93 40.21 105.31 85.72 41.45 107.72 27.83 5.60 -34.20 26.72 6.80 -36.49 coo 83.38 41.19 112.55 85.47 40.59 112.72 30.72 -0.04 -34.79 31.42 -2.01 -34.30 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 6 3 # 6 B 451 GLU D 436 GLU^? 11.06 C3 GOL D 601 B 504 TYR D 355 TYR^? 12.42 O3 GOL D 601 B 540 GLU D 342 GLU^? -3.57 O3 GOL D 601s coo 86.52 35.28 112.74 87.08 36.38 110.99 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 84.93 40.21 105.31 85.72 41.45 107.72 36.51 0.70 -26.17 37.53 -0.88 -24.11 coo 83.38 41.19 112.55 85.47 40.59 112.72 28.06 0.59 -26.56 27.66 -1.50 -26.76 1bhg_c03 source 1bhg BETA-GLUCURONIDASE : 6 hits 1bhg_c03 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG A 368 ARG.? 24.16 C1 EDO B 603 A 451 GLU A 342 GLU^? 20.93 C1 EDO B 603 A 540 GLU A 436 GLU^? 20.55 O1 EDO B 603 coo 79.04 80.20 80.81 79.58 81.40 83.63 23.91 7.22 12.24 22.49 6.03 9.76 coo 81.34 87.29 87.22 82.36 86.09 88.61 16.70 11.35 13.94 16.42 9.25 14.14 coo 79.94 80.46 88.84 81.11 81.36 87.27 19.93 9.98 5.88 20.55 8.03 6.42 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 2 3 # 2 A 382 ARG A 368 ARG.? 24.16 C1 EDO B 603 A 451 GLU A 436 GLU^? 20.55 O1 EDO B 603 A 540 GLU A 342 GLU^? 20.93 C1 EDO B 603 coo 79.04 80.20 80.81 79.58 81.40 83.63 23.91 7.22 12.24 22.49 6.03 9.76 coo 81.34 87.29 87.22 82.36 86.09 88.61 19.93 9.98 5.88 20.55 8.03 6.42 coo 79.94 80.46 88.84 81.11 81.36 87.27 16.70 11.35 13.94 16.42 9.25 14.14 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 3 3 # 3 A 382 ARG B 368 ARG.? 11.04 O2 EDO B 603 A 451 GLU B 342 GLU^? -3.54 O2 EDO B 603s A 540 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo 79.04 80.20 80.81 79.58 81.40 83.63 11.09 36.07 6.20 8.36 35.36 7.43 coo 81.34 87.29 87.22 82.36 86.09 88.61 10.25 28.44 3.00 8.52 29.59 2.44 coo 79.94 80.46 88.84 81.11 81.36 87.27 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 4 3 # 4 A 382 ARG B 368 ARG.? 11.04 O2 EDO B 603 A 451 GLU B 436 GLU^? 10.42 C2 EDO B 603 A 540 GLU B 342 GLU^? -3.54 O2 EDO B 603s coo 79.04 80.20 80.81 79.58 81.40 83.63 11.09 36.07 6.20 8.36 35.36 7.43 coo 81.34 87.29 87.22 82.36 86.09 88.61 8.55 30.19 11.17 7.66 31.90 10.29 coo 79.94 80.46 88.84 81.11 81.36 87.27 10.25 28.44 3.00 8.52 29.59 2.44 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 5 3 # 5 A 382 ARG C 368 ARG.? 10.85 O2 EDO C 602 A 451 GLU C 342 GLU^? -3.52 O2 EDO C 602s A 540 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 79.04 80.20 80.81 79.58 81.40 83.63 24.45 26.16 -32.00 21.85 25.58 -30.53 coo 81.34 87.29 87.22 82.36 86.09 88.61 22.61 19.18 -35.41 20.92 20.43 -35.77 coo 79.94 80.46 88.84 81.11 81.36 87.27 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 6 3 # 6 A 382 ARG C 368 ARG.? 10.85 O2 EDO C 602 A 451 GLU C 436 GLU^? 10.62 C2 EDO C 602 A 540 GLU C 342 GLU^? -3.52 O2 EDO C 602s coo 79.04 80.20 80.81 79.58 81.40 83.63 24.45 26.16 -32.00 21.85 25.58 -30.53 coo 81.34 87.29 87.22 82.36 86.09 88.61 21.74 20.63 -27.21 21.00 22.48 -27.90 coo 79.94 80.46 88.84 81.11 81.36 87.27 22.61 19.18 -35.41 20.92 20.43 -35.77 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 7 3 # 7 A 382 ARG D 368 ARG.? 11.23 O3 GOL D 601 A 451 GLU D 342 GLU^? -3.57 O3 GOL D 601s A 540 GLU D 436 GLU^? 11.06 C3 GOL D 601 coo 79.04 80.20 80.81 79.58 81.40 83.63 34.63 -3.42 -28.94 33.31 -3.73 -31.69 coo 81.34 87.29 87.22 82.36 86.09 88.61 28.06 0.59 -26.56 27.66 -1.50 -26.76 coo 79.94 80.46 88.84 81.11 81.36 87.27 30.72 -0.04 -34.79 31.42 -2.01 -34.30 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 8 3 # 8 A 382 ARG D 368 ARG.? 11.23 O3 GOL D 601 A 451 GLU D 436 GLU^? 11.06 C3 GOL D 601 A 540 GLU D 342 GLU^? -3.57 O3 GOL D 601s coo 79.04 80.20 80.81 79.58 81.40 83.63 34.63 -3.42 -28.94 33.31 -3.73 -31.69 coo 81.34 87.29 87.22 82.36 86.09 88.61 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 79.94 80.46 88.84 81.11 81.36 87.27 28.06 0.59 -26.56 27.66 -1.50 -26.76 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 8 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG B 368 ARG.? 11.04 O2 EDO B 603 B 451 GLU B 342 GLU^? -3.54 O2 EDO B 603s B 540 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo 82.21 41.07 119.14 83.95 40.66 116.59 11.09 36.07 6.20 8.36 35.36 7.43 coo 86.52 35.28 112.74 87.08 36.38 110.99 10.25 28.44 3.00 8.52 29.59 2.44 coo 83.38 41.19 112.55 85.47 40.59 112.72 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 2 3 # 2 B 382 ARG B 368 ARG.? 11.04 O2 EDO B 603 B 451 GLU B 436 GLU^? 10.42 C2 EDO B 603 B 540 GLU B 342 GLU^? -3.54 O2 EDO B 603s coo 82.21 41.07 119.14 83.95 40.66 116.59 11.09 36.07 6.20 8.36 35.36 7.43 coo 86.52 35.28 112.74 87.08 36.38 110.99 8.55 30.19 11.17 7.66 31.90 10.29 coo 83.38 41.19 112.55 85.47 40.59 112.72 10.25 28.44 3.00 8.52 29.59 2.44 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 3 3 # 3 B 382 ARG C 368 ARG.? 10.85 O2 EDO C 602 B 451 GLU C 342 GLU^? -3.52 O2 EDO C 602s B 540 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 82.21 41.07 119.14 83.95 40.66 116.59 24.45 26.16 -32.00 21.85 25.58 -30.53 coo 86.52 35.28 112.74 87.08 36.38 110.99 22.61 19.18 -35.41 20.92 20.43 -35.77 coo 83.38 41.19 112.55 85.47 40.59 112.72 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 4 3 # 4 B 382 ARG C 368 ARG.? 10.85 O2 EDO C 602 B 451 GLU C 436 GLU^? 10.62 C2 EDO C 602 B 540 GLU C 342 GLU^? -3.52 O2 EDO C 602s coo 82.21 41.07 119.14 83.95 40.66 116.59 24.45 26.16 -32.00 21.85 25.58 -30.53 coo 86.52 35.28 112.74 87.08 36.38 110.99 21.74 20.63 -27.21 21.00 22.48 -27.90 coo 83.38 41.19 112.55 85.47 40.59 112.72 22.61 19.18 -35.41 20.92 20.43 -35.77 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 5 3 # 5 B 382 ARG D 368 ARG.? 11.23 O3 GOL D 601 B 451 GLU D 342 GLU^? -3.57 O3 GOL D 601s B 540 GLU D 436 GLU^? 11.06 C3 GOL D 601 coo 82.21 41.07 119.14 83.95 40.66 116.59 34.63 -3.42 -28.94 33.31 -3.73 -31.69 coo 86.52 35.28 112.74 87.08 36.38 110.99 28.06 0.59 -26.56 27.66 -1.50 -26.76 coo 83.38 41.19 112.55 85.47 40.59 112.72 30.72 -0.04 -34.79 31.42 -2.01 -34.30 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 6 3 # 6 B 382 ARG D 368 ARG.? 11.23 O3 GOL D 601 B 451 GLU D 436 GLU^? 11.06 C3 GOL D 601 B 540 GLU D 342 GLU^? -3.57 O3 GOL D 601s coo 82.21 41.07 119.14 83.95 40.66 116.59 34.63 -3.42 -28.94 33.31 -3.73 -31.69 coo 86.52 35.28 112.74 87.08 36.38 110.99 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 83.38 41.19 112.55 85.47 40.59 112.72 28.06 0.59 -26.56 27.66 -1.50 -26.76 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 6 hits 1bhg_c05 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 397 ARG~? 24.94 O2 GOL D 601 183 LYS A 391 LYS~? 19.54 O2 GOL D 601 317 ARG A 368 ARG.? 24.16 C1 EDO B 603 coo 76.57 109.19 73.41 73.86 110.26 72.16 31.00 11.06 -6.51 32.72 12.02 -4.11 coo 82.09 117.51 66.37 80.60 114.32 71.44 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 65.21 120.62 58.76 63.62 123.14 59.66 23.91 7.22 12.24 22.49 6.03 9.76 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG A 397 ARG~? 24.94 O2 GOL D 601 183 LYS A 391 LYS~? 19.54 O2 GOL D 601 317 ARG A 375 ARG.? 36.99 C1 EDO B 603 coo 76.57 109.19 73.41 73.86 110.26 72.16 31.00 11.06 -6.51 32.72 12.02 -4.11 coo 82.09 117.51 66.37 80.60 114.32 71.44 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 65.21 120.62 58.76 63.62 123.14 59.66 34.50 3.88 12.57 36.52 3.36 14.83 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 3 3 # 3 118 ARG A 397 ARG~? 24.94 O2 GOL D 601 183 LYS A 403 LYS^? 8.85 O1 EDO B 603 317 ARG A 368 ARG.? 24.16 C1 EDO B 603 coo 76.57 109.19 73.41 73.86 110.26 72.16 31.00 11.06 -6.51 32.72 12.02 -4.11 coo 82.09 117.51 66.37 80.60 114.32 71.44 17.56 13.24 -3.73 14.59 17.27 -0.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 23.91 7.22 12.24 22.49 6.03 9.76 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 4 3 # 4 118 ARG A 401 ARG.? 15.99 O2 GOL D 601 183 LYS A 391 LYS~? 19.54 O2 GOL D 601 317 ARG A 368 ARG.? 24.16 C1 EDO B 603 coo 76.57 109.19 73.41 73.86 110.26 72.16 17.05 9.37 -8.73 16.66 7.27 -10.98 coo 82.09 117.51 66.37 80.60 114.32 71.44 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 65.21 120.62 58.76 63.62 123.14 59.66 23.91 7.22 12.24 22.49 6.03 9.76 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 5 3 # 5 118 ARG A 425 ARG^? 21.19 O1 EDO B 603 183 LYS A 348 LYS.? 29.38 O1 EDO B 603 317 ARG A 368 ARG.? 24.16 C1 EDO B 603 coo 76.57 109.19 73.41 73.86 110.26 72.16 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 82.09 117.51 66.37 80.60 114.32 71.44 33.03 14.06 -0.37 37.33 16.69 -0.99 coo 65.21 120.62 58.76 63.62 123.14 59.66 23.91 7.22 12.24 22.49 6.03 9.76 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 6 3 # 6 118 ARG B 397 ARG~? 26.01 C2 EDO B 603 183 LYS B 391 LYS~? 27.06 C2 EDO B 603 317 ARG B 368 ARG.? 11.04 O2 EDO B 603 coo 76.57 109.19 73.41 73.86 110.26 72.16 10.79 36.41 26.32 12.94 37.68 24.51 coo 82.09 117.51 66.37 80.60 114.32 71.44 1.34 36.06 21.83 0.02 35.49 25.91 coo 65.21 120.62 58.76 63.62 123.14 59.66 11.09 36.07 6.20 8.36 35.36 7.43 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 7 3 # 7 118 ARG B 397 ARG~? 26.01 C2 EDO B 603 183 LYS B 391 LYS~? 27.06 C2 EDO B 603 317 ARG B 375 ARG.? 22.49 O2 EDO B 603 coo 76.57 109.19 73.41 73.86 110.26 72.16 10.79 36.41 26.32 12.94 37.68 24.51 coo 82.09 117.51 66.37 80.60 114.32 71.44 1.34 36.06 21.83 0.02 35.49 25.91 coo 65.21 120.62 58.76 63.62 123.14 59.66 13.81 46.43 8.85 13.44 47.64 6.03 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 8 3 # 8 118 ARG B 401 ARG.? 20.08 C2 EDO B 603 183 LYS B 391 LYS~? 27.06 C2 EDO B 603 317 ARG B 368 ARG.? 11.04 O2 EDO B 603 coo 76.57 109.19 73.41 73.86 110.26 72.16 1.75 25.80 23.58 1.16 24.37 20.91 coo 82.09 117.51 66.37 80.60 114.32 71.44 1.34 36.06 21.83 0.02 35.49 25.91 coo 65.21 120.62 58.76 63.62 123.14 59.66 11.09 36.07 6.20 8.36 35.36 7.43 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 9 3 # 9 118 ARG B 425 ARG^? 24.19 C2 EDO B 603 183 LYS B 348 LYS.? 28.30 C2 EDO B 603 317 ARG A 316 ARG.? 27.22 C1 EDO B 603 coo 76.57 109.19 73.41 73.86 110.26 72.16 13.19 26.25 26.41 10.66 27.96 25.98 coo 82.09 117.51 66.37 80.60 114.32 71.44 16.25 36.62 22.07 20.01 34.44 26.08 coo 65.21 120.62 58.76 63.62 123.14 59.66 32.66 26.75 19.60 30.80 24.65 18.26 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 10 3 # 10 118 ARG C 397 ARG~? 23.93 O1 EDO B 603 183 LYS C 391 LYS~? 16.77 O1 EDO B 603 317 ARG C 368 ARG.? 10.85 O2 EDO C 602 coo 76.57 109.19 73.41 73.86 110.26 72.16 25.49 26.02 -11.91 27.94 26.82 -13.64 coo 82.09 117.51 66.37 80.60 114.32 71.44 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 65.21 120.62 58.76 63.62 123.14 59.66 24.45 26.16 -32.00 21.85 25.58 -30.53 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 11 3 # 11 118 ARG C 397 ARG~? 23.93 O1 EDO B 603 183 LYS C 403 LYS^? 9.83 O1 GOL D 601 317 ARG C 368 ARG.? 10.85 O2 EDO C 602 coo 76.57 109.19 73.41 73.86 110.26 72.16 25.49 26.02 -11.91 27.94 26.82 -13.64 coo 82.09 117.51 66.37 80.60 114.32 71.44 19.56 15.05 -18.65 18.30 10.78 -20.22 coo 65.21 120.62 58.76 63.62 123.14 59.66 24.45 26.16 -32.00 21.85 25.58 -30.53 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 12 3 # 12 118 ARG C 401 ARG.? 15.33 O1 EDO B 603 183 LYS C 391 LYS~? 16.77 O1 EDO B 603 317 ARG C 368 ARG.? 10.85 O2 EDO C 602 coo 76.57 109.19 73.41 73.86 110.26 72.16 15.13 16.06 -14.86 13.60 17.63 -12.63 coo 82.09 117.51 66.37 80.60 114.32 71.44 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 65.21 120.62 58.76 63.62 123.14 59.66 24.45 26.16 -32.00 21.85 25.58 -30.53 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 13 3 # 13 118 ARG C 425 ARG^? 21.48 O1 GOL D 601 183 LYS C 348 LYS.? 28.33 O1 GOL D 601 317 ARG C 368 ARG.? 10.85 O2 EDO C 602 coo 76.57 109.19 73.41 73.86 110.26 72.16 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 82.09 117.51 66.37 80.60 114.32 71.44 31.02 25.73 -16.52 36.61 24.80 -13.64 coo 65.21 120.62 58.76 63.62 123.14 59.66 24.45 26.16 -32.00 21.85 25.58 -30.53 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 14 3 # 14 118 ARG D 397 ARG~? 26.17 C3 GOL D 601 183 LYS D 391 LYS~? 24.88 C3 GOL D 601 317 ARG D 368 ARG.? 11.23 O3 GOL D 601 coo 76.57 109.19 73.41 73.86 110.26 72.16 40.54 0.77 -47.66 42.41 1.45 -45.29 coo 82.09 117.51 66.37 80.60 114.32 71.44 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo 65.21 120.62 58.76 63.62 123.14 59.66 34.63 -3.42 -28.94 33.31 -3.73 -31.69 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 15 3 # 15 118 ARG D 397 ARG~? 26.17 C3 GOL D 601 183 LYS D 403 LYS^? 8.04 O1 EDO C 602 317 ARG D 368 ARG.? 11.23 O3 GOL D 601 coo 76.57 109.19 73.41 73.86 110.26 72.16 40.54 0.77 -47.66 42.41 1.45 -45.29 coo 82.09 117.51 66.37 80.60 114.32 71.44 27.51 4.47 -43.69 23.30 8.13 -41.81 coo 65.21 120.62 58.76 63.62 123.14 59.66 34.63 -3.42 -28.94 33.31 -3.73 -31.69 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 16 3 # 16 118 ARG D 401 ARG.? 17.46 O1 EDO C 602 183 LYS D 391 LYS~? 24.88 C3 GOL D 601 317 ARG D 368 ARG.? 11.23 O3 GOL D 601 coo 76.57 109.19 73.41 73.86 110.26 72.16 26.50 1.94 -49.52 24.85 0.58 -47.31 coo 82.09 117.51 66.37 80.60 114.32 71.44 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo 65.21 120.62 58.76 63.62 123.14 59.66 34.63 -3.42 -28.94 33.31 -3.73 -31.69 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 17 3 # 17 118 ARG D 425 ARG^? 16.89 O1 EDO C 602 183 LYS D 348 LYS.? 27.59 O1 EDO C 602 317 ARG D 368 ARG.? 11.23 O3 GOL D 601 coo 76.57 109.19 73.41 73.86 110.26 72.16 35.18 9.71 -47.18 32.90 7.74 -47.72 coo 82.09 117.51 66.37 80.60 114.32 71.44 43.15 3.71 -41.93 47.18 7.62 -43.42 coo 65.21 120.62 58.76 63.62 123.14 59.66 34.63 -3.42 -28.94 33.31 -3.73 -31.69 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 17 hits 1bib_c00 naa= 3 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 1 3 # 1 A 102 TRP A 407 TRP^? 17.84 O1 EDO B 603 A 174 ASP B 448 ASP.? 21.29 O1 EDO B 603 A 198 LYS A 442 LYS~? 23.27 C1 EDO B 603 coo 21.59 67.76 35.19 19.10 64.95 36.34 6.49 5.24 2.04 7.76 7.03 -1.22 coo 19.39 73.14 39.98 19.70 71.07 40.14 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo 27.94 65.10 43.55 24.20 64.94 40.01 2.76 10.16 11.03 0.96 5.43 12.32 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 2 3 # 2 A 102 TRP C 407 TRP^? 15.00 C2 EDO C 602 A 174 ASP D 448 ASP.? 19.66 C2 EDO C 602 A 198 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 21.59 67.76 35.19 19.10 64.95 36.34 8.62 13.87 -28.54 9.69 13.09 -24.84 coo 19.39 73.14 39.98 19.70 71.07 40.14 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 27.94 65.10 43.55 24.20 64.94 40.01 12.96 9.36 -37.91 9.04 10.02 -41.38 1bjo_c00 source 1bjo PHOSPHOSERINE AMINOTRANSFERASE : 2 hits 1bjo_c00 naa= 3 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 1 3 # 1 30 GLY A 433 GLY^? 21.75 O1 EDO B 603 48 HIS B 338 HIS.? 13.66 O1 EDO B 603 99 ASP A 402 ASP.? 12.59 O1 EDO B 603 coo 12.38 5.55 24.25 13.27 5.59 24.39 28.83 15.24 0.20 28.24 15.62 -0.26 coo 18.80 12.68 24.53 17.69 13.54 26.08 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 17.07 18.51 26.62 16.67 17.07 28.09 18.87 16.83 -6.49 16.77 17.04 -6.49 1bp2_c00 source 1bp2 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSPHATIDE AC: 1 hits 1bp2_c00 naa= 3 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 A 82 HIS A 338 HIS~? 19.64 C1 EDO B 603 A 168 ARG B 397 ARG~? 26.01 C2 EDO B 603 A 187 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo 62.47 12.00 59.65 61.76 10.14 60.31 16.13 23.68 19.02 16.84 23.99 20.97 coo 55.10 8.37 73.00 55.48 9.59 70.20 10.79 36.41 26.32 12.94 37.68 24.51 coo 66.76 10.09 66.23 61.80 8.06 65.82 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 2 3 # 2 A 82 HIS A 381 HIS.? 27.31 O1 EDO B 603 A 168 ARG A 397 ARG~? 24.94 O2 GOL D 601 A 187 LYS A 388 LYS~? 27.25 O2 GOL D 601 coo 62.47 12.00 59.65 61.76 10.14 60.31 25.64 1.98 6.69 25.07 4.00 6.65 coo 55.10 8.37 73.00 55.48 9.59 70.20 31.00 11.06 -6.51 32.72 12.02 -4.11 coo 66.76 10.09 66.23 61.80 8.06 65.82 22.21 -0.11 -1.07 17.85 -4.01 1.39 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 3 3 # 3 A 82 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 168 ARG A 397 ARG~? 24.94 O2 GOL D 601 A 187 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 62.47 12.00 59.65 61.76 10.14 60.31 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 55.10 8.37 73.00 55.48 9.59 70.20 31.00 11.06 -6.51 32.72 12.02 -4.11 coo 66.76 10.09 66.23 61.80 8.06 65.82 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 4 3 # 4 A 82 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 168 ARG C 401 ARG.? 15.33 O1 EDO B 603 A 187 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 62.47 12.00 59.65 61.76 10.14 60.31 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 55.10 8.37 73.00 55.48 9.59 70.20 15.13 16.06 -14.86 13.60 17.63 -12.63 coo 66.76 10.09 66.23 61.80 8.06 65.82 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 5 3 # 5 A 82 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 168 ARG C 425 ARG^? 21.48 O1 GOL D 601 A 187 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 62.47 12.00 59.65 61.76 10.14 60.31 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 55.10 8.37 73.00 55.48 9.59 70.20 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 66.76 10.09 66.23 61.80 8.06 65.82 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 6 3 # 6 A 82 HIS B 381 HIS.? 15.29 C2 EDO B 603 A 168 ARG B 397 ARG~? 26.01 C2 EDO B 603 A 187 LYS B 388 LYS~? 19.48 C2 EDO B 603 coo 62.47 12.00 59.65 61.76 10.14 60.31 4.86 38.27 11.07 6.17 36.67 11.45 coo 55.10 8.37 73.00 55.48 9.59 70.20 10.79 36.41 26.32 12.94 37.68 24.51 coo 66.76 10.09 66.23 61.80 8.06 65.82 -0.92 37.13 17.34 -4.46 33.66 14.61 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 7 3 # 7 A 82 HIS C 338 HIS~? 12.91 O1 EDO C 602 A 168 ARG D 397 ARG~? 26.17 C3 GOL D 601 A 187 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 62.47 12.00 59.65 61.76 10.14 60.31 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 55.10 8.37 73.00 55.48 9.59 70.20 40.54 0.77 -47.66 42.41 1.45 -45.29 coo 66.76 10.09 66.23 61.80 8.06 65.82 27.51 4.47 -43.69 23.30 8.13 -41.81 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 8 3 # 8 A 82 HIS C 381 HIS~? 16.26 O2 EDO C 602 A 168 ARG C 397 ARG~? 23.93 O1 EDO B 603 A 187 LYS C 388 LYS~? 20.15 C2 EDO C 602 coo 62.47 12.00 59.65 61.76 10.14 60.31 19.26 30.57 -26.59 20.09 28.69 -27.02 coo 55.10 8.37 73.00 55.48 9.59 70.20 25.49 26.02 -11.91 27.94 26.82 -13.64 coo 66.76 10.09 66.23 61.80 8.06 65.82 13.46 28.58 -20.25 9.42 25.73 -22.18 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 9 3 # 9 A 82 HIS D 338 HIS~? 13.70 C1 GOL D 601 A 168 ARG A 401 ARG.? 15.99 O2 GOL D 601 A 187 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 62.47 12.00 59.65 61.76 10.14 60.31 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 55.10 8.37 73.00 55.48 9.59 70.20 17.05 9.37 -8.73 16.66 7.27 -10.98 coo 66.76 10.09 66.23 61.80 8.06 65.82 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 10 3 # 10 A 82 HIS D 338 HIS~? 13.70 C1 GOL D 601 A 168 ARG A 425 ARG^? 21.19 O1 EDO B 603 A 187 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 62.47 12.00 59.65 61.76 10.14 60.31 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 55.10 8.37 73.00 55.48 9.59 70.20 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 66.76 10.09 66.23 61.80 8.06 65.82 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 11 3 # 11 A 82 HIS D 338 HIS~? 13.70 C1 GOL D 601 A 168 ARG C 397 ARG~? 23.93 O1 EDO B 603 A 187 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 62.47 12.00 59.65 61.76 10.14 60.31 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 55.10 8.37 73.00 55.48 9.59 70.20 25.49 26.02 -11.91 27.94 26.82 -13.64 coo 66.76 10.09 66.23 61.80 8.06 65.82 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 12 3 # 12 A 82 HIS D 381 HIS.? 16.49 O3 GOL D 601 A 168 ARG D 397 ARG~? 26.17 C3 GOL D 601 A 187 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo 62.47 12.00 59.65 61.76 10.14 60.31 36.03 -8.97 -35.15 35.55 -7.12 -34.29 coo 55.10 8.37 73.00 55.48 9.59 70.20 40.54 0.77 -47.66 42.41 1.45 -45.29 coo 66.76 10.09 66.23 61.80 8.06 65.82 31.25 -9.34 -42.79 29.68 -12.48 -44.35 1brw_c00 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 12 hits 1brw_c00 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 416 PHE^? 19.67 O1 EDO B 603 A 205 ASP A 448 ASP~? 19.70 O1 EDO B 603 A 236 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 4.14 2.10 36.34 6.69 3.08 36.92 4.63 6.30 7.93 4.64 5.09 5.42 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -6.12 13.55 5.97 -7.03 12.86 4.20 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE B 408 PHE^? 9.99 C2 EDO B 603 A 205 ASP A 448 ASP~? 19.70 O1 EDO B 603 A 236 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 4.14 2.10 36.34 6.69 3.08 36.92 -2.06 28.13 5.41 0.32 29.58 4.96 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -6.12 13.55 5.97 -7.03 12.86 4.20 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE C 408 PHE^? 10.06 C2 EDO C 602 A 205 ASP D 448 ASP.? 19.66 C2 EDO C 602 A 236 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 4.14 2.10 36.34 6.69 3.08 36.92 10.46 19.61 -32.22 12.82 20.96 -32.91 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 12.96 9.36 -37.91 9.04 10.02 -41.38 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE D 416 PHE^? 11.70 C3 GOL D 601 A 205 ASP D 448 ASP.? 19.66 C2 EDO C 602 A 236 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 4.14 2.10 36.34 6.69 3.08 36.92 15.40 -2.83 -31.27 15.07 -3.80 -33.86 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 12.96 9.36 -37.91 9.04 10.02 -41.38 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 4 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN C 400 GLN.? 12.85 O1 EDO B 603 A 91 LEU C 396 LEU~? 18.49 O1 GOL D 601 A 133 GLU C 394 GLU~? 16.86 O1 EDO B 603 coo 43.58 43.67 66.73 42.32 42.78 68.15 17.76 19.88 -9.09 16.75 21.72 -9.38 coo 38.58 45.09 70.44 38.28 45.21 72.59 21.93 20.60 -16.19 21.00 19.44 -17.76 coo 44.05 36.87 70.65 43.15 38.64 69.97 19.77 27.90 -12.93 18.57 29.44 -12.10 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 1 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN C 400 GLN.? 12.85 O1 EDO B 603 B 591 LEU C 396 LEU~? 18.49 O1 GOL D 601 B 633 GLU C 394 GLU~? 16.86 O1 EDO B 603 coo 88.06 44.34 57.19 89.06 45.53 55.74 17.76 19.88 -9.09 16.75 21.72 -9.38 coo 86.70 48.66 52.61 87.15 48.69 50.51 21.93 20.60 -16.19 21.00 19.44 -17.76 coo 95.42 44.52 54.43 93.46 45.31 54.70 19.77 27.90 -12.93 18.57 29.44 -12.10 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 1 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN C 400 GLN.? 12.85 O1 EDO B 603 C1091 LEU C 396 LEU~? 18.49 O1 GOL D 601 C1133 GLU C 394 GLU~? 16.86 O1 EDO B 603 coo 68.29 34.44 43.03 66.67 34.74 44.37 17.76 19.88 -9.09 16.75 21.72 -9.38 coo 65.83 38.95 47.05 65.46 38.90 49.20 21.93 20.60 -16.19 21.00 19.44 -17.76 coo 63.14 29.39 46.25 63.84 31.31 45.74 19.77 27.90 -12.93 18.57 29.44 -12.10 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 1 hits 1bs4_c02 naa= 3 ULMN 3 1bu7_c02 CYTOCHROME P450 user 1 3 # 1 A 268 THR A 369 THR~? 31.64 C1 EDO B 603 A 393 PHE A 352 PHE^? 25.89 C1 EDO B 603 A 400 CYH A 380 CYH~? 29.74 C1 EDO B 603 coo 45.81 71.19 43.26 47.70 70.19 43.25 27.07 6.63 18.00 27.23 4.49 18.30 coo 48.54 63.17 48.16 46.74 64.99 49.22 29.09 9.19 9.94 27.10 9.67 11.86 coo 53.76 64.39 46.87 52.06 66.55 47.33 29.01 2.63 9.50 30.23 5.08 9.65 ULMN 3 1bu7_c02 CYTOCHROME P450 user 2 3 # 2 A 268 THR B 369 THR~? 15.82 O2 EDO B 603 A 393 PHE B 352 PHE^? 15.29 O2 EDO B 603 A 400 CYH B 380 CYH~? 15.26 O2 EDO B 603 coo 45.81 71.19 43.26 47.70 70.19 43.25 14.08 40.07 2.07 12.56 41.55 1.60 coo 48.54 63.17 48.16 46.74 64.99 49.22 14.23 38.41 10.43 14.31 36.78 8.15 coo 53.76 64.39 46.87 52.06 66.55 47.33 8.08 40.31 9.00 10.50 39.00 9.22 ULMN 3 1bu7_c02 CYTOCHROME P450 user 3 3 # 3 A 268 THR C 369 THR~? 15.84 O2 EDO C 602 A 393 PHE C 352 PHE^? 15.48 O2 EDO C 602 A 400 CYH C 380 CYH~? 18.52 O2 EDO C 602 coo 45.81 71.19 43.26 47.70 70.19 43.25 27.27 30.44 -36.03 26.03 32.19 -36.25 coo 48.54 63.17 48.16 46.74 64.99 49.22 27.97 28.62 -27.76 27.73 27.28 -30.22 coo 53.76 64.39 46.87 52.06 66.55 47.33 22.88 33.08 -27.72 25.47 32.05 -27.37 ULMN 3 1bu7_c02 CYTOCHROME P450 user 4 3 # 4 A 268 THR D 369 THR~? 16.21 O3 GOL D 601 A 393 PHE D 352 PHE^? 15.53 O3 GOL D 601 A 400 CYH D 380 CYH~? 19.05 O3 GOL D 601 coo 45.81 71.19 43.26 47.70 70.19 43.25 38.48 -5.77 -24.43 38.79 -7.85 -25.06 coo 48.54 63.17 48.16 46.74 64.99 49.22 40.13 -1.84 -31.50 38.47 -1.47 -29.25 coo 53.76 64.39 46.87 52.06 66.55 47.33 39.90 -9.16 -33.04 41.11 -6.65 -32.46 1bu7_c02 source 1bu7 CYTOCHROME P450 : 4 hits 1bu7_c02 naa= 3 ULMN 3 1bu7_c03 CYTOCHROME P450 user 1 3 # 1 B 268 THR A 369 THR~? 31.64 C1 EDO B 603 B 393 PHE A 352 PHE^? 25.89 C1 EDO B 603 B 400 CYH A 380 CYH~? 29.74 C1 EDO B 603 coo 37.20 116.32 52.00 35.18 117.07 52.13 27.07 6.63 18.00 27.23 4.49 18.30 coo 33.81 121.65 59.26 35.49 119.55 59.81 29.09 9.19 9.94 27.10 9.67 11.86 coo 28.79 121.15 57.00 30.51 118.99 56.70 29.01 2.63 9.50 30.23 5.08 9.65 ULMN 3 1bu7_c03 CYTOCHROME P450 user 2 3 # 2 B 268 THR B 369 THR~? 15.82 O2 EDO B 603 B 393 PHE B 352 PHE^? 15.29 O2 EDO B 603 B 400 CYH B 380 CYH~? 15.26 O2 EDO B 603 coo 37.20 116.32 52.00 35.18 117.07 52.13 14.08 40.07 2.07 12.56 41.55 1.60 coo 33.81 121.65 59.26 35.49 119.55 59.81 14.23 38.41 10.43 14.31 36.78 8.15 coo 28.79 121.15 57.00 30.51 118.99 56.70 8.08 40.31 9.00 10.50 39.00 9.22 ULMN 3 1bu7_c03 CYTOCHROME P450 user 3 3 # 3 B 268 THR C 369 THR~? 15.84 O2 EDO C 602 B 393 PHE C 352 PHE^? 15.48 O2 EDO C 602 B 400 CYH C 380 CYH~? 18.52 O2 EDO C 602 coo 37.20 116.32 52.00 35.18 117.07 52.13 27.27 30.44 -36.03 26.03 32.19 -36.25 coo 33.81 121.65 59.26 35.49 119.55 59.81 27.97 28.62 -27.76 27.73 27.28 -30.22 coo 28.79 121.15 57.00 30.51 118.99 56.70 22.88 33.08 -27.72 25.47 32.05 -27.37 ULMN 3 1bu7_c03 CYTOCHROME P450 user 4 3 # 4 B 268 THR D 369 THR~? 16.21 O3 GOL D 601 B 393 PHE D 352 PHE^? 15.53 O3 GOL D 601 B 400 CYH D 380 CYH~? 19.05 O3 GOL D 601 coo 37.20 116.32 52.00 35.18 117.07 52.13 38.48 -5.77 -24.43 38.79 -7.85 -25.06 coo 33.81 121.65 59.26 35.49 119.55 59.81 40.13 -1.84 -31.50 38.47 -1.47 -29.25 coo 28.79 121.15 57.00 30.51 118.99 56.70 39.90 -9.16 -33.04 41.11 -6.65 -32.46 1bu7_c03 source 1bu7 CYTOCHROME P450 : 4 hits 1bu7_c03 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP B 448 ASP.? 21.29 O1 EDO B 603 B 354 GLU B 446 GLU~? 12.80 O1 EDO B 603 B 421 ASP A 448 ASP~? 19.70 O1 EDO B 603 coo 25.90 8.19 53.87 25.36 6.97 52.29 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo 27.87 10.66 47.95 27.82 8.60 48.27 0.25 13.76 -3.23 0.76 15.38 -4.51 coo 26.02 1.87 43.38 25.90 1.97 45.49 -6.12 13.55 5.97 -7.03 12.86 4.20 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 1 hits 1bvz_c09 naa= 3 ULMN 3 1c54_c00 RIBONUCLEASE SA user 1 3 # 1 A 54 GLU B 436 GLU^? 10.42 C2 EDO B 603 A 65 ARG B 368 ARG.? 11.04 O2 EDO B 603 A 85 HIS B 381 HIS.? 15.29 C2 EDO B 603 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 8.55 30.19 11.17 7.66 31.90 10.29 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 11.09 36.07 6.20 8.36 35.36 7.43 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 4.86 38.27 11.07 6.17 36.67 11.45 ULMN 3 1c54_c00 RIBONUCLEASE SA user 2 3 # 2 A 54 GLU D 378 GLU~? 27.27 O3 GOL D 601 A 65 ARG D 375 ARG.? 23.45 O3 GOL D 601 A 85 HIS D 381 HIS.? 16.49 O3 GOL D 601 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 43.18 -8.44 -40.40 44.74 -9.12 -41.62 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 45.57 -7.61 -30.32 45.87 -9.61 -28.01 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 36.03 -8.97 -35.15 35.55 -7.12 -34.29 1c54_c00 source 1c54 RIBONUCLEASE SA : 2 hits 1c54_c00 naa= 3 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 3 # 1 71 ARG A 425 ARG^? 21.19 O1 EDO B 603 127 ARG C 425 ARG^? 21.48 O1 GOL D 601 270 GLU A 394 GLU~? 15.90 O2 GOL D 601 coo -0.83 25.63 1.57 0.97 28.05 0.90 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 27.32 15.93 -12.34 26.51 18.69 -11.26 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 27.33 5.77 -8.72 27.90 4.03 -9.75 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 2 3 # 2 71 ARG A 425 ARG^? 21.19 O1 EDO B 603 127 ARG C 425 ARG^? 21.48 O1 GOL D 601 270 GLU C 394 GLU~? 16.86 O1 EDO B 603 coo -0.83 25.63 1.57 0.97 28.05 0.90 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 27.32 15.93 -12.34 26.51 18.69 -11.26 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 19.77 27.90 -12.93 18.57 29.44 -12.10 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 3 3 # 3 71 ARG C 425 ARG^? 21.48 O1 GOL D 601 127 ARG A 425 ARG^? 21.19 O1 EDO B 603 270 GLU C 394 GLU~? 16.86 O1 EDO B 603 coo -0.83 25.63 1.57 0.97 28.05 0.90 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 25.04 18.93 -7.11 26.86 16.62 -8.01 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 19.77 27.90 -12.93 18.57 29.44 -12.10 1cbx_c01 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 3 hits 1cbx_c01 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 426 ASP.? 22.31 O1 EDO B 603 264 GLU A 394 GLU~? 15.90 O2 GOL D 601 328 ASP C 430 ASP.? 26.01 O2 GOL D 601 coo 45.62 80.42 43.69 45.65 82.01 45.07 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 59.69 92.71 39.85 58.53 92.03 41.47 27.33 5.77 -8.72 27.90 4.03 -9.75 coo 45.39 90.72 40.63 45.07 89.14 41.90 33.23 18.77 -9.92 33.78 18.54 -7.88 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 426 ASP.? 22.31 O1 EDO B 603 264 GLU B 363 GLU~? 7.89 O1 EDO B 603 328 ASP B 357 ASP.? 13.04 C1 EDO B 603 coo 45.62 80.42 43.69 45.65 82.01 45.07 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 59.69 92.71 39.85 58.53 92.03 41.47 8.83 27.73 -6.37 10.21 26.17 -6.89 coo 45.39 90.72 40.63 45.07 89.14 41.90 19.95 30.44 0.55 20.02 30.85 -1.53 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP B 426 ASP.? 28.68 C1 EDO B 603 264 GLU A 363 GLU~? 27.04 C1 EDO B 603 328 ASP A 357 ASP.? 25.14 C1 EDO B 603 coo 45.62 80.42 43.69 45.65 82.01 45.07 21.11 26.70 26.04 20.61 27.63 27.90 coo 59.69 92.71 39.85 58.53 92.03 41.47 14.23 7.65 22.80 13.44 9.34 23.77 coo 45.39 90.72 40.63 45.07 89.14 41.90 22.54 16.74 19.72 22.05 16.00 21.61 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP C 426 ASP.? 22.72 C2 GOL D 601 264 GLU C 394 GLU~? 16.86 O1 EDO B 603 328 ASP A 430 ASP.? 25.41 O1 EDO B 603 coo 45.62 80.42 43.69 45.65 82.01 45.07 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 59.69 92.71 39.85 58.53 92.03 41.47 19.77 27.90 -12.93 18.57 29.44 -12.10 coo 45.39 90.72 40.63 45.07 89.14 41.90 31.59 21.51 -7.17 32.38 22.31 -9.00 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP D 426 ASP.? 21.84 O1 EDO C 602 264 GLU C 363 GLU~? 7.78 O2 EDO C 602 328 ASP C 357 ASP.? 12.50 O2 EDO C 602 coo 45.62 80.42 43.69 45.65 82.01 45.07 40.54 14.64 -43.98 41.47 13.99 -45.77 coo 59.69 92.71 39.85 58.53 92.03 41.47 20.56 19.64 -44.58 21.56 17.87 -45.23 coo 45.39 90.72 40.63 45.07 89.14 41.90 32.02 20.63 -38.57 31.77 21.72 -40.39 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 5 hits 1cdg_c00 naa= 3 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 1 3 # 1 34 ASP B 315 ASP.? 32.42 C1 EDO B 603 37 SER A 313 SER.? 36.10 C1 EDO B 603 216 ASP A 315 ASP.? 32.31 C1 EDO B 603 coo 16.90 26.20 29.49 16.22 24.50 28.41 37.58 31.51 9.95 39.21 32.46 10.92 coo 12.23 24.31 30.40 14.55 23.96 31.03 39.91 33.41 13.35 41.22 34.11 15.24 coo 13.93 25.52 22.10 14.75 24.44 23.75 35.16 33.09 19.50 33.98 34.83 19.67 1cms_c04 source 1cms CHYMOSIN B (FORMERLY KNOWN AS RENNIN) (E.C.3.4: 1 hits 1cms_c04 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU B 363 GLU~? 7.89 O1 EDO B 603 A 89 GLU B 342 GLU^? -3.54 O2 EDO B 603s A 120 SER B 358 SER.? 7.25 C1 EDO B 603 coo -24.35 9.53 67.64 -25.07 11.29 68.60 8.83 27.73 -6.37 10.21 26.17 -6.89 coo -31.18 6.91 75.60 -32.39 8.51 74.91 10.25 28.44 3.00 8.52 29.59 2.44 coo -34.73 8.57 68.21 -33.63 9.08 70.28 16.90 26.63 0.02 16.29 24.39 0.69 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU C 363 GLU~? 7.78 O2 EDO C 602 A 89 GLU C 342 GLU^? -3.52 O2 EDO C 602s A 120 SER C 358 SER.? 6.66 O1 EDO C 602 coo -24.35 9.53 67.64 -25.07 11.29 68.60 20.56 19.64 -44.58 21.56 17.87 -45.23 coo -31.18 6.91 75.60 -32.39 8.51 74.91 22.61 19.18 -35.41 20.92 20.43 -35.77 coo -34.73 8.57 68.21 -33.63 9.08 70.28 28.49 17.26 -38.81 27.76 14.99 -38.31 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU D 363 GLU~? 7.90 O2 GOL D 601 A 89 GLU D 342 GLU^? -3.57 O3 GOL D 601s A 120 SER D 358 SER.? 6.75 C2 GOL D 601 coo -24.35 9.53 67.64 -25.07 11.29 68.60 24.65 -2.66 -18.42 24.14 -0.86 -17.43 coo -31.18 6.91 75.60 -32.39 8.51 74.91 28.06 0.59 -26.56 27.66 -1.50 -26.76 coo -34.73 8.57 68.21 -33.63 9.08 70.28 29.79 5.62 -21.71 27.82 6.72 -22.45 1cns_c00 source 1cns CHITINASE : 3 hits 1cns_c00 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 368 ARG.? 24.16 C1 EDO B 603 D 101 TYR A 354 TYR^? 20.91 C1 EDO B 603 D 173 ASP A 357 ASP.? 25.14 C1 EDO B 603 coo 69.08 8.58 32.60 69.70 10.81 30.58 23.91 7.22 12.24 22.49 6.03 9.76 coo 71.77 11.86 24.26 70.23 12.22 26.56 27.10 16.84 11.56 24.90 18.34 12.50 coo 71.60 6.14 19.25 70.26 6.87 20.69 22.54 16.74 19.72 22.05 16.00 21.61 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG B 368 ARG.? 11.04 O2 EDO B 603 D 101 TYR B 354 TYR^? 14.48 C1 EDO B 603 D 173 ASP B 357 ASP.? 13.04 C1 EDO B 603 coo 69.08 8.58 32.60 69.70 10.81 30.58 11.09 36.07 6.20 8.36 35.36 7.43 coo 71.77 11.86 24.26 70.23 12.22 26.56 19.63 32.53 9.54 19.95 30.09 8.18 coo 71.60 6.14 19.25 70.26 6.87 20.69 19.95 30.44 0.55 20.02 30.85 -1.53 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 48 ARG D 368 ARG.? 11.23 O3 GOL D 601 D 101 TYR D 354 TYR^? 14.76 C3 GOL D 601 D 173 ASP D 357 ASP.? 12.64 O3 GOL D 601 coo 69.08 8.58 32.60 69.70 10.81 30.58 34.63 -3.42 -28.94 33.31 -3.73 -31.69 coo 71.77 11.86 24.26 70.23 12.22 26.56 38.74 5.77 -29.00 36.83 7.38 -27.74 coo 71.60 6.14 19.25 70.26 6.87 20.69 34.52 5.19 -20.65 34.58 3.94 -18.98 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1cs1_c02 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 357 ASP.? 25.14 C1 EDO B 603 A 56 ILE A 343 ILE^? 16.04 C1 EDO B 603 A 82 TYR A 354 TYR^? 20.91 C1 EDO B 603 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 22.54 16.74 19.72 22.05 16.00 21.61 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 20.64 16.14 10.29 20.44 17.51 9.77 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 27.10 16.84 11.56 24.90 18.34 12.50 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP A 440 ASP^? 18.54 C1 EDO B 603 A 56 ILE B 441 ILE.? 9.38 C2 EDO B 603 A 82 TYR B 418 TYR^? 11.01 C2 EDO B 603 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 8.21 11.09 12.88 6.30 10.30 13.36 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 3.03 18.37 4.96 2.52 18.77 6.24 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 3.01 21.54 9.44 2.74 20.74 12.09 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 3 3 # 3 A 37 ASP B 440 ASP^? 5.62 O1 EDO B 603 A 56 ILE A 441 ILE.? 14.03 O1 EDO B 603 A 82 TYR A 418 TYR^? 12.62 O1 EDO B 603 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 5.66 21.79 0.79 4.10 21.14 -0.54 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 5.61 12.02 7.58 6.18 11.56 6.38 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 9.59 11.03 3.92 9.74 11.89 1.25 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 4 3 # 4 A 37 ASP B 440 ASP^? 5.62 O1 EDO B 603 A 56 ILE B 343 ILE^? 9.73 C1 EDO B 603 A 82 TYR B 437 TYR^? 10.72 C1 EDO B 603 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 5.66 21.79 0.79 4.10 21.14 -0.54 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 15.28 27.72 8.19 16.05 26.58 8.83 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 10.92 24.41 11.32 10.27 22.67 13.43 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 5 3 # 5 A 37 ASP C 440 ASP^? 5.97 O1 EDO C 602 A 56 ILE C 343 ILE^? 9.70 C1 EDO C 602 A 82 TYR C 437 TYR^? 9.81 O1 GOL D 601 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 17.33 13.03 -37.56 15.74 12.38 -38.82 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 27.88 17.86 -30.52 28.64 16.75 -30.01 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 23.51 14.66 -27.39 22.94 13.02 -25.21 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 6 3 # 6 A 37 ASP C 440 ASP^? 5.97 O1 EDO C 602 A 56 ILE D 441 ILE~? 7.75 O1 GOL D 601 A 82 TYR D 418 TYR^? 10.77 C1 GOL D 601 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 17.33 13.03 -37.56 15.74 12.38 -38.82 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 16.80 2.80 -31.40 17.16 2.42 -32.70 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 20.16 1.85 -35.57 20.10 2.87 -38.19 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 7 3 # 7 A 37 ASP D 440 ASP^? -5.34 O2 GOL D 601s A 56 ILE C 441 ILE.? 9.42 C2 EDO C 602 A 82 TYR C 418 TYR^? 10.50 O1 GOL D 601 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 19.76 1.27 -26.39 17.89 0.46 -25.75 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 14.80 9.51 -33.42 14.46 10.01 -32.08 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 15.25 12.39 -28.72 15.00 11.49 -26.08 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 8 3 # 8 A 37 ASP D 440 ASP^? -5.34 O2 GOL D 601s A 56 ILE D 343 ILE^? 9.81 C1 GOL D 601 A 82 TYR D 437 TYR^? 9.97 C1 GOL D 601 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 19.76 1.27 -26.39 17.89 0.46 -25.75 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 32.09 5.76 -29.71 31.97 7.15 -30.08 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 27.83 5.60 -34.20 26.72 6.80 -36.49 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 8 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 357 ASP.? 25.14 C1 EDO B 603 B 56 ILE A 343 ILE^? 16.04 C1 EDO B 603 B 82 TYR A 354 TYR^? 20.91 C1 EDO B 603 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 22.54 16.74 19.72 22.05 16.00 21.61 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 20.64 16.14 10.29 20.44 17.51 9.77 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 27.10 16.84 11.56 24.90 18.34 12.50 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP A 440 ASP^? 18.54 C1 EDO B 603 B 56 ILE B 441 ILE.? 9.38 C2 EDO B 603 B 82 TYR B 418 TYR^? 11.01 C2 EDO B 603 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 8.21 11.09 12.88 6.30 10.30 13.36 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 3.03 18.37 4.96 2.52 18.77 6.24 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 3.01 21.54 9.44 2.74 20.74 12.09 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 3 3 # 3 B 37 ASP B 440 ASP^? 5.62 O1 EDO B 603 B 56 ILE A 441 ILE.? 14.03 O1 EDO B 603 B 82 TYR A 418 TYR^? 12.62 O1 EDO B 603 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 5.66 21.79 0.79 4.10 21.14 -0.54 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 5.61 12.02 7.58 6.18 11.56 6.38 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 9.59 11.03 3.92 9.74 11.89 1.25 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 4 3 # 4 B 37 ASP C 357 ASP.? 12.50 O2 EDO C 602 B 56 ILE C 343 ILE^? 9.70 C1 EDO C 602 B 82 TYR C 354 TYR^? 14.37 C1 EDO C 602 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 27.88 17.86 -30.52 28.64 16.75 -30.01 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 32.76 22.10 -29.37 32.74 19.75 -30.93 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 5 3 # 5 B 37 ASP C 440 ASP^? 5.97 O1 EDO C 602 B 56 ILE D 441 ILE~? 7.75 O1 GOL D 601 B 82 TYR D 418 TYR^? 10.77 C1 GOL D 601 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 17.33 13.03 -37.56 15.74 12.38 -38.82 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 16.80 2.80 -31.40 17.16 2.42 -32.70 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 20.16 1.85 -35.57 20.10 2.87 -38.19 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 6 3 # 6 B 37 ASP D 440 ASP^? -5.34 O2 GOL D 601s B 56 ILE C 441 ILE.? 9.42 C2 EDO C 602 B 82 TYR C 418 TYR^? 10.50 O1 GOL D 601 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 19.76 1.27 -26.39 17.89 0.46 -25.75 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 14.80 9.51 -33.42 14.46 10.01 -32.08 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 15.25 12.39 -28.72 15.00 11.49 -26.08 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 6 hits 1d6o_c01 naa= 3 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 138 TRP B 407 TRP^? 14.83 C2 EDO B 603 A 243 ASP A 448 ASP~? 19.70 O1 EDO B 603 A 272 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 18.21 54.75 18.05 19.91 55.17 21.59 -3.73 22.30 9.20 -2.79 21.98 13.01 coo 16.93 55.67 9.65 17.16 54.23 11.19 -6.12 13.55 5.97 -7.03 12.86 4.20 coo 14.13 45.79 13.40 14.25 49.41 18.30 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 138 TRP C 407 TRP^? 15.00 C2 EDO C 602 A 243 ASP D 448 ASP.? 19.66 C2 EDO C 602 A 272 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 18.21 54.75 18.05 19.91 55.17 21.59 8.62 13.87 -28.54 9.69 13.09 -24.84 coo 16.93 55.67 9.65 17.16 54.23 11.19 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 14.13 45.79 13.40 14.25 49.41 18.30 12.96 9.36 -37.91 9.04 10.02 -41.38 1d7r_c01 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 2 hits 1d7r_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 354 TYR^? 20.91 C1 EDO B 603 A 243 ASP B 430 ASP.? 31.57 C2 EDO B 603 A 272 LYS B 348 LYS.? 28.30 C2 EDO B 603 coo 2.03 68.31 21.46 0.66 68.36 23.90 27.10 16.84 11.56 24.90 18.34 12.50 coo 16.93 55.67 9.65 17.16 54.23 11.19 18.19 29.66 29.51 18.36 29.43 31.62 coo 14.13 45.79 13.40 14.25 49.41 18.30 16.25 36.62 22.07 20.01 34.44 26.08 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR A 355 TYR^? 25.32 C1 EDO B 603 A 243 ASP B 430 ASP.? 31.57 C2 EDO B 603 A 272 LYS B 348 LYS.? 28.30 C2 EDO B 603 coo 2.03 68.31 21.46 0.66 68.36 23.90 25.00 11.79 14.66 25.82 10.48 17.03 coo 16.93 55.67 9.65 17.16 54.23 11.19 18.19 29.66 29.51 18.36 29.43 31.62 coo 14.13 45.79 13.40 14.25 49.41 18.30 16.25 36.62 22.07 20.01 34.44 26.08 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR A 421 TYR^? 19.72 O1 EDO B 603 A 243 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 272 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo 2.03 68.31 21.46 0.66 68.36 23.90 20.02 8.83 1.38 20.18 6.69 3.20 coo 16.93 55.67 9.65 17.16 54.23 11.19 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 14.13 45.79 13.40 14.25 49.41 18.30 31.02 25.73 -16.52 36.61 24.80 -13.64 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 173 TYR A 437 TYR^? 11.45 C1 EDO B 603 A 243 ASP B 426 ASP.? 28.68 C1 EDO B 603 A 272 LYS B 348 LYS.? 28.30 C2 EDO B 603 coo 2.03 68.31 21.46 0.66 68.36 23.90 16.79 15.50 5.48 15.91 16.43 3.01 coo 16.93 55.67 9.65 17.16 54.23 11.19 21.11 26.70 26.04 20.61 27.63 27.90 coo 14.13 45.79 13.40 14.25 49.41 18.30 16.25 36.62 22.07 20.01 34.44 26.08 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 173 TYR A 437 TYR^? 11.45 C1 EDO B 603 A 243 ASP C 430 ASP.? 26.01 O2 GOL D 601 A 272 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo 2.03 68.31 21.46 0.66 68.36 23.90 16.79 15.50 5.48 15.91 16.43 3.01 coo 16.93 55.67 9.65 17.16 54.23 11.19 33.23 18.77 -9.92 33.78 18.54 -7.88 coo 14.13 45.79 13.40 14.25 49.41 18.30 31.02 25.73 -16.52 36.61 24.80 -13.64 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 173 TYR B 354 TYR^? 14.48 C1 EDO B 603 A 243 ASP A 430 ASP.? 25.41 O1 EDO B 603 A 272 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo 2.03 68.31 21.46 0.66 68.36 23.90 19.63 32.53 9.54 19.95 30.09 8.18 coo 16.93 55.67 9.65 17.16 54.23 11.19 31.59 21.51 -7.17 32.38 22.31 -9.00 coo 14.13 45.79 13.40 14.25 49.41 18.30 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 7 3 # 7 A 173 TYR B 355 TYR^? 12.60 O2 EDO B 603 A 243 ASP A 430 ASP.? 25.41 O1 EDO B 603 A 272 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo 2.03 68.31 21.46 0.66 68.36 23.90 15.82 34.63 5.10 16.14 36.63 3.16 coo 16.93 55.67 9.65 17.16 54.23 11.19 31.59 21.51 -7.17 32.38 22.31 -9.00 coo 14.13 45.79 13.40 14.25 49.41 18.30 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 8 3 # 8 A 173 TYR B 355 TYR^? 12.60 O2 EDO B 603 A 243 ASP A 430 ASP.? 25.41 O1 EDO B 603 A 272 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo 2.03 68.31 21.46 0.66 68.36 23.90 15.82 34.63 5.10 16.14 36.63 3.16 coo 16.93 55.67 9.65 17.16 54.23 11.19 31.59 21.51 -7.17 32.38 22.31 -9.00 coo 14.13 45.79 13.40 14.25 49.41 18.30 31.02 25.73 -16.52 36.61 24.80 -13.64 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 9 3 # 9 A 173 TYR B 418 TYR^? 11.01 C2 EDO B 603 A 243 ASP A 357 ASP.? 25.14 C1 EDO B 603 A 272 LYS A 367 LYS.? 27.79 C1 EDO B 603 coo 2.03 68.31 21.46 0.66 68.36 23.90 3.01 21.54 9.44 2.74 20.74 12.09 coo 16.93 55.67 9.65 17.16 54.23 11.19 22.54 16.74 19.72 22.05 16.00 21.61 coo 14.13 45.79 13.40 14.25 49.41 18.30 21.09 4.68 15.64 17.32 4.21 18.91 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 10 3 # 10 A 173 TYR B 437 TYR^? 10.72 C1 EDO B 603 A 243 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 272 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo 2.03 68.31 21.46 0.66 68.36 23.90 10.92 24.41 11.32 10.27 22.67 13.43 coo 16.93 55.67 9.65 17.16 54.23 11.19 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 14.13 45.79 13.40 14.25 49.41 18.30 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 11 3 # 11 A 173 TYR C 326 TYR^? 22.46 O3 GOL D 601 A 243 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 272 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo 2.03 68.31 21.46 0.66 68.36 23.90 45.91 5.03 -28.85 46.66 3.15 -30.76 coo 16.93 55.67 9.65 17.16 54.23 11.19 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 14.13 45.79 13.40 14.25 49.41 18.30 31.02 25.73 -16.52 36.61 24.80 -13.64 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 12 3 # 12 A 173 TYR C 355 TYR^? 12.28 O2 EDO C 602 A 243 ASP D 430 ASP.? 24.82 O1 EDO C 602 A 272 LYS D 348 LYS.? 27.59 O1 EDO C 602 coo 2.03 68.31 21.46 0.66 68.36 23.90 28.68 24.77 -33.28 28.94 26.73 -35.28 coo 16.93 55.67 9.65 17.16 54.23 11.19 41.96 11.40 -47.93 42.69 12.01 -49.83 coo 14.13 45.79 13.40 14.25 49.41 18.30 43.15 3.71 -41.93 47.18 7.62 -43.42 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 13 3 # 13 A 173 TYR C 418 TYR^? 10.50 O1 GOL D 601 A 243 ASP D 357 ASP.? 12.64 O3 GOL D 601 A 272 LYS D 367 LYS.? 8.67 O3 GOL D 601 coo 2.03 68.31 21.46 0.66 68.36 23.90 15.25 12.39 -28.72 15.00 11.49 -26.08 coo 16.93 55.67 9.65 17.16 54.23 11.19 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 14.13 45.79 13.40 14.25 49.41 18.30 32.17 -6.41 -25.63 28.00 -7.23 -22.20 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 14 3 # 14 A 173 TYR C 421 TYR^? 13.35 C2 EDO C 602 A 243 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 272 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo 2.03 68.31 21.46 0.66 68.36 23.90 19.38 20.76 -23.26 18.18 22.24 -25.31 coo 16.93 55.67 9.65 17.16 54.23 11.19 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 14.13 45.79 13.40 14.25 49.41 18.30 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 15 3 # 15 A 173 TYR C 437 TYR^? 9.81 O1 GOL D 601 A 243 ASP A 430 ASP.? 25.41 O1 EDO B 603 A 272 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo 2.03 68.31 21.46 0.66 68.36 23.90 23.51 14.66 -27.39 22.94 13.02 -25.21 coo 16.93 55.67 9.65 17.16 54.23 11.19 31.59 21.51 -7.17 32.38 22.31 -9.00 coo 14.13 45.79 13.40 14.25 49.41 18.30 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 16 3 # 16 A 173 TYR C 437 TYR^? 9.81 O1 GOL D 601 A 243 ASP D 426 ASP.? 21.84 O1 EDO C 602 A 272 LYS D 348 LYS.? 27.59 O1 EDO C 602 coo 2.03 68.31 21.46 0.66 68.36 23.90 23.51 14.66 -27.39 22.94 13.02 -25.21 coo 16.93 55.67 9.65 17.16 54.23 11.19 40.54 14.64 -43.98 41.47 13.99 -45.77 coo 14.13 45.79 13.40 14.25 49.41 18.30 43.15 3.71 -41.93 47.18 7.62 -43.42 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 17 3 # 17 A 173 TYR D 355 TYR^? 12.42 O3 GOL D 601 A 243 ASP C 430 ASP.? 26.01 O2 GOL D 601 A 272 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo 2.03 68.31 21.46 0.66 68.36 23.90 36.51 0.70 -26.17 37.53 -0.88 -24.11 coo 16.93 55.67 9.65 17.16 54.23 11.19 33.23 18.77 -9.92 33.78 18.54 -7.88 coo 14.13 45.79 13.40 14.25 49.41 18.30 31.02 25.73 -16.52 36.61 24.80 -13.64 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 18 3 # 18 A 173 TYR D 418 TYR^? 10.77 C1 GOL D 601 A 243 ASP C 357 ASP.? 12.50 O2 EDO C 602 A 272 LYS C 367 LYS.? 10.18 O2 EDO C 602 coo 2.03 68.31 21.46 0.66 68.36 23.90 20.16 1.85 -35.57 20.10 2.87 -38.19 coo 16.93 55.67 9.65 17.16 54.23 11.19 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 14.13 45.79 13.40 14.25 49.41 18.30 21.41 26.99 -36.15 19.64 26.87 -41.36 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 19 3 # 19 A 173 TYR D 437 TYR^? 9.97 C1 GOL D 601 A 243 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 272 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo 2.03 68.31 21.46 0.66 68.36 23.90 27.83 5.60 -34.20 26.72 6.80 -36.49 coo 16.93 55.67 9.65 17.16 54.23 11.19 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 14.13 45.79 13.40 14.25 49.41 18.30 31.02 25.73 -16.52 36.61 24.80 -13.64 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 19 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 384 LYS~? 32.89 O2 GOL D 601 A 177 GLU A 378 GLU~? 27.85 O2 GOL D 601 A 201 LEU A 386 LEU~? 28.62 O2 GOL D 601 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 23.52 -5.65 3.37 24.45 -7.36 6.79 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 32.59 2.13 2.36 33.95 1.57 0.86 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 27.29 -1.26 3.33 29.16 -0.11 3.24 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS A 388 LYS~? 27.25 O2 GOL D 601 A 177 GLU A 378 GLU~? 27.85 O2 GOL D 601 A 201 LEU A 386 LEU~? 28.62 O2 GOL D 601 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 32.59 2.13 2.36 33.95 1.57 0.86 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 27.29 -1.26 3.33 29.16 -0.11 3.24 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 A 145 LYS A 415 LYS^? 20.91 C1 EDO B 603 A 177 GLU A 363 GLU~? 27.04 C1 EDO B 603 A 201 LEU A 413 LEU.? 25.23 C1 EDO B 603 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 6.45 6.62 13.73 11.23 9.80 16.52 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 14.23 7.65 22.80 13.44 9.34 23.77 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 9.88 4.62 16.62 11.96 3.97 16.95 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 A 145 LYS B 384 LYS~? 21.93 O2 EDO B 603 A 177 GLU B 378 GLU~? 25.07 O2 EDO B 603 A 201 LEU B 386 LEU~? 22.37 O2 EDO B 603 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -3.14 43.46 11.59 -5.82 40.34 10.77 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 7.63 44.96 15.04 7.63 45.65 17.05 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 1.45 43.13 15.24 3.53 42.84 14.65 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 A 145 LYS B 388 LYS~? 19.48 C2 EDO B 603 A 177 GLU B 378 GLU~? 25.07 O2 EDO B 603 A 201 LEU B 386 LEU~? 22.37 O2 EDO B 603 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 7.63 44.96 15.04 7.63 45.65 17.05 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 1.45 43.13 15.24 3.53 42.84 14.65 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 A 145 LYS B 390 LYS~? 27.12 C2 EDO B 603 A 177 GLU B 378 GLU~? 25.07 O2 EDO B 603 A 201 LEU B 386 LEU~? 22.37 O2 EDO B 603 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 3.52 38.72 20.17 3.15 45.06 20.21 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 7.63 44.96 15.04 7.63 45.65 17.05 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 1.45 43.13 15.24 3.53 42.84 14.65 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 A 145 LYS B 415 LYS^? -2.82 O2 EDO B 603s A 177 GLU B 363 GLU~? 7.89 O1 EDO B 603 A 201 LEU B 413 LEU.? 6.78 O2 EDO B 603 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 1.57 23.62 -1.31 7.49 26.02 -1.78 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 8.83 27.73 -6.37 10.21 26.17 -6.89 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 2.80 27.88 -3.45 3.94 29.76 -3.32 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 8 3 # 8 A 145 LYS C 384 LYS~? 20.68 O2 EDO C 602 A 177 GLU C 378 GLU~? 24.96 O2 EDO B 603 A 201 LEU C 386 LEU~? 24.76 O2 EDO B 603 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 11.81 35.96 -24.38 11.26 34.03 -29.22 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 22.14 33.77 -19.82 21.71 34.90 -18.09 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 16.14 34.82 -20.97 17.87 35.49 -19.78 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 9 3 # 9 A 145 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 177 GLU C 378 GLU~? 24.96 O2 EDO B 603 A 201 LEU C 386 LEU~? 24.76 O2 EDO B 603 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 22.14 33.77 -19.82 21.71 34.90 -18.09 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 16.14 34.82 -20.97 17.87 35.49 -19.78 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 10 3 # 10 A 145 LYS C 415 LYS^? -2.71 O2 EDO C 602s A 177 GLU C 363 GLU~? 7.78 O2 EDO C 602 A 201 LEU C 413 LEU.? 6.85 O2 EDO C 602 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 13.38 15.08 -39.34 19.41 17.19 -40.08 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 20.56 19.64 -44.58 21.56 17.87 -45.23 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 14.75 19.64 -41.35 16.02 21.33 -40.94 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 11 3 # 11 A 145 LYS D 384 LYS~? 21.94 O3 GOL D 601 A 177 GLU D 378 GLU~? 27.27 O3 GOL D 601 A 201 LEU D 386 LEU~? 22.23 O3 GOL D 601 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 32.39 -15.23 -40.24 32.53 -17.53 -36.22 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 43.18 -8.44 -40.40 44.74 -9.12 -41.62 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 36.94 -11.45 -39.76 38.82 -10.32 -39.79 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 12 3 # 12 A 145 LYS D 388 LYS~? 23.05 O3 GOL D 601 A 177 GLU D 378 GLU~? 27.27 O3 GOL D 601 A 201 LEU D 386 LEU~? 22.23 O3 GOL D 601 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 43.18 -8.44 -40.40 44.74 -9.12 -41.62 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 36.94 -11.45 -39.76 38.82 -10.32 -39.79 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 13 3 # 13 A 145 LYS D 403 LYS^? 8.04 O1 EDO C 602 A 177 GLU D 394 GLU~? 26.98 C3 GOL D 601 A 201 LEU D 396 LEU~? 18.34 O1 EDO C 602 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 27.51 4.47 -43.69 23.30 8.13 -41.81 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 35.24 -3.52 -50.42 34.05 -5.26 -50.80 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 33.65 2.40 -45.26 31.89 2.25 -43.96 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 14 3 # 14 A 145 LYS D 415 LYS^? -2.91 O3 GOL D 601s A 177 GLU D 363 GLU~? 7.90 O2 GOL D 601 A 201 LEU D 413 LEU.? 7.06 O3 GOL D 601 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 17.93 -3.17 -25.73 23.39 -0.99 -23.17 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 24.65 -2.66 -18.42 24.14 -0.86 -17.43 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 21.27 -6.03 -23.40 23.42 -6.57 -23.22 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 14 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 384 LYS~? 32.89 O2 GOL D 601 B 177 GLU A 378 GLU~? 27.85 O2 GOL D 601 B 201 LEU A 386 LEU~? 28.62 O2 GOL D 601 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 23.52 -5.65 3.37 24.45 -7.36 6.79 coo 27.00 6.35 51.01 26.30 4.53 50.18 32.59 2.13 2.36 33.95 1.57 0.86 coo 23.74 1.68 49.50 22.87 -0.24 49.97 27.29 -1.26 3.33 29.16 -0.11 3.24 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS A 388 LYS~? 27.25 O2 GOL D 601 B 177 GLU A 378 GLU~? 27.85 O2 GOL D 601 B 201 LEU A 386 LEU~? 28.62 O2 GOL D 601 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 27.00 6.35 51.01 26.30 4.53 50.18 32.59 2.13 2.36 33.95 1.57 0.86 coo 23.74 1.68 49.50 22.87 -0.24 49.97 27.29 -1.26 3.33 29.16 -0.11 3.24 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 B 145 LYS B 384 LYS~? 21.93 O2 EDO B 603 B 177 GLU B 378 GLU~? 25.07 O2 EDO B 603 B 201 LEU B 386 LEU~? 22.37 O2 EDO B 603 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -3.14 43.46 11.59 -5.82 40.34 10.77 coo 27.00 6.35 51.01 26.30 4.53 50.18 7.63 44.96 15.04 7.63 45.65 17.05 coo 23.74 1.68 49.50 22.87 -0.24 49.97 1.45 43.13 15.24 3.53 42.84 14.65 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 B 145 LYS B 388 LYS~? 19.48 C2 EDO B 603 B 177 GLU B 378 GLU~? 25.07 O2 EDO B 603 B 201 LEU B 386 LEU~? 22.37 O2 EDO B 603 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 27.00 6.35 51.01 26.30 4.53 50.18 7.63 44.96 15.04 7.63 45.65 17.05 coo 23.74 1.68 49.50 22.87 -0.24 49.97 1.45 43.13 15.24 3.53 42.84 14.65 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 B 145 LYS B 390 LYS~? 27.12 C2 EDO B 603 B 177 GLU B 378 GLU~? 25.07 O2 EDO B 603 B 201 LEU B 386 LEU~? 22.37 O2 EDO B 603 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 3.52 38.72 20.17 3.15 45.06 20.21 coo 27.00 6.35 51.01 26.30 4.53 50.18 7.63 44.96 15.04 7.63 45.65 17.05 coo 23.74 1.68 49.50 22.87 -0.24 49.97 1.45 43.13 15.24 3.53 42.84 14.65 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 B 145 LYS B 415 LYS^? -2.82 O2 EDO B 603s B 177 GLU B 363 GLU~? 7.89 O1 EDO B 603 B 201 LEU B 413 LEU.? 6.78 O2 EDO B 603 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 1.57 23.62 -1.31 7.49 26.02 -1.78 coo 27.00 6.35 51.01 26.30 4.53 50.18 8.83 27.73 -6.37 10.21 26.17 -6.89 coo 23.74 1.68 49.50 22.87 -0.24 49.97 2.80 27.88 -3.45 3.94 29.76 -3.32 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 B 145 LYS C 384 LYS~? 20.68 O2 EDO C 602 B 177 GLU C 378 GLU~? 24.96 O2 EDO B 603 B 201 LEU C 386 LEU~? 24.76 O2 EDO B 603 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 11.81 35.96 -24.38 11.26 34.03 -29.22 coo 27.00 6.35 51.01 26.30 4.53 50.18 22.14 33.77 -19.82 21.71 34.90 -18.09 coo 23.74 1.68 49.50 22.87 -0.24 49.97 16.14 34.82 -20.97 17.87 35.49 -19.78 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 8 3 # 8 B 145 LYS C 388 LYS~? 20.15 C2 EDO C 602 B 177 GLU C 378 GLU~? 24.96 O2 EDO B 603 B 201 LEU C 386 LEU~? 24.76 O2 EDO B 603 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 27.00 6.35 51.01 26.30 4.53 50.18 22.14 33.77 -19.82 21.71 34.90 -18.09 coo 23.74 1.68 49.50 22.87 -0.24 49.97 16.14 34.82 -20.97 17.87 35.49 -19.78 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 9 3 # 9 B 145 LYS C 415 LYS^? -2.71 O2 EDO C 602s B 177 GLU C 363 GLU~? 7.78 O2 EDO C 602 B 201 LEU C 413 LEU.? 6.85 O2 EDO C 602 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 13.38 15.08 -39.34 19.41 17.19 -40.08 coo 27.00 6.35 51.01 26.30 4.53 50.18 20.56 19.64 -44.58 21.56 17.87 -45.23 coo 23.74 1.68 49.50 22.87 -0.24 49.97 14.75 19.64 -41.35 16.02 21.33 -40.94 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 10 3 # 10 B 145 LYS D 388 LYS~? 23.05 O3 GOL D 601 B 177 GLU D 378 GLU~? 27.27 O3 GOL D 601 B 201 LEU D 386 LEU~? 22.23 O3 GOL D 601 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 27.00 6.35 51.01 26.30 4.53 50.18 43.18 -8.44 -40.40 44.74 -9.12 -41.62 coo 23.74 1.68 49.50 22.87 -0.24 49.97 36.94 -11.45 -39.76 38.82 -10.32 -39.79 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 11 3 # 11 B 145 LYS D 415 LYS^? -2.91 O3 GOL D 601s B 177 GLU D 363 GLU~? 7.90 O2 GOL D 601 B 201 LEU D 413 LEU.? 7.06 O3 GOL D 601 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 17.93 -3.17 -25.73 23.39 -0.99 -23.17 coo 27.00 6.35 51.01 26.30 4.53 50.18 24.65 -2.66 -18.42 24.14 -0.86 -17.43 coo 23.74 1.68 49.50 22.87 -0.24 49.97 21.27 -6.03 -23.40 23.42 -6.57 -23.22 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 11 hits 1daa_c01 naa= 3 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 1 3 # 1 A 132 THR D 369 THR~? 16.21 O3 GOL D 601 A 156 TYR D 355 TYR^? 12.42 O3 GOL D 601 A 160 LYS D 367 LYS.? 8.67 O3 GOL D 601 coo 10.50 56.87 17.73 11.24 57.93 19.43 38.48 -5.77 -24.43 38.79 -7.85 -25.06 coo 11.64 63.07 23.95 11.76 62.47 21.20 36.51 0.70 -26.17 37.53 -0.88 -24.11 coo 5.78 61.30 21.65 8.04 62.89 17.54 32.17 -6.41 -25.63 28.00 -7.23 -22.20 1db3_c01 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 1 hits 1db3_c01 naa= 3 ULMN 3 1ddj_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 646 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 739 GLY C 429 GLY.? 21.29 O2 GOL D 601 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 11.37 50.89 2.29 11.05 51.63 2.25 30.74 14.63 -9.51 31.39 15.13 -9.63 1ddj_c12 source 1ddj PLASMINOGEN : 1 hits 1ddj_c12 naa= 3 ULMN 3 1ddj_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS D 338 HIS~? 13.70 C1 GOL D 601 B 646 ASP C 402 ASP.? 12.78 O1 GOL D 601 B 739 GLY A 429 GLY.? 20.67 O1 EDO B 603 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 29.23 12.85 -20.11 30.06 13.12 -18.20 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 22.26 13.02 -15.38 21.01 11.37 -15.92 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 27.23 22.60 -8.91 27.96 22.71 -8.54 1ddj_c13 source 1ddj PLASMINOGEN : 1 hits 1ddj_c13 naa= 3 ULMN 3 1ddj_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS B 338 HIS.? 13.66 O1 EDO B 603 C 646 ASP A 402 ASP.? 12.59 O1 EDO B 603 C 739 GLY C 429 GLY.? 21.29 O2 GOL D 601 coo 15.33 59.81 59.60 13.98 60.99 60.69 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 16.06 55.72 54.73 15.97 56.49 56.70 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 9.38 49.29 65.28 9.01 50.03 65.31 30.74 14.63 -9.51 31.39 15.13 -9.63 1ddj_c14 source 1ddj PLASMINOGEN : 1 hits 1ddj_c14 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 330 GLU~? 26.93 C1 EDO B 603 A 226 THR A 369 THR~? 31.64 C1 EDO B 603 A 229 LYS A 367 LYS.? 27.79 C1 EDO B 603 coo 9.66 102.78 70.07 9.79 101.18 71.42 25.78 29.04 20.96 25.48 30.78 22.26 coo 7.24 97.46 49.60 8.11 95.69 48.80 27.07 6.63 18.00 27.23 4.49 18.30 coo 10.53 97.56 43.71 9.33 93.71 47.17 21.09 4.68 15.64 17.32 4.21 18.91 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU A 363 GLU~? 27.04 C1 EDO B 603 A 226 THR A 420 THR^? 12.22 O1 EDO B 603 A 229 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 9.66 102.78 70.07 9.79 101.18 71.42 14.23 7.65 22.80 13.44 9.34 23.77 coo 7.24 97.46 49.60 8.11 95.69 48.80 15.83 11.51 2.31 14.98 13.34 1.54 coo 10.53 97.56 43.71 9.33 93.71 47.17 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 57 GLU A 411 GLU.? 28.28 O1 EDO B 603 A 226 THR A 420 THR^? 12.22 O1 EDO B 603 A 229 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 9.66 102.78 70.07 9.79 101.18 71.42 3.89 -1.22 13.75 2.15 -0.02 14.05 coo 7.24 97.46 49.60 8.11 95.69 48.80 15.83 11.51 2.31 14.98 13.34 1.54 coo 10.53 97.56 43.71 9.33 93.71 47.17 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 57 GLU A 446 GLU~? 20.77 C2 EDO B 603 A 226 THR A 420 THR^? 12.22 O1 EDO B 603 A 229 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 9.66 102.78 70.07 9.79 101.18 71.42 -3.62 12.85 13.27 -2.92 11.09 12.27 coo 7.24 97.46 49.60 8.11 95.69 48.80 15.83 11.51 2.31 14.98 13.34 1.54 coo 10.53 97.56 43.71 9.33 93.71 47.17 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 57 GLU B 330 GLU~? 24.65 C1 EDO B 603 A 226 THR B 369 THR~? 15.82 O2 EDO B 603 A 229 LYS B 367 LYS.? 8.96 O2 EDO B 603 coo 9.66 102.78 70.07 9.79 101.18 71.42 31.94 25.81 2.71 33.76 25.37 1.74 coo 7.24 97.46 49.60 8.11 95.69 48.80 14.08 40.07 2.07 12.56 41.55 1.60 coo 10.53 97.56 43.71 9.33 93.71 47.17 8.46 36.63 1.57 6.31 34.95 -1.21 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 57 GLU B 363 GLU~? 7.89 O1 EDO B 603 A 226 THR B 420 THR^? 12.07 C2 EDO B 603 A 229 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo 9.66 102.78 70.07 9.79 101.18 71.42 8.83 27.73 -6.37 10.21 26.17 -6.89 coo 7.24 97.46 49.60 8.11 95.69 48.80 6.28 25.69 13.21 6.93 23.74 13.95 coo 10.53 97.56 43.71 9.33 93.71 47.17 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 57 GLU B 411 GLU.? 15.09 O2 EDO B 603 A 226 THR B 420 THR^? 12.07 C2 EDO B 603 A 229 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo 9.66 102.78 70.07 9.79 101.18 71.42 -5.72 28.81 -2.48 -6.82 27.11 -1.89 coo 7.24 97.46 49.60 8.11 95.69 48.80 6.28 25.69 13.21 6.93 23.74 13.95 coo 10.53 97.56 43.71 9.33 93.71 47.17 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 A 57 GLU B 446 GLU~? 12.80 O1 EDO B 603 A 226 THR B 420 THR^? 12.07 C2 EDO B 603 A 229 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo 9.66 102.78 70.07 9.79 101.18 71.42 0.25 13.76 -3.23 0.76 15.38 -4.51 coo 7.24 97.46 49.60 8.11 95.69 48.80 6.28 25.69 13.21 6.93 23.74 13.95 coo 10.53 97.56 43.71 9.33 93.71 47.17 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 A 57 GLU C 330 GLU~? 24.03 O1 EDO C 602 A 226 THR C 369 THR~? 15.84 O2 EDO C 602 A 229 LYS C 367 LYS.? 10.18 O2 EDO C 602 coo 9.66 102.78 70.07 9.79 101.18 71.42 43.59 14.91 -37.76 45.12 14.02 -38.99 coo 7.24 97.46 49.60 8.11 95.69 48.80 27.27 30.44 -36.03 26.03 32.19 -36.25 coo 10.53 97.56 43.71 9.33 93.71 47.17 21.41 26.99 -36.15 19.64 26.87 -41.36 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 A 57 GLU C 363 GLU~? 7.78 O2 EDO C 602 A 226 THR C 420 THR^? 10.46 O1 GOL D 601 A 229 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 9.66 102.78 70.07 9.79 101.18 71.42 20.56 19.64 -44.58 21.56 17.87 -45.23 coo 7.24 97.46 49.60 8.11 95.69 48.80 19.08 16.16 -25.00 19.73 14.12 -24.43 coo 10.53 97.56 43.71 9.33 93.71 47.17 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 A 57 GLU C 411 GLU.? 15.78 O2 EDO C 602 A 226 THR C 420 THR^? 10.46 O1 GOL D 601 A 229 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 9.66 102.78 70.07 9.79 101.18 71.42 6.23 19.30 -42.44 5.28 17.46 -42.16 coo 7.24 97.46 49.60 8.11 95.69 48.80 19.08 16.16 -25.00 19.73 14.12 -24.43 coo 10.53 97.56 43.71 9.33 93.71 47.17 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 A 57 GLU C 446 GLU~? 12.66 O1 EDO C 602 A 226 THR C 420 THR^? 10.46 O1 GOL D 601 A 229 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 9.66 102.78 70.07 9.79 101.18 71.42 12.37 5.19 -42.08 12.22 7.23 -42.76 coo 7.24 97.46 49.60 8.11 95.69 48.80 19.08 16.16 -25.00 19.73 14.12 -24.43 coo 10.53 97.56 43.71 9.33 93.71 47.17 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 A 57 GLU D 363 GLU~? 7.90 O2 GOL D 601 A 226 THR D 420 THR^? 11.62 O1 EDO C 602 A 229 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 9.66 102.78 70.07 9.79 101.18 71.42 24.65 -2.66 -18.42 24.14 -0.86 -17.43 coo 7.24 97.46 49.60 8.11 95.69 48.80 26.36 2.12 -37.74 25.52 4.03 -38.26 coo 10.53 97.56 43.71 9.33 93.71 47.17 27.51 4.47 -43.69 23.30 8.13 -41.81 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 A 57 GLU D 411 GLU.? 16.70 O3 GOL D 601 A 226 THR D 420 THR^? 11.62 O1 EDO C 602 A 229 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 9.66 102.78 70.07 9.79 101.18 71.42 14.38 -10.66 -25.01 13.15 -12.19 -25.81 coo 7.24 97.46 49.60 8.11 95.69 48.80 26.36 2.12 -37.74 25.52 4.03 -38.26 coo 10.53 97.56 43.71 9.33 93.71 47.17 27.51 4.47 -43.69 23.30 8.13 -41.81 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 A 57 GLU D 446 GLU~? 12.65 O1 GOL D 601 A 226 THR D 420 THR^? 11.62 O1 EDO C 602 A 229 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 9.66 102.78 70.07 9.79 101.18 71.42 8.69 3.92 -24.74 9.85 4.42 -23.05 coo 7.24 97.46 49.60 8.11 95.69 48.80 26.36 2.12 -37.74 25.52 4.03 -38.26 coo 10.53 97.56 43.71 9.33 93.71 47.17 27.51 4.47 -43.69 23.30 8.13 -41.81 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 15 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 330 GLU~? 26.93 C1 EDO B 603 B 226 THR A 369 THR~? 31.64 C1 EDO B 603 B 229 LYS A 367 LYS.? 27.79 C1 EDO B 603 coo 15.90 87.61 49.61 13.92 86.96 49.36 25.78 29.04 20.96 25.48 30.78 22.26 coo 20.74 95.78 68.68 19.29 96.84 69.83 27.07 6.63 18.00 27.23 4.49 18.30 coo 22.32 101.61 71.64 17.89 98.63 71.55 21.09 4.68 15.64 17.32 4.21 18.91 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU A 363 GLU~? 27.04 C1 EDO B 603 B 226 THR A 420 THR^? 12.22 O1 EDO B 603 B 229 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 15.90 87.61 49.61 13.92 86.96 49.36 14.23 7.65 22.80 13.44 9.34 23.77 coo 20.74 95.78 68.68 19.29 96.84 69.83 15.83 11.51 2.31 14.98 13.34 1.54 coo 22.32 101.61 71.64 17.89 98.63 71.55 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 57 GLU A 411 GLU.? 28.28 O1 EDO B 603 B 226 THR A 420 THR^? 12.22 O1 EDO B 603 B 229 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 15.90 87.61 49.61 13.92 86.96 49.36 3.89 -1.22 13.75 2.15 -0.02 14.05 coo 20.74 95.78 68.68 19.29 96.84 69.83 15.83 11.51 2.31 14.98 13.34 1.54 coo 22.32 101.61 71.64 17.89 98.63 71.55 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 57 GLU A 446 GLU~? 20.77 C2 EDO B 603 B 226 THR A 420 THR^? 12.22 O1 EDO B 603 B 229 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 15.90 87.61 49.61 13.92 86.96 49.36 -3.62 12.85 13.27 -2.92 11.09 12.27 coo 20.74 95.78 68.68 19.29 96.84 69.83 15.83 11.51 2.31 14.98 13.34 1.54 coo 22.32 101.61 71.64 17.89 98.63 71.55 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 57 GLU B 330 GLU~? 24.65 C1 EDO B 603 B 226 THR B 369 THR~? 15.82 O2 EDO B 603 B 229 LYS B 367 LYS.? 8.96 O2 EDO B 603 coo 15.90 87.61 49.61 13.92 86.96 49.36 31.94 25.81 2.71 33.76 25.37 1.74 coo 20.74 95.78 68.68 19.29 96.84 69.83 14.08 40.07 2.07 12.56 41.55 1.60 coo 22.32 101.61 71.64 17.89 98.63 71.55 8.46 36.63 1.57 6.31 34.95 -1.21 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 57 GLU B 363 GLU~? 7.89 O1 EDO B 603 B 226 THR B 420 THR^? 12.07 C2 EDO B 603 B 229 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo 15.90 87.61 49.61 13.92 86.96 49.36 8.83 27.73 -6.37 10.21 26.17 -6.89 coo 20.74 95.78 68.68 19.29 96.84 69.83 6.28 25.69 13.21 6.93 23.74 13.95 coo 22.32 101.61 71.64 17.89 98.63 71.55 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 B 57 GLU B 411 GLU.? 15.09 O2 EDO B 603 B 226 THR B 420 THR^? 12.07 C2 EDO B 603 B 229 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo 15.90 87.61 49.61 13.92 86.96 49.36 -5.72 28.81 -2.48 -6.82 27.11 -1.89 coo 20.74 95.78 68.68 19.29 96.84 69.83 6.28 25.69 13.21 6.93 23.74 13.95 coo 22.32 101.61 71.64 17.89 98.63 71.55 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 B 57 GLU B 446 GLU~? 12.80 O1 EDO B 603 B 226 THR B 420 THR^? 12.07 C2 EDO B 603 B 229 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo 15.90 87.61 49.61 13.92 86.96 49.36 0.25 13.76 -3.23 0.76 15.38 -4.51 coo 20.74 95.78 68.68 19.29 96.84 69.83 6.28 25.69 13.21 6.93 23.74 13.95 coo 22.32 101.61 71.64 17.89 98.63 71.55 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 B 57 GLU C 330 GLU~? 24.03 O1 EDO C 602 B 226 THR C 369 THR~? 15.84 O2 EDO C 602 B 229 LYS C 367 LYS.? 10.18 O2 EDO C 602 coo 15.90 87.61 49.61 13.92 86.96 49.36 43.59 14.91 -37.76 45.12 14.02 -38.99 coo 20.74 95.78 68.68 19.29 96.84 69.83 27.27 30.44 -36.03 26.03 32.19 -36.25 coo 22.32 101.61 71.64 17.89 98.63 71.55 21.41 26.99 -36.15 19.64 26.87 -41.36 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 B 57 GLU C 363 GLU~? 7.78 O2 EDO C 602 B 226 THR C 420 THR^? 10.46 O1 GOL D 601 B 229 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 15.90 87.61 49.61 13.92 86.96 49.36 20.56 19.64 -44.58 21.56 17.87 -45.23 coo 20.74 95.78 68.68 19.29 96.84 69.83 19.08 16.16 -25.00 19.73 14.12 -24.43 coo 22.32 101.61 71.64 17.89 98.63 71.55 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 B 57 GLU C 411 GLU.? 15.78 O2 EDO C 602 B 226 THR C 420 THR^? 10.46 O1 GOL D 601 B 229 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 15.90 87.61 49.61 13.92 86.96 49.36 6.23 19.30 -42.44 5.28 17.46 -42.16 coo 20.74 95.78 68.68 19.29 96.84 69.83 19.08 16.16 -25.00 19.73 14.12 -24.43 coo 22.32 101.61 71.64 17.89 98.63 71.55 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 B 57 GLU C 446 GLU~? 12.66 O1 EDO C 602 B 226 THR C 420 THR^? 10.46 O1 GOL D 601 B 229 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 15.90 87.61 49.61 13.92 86.96 49.36 12.37 5.19 -42.08 12.22 7.23 -42.76 coo 20.74 95.78 68.68 19.29 96.84 69.83 19.08 16.16 -25.00 19.73 14.12 -24.43 coo 22.32 101.61 71.64 17.89 98.63 71.55 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 B 57 GLU D 363 GLU~? 7.90 O2 GOL D 601 B 226 THR D 420 THR^? 11.62 O1 EDO C 602 B 229 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 15.90 87.61 49.61 13.92 86.96 49.36 24.65 -2.66 -18.42 24.14 -0.86 -17.43 coo 20.74 95.78 68.68 19.29 96.84 69.83 26.36 2.12 -37.74 25.52 4.03 -38.26 coo 22.32 101.61 71.64 17.89 98.63 71.55 27.51 4.47 -43.69 23.30 8.13 -41.81 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 B 57 GLU D 411 GLU.? 16.70 O3 GOL D 601 B 226 THR D 420 THR^? 11.62 O1 EDO C 602 B 229 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 15.90 87.61 49.61 13.92 86.96 49.36 14.38 -10.66 -25.01 13.15 -12.19 -25.81 coo 20.74 95.78 68.68 19.29 96.84 69.83 26.36 2.12 -37.74 25.52 4.03 -38.26 coo 22.32 101.61 71.64 17.89 98.63 71.55 27.51 4.47 -43.69 23.30 8.13 -41.81 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 B 57 GLU D 446 GLU~? 12.65 O1 GOL D 601 B 226 THR D 420 THR^? 11.62 O1 EDO C 602 B 229 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 15.90 87.61 49.61 13.92 86.96 49.36 8.69 3.92 -24.74 9.85 4.42 -23.05 coo 20.74 95.78 68.68 19.29 96.84 69.83 26.36 2.12 -37.74 25.52 4.03 -38.26 coo 22.32 101.61 71.64 17.89 98.63 71.55 27.51 4.47 -43.69 23.30 8.13 -41.81 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 15 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 330 GLU~? 26.93 C1 EDO B 603 C 226 THR A 369 THR~? 31.64 C1 EDO B 603 C 229 LYS A 367 LYS.? 27.79 C1 EDO B 603 coo 5.43 40.40 61.63 4.27 41.99 60.90 25.78 29.04 20.96 25.48 30.78 22.26 coo 22.16 45.88 73.63 23.23 47.70 73.25 27.07 6.63 18.00 27.23 4.49 18.30 coo 28.90 45.91 73.55 25.22 49.72 72.97 21.09 4.68 15.64 17.32 4.21 18.91 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU A 363 GLU~? 27.04 C1 EDO B 603 C 226 THR A 420 THR^? 12.22 O1 EDO B 603 C 229 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 5.43 40.40 61.63 4.27 41.99 60.90 14.23 7.65 22.80 13.44 9.34 23.77 coo 22.16 45.88 73.63 23.23 47.70 73.25 15.83 11.51 2.31 14.98 13.34 1.54 coo 28.90 45.91 73.55 25.22 49.72 72.97 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 57 GLU A 411 GLU.? 28.28 O1 EDO B 603 C 226 THR A 420 THR^? 12.22 O1 EDO B 603 C 229 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 5.43 40.40 61.63 4.27 41.99 60.90 3.89 -1.22 13.75 2.15 -0.02 14.05 coo 22.16 45.88 73.63 23.23 47.70 73.25 15.83 11.51 2.31 14.98 13.34 1.54 coo 28.90 45.91 73.55 25.22 49.72 72.97 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 57 GLU A 446 GLU~? 20.77 C2 EDO B 603 C 226 THR A 420 THR^? 12.22 O1 EDO B 603 C 229 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 5.43 40.40 61.63 4.27 41.99 60.90 -3.62 12.85 13.27 -2.92 11.09 12.27 coo 22.16 45.88 73.63 23.23 47.70 73.25 15.83 11.51 2.31 14.98 13.34 1.54 coo 28.90 45.91 73.55 25.22 49.72 72.97 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 57 GLU B 330 GLU~? 24.65 C1 EDO B 603 C 226 THR B 369 THR~? 15.82 O2 EDO B 603 C 229 LYS B 367 LYS.? 8.96 O2 EDO B 603 coo 5.43 40.40 61.63 4.27 41.99 60.90 31.94 25.81 2.71 33.76 25.37 1.74 coo 22.16 45.88 73.63 23.23 47.70 73.25 14.08 40.07 2.07 12.56 41.55 1.60 coo 28.90 45.91 73.55 25.22 49.72 72.97 8.46 36.63 1.57 6.31 34.95 -1.21 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 57 GLU B 363 GLU~? 7.89 O1 EDO B 603 C 226 THR B 420 THR^? 12.07 C2 EDO B 603 C 229 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo 5.43 40.40 61.63 4.27 41.99 60.90 8.83 27.73 -6.37 10.21 26.17 -6.89 coo 22.16 45.88 73.63 23.23 47.70 73.25 6.28 25.69 13.21 6.93 23.74 13.95 coo 28.90 45.91 73.55 25.22 49.72 72.97 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 C 57 GLU B 411 GLU.? 15.09 O2 EDO B 603 C 226 THR B 420 THR^? 12.07 C2 EDO B 603 C 229 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo 5.43 40.40 61.63 4.27 41.99 60.90 -5.72 28.81 -2.48 -6.82 27.11 -1.89 coo 22.16 45.88 73.63 23.23 47.70 73.25 6.28 25.69 13.21 6.93 23.74 13.95 coo 28.90 45.91 73.55 25.22 49.72 72.97 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 C 57 GLU B 446 GLU~? 12.80 O1 EDO B 603 C 226 THR B 420 THR^? 12.07 C2 EDO B 603 C 229 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo 5.43 40.40 61.63 4.27 41.99 60.90 0.25 13.76 -3.23 0.76 15.38 -4.51 coo 22.16 45.88 73.63 23.23 47.70 73.25 6.28 25.69 13.21 6.93 23.74 13.95 coo 28.90 45.91 73.55 25.22 49.72 72.97 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 C 57 GLU C 330 GLU~? 24.03 O1 EDO C 602 C 226 THR C 369 THR~? 15.84 O2 EDO C 602 C 229 LYS C 367 LYS.? 10.18 O2 EDO C 602 coo 5.43 40.40 61.63 4.27 41.99 60.90 43.59 14.91 -37.76 45.12 14.02 -38.99 coo 22.16 45.88 73.63 23.23 47.70 73.25 27.27 30.44 -36.03 26.03 32.19 -36.25 coo 28.90 45.91 73.55 25.22 49.72 72.97 21.41 26.99 -36.15 19.64 26.87 -41.36 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 C 57 GLU C 363 GLU~? 7.78 O2 EDO C 602 C 226 THR C 420 THR^? 10.46 O1 GOL D 601 C 229 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 5.43 40.40 61.63 4.27 41.99 60.90 20.56 19.64 -44.58 21.56 17.87 -45.23 coo 22.16 45.88 73.63 23.23 47.70 73.25 19.08 16.16 -25.00 19.73 14.12 -24.43 coo 28.90 45.91 73.55 25.22 49.72 72.97 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 C 57 GLU C 411 GLU.? 15.78 O2 EDO C 602 C 226 THR C 420 THR^? 10.46 O1 GOL D 601 C 229 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 5.43 40.40 61.63 4.27 41.99 60.90 6.23 19.30 -42.44 5.28 17.46 -42.16 coo 22.16 45.88 73.63 23.23 47.70 73.25 19.08 16.16 -25.00 19.73 14.12 -24.43 coo 28.90 45.91 73.55 25.22 49.72 72.97 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 C 57 GLU C 446 GLU~? 12.66 O1 EDO C 602 C 226 THR C 420 THR^? 10.46 O1 GOL D 601 C 229 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 5.43 40.40 61.63 4.27 41.99 60.90 12.37 5.19 -42.08 12.22 7.23 -42.76 coo 22.16 45.88 73.63 23.23 47.70 73.25 19.08 16.16 -25.00 19.73 14.12 -24.43 coo 28.90 45.91 73.55 25.22 49.72 72.97 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 C 57 GLU D 363 GLU~? 7.90 O2 GOL D 601 C 226 THR D 420 THR^? 11.62 O1 EDO C 602 C 229 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 5.43 40.40 61.63 4.27 41.99 60.90 24.65 -2.66 -18.42 24.14 -0.86 -17.43 coo 22.16 45.88 73.63 23.23 47.70 73.25 26.36 2.12 -37.74 25.52 4.03 -38.26 coo 28.90 45.91 73.55 25.22 49.72 72.97 27.51 4.47 -43.69 23.30 8.13 -41.81 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 C 57 GLU D 411 GLU.? 16.70 O3 GOL D 601 C 226 THR D 420 THR^? 11.62 O1 EDO C 602 C 229 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 5.43 40.40 61.63 4.27 41.99 60.90 14.38 -10.66 -25.01 13.15 -12.19 -25.81 coo 22.16 45.88 73.63 23.23 47.70 73.25 26.36 2.12 -37.74 25.52 4.03 -38.26 coo 28.90 45.91 73.55 25.22 49.72 72.97 27.51 4.47 -43.69 23.30 8.13 -41.81 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 C 57 GLU D 446 GLU~? 12.65 O1 GOL D 601 C 226 THR D 420 THR^? 11.62 O1 EDO C 602 C 229 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 5.43 40.40 61.63 4.27 41.99 60.90 8.69 3.92 -24.74 9.85 4.42 -23.05 coo 22.16 45.88 73.63 23.23 47.70 73.25 26.36 2.12 -37.74 25.52 4.03 -38.26 coo 28.90 45.91 73.55 25.22 49.72 72.97 27.51 4.47 -43.69 23.30 8.13 -41.81 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 15 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 330 GLU~? 26.93 C1 EDO B 603 D 226 THR A 369 THR~? 31.64 C1 EDO B 603 D 229 LYS A 367 LYS.? 27.79 C1 EDO B 603 coo 26.07 55.89 66.14 25.33 56.50 68.01 25.78 29.04 20.96 25.48 30.78 22.26 coo 11.79 47.62 52.67 10.10 46.51 53.39 27.07 6.63 18.00 27.23 4.49 18.30 coo 10.05 41.79 49.80 7.94 44.71 53.76 21.09 4.68 15.64 17.32 4.21 18.91 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU A 363 GLU~? 27.04 C1 EDO B 603 D 226 THR A 420 THR^? 12.22 O1 EDO B 603 D 229 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 26.07 55.89 66.14 25.33 56.50 68.01 14.23 7.65 22.80 13.44 9.34 23.77 coo 11.79 47.62 52.67 10.10 46.51 53.39 15.83 11.51 2.31 14.98 13.34 1.54 coo 10.05 41.79 49.80 7.94 44.71 53.76 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 57 GLU A 411 GLU.? 28.28 O1 EDO B 603 D 226 THR A 420 THR^? 12.22 O1 EDO B 603 D 229 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 26.07 55.89 66.14 25.33 56.50 68.01 3.89 -1.22 13.75 2.15 -0.02 14.05 coo 11.79 47.62 52.67 10.10 46.51 53.39 15.83 11.51 2.31 14.98 13.34 1.54 coo 10.05 41.79 49.80 7.94 44.71 53.76 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 57 GLU A 446 GLU~? 20.77 C2 EDO B 603 D 226 THR A 420 THR^? 12.22 O1 EDO B 603 D 229 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 26.07 55.89 66.14 25.33 56.50 68.01 -3.62 12.85 13.27 -2.92 11.09 12.27 coo 11.79 47.62 52.67 10.10 46.51 53.39 15.83 11.51 2.31 14.98 13.34 1.54 coo 10.05 41.79 49.80 7.94 44.71 53.76 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 57 GLU B 330 GLU~? 24.65 C1 EDO B 603 D 226 THR B 369 THR~? 15.82 O2 EDO B 603 D 229 LYS B 367 LYS.? 8.96 O2 EDO B 603 coo 26.07 55.89 66.14 25.33 56.50 68.01 31.94 25.81 2.71 33.76 25.37 1.74 coo 11.79 47.62 52.67 10.10 46.51 53.39 14.08 40.07 2.07 12.56 41.55 1.60 coo 10.05 41.79 49.80 7.94 44.71 53.76 8.46 36.63 1.57 6.31 34.95 -1.21 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 57 GLU B 363 GLU~? 7.89 O1 EDO B 603 D 226 THR B 420 THR^? 12.07 C2 EDO B 603 D 229 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo 26.07 55.89 66.14 25.33 56.50 68.01 8.83 27.73 -6.37 10.21 26.17 -6.89 coo 11.79 47.62 52.67 10.10 46.51 53.39 6.28 25.69 13.21 6.93 23.74 13.95 coo 10.05 41.79 49.80 7.94 44.71 53.76 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 D 57 GLU B 411 GLU.? 15.09 O2 EDO B 603 D 226 THR B 420 THR^? 12.07 C2 EDO B 603 D 229 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo 26.07 55.89 66.14 25.33 56.50 68.01 -5.72 28.81 -2.48 -6.82 27.11 -1.89 coo 11.79 47.62 52.67 10.10 46.51 53.39 6.28 25.69 13.21 6.93 23.74 13.95 coo 10.05 41.79 49.80 7.94 44.71 53.76 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 D 57 GLU B 446 GLU~? 12.80 O1 EDO B 603 D 226 THR B 420 THR^? 12.07 C2 EDO B 603 D 229 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo 26.07 55.89 66.14 25.33 56.50 68.01 0.25 13.76 -3.23 0.76 15.38 -4.51 coo 11.79 47.62 52.67 10.10 46.51 53.39 6.28 25.69 13.21 6.93 23.74 13.95 coo 10.05 41.79 49.80 7.94 44.71 53.76 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 D 57 GLU C 330 GLU~? 24.03 O1 EDO C 602 D 226 THR C 369 THR~? 15.84 O2 EDO C 602 D 229 LYS C 367 LYS.? 10.18 O2 EDO C 602 coo 26.07 55.89 66.14 25.33 56.50 68.01 43.59 14.91 -37.76 45.12 14.02 -38.99 coo 11.79 47.62 52.67 10.10 46.51 53.39 27.27 30.44 -36.03 26.03 32.19 -36.25 coo 10.05 41.79 49.80 7.94 44.71 53.76 21.41 26.99 -36.15 19.64 26.87 -41.36 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 D 57 GLU C 363 GLU~? 7.78 O2 EDO C 602 D 226 THR C 420 THR^? 10.46 O1 GOL D 601 D 229 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 26.07 55.89 66.14 25.33 56.50 68.01 20.56 19.64 -44.58 21.56 17.87 -45.23 coo 11.79 47.62 52.67 10.10 46.51 53.39 19.08 16.16 -25.00 19.73 14.12 -24.43 coo 10.05 41.79 49.80 7.94 44.71 53.76 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 D 57 GLU C 411 GLU.? 15.78 O2 EDO C 602 D 226 THR C 420 THR^? 10.46 O1 GOL D 601 D 229 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 26.07 55.89 66.14 25.33 56.50 68.01 6.23 19.30 -42.44 5.28 17.46 -42.16 coo 11.79 47.62 52.67 10.10 46.51 53.39 19.08 16.16 -25.00 19.73 14.12 -24.43 coo 10.05 41.79 49.80 7.94 44.71 53.76 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 D 57 GLU C 446 GLU~? 12.66 O1 EDO C 602 D 226 THR C 420 THR^? 10.46 O1 GOL D 601 D 229 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 26.07 55.89 66.14 25.33 56.50 68.01 12.37 5.19 -42.08 12.22 7.23 -42.76 coo 11.79 47.62 52.67 10.10 46.51 53.39 19.08 16.16 -25.00 19.73 14.12 -24.43 coo 10.05 41.79 49.80 7.94 44.71 53.76 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 D 57 GLU D 363 GLU~? 7.90 O2 GOL D 601 D 226 THR D 420 THR^? 11.62 O1 EDO C 602 D 229 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 26.07 55.89 66.14 25.33 56.50 68.01 24.65 -2.66 -18.42 24.14 -0.86 -17.43 coo 11.79 47.62 52.67 10.10 46.51 53.39 26.36 2.12 -37.74 25.52 4.03 -38.26 coo 10.05 41.79 49.80 7.94 44.71 53.76 27.51 4.47 -43.69 23.30 8.13 -41.81 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 D 57 GLU D 411 GLU.? 16.70 O3 GOL D 601 D 226 THR D 420 THR^? 11.62 O1 EDO C 602 D 229 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 26.07 55.89 66.14 25.33 56.50 68.01 14.38 -10.66 -25.01 13.15 -12.19 -25.81 coo 11.79 47.62 52.67 10.10 46.51 53.39 26.36 2.12 -37.74 25.52 4.03 -38.26 coo 10.05 41.79 49.80 7.94 44.71 53.76 27.51 4.47 -43.69 23.30 8.13 -41.81 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 D 57 GLU D 446 GLU~? 12.65 O1 GOL D 601 D 226 THR D 420 THR^? 11.62 O1 EDO C 602 D 229 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 26.07 55.89 66.14 25.33 56.50 68.01 8.69 3.92 -24.74 9.85 4.42 -23.05 coo 11.79 47.62 52.67 10.10 46.51 53.39 26.36 2.12 -37.74 25.52 4.03 -38.26 coo 10.05 41.79 49.80 7.94 44.71 53.76 27.51 4.47 -43.69 23.30 8.13 -41.81 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 15 hits 1dfo_c07 naa= 3 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 123 HIS A 338 HIS~? 19.64 C1 EDO B 603 A 200 ASP B 350 ASP.? 23.89 C2 EDO B 603 A 229 LYS B 388 LYS~? 19.48 C2 EDO B 603 coo 1.13 77.49 40.64 0.62 75.57 39.98 16.13 23.68 19.02 16.84 23.99 20.97 coo 0.84 91.24 49.01 2.91 91.61 49.23 12.16 40.72 19.41 11.14 39.74 20.98 coo 10.53 97.56 43.71 9.33 93.71 47.17 -0.92 37.13 17.34 -4.46 33.66 14.61 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 123 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 200 ASP A 350 ASP.? 26.92 O2 GOL D 601 A 229 LYS A 388 LYS~? 27.25 O2 GOL D 601 coo 1.13 77.49 40.64 0.62 75.57 39.98 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 0.84 91.24 49.01 2.91 91.61 49.23 33.51 7.96 1.59 32.78 7.85 -0.37 coo 10.53 97.56 43.71 9.33 93.71 47.17 22.21 -0.11 -1.07 17.85 -4.01 1.39 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 123 HIS C 338 HIS~? 12.91 O1 EDO C 602 A 200 ASP D 350 ASP.? 24.09 C3 GOL D 601 A 229 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo 1.13 77.49 40.64 0.62 75.57 39.98 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 0.84 91.24 49.01 2.91 91.61 49.23 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 10.53 97.56 43.71 9.33 93.71 47.17 31.25 -9.34 -42.79 29.68 -12.48 -44.35 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 123 HIS D 338 HIS~? 13.70 C1 GOL D 601 A 200 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 229 LYS C 388 LYS~? 20.15 C2 EDO C 602 coo 1.13 77.49 40.64 0.62 75.57 39.98 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 0.84 91.24 49.01 2.91 91.61 49.23 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 10.53 97.56 43.71 9.33 93.71 47.17 13.46 28.58 -20.25 9.42 25.73 -22.18 1dfo_c12 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 4 hits 1dfo_c12 naa= 3 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 123 HIS A 338 HIS~? 19.64 C1 EDO B 603 B 200 ASP B 350 ASP.? 23.89 C2 EDO B 603 B 229 LYS B 388 LYS~? 19.48 C2 EDO B 603 coo 9.24 94.26 88.22 8.02 94.07 89.92 16.13 23.68 19.02 16.84 23.99 20.97 coo 17.54 90.31 75.01 17.17 92.01 73.80 12.16 40.72 19.41 11.14 39.74 20.98 coo 22.32 101.61 71.64 17.89 98.63 71.55 -0.92 37.13 17.34 -4.46 33.66 14.61 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 123 HIS B 338 HIS.? 13.66 O1 EDO B 603 B 200 ASP A 350 ASP.? 26.92 O2 GOL D 601 B 229 LYS A 388 LYS~? 27.25 O2 GOL D 601 coo 9.24 94.26 88.22 8.02 94.07 89.92 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 17.54 90.31 75.01 17.17 92.01 73.80 33.51 7.96 1.59 32.78 7.85 -0.37 coo 22.32 101.61 71.64 17.89 98.63 71.55 22.21 -0.11 -1.07 17.85 -4.01 1.39 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 123 HIS C 338 HIS~? 12.91 O1 EDO C 602 B 200 ASP D 350 ASP.? 24.09 C3 GOL D 601 B 229 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo 9.24 94.26 88.22 8.02 94.07 89.92 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 17.54 90.31 75.01 17.17 92.01 73.80 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 22.32 101.61 71.64 17.89 98.63 71.55 31.25 -9.34 -42.79 29.68 -12.48 -44.35 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 123 HIS D 338 HIS~? 13.70 C1 GOL D 601 B 200 ASP C 350 ASP.? 24.48 C2 EDO C 602 B 229 LYS C 388 LYS~? 20.15 C2 EDO C 602 coo 9.24 94.26 88.22 8.02 94.07 89.92 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 17.54 90.31 75.01 17.17 92.01 73.80 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 22.32 101.61 71.64 17.89 98.63 71.55 13.46 28.58 -20.25 9.42 25.73 -22.18 1dfo_c13 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 4 hits 1dfo_c13 naa= 3 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 123 HIS A 338 HIS~? 19.64 C1 EDO B 603 C 200 ASP B 350 ASP.? 23.89 C2 EDO B 603 C 229 LYS B 388 LYS~? 19.48 C2 EDO B 603 coo 26.77 65.84 83.49 27.06 67.76 84.27 16.13 23.68 19.02 16.84 23.99 20.97 coo 19.52 52.01 79.59 20.28 51.65 77.65 12.16 40.72 19.41 11.14 39.74 20.98 coo 28.90 45.91 73.55 25.22 49.72 72.97 -0.92 37.13 17.34 -4.46 33.66 14.61 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 123 HIS B 338 HIS.? 13.66 O1 EDO B 603 C 200 ASP A 350 ASP.? 26.92 O2 GOL D 601 C 229 LYS A 388 LYS~? 27.25 O2 GOL D 601 coo 26.77 65.84 83.49 27.06 67.76 84.27 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 19.52 52.01 79.59 20.28 51.65 77.65 33.51 7.96 1.59 32.78 7.85 -0.37 coo 28.90 45.91 73.55 25.22 49.72 72.97 22.21 -0.11 -1.07 17.85 -4.01 1.39 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 123 HIS C 338 HIS~? 12.91 O1 EDO C 602 C 200 ASP D 350 ASP.? 24.09 C3 GOL D 601 C 229 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo 26.77 65.84 83.49 27.06 67.76 84.27 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 19.52 52.01 79.59 20.28 51.65 77.65 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 28.90 45.91 73.55 25.22 49.72 72.97 31.25 -9.34 -42.79 29.68 -12.48 -44.35 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 123 HIS D 338 HIS~? 13.70 C1 GOL D 601 C 200 ASP C 350 ASP.? 24.48 C2 EDO C 602 C 229 LYS C 388 LYS~? 20.15 C2 EDO C 602 coo 26.77 65.84 83.49 27.06 67.76 84.27 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 19.52 52.01 79.59 20.28 51.65 77.65 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 28.90 45.91 73.55 25.22 49.72 72.97 13.46 28.58 -20.25 9.42 25.73 -22.18 1dfo_c14 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 4 hits 1dfo_c14 naa= 3 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 123 HIS A 338 HIS~? 19.64 C1 EDO B 603 D 200 ASP B 350 ASP.? 23.89 C2 EDO B 603 D 229 LYS B 388 LYS~? 19.48 C2 EDO B 603 coo -10.90 48.74 53.41 -12.98 48.90 53.67 16.13 23.68 19.02 16.84 23.99 20.97 coo 4.60 52.95 52.50 5.57 51.29 53.40 12.16 40.72 19.41 11.14 39.74 20.98 coo 10.05 41.79 49.80 7.94 44.71 53.76 -0.92 37.13 17.34 -4.46 33.66 14.61 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 123 HIS B 338 HIS.? 13.66 O1 EDO B 603 D 200 ASP A 350 ASP.? 26.92 O2 GOL D 601 D 229 LYS A 388 LYS~? 27.25 O2 GOL D 601 coo -10.90 48.74 53.41 -12.98 48.90 53.67 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 4.60 52.95 52.50 5.57 51.29 53.40 33.51 7.96 1.59 32.78 7.85 -0.37 coo 10.05 41.79 49.80 7.94 44.71 53.76 22.21 -0.11 -1.07 17.85 -4.01 1.39 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 123 HIS C 338 HIS~? 12.91 O1 EDO C 602 D 200 ASP D 350 ASP.? 24.09 C3 GOL D 601 D 229 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo -10.90 48.74 53.41 -12.98 48.90 53.67 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 4.60 52.95 52.50 5.57 51.29 53.40 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 10.05 41.79 49.80 7.94 44.71 53.76 31.25 -9.34 -42.79 29.68 -12.48 -44.35 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 123 HIS D 338 HIS~? 13.70 C1 GOL D 601 D 200 ASP C 350 ASP.? 24.48 C2 EDO C 602 D 229 LYS C 388 LYS~? 20.15 C2 EDO C 602 coo -10.90 48.74 53.41 -12.98 48.90 53.67 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 4.60 52.95 52.50 5.57 51.29 53.40 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 10.05 41.79 49.80 7.94 44.71 53.76 13.46 28.58 -20.25 9.42 25.73 -22.18 1dfo_c15 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 4 hits 1dfo_c15 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 317 THR.? 30.13 C1 EDO B 603 A 45 THR A 318 THR.? 30.43 C1 EDO B 603 A 161 LYS B 348 LYS.? 28.30 C2 EDO B 603 coo 26.16 88.25 79.16 25.22 89.47 80.71 29.57 32.99 19.64 30.09 32.97 21.72 coo 27.73 89.90 76.08 29.24 91.46 75.95 30.31 35.91 17.26 32.03 37.29 17.23 coo 33.83 91.15 88.62 31.07 91.06 83.02 16.25 36.62 22.07 20.01 34.44 26.08 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 44 THR B 317 THR.? 28.99 C1 EDO B 603 A 45 THR B 318 THR.? 31.71 C1 EDO B 603 A 161 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo 26.16 88.25 79.16 25.22 89.47 80.71 36.64 25.71 6.15 37.93 26.34 4.55 coo 27.73 89.90 76.08 29.24 91.46 75.95 38.06 24.71 9.55 39.51 25.67 10.82 coo 33.83 91.15 88.62 31.07 91.06 83.02 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 44 THR C 317 THR.? 28.45 C1 EDO C 602 A 45 THR C 318 THR.? 30.49 C2 GOL D 601 A 161 LYS D 348 LYS.? 27.59 O1 EDO C 602 coo 26.16 88.25 79.16 25.22 89.47 80.71 48.45 14.16 -34.83 49.57 14.57 -36.66 coo 27.73 89.90 76.08 29.24 91.46 75.95 50.21 12.77 -31.72 51.79 13.54 -30.47 coo 33.83 91.15 88.62 31.07 91.06 83.02 43.15 3.71 -41.93 47.18 7.62 -43.42 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 A 44 THR D 317 THR.? 28.79 C1 GOL D 601 A 45 THR D 318 THR.? 30.09 C1 EDO C 602 A 161 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo 26.16 88.25 79.16 25.22 89.47 80.71 43.40 21.29 -20.10 44.08 21.40 -18.06 coo 27.73 89.90 76.08 29.24 91.46 75.95 44.56 23.70 -22.81 46.55 24.41 -23.21 coo 33.83 91.15 88.62 31.07 91.06 83.02 31.02 25.73 -16.52 36.61 24.80 -13.64 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 4 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 317 THR.? 30.13 C1 EDO B 603 B 45 THR A 318 THR.? 30.43 C1 EDO B 603 B 161 LYS B 348 LYS.? 28.30 C2 EDO B 603 coo 7.39 128.28 94.56 8.34 126.36 94.79 29.57 32.99 19.64 30.09 32.97 21.72 coo 5.75 129.25 91.25 4.29 128.16 90.07 30.31 35.91 17.26 32.03 37.29 17.23 coo -0.17 119.75 99.65 2.51 123.83 95.70 16.25 36.62 22.07 20.01 34.44 26.08 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 44 THR B 317 THR.? 28.99 C1 EDO B 603 B 45 THR B 318 THR.? 31.71 C1 EDO B 603 B 161 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo 7.39 128.28 94.56 8.34 126.36 94.79 36.64 25.71 6.15 37.93 26.34 4.55 coo 5.75 129.25 91.25 4.29 128.16 90.07 38.06 24.71 9.55 39.51 25.67 10.82 coo -0.17 119.75 99.65 2.51 123.83 95.70 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 44 THR C 317 THR.? 28.45 C1 EDO C 602 B 45 THR C 318 THR.? 30.49 C2 GOL D 601 B 161 LYS D 348 LYS.? 27.59 O1 EDO C 602 coo 7.39 128.28 94.56 8.34 126.36 94.79 48.45 14.16 -34.83 49.57 14.57 -36.66 coo 5.75 129.25 91.25 4.29 128.16 90.07 50.21 12.77 -31.72 51.79 13.54 -30.47 coo -0.17 119.75 99.65 2.51 123.83 95.70 43.15 3.71 -41.93 47.18 7.62 -43.42 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 B 44 THR D 317 THR.? 28.79 C1 GOL D 601 B 45 THR D 318 THR.? 30.09 C1 EDO C 602 B 161 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo 7.39 128.28 94.56 8.34 126.36 94.79 43.40 21.29 -20.10 44.08 21.40 -18.06 coo 5.75 129.25 91.25 4.29 128.16 90.07 44.56 23.70 -22.81 46.55 24.41 -23.21 coo -0.17 119.75 99.65 2.51 123.83 95.70 31.02 25.73 -16.52 36.61 24.80 -13.64 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 4 hits 1dhp_c03 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 355 TYR^? 25.32 C1 EDO B 603 150 LYS A 367 LYS.? 27.79 C1 EDO B 603 186 ASN A 347 ASN^? 27.63 C1 EDO B 603 coo 32.88 50.55 24.33 31.89 51.78 26.65 25.00 11.79 14.66 25.82 10.48 17.03 coo 27.04 52.42 22.30 26.88 49.99 27.00 21.09 4.68 15.64 17.32 4.21 18.91 coo 36.98 50.30 37.29 35.85 50.29 35.50 32.85 15.10 3.85 34.45 13.77 4.43 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR A 355 TYR^? 25.32 C1 EDO B 603 150 LYS A 367 LYS.? 27.79 C1 EDO B 603 186 ASN A 376 ASN~? 30.77 O2 GOL D 601 coo 32.88 50.55 24.33 31.89 51.78 26.65 25.00 11.79 14.66 25.82 10.48 17.03 coo 27.04 52.42 22.30 26.88 49.99 27.00 21.09 4.68 15.64 17.32 4.21 18.91 coo 36.98 50.30 37.29 35.85 50.29 35.50 35.45 5.09 5.49 35.04 5.15 3.39 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 3 # 3 146 TYR A 421 TYR^? 19.72 O1 EDO B 603 150 LYS A 403 LYS^? 8.85 O1 EDO B 603 186 ASN A 347 ASN^? 27.63 C1 EDO B 603 coo 32.88 50.55 24.33 31.89 51.78 26.65 20.02 8.83 1.38 20.18 6.69 3.20 coo 27.04 52.42 22.30 26.88 49.99 27.00 17.56 13.24 -3.73 14.59 17.27 -0.83 coo 36.98 50.30 37.29 35.85 50.29 35.50 32.85 15.10 3.85 34.45 13.77 4.43 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 4 3 # 4 146 TYR A 421 TYR^? 19.72 O1 EDO B 603 150 LYS A 403 LYS^? 8.85 O1 EDO B 603 186 ASN A 356 ASN.? 18.20 C1 EDO B 603 coo 32.88 50.55 24.33 31.89 51.78 26.65 20.02 8.83 1.38 20.18 6.69 3.20 coo 27.04 52.42 22.30 26.88 49.99 27.00 17.56 13.24 -3.73 14.59 17.27 -0.83 coo 36.98 50.30 37.29 35.85 50.29 35.50 21.62 17.22 14.34 19.81 16.20 13.98 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 5 3 # 5 146 TYR B 355 TYR^? 12.60 O2 EDO B 603 150 LYS B 367 LYS.? 8.96 O2 EDO B 603 186 ASN B 347 ASN^? 23.37 C2 EDO B 603 coo 32.88 50.55 24.33 31.89 51.78 26.65 15.82 34.63 5.10 16.14 36.63 3.16 coo 27.04 52.42 22.30 26.88 49.99 27.00 8.46 36.63 1.57 6.31 34.95 -1.21 coo 36.98 50.30 37.29 35.85 50.29 35.50 18.47 36.73 18.25 18.44 38.86 18.15 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 6 3 # 6 146 TYR B 355 TYR^? 12.60 O2 EDO B 603 150 LYS B 367 LYS.? 8.96 O2 EDO B 603 186 ASN B 376 ASN~? 24.05 C2 EDO B 603 coo 32.88 50.55 24.33 31.89 51.78 26.65 15.82 34.63 5.10 16.14 36.63 3.16 coo 27.04 52.42 22.30 26.88 49.99 27.00 8.46 36.63 1.57 6.31 34.95 -1.21 coo 36.98 50.30 37.29 35.85 50.29 35.50 11.86 44.76 15.81 10.83 43.80 17.41 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 7 3 # 7 146 TYR B 421 TYR^? 13.58 C2 EDO B 603 150 LYS B 403 LYS^? 16.64 C2 EDO B 603 186 ASN B 347 ASN^? 23.37 C2 EDO B 603 coo 32.88 50.55 24.33 31.89 51.78 26.65 6.36 30.57 15.08 5.68 32.41 13.09 coo 27.04 52.42 22.30 26.88 49.99 27.00 6.24 24.71 19.66 5.62 19.48 17.38 coo 36.98 50.30 37.29 35.85 50.29 35.50 18.47 36.73 18.25 18.44 38.86 18.15 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 8 3 # 8 146 TYR B 421 TYR^? 13.58 C2 EDO B 603 150 LYS B 403 LYS^? 16.64 C2 EDO B 603 186 ASN B 356 ASN.? 8.23 C1 EDO B 603 coo 32.88 50.55 24.33 31.89 51.78 26.65 6.36 30.57 15.08 5.68 32.41 13.09 coo 27.04 52.42 22.30 26.88 49.99 27.00 6.24 24.71 19.66 5.62 19.48 17.38 coo 36.98 50.30 37.29 35.85 50.29 35.50 18.03 28.57 5.10 16.12 27.74 4.68 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 9 3 # 9 146 TYR C 355 TYR^? 12.28 O2 EDO C 602 150 LYS C 367 LYS.? 10.18 O2 EDO C 602 186 ASN C 333 ASN~? 16.90 C1 EDO C 602 coo 32.88 50.55 24.33 31.89 51.78 26.65 28.68 24.77 -33.28 28.94 26.73 -35.28 coo 27.04 52.42 22.30 26.88 49.99 27.00 21.41 26.99 -36.15 19.64 26.87 -41.36 coo 36.98 50.30 37.29 35.85 50.29 35.50 38.73 17.09 -34.48 37.68 18.68 -35.44 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 10 3 # 10 146 TYR C 355 TYR^? 12.28 O2 EDO C 602 150 LYS C 367 LYS.? 10.18 O2 EDO C 602 186 ASN C 347 ASN^? 23.48 C1 EDO C 602 coo 32.88 50.55 24.33 31.89 51.78 26.65 28.68 24.77 -33.28 28.94 26.73 -35.28 coo 27.04 52.42 22.30 26.88 49.99 27.00 21.41 26.99 -36.15 19.64 26.87 -41.36 coo 36.98 50.30 37.29 35.85 50.29 35.50 32.68 25.81 -20.60 32.92 27.92 -20.57 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 11 3 # 11 146 TYR C 355 TYR^? 12.28 O2 EDO C 602 150 LYS C 367 LYS.? 10.18 O2 EDO C 602 186 ASN C 376 ASN~? 24.86 O2 EDO C 602 coo 32.88 50.55 24.33 31.89 51.78 26.65 28.68 24.77 -33.28 28.94 26.73 -35.28 coo 27.04 52.42 22.30 26.88 49.99 27.00 21.41 26.99 -36.15 19.64 26.87 -41.36 coo 36.98 50.30 37.29 35.85 50.29 35.50 27.15 34.69 -21.55 26.19 33.87 -19.83 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 12 3 # 12 146 TYR C 421 TYR^? 13.35 C2 EDO C 602 150 LYS C 403 LYS^? 9.83 O1 GOL D 601 186 ASN C 347 ASN^? 23.48 C1 EDO C 602 coo 32.88 50.55 24.33 31.89 51.78 26.65 19.38 20.76 -23.26 18.18 22.24 -25.31 coo 27.04 52.42 22.30 26.88 49.99 27.00 19.56 15.05 -18.65 18.30 10.78 -20.22 coo 36.98 50.30 37.29 35.85 50.29 35.50 32.68 25.81 -20.60 32.92 27.92 -20.57 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 13 3 # 13 146 TYR C 421 TYR^? 13.35 C2 EDO C 602 150 LYS C 403 LYS^? 9.83 O1 GOL D 601 186 ASN C 356 ASN.? 8.10 C1 EDO C 602 coo 32.88 50.55 24.33 31.89 51.78 26.65 19.38 20.76 -23.26 18.18 22.24 -25.31 coo 27.04 52.42 22.30 26.88 49.99 27.00 19.56 15.05 -18.65 18.30 10.78 -20.22 coo 36.98 50.30 37.29 35.85 50.29 35.50 30.42 18.66 -33.90 28.43 18.01 -34.20 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 14 3 # 14 146 TYR D 355 TYR^? 12.42 O3 GOL D 601 150 LYS D 367 LYS.? 8.67 O3 GOL D 601 186 ASN D 347 ASN^? 23.69 C3 GOL D 601 coo 32.88 50.55 24.33 31.89 51.78 26.65 36.51 0.70 -26.17 37.53 -0.88 -24.11 coo 27.04 52.42 22.30 26.88 49.99 27.00 32.17 -6.41 -25.63 28.00 -7.23 -22.20 coo 36.98 50.30 37.29 35.85 50.29 35.50 43.61 4.31 -37.61 45.14 2.83 -37.46 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 15 3 # 15 146 TYR D 421 TYR^? 13.63 C3 GOL D 601 150 LYS D 403 LYS^? 8.04 O1 EDO C 602 186 ASN D 347 ASN^? 23.69 C3 GOL D 601 coo 32.88 50.55 24.33 31.89 51.78 26.65 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo 27.04 52.42 22.30 26.88 49.99 27.00 27.51 4.47 -43.69 23.30 8.13 -41.81 coo 36.98 50.30 37.29 35.85 50.29 35.50 43.61 4.31 -37.61 45.14 2.83 -37.46 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 15 hits 1dhr_c00 naa= 3 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 1 3 # 1 A 107 ALA A 361 ALA~? 29.16 C1 EDO B 603 A 136 TYR A 355 TYR^? 25.32 C1 EDO B 603 A 140 LYS A 367 LYS.? 27.79 C1 EDO B 603 coo 55.90 7.49 23.83 56.71 8.23 22.76 20.58 8.39 21.62 21.97 8.14 22.23 coo 59.38 10.02 17.51 59.95 9.89 20.21 25.00 11.79 14.66 25.82 10.48 17.03 coo 59.52 3.69 18.67 62.31 6.19 22.58 21.09 4.68 15.64 17.32 4.21 18.91 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 2 3 # 2 A 107 ALA A 423 ALA^? 17.43 O1 EDO B 603 A 136 TYR A 421 TYR^? 19.72 O1 EDO B 603 A 140 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 55.90 7.49 23.83 56.71 8.23 22.76 23.34 15.61 -2.79 23.45 15.65 -4.34 coo 59.38 10.02 17.51 59.95 9.89 20.21 20.02 8.83 1.38 20.18 6.69 3.20 coo 59.52 3.69 18.67 62.31 6.19 22.58 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 3 3 # 3 A 107 ALA B 423 ALA^? 20.91 C2 EDO B 603 A 136 TYR B 421 TYR^? 13.58 C2 EDO B 603 A 140 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo 55.90 7.49 23.83 56.71 8.23 22.76 11.54 27.99 21.15 11.04 27.92 22.61 coo 59.38 10.02 17.51 59.95 9.89 20.21 6.36 30.57 15.08 5.68 32.41 13.09 coo 59.52 3.69 18.67 62.31 6.19 22.58 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 4 3 # 4 A 107 ALA C 423 ALA^? 17.19 O1 GOL D 601 A 136 TYR C 421 TYR^? 13.35 C2 EDO C 602 A 140 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 55.90 7.49 23.83 56.71 8.23 22.76 25.18 17.70 -17.34 24.76 17.44 -15.88 coo 59.38 10.02 17.51 59.95 9.89 20.21 19.38 20.76 -23.26 18.18 22.24 -25.31 coo 59.52 3.69 18.67 62.31 6.19 22.58 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 5 3 # 5 A 107 ALA D 361 ALA~? 11.04 O3 GOL D 601 A 136 TYR D 355 TYR^? 12.42 O3 GOL D 601 A 140 LYS D 367 LYS.? 8.67 O3 GOL D 601 coo 55.90 7.49 23.83 56.71 8.23 22.76 31.17 -3.31 -19.50 32.51 -3.83 -18.93 coo 59.38 10.02 17.51 59.95 9.89 20.21 36.51 0.70 -26.17 37.53 -0.88 -24.11 coo 59.52 3.69 18.67 62.31 6.19 22.58 32.17 -6.41 -25.63 28.00 -7.23 -22.20 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 6 3 # 6 A 107 ALA D 423 ALA^? 16.44 O1 EDO C 602 A 136 TYR D 421 TYR^? 13.63 C3 GOL D 601 A 140 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 55.90 7.49 23.83 56.71 8.23 22.76 33.47 6.23 -43.05 33.47 6.26 -44.59 coo 59.38 10.02 17.51 59.95 9.89 20.21 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo 59.52 3.69 18.67 62.31 6.19 22.58 27.51 4.47 -43.69 23.30 8.13 -41.81 1e7q_c01 source 1e7q GDP-FUCOSE SYNTHETASE : 6 hits 1e7q_c01 naa= 3 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 1 3 # 1 A 99 HIS A 338 HIS~? 19.64 C1 EDO B 603 A 177 ASP B 426 ASP.? 28.68 C1 EDO B 603 A 203 LYS B 348 LYS.? 28.30 C2 EDO B 603 coo 8.74 45.76 47.19 9.33 46.93 45.56 16.13 23.68 19.02 16.84 23.99 20.97 coo 11.68 42.31 52.96 12.05 43.92 51.65 21.11 26.70 26.04 20.61 27.63 27.90 coo 18.07 52.81 49.62 14.17 49.99 48.07 16.25 36.62 22.07 20.01 34.44 26.08 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 2 3 # 2 A 99 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 177 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 203 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo 8.74 45.76 47.19 9.33 46.93 45.56 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 11.68 42.31 52.96 12.05 43.92 51.65 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 18.07 52.81 49.62 14.17 49.99 48.07 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 3 3 # 3 A 99 HIS D 338 HIS~? 13.70 C1 GOL D 601 A 177 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 203 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo 8.74 45.76 47.19 9.33 46.93 45.56 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 11.68 42.31 52.96 12.05 43.92 51.65 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 18.07 52.81 49.62 14.17 49.99 48.07 31.02 25.73 -16.52 36.61 24.80 -13.64 1ecx_c02 source 1ecx AMINOTRANSFERASE : 3 hits 1ecx_c02 naa= 3 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 1 3 # 1 B 99 HIS A 338 HIS~? 19.64 C1 EDO B 603 B 177 ASP B 426 ASP.? 28.68 C1 EDO B 603 B 203 LYS B 348 LYS.? 28.30 C2 EDO B 603 coo 14.87 88.04 21.51 13.64 87.90 19.81 16.13 23.68 19.02 16.84 23.99 20.97 coo 15.87 92.46 27.37 14.46 91.76 25.94 21.11 26.70 26.04 20.61 27.63 27.90 coo 3.60 91.42 23.52 8.20 89.55 22.63 16.25 36.62 22.07 20.01 34.44 26.08 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 2 3 # 2 B 99 HIS B 338 HIS.? 13.66 O1 EDO B 603 B 177 ASP A 426 ASP.? 22.31 O1 EDO B 603 B 203 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo 14.87 88.04 21.51 13.64 87.90 19.81 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 15.87 92.46 27.37 14.46 91.76 25.94 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 3.60 91.42 23.52 8.20 89.55 22.63 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 3 3 # 3 B 99 HIS C 338 HIS~? 12.91 O1 EDO C 602 B 177 ASP D 426 ASP.? 21.84 O1 EDO C 602 B 203 LYS D 348 LYS.? 27.59 O1 EDO C 602 coo 14.87 88.04 21.51 13.64 87.90 19.81 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 15.87 92.46 27.37 14.46 91.76 25.94 40.54 14.64 -43.98 41.47 13.99 -45.77 coo 3.60 91.42 23.52 8.20 89.55 22.63 43.15 3.71 -41.93 47.18 7.62 -43.42 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 4 3 # 4 B 99 HIS D 338 HIS~? 13.70 C1 GOL D 601 B 177 ASP C 426 ASP.? 22.72 C2 GOL D 601 B 203 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo 14.87 88.04 21.51 13.64 87.90 19.81 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 15.87 92.46 27.37 14.46 91.76 25.94 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 3.60 91.42 23.52 8.20 89.55 22.63 31.02 25.73 -16.52 36.61 24.80 -13.64 1ecx_c03 source 1ecx AMINOTRANSFERASE : 4 hits 1ecx_c03 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS A 338 HIS~? 19.64 C1 EDO B 603 A 197 ASP B 426 ASP.? 28.68 C1 EDO B 603 A 223 LYS B 348 LYS.? 28.30 C2 EDO B 603 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 16.13 23.68 19.02 16.84 23.99 20.97 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 21.11 26.70 26.04 20.61 27.63 27.90 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 16.25 36.62 22.07 20.01 34.44 26.08 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 A 114 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 197 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 223 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 29.17 24.78 -3.72 30.40 24.16 -5.34 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 A 114 HIS C 338 HIS~? 12.91 O1 EDO C 602 A 197 ASP D 426 ASP.? 21.84 O1 EDO C 602 A 223 LYS D 348 LYS.? 27.59 O1 EDO C 602 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 40.54 14.64 -43.98 41.47 13.99 -45.77 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 43.15 3.71 -41.93 47.18 7.62 -43.42 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 A 114 HIS D 338 HIS~? 13.70 C1 GOL D 601 A 197 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 223 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 29.23 12.85 -20.11 30.06 13.12 -18.20 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 35.09 15.28 -13.55 34.97 16.40 -11.75 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 31.02 25.73 -16.52 36.61 24.80 -13.64 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 4 hits 1elq_c02 naa= 3 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 B 114 HIS A 338 HIS~? 19.64 C1 EDO B 603 B 197 ASP B 426 ASP.? 28.68 C1 EDO B 603 B 223 LYS B 348 LYS.? 28.30 C2 EDO B 603 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 16.13 23.68 19.02 16.84 23.99 20.97 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 21.11 26.70 26.04 20.61 27.63 27.90 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 16.25 36.62 22.07 20.01 34.44 26.08 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 B 114 HIS B 338 HIS.? 13.66 O1 EDO B 603 B 197 ASP A 426 ASP.? 22.31 O1 EDO B 603 B 223 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 29.17 24.78 -3.72 30.40 24.16 -5.34 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 B 114 HIS C 338 HIS~? 12.91 O1 EDO C 602 B 197 ASP D 426 ASP.? 21.84 O1 EDO C 602 B 223 LYS D 348 LYS.? 27.59 O1 EDO C 602 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 40.54 14.64 -43.98 41.47 13.99 -45.77 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 43.15 3.71 -41.93 47.18 7.62 -43.42 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 B 114 HIS D 338 HIS~? 13.70 C1 GOL D 601 B 197 ASP C 426 ASP.? 22.72 C2 GOL D 601 B 223 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 29.23 12.85 -20.11 30.06 13.12 -18.20 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 35.09 15.28 -13.55 34.97 16.40 -11.75 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 31.02 25.73 -16.52 36.61 24.80 -13.64 1elq_c03 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 4 hits 1elq_c03 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS A 388 LYS~? 27.25 O2 GOL D 601 A 193 GLU A 394 GLU~? 15.90 O2 GOL D 601 A 217 VAL A 392 VAL~? 22.23 O1 EDO B 603 coo 2.10 10.68 61.44 -2.14 13.16 60.61 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo -5.33 11.71 69.72 -4.62 11.92 67.73 27.33 5.77 -8.72 27.90 4.03 -9.75 coo 0.07 12.29 66.53 -0.24 11.95 64.38 22.40 5.80 -3.48 20.93 6.18 -1.90 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 159 LYS B 388 LYS~? 19.48 C2 EDO B 603 A 193 GLU B 394 GLU~? 28.21 C2 EDO B 603 A 217 VAL B 392 VAL~? 19.13 C2 EDO B 603 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -0.92 37.13 17.34 -4.46 33.66 14.61 coo -5.33 11.71 69.72 -4.62 11.92 67.73 4.47 36.77 26.38 2.63 37.63 26.96 coo 0.07 12.29 66.53 -0.24 11.95 64.38 3.37 33.31 20.09 3.37 32.29 18.15 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 159 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 193 GLU C 378 GLU~? 24.96 O2 EDO B 603 A 217 VAL C 389 VAL~? 19.67 C2 EDO C 602 coo 2.10 10.68 61.44 -2.14 13.16 60.61 13.46 28.58 -20.25 9.42 25.73 -22.18 coo -5.33 11.71 69.72 -4.62 11.92 67.73 22.14 33.77 -19.82 21.71 34.90 -18.09 coo 0.07 12.29 66.53 -0.24 11.95 64.38 17.26 28.56 -20.86 18.61 29.49 -22.34 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 159 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 193 GLU C 394 GLU~? 16.86 O1 EDO B 603 A 217 VAL C 392 VAL~? 19.19 C2 EDO C 602 coo 2.10 10.68 61.44 -2.14 13.16 60.61 13.46 28.58 -20.25 9.42 25.73 -22.18 coo -5.33 11.71 69.72 -4.62 11.92 67.73 19.77 27.90 -12.93 18.57 29.44 -12.10 coo 0.07 12.29 66.53 -0.24 11.95 64.38 17.29 23.91 -17.96 17.04 22.99 -19.94 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 159 LYS C 391 LYS~? 16.77 O1 EDO B 603 A 193 GLU C 378 GLU~? 24.96 O2 EDO B 603 A 217 VAL C 389 VAL~? 19.67 C2 EDO C 602 coo 2.10 10.68 61.44 -2.14 13.16 60.61 15.56 26.67 -15.99 9.90 23.87 -16.19 coo -5.33 11.71 69.72 -4.62 11.92 67.73 22.14 33.77 -19.82 21.71 34.90 -18.09 coo 0.07 12.29 66.53 -0.24 11.95 64.38 17.26 28.56 -20.86 18.61 29.49 -22.34 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 159 LYS D 388 LYS~? 23.05 O3 GOL D 601 A 193 GLU D 394 GLU~? 26.98 C3 GOL D 601 A 217 VAL D 392 VAL~? 19.27 C3 GOL D 601 coo 2.10 10.68 61.44 -2.14 13.16 60.61 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo -5.33 11.71 69.72 -4.62 11.92 67.73 35.24 -3.52 -50.42 34.05 -5.26 -50.80 coo 0.07 12.29 66.53 -0.24 11.95 64.38 31.64 -3.25 -44.92 30.43 -3.03 -43.10 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 6 hits 1et0_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 344 THR^? 21.00 C1 EDO B 603 A 159 LYS A 367 LYS.? 27.79 C1 EDO B 603 A 193 GLU A 363 GLU~? 27.04 C1 EDO B 603 coo -2.58 16.31 54.79 -4.02 14.93 55.64 23.70 12.96 9.21 23.27 10.80 9.07 coo 2.10 10.68 61.44 -2.14 13.16 60.61 21.09 4.68 15.64 17.32 4.21 18.91 coo -5.33 11.71 69.72 -4.62 11.92 67.73 14.23 7.65 22.80 13.44 9.34 23.77 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR B 344 THR^? 10.89 C2 EDO B 603 A 159 LYS B 367 LYS.? 8.96 O2 EDO B 603 A 193 GLU B 363 GLU~? 7.89 O1 EDO B 603 coo -2.58 16.31 54.79 -4.02 14.93 55.64 14.01 31.82 9.85 12.08 32.62 9.23 coo 2.10 10.68 61.44 -2.14 13.16 60.61 8.46 36.63 1.57 6.31 34.95 -1.21 coo -5.33 11.71 69.72 -4.62 11.92 67.73 8.83 27.73 -6.37 10.21 26.17 -6.89 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR C 344 THR^? 11.72 O2 EDO C 602 A 159 LYS C 367 LYS.? 10.18 O2 EDO C 602 A 193 GLU C 363 GLU~? 7.78 O2 EDO C 602 coo -2.58 16.31 54.79 -4.02 14.93 55.64 26.88 22.01 -28.65 25.52 23.63 -29.04 coo 2.10 10.68 61.44 -2.14 13.16 60.61 21.41 26.99 -36.15 19.64 26.87 -41.36 coo -5.33 11.71 69.72 -4.62 11.92 67.73 20.56 19.64 -44.58 21.56 17.87 -45.23 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR D 344 THR^? 11.84 C3 GOL D 601 A 159 LYS D 367 LYS.? 8.67 O3 GOL D 601 A 193 GLU D 363 GLU~? 7.90 O2 GOL D 601 coo -2.58 16.31 54.79 -4.02 14.93 55.64 34.76 2.40 -31.44 34.92 0.24 -31.49 coo 2.10 10.68 61.44 -2.14 13.16 60.61 32.17 -6.41 -25.63 28.00 -7.23 -22.20 coo -5.33 11.71 69.72 -4.62 11.92 67.73 24.65 -2.66 -18.42 24.14 -0.86 -17.43 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 4 hits 1et0_c02 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 330 GLU~? 26.93 C1 EDO B 603 A 260 ARG B 425 ARG^? 24.19 C2 EDO B 603 A 270 LYS B 348 LYS.? 28.30 C2 EDO B 603 coo 50.99 29.43 12.86 52.11 29.45 14.65 25.78 29.04 20.96 25.48 30.78 22.26 coo 39.80 27.50 22.98 42.20 26.56 21.34 13.19 26.25 26.41 10.66 27.96 25.98 coo 48.83 21.70 19.50 47.44 24.99 15.25 16.25 36.62 22.07 20.01 34.44 26.08 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU A 436 GLU^? 20.55 O1 EDO B 603 A 260 ARG A 412 ARG.? 27.85 C1 EDO B 603 A 270 LYS A 367 LYS.? 27.79 C1 EDO B 603 coo 50.99 29.43 12.86 52.11 29.45 14.65 19.93 9.98 5.88 20.55 8.03 6.42 coo 39.80 27.50 22.98 42.20 26.56 21.34 12.54 -0.59 17.25 14.66 0.99 15.65 coo 48.83 21.70 19.50 47.44 24.99 15.25 21.09 4.68 15.64 17.32 4.21 18.91 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU A 436 GLU^? 20.55 O1 EDO B 603 A 260 ARG A 425 ARG^? 21.19 O1 EDO B 603 A 270 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 50.99 29.43 12.86 52.11 29.45 14.65 19.93 9.98 5.88 20.55 8.03 6.42 coo 39.80 27.50 22.98 42.20 26.56 21.34 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 48.83 21.70 19.50 47.44 24.99 15.25 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 4 3 # 4 A 34 GLU B 330 GLU~? 24.65 C1 EDO B 603 A 260 ARG A 425 ARG^? 21.19 O1 EDO B 603 A 270 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo 50.99 29.43 12.86 52.11 29.45 14.65 31.94 25.81 2.71 33.76 25.37 1.74 coo 39.80 27.50 22.98 42.20 26.56 21.34 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 48.83 21.70 19.50 47.44 24.99 15.25 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 5 3 # 5 A 34 GLU B 342 GLU^? -3.54 O2 EDO B 603s A 260 ARG B 412 ARG.? 9.95 O2 EDO B 603 A 270 LYS B 367 LYS.? 8.96 O2 EDO B 603 coo 50.99 29.43 12.86 52.11 29.45 14.65 10.25 28.44 3.00 8.52 29.59 2.44 coo 39.80 27.50 22.98 42.20 26.56 21.34 0.52 33.64 -5.37 3.42 33.47 -4.37 coo 48.83 21.70 19.50 47.44 24.99 15.25 8.46 36.63 1.57 6.31 34.95 -1.21 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 6 3 # 6 A 34 GLU B 342 GLU^? -3.54 O2 EDO B 603s A 260 ARG B 412 ARG.? 9.95 O2 EDO B 603 A 270 LYS B 415 LYS^? -2.82 O2 EDO B 603s coo 50.99 29.43 12.86 52.11 29.45 14.65 10.25 28.44 3.00 8.52 29.59 2.44 coo 39.80 27.50 22.98 42.20 26.56 21.34 0.52 33.64 -5.37 3.42 33.47 -4.37 coo 48.83 21.70 19.50 47.44 24.99 15.25 1.57 23.62 -1.31 7.49 26.02 -1.78 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 7 3 # 7 A 34 GLU B 363 GLU~? 7.89 O1 EDO B 603 A 260 ARG C 401 ARG.? 15.33 O1 EDO B 603 A 270 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 50.99 29.43 12.86 52.11 29.45 14.65 8.83 27.73 -6.37 10.21 26.17 -6.89 coo 39.80 27.50 22.98 42.20 26.56 21.34 15.13 16.06 -14.86 13.60 17.63 -12.63 coo 48.83 21.70 19.50 47.44 24.99 15.25 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 8 3 # 8 A 34 GLU B 378 GLU~? 25.07 O2 EDO B 603 A 260 ARG B 397 ARG~? 26.01 C2 EDO B 603 A 270 LYS B 390 LYS~? 27.12 C2 EDO B 603 coo 50.99 29.43 12.86 52.11 29.45 14.65 7.63 44.96 15.04 7.63 45.65 17.05 coo 39.80 27.50 22.98 42.20 26.56 21.34 10.79 36.41 26.32 12.94 37.68 24.51 coo 48.83 21.70 19.50 47.44 24.99 15.25 3.52 38.72 20.17 3.15 45.06 20.21 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 9 3 # 9 A 34 GLU B 436 GLU^? 10.42 C2 EDO B 603 A 260 ARG B 425 ARG^? 24.19 C2 EDO B 603 A 270 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo 50.99 29.43 12.86 52.11 29.45 14.65 8.55 30.19 11.17 7.66 31.90 10.29 coo 39.80 27.50 22.98 42.20 26.56 21.34 13.19 26.25 26.41 10.66 27.96 25.98 coo 48.83 21.70 19.50 47.44 24.99 15.25 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 10 3 # 10 A 34 GLU C 330 GLU~? 24.03 O1 EDO C 602 A 260 ARG D 425 ARG^? 16.89 O1 EDO C 602 A 270 LYS D 348 LYS.? 27.59 O1 EDO C 602 coo 50.99 29.43 12.86 52.11 29.45 14.65 43.59 14.91 -37.76 45.12 14.02 -38.99 coo 39.80 27.50 22.98 42.20 26.56 21.34 35.18 9.71 -47.18 32.90 7.74 -47.72 coo 48.83 21.70 19.50 47.44 24.99 15.25 43.15 3.71 -41.93 47.18 7.62 -43.42 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 11 3 # 11 A 34 GLU C 342 GLU^? -3.52 O2 EDO C 602s A 260 ARG C 412 ARG.? 10.38 O2 EDO C 602 A 270 LYS C 415 LYS^? -2.71 O2 EDO C 602s coo 50.99 29.43 12.86 52.11 29.45 14.65 22.61 19.18 -35.41 20.92 20.43 -35.77 coo 39.80 27.50 22.98 42.20 26.56 21.34 12.55 24.65 -43.59 15.36 25.14 -42.41 coo 48.83 21.70 19.50 47.44 24.99 15.25 13.38 15.08 -39.34 19.41 17.19 -40.08 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 12 3 # 12 A 34 GLU C 394 GLU~? 16.86 O1 EDO B 603 A 260 ARG C 425 ARG^? 21.48 O1 GOL D 601 A 270 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo 50.99 29.43 12.86 52.11 29.45 14.65 19.77 27.90 -12.93 18.57 29.44 -12.10 coo 39.80 27.50 22.98 42.20 26.56 21.34 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 48.83 21.70 19.50 47.44 24.99 15.25 31.02 25.73 -16.52 36.61 24.80 -13.64 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 13 3 # 13 A 34 GLU C 436 GLU^? 10.62 C2 EDO C 602 A 260 ARG C 425 ARG^? 21.48 O1 GOL D 601 A 270 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 50.99 29.43 12.86 52.11 29.45 14.65 21.74 20.63 -27.21 21.00 22.48 -27.90 coo 39.80 27.50 22.98 42.20 26.56 21.34 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 48.83 21.70 19.50 47.44 24.99 15.25 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 14 3 # 14 A 34 GLU D 330 GLU~? 24.51 C2 GOL D 601 A 260 ARG C 425 ARG^? 21.48 O1 GOL D 601 A 270 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo 50.99 29.43 12.86 52.11 29.45 14.65 39.35 17.44 -18.72 40.01 18.64 -17.10 coo 39.80 27.50 22.98 42.20 26.56 21.34 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 48.83 21.70 19.50 47.44 24.99 15.25 31.02 25.73 -16.52 36.61 24.80 -13.64 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 15 3 # 15 A 34 GLU D 342 GLU^? -3.57 O3 GOL D 601s A 260 ARG D 412 ARG.? 9.98 O3 GOL D 601 A 270 LYS D 415 LYS^? -2.91 O3 GOL D 601s coo 50.99 29.43 12.86 52.11 29.45 14.65 28.06 0.59 -26.56 27.66 -1.50 -26.76 coo 39.80 27.50 22.98 42.20 26.56 21.34 23.08 -11.80 -22.54 24.95 -9.89 -24.12 coo 48.83 21.70 19.50 47.44 24.99 15.25 17.93 -3.17 -25.73 23.39 -0.99 -23.17 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 16 3 # 16 A 34 GLU D 436 GLU^? 11.06 C3 GOL D 601 A 260 ARG D 425 ARG^? 16.89 O1 EDO C 602 A 270 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 50.99 29.43 12.86 52.11 29.45 14.65 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 39.80 27.50 22.98 42.20 26.56 21.34 35.18 9.71 -47.18 32.90 7.74 -47.72 coo 48.83 21.70 19.50 47.44 24.99 15.25 27.51 4.47 -43.69 23.30 8.13 -41.81 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 16 hits 1euy_c00 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS A 338 HIS~? 19.64 C1 EDO B 603 C 62 LYS B 348 LYS.? 28.30 C2 EDO B 603 F 35 ASP B 426 ASP.? 28.68 C1 EDO B 603 coo 15.40 22.79 16.66 13.93 24.10 15.98 16.13 23.68 19.02 16.84 23.99 20.97 coo 19.95 18.98 4.81 18.82 20.94 10.49 16.25 36.62 22.07 20.01 34.44 26.08 coo 16.32 15.30 17.19 17.71 14.73 18.69 21.11 26.70 26.04 20.61 27.63 27.90 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 2 3 # 2 A 105 HIS B 338 HIS.? 13.66 O1 EDO B 603 C 62 LYS A 348 LYS.? 29.38 O1 EDO B 603 F 35 ASP A 426 ASP.? 22.31 O1 EDO B 603 coo 15.40 22.79 16.66 13.93 24.10 15.98 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 19.95 18.98 4.81 18.82 20.94 10.49 33.03 14.06 -0.37 37.33 16.69 -0.99 coo 16.32 15.30 17.19 17.71 14.73 18.69 29.17 24.78 -3.72 30.40 24.16 -5.34 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 3 3 # 3 A 105 HIS C 338 HIS~? 12.91 O1 EDO C 602 C 62 LYS D 348 LYS.? 27.59 O1 EDO C 602 F 35 ASP D 426 ASP.? 21.84 O1 EDO C 602 coo 15.40 22.79 16.66 13.93 24.10 15.98 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 19.95 18.98 4.81 18.82 20.94 10.49 43.15 3.71 -41.93 47.18 7.62 -43.42 coo 16.32 15.30 17.19 17.71 14.73 18.69 40.54 14.64 -43.98 41.47 13.99 -45.77 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 4 3 # 4 A 105 HIS D 338 HIS~? 13.70 C1 GOL D 601 C 62 LYS C 348 LYS.? 28.33 O1 GOL D 601 F 35 ASP C 426 ASP.? 22.72 C2 GOL D 601 coo 15.40 22.79 16.66 13.93 24.10 15.98 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 19.95 18.98 4.81 18.82 20.94 10.49 31.02 25.73 -16.52 36.61 24.80 -13.64 coo 16.32 15.30 17.19 17.71 14.73 18.69 35.09 15.28 -13.55 34.97 16.40 -11.75 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 4 hits 1f80_c03 naa= 3 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 1 3 # 1 B 62 LYS A 348 LYS.? 29.38 O1 EDO B 603 C 105 HIS B 338 HIS.? 13.66 O1 EDO B 603 D 35 ASP A 402 ASP.? 12.59 O1 EDO B 603 coo 38.76 28.25 7.87 36.33 26.41 13.58 33.03 14.06 -0.37 37.33 16.69 -0.99 coo 34.93 19.72 17.37 34.72 18.17 15.98 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 41.01 23.02 20.83 40.65 24.26 22.55 18.87 16.83 -6.49 16.77 17.04 -6.49 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 2 3 # 2 B 62 LYS B 348 LYS.? 28.30 C2 EDO B 603 C 105 HIS A 338 HIS~? 19.64 C1 EDO B 603 D 35 ASP B 402 ASP.? 23.46 C2 EDO B 603 coo 38.76 28.25 7.87 36.33 26.41 13.58 16.25 36.62 22.07 20.01 34.44 26.08 coo 34.93 19.72 17.37 34.72 18.17 15.98 16.13 23.68 19.02 16.84 23.99 20.97 coo 41.01 23.02 20.83 40.65 24.26 22.55 8.17 23.01 23.39 8.93 22.69 25.33 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 3 3 # 3 B 62 LYS C 348 LYS.? 28.33 O1 GOL D 601 C 105 HIS D 338 HIS~? 13.70 C1 GOL D 601 D 35 ASP C 402 ASP.? 12.78 O1 GOL D 601 coo 38.76 28.25 7.87 36.33 26.41 13.58 31.02 25.73 -16.52 36.61 24.80 -13.64 coo 34.93 19.72 17.37 34.72 18.17 15.98 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 41.01 23.02 20.83 40.65 24.26 22.55 22.26 13.02 -15.38 21.01 11.37 -15.92 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 4 3 # 4 B 62 LYS D 348 LYS.? 27.59 O1 EDO C 602 C 105 HIS C 338 HIS~? 12.91 O1 EDO C 602 D 35 ASP D 402 ASP.? 14.20 O1 EDO C 602 coo 38.76 28.25 7.87 36.33 26.41 13.58 43.15 3.71 -41.93 47.18 7.62 -43.42 coo 34.93 19.72 17.37 34.72 18.17 15.98 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 41.01 23.02 20.83 40.65 24.26 22.55 28.53 7.95 -46.44 29.10 9.08 -48.14 1f80_c04 source 1f80 ACYL CARRIER PROTEIN : 4 hits 1f80_c04 naa= 3 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 1 3 # 1 A 62 LYS A 348 LYS.? 29.38 O1 EDO B 603 B 105 HIS B 338 HIS.? 13.66 O1 EDO B 603 E 35 ASP A 426 ASP.? 22.31 O1 EDO B 603 coo 20.51 39.76 8.83 21.23 37.38 14.18 33.03 14.06 -0.37 37.33 16.69 -0.99 coo 27.18 37.56 20.68 29.07 38.28 20.13 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 19.97 40.39 22.03 18.53 39.30 23.18 29.17 24.78 -3.72 30.40 24.16 -5.34 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 2 3 # 2 A 62 LYS B 348 LYS.? 28.30 C2 EDO B 603 B 105 HIS A 338 HIS~? 19.64 C1 EDO B 603 E 35 ASP B 426 ASP.? 28.68 C1 EDO B 603 coo 20.51 39.76 8.83 21.23 37.38 14.18 16.25 36.62 22.07 20.01 34.44 26.08 coo 27.18 37.56 20.68 29.07 38.28 20.13 16.13 23.68 19.02 16.84 23.99 20.97 coo 19.97 40.39 22.03 18.53 39.30 23.18 21.11 26.70 26.04 20.61 27.63 27.90 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 3 3 # 3 A 62 LYS C 348 LYS.? 28.33 O1 GOL D 601 B 105 HIS D 338 HIS~? 13.70 C1 GOL D 601 E 35 ASP C 426 ASP.? 22.72 C2 GOL D 601 coo 20.51 39.76 8.83 21.23 37.38 14.18 31.02 25.73 -16.52 36.61 24.80 -13.64 coo 27.18 37.56 20.68 29.07 38.28 20.13 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 19.97 40.39 22.03 18.53 39.30 23.18 35.09 15.28 -13.55 34.97 16.40 -11.75 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 4 3 # 4 A 62 LYS D 348 LYS.? 27.59 O1 EDO C 602 B 105 HIS C 338 HIS~? 12.91 O1 EDO C 602 E 35 ASP D 426 ASP.? 21.84 O1 EDO C 602 coo 20.51 39.76 8.83 21.23 37.38 14.18 43.15 3.71 -41.93 47.18 7.62 -43.42 coo 27.18 37.56 20.68 29.07 38.28 20.13 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 19.97 40.39 22.03 18.53 39.30 23.18 40.54 14.64 -43.98 41.47 13.99 -45.77 1f80_c05 source 1f80 ACYL CARRIER PROTEIN : 4 hits 1f80_c05 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 352 PHE^? 25.89 C1 EDO B 603 A 210 ASP A 349 ASP.? 30.68 C1 EDO B 603 A 244 LYS A 390 LYS~? 25.88 O2 GOL D 601 coo 9.23 46.77 25.11 11.48 48.39 24.76 29.09 9.19 9.94 27.10 9.67 11.86 coo 10.51 37.86 19.71 9.07 39.38 20.04 36.99 12.23 1.79 37.88 13.87 0.83 coo -1.20 42.34 17.67 3.19 45.13 19.06 26.64 2.81 -1.98 30.91 -1.55 -0.35 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 408 PHE^? 22.46 O1 EDO B 603 A 210 ASP A 440 ASP^? 18.54 C1 EDO B 603 A 244 LYS A 367 LYS.? 27.79 C1 EDO B 603 coo 9.23 46.77 25.11 11.48 48.39 24.76 10.58 2.38 7.11 12.62 3.36 8.80 coo 10.51 37.86 19.71 9.07 39.38 20.04 8.21 11.09 12.88 6.30 10.30 13.36 coo -1.20 42.34 17.67 3.19 45.13 19.06 21.09 4.68 15.64 17.32 4.21 18.91 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE A 416 PHE^? 19.67 O1 EDO B 603 A 210 ASP B 448 ASP.? 21.29 O1 EDO B 603 A 244 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 9.23 46.77 25.11 11.48 48.39 24.76 4.63 6.30 7.93 4.64 5.09 5.42 coo 10.51 37.86 19.71 9.07 39.38 20.04 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo -1.20 42.34 17.67 3.19 45.13 19.06 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE A 431 PHE^? 22.59 O1 EDO B 603 A 210 ASP A 349 ASP.? 30.68 C1 EDO B 603 A 244 LYS A 390 LYS~? 25.88 O2 GOL D 601 coo 9.23 46.77 25.11 11.48 48.39 24.76 29.40 15.33 -4.65 28.40 13.37 -2.94 coo 10.51 37.86 19.71 9.07 39.38 20.04 36.99 12.23 1.79 37.88 13.87 0.83 coo -1.20 42.34 17.67 3.19 45.13 19.06 26.64 2.81 -1.98 30.91 -1.55 -0.35 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 112 PHE A 431 PHE^? 22.59 O1 EDO B 603 A 210 ASP A 350 ASP.? 26.92 O2 GOL D 601 A 244 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo 9.23 46.77 25.11 11.48 48.39 24.76 29.40 15.33 -4.65 28.40 13.37 -2.94 coo 10.51 37.86 19.71 9.07 39.38 20.04 33.51 7.96 1.59 32.78 7.85 -0.37 coo -1.20 42.34 17.67 3.19 45.13 19.06 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 112 PHE A 444 PHE~? 11.79 C1 EDO B 603 A 210 ASP A 448 ASP~? 19.70 O1 EDO B 603 A 244 LYS B 415 LYS^? -2.82 O2 EDO B 603s coo 9.23 46.77 25.11 11.48 48.39 24.76 2.91 15.92 8.56 5.14 17.37 9.33 coo 10.51 37.86 19.71 9.07 39.38 20.04 -6.12 13.55 5.97 -7.03 12.86 4.20 coo -1.20 42.34 17.67 3.19 45.13 19.06 1.57 23.62 -1.31 7.49 26.02 -1.78 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 112 PHE B 352 PHE^? 15.29 O2 EDO B 603 A 210 ASP B 349 ASP.? 28.06 C2 EDO B 603 A 244 LYS B 390 LYS~? 27.12 C2 EDO B 603 coo 9.23 46.77 25.11 11.48 48.39 24.76 14.23 38.41 10.43 14.31 36.78 8.15 coo 10.51 37.86 19.71 9.07 39.38 20.04 17.36 41.29 21.17 18.85 41.14 22.68 coo -1.20 42.34 17.67 3.19 45.13 19.06 3.52 38.72 20.17 3.15 45.06 20.21 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 112 PHE B 416 PHE^? 11.67 C2 EDO B 603 A 210 ASP A 448 ASP~? 19.70 O1 EDO B 603 A 244 LYS A 442 LYS~? 23.27 C1 EDO B 603 coo 9.23 46.77 25.11 11.48 48.39 24.76 -1.62 21.04 3.18 -3.66 21.32 5.09 coo 10.51 37.86 19.71 9.07 39.38 20.04 -6.12 13.55 5.97 -7.03 12.86 4.20 coo -1.20 42.34 17.67 3.19 45.13 19.06 2.76 10.16 11.03 0.96 5.43 12.32 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 112 PHE B 431 PHE^? 23.47 C2 EDO B 603 A 210 ASP B 349 ASP.? 28.06 C2 EDO B 603 A 244 LYS B 390 LYS~? 27.12 C2 EDO B 603 coo 9.23 46.77 25.11 11.48 48.39 24.76 13.65 32.28 24.99 12.40 33.20 22.64 coo 10.51 37.86 19.71 9.07 39.38 20.04 17.36 41.29 21.17 18.85 41.14 22.68 coo -1.20 42.34 17.67 3.19 45.13 19.06 3.52 38.72 20.17 3.15 45.06 20.21 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 A 112 PHE B 431 PHE^? 23.47 C2 EDO B 603 A 210 ASP B 350 ASP.? 23.89 C2 EDO B 603 A 244 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo 9.23 46.77 25.11 11.48 48.39 24.76 13.65 32.28 24.99 12.40 33.20 22.64 coo 10.51 37.86 19.71 9.07 39.38 20.04 12.16 40.72 19.41 11.14 39.74 20.98 coo -1.20 42.34 17.67 3.19 45.13 19.06 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 A 112 PHE C 352 PHE^? 15.48 O2 EDO C 602 A 210 ASP C 349 ASP.? 28.09 C1 EDO C 602 A 244 LYS C 390 LYS~? 21.48 O2 EDO B 603 coo 9.23 46.77 25.11 11.48 48.39 24.76 27.97 28.62 -27.76 27.73 27.28 -30.22 coo 10.51 37.86 19.71 9.07 39.38 20.04 32.59 30.21 -17.31 34.23 29.55 -16.13 coo -1.20 42.34 17.67 3.19 45.13 19.06 17.95 29.37 -17.21 18.11 35.53 -15.65 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 A 112 PHE C 408 PHE^? 10.06 C2 EDO C 602 A 210 ASP C 440 ASP^? 5.97 O1 EDO C 602 A 244 LYS C 367 LYS.? 10.18 O2 EDO C 602 coo 9.23 46.77 25.11 11.48 48.39 24.76 10.46 19.61 -32.22 12.82 20.96 -32.91 coo 10.51 37.86 19.71 9.07 39.38 20.04 17.33 13.03 -37.56 15.74 12.38 -38.82 coo -1.20 42.34 17.67 3.19 45.13 19.06 21.41 26.99 -36.15 19.64 26.87 -41.36 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 A 112 PHE C 416 PHE^? 11.78 C2 EDO C 602 A 210 ASP D 448 ASP.? 19.66 C2 EDO C 602 A 244 LYS D 442 LYS~? 12.65 O2 GOL D 601 coo 9.23 46.77 25.11 11.48 48.39 24.76 10.28 12.37 -34.72 8.44 12.42 -32.58 coo 10.51 37.86 19.71 9.07 39.38 20.04 3.66 6.43 -31.01 2.94 8.46 -31.03 coo -1.20 42.34 17.67 3.19 45.13 19.06 14.14 0.83 -27.84 11.41 -3.18 -25.91 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 A 112 PHE C 431 PHE^? 22.21 O1 GOL D 601 A 210 ASP C 349 ASP.? 28.09 C1 EDO C 602 A 244 LYS C 390 LYS~? 21.48 O2 EDO B 603 coo 9.23 46.77 25.11 11.48 48.39 24.76 28.24 21.80 -13.63 26.64 22.64 -15.77 coo 10.51 37.86 19.71 9.07 39.38 20.04 32.59 30.21 -17.31 34.23 29.55 -16.13 coo -1.20 42.34 17.67 3.19 45.13 19.06 17.95 29.37 -17.21 18.11 35.53 -15.65 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 A 112 PHE C 431 PHE^? 22.21 O1 GOL D 601 A 210 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 244 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 9.23 46.77 25.11 11.48 48.39 24.76 28.24 21.80 -13.63 26.64 22.64 -15.77 coo 10.51 37.86 19.71 9.07 39.38 20.04 27.03 30.18 -18.47 26.26 29.33 -16.72 coo -1.20 42.34 17.67 3.19 45.13 19.06 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 A 112 PHE D 352 PHE^? 15.53 O3 GOL D 601 A 210 ASP D 349 ASP.? 28.27 C3 GOL D 601 A 244 LYS D 390 LYS~? 25.65 O3 GOL D 601 coo 9.23 46.77 25.11 11.48 48.39 24.76 40.13 -1.84 -31.50 38.47 -1.47 -29.25 coo 10.51 37.86 19.71 9.07 39.38 20.04 47.11 1.34 -40.59 48.04 2.96 -41.60 coo -1.20 42.34 17.67 3.19 45.13 19.06 35.81 -6.92 -44.49 39.58 -10.95 -43.36 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 17 3 # 17 A 112 PHE D 408 PHE^? 10.09 O3 GOL D 601 A 210 ASP D 440 ASP^? -5.34 O2 GOL D 601s A 244 LYS D 367 LYS.? 8.67 O3 GOL D 601 coo 9.23 46.77 25.11 11.48 48.39 24.76 21.02 -7.07 -33.42 23.42 -6.37 -32.18 coo 10.51 37.86 19.71 9.07 39.38 20.04 19.76 1.27 -26.39 17.89 0.46 -25.75 coo -1.20 42.34 17.67 3.19 45.13 19.06 32.17 -6.41 -25.63 28.00 -7.23 -22.20 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 18 3 # 18 A 112 PHE D 416 PHE^? 11.70 C3 GOL D 601 A 210 ASP C 448 ASP.? 19.32 O1 GOL D 601 A 244 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 9.23 46.77 25.11 11.48 48.39 24.76 15.40 -2.83 -31.27 15.07 -3.80 -33.86 coo 10.51 37.86 19.71 9.07 39.38 20.04 9.52 -2.93 -40.85 10.47 -4.20 -39.42 coo -1.20 42.34 17.67 3.19 45.13 19.06 12.96 9.36 -37.91 9.04 10.02 -41.38 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 19 3 # 19 A 112 PHE D 431 PHE^? 21.51 O1 EDO C 602 A 210 ASP D 349 ASP.? 28.27 C3 GOL D 601 A 244 LYS D 390 LYS~? 25.65 O3 GOL D 601 coo 9.23 46.77 25.11 11.48 48.39 24.76 39.18 5.51 -45.56 38.23 3.44 -43.92 coo 10.51 37.86 19.71 9.07 39.38 20.04 47.11 1.34 -40.59 48.04 2.96 -41.60 coo -1.20 42.34 17.67 3.19 45.13 19.06 35.81 -6.92 -44.49 39.58 -10.95 -43.36 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 20 3 # 20 A 112 PHE D 431 PHE^? 21.51 O1 EDO C 602 A 210 ASP D 350 ASP.? 24.09 C3 GOL D 601 A 244 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo 9.23 46.77 25.11 11.48 48.39 24.76 39.18 5.51 -45.56 38.23 3.44 -43.92 coo 10.51 37.86 19.71 9.07 39.38 20.04 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo -1.20 42.34 17.67 3.19 45.13 19.06 32.90 -6.30 -46.84 30.42 -11.34 -47.14 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 20 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 352 PHE^? 25.89 C1 EDO B 603 B 210 ASP A 349 ASP.? 30.68 C1 EDO B 603 B 244 LYS A 390 LYS~? 25.88 O2 GOL D 601 coo 8.76 47.85 34.91 11.08 46.36 35.41 29.09 9.19 9.94 27.10 9.67 11.86 coo 9.06 56.85 40.30 7.71 55.27 39.90 36.99 12.23 1.79 37.88 13.87 0.83 coo -2.38 51.82 41.62 2.07 49.19 40.42 26.64 2.81 -1.98 30.91 -1.55 -0.35 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 416 PHE^? 19.67 O1 EDO B 603 B 210 ASP B 448 ASP.? 21.29 O1 EDO B 603 B 244 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 8.76 47.85 34.91 11.08 46.36 35.41 4.63 6.30 7.93 4.64 5.09 5.42 coo 9.06 56.85 40.30 7.71 55.27 39.90 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo -2.38 51.82 41.62 2.07 49.19 40.42 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE A 431 PHE^? 22.59 O1 EDO B 603 B 210 ASP A 349 ASP.? 30.68 C1 EDO B 603 B 244 LYS A 390 LYS~? 25.88 O2 GOL D 601 coo 8.76 47.85 34.91 11.08 46.36 35.41 29.40 15.33 -4.65 28.40 13.37 -2.94 coo 9.06 56.85 40.30 7.71 55.27 39.90 36.99 12.23 1.79 37.88 13.87 0.83 coo -2.38 51.82 41.62 2.07 49.19 40.42 26.64 2.81 -1.98 30.91 -1.55 -0.35 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE A 431 PHE^? 22.59 O1 EDO B 603 B 210 ASP A 350 ASP.? 26.92 O2 GOL D 601 B 244 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo 8.76 47.85 34.91 11.08 46.36 35.41 29.40 15.33 -4.65 28.40 13.37 -2.94 coo 9.06 56.85 40.30 7.71 55.27 39.90 33.51 7.96 1.59 32.78 7.85 -0.37 coo -2.38 51.82 41.62 2.07 49.19 40.42 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 112 PHE B 352 PHE^? 15.29 O2 EDO B 603 B 210 ASP B 349 ASP.? 28.06 C2 EDO B 603 B 244 LYS B 390 LYS~? 27.12 C2 EDO B 603 coo 8.76 47.85 34.91 11.08 46.36 35.41 14.23 38.41 10.43 14.31 36.78 8.15 coo 9.06 56.85 40.30 7.71 55.27 39.90 17.36 41.29 21.17 18.85 41.14 22.68 coo -2.38 51.82 41.62 2.07 49.19 40.42 3.52 38.72 20.17 3.15 45.06 20.21 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 112 PHE B 416 PHE^? 11.67 C2 EDO B 603 B 210 ASP A 448 ASP~? 19.70 O1 EDO B 603 B 244 LYS A 442 LYS~? 23.27 C1 EDO B 603 coo 8.76 47.85 34.91 11.08 46.36 35.41 -1.62 21.04 3.18 -3.66 21.32 5.09 coo 9.06 56.85 40.30 7.71 55.27 39.90 -6.12 13.55 5.97 -7.03 12.86 4.20 coo -2.38 51.82 41.62 2.07 49.19 40.42 2.76 10.16 11.03 0.96 5.43 12.32 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 112 PHE B 431 PHE^? 23.47 C2 EDO B 603 B 210 ASP B 349 ASP.? 28.06 C2 EDO B 603 B 244 LYS B 390 LYS~? 27.12 C2 EDO B 603 coo 8.76 47.85 34.91 11.08 46.36 35.41 13.65 32.28 24.99 12.40 33.20 22.64 coo 9.06 56.85 40.30 7.71 55.27 39.90 17.36 41.29 21.17 18.85 41.14 22.68 coo -2.38 51.82 41.62 2.07 49.19 40.42 3.52 38.72 20.17 3.15 45.06 20.21 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 112 PHE B 431 PHE^? 23.47 C2 EDO B 603 B 210 ASP B 350 ASP.? 23.89 C2 EDO B 603 B 244 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo 8.76 47.85 34.91 11.08 46.36 35.41 13.65 32.28 24.99 12.40 33.20 22.64 coo 9.06 56.85 40.30 7.71 55.27 39.90 12.16 40.72 19.41 11.14 39.74 20.98 coo -2.38 51.82 41.62 2.07 49.19 40.42 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 112 PHE C 416 PHE^? 11.78 C2 EDO C 602 B 210 ASP D 448 ASP.? 19.66 C2 EDO C 602 B 244 LYS D 442 LYS~? 12.65 O2 GOL D 601 coo 8.76 47.85 34.91 11.08 46.36 35.41 10.28 12.37 -34.72 8.44 12.42 -32.58 coo 9.06 56.85 40.30 7.71 55.27 39.90 3.66 6.43 -31.01 2.94 8.46 -31.03 coo -2.38 51.82 41.62 2.07 49.19 40.42 14.14 0.83 -27.84 11.41 -3.18 -25.91 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 B 112 PHE C 431 PHE^? 22.21 O1 GOL D 601 B 210 ASP C 350 ASP.? 24.48 C2 EDO C 602 B 244 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 8.76 47.85 34.91 11.08 46.36 35.41 28.24 21.80 -13.63 26.64 22.64 -15.77 coo 9.06 56.85 40.30 7.71 55.27 39.90 27.03 30.18 -18.47 26.26 29.33 -16.72 coo -2.38 51.82 41.62 2.07 49.19 40.42 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 B 112 PHE D 352 PHE^? 15.53 O3 GOL D 601 B 210 ASP D 349 ASP.? 28.27 C3 GOL D 601 B 244 LYS D 390 LYS~? 25.65 O3 GOL D 601 coo 8.76 47.85 34.91 11.08 46.36 35.41 40.13 -1.84 -31.50 38.47 -1.47 -29.25 coo 9.06 56.85 40.30 7.71 55.27 39.90 47.11 1.34 -40.59 48.04 2.96 -41.60 coo -2.38 51.82 41.62 2.07 49.19 40.42 35.81 -6.92 -44.49 39.58 -10.95 -43.36 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 B 112 PHE D 416 PHE^? 11.70 C3 GOL D 601 B 210 ASP C 448 ASP.? 19.32 O1 GOL D 601 B 244 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 8.76 47.85 34.91 11.08 46.36 35.41 15.40 -2.83 -31.27 15.07 -3.80 -33.86 coo 9.06 56.85 40.30 7.71 55.27 39.90 9.52 -2.93 -40.85 10.47 -4.20 -39.42 coo -2.38 51.82 41.62 2.07 49.19 40.42 12.96 9.36 -37.91 9.04 10.02 -41.38 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 B 112 PHE D 431 PHE^? 21.51 O1 EDO C 602 B 210 ASP D 349 ASP.? 28.27 C3 GOL D 601 B 244 LYS D 390 LYS~? 25.65 O3 GOL D 601 coo 8.76 47.85 34.91 11.08 46.36 35.41 39.18 5.51 -45.56 38.23 3.44 -43.92 coo 9.06 56.85 40.30 7.71 55.27 39.90 47.11 1.34 -40.59 48.04 2.96 -41.60 coo -2.38 51.82 41.62 2.07 49.19 40.42 35.81 -6.92 -44.49 39.58 -10.95 -43.36 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 B 112 PHE D 431 PHE^? 21.51 O1 EDO C 602 B 210 ASP D 350 ASP.? 24.09 C3 GOL D 601 B 244 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo 8.76 47.85 34.91 11.08 46.36 35.41 39.18 5.51 -45.56 38.23 3.44 -43.92 coo 9.06 56.85 40.30 7.71 55.27 39.90 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo -2.38 51.82 41.62 2.07 49.19 40.42 32.90 -6.30 -46.84 30.42 -11.34 -47.14 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 14 hits 1fc4_c03 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER A 328 SER~? 24.32 C1 EDO B 603 A 48 THR A 317 THR.? 30.13 C1 EDO B 603 A 165 LYS B 348 LYS.? 28.30 C2 EDO B 603 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 27.10 32.44 15.23 26.15 32.07 17.43 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 29.57 32.99 19.64 30.09 32.97 21.72 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 16.25 36.62 22.07 20.01 34.44 26.08 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER A 328 SER~? 24.32 C1 EDO B 603 A 48 THR A 318 THR.? 30.43 C1 EDO B 603 A 165 LYS B 348 LYS.? 28.30 C2 EDO B 603 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 27.10 32.44 15.23 26.15 32.07 17.43 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 30.31 35.91 17.26 32.03 37.29 17.23 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 16.25 36.62 22.07 20.01 34.44 26.08 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 47 SER B 328 SER~? 24.34 C1 EDO B 603 A 48 THR B 317 THR.? 28.99 C1 EDO B 603 A 165 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 32.93 23.60 9.01 32.97 23.42 6.61 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 36.64 25.71 6.15 37.93 26.34 4.55 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 47 SER B 328 SER~? 24.34 C1 EDO B 603 A 48 THR B 318 THR.? 31.71 C1 EDO B 603 A 165 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 32.93 23.60 9.01 32.97 23.42 6.61 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 38.06 24.71 9.55 39.51 25.67 10.82 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 47 SER C 328 SER~? 23.98 C1 EDO C 602 A 48 THR C 317 THR.? 28.45 C1 EDO C 602 A 165 LYS D 348 LYS.? 27.59 O1 EDO C 602 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 45.06 12.12 -31.74 44.78 12.22 -34.15 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 48.45 14.16 -34.83 49.57 14.57 -36.66 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 43.15 3.71 -41.93 47.18 7.62 -43.42 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 A 47 SER C 328 SER~? 23.98 C1 EDO C 602 A 48 THR C 318 THR.? 30.49 C2 GOL D 601 A 165 LYS D 348 LYS.? 27.59 O1 EDO C 602 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 45.06 12.12 -31.74 44.78 12.22 -34.15 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 50.21 12.77 -31.72 51.79 13.54 -30.47 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 43.15 3.71 -41.93 47.18 7.62 -43.42 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 A 47 SER D 328 SER~? 24.00 C1 EDO C 602 A 48 THR D 317 THR.? 28.79 C1 GOL D 601 A 165 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 40.49 20.83 -24.30 39.56 20.57 -22.09 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 43.40 21.29 -20.10 44.08 21.40 -18.06 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 31.02 25.73 -16.52 36.61 24.80 -13.64 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 A 47 SER D 328 SER~? 24.00 C1 EDO C 602 A 48 THR D 318 THR.? 30.09 C1 EDO C 602 A 165 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 40.49 20.83 -24.30 39.56 20.57 -22.09 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 44.56 23.70 -22.81 46.55 24.41 -23.21 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 31.02 25.73 -16.52 36.61 24.80 -13.64 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 8 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER A 328 SER~? 24.32 C1 EDO B 603 B 48 THR A 317 THR.? 30.13 C1 EDO B 603 B 165 LYS B 348 LYS.? 28.30 C2 EDO B 603 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 27.10 32.44 15.23 26.15 32.07 17.43 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 29.57 32.99 19.64 30.09 32.97 21.72 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 16.25 36.62 22.07 20.01 34.44 26.08 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER A 328 SER~? 24.32 C1 EDO B 603 B 48 THR A 318 THR.? 30.43 C1 EDO B 603 B 165 LYS B 348 LYS.? 28.30 C2 EDO B 603 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 27.10 32.44 15.23 26.15 32.07 17.43 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 30.31 35.91 17.26 32.03 37.29 17.23 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 16.25 36.62 22.07 20.01 34.44 26.08 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 47 SER B 328 SER~? 24.34 C1 EDO B 603 B 48 THR B 317 THR.? 28.99 C1 EDO B 603 B 165 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 32.93 23.60 9.01 32.97 23.42 6.61 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 36.64 25.71 6.15 37.93 26.34 4.55 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 47 SER B 328 SER~? 24.34 C1 EDO B 603 B 48 THR B 318 THR.? 31.71 C1 EDO B 603 B 165 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 32.93 23.60 9.01 32.97 23.42 6.61 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 38.06 24.71 9.55 39.51 25.67 10.82 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 47 SER C 328 SER~? 23.98 C1 EDO C 602 B 48 THR C 317 THR.? 28.45 C1 EDO C 602 B 165 LYS D 348 LYS.? 27.59 O1 EDO C 602 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 45.06 12.12 -31.74 44.78 12.22 -34.15 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 48.45 14.16 -34.83 49.57 14.57 -36.66 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 43.15 3.71 -41.93 47.18 7.62 -43.42 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 B 47 SER C 328 SER~? 23.98 C1 EDO C 602 B 48 THR C 318 THR.? 30.49 C2 GOL D 601 B 165 LYS D 348 LYS.? 27.59 O1 EDO C 602 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 45.06 12.12 -31.74 44.78 12.22 -34.15 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 50.21 12.77 -31.72 51.79 13.54 -30.47 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 43.15 3.71 -41.93 47.18 7.62 -43.42 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 B 47 SER D 328 SER~? 24.00 C1 EDO C 602 B 48 THR D 317 THR.? 28.79 C1 GOL D 601 B 165 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 40.49 20.83 -24.30 39.56 20.57 -22.09 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 43.40 21.29 -20.10 44.08 21.40 -18.06 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 31.02 25.73 -16.52 36.61 24.80 -13.64 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 B 47 SER D 328 SER~? 24.00 C1 EDO C 602 B 48 THR D 318 THR.? 30.09 C1 EDO C 602 B 165 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 40.49 20.83 -24.30 39.56 20.57 -22.09 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 44.56 23.70 -22.81 46.55 24.41 -23.21 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 31.02 25.73 -16.52 36.61 24.80 -13.64 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 8 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER A 328 SER~? 24.32 C1 EDO B 603 C 48 THR A 317 THR.? 30.13 C1 EDO B 603 C 165 LYS B 348 LYS.? 28.30 C2 EDO B 603 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 27.10 32.44 15.23 26.15 32.07 17.43 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 29.57 32.99 19.64 30.09 32.97 21.72 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 16.25 36.62 22.07 20.01 34.44 26.08 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER A 328 SER~? 24.32 C1 EDO B 603 C 48 THR A 318 THR.? 30.43 C1 EDO B 603 C 165 LYS B 348 LYS.? 28.30 C2 EDO B 603 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 27.10 32.44 15.23 26.15 32.07 17.43 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 30.31 35.91 17.26 32.03 37.29 17.23 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 16.25 36.62 22.07 20.01 34.44 26.08 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 47 SER B 328 SER~? 24.34 C1 EDO B 603 C 48 THR B 317 THR.? 28.99 C1 EDO B 603 C 165 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 32.93 23.60 9.01 32.97 23.42 6.61 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 36.64 25.71 6.15 37.93 26.34 4.55 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 47 SER B 328 SER~? 24.34 C1 EDO B 603 C 48 THR B 318 THR.? 31.71 C1 EDO B 603 C 165 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 32.93 23.60 9.01 32.97 23.42 6.61 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 38.06 24.71 9.55 39.51 25.67 10.82 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 47 SER C 328 SER~? 23.98 C1 EDO C 602 C 48 THR C 317 THR.? 28.45 C1 EDO C 602 C 165 LYS D 348 LYS.? 27.59 O1 EDO C 602 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 45.06 12.12 -31.74 44.78 12.22 -34.15 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 48.45 14.16 -34.83 49.57 14.57 -36.66 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 43.15 3.71 -41.93 47.18 7.62 -43.42 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 C 47 SER C 328 SER~? 23.98 C1 EDO C 602 C 48 THR C 318 THR.? 30.49 C2 GOL D 601 C 165 LYS D 348 LYS.? 27.59 O1 EDO C 602 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 45.06 12.12 -31.74 44.78 12.22 -34.15 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 50.21 12.77 -31.72 51.79 13.54 -30.47 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 43.15 3.71 -41.93 47.18 7.62 -43.42 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 C 47 SER D 328 SER~? 24.00 C1 EDO C 602 C 48 THR D 317 THR.? 28.79 C1 GOL D 601 C 165 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 40.49 20.83 -24.30 39.56 20.57 -22.09 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 43.40 21.29 -20.10 44.08 21.40 -18.06 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 31.02 25.73 -16.52 36.61 24.80 -13.64 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 C 47 SER D 328 SER~? 24.00 C1 EDO C 602 C 48 THR D 318 THR.? 30.09 C1 EDO C 602 C 165 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 40.49 20.83 -24.30 39.56 20.57 -22.09 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 44.56 23.70 -22.81 46.55 24.41 -23.21 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 31.02 25.73 -16.52 36.61 24.80 -13.64 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 8 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER A 328 SER~? 24.32 C1 EDO B 603 D 48 THR A 317 THR.? 30.13 C1 EDO B 603 D 165 LYS B 348 LYS.? 28.30 C2 EDO B 603 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 27.10 32.44 15.23 26.15 32.07 17.43 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 29.57 32.99 19.64 30.09 32.97 21.72 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 16.25 36.62 22.07 20.01 34.44 26.08 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 47 SER A 328 SER~? 24.32 C1 EDO B 603 D 48 THR A 318 THR.? 30.43 C1 EDO B 603 D 165 LYS B 348 LYS.? 28.30 C2 EDO B 603 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 27.10 32.44 15.23 26.15 32.07 17.43 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 30.31 35.91 17.26 32.03 37.29 17.23 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 16.25 36.62 22.07 20.01 34.44 26.08 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 47 SER B 328 SER~? 24.34 C1 EDO B 603 D 48 THR B 317 THR.? 28.99 C1 EDO B 603 D 165 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 32.93 23.60 9.01 32.97 23.42 6.61 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 36.64 25.71 6.15 37.93 26.34 4.55 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 47 SER B 328 SER~? 24.34 C1 EDO B 603 D 48 THR B 318 THR.? 31.71 C1 EDO B 603 D 165 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 32.93 23.60 9.01 32.97 23.42 6.61 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 38.06 24.71 9.55 39.51 25.67 10.82 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 D 47 SER C 328 SER~? 23.98 C1 EDO C 602 D 48 THR C 317 THR.? 28.45 C1 EDO C 602 D 165 LYS D 348 LYS.? 27.59 O1 EDO C 602 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 45.06 12.12 -31.74 44.78 12.22 -34.15 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 48.45 14.16 -34.83 49.57 14.57 -36.66 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 43.15 3.71 -41.93 47.18 7.62 -43.42 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 D 47 SER C 328 SER~? 23.98 C1 EDO C 602 D 48 THR C 318 THR.? 30.49 C2 GOL D 601 D 165 LYS D 348 LYS.? 27.59 O1 EDO C 602 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 45.06 12.12 -31.74 44.78 12.22 -34.15 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 50.21 12.77 -31.72 51.79 13.54 -30.47 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 43.15 3.71 -41.93 47.18 7.62 -43.42 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 D 47 SER D 328 SER~? 24.00 C1 EDO C 602 D 48 THR D 317 THR.? 28.79 C1 GOL D 601 D 165 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 40.49 20.83 -24.30 39.56 20.57 -22.09 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 43.40 21.29 -20.10 44.08 21.40 -18.06 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 31.02 25.73 -16.52 36.61 24.80 -13.64 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 D 47 SER D 328 SER~? 24.00 C1 EDO C 602 D 48 THR D 318 THR.? 30.09 C1 EDO C 602 D 165 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 40.49 20.83 -24.30 39.56 20.57 -22.09 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 44.56 23.70 -22.81 46.55 24.41 -23.21 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 31.02 25.73 -16.52 36.61 24.80 -13.64 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 8 hits 1fdy_c07 naa= 3 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 B 317 GLU A 330 GLU~? 26.93 C1 EDO B 603 B 319 ASP B 426 ASP.? 28.68 C1 EDO B 603 B 359 ARG B 425 ARG^? 24.19 C2 EDO B 603 coo 10.77 13.13 40.94 11.03 14.73 39.51 25.78 29.04 20.96 25.48 30.78 22.26 coo 3.77 12.64 38.21 3.35 14.53 37.39 21.11 26.70 26.04 20.61 27.63 27.90 coo -1.16 15.32 35.60 -3.32 13.56 36.98 13.19 26.25 26.41 10.66 27.96 25.98 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 B 317 GLU B 330 GLU~? 24.65 C1 EDO B 603 B 319 ASP A 426 ASP.? 22.31 O1 EDO B 603 B 359 ARG A 425 ARG^? 21.19 O1 EDO B 603 coo 10.77 13.13 40.94 11.03 14.73 39.51 31.94 25.81 2.71 33.76 25.37 1.74 coo 3.77 12.64 38.21 3.35 14.53 37.39 29.17 24.78 -3.72 30.40 24.16 -5.34 coo -1.16 15.32 35.60 -3.32 13.56 36.98 25.04 18.93 -7.11 26.86 16.62 -8.01 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 B 317 GLU C 330 GLU~? 24.03 O1 EDO C 602 B 319 ASP D 426 ASP.? 21.84 O1 EDO C 602 B 359 ARG D 425 ARG^? 16.89 O1 EDO C 602 coo 10.77 13.13 40.94 11.03 14.73 39.51 43.59 14.91 -37.76 45.12 14.02 -38.99 coo 3.77 12.64 38.21 3.35 14.53 37.39 40.54 14.64 -43.98 41.47 13.99 -45.77 coo -1.16 15.32 35.60 -3.32 13.56 36.98 35.18 9.71 -47.18 32.90 7.74 -47.72 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 B 317 GLU C 378 GLU~? 24.96 O2 EDO B 603 B 319 ASP C 350 ASP.? 24.48 C2 EDO C 602 B 359 ARG C 397 ARG~? 23.93 O1 EDO B 603 coo 10.77 13.13 40.94 11.03 14.73 39.51 22.14 33.77 -19.82 21.71 34.90 -18.09 coo 3.77 12.64 38.21 3.35 14.53 37.39 27.03 30.18 -18.47 26.26 29.33 -16.72 coo -1.16 15.32 35.60 -3.32 13.56 36.98 25.49 26.02 -11.91 27.94 26.82 -13.64 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 5 3 # 5 B 317 GLU D 330 GLU~? 24.51 C2 GOL D 601 B 319 ASP C 426 ASP.? 22.72 C2 GOL D 601 B 359 ARG C 425 ARG^? 21.48 O1 GOL D 601 coo 10.77 13.13 40.94 11.03 14.73 39.51 39.35 17.44 -18.72 40.01 18.64 -17.10 coo 3.77 12.64 38.21 3.35 14.53 37.39 35.09 15.28 -13.55 34.97 16.40 -11.75 coo -1.16 15.32 35.60 -3.32 13.56 36.98 27.32 15.93 -12.34 26.51 18.69 -11.26 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 6 3 # 6 B 317 GLU D 378 GLU~? 27.27 O3 GOL D 601 B 319 ASP D 350 ASP.? 24.09 C3 GOL D 601 B 359 ARG D 397 ARG~? 26.17 C3 GOL D 601 coo 10.77 13.13 40.94 11.03 14.73 39.51 43.18 -8.44 -40.40 44.74 -9.12 -41.62 coo 3.77 12.64 38.21 3.35 14.53 37.39 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo -1.16 15.32 35.60 -3.32 13.56 36.98 40.54 0.77 -47.66 42.41 1.45 -45.29 1fr8_c01 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 6 hits 1fr8_c01 naa= 3 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 1 3 # 1 A 130 ASP A 349 ASP.? 30.68 C1 EDO B 603 A 153 ASN A 347 ASN^? 27.63 C1 EDO B 603 A 189 GLN A 353 GLN^? 25.63 C1 EDO B 603 coo 27.45 53.97 73.24 26.29 54.34 71.54 36.99 12.23 1.79 37.88 13.87 0.83 coo 29.93 52.22 70.56 29.34 51.93 68.54 32.85 15.10 3.85 34.45 13.77 4.43 coo 26.19 47.96 71.25 25.92 49.81 70.24 32.87 15.04 8.35 32.95 16.99 7.51 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 2 3 # 2 A 130 ASP B 349 ASP.? 28.06 C2 EDO B 603 A 153 ASN B 347 ASN^? 23.37 C2 EDO B 603 A 189 GLN B 353 GLN^? 21.64 C2 EDO B 603 coo 27.45 53.97 73.24 26.29 54.34 71.54 17.36 41.29 21.17 18.85 41.14 22.68 coo 29.93 52.22 70.56 29.34 51.93 68.54 18.47 36.73 18.25 18.44 38.86 18.15 coo 26.19 47.96 71.25 25.92 49.81 70.24 20.30 37.54 14.15 21.36 36.14 15.36 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 3 3 # 3 A 130 ASP D 349 ASP.? 28.27 C3 GOL D 601 A 153 ASN D 347 ASN^? 23.69 C3 GOL D 601 A 189 GLN D 353 GLN^? 21.85 C3 GOL D 601 coo 27.45 53.97 73.24 26.29 54.34 71.54 47.11 1.34 -40.59 48.04 2.96 -41.60 coo 29.93 52.22 70.56 29.34 51.93 68.54 43.61 4.31 -37.61 45.14 2.83 -37.46 coo 26.19 47.96 71.25 25.92 49.81 70.24 43.78 3.80 -33.32 44.28 5.80 -33.72 1ga8_c00 source 1ga8 GALACTOSYL TRANSFERASE LGTC : 3 hits 1ga8_c00 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU A 436 GLU^? 20.55 O1 EDO B 603 A 47 ASP A 350 ASP.? 26.92 O2 GOL D 601 A 161 TYR A 421 TYR^? 19.72 O1 EDO B 603 coo 37.12 18.35 73.76 37.09 16.69 72.44 19.93 9.98 5.88 20.55 8.03 6.42 coo 29.81 8.06 73.13 30.21 10.11 72.95 33.51 7.96 1.59 32.78 7.85 -0.37 coo 37.29 15.56 67.90 37.37 13.79 70.08 20.02 8.83 1.38 20.18 6.69 3.20 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 A 36 GLU A 436 GLU^? 20.55 O1 EDO B 603 A 47 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 161 TYR A 421 TYR^? 19.72 O1 EDO B 603 coo 37.12 18.35 73.76 37.09 16.69 72.44 19.93 9.98 5.88 20.55 8.03 6.42 coo 29.81 8.06 73.13 30.21 10.11 72.95 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 37.29 15.56 67.90 37.37 13.79 70.08 20.02 8.83 1.38 20.18 6.69 3.20 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 A 36 GLU A 436 GLU^? 20.55 O1 EDO B 603 A 47 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 161 TYR A 437 TYR^? 11.45 C1 EDO B 603 coo 37.12 18.35 73.76 37.09 16.69 72.44 19.93 9.98 5.88 20.55 8.03 6.42 coo 29.81 8.06 73.13 30.21 10.11 72.95 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 37.29 15.56 67.90 37.37 13.79 70.08 16.79 15.50 5.48 15.91 16.43 3.01 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 A 36 GLU A 436 GLU^? 20.55 O1 EDO B 603 A 47 ASP A 440 ASP^? 18.54 C1 EDO B 603 A 161 TYR A 437 TYR^? 11.45 C1 EDO B 603 coo 37.12 18.35 73.76 37.09 16.69 72.44 19.93 9.98 5.88 20.55 8.03 6.42 coo 29.81 8.06 73.13 30.21 10.11 72.95 8.21 11.09 12.88 6.30 10.30 13.36 coo 37.29 15.56 67.90 37.37 13.79 70.08 16.79 15.50 5.48 15.91 16.43 3.01 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 5 3 # 5 A 36 GLU B 436 GLU^? 10.42 C2 EDO B 603 A 47 ASP B 402 ASP.? 23.46 C2 EDO B 603 A 161 TYR B 437 TYR^? 10.72 C1 EDO B 603 coo 37.12 18.35 73.76 37.09 16.69 72.44 8.55 30.19 11.17 7.66 31.90 10.29 coo 29.81 8.06 73.13 30.21 10.11 72.95 8.17 23.01 23.39 8.93 22.69 25.33 coo 37.29 15.56 67.90 37.37 13.79 70.08 10.92 24.41 11.32 10.27 22.67 13.43 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 6 3 # 6 A 36 GLU B 436 GLU^? 10.42 C2 EDO B 603 A 47 ASP B 440 ASP^? 5.62 O1 EDO B 603 A 161 TYR B 437 TYR^? 10.72 C1 EDO B 603 coo 37.12 18.35 73.76 37.09 16.69 72.44 8.55 30.19 11.17 7.66 31.90 10.29 coo 29.81 8.06 73.13 30.21 10.11 72.95 5.66 21.79 0.79 4.10 21.14 -0.54 coo 37.29 15.56 67.90 37.37 13.79 70.08 10.92 24.41 11.32 10.27 22.67 13.43 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 7 3 # 7 A 36 GLU C 436 GLU^? 10.62 C2 EDO C 602 A 47 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 161 TYR C 421 TYR^? 13.35 C2 EDO C 602 coo 37.12 18.35 73.76 37.09 16.69 72.44 21.74 20.63 -27.21 21.00 22.48 -27.90 coo 29.81 8.06 73.13 30.21 10.11 72.95 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 37.29 15.56 67.90 37.37 13.79 70.08 19.38 20.76 -23.26 18.18 22.24 -25.31 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 8 3 # 8 A 36 GLU C 436 GLU^? 10.62 C2 EDO C 602 A 47 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 161 TYR C 421 TYR^? 13.35 C2 EDO C 602 coo 37.12 18.35 73.76 37.09 16.69 72.44 21.74 20.63 -27.21 21.00 22.48 -27.90 coo 29.81 8.06 73.13 30.21 10.11 72.95 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 37.29 15.56 67.90 37.37 13.79 70.08 19.38 20.76 -23.26 18.18 22.24 -25.31 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 9 3 # 9 A 36 GLU C 436 GLU^? 10.62 C2 EDO C 602 A 47 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 161 TYR C 437 TYR^? 9.81 O1 GOL D 601 coo 37.12 18.35 73.76 37.09 16.69 72.44 21.74 20.63 -27.21 21.00 22.48 -27.90 coo 29.81 8.06 73.13 30.21 10.11 72.95 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 37.29 15.56 67.90 37.37 13.79 70.08 23.51 14.66 -27.39 22.94 13.02 -25.21 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 10 3 # 10 A 36 GLU C 436 GLU^? 10.62 C2 EDO C 602 A 47 ASP C 440 ASP^? 5.97 O1 EDO C 602 A 161 TYR C 437 TYR^? 9.81 O1 GOL D 601 coo 37.12 18.35 73.76 37.09 16.69 72.44 21.74 20.63 -27.21 21.00 22.48 -27.90 coo 29.81 8.06 73.13 30.21 10.11 72.95 17.33 13.03 -37.56 15.74 12.38 -38.82 coo 37.29 15.56 67.90 37.37 13.79 70.08 23.51 14.66 -27.39 22.94 13.02 -25.21 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 11 3 # 11 A 36 GLU D 436 GLU^? 11.06 C3 GOL D 601 A 47 ASP D 350 ASP.? 24.09 C3 GOL D 601 A 161 TYR D 421 TYR^? 13.63 C3 GOL D 601 coo 37.12 18.35 73.76 37.09 16.69 72.44 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 29.81 8.06 73.13 30.21 10.11 72.95 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 37.29 15.56 67.90 37.37 13.79 70.08 30.12 -0.70 -39.30 29.82 -2.95 -37.69 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 12 3 # 12 A 36 GLU D 436 GLU^? 11.06 C3 GOL D 601 A 47 ASP D 402 ASP.? 14.20 O1 EDO C 602 A 161 TYR D 421 TYR^? 13.63 C3 GOL D 601 coo 37.12 18.35 73.76 37.09 16.69 72.44 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 29.81 8.06 73.13 30.21 10.11 72.95 28.53 7.95 -46.44 29.10 9.08 -48.14 coo 37.29 15.56 67.90 37.37 13.79 70.08 30.12 -0.70 -39.30 29.82 -2.95 -37.69 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 13 3 # 13 A 36 GLU D 436 GLU^? 11.06 C3 GOL D 601 A 47 ASP D 402 ASP.? 14.20 O1 EDO C 602 A 161 TYR D 437 TYR^? 9.97 C1 GOL D 601 coo 37.12 18.35 73.76 37.09 16.69 72.44 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 29.81 8.06 73.13 30.21 10.11 72.95 28.53 7.95 -46.44 29.10 9.08 -48.14 coo 37.29 15.56 67.90 37.37 13.79 70.08 27.83 5.60 -34.20 26.72 6.80 -36.49 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 14 3 # 14 A 36 GLU D 436 GLU^? 11.06 C3 GOL D 601 A 47 ASP D 440 ASP^? -5.34 O2 GOL D 601s A 161 TYR D 437 TYR^? 9.97 C1 GOL D 601 coo 37.12 18.35 73.76 37.09 16.69 72.44 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 29.81 8.06 73.13 30.21 10.11 72.95 19.76 1.27 -26.39 17.89 0.46 -25.75 coo 37.29 15.56 67.90 37.37 13.79 70.08 27.83 5.60 -34.20 26.72 6.80 -36.49 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 14 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU A 436 GLU^? 20.55 O1 EDO B 603 B 47 ASP A 350 ASP.? 26.92 O2 GOL D 601 B 161 TYR A 421 TYR^? 19.72 O1 EDO B 603 coo 53.87 35.49 53.22 55.44 35.72 54.61 19.93 9.98 5.88 20.55 8.03 6.42 coo 63.47 43.65 53.95 61.45 43.07 54.06 33.51 7.96 1.59 32.78 7.85 -0.37 coo 56.38 35.81 59.19 58.25 35.77 57.10 20.02 8.83 1.38 20.18 6.69 3.20 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 B 36 GLU A 436 GLU^? 20.55 O1 EDO B 603 B 47 ASP A 402 ASP.? 12.59 O1 EDO B 603 B 161 TYR A 421 TYR^? 19.72 O1 EDO B 603 coo 53.87 35.49 53.22 55.44 35.72 54.61 19.93 9.98 5.88 20.55 8.03 6.42 coo 63.47 43.65 53.95 61.45 43.07 54.06 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 56.38 35.81 59.19 58.25 35.77 57.10 20.02 8.83 1.38 20.18 6.69 3.20 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 B 36 GLU A 436 GLU^? 20.55 O1 EDO B 603 B 47 ASP A 402 ASP.? 12.59 O1 EDO B 603 B 161 TYR A 437 TYR^? 11.45 C1 EDO B 603 coo 53.87 35.49 53.22 55.44 35.72 54.61 19.93 9.98 5.88 20.55 8.03 6.42 coo 63.47 43.65 53.95 61.45 43.07 54.06 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 56.38 35.81 59.19 58.25 35.77 57.10 16.79 15.50 5.48 15.91 16.43 3.01 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 B 36 GLU A 436 GLU^? 20.55 O1 EDO B 603 B 47 ASP A 440 ASP^? 18.54 C1 EDO B 603 B 161 TYR A 437 TYR^? 11.45 C1 EDO B 603 coo 53.87 35.49 53.22 55.44 35.72 54.61 19.93 9.98 5.88 20.55 8.03 6.42 coo 63.47 43.65 53.95 61.45 43.07 54.06 8.21 11.09 12.88 6.30 10.30 13.36 coo 56.38 35.81 59.19 58.25 35.77 57.10 16.79 15.50 5.48 15.91 16.43 3.01 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 5 3 # 5 B 36 GLU B 436 GLU^? 10.42 C2 EDO B 603 B 47 ASP B 402 ASP.? 23.46 C2 EDO B 603 B 161 TYR B 437 TYR^? 10.72 C1 EDO B 603 coo 53.87 35.49 53.22 55.44 35.72 54.61 8.55 30.19 11.17 7.66 31.90 10.29 coo 63.47 43.65 53.95 61.45 43.07 54.06 8.17 23.01 23.39 8.93 22.69 25.33 coo 56.38 35.81 59.19 58.25 35.77 57.10 10.92 24.41 11.32 10.27 22.67 13.43 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 6 3 # 6 B 36 GLU B 436 GLU^? 10.42 C2 EDO B 603 B 47 ASP B 440 ASP^? 5.62 O1 EDO B 603 B 161 TYR B 437 TYR^? 10.72 C1 EDO B 603 coo 53.87 35.49 53.22 55.44 35.72 54.61 8.55 30.19 11.17 7.66 31.90 10.29 coo 63.47 43.65 53.95 61.45 43.07 54.06 5.66 21.79 0.79 4.10 21.14 -0.54 coo 56.38 35.81 59.19 58.25 35.77 57.10 10.92 24.41 11.32 10.27 22.67 13.43 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 7 3 # 7 B 36 GLU C 436 GLU^? 10.62 C2 EDO C 602 B 47 ASP C 350 ASP.? 24.48 C2 EDO C 602 B 161 TYR C 421 TYR^? 13.35 C2 EDO C 602 coo 53.87 35.49 53.22 55.44 35.72 54.61 21.74 20.63 -27.21 21.00 22.48 -27.90 coo 63.47 43.65 53.95 61.45 43.07 54.06 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 56.38 35.81 59.19 58.25 35.77 57.10 19.38 20.76 -23.26 18.18 22.24 -25.31 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 8 3 # 8 B 36 GLU C 436 GLU^? 10.62 C2 EDO C 602 B 47 ASP C 402 ASP.? 12.78 O1 GOL D 601 B 161 TYR C 421 TYR^? 13.35 C2 EDO C 602 coo 53.87 35.49 53.22 55.44 35.72 54.61 21.74 20.63 -27.21 21.00 22.48 -27.90 coo 63.47 43.65 53.95 61.45 43.07 54.06 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 56.38 35.81 59.19 58.25 35.77 57.10 19.38 20.76 -23.26 18.18 22.24 -25.31 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 9 3 # 9 B 36 GLU C 436 GLU^? 10.62 C2 EDO C 602 B 47 ASP C 402 ASP.? 12.78 O1 GOL D 601 B 161 TYR C 437 TYR^? 9.81 O1 GOL D 601 coo 53.87 35.49 53.22 55.44 35.72 54.61 21.74 20.63 -27.21 21.00 22.48 -27.90 coo 63.47 43.65 53.95 61.45 43.07 54.06 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 56.38 35.81 59.19 58.25 35.77 57.10 23.51 14.66 -27.39 22.94 13.02 -25.21 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 10 3 # 10 B 36 GLU C 436 GLU^? 10.62 C2 EDO C 602 B 47 ASP C 440 ASP^? 5.97 O1 EDO C 602 B 161 TYR C 437 TYR^? 9.81 O1 GOL D 601 coo 53.87 35.49 53.22 55.44 35.72 54.61 21.74 20.63 -27.21 21.00 22.48 -27.90 coo 63.47 43.65 53.95 61.45 43.07 54.06 17.33 13.03 -37.56 15.74 12.38 -38.82 coo 56.38 35.81 59.19 58.25 35.77 57.10 23.51 14.66 -27.39 22.94 13.02 -25.21 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 11 3 # 11 B 36 GLU D 436 GLU^? 11.06 C3 GOL D 601 B 47 ASP D 350 ASP.? 24.09 C3 GOL D 601 B 161 TYR D 421 TYR^? 13.63 C3 GOL D 601 coo 53.87 35.49 53.22 55.44 35.72 54.61 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 63.47 43.65 53.95 61.45 43.07 54.06 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 56.38 35.81 59.19 58.25 35.77 57.10 30.12 -0.70 -39.30 29.82 -2.95 -37.69 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 12 3 # 12 B 36 GLU D 436 GLU^? 11.06 C3 GOL D 601 B 47 ASP D 402 ASP.? 14.20 O1 EDO C 602 B 161 TYR D 421 TYR^? 13.63 C3 GOL D 601 coo 53.87 35.49 53.22 55.44 35.72 54.61 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 63.47 43.65 53.95 61.45 43.07 54.06 28.53 7.95 -46.44 29.10 9.08 -48.14 coo 56.38 35.81 59.19 58.25 35.77 57.10 30.12 -0.70 -39.30 29.82 -2.95 -37.69 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 13 3 # 13 B 36 GLU D 436 GLU^? 11.06 C3 GOL D 601 B 47 ASP D 402 ASP.? 14.20 O1 EDO C 602 B 161 TYR D 437 TYR^? 9.97 C1 GOL D 601 coo 53.87 35.49 53.22 55.44 35.72 54.61 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 63.47 43.65 53.95 61.45 43.07 54.06 28.53 7.95 -46.44 29.10 9.08 -48.14 coo 56.38 35.81 59.19 58.25 35.77 57.10 27.83 5.60 -34.20 26.72 6.80 -36.49 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 14 3 # 14 B 36 GLU D 436 GLU^? 11.06 C3 GOL D 601 B 47 ASP D 440 ASP^? -5.34 O2 GOL D 601s B 161 TYR D 437 TYR^? 9.97 C1 GOL D 601 coo 53.87 35.49 53.22 55.44 35.72 54.61 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 63.47 43.65 53.95 61.45 43.07 54.06 19.76 1.27 -26.39 17.89 0.46 -25.75 coo 56.38 35.81 59.19 58.25 35.77 57.10 27.83 5.60 -34.20 26.72 6.80 -36.49 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 14 hits 1geq_c03 naa= 3 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 1 3 # 1 13 ASP A 357 ASP.? 25.14 C1 EDO B 603 41 HIS A 338 HIS~? 19.64 C1 EDO B 603 224 GLN B 427 GLN.? 29.97 C1 EDO B 603 coo -3.80 50.71 49.48 -5.59 51.85 49.27 22.54 16.74 19.72 22.05 16.00 21.61 coo -6.45 47.32 41.99 -8.32 46.87 42.83 16.13 23.68 19.02 16.84 23.99 20.97 coo -12.35 49.13 49.89 -13.38 48.89 48.03 23.38 22.78 27.87 25.12 21.92 27.02 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 2 3 # 2 13 ASP A 426 ASP.? 22.31 O1 EDO B 603 41 HIS B 338 HIS.? 13.66 O1 EDO B 603 224 GLN B 331 GLN~? 24.19 C1 EDO B 603 coo -3.80 50.71 49.48 -5.59 51.85 49.27 29.17 24.78 -3.72 30.40 24.16 -5.34 coo -6.45 47.32 41.99 -8.32 46.87 42.83 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -12.35 49.13 49.89 -13.38 48.89 48.03 31.22 21.08 5.08 32.44 19.62 5.97 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 3 3 # 3 13 ASP B 357 ASP.? 13.04 C1 EDO B 603 41 HIS B 338 HIS.? 13.66 O1 EDO B 603 224 GLN A 427 GLN.? 20.08 O1 EDO B 603 coo -3.80 50.71 49.48 -5.59 51.85 49.27 19.95 30.44 0.55 20.02 30.85 -1.53 coo -6.45 47.32 41.99 -8.32 46.87 42.83 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -12.35 49.13 49.89 -13.38 48.89 48.03 25.85 29.74 -6.76 26.03 31.82 -6.25 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 4 3 # 4 13 ASP B 426 ASP.? 28.68 C1 EDO B 603 41 HIS A 338 HIS~? 19.64 C1 EDO B 603 224 GLN A 331 GLN~? 22.54 C1 EDO B 603 coo -3.80 50.71 49.48 -5.59 51.85 49.27 21.11 26.70 26.04 20.61 27.63 27.90 coo -6.45 47.32 41.99 -8.32 46.87 42.83 16.13 23.68 19.02 16.84 23.99 20.97 coo -12.35 49.13 49.89 -13.38 48.89 48.03 22.78 31.90 17.78 22.64 33.92 17.20 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 5 3 # 5 13 ASP C 357 ASP.? 12.50 O2 EDO C 602 41 HIS C 338 HIS~? 12.91 O1 EDO C 602 224 GLN D 427 GLN.? 16.15 O1 EDO C 602 coo -3.80 50.71 49.48 -5.59 51.85 49.27 32.02 20.63 -38.57 31.77 21.72 -40.39 coo -6.45 47.32 41.99 -8.32 46.87 42.83 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -12.35 49.13 49.89 -13.38 48.89 48.03 37.54 19.53 -43.91 35.37 19.33 -43.95 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 6 3 # 6 13 ASP C 426 ASP.? 22.72 C2 GOL D 601 41 HIS D 338 HIS~? 13.70 C1 GOL D 601 224 GLN D 331 GLN~? 22.40 C1 EDO C 602 coo -3.80 50.71 49.48 -5.59 51.85 49.27 35.09 15.28 -13.55 34.97 16.40 -11.75 coo -6.45 47.32 41.99 -8.32 46.87 42.83 29.23 12.85 -20.11 30.06 13.12 -18.20 coo -12.35 49.13 49.89 -13.38 48.89 48.03 36.40 20.60 -21.50 36.46 22.66 -21.93 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 7 3 # 7 13 ASP D 426 ASP.? 21.84 O1 EDO C 602 41 HIS C 338 HIS~? 12.91 O1 EDO C 602 224 GLN C 331 GLN~? 22.65 C3 GOL D 601 coo -3.80 50.71 49.48 -5.59 51.85 49.27 40.54 14.64 -43.98 41.47 13.99 -45.77 coo -6.45 47.32 41.99 -8.32 46.87 42.83 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -12.35 49.13 49.89 -13.38 48.89 48.03 42.71 10.11 -35.60 43.90 8.50 -34.90 1gim_c00 source 1gim ADENYLOSUCCINATE SYNTHETASE : 7 hits 1gim_c00 naa= 3 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 B 106 ASN B 333 ASN~? 17.11 C1 EDO B 603 B 108 HIS B 338 HIS.? 13.66 O1 EDO B 603 B 144 ASP A 430 ASP.? 25.41 O1 EDO B 603 coo 36.64 101.02 13.15 38.55 101.84 12.78 26.50 27.72 5.31 25.42 29.17 4.18 coo 41.00 107.18 12.86 42.70 107.82 11.96 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 31.60 110.69 6.14 29.69 109.74 5.94 31.59 21.51 -7.17 32.38 22.31 -9.00 1grc_c03 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 1 hits 1grc_c03 naa= 3 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 1 3 # 1 160 LYS A 390 LYS~? 25.88 O2 GOL D 601 210 ARG A 425 ARG^? 21.19 O1 EDO B 603 225 ARG C 425 ARG^? 21.48 O1 GOL D 601 coo 17.51 28.50 73.42 17.24 23.02 75.86 26.64 2.81 -1.98 30.91 -1.55 -0.35 coo 24.74 11.56 73.05 25.29 14.32 71.80 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 27.81 15.44 77.10 25.66 16.50 75.19 27.32 15.93 -12.34 26.51 18.69 -11.26 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 2 3 # 2 160 LYS A 390 LYS~? 25.88 O2 GOL D 601 210 ARG C 425 ARG^? 21.48 O1 GOL D 601 225 ARG A 425 ARG^? 21.19 O1 EDO B 603 coo 17.51 28.50 73.42 17.24 23.02 75.86 26.64 2.81 -1.98 30.91 -1.55 -0.35 coo 24.74 11.56 73.05 25.29 14.32 71.80 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 27.81 15.44 77.10 25.66 16.50 75.19 25.04 18.93 -7.11 26.86 16.62 -8.01 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 3 3 # 3 160 LYS C 390 LYS~? 21.48 O2 EDO B 603 210 ARG C 425 ARG^? 21.48 O1 GOL D 601 225 ARG A 425 ARG^? 21.19 O1 EDO B 603 coo 17.51 28.50 73.42 17.24 23.02 75.86 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 24.74 11.56 73.05 25.29 14.32 71.80 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 27.81 15.44 77.10 25.66 16.50 75.19 25.04 18.93 -7.11 26.86 16.62 -8.01 1gsa_c00 source 1gsa GLUTATHIONE SYNTHETASE : 3 hits 1gsa_c00 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 431 PHE^? 22.59 O1 EDO B 603 A 298 ASP A 350 ASP.? 26.92 O2 GOL D 601 A 329 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 29.40 15.33 -4.65 28.40 13.37 -2.94 coo 2.59 0.29 25.55 4.65 0.18 25.07 33.51 7.96 1.59 32.78 7.85 -0.37 coo 12.42 6.10 23.27 9.95 1.57 20.16 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE A 445 PHE~? 17.72 O1 EDO B 603 A 298 ASP A 448 ASP~? 19.70 O1 EDO B 603 A 329 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -0.28 10.05 7.85 1.97 9.05 6.47 coo 2.59 0.29 25.55 4.65 0.18 25.07 -6.12 13.55 5.97 -7.03 12.86 4.20 coo 12.42 6.10 23.27 9.95 1.57 20.16 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE A 445 PHE~? 17.72 O1 EDO B 603 A 298 ASP B 448 ASP.? 21.29 O1 EDO B 603 A 329 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -0.28 10.05 7.85 1.97 9.05 6.47 coo 2.59 0.29 25.55 4.65 0.18 25.07 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo 12.42 6.10 23.27 9.95 1.57 20.16 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 A 189 PHE B 416 PHE^? 11.67 C2 EDO B 603 A 298 ASP A 448 ASP~? 19.70 O1 EDO B 603 A 329 LYS A 442 LYS~? 23.27 C1 EDO B 603 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -1.62 21.04 3.18 -3.66 21.32 5.09 coo 2.59 0.29 25.55 4.65 0.18 25.07 -6.12 13.55 5.97 -7.03 12.86 4.20 coo 12.42 6.10 23.27 9.95 1.57 20.16 2.76 10.16 11.03 0.96 5.43 12.32 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 A 189 PHE B 431 PHE^? 23.47 C2 EDO B 603 A 298 ASP B 350 ASP.? 23.89 C2 EDO B 603 A 329 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 13.65 32.28 24.99 12.40 33.20 22.64 coo 2.59 0.29 25.55 4.65 0.18 25.07 12.16 40.72 19.41 11.14 39.74 20.98 coo 12.42 6.10 23.27 9.95 1.57 20.16 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 A 189 PHE C 416 PHE^? 11.78 C2 EDO C 602 A 298 ASP D 448 ASP.? 19.66 C2 EDO C 602 A 329 LYS D 442 LYS~? 12.65 O2 GOL D 601 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 10.28 12.37 -34.72 8.44 12.42 -32.58 coo 2.59 0.29 25.55 4.65 0.18 25.07 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 12.42 6.10 23.27 9.95 1.57 20.16 14.14 0.83 -27.84 11.41 -3.18 -25.91 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 A 189 PHE C 431 PHE^? 22.21 O1 GOL D 601 A 298 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 329 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 28.24 21.80 -13.63 26.64 22.64 -15.77 coo 2.59 0.29 25.55 4.65 0.18 25.07 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 12.42 6.10 23.27 9.95 1.57 20.16 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 A 189 PHE D 431 PHE^? 21.51 O1 EDO C 602 A 298 ASP D 350 ASP.? 24.09 C3 GOL D 601 A 329 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 39.18 5.51 -45.56 38.23 3.44 -43.92 coo 2.59 0.29 25.55 4.65 0.18 25.07 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 12.42 6.10 23.27 9.95 1.57 20.16 32.90 -6.30 -46.84 30.42 -11.34 -47.14 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 A 189 PHE D 445 PHE~? 11.88 O1 GOL D 601 A 298 ASP D 448 ASP.? 19.66 C2 EDO C 602 A 329 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 10.86 1.23 -30.60 12.85 0.20 -32.29 coo 2.59 0.29 25.55 4.65 0.18 25.07 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 12.42 6.10 23.27 9.95 1.57 20.16 12.96 9.36 -37.91 9.04 10.02 -41.38 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 9 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 431 PHE^? 22.59 O1 EDO B 603 B 298 ASP A 350 ASP.? 26.92 O2 GOL D 601 B 329 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 29.40 15.33 -4.65 28.40 13.37 -2.94 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 33.51 7.96 1.59 32.78 7.85 -0.37 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE A 445 PHE~? 17.72 O1 EDO B 603 B 298 ASP A 448 ASP~? 19.70 O1 EDO B 603 B 329 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -0.28 10.05 7.85 1.97 9.05 6.47 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -6.12 13.55 5.97 -7.03 12.86 4.20 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE A 445 PHE~? 17.72 O1 EDO B 603 B 298 ASP B 448 ASP.? 21.29 O1 EDO B 603 B 329 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -0.28 10.05 7.85 1.97 9.05 6.47 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 B 189 PHE B 416 PHE^? 11.67 C2 EDO B 603 B 298 ASP A 448 ASP~? 19.70 O1 EDO B 603 B 329 LYS A 442 LYS~? 23.27 C1 EDO B 603 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -1.62 21.04 3.18 -3.66 21.32 5.09 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -6.12 13.55 5.97 -7.03 12.86 4.20 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 2.76 10.16 11.03 0.96 5.43 12.32 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 B 189 PHE B 431 PHE^? 23.47 C2 EDO B 603 B 298 ASP B 350 ASP.? 23.89 C2 EDO B 603 B 329 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 13.65 32.28 24.99 12.40 33.20 22.64 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 12.16 40.72 19.41 11.14 39.74 20.98 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 B 189 PHE C 416 PHE^? 11.78 C2 EDO C 602 B 298 ASP D 448 ASP.? 19.66 C2 EDO C 602 B 329 LYS D 442 LYS~? 12.65 O2 GOL D 601 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 10.28 12.37 -34.72 8.44 12.42 -32.58 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 14.14 0.83 -27.84 11.41 -3.18 -25.91 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 B 189 PHE C 431 PHE^? 22.21 O1 GOL D 601 B 298 ASP C 350 ASP.? 24.48 C2 EDO C 602 B 329 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 28.24 21.80 -13.63 26.64 22.64 -15.77 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 B 189 PHE D 431 PHE^? 21.51 O1 EDO C 602 B 298 ASP D 350 ASP.? 24.09 C3 GOL D 601 B 329 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 39.18 5.51 -45.56 38.23 3.44 -43.92 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 32.90 -6.30 -46.84 30.42 -11.34 -47.14 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 B 189 PHE D 445 PHE~? 11.88 O1 GOL D 601 B 298 ASP D 448 ASP.? 19.66 C2 EDO C 602 B 329 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 10.86 1.23 -30.60 12.85 0.20 -32.29 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 12.96 9.36 -37.91 9.04 10.02 -41.38 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 9 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 431 PHE^? 22.59 O1 EDO B 603 C 298 ASP A 350 ASP.? 26.92 O2 GOL D 601 C 329 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo 17.41 60.57 64.39 18.40 58.12 65.34 29.40 15.33 -4.65 28.40 13.37 -2.94 coo 24.10 66.43 63.33 24.18 64.30 63.40 33.51 7.96 1.59 32.78 7.85 -0.37 coo 27.64 56.61 58.17 22.18 57.92 60.36 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE A 445 PHE~? 17.72 O1 EDO B 603 C 298 ASP A 448 ASP~? 19.70 O1 EDO B 603 C 329 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 17.41 60.57 64.39 18.40 58.12 65.34 -0.28 10.05 7.85 1.97 9.05 6.47 coo 24.10 66.43 63.33 24.18 64.30 63.40 -6.12 13.55 5.97 -7.03 12.86 4.20 coo 27.64 56.61 58.17 22.18 57.92 60.36 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE A 445 PHE~? 17.72 O1 EDO B 603 C 298 ASP B 448 ASP.? 21.29 O1 EDO B 603 C 329 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 17.41 60.57 64.39 18.40 58.12 65.34 -0.28 10.05 7.85 1.97 9.05 6.47 coo 24.10 66.43 63.33 24.18 64.30 63.40 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo 27.64 56.61 58.17 22.18 57.92 60.36 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 C 189 PHE B 416 PHE^? 11.67 C2 EDO B 603 C 298 ASP A 448 ASP~? 19.70 O1 EDO B 603 C 329 LYS A 442 LYS~? 23.27 C1 EDO B 603 coo 17.41 60.57 64.39 18.40 58.12 65.34 -1.62 21.04 3.18 -3.66 21.32 5.09 coo 24.10 66.43 63.33 24.18 64.30 63.40 -6.12 13.55 5.97 -7.03 12.86 4.20 coo 27.64 56.61 58.17 22.18 57.92 60.36 2.76 10.16 11.03 0.96 5.43 12.32 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 C 189 PHE B 431 PHE^? 23.47 C2 EDO B 603 C 298 ASP B 350 ASP.? 23.89 C2 EDO B 603 C 329 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo 17.41 60.57 64.39 18.40 58.12 65.34 13.65 32.28 24.99 12.40 33.20 22.64 coo 24.10 66.43 63.33 24.18 64.30 63.40 12.16 40.72 19.41 11.14 39.74 20.98 coo 27.64 56.61 58.17 22.18 57.92 60.36 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 C 189 PHE C 416 PHE^? 11.78 C2 EDO C 602 C 298 ASP D 448 ASP.? 19.66 C2 EDO C 602 C 329 LYS D 442 LYS~? 12.65 O2 GOL D 601 coo 17.41 60.57 64.39 18.40 58.12 65.34 10.28 12.37 -34.72 8.44 12.42 -32.58 coo 24.10 66.43 63.33 24.18 64.30 63.40 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 27.64 56.61 58.17 22.18 57.92 60.36 14.14 0.83 -27.84 11.41 -3.18 -25.91 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 C 189 PHE C 431 PHE^? 22.21 O1 GOL D 601 C 298 ASP C 350 ASP.? 24.48 C2 EDO C 602 C 329 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 17.41 60.57 64.39 18.40 58.12 65.34 28.24 21.80 -13.63 26.64 22.64 -15.77 coo 24.10 66.43 63.33 24.18 64.30 63.40 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 27.64 56.61 58.17 22.18 57.92 60.36 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 C 189 PHE D 431 PHE^? 21.51 O1 EDO C 602 C 298 ASP D 350 ASP.? 24.09 C3 GOL D 601 C 329 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo 17.41 60.57 64.39 18.40 58.12 65.34 39.18 5.51 -45.56 38.23 3.44 -43.92 coo 24.10 66.43 63.33 24.18 64.30 63.40 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 27.64 56.61 58.17 22.18 57.92 60.36 32.90 -6.30 -46.84 30.42 -11.34 -47.14 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 C 189 PHE D 445 PHE~? 11.88 O1 GOL D 601 C 298 ASP D 448 ASP.? 19.66 C2 EDO C 602 C 329 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 17.41 60.57 64.39 18.40 58.12 65.34 10.86 1.23 -30.60 12.85 0.20 -32.29 coo 24.10 66.43 63.33 24.18 64.30 63.40 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 27.64 56.61 58.17 22.18 57.92 60.36 12.96 9.36 -37.91 9.04 10.02 -41.38 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 9 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 431 PHE^? 22.59 O1 EDO B 603 D 298 ASP A 350 ASP.? 26.92 O2 GOL D 601 D 329 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo 35.44 53.35 83.81 35.65 54.53 81.28 29.40 15.33 -4.65 28.40 13.37 -2.94 coo 29.72 46.46 83.60 30.79 47.36 81.99 33.51 7.96 1.59 32.78 7.85 -0.37 coo 36.89 44.91 74.55 37.33 48.94 79.01 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE A 445 PHE~? 17.72 O1 EDO B 603 D 298 ASP A 448 ASP~? 19.70 O1 EDO B 603 D 329 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 35.44 53.35 83.81 35.65 54.53 81.28 -0.28 10.05 7.85 1.97 9.05 6.47 coo 29.72 46.46 83.60 30.79 47.36 81.99 -6.12 13.55 5.97 -7.03 12.86 4.20 coo 36.89 44.91 74.55 37.33 48.94 79.01 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE A 445 PHE~? 17.72 O1 EDO B 603 D 298 ASP B 448 ASP.? 21.29 O1 EDO B 603 D 329 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 35.44 53.35 83.81 35.65 54.53 81.28 -0.28 10.05 7.85 1.97 9.05 6.47 coo 29.72 46.46 83.60 30.79 47.36 81.99 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo 36.89 44.91 74.55 37.33 48.94 79.01 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 D 189 PHE B 416 PHE^? 11.67 C2 EDO B 603 D 298 ASP A 448 ASP~? 19.70 O1 EDO B 603 D 329 LYS A 442 LYS~? 23.27 C1 EDO B 603 coo 35.44 53.35 83.81 35.65 54.53 81.28 -1.62 21.04 3.18 -3.66 21.32 5.09 coo 29.72 46.46 83.60 30.79 47.36 81.99 -6.12 13.55 5.97 -7.03 12.86 4.20 coo 36.89 44.91 74.55 37.33 48.94 79.01 2.76 10.16 11.03 0.96 5.43 12.32 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 D 189 PHE B 431 PHE^? 23.47 C2 EDO B 603 D 298 ASP B 350 ASP.? 23.89 C2 EDO B 603 D 329 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo 35.44 53.35 83.81 35.65 54.53 81.28 13.65 32.28 24.99 12.40 33.20 22.64 coo 29.72 46.46 83.60 30.79 47.36 81.99 12.16 40.72 19.41 11.14 39.74 20.98 coo 36.89 44.91 74.55 37.33 48.94 79.01 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 D 189 PHE C 416 PHE^? 11.78 C2 EDO C 602 D 298 ASP D 448 ASP.? 19.66 C2 EDO C 602 D 329 LYS D 442 LYS~? 12.65 O2 GOL D 601 coo 35.44 53.35 83.81 35.65 54.53 81.28 10.28 12.37 -34.72 8.44 12.42 -32.58 coo 29.72 46.46 83.60 30.79 47.36 81.99 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 36.89 44.91 74.55 37.33 48.94 79.01 14.14 0.83 -27.84 11.41 -3.18 -25.91 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 D 189 PHE C 431 PHE^? 22.21 O1 GOL D 601 D 298 ASP C 350 ASP.? 24.48 C2 EDO C 602 D 329 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 35.44 53.35 83.81 35.65 54.53 81.28 28.24 21.80 -13.63 26.64 22.64 -15.77 coo 29.72 46.46 83.60 30.79 47.36 81.99 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 36.89 44.91 74.55 37.33 48.94 79.01 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 D 189 PHE D 431 PHE^? 21.51 O1 EDO C 602 D 298 ASP D 350 ASP.? 24.09 C3 GOL D 601 D 329 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo 35.44 53.35 83.81 35.65 54.53 81.28 39.18 5.51 -45.56 38.23 3.44 -43.92 coo 29.72 46.46 83.60 30.79 47.36 81.99 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 36.89 44.91 74.55 37.33 48.94 79.01 32.90 -6.30 -46.84 30.42 -11.34 -47.14 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 D 189 PHE D 445 PHE~? 11.88 O1 GOL D 601 D 298 ASP D 448 ASP.? 19.66 C2 EDO C 602 D 329 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 35.44 53.35 83.81 35.65 54.53 81.28 10.86 1.23 -30.60 12.85 0.20 -32.29 coo 29.72 46.46 83.60 30.79 47.36 81.99 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 36.89 44.91 74.55 37.33 48.94 79.01 12.96 9.36 -37.91 9.04 10.02 -41.38 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 9 hits 1gtx_c03 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 387 ASP~? 25.21 O2 GOL D 601 A 327 GLU D 394 GLU~? 26.98 C3 GOL D 601 A 339 ARG D 397 ARG~? 26.17 C3 GOL D 601 coo 85.81 57.99 116.01 86.03 55.86 115.89 25.11 -3.56 -1.18 26.67 -4.92 -0.75 coo 75.11 41.01 160.30 76.65 40.06 161.41 35.24 -3.52 -50.42 34.05 -5.26 -50.80 coo 82.23 40.35 159.87 85.09 40.67 161.01 40.54 0.77 -47.66 42.41 1.45 -45.29 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP A 430 ASP.? 25.41 O1 EDO B 603 A 327 GLU D 394 GLU~? 26.98 C3 GOL D 601 A 339 ARG D 397 ARG~? 26.17 C3 GOL D 601 coo 85.81 57.99 116.01 86.03 55.86 115.89 31.59 21.51 -7.17 32.38 22.31 -9.00 coo 75.11 41.01 160.30 76.65 40.06 161.41 35.24 -3.52 -50.42 34.05 -5.26 -50.80 coo 82.23 40.35 159.87 85.09 40.67 161.01 40.54 0.77 -47.66 42.41 1.45 -45.29 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP B 357 ASP.? 13.04 C1 EDO B 603 A 327 GLU D 411 GLU.? 16.70 O3 GOL D 601 A 339 ARG D 412 ARG.? 9.98 O3 GOL D 601 coo 85.81 57.99 116.01 86.03 55.86 115.89 19.95 30.44 0.55 20.02 30.85 -1.53 coo 75.11 41.01 160.30 76.65 40.06 161.41 14.38 -10.66 -25.01 13.15 -12.19 -25.81 coo 82.23 40.35 159.87 85.09 40.67 161.01 23.08 -11.80 -22.54 24.95 -9.89 -24.12 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP B 357 ASP.? 13.04 C1 EDO B 603 A 327 GLU D 436 GLU^? 11.06 C3 GOL D 601 A 339 ARG D 368 ARG.? 11.23 O3 GOL D 601 coo 85.81 57.99 116.01 86.03 55.86 115.89 19.95 30.44 0.55 20.02 30.85 -1.53 coo 75.11 41.01 160.30 76.65 40.06 161.41 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 82.23 40.35 159.87 85.09 40.67 161.01 34.63 -3.42 -28.94 33.31 -3.73 -31.69 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 5 3 # 5 A 50 ASP B 440 ASP^? 5.62 O1 EDO B 603 A 327 GLU D 436 GLU^? 11.06 C3 GOL D 601 A 339 ARG D 368 ARG.? 11.23 O3 GOL D 601 coo 85.81 57.99 116.01 86.03 55.86 115.89 5.66 21.79 0.79 4.10 21.14 -0.54 coo 75.11 41.01 160.30 76.65 40.06 161.41 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 82.23 40.35 159.87 85.09 40.67 161.01 34.63 -3.42 -28.94 33.31 -3.73 -31.69 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 6 3 # 6 A 50 ASP C 430 ASP.? 26.01 O2 GOL D 601 A 327 GLU B 394 GLU~? 28.21 C2 EDO B 603 A 339 ARG B 397 ARG~? 26.01 C2 EDO B 603 coo 85.81 57.99 116.01 86.03 55.86 115.89 33.23 18.77 -9.92 33.78 18.54 -7.88 coo 75.11 41.01 160.30 76.65 40.06 161.41 4.47 36.77 26.38 2.63 37.63 26.96 coo 82.23 40.35 159.87 85.09 40.67 161.01 10.79 36.41 26.32 12.94 37.68 24.51 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 7 3 # 7 A 50 ASP D 357 ASP.? 12.64 O3 GOL D 601 A 327 GLU A 330 GLU~? 26.93 C1 EDO B 603 A 339 ARG A 316 ARG.? 27.22 C1 EDO B 603 coo 85.81 57.99 116.01 86.03 55.86 115.89 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 75.11 41.01 160.30 76.65 40.06 161.41 25.78 29.04 20.96 25.48 30.78 22.26 coo 82.23 40.35 159.87 85.09 40.67 161.01 32.66 26.75 19.60 30.80 24.65 18.26 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 8 3 # 8 A 50 ASP D 357 ASP.? 12.64 O3 GOL D 601 A 327 GLU B 411 GLU.? 15.09 O2 EDO B 603 A 339 ARG B 412 ARG.? 9.95 O2 EDO B 603 coo 85.81 57.99 116.01 86.03 55.86 115.89 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 75.11 41.01 160.30 76.65 40.06 161.41 -5.72 28.81 -2.48 -6.82 27.11 -1.89 coo 82.23 40.35 159.87 85.09 40.67 161.01 0.52 33.64 -5.37 3.42 33.47 -4.37 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 9 3 # 9 A 50 ASP D 357 ASP.? 12.64 O3 GOL D 601 A 327 GLU B 436 GLU^? 10.42 C2 EDO B 603 A 339 ARG B 368 ARG.? 11.04 O2 EDO B 603 coo 85.81 57.99 116.01 86.03 55.86 115.89 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 75.11 41.01 160.30 76.65 40.06 161.41 8.55 30.19 11.17 7.66 31.90 10.29 coo 82.23 40.35 159.87 85.09 40.67 161.01 11.09 36.07 6.20 8.36 35.36 7.43 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 10 3 # 10 A 50 ASP D 440 ASP^? -5.34 O2 GOL D 601s A 327 GLU B 436 GLU^? 10.42 C2 EDO B 603 A 339 ARG B 368 ARG.? 11.04 O2 EDO B 603 coo 85.81 57.99 116.01 86.03 55.86 115.89 19.76 1.27 -26.39 17.89 0.46 -25.75 coo 75.11 41.01 160.30 76.65 40.06 161.41 8.55 30.19 11.17 7.66 31.90 10.29 coo 82.23 40.35 159.87 85.09 40.67 161.01 11.09 36.07 6.20 8.36 35.36 7.43 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 11 3 # 11 A 50 ASP D 448 ASP.? 19.66 C2 EDO C 602 A 327 GLU A 342 GLU^? 20.93 C1 EDO B 603 A 339 ARG A 368 ARG.? 24.16 C1 EDO B 603 coo 85.81 57.99 116.01 86.03 55.86 115.89 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 75.11 41.01 160.30 76.65 40.06 161.41 16.70 11.35 13.94 16.42 9.25 14.14 coo 82.23 40.35 159.87 85.09 40.67 161.01 23.91 7.22 12.24 22.49 6.03 9.76 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 12 3 # 12 A 50 ASP D 448 ASP.? 19.66 C2 EDO C 602 A 327 GLU B 436 GLU^? 10.42 C2 EDO B 603 A 339 ARG B 368 ARG.? 11.04 O2 EDO B 603 coo 85.81 57.99 116.01 86.03 55.86 115.89 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 75.11 41.01 160.30 76.65 40.06 161.41 8.55 30.19 11.17 7.66 31.90 10.29 coo 82.23 40.35 159.87 85.09 40.67 161.01 11.09 36.07 6.20 8.36 35.36 7.43 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 12 hits 1hto_c00 naa= 3 ULMN 3 1i29_c01 CSDB user 1 3 # 1 A 123 HIS A 338 HIS~? 19.64 C1 EDO B 603 A 200 ASP B 426 ASP.? 28.68 C1 EDO B 603 A 226 LYS B 348 LYS.? 28.30 C2 EDO B 603 coo 23.24 46.58 4.39 24.43 46.59 2.66 16.13 23.68 19.02 16.84 23.99 20.97 coo 24.51 43.28 11.18 25.17 44.50 9.58 21.11 26.70 26.04 20.61 27.63 27.90 coo 34.47 51.09 7.19 28.58 51.18 7.53 16.25 36.62 22.07 20.01 34.44 26.08 ULMN 3 1i29_c01 CSDB user 2 3 # 2 A 123 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 200 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 226 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo 23.24 46.58 4.39 24.43 46.59 2.66 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 24.51 43.28 11.18 25.17 44.50 9.58 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 34.47 51.09 7.19 28.58 51.18 7.53 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 1i29_c01 CSDB user 3 3 # 3 A 123 HIS C 338 HIS~? 12.91 O1 EDO C 602 A 200 ASP D 426 ASP.? 21.84 O1 EDO C 602 A 226 LYS D 348 LYS.? 27.59 O1 EDO C 602 coo 23.24 46.58 4.39 24.43 46.59 2.66 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 24.51 43.28 11.18 25.17 44.50 9.58 40.54 14.64 -43.98 41.47 13.99 -45.77 coo 34.47 51.09 7.19 28.58 51.18 7.53 43.15 3.71 -41.93 47.18 7.62 -43.42 ULMN 3 1i29_c01 CSDB user 4 3 # 4 A 123 HIS D 338 HIS~? 13.70 C1 GOL D 601 A 200 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 226 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo 23.24 46.58 4.39 24.43 46.59 2.66 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 24.51 43.28 11.18 25.17 44.50 9.58 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 34.47 51.09 7.19 28.58 51.18 7.53 31.02 25.73 -16.52 36.61 24.80 -13.64 1i29_c01 source 1i29 CSDB : 4 hits 1i29_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 373 VAL~? 29.36 C1 EDO B 603 A 200 ASP A 350 ASP.? 26.92 O2 GOL D 601 A 226 LYS A 388 LYS~? 27.25 O2 GOL D 601 coo 19.13 38.05 1.41 19.72 38.80 -0.53 32.23 9.76 13.66 31.62 11.66 14.58 coo 24.51 43.28 11.18 25.17 44.50 9.58 33.51 7.96 1.59 32.78 7.85 -0.37 coo 34.47 51.09 7.19 28.58 51.18 7.53 22.21 -0.11 -1.07 17.85 -4.01 1.39 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 373 VAL~? 29.36 C1 EDO B 603 A 200 ASP A 350 ASP.? 26.92 O2 GOL D 601 A 226 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo 19.13 38.05 1.41 19.72 38.80 -0.53 32.23 9.76 13.66 31.62 11.66 14.58 coo 24.51 43.28 11.18 25.17 44.50 9.58 33.51 7.96 1.59 32.78 7.85 -0.37 coo 34.47 51.09 7.19 28.58 51.18 7.53 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL A 404 VAL^? 17.61 O1 EDO B 603 A 200 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 226 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 19.13 38.05 1.41 19.72 38.80 -0.53 16.49 9.66 -3.07 17.67 7.94 -3.69 coo 24.51 43.28 11.18 25.17 44.50 9.58 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 34.47 51.09 7.19 28.58 51.18 7.53 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL A 424 VAL^? 17.06 O1 EDO B 603 A 200 ASP A 350 ASP.? 26.92 O2 GOL D 601 A 226 LYS A 388 LYS~? 27.25 O2 GOL D 601 coo 19.13 38.05 1.41 19.72 38.80 -0.53 24.97 18.63 -1.16 25.35 19.02 0.96 coo 24.51 43.28 11.18 25.17 44.50 9.58 33.51 7.96 1.59 32.78 7.85 -0.37 coo 34.47 51.09 7.19 28.58 51.18 7.53 22.21 -0.11 -1.07 17.85 -4.01 1.39 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL A 434 VAL^? 19.93 O1 EDO B 603 A 200 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 226 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 19.13 38.05 1.41 19.72 38.80 -0.53 25.58 13.52 1.08 24.99 11.62 0.22 coo 24.51 43.28 11.18 25.17 44.50 9.58 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 34.47 51.09 7.19 28.58 51.18 7.53 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL A 434 VAL^? 19.93 O1 EDO B 603 A 200 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 226 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo 19.13 38.05 1.41 19.72 38.80 -0.53 25.58 13.52 1.08 24.99 11.62 0.22 coo 24.51 43.28 11.18 25.17 44.50 9.58 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 34.47 51.09 7.19 28.58 51.18 7.53 31.02 25.73 -16.52 36.61 24.80 -13.64 ULMN 3 1i29_c03 CSDB user 7 3 # 7 A 128 VAL B 359 VAL.? 5.09 O2 EDO B 603 A 200 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 226 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 19.13 38.05 1.41 19.72 38.80 -0.53 13.54 27.41 -1.56 11.54 27.07 -0.75 coo 24.51 43.28 11.18 25.17 44.50 9.58 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 34.47 51.09 7.19 28.58 51.18 7.53 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1i29_c03 CSDB user 8 3 # 8 A 128 VAL B 373 VAL~? 18.76 O2 EDO B 603 A 200 ASP B 350 ASP.? 23.89 C2 EDO B 603 A 226 LYS B 388 LYS~? 19.48 C2 EDO B 603 coo 19.13 38.05 1.41 19.72 38.80 -0.53 17.47 41.24 8.39 18.88 39.68 7.76 coo 24.51 43.28 11.18 25.17 44.50 9.58 12.16 40.72 19.41 11.14 39.74 20.98 coo 34.47 51.09 7.19 28.58 51.18 7.53 -0.92 37.13 17.34 -4.46 33.66 14.61 ULMN 3 1i29_c03 CSDB user 9 3 # 9 A 128 VAL B 373 VAL~? 18.76 O2 EDO B 603 A 200 ASP B 350 ASP.? 23.89 C2 EDO B 603 A 226 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo 19.13 38.05 1.41 19.72 38.80 -0.53 17.47 41.24 8.39 18.88 39.68 7.76 coo 24.51 43.28 11.18 25.17 44.50 9.58 12.16 40.72 19.41 11.14 39.74 20.98 coo 34.47 51.09 7.19 28.58 51.18 7.53 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 1i29_c03 CSDB user 10 3 # 10 A 128 VAL B 424 VAL^? 19.75 C1 EDO B 603 A 200 ASP B 350 ASP.? 23.89 C2 EDO B 603 A 226 LYS B 388 LYS~? 19.48 C2 EDO B 603 coo 19.13 38.05 1.41 19.72 38.80 -0.53 15.29 27.52 20.89 16.63 28.05 19.20 coo 24.51 43.28 11.18 25.17 44.50 9.58 12.16 40.72 19.41 11.14 39.74 20.98 coo 34.47 51.09 7.19 28.58 51.18 7.53 -0.92 37.13 17.34 -4.46 33.66 14.61 ULMN 3 1i29_c03 CSDB user 11 3 # 11 A 128 VAL C 373 VAL~? 18.82 O2 EDO C 602 A 200 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 226 LYS C 388 LYS~? 20.15 C2 EDO C 602 coo 19.13 38.05 1.41 19.72 38.80 -0.53 31.44 31.04 -29.85 32.72 29.43 -30.65 coo 24.51 43.28 11.18 25.17 44.50 9.58 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 34.47 51.09 7.19 28.58 51.18 7.53 13.46 28.58 -20.25 9.42 25.73 -22.18 ULMN 3 1i29_c03 CSDB user 12 3 # 12 A 128 VAL C 373 VAL~? 18.82 O2 EDO C 602 A 200 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 226 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 19.13 38.05 1.41 19.72 38.80 -0.53 31.44 31.04 -29.85 32.72 29.43 -30.65 coo 24.51 43.28 11.18 25.17 44.50 9.58 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 34.47 51.09 7.19 28.58 51.18 7.53 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1i29_c03 CSDB user 13 3 # 13 A 128 VAL C 404 VAL^? 16.48 O1 GOL D 601 A 200 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 226 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo 19.13 38.05 1.41 19.72 38.80 -0.53 16.52 16.94 -19.97 15.92 18.97 -19.27 coo 24.51 43.28 11.18 25.17 44.50 9.58 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 34.47 51.09 7.19 28.58 51.18 7.53 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 1i29_c03 CSDB user 14 3 # 14 A 128 VAL C 424 VAL^? 16.76 O1 GOL D 601 A 200 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 226 LYS C 388 LYS~? 20.15 C2 EDO C 602 coo 19.13 38.05 1.41 19.72 38.80 -0.53 28.86 16.99 -18.02 30.08 17.32 -19.82 coo 24.51 43.28 11.18 25.17 44.50 9.58 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 34.47 51.09 7.19 28.58 51.18 7.53 13.46 28.58 -20.25 9.42 25.73 -22.18 ULMN 3 1i29_c03 CSDB user 15 3 # 15 A 128 VAL C 434 VAL^? 17.86 C2 EDO C 602 A 200 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 226 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 19.13 38.05 1.41 19.72 38.80 -0.53 26.19 21.35 -20.48 24.16 22.12 -20.14 coo 24.51 43.28 11.18 25.17 44.50 9.58 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 34.47 51.09 7.19 28.58 51.18 7.53 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1i29_c03 CSDB user 16 3 # 16 A 128 VAL C 434 VAL^? 17.86 C2 EDO C 602 A 200 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 226 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo 19.13 38.05 1.41 19.72 38.80 -0.53 26.19 21.35 -20.48 24.16 22.12 -20.14 coo 24.51 43.28 11.18 25.17 44.50 9.58 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 34.47 51.09 7.19 28.58 51.18 7.53 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 1i29_c03 CSDB user 17 3 # 17 A 128 VAL D 373 VAL~? 18.76 O3 GOL D 601 A 200 ASP D 350 ASP.? 24.09 C3 GOL D 601 A 226 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo 19.13 38.05 1.41 19.72 38.80 -0.53 43.50 -1.92 -28.24 42.94 -0.16 -27.07 coo 24.51 43.28 11.18 25.17 44.50 9.58 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 34.47 51.09 7.19 28.58 51.18 7.53 31.25 -9.34 -42.79 29.68 -12.48 -44.35 ULMN 3 1i29_c03 CSDB user 18 3 # 18 A 128 VAL D 373 VAL~? 18.76 O3 GOL D 601 A 200 ASP D 350 ASP.? 24.09 C3 GOL D 601 A 226 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo 19.13 38.05 1.41 19.72 38.80 -0.53 43.50 -1.92 -28.24 42.94 -0.16 -27.07 coo 24.51 43.28 11.18 25.17 44.50 9.58 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 34.47 51.09 7.19 28.58 51.18 7.53 32.90 -6.30 -46.84 30.42 -11.34 -47.14 1i29_c03 source 1i29 CSDB : 18 hits 1i29_c03 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS B 390 LYS~? 27.12 C2 EDO B 603 A 74 LYS B 388 LYS~? 19.48 C2 EDO B 603 A 165 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 3.52 38.72 20.17 3.15 45.06 20.21 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS B 391 LYS~? 27.06 C2 EDO B 603 A 74 LYS B 388 LYS~? 19.48 C2 EDO B 603 A 165 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 1.34 36.06 21.83 0.02 35.49 25.91 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 A 14 LYS B 415 LYS^? -2.82 O2 EDO B 603s A 74 LYS B 442 LYS~? 13.00 O1 EDO B 603 A 165 GLU A 450 GLU~? 18.15 C2 EDO B 603 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 1.57 23.62 -1.31 7.49 26.02 -1.78 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 1.48 17.85 0.41 -2.11 18.47 -3.79 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -8.36 20.71 9.57 -7.00 20.85 11.17 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 A 14 LYS B 442 LYS~? 13.00 O1 EDO B 603 A 74 LYS B 415 LYS^? -2.82 O2 EDO B 603s A 165 GLU A 450 GLU~? 18.15 C2 EDO B 603 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 1.48 17.85 0.41 -2.11 18.47 -3.79 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 1.57 23.62 -1.31 7.49 26.02 -1.78 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -8.36 20.71 9.57 -7.00 20.85 11.17 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 A 14 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 74 LYS C 390 LYS~? 21.48 O2 EDO B 603 A 165 GLU B 363 GLU~? 7.89 O1 EDO B 603 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 8.83 27.73 -6.37 10.21 26.17 -6.89 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 A 14 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 74 LYS C 390 LYS~? 21.48 O2 EDO B 603 A 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 A 14 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 74 LYS C 391 LYS~? 16.77 O1 EDO B 603 A 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 A 14 LYS C 390 LYS~? 21.48 O2 EDO B 603 A 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 165 GLU B 363 GLU~? 7.89 O1 EDO B 603 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 8.83 27.73 -6.37 10.21 26.17 -6.89 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 A 14 LYS C 390 LYS~? 21.48 O2 EDO B 603 A 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 A 14 LYS C 391 LYS~? 16.77 O1 EDO B 603 A 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 21.74 20.63 -27.21 21.00 22.48 -27.90 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 10 hits 1idt_c00 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS B 391 LYS~? 27.06 C2 EDO B 603 B 74 LYS B 388 LYS~? 19.48 C2 EDO B 603 B 165 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 1.34 36.06 21.83 0.02 35.49 25.91 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -0.92 37.13 17.34 -4.46 33.66 14.61 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 B 14 LYS B 415 LYS^? -2.82 O2 EDO B 603s B 74 LYS B 442 LYS~? 13.00 O1 EDO B 603 B 165 GLU A 450 GLU~? 18.15 C2 EDO B 603 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 1.57 23.62 -1.31 7.49 26.02 -1.78 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 1.48 17.85 0.41 -2.11 18.47 -3.79 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -8.36 20.71 9.57 -7.00 20.85 11.17 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 B 14 LYS B 442 LYS~? 13.00 O1 EDO B 603 B 74 LYS B 415 LYS^? -2.82 O2 EDO B 603s B 165 GLU A 450 GLU~? 18.15 C2 EDO B 603 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 1.48 17.85 0.41 -2.11 18.47 -3.79 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 1.57 23.62 -1.31 7.49 26.02 -1.78 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -8.36 20.71 9.57 -7.00 20.85 11.17 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 B 14 LYS C 388 LYS~? 20.15 C2 EDO C 602 B 74 LYS C 390 LYS~? 21.48 O2 EDO B 603 B 165 GLU B 363 GLU~? 7.89 O1 EDO B 603 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 13.46 28.58 -20.25 9.42 25.73 -22.18 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 17.95 29.37 -17.21 18.11 35.53 -15.65 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 8.83 27.73 -6.37 10.21 26.17 -6.89 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 B 14 LYS C 390 LYS~? 21.48 O2 EDO B 603 B 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 B 165 GLU B 363 GLU~? 7.89 O1 EDO B 603 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 17.95 29.37 -17.21 18.11 35.53 -15.65 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 13.46 28.58 -20.25 9.42 25.73 -22.18 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 8.83 27.73 -6.37 10.21 26.17 -6.89 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 B 14 LYS C 390 LYS~? 21.48 O2 EDO B 603 B 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 B 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 17.95 29.37 -17.21 18.11 35.53 -15.65 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 13.46 28.58 -20.25 9.42 25.73 -22.18 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 B 14 LYS C 391 LYS~? 16.77 O1 EDO B 603 B 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 B 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 15.56 26.67 -15.99 9.90 23.87 -16.19 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 13.46 28.58 -20.25 9.42 25.73 -22.18 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 21.74 20.63 -27.21 21.00 22.48 -27.90 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 7 hits 1idt_c01 naa= 3 ULMN 3 1iph_c00 CATALASE HPII user 1 3 # 1 A 128 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 167 SER B 358 SER.? 7.25 C1 EDO B 603 A 201 ASN B 333 ASN~? 17.11 C1 EDO B 603 coo 12.95 4.49 19.05 14.87 4.39 19.77 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 10.44 7.96 22.51 12.16 7.57 20.82 16.90 26.63 0.02 16.29 24.39 0.69 coo 19.43 6.74 22.83 19.09 5.15 21.60 26.50 27.72 5.31 25.42 29.17 4.18 ULMN 3 1iph_c00 CATALASE HPII user 2 3 # 2 A 128 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 167 SER B 358 SER.? 7.25 C1 EDO B 603 A 201 ASN C 398 ASN~? 15.53 O1 EDO B 603 coo 12.95 4.49 19.05 14.87 4.39 19.77 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 10.44 7.96 22.51 12.16 7.57 20.82 16.90 26.63 0.02 16.29 24.39 0.69 coo 19.43 6.74 22.83 19.09 5.15 21.60 21.01 22.53 -8.94 21.24 24.62 -8.84 1iph_c00 source 1iph CATALASE HPII : 2 hits 1iph_c00 naa= 3 ULMN 3 1iph_c01 CATALASE HPII user 1 3 # 1 B 128 HIS B 338 HIS.? 13.66 O1 EDO B 603 B 167 SER B 358 SER.? 7.25 C1 EDO B 603 B 201 ASN B 333 ASN~? 17.11 C1 EDO B 603 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 16.90 26.63 0.02 16.29 24.39 0.69 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 26.50 27.72 5.31 25.42 29.17 4.18 ULMN 3 1iph_c01 CATALASE HPII user 2 3 # 2 B 128 HIS B 338 HIS.? 13.66 O1 EDO B 603 B 167 SER B 358 SER.? 7.25 C1 EDO B 603 B 201 ASN C 398 ASN~? 15.53 O1 EDO B 603 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 16.90 26.63 0.02 16.29 24.39 0.69 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 21.01 22.53 -8.94 21.24 24.62 -8.84 1iph_c01 source 1iph CATALASE HPII : 2 hits 1iph_c01 naa= 3 ULMN 3 1iph_c02 CATALASE HPII user 1 3 # 1 C 128 HIS B 338 HIS.? 13.66 O1 EDO B 603 C 167 SER B 358 SER.? 7.25 C1 EDO B 603 C 201 ASN B 333 ASN~? 17.11 C1 EDO B 603 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 16.90 26.63 0.02 16.29 24.39 0.69 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 26.50 27.72 5.31 25.42 29.17 4.18 ULMN 3 1iph_c02 CATALASE HPII user 2 3 # 2 C 128 HIS B 338 HIS.? 13.66 O1 EDO B 603 C 167 SER B 358 SER.? 7.25 C1 EDO B 603 C 201 ASN C 398 ASN~? 15.53 O1 EDO B 603 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 16.90 26.63 0.02 16.29 24.39 0.69 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 21.01 22.53 -8.94 21.24 24.62 -8.84 1iph_c02 source 1iph CATALASE HPII : 2 hits 1iph_c02 naa= 3 ULMN 3 1iph_c03 CATALASE HPII user 1 3 # 1 D 128 HIS B 338 HIS.? 13.66 O1 EDO B 603 D 167 SER B 358 SER.? 7.25 C1 EDO B 603 D 201 ASN B 333 ASN~? 17.11 C1 EDO B 603 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 16.90 26.63 0.02 16.29 24.39 0.69 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 26.50 27.72 5.31 25.42 29.17 4.18 ULMN 3 1iph_c03 CATALASE HPII user 2 3 # 2 D 128 HIS B 338 HIS.? 13.66 O1 EDO B 603 D 167 SER B 358 SER.? 7.25 C1 EDO B 603 D 201 ASN C 398 ASN~? 15.53 O1 EDO B 603 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 16.90 26.63 0.02 16.29 24.39 0.69 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 21.01 22.53 -8.94 21.24 24.62 -8.84 1iph_c03 source 1iph CATALASE HPII : 2 hits 1iph_c03 naa= 3 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 1 3 # 1 B 55 ASP A 430 ASP.? 25.41 O1 EDO B 603 B 58 ASP A 426 ASP.? 22.31 O1 EDO B 603 B 424 GLU B 330 GLU~? 24.65 C1 EDO B 603 coo 112.10 61.46 19.99 111.82 60.65 18.07 31.59 21.51 -7.17 32.38 22.31 -9.00 coo 117.85 63.62 21.08 115.96 63.25 20.18 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 118.47 57.23 15.57 119.32 58.77 16.73 31.94 25.81 2.71 33.76 25.37 1.74 1js4_c01 source 1js4 ENDO-EXOCELLULASE E4 : 1 hits 1js4_c01 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 378 GLU~? 27.85 O2 GOL D 601 A 56 LYS A 390 LYS~? 25.88 O2 GOL D 601 A 258 ARG A 375 ARG.? 36.99 C1 EDO B 603 coo 42.33 1.56 26.99 42.38 2.91 28.66 32.59 2.13 2.36 33.95 1.57 0.86 coo 38.45 -0.44 19.89 37.36 0.90 25.90 26.64 2.81 -1.98 30.91 -1.55 -0.35 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 34.50 3.88 12.57 36.52 3.36 14.83 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU A 394 GLU~? 15.90 O2 GOL D 601 A 56 LYS A 390 LYS~? 25.88 O2 GOL D 601 A 258 ARG C 425 ARG^? 21.48 O1 GOL D 601 coo 42.33 1.56 26.99 42.38 2.91 28.66 27.33 5.77 -8.72 27.90 4.03 -9.75 coo 38.45 -0.44 19.89 37.36 0.90 25.90 26.64 2.81 -1.98 30.91 -1.55 -0.35 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 27.32 15.93 -12.34 26.51 18.69 -11.26 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 A 2 GLU C 378 GLU~? 24.96 O2 EDO B 603 A 56 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 258 ARG C 397 ARG~? 23.93 O1 EDO B 603 coo 42.33 1.56 26.99 42.38 2.91 28.66 22.14 33.77 -19.82 21.71 34.90 -18.09 coo 38.45 -0.44 19.89 37.36 0.90 25.90 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 25.49 26.02 -11.91 27.94 26.82 -13.64 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 A 2 GLU C 378 GLU~? 24.96 O2 EDO B 603 A 56 LYS C 390 LYS~? 21.48 O2 EDO B 603 A 258 ARG C 375 ARG.? 20.99 O2 EDO C 602 coo 42.33 1.56 26.99 42.38 2.91 28.66 22.14 33.77 -19.82 21.71 34.90 -18.09 coo 38.45 -0.44 19.89 37.36 0.90 25.90 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 27.90 36.71 -28.33 26.60 36.43 -31.10 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 A 2 GLU D 378 GLU~? 27.27 O3 GOL D 601 A 56 LYS D 390 LYS~? 25.65 O3 GOL D 601 A 258 ARG D 375 ARG.? 23.45 O3 GOL D 601 coo 42.33 1.56 26.99 42.38 2.91 28.66 43.18 -8.44 -40.40 44.74 -9.12 -41.62 coo 38.45 -0.44 19.89 37.36 0.90 25.90 35.81 -6.92 -44.49 39.58 -10.95 -43.36 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 45.57 -7.61 -30.32 45.87 -9.61 -28.01 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 A 2 GLU D 394 GLU~? 26.98 C3 GOL D 601 A 56 LYS D 390 LYS~? 25.65 O3 GOL D 601 A 258 ARG D 401 ARG.? 17.46 O1 EDO C 602 coo 42.33 1.56 26.99 42.38 2.91 28.66 35.24 -3.52 -50.42 34.05 -5.26 -50.80 coo 38.45 -0.44 19.89 37.36 0.90 25.90 35.81 -6.92 -44.49 39.58 -10.95 -43.36 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 26.50 1.94 -49.52 24.85 0.58 -47.31 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 6 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 378 GLU~? 27.85 O2 GOL D 601 B 56 LYS A 390 LYS~? 25.88 O2 GOL D 601 B 258 ARG A 375 ARG.? 36.99 C1 EDO B 603 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 32.59 2.13 2.36 33.95 1.57 0.86 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 26.64 2.81 -1.98 30.91 -1.55 -0.35 coo 2.64 1.83 34.81 1.56 1.13 32.02 34.50 3.88 12.57 36.52 3.36 14.83 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU A 394 GLU~? 15.90 O2 GOL D 601 B 56 LYS A 390 LYS~? 25.88 O2 GOL D 601 B 258 ARG C 425 ARG^? 21.48 O1 GOL D 601 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 27.33 5.77 -8.72 27.90 4.03 -9.75 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 26.64 2.81 -1.98 30.91 -1.55 -0.35 coo 2.64 1.83 34.81 1.56 1.13 32.02 27.32 15.93 -12.34 26.51 18.69 -11.26 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 B 2 GLU C 378 GLU~? 24.96 O2 EDO B 603 B 56 LYS C 388 LYS~? 20.15 C2 EDO C 602 B 258 ARG C 397 ARG~? 23.93 O1 EDO B 603 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 22.14 33.77 -19.82 21.71 34.90 -18.09 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 2.64 1.83 34.81 1.56 1.13 32.02 25.49 26.02 -11.91 27.94 26.82 -13.64 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 B 2 GLU C 378 GLU~? 24.96 O2 EDO B 603 B 56 LYS C 390 LYS~? 21.48 O2 EDO B 603 B 258 ARG C 375 ARG.? 20.99 O2 EDO C 602 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 22.14 33.77 -19.82 21.71 34.90 -18.09 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 2.64 1.83 34.81 1.56 1.13 32.02 27.90 36.71 -28.33 26.60 36.43 -31.10 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 B 2 GLU D 378 GLU~? 27.27 O3 GOL D 601 B 56 LYS D 390 LYS~? 25.65 O3 GOL D 601 B 258 ARG D 375 ARG.? 23.45 O3 GOL D 601 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 43.18 -8.44 -40.40 44.74 -9.12 -41.62 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 35.81 -6.92 -44.49 39.58 -10.95 -43.36 coo 2.64 1.83 34.81 1.56 1.13 32.02 45.57 -7.61 -30.32 45.87 -9.61 -28.01 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 B 2 GLU D 394 GLU~? 26.98 C3 GOL D 601 B 56 LYS D 388 LYS~? 23.05 O3 GOL D 601 B 258 ARG D 401 ARG.? 17.46 O1 EDO C 602 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 35.24 -3.52 -50.42 34.05 -5.26 -50.80 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 2.64 1.83 34.81 1.56 1.13 32.02 26.50 1.94 -49.52 24.85 0.58 -47.31 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 B 2 GLU D 394 GLU~? 26.98 C3 GOL D 601 B 56 LYS D 390 LYS~? 25.65 O3 GOL D 601 B 258 ARG D 401 ARG.? 17.46 O1 EDO C 602 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 35.24 -3.52 -50.42 34.05 -5.26 -50.80 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 35.81 -6.92 -44.49 39.58 -10.95 -43.36 coo 2.64 1.83 34.81 1.56 1.13 32.02 26.50 1.94 -49.52 24.85 0.58 -47.31 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 7 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 378 GLU~? 27.85 O2 GOL D 601 C 56 LYS A 390 LYS~? 25.88 O2 GOL D 601 C 258 ARG A 375 ARG.? 36.99 C1 EDO B 603 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 32.59 2.13 2.36 33.95 1.57 0.86 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 26.64 2.81 -1.98 30.91 -1.55 -0.35 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 34.50 3.88 12.57 36.52 3.36 14.83 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU A 394 GLU~? 15.90 O2 GOL D 601 C 56 LYS A 390 LYS~? 25.88 O2 GOL D 601 C 258 ARG C 425 ARG^? 21.48 O1 GOL D 601 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 27.33 5.77 -8.72 27.90 4.03 -9.75 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 26.64 2.81 -1.98 30.91 -1.55 -0.35 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 27.32 15.93 -12.34 26.51 18.69 -11.26 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 C 2 GLU C 378 GLU~? 24.96 O2 EDO B 603 C 56 LYS C 388 LYS~? 20.15 C2 EDO C 602 C 258 ARG C 397 ARG~? 23.93 O1 EDO B 603 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 22.14 33.77 -19.82 21.71 34.90 -18.09 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 25.49 26.02 -11.91 27.94 26.82 -13.64 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 C 2 GLU C 378 GLU~? 24.96 O2 EDO B 603 C 56 LYS C 390 LYS~? 21.48 O2 EDO B 603 C 258 ARG C 375 ARG.? 20.99 O2 EDO C 602 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 22.14 33.77 -19.82 21.71 34.90 -18.09 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 27.90 36.71 -28.33 26.60 36.43 -31.10 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 C 2 GLU C 394 GLU~? 16.86 O1 EDO B 603 C 56 LYS C 388 LYS~? 20.15 C2 EDO C 602 C 258 ARG C 401 ARG.? 15.33 O1 EDO B 603 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 19.77 27.90 -12.93 18.57 29.44 -12.10 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 15.13 16.06 -14.86 13.60 17.63 -12.63 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 C 2 GLU D 378 GLU~? 27.27 O3 GOL D 601 C 56 LYS D 390 LYS~? 25.65 O3 GOL D 601 C 258 ARG D 375 ARG.? 23.45 O3 GOL D 601 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 43.18 -8.44 -40.40 44.74 -9.12 -41.62 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 35.81 -6.92 -44.49 39.58 -10.95 -43.36 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 45.57 -7.61 -30.32 45.87 -9.61 -28.01 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 C 2 GLU D 394 GLU~? 26.98 C3 GOL D 601 C 56 LYS D 388 LYS~? 23.05 O3 GOL D 601 C 258 ARG D 401 ARG.? 17.46 O1 EDO C 602 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 35.24 -3.52 -50.42 34.05 -5.26 -50.80 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 26.50 1.94 -49.52 24.85 0.58 -47.31 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 C 2 GLU D 394 GLU~? 26.98 C3 GOL D 601 C 56 LYS D 390 LYS~? 25.65 O3 GOL D 601 C 258 ARG D 401 ARG.? 17.46 O1 EDO C 602 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 35.24 -3.52 -50.42 34.05 -5.26 -50.80 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 35.81 -6.92 -44.49 39.58 -10.95 -43.36 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 26.50 1.94 -49.52 24.85 0.58 -47.31 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 8 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 378 GLU~? 27.85 O2 GOL D 601 D 56 LYS A 390 LYS~? 25.88 O2 GOL D 601 D 258 ARG A 375 ARG.? 36.99 C1 EDO B 603 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 32.59 2.13 2.36 33.95 1.57 0.86 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 26.64 2.81 -1.98 30.91 -1.55 -0.35 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 34.50 3.88 12.57 36.52 3.36 14.83 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU A 394 GLU~? 15.90 O2 GOL D 601 D 56 LYS A 390 LYS~? 25.88 O2 GOL D 601 D 258 ARG C 425 ARG^? 21.48 O1 GOL D 601 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 27.33 5.77 -8.72 27.90 4.03 -9.75 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 26.64 2.81 -1.98 30.91 -1.55 -0.35 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 27.32 15.93 -12.34 26.51 18.69 -11.26 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 D 2 GLU C 378 GLU~? 24.96 O2 EDO B 603 D 56 LYS C 388 LYS~? 20.15 C2 EDO C 602 D 258 ARG C 397 ARG~? 23.93 O1 EDO B 603 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 22.14 33.77 -19.82 21.71 34.90 -18.09 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 25.49 26.02 -11.91 27.94 26.82 -13.64 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 D 2 GLU C 378 GLU~? 24.96 O2 EDO B 603 D 56 LYS C 390 LYS~? 21.48 O2 EDO B 603 D 258 ARG C 375 ARG.? 20.99 O2 EDO C 602 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 22.14 33.77 -19.82 21.71 34.90 -18.09 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 27.90 36.71 -28.33 26.60 36.43 -31.10 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 D 2 GLU C 394 GLU~? 16.86 O1 EDO B 603 D 56 LYS C 388 LYS~? 20.15 C2 EDO C 602 D 258 ARG C 401 ARG.? 15.33 O1 EDO B 603 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 19.77 27.90 -12.93 18.57 29.44 -12.10 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 15.13 16.06 -14.86 13.60 17.63 -12.63 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 D 2 GLU D 378 GLU~? 27.27 O3 GOL D 601 D 56 LYS D 390 LYS~? 25.65 O3 GOL D 601 D 258 ARG D 375 ARG.? 23.45 O3 GOL D 601 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 43.18 -8.44 -40.40 44.74 -9.12 -41.62 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 35.81 -6.92 -44.49 39.58 -10.95 -43.36 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 45.57 -7.61 -30.32 45.87 -9.61 -28.01 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 D 2 GLU D 394 GLU~? 26.98 C3 GOL D 601 D 56 LYS D 388 LYS~? 23.05 O3 GOL D 601 D 258 ARG D 401 ARG.? 17.46 O1 EDO C 602 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 35.24 -3.52 -50.42 34.05 -5.26 -50.80 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 26.50 1.94 -49.52 24.85 0.58 -47.31 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 D 2 GLU D 394 GLU~? 26.98 C3 GOL D 601 D 56 LYS D 390 LYS~? 25.65 O3 GOL D 601 D 258 ARG D 401 ARG.? 17.46 O1 EDO C 602 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 35.24 -3.52 -50.42 34.05 -5.26 -50.80 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 35.81 -6.92 -44.49 39.58 -10.95 -43.36 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 26.50 1.94 -49.52 24.85 0.58 -47.31 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 8 hits 1k82_c03 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS B 391 LYS~? 27.06 C2 EDO B 603 A 74 LYS B 388 LYS~? 19.48 C2 EDO B 603 A 165 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo 24.97 5.82 58.78 26.79 1.97 55.46 1.34 36.06 21.83 0.02 35.49 25.91 coo 19.46 3.44 61.93 23.95 1.12 60.13 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS B 415 LYS^? -2.82 O2 EDO B 603s A 74 LYS B 442 LYS~? 13.00 O1 EDO B 603 A 165 GLU A 450 GLU~? 18.15 C2 EDO B 603 coo 24.97 5.82 58.78 26.79 1.97 55.46 1.57 23.62 -1.31 7.49 26.02 -1.78 coo 19.46 3.44 61.93 23.95 1.12 60.13 1.48 17.85 0.41 -2.11 18.47 -3.79 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -8.36 20.71 9.57 -7.00 20.85 11.17 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS B 442 LYS~? 13.00 O1 EDO B 603 A 74 LYS B 415 LYS^? -2.82 O2 EDO B 603s A 165 GLU A 450 GLU~? 18.15 C2 EDO B 603 coo 24.97 5.82 58.78 26.79 1.97 55.46 1.48 17.85 0.41 -2.11 18.47 -3.79 coo 19.46 3.44 61.93 23.95 1.12 60.13 1.57 23.62 -1.31 7.49 26.02 -1.78 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -8.36 20.71 9.57 -7.00 20.85 11.17 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 74 LYS C 390 LYS~? 21.48 O2 EDO B 603 A 165 GLU B 363 GLU~? 7.89 O1 EDO B 603 coo 24.97 5.82 58.78 26.79 1.97 55.46 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 19.46 3.44 61.93 23.95 1.12 60.13 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 8.83 27.73 -6.37 10.21 26.17 -6.89 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS C 390 LYS~? 21.48 O2 EDO B 603 A 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 165 GLU B 363 GLU~? 7.89 O1 EDO B 603 coo 24.97 5.82 58.78 26.79 1.97 55.46 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 19.46 3.44 61.93 23.95 1.12 60.13 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 8.83 27.73 -6.37 10.21 26.17 -6.89 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS C 390 LYS~? 21.48 O2 EDO B 603 A 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 24.97 5.82 58.78 26.79 1.97 55.46 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 19.46 3.44 61.93 23.95 1.12 60.13 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS C 391 LYS~? 16.77 O1 EDO B 603 A 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 24.97 5.82 58.78 26.79 1.97 55.46 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 19.46 3.44 61.93 23.95 1.12 60.13 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 21.74 20.63 -27.21 21.00 22.48 -27.90 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 7 hits 1kqc_c00 naa= 3 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS B 391 LYS~? 27.06 C2 EDO B 603 B 74 LYS B 388 LYS~? 19.48 C2 EDO B 603 B 165 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo 4.84 5.09 23.75 3.30 1.39 27.48 1.34 36.06 21.83 0.02 35.49 25.91 coo 10.43 2.88 20.75 5.72 0.41 23.95 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS B 415 LYS^? -2.82 O2 EDO B 603s B 74 LYS B 442 LYS~? 13.00 O1 EDO B 603 B 165 GLU A 450 GLU~? 18.15 C2 EDO B 603 coo 4.84 5.09 23.75 3.30 1.39 27.48 1.57 23.62 -1.31 7.49 26.02 -1.78 coo 10.43 2.88 20.75 5.72 0.41 23.95 1.48 17.85 0.41 -2.11 18.47 -3.79 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -8.36 20.71 9.57 -7.00 20.85 11.17 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS B 442 LYS~? 13.00 O1 EDO B 603 B 74 LYS B 415 LYS^? -2.82 O2 EDO B 603s B 165 GLU A 450 GLU~? 18.15 C2 EDO B 603 coo 4.84 5.09 23.75 3.30 1.39 27.48 1.48 17.85 0.41 -2.11 18.47 -3.79 coo 10.43 2.88 20.75 5.72 0.41 23.95 1.57 23.62 -1.31 7.49 26.02 -1.78 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -8.36 20.71 9.57 -7.00 20.85 11.17 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS C 388 LYS~? 20.15 C2 EDO C 602 B 74 LYS C 390 LYS~? 21.48 O2 EDO B 603 B 165 GLU B 363 GLU~? 7.89 O1 EDO B 603 coo 4.84 5.09 23.75 3.30 1.39 27.48 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 10.43 2.88 20.75 5.72 0.41 23.95 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 8.83 27.73 -6.37 10.21 26.17 -6.89 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS C 388 LYS~? 20.15 C2 EDO C 602 B 74 LYS C 390 LYS~? 21.48 O2 EDO B 603 B 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 4.84 5.09 23.75 3.30 1.39 27.48 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 10.43 2.88 20.75 5.72 0.41 23.95 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS C 388 LYS~? 20.15 C2 EDO C 602 B 74 LYS C 391 LYS~? 16.77 O1 EDO B 603 B 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 4.84 5.09 23.75 3.30 1.39 27.48 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 10.43 2.88 20.75 5.72 0.41 23.95 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS C 390 LYS~? 21.48 O2 EDO B 603 B 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 B 165 GLU B 363 GLU~? 7.89 O1 EDO B 603 coo 4.84 5.09 23.75 3.30 1.39 27.48 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 10.43 2.88 20.75 5.72 0.41 23.95 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 8.83 27.73 -6.37 10.21 26.17 -6.89 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS C 390 LYS~? 21.48 O2 EDO B 603 B 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 B 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 4.84 5.09 23.75 3.30 1.39 27.48 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 10.43 2.88 20.75 5.72 0.41 23.95 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 B 14 LYS C 391 LYS~? 16.77 O1 EDO B 603 B 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 B 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 4.84 5.09 23.75 3.30 1.39 27.48 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 10.43 2.88 20.75 5.72 0.41 23.95 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 21.74 20.63 -27.21 21.00 22.48 -27.90 1kqc_c01 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 9 hits 1kqc_c01 naa= 3 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 C 14 LYS B 391 LYS~? 27.06 C2 EDO B 603 C 74 LYS B 388 LYS~? 19.48 C2 EDO B 603 C 165 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo 17.59 37.25 25.80 19.64 34.15 21.60 1.34 36.06 21.83 0.02 35.49 25.91 coo 12.29 34.52 28.11 16.84 32.47 25.43 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 12.06 27.10 15.56 13.23 27.02 13.80 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 C 14 LYS B 415 LYS^? -2.82 O2 EDO B 603s C 74 LYS B 442 LYS~? 13.00 O1 EDO B 603 C 165 GLU A 450 GLU~? 18.15 C2 EDO B 603 coo 17.59 37.25 25.80 19.64 34.15 21.60 1.57 23.62 -1.31 7.49 26.02 -1.78 coo 12.29 34.52 28.11 16.84 32.47 25.43 1.48 17.85 0.41 -2.11 18.47 -3.79 coo 12.06 27.10 15.56 13.23 27.02 13.80 -8.36 20.71 9.57 -7.00 20.85 11.17 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 C 14 LYS B 442 LYS~? 13.00 O1 EDO B 603 C 74 LYS B 415 LYS^? -2.82 O2 EDO B 603s C 165 GLU A 450 GLU~? 18.15 C2 EDO B 603 coo 17.59 37.25 25.80 19.64 34.15 21.60 1.48 17.85 0.41 -2.11 18.47 -3.79 coo 12.29 34.52 28.11 16.84 32.47 25.43 1.57 23.62 -1.31 7.49 26.02 -1.78 coo 12.06 27.10 15.56 13.23 27.02 13.80 -8.36 20.71 9.57 -7.00 20.85 11.17 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 C 14 LYS C 388 LYS~? 20.15 C2 EDO C 602 C 74 LYS C 390 LYS~? 21.48 O2 EDO B 603 C 165 GLU B 363 GLU~? 7.89 O1 EDO B 603 coo 17.59 37.25 25.80 19.64 34.15 21.60 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 12.29 34.52 28.11 16.84 32.47 25.43 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 12.06 27.10 15.56 13.23 27.02 13.80 8.83 27.73 -6.37 10.21 26.17 -6.89 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 C 14 LYS C 388 LYS~? 20.15 C2 EDO C 602 C 74 LYS C 390 LYS~? 21.48 O2 EDO B 603 C 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 17.59 37.25 25.80 19.64 34.15 21.60 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 12.29 34.52 28.11 16.84 32.47 25.43 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 12.06 27.10 15.56 13.23 27.02 13.80 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 C 14 LYS C 388 LYS~? 20.15 C2 EDO C 602 C 74 LYS C 391 LYS~? 16.77 O1 EDO B 603 C 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 17.59 37.25 25.80 19.64 34.15 21.60 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 12.29 34.52 28.11 16.84 32.47 25.43 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 12.06 27.10 15.56 13.23 27.02 13.80 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 C 14 LYS C 390 LYS~? 21.48 O2 EDO B 603 C 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 C 165 GLU B 363 GLU~? 7.89 O1 EDO B 603 coo 17.59 37.25 25.80 19.64 34.15 21.60 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 12.29 34.52 28.11 16.84 32.47 25.43 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 12.06 27.10 15.56 13.23 27.02 13.80 8.83 27.73 -6.37 10.21 26.17 -6.89 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 C 14 LYS C 390 LYS~? 21.48 O2 EDO B 603 C 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 C 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 17.59 37.25 25.80 19.64 34.15 21.60 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 12.29 34.52 28.11 16.84 32.47 25.43 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 12.06 27.10 15.56 13.23 27.02 13.80 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 C 14 LYS C 391 LYS~? 16.77 O1 EDO B 603 C 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 C 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 17.59 37.25 25.80 19.64 34.15 21.60 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 12.29 34.52 28.11 16.84 32.47 25.43 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 12.06 27.10 15.56 13.23 27.02 13.80 21.74 20.63 -27.21 21.00 22.48 -27.90 1kqc_c02 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 9 hits 1kqc_c02 naa= 3 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 D 14 LYS B 391 LYS~? 27.06 C2 EDO B 603 D 74 LYS B 388 LYS~? 19.48 C2 EDO B 603 D 165 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 1.34 36.06 21.83 0.02 35.49 25.91 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 D 14 LYS B 415 LYS^? -2.82 O2 EDO B 603s D 74 LYS B 442 LYS~? 13.00 O1 EDO B 603 D 165 GLU A 450 GLU~? 18.15 C2 EDO B 603 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 1.57 23.62 -1.31 7.49 26.02 -1.78 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 1.48 17.85 0.41 -2.11 18.47 -3.79 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -8.36 20.71 9.57 -7.00 20.85 11.17 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 D 14 LYS B 442 LYS~? 13.00 O1 EDO B 603 D 74 LYS B 415 LYS^? -2.82 O2 EDO B 603s D 165 GLU A 450 GLU~? 18.15 C2 EDO B 603 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 1.48 17.85 0.41 -2.11 18.47 -3.79 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 1.57 23.62 -1.31 7.49 26.02 -1.78 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -8.36 20.71 9.57 -7.00 20.85 11.17 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 D 14 LYS C 388 LYS~? 20.15 C2 EDO C 602 D 74 LYS C 390 LYS~? 21.48 O2 EDO B 603 D 165 GLU B 363 GLU~? 7.89 O1 EDO B 603 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 8.83 27.73 -6.37 10.21 26.17 -6.89 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 D 14 LYS C 388 LYS~? 20.15 C2 EDO C 602 D 74 LYS C 390 LYS~? 21.48 O2 EDO B 603 D 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 D 14 LYS C 388 LYS~? 20.15 C2 EDO C 602 D 74 LYS C 391 LYS~? 16.77 O1 EDO B 603 D 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 D 14 LYS C 390 LYS~? 21.48 O2 EDO B 603 D 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 D 165 GLU B 363 GLU~? 7.89 O1 EDO B 603 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 8.83 27.73 -6.37 10.21 26.17 -6.89 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 D 14 LYS C 390 LYS~? 21.48 O2 EDO B 603 D 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 D 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 D 14 LYS C 391 LYS~? 16.77 O1 EDO B 603 D 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 D 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 21.74 20.63 -27.21 21.00 22.48 -27.90 1kqc_c03 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 9 hits 1kqc_c03 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP A 350 ASP.? 26.92 O2 GOL D 601 262 LYS A 390 LYS~? 25.88 O2 GOL D 601 336 ARG A 368 ARG.? 24.16 C1 EDO B 603 coo 61.88 50.78 12.96 63.84 50.60 13.71 33.51 7.96 1.59 32.78 7.85 -0.37 coo 63.59 44.40 18.32 63.20 49.74 17.95 26.64 2.81 -1.98 30.91 -1.55 -0.35 coo 72.60 57.42 15.86 71.61 56.68 18.70 23.91 7.22 12.24 22.49 6.03 9.76 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP A 350 ASP.? 26.92 O2 GOL D 601 262 LYS A 390 LYS~? 25.88 O2 GOL D 601 336 ARG A 375 ARG.? 36.99 C1 EDO B 603 coo 61.88 50.78 12.96 63.84 50.60 13.71 33.51 7.96 1.59 32.78 7.85 -0.37 coo 63.59 44.40 18.32 63.20 49.74 17.95 26.64 2.81 -1.98 30.91 -1.55 -0.35 coo 72.60 57.42 15.86 71.61 56.68 18.70 34.50 3.88 12.57 36.52 3.36 14.83 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 3 3 # 3 255 ASP B 350 ASP.? 23.89 C2 EDO B 603 262 LYS B 390 LYS~? 27.12 C2 EDO B 603 336 ARG B 368 ARG.? 11.04 O2 EDO B 603 coo 61.88 50.78 12.96 63.84 50.60 13.71 12.16 40.72 19.41 11.14 39.74 20.98 coo 63.59 44.40 18.32 63.20 49.74 17.95 3.52 38.72 20.17 3.15 45.06 20.21 coo 72.60 57.42 15.86 71.61 56.68 18.70 11.09 36.07 6.20 8.36 35.36 7.43 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 4 3 # 4 255 ASP B 350 ASP.? 23.89 C2 EDO B 603 262 LYS B 390 LYS~? 27.12 C2 EDO B 603 336 ARG B 375 ARG.? 22.49 O2 EDO B 603 coo 61.88 50.78 12.96 63.84 50.60 13.71 12.16 40.72 19.41 11.14 39.74 20.98 coo 63.59 44.40 18.32 63.20 49.74 17.95 3.52 38.72 20.17 3.15 45.06 20.21 coo 72.60 57.42 15.86 71.61 56.68 18.70 13.81 46.43 8.85 13.44 47.64 6.03 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 5 3 # 5 255 ASP C 350 ASP.? 24.48 C2 EDO C 602 262 LYS C 390 LYS~? 21.48 O2 EDO B 603 336 ARG C 368 ARG.? 10.85 O2 EDO C 602 coo 61.88 50.78 12.96 63.84 50.60 13.71 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 63.59 44.40 18.32 63.20 49.74 17.95 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 72.60 57.42 15.86 71.61 56.68 18.70 24.45 26.16 -32.00 21.85 25.58 -30.53 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 6 3 # 6 255 ASP C 350 ASP.? 24.48 C2 EDO C 602 262 LYS C 390 LYS~? 21.48 O2 EDO B 603 336 ARG C 375 ARG.? 20.99 O2 EDO C 602 coo 61.88 50.78 12.96 63.84 50.60 13.71 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 63.59 44.40 18.32 63.20 49.74 17.95 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 72.60 57.42 15.86 71.61 56.68 18.70 27.90 36.71 -28.33 26.60 36.43 -31.10 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 7 3 # 7 255 ASP D 350 ASP.? 24.09 C3 GOL D 601 262 LYS D 390 LYS~? 25.65 O3 GOL D 601 336 ARG D 368 ARG.? 11.23 O3 GOL D 601 coo 61.88 50.78 12.96 63.84 50.60 13.71 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 63.59 44.40 18.32 63.20 49.74 17.95 35.81 -6.92 -44.49 39.58 -10.95 -43.36 coo 72.60 57.42 15.86 71.61 56.68 18.70 34.63 -3.42 -28.94 33.31 -3.73 -31.69 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 8 3 # 8 255 ASP D 350 ASP.? 24.09 C3 GOL D 601 262 LYS D 390 LYS~? 25.65 O3 GOL D 601 336 ARG D 375 ARG.? 23.45 O3 GOL D 601 coo 61.88 50.78 12.96 63.84 50.60 13.71 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 63.59 44.40 18.32 63.20 49.74 17.95 35.81 -6.92 -44.49 39.58 -10.95 -43.36 coo 72.60 57.42 15.86 71.61 56.68 18.70 45.57 -7.61 -30.32 45.87 -9.61 -28.01 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 8 hits 1lam_c00 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 428 ALA.? 23.52 O1 EDO B 603 A 317 GLY A 429 GLY.? 20.67 O1 EDO B 603 A 318 ASP A 426 ASP.? 22.31 O1 EDO B 603 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 28.89 26.05 -8.94 30.39 25.95 -8.77 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 27.23 22.60 -8.91 27.96 22.71 -8.54 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 29.17 24.78 -3.72 30.40 24.16 -5.34 ULMN 3 1lij_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA A 428 ALA.? 23.52 O1 EDO B 603 A 317 GLY A 429 GLY.? 20.67 O1 EDO B 603 A 318 ASP A 430 ASP.? 25.41 O1 EDO B 603 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 28.89 26.05 -8.94 30.39 25.95 -8.77 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 27.23 22.60 -8.91 27.96 22.71 -8.54 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 31.59 21.51 -7.17 32.38 22.31 -9.00 ULMN 3 1lij_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA B 428 ALA.? 31.84 C1 EDO B 603 A 317 GLY B 429 GLY.? 28.53 C1 EDO B 603 A 318 ASP B 426 ASP.? 28.68 C1 EDO B 603 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 20.07 24.52 30.82 20.88 25.70 31.37 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 16.61 25.09 29.33 17.13 25.70 29.37 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 21.11 26.70 26.04 20.61 27.63 27.90 ULMN 3 1lij_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA B 428 ALA.? 31.84 C1 EDO B 603 A 317 GLY B 429 GLY.? 28.53 C1 EDO B 603 A 318 ASP B 430 ASP.? 31.57 C2 EDO B 603 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 20.07 24.52 30.82 20.88 25.70 31.37 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 16.61 25.09 29.33 17.13 25.70 29.37 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 18.19 29.66 29.51 18.36 29.43 31.62 ULMN 3 1lij_c01 ADENOSINE KINASE user 5 3 # 5 A 316 ALA C 428 ALA.? 24.22 O2 GOL D 601 A 317 GLY C 429 GLY.? 21.29 O2 GOL D 601 A 318 ASP C 426 ASP.? 22.72 C2 GOL D 601 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 34.28 13.61 -8.51 35.19 14.79 -8.24 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 30.74 14.63 -9.51 31.39 15.13 -9.63 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 35.09 15.28 -13.55 34.97 16.40 -11.75 ULMN 3 1lij_c01 ADENOSINE KINASE user 6 3 # 6 A 316 ALA C 428 ALA.? 24.22 O2 GOL D 601 A 317 GLY C 429 GLY.? 21.29 O2 GOL D 601 A 318 ASP C 430 ASP.? 26.01 O2 GOL D 601 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 34.28 13.61 -8.51 35.19 14.79 -8.24 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 30.74 14.63 -9.51 31.39 15.13 -9.63 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 33.23 18.77 -9.92 33.78 18.54 -7.88 ULMN 3 1lij_c01 ADENOSINE KINASE user 7 3 # 7 A 316 ALA D 428 ALA.? 23.04 O1 EDO C 602 A 317 GLY D 429 GLY.? 19.97 O1 EDO C 602 A 318 ASP D 426 ASP.? 21.84 O1 EDO C 602 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 39.85 16.46 -48.84 41.33 16.15 -48.85 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 37.64 13.34 -48.99 38.39 13.31 -48.67 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 40.54 14.64 -43.98 41.47 13.99 -45.77 ULMN 3 1lij_c01 ADENOSINE KINASE user 8 3 # 8 A 316 ALA D 428 ALA.? 23.04 O1 EDO C 602 A 317 GLY D 429 GLY.? 19.97 O1 EDO C 602 A 318 ASP D 430 ASP.? 24.82 O1 EDO C 602 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 39.85 16.46 -48.84 41.33 16.15 -48.85 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 37.64 13.34 -48.99 38.39 13.31 -48.67 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 41.96 11.40 -47.93 42.69 12.01 -49.83 1lij_c01 source 1lij ADENOSINE KINASE : 8 hits 1lij_c01 naa= 3 ULMN 3 1lio_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 428 ALA.? 23.52 O1 EDO B 603 A 317 GLY A 429 GLY.? 20.67 O1 EDO B 603 A 318 ASP A 426 ASP.? 22.31 O1 EDO B 603 coo 27.04 23.54 41.85 25.72 24.19 42.18 28.89 26.05 -8.94 30.39 25.95 -8.77 coo 27.87 23.16 38.17 28.43 22.97 38.87 27.23 22.60 -8.91 27.96 22.71 -8.54 coo 32.11 22.71 40.58 33.42 24.22 39.78 29.17 24.78 -3.72 30.40 24.16 -5.34 ULMN 3 1lio_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA A 428 ALA.? 23.52 O1 EDO B 603 A 317 GLY A 429 GLY.? 20.67 O1 EDO B 603 A 318 ASP A 430 ASP.? 25.41 O1 EDO B 603 coo 27.04 23.54 41.85 25.72 24.19 42.18 28.89 26.05 -8.94 30.39 25.95 -8.77 coo 27.87 23.16 38.17 28.43 22.97 38.87 27.23 22.60 -8.91 27.96 22.71 -8.54 coo 32.11 22.71 40.58 33.42 24.22 39.78 31.59 21.51 -7.17 32.38 22.31 -9.00 ULMN 3 1lio_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA B 428 ALA.? 31.84 C1 EDO B 603 A 317 GLY B 429 GLY.? 28.53 C1 EDO B 603 A 318 ASP B 426 ASP.? 28.68 C1 EDO B 603 coo 27.04 23.54 41.85 25.72 24.19 42.18 20.07 24.52 30.82 20.88 25.70 31.37 coo 27.87 23.16 38.17 28.43 22.97 38.87 16.61 25.09 29.33 17.13 25.70 29.37 coo 32.11 22.71 40.58 33.42 24.22 39.78 21.11 26.70 26.04 20.61 27.63 27.90 ULMN 3 1lio_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA B 428 ALA.? 31.84 C1 EDO B 603 A 317 GLY B 429 GLY.? 28.53 C1 EDO B 603 A 318 ASP B 430 ASP.? 31.57 C2 EDO B 603 coo 27.04 23.54 41.85 25.72 24.19 42.18 20.07 24.52 30.82 20.88 25.70 31.37 coo 27.87 23.16 38.17 28.43 22.97 38.87 16.61 25.09 29.33 17.13 25.70 29.37 coo 32.11 22.71 40.58 33.42 24.22 39.78 18.19 29.66 29.51 18.36 29.43 31.62 ULMN 3 1lio_c01 ADENOSINE KINASE user 5 3 # 5 A 316 ALA C 428 ALA.? 24.22 O2 GOL D 601 A 317 GLY C 429 GLY.? 21.29 O2 GOL D 601 A 318 ASP C 426 ASP.? 22.72 C2 GOL D 601 coo 27.04 23.54 41.85 25.72 24.19 42.18 34.28 13.61 -8.51 35.19 14.79 -8.24 coo 27.87 23.16 38.17 28.43 22.97 38.87 30.74 14.63 -9.51 31.39 15.13 -9.63 coo 32.11 22.71 40.58 33.42 24.22 39.78 35.09 15.28 -13.55 34.97 16.40 -11.75 ULMN 3 1lio_c01 ADENOSINE KINASE user 6 3 # 6 A 316 ALA C 428 ALA.? 24.22 O2 GOL D 601 A 317 GLY C 429 GLY.? 21.29 O2 GOL D 601 A 318 ASP C 430 ASP.? 26.01 O2 GOL D 601 coo 27.04 23.54 41.85 25.72 24.19 42.18 34.28 13.61 -8.51 35.19 14.79 -8.24 coo 27.87 23.16 38.17 28.43 22.97 38.87 30.74 14.63 -9.51 31.39 15.13 -9.63 coo 32.11 22.71 40.58 33.42 24.22 39.78 33.23 18.77 -9.92 33.78 18.54 -7.88 ULMN 3 1lio_c01 ADENOSINE KINASE user 7 3 # 7 A 316 ALA D 428 ALA.? 23.04 O1 EDO C 602 A 317 GLY D 429 GLY.? 19.97 O1 EDO C 602 A 318 ASP D 426 ASP.? 21.84 O1 EDO C 602 coo 27.04 23.54 41.85 25.72 24.19 42.18 39.85 16.46 -48.84 41.33 16.15 -48.85 coo 27.87 23.16 38.17 28.43 22.97 38.87 37.64 13.34 -48.99 38.39 13.31 -48.67 coo 32.11 22.71 40.58 33.42 24.22 39.78 40.54 14.64 -43.98 41.47 13.99 -45.77 ULMN 3 1lio_c01 ADENOSINE KINASE user 8 3 # 8 A 316 ALA D 428 ALA.? 23.04 O1 EDO C 602 A 317 GLY D 429 GLY.? 19.97 O1 EDO C 602 A 318 ASP D 430 ASP.? 24.82 O1 EDO C 602 coo 27.04 23.54 41.85 25.72 24.19 42.18 39.85 16.46 -48.84 41.33 16.15 -48.85 coo 27.87 23.16 38.17 28.43 22.97 38.87 37.64 13.34 -48.99 38.39 13.31 -48.67 coo 32.11 22.71 40.58 33.42 24.22 39.78 41.96 11.40 -47.93 42.69 12.01 -49.83 1lio_c01 source 1lio ADENOSINE KINASE : 8 hits 1lio_c01 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 279 GLU B 342 GLU^? -3.54 O2 EDO B 603s A 369 ASP C 402 ASP.? 12.78 O1 GOL D 601 coo 11.74 38.14 80.19 10.63 36.40 80.65 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 16.54 46.37 63.94 14.77 45.79 62.95 10.25 28.44 3.00 8.52 29.59 2.44 coo 12.19 31.08 87.29 11.13 32.66 86.38 22.26 13.02 -15.38 21.01 11.37 -15.92 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 279 GLU A 394 GLU~? 15.90 O2 GOL D 601 A 369 ASP B 357 ASP.? 13.04 C1 EDO B 603 coo 11.74 38.14 80.19 10.63 36.40 80.65 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 16.54 46.37 63.94 14.77 45.79 62.95 27.33 5.77 -8.72 27.90 4.03 -9.75 coo 12.19 31.08 87.29 11.13 32.66 86.38 19.95 30.44 0.55 20.02 30.85 -1.53 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 279 GLU B 342 GLU^? -3.54 O2 EDO B 603s A 369 ASP C 430 ASP.? 26.01 O2 GOL D 601 coo 11.74 38.14 80.19 10.63 36.40 80.65 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 16.54 46.37 63.94 14.77 45.79 62.95 10.25 28.44 3.00 8.52 29.59 2.44 coo 12.19 31.08 87.29 11.13 32.66 86.38 33.23 18.77 -9.92 33.78 18.54 -7.88 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 279 GLU B 363 GLU~? 7.89 O1 EDO B 603 A 369 ASP C 430 ASP.? 26.01 O2 GOL D 601 coo 11.74 38.14 80.19 10.63 36.40 80.65 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 16.54 46.37 63.94 14.77 45.79 62.95 8.83 27.73 -6.37 10.21 26.17 -6.89 coo 12.19 31.08 87.29 11.13 32.66 86.38 33.23 18.77 -9.92 33.78 18.54 -7.88 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP B 426 ASP.? 28.68 C1 EDO B 603 A 279 GLU B 394 GLU~? 28.21 C2 EDO B 603 A 369 ASP A 357 ASP.? 25.14 C1 EDO B 603 coo 11.74 38.14 80.19 10.63 36.40 80.65 21.11 26.70 26.04 20.61 27.63 27.90 coo 16.54 46.37 63.94 14.77 45.79 62.95 4.47 36.77 26.38 2.63 37.63 26.96 coo 12.19 31.08 87.29 11.13 32.66 86.38 22.54 16.74 19.72 22.05 16.00 21.61 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 279 GLU D 342 GLU^? -3.57 O3 GOL D 601s A 369 ASP A 402 ASP.? 12.59 O1 EDO B 603 coo 11.74 38.14 80.19 10.63 36.40 80.65 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 16.54 46.37 63.94 14.77 45.79 62.95 28.06 0.59 -26.56 27.66 -1.50 -26.76 coo 12.19 31.08 87.29 11.13 32.66 86.38 18.87 16.83 -6.49 16.77 17.04 -6.49 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP D 426 ASP.? 21.84 O1 EDO C 602 A 279 GLU D 394 GLU~? 26.98 C3 GOL D 601 A 369 ASP C 357 ASP.? 12.50 O2 EDO C 602 coo 11.74 38.14 80.19 10.63 36.40 80.65 40.54 14.64 -43.98 41.47 13.99 -45.77 coo 16.54 46.37 63.94 14.77 45.79 62.95 35.24 -3.52 -50.42 34.05 -5.26 -50.80 coo 12.19 31.08 87.29 11.13 32.66 86.38 32.02 20.63 -38.57 31.77 21.72 -40.39 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 7 hits 1m53_c06 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 384 LYS~? 32.89 O2 GOL D 601 166 LYS A 388 LYS~? 27.25 O2 GOL D 601 324 SER A 371 SER~? 34.73 C1 EDO B 603 coo 25.93 8.11 25.51 26.40 7.80 19.66 23.52 -5.65 3.37 24.45 -7.36 6.79 coo 27.27 1.43 25.09 29.18 5.25 22.89 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 46.32 14.55 19.93 45.95 12.72 21.27 32.36 6.06 17.83 31.41 4.72 19.63 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS A 388 LYS~? 27.25 O2 GOL D 601 166 LYS A 391 LYS~? 19.54 O2 GOL D 601 324 SER A 371 SER~? 34.73 C1 EDO B 603 coo 25.93 8.11 25.51 26.40 7.80 19.66 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 27.27 1.43 25.09 29.18 5.25 22.89 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 46.32 14.55 19.93 45.95 12.72 21.27 32.36 6.06 17.83 31.41 4.72 19.63 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 3 3 # 3 164 LYS A 388 LYS~? 27.25 O2 GOL D 601 166 LYS A 391 LYS~? 19.54 O2 GOL D 601 324 SER B 449 SER.? 19.37 O1 EDO B 603 coo 25.93 8.11 25.51 26.40 7.80 19.66 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 27.27 1.43 25.09 29.18 5.25 22.89 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 46.32 14.55 19.93 45.95 12.72 21.27 1.07 6.55 -6.47 1.69 8.16 -8.19 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 4 3 # 4 164 LYS A 390 LYS~? 25.88 O2 GOL D 601 166 LYS A 388 LYS~? 27.25 O2 GOL D 601 324 SER A 371 SER~? 34.73 C1 EDO B 603 coo 25.93 8.11 25.51 26.40 7.80 19.66 26.64 2.81 -1.98 30.91 -1.55 -0.35 coo 27.27 1.43 25.09 29.18 5.25 22.89 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 46.32 14.55 19.93 45.95 12.72 21.27 32.36 6.06 17.83 31.41 4.72 19.63 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 5 3 # 5 164 LYS A 390 LYS~? 25.88 O2 GOL D 601 166 LYS A 388 LYS~? 27.25 O2 GOL D 601 324 SER D 358 SER.? 6.75 C2 GOL D 601 coo 25.93 8.11 25.51 26.40 7.80 19.66 26.64 2.81 -1.98 30.91 -1.55 -0.35 coo 27.27 1.43 25.09 29.18 5.25 22.89 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 46.32 14.55 19.93 45.95 12.72 21.27 29.79 5.62 -21.71 27.82 6.72 -22.45 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 6 3 # 6 164 LYS A 391 LYS~? 19.54 O2 GOL D 601 166 LYS A 388 LYS~? 27.25 O2 GOL D 601 324 SER B 449 SER.? 19.37 O1 EDO B 603 coo 25.93 8.11 25.51 26.40 7.80 19.66 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 27.27 1.43 25.09 29.18 5.25 22.89 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 46.32 14.55 19.93 45.95 12.72 21.27 1.07 6.55 -6.47 1.69 8.16 -8.19 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 7 3 # 7 164 LYS B 388 LYS~? 19.48 C2 EDO B 603 166 LYS B 390 LYS~? 27.12 C2 EDO B 603 324 SER B 410 SER^? 8.36 O2 EDO B 603 coo 25.93 8.11 25.51 26.40 7.80 19.66 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 27.27 1.43 25.09 29.18 5.25 22.89 3.52 38.72 20.17 3.15 45.06 20.21 coo 46.32 14.55 19.93 45.95 12.72 21.27 -1.48 27.73 -0.43 0.38 29.00 -1.36 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 8 3 # 8 164 LYS B 388 LYS~? 19.48 C2 EDO B 603 166 LYS B 391 LYS~? 27.06 C2 EDO B 603 324 SER B 371 SER~? 20.39 O2 EDO B 603 coo 25.93 8.11 25.51 26.40 7.80 19.66 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 27.27 1.43 25.09 29.18 5.25 22.89 1.34 36.06 21.83 0.02 35.49 25.91 coo 46.32 14.55 19.93 45.95 12.72 21.27 16.10 44.50 4.20 15.46 45.36 2.02 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 9 3 # 9 164 LYS B 388 LYS~? 19.48 C2 EDO B 603 166 LYS B 391 LYS~? 27.06 C2 EDO B 603 324 SER B 410 SER^? 8.36 O2 EDO B 603 coo 25.93 8.11 25.51 26.40 7.80 19.66 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 27.27 1.43 25.09 29.18 5.25 22.89 1.34 36.06 21.83 0.02 35.49 25.91 coo 46.32 14.55 19.93 45.95 12.72 21.27 -1.48 27.73 -0.43 0.38 29.00 -1.36 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 10 3 # 10 164 LYS B 390 LYS~? 27.12 C2 EDO B 603 166 LYS B 388 LYS~? 19.48 C2 EDO B 603 324 SER B 371 SER~? 20.39 O2 EDO B 603 coo 25.93 8.11 25.51 26.40 7.80 19.66 3.52 38.72 20.17 3.15 45.06 20.21 coo 27.27 1.43 25.09 29.18 5.25 22.89 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 46.32 14.55 19.93 45.95 12.72 21.27 16.10 44.50 4.20 15.46 45.36 2.02 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 11 3 # 11 164 LYS C 384 LYS~? 20.68 O2 EDO C 602 166 LYS C 388 LYS~? 20.15 C2 EDO C 602 324 SER C 371 SER~? 19.63 O2 EDO C 602 coo 25.93 8.11 25.51 26.40 7.80 19.66 11.81 35.96 -24.38 11.26 34.03 -29.22 coo 27.27 1.43 25.09 29.18 5.25 22.89 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 46.32 14.55 19.93 45.95 12.72 21.27 30.17 34.40 -34.13 29.04 35.01 -36.23 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 12 3 # 12 164 LYS C 388 LYS~? 20.15 C2 EDO C 602 166 LYS C 390 LYS~? 21.48 O2 EDO B 603 324 SER C 410 SER^? 8.67 O2 EDO C 602 coo 25.93 8.11 25.51 26.40 7.80 19.66 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 27.27 1.43 25.09 29.18 5.25 22.89 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 46.32 14.55 19.93 45.95 12.72 21.27 10.49 19.19 -38.07 12.37 20.48 -39.01 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 13 3 # 13 164 LYS C 388 LYS~? 20.15 C2 EDO C 602 166 LYS C 391 LYS~? 16.77 O1 EDO B 603 324 SER C 371 SER~? 19.63 O2 EDO C 602 coo 25.93 8.11 25.51 26.40 7.80 19.66 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 27.27 1.43 25.09 29.18 5.25 22.89 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 46.32 14.55 19.93 45.95 12.72 21.27 30.17 34.40 -34.13 29.04 35.01 -36.23 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 14 3 # 14 164 LYS C 388 LYS~? 20.15 C2 EDO C 602 166 LYS C 391 LYS~? 16.77 O1 EDO B 603 324 SER C 410 SER^? 8.67 O2 EDO C 602 coo 25.93 8.11 25.51 26.40 7.80 19.66 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 27.27 1.43 25.09 29.18 5.25 22.89 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 46.32 14.55 19.93 45.95 12.72 21.27 10.49 19.19 -38.07 12.37 20.48 -39.01 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 15 3 # 15 164 LYS C 390 LYS~? 21.48 O2 EDO B 603 166 LYS C 388 LYS~? 20.15 C2 EDO C 602 324 SER C 371 SER~? 19.63 O2 EDO C 602 coo 25.93 8.11 25.51 26.40 7.80 19.66 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 27.27 1.43 25.09 29.18 5.25 22.89 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 46.32 14.55 19.93 45.95 12.72 21.27 30.17 34.40 -34.13 29.04 35.01 -36.23 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 16 3 # 16 164 LYS C 391 LYS~? 16.77 O1 EDO B 603 166 LYS C 388 LYS~? 20.15 C2 EDO C 602 324 SER B 410 SER^? 8.36 O2 EDO B 603 coo 25.93 8.11 25.51 26.40 7.80 19.66 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 27.27 1.43 25.09 29.18 5.25 22.89 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 46.32 14.55 19.93 45.95 12.72 21.27 -1.48 27.73 -0.43 0.38 29.00 -1.36 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 17 3 # 17 164 LYS D 384 LYS~? 21.94 O3 GOL D 601 166 LYS D 388 LYS~? 23.05 O3 GOL D 601 324 SER D 371 SER~? 20.50 O3 GOL D 601 coo 25.93 8.11 25.51 26.40 7.80 19.66 32.39 -15.23 -40.24 32.53 -17.53 -36.22 coo 27.27 1.43 25.09 29.18 5.25 22.89 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 46.32 14.55 19.93 45.95 12.72 21.27 43.73 -6.40 -24.93 43.24 -8.29 -23.45 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 18 3 # 18 164 LYS D 388 LYS~? 23.05 O3 GOL D 601 166 LYS D 391 LYS~? 24.88 C3 GOL D 601 324 SER D 371 SER~? 20.50 O3 GOL D 601 coo 25.93 8.11 25.51 26.40 7.80 19.66 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 27.27 1.43 25.09 29.18 5.25 22.89 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo 46.32 14.55 19.93 45.95 12.72 21.27 43.73 -6.40 -24.93 43.24 -8.29 -23.45 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 19 3 # 19 164 LYS D 390 LYS~? 25.65 O3 GOL D 601 166 LYS D 388 LYS~? 23.05 O3 GOL D 601 324 SER D 371 SER~? 20.50 O3 GOL D 601 coo 25.93 8.11 25.51 26.40 7.80 19.66 35.81 -6.92 -44.49 39.58 -10.95 -43.36 coo 27.27 1.43 25.09 29.18 5.25 22.89 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 46.32 14.55 19.93 45.95 12.72 21.27 43.73 -6.40 -24.93 43.24 -8.29 -23.45 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 19 hits 1mdr_c01 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 325 GLY^? 18.29 O2 EDO B 603 A 501 ASP B 430 ASP.? 31.57 C2 EDO B 603 B 367 TYR A 421 TYR^? 19.72 O1 EDO B 603 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 21.68 36.85 7.13 22.11 36.17 7.00 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 18.19 29.66 29.51 18.36 29.43 31.62 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 20.02 8.83 1.38 20.18 6.69 3.20 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY A 374 GLY.? 31.41 C1 EDO B 603 A 501 ASP A 315 ASP.? 32.31 C1 EDO B 603 B 367 TYR A 418 TYR^? 12.62 O1 EDO B 603 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 35.36 10.25 11.54 34.84 9.63 11.39 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 35.16 33.09 19.50 33.98 34.83 19.67 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 9.59 11.03 3.92 9.74 11.89 1.25 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY A 374 GLY.? 31.41 C1 EDO B 603 A 501 ASP A 387 ASP~? 25.21 O2 GOL D 601 B 367 TYR B 354 TYR^? 14.48 C1 EDO B 603 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 35.36 10.25 11.54 34.84 9.63 11.39 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 25.11 -3.56 -1.18 26.67 -4.92 -0.75 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 19.63 32.53 9.54 19.95 30.09 8.18 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY A 374 GLY.? 31.41 C1 EDO B 603 A 501 ASP B 315 ASP.? 32.42 C1 EDO B 603 B 367 TYR A 418 TYR^? 12.62 O1 EDO B 603 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 35.36 10.25 11.54 34.84 9.63 11.39 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 37.58 31.51 9.95 39.21 32.46 10.92 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 9.59 11.03 3.92 9.74 11.89 1.25 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY A 399 GLY.? 18.69 O2 GOL D 601 A 501 ASP C 387 ASP~? 19.92 O2 EDO B 603 B 367 TYR D 418 TYR^? 10.77 C1 GOL D 601 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 24.04 14.08 -10.54 23.93 13.28 -10.73 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 12.27 32.40 -18.16 12.25 34.11 -16.91 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 20.16 1.85 -35.57 20.10 2.87 -38.19 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 6 3 # 6 A 465 GLY A 429 GLY.? 20.67 O1 EDO B 603 A 501 ASP D 357 ASP.? 12.64 O3 GOL D 601 B 367 TYR A 355 TYR^? 25.32 C1 EDO B 603 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 27.23 22.60 -8.91 27.96 22.71 -8.54 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 25.00 11.79 14.66 25.82 10.48 17.03 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 7 3 # 7 A 465 GLY A 433 GLY^? 21.75 O1 EDO B 603 A 501 ASP B 315 ASP.? 32.42 C1 EDO B 603 B 367 TYR B 418 TYR^? 11.01 C2 EDO B 603 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 28.83 15.24 0.20 28.24 15.62 -0.26 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 37.58 31.51 9.95 39.21 32.46 10.92 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 3.01 21.54 9.44 2.74 20.74 12.09 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 8 3 # 8 A 465 GLY A 433 GLY^? 21.75 O1 EDO B 603 A 501 ASP C 350 ASP.? 24.48 C2 EDO C 602 B 367 TYR B 418 TYR^? 11.01 C2 EDO B 603 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 28.83 15.24 0.20 28.24 15.62 -0.26 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 3.01 21.54 9.44 2.74 20.74 12.09 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 9 3 # 9 A 465 GLY B 374 GLY.? 22.43 O2 EDO B 603 A 501 ASP A 315 ASP.? 32.31 C1 EDO B 603 B 367 TYR B 418 TYR^? 11.01 C2 EDO B 603 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 18.55 43.16 11.52 17.75 43.08 11.36 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 35.16 33.09 19.50 33.98 34.83 19.67 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 3.01 21.54 9.44 2.74 20.74 12.09 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 10 3 # 10 A 465 GLY B 374 GLY.? 22.43 O2 EDO B 603 A 501 ASP B 315 ASP.? 32.42 C1 EDO B 603 B 367 TYR B 418 TYR^? 11.01 C2 EDO B 603 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 18.55 43.16 11.52 17.75 43.08 11.36 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 37.58 31.51 9.95 39.21 32.46 10.92 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 3.01 21.54 9.44 2.74 20.74 12.09 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 11 3 # 11 A 465 GLY C 374 GLY.? 22.52 O2 EDO C 602 A 501 ASP C 315 ASP.? 32.88 C1 EDO C 602 B 367 TYR C 418 TYR^? 10.50 O1 GOL D 601 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 32.81 32.80 -26.75 31.99 32.73 -26.83 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 51.14 17.66 -30.05 53.19 17.33 -29.52 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 15.25 12.39 -28.72 15.00 11.49 -26.08 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 12 3 # 12 A 465 GLY C 374 GLY.? 22.52 O2 EDO C 602 A 501 ASP D 315 ASP.? 31.69 C1 GOL D 601 B 367 TYR C 418 TYR^? 10.50 O1 GOL D 601 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 32.81 32.80 -26.75 31.99 32.73 -26.83 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 48.83 21.16 -21.57 48.15 21.79 -19.66 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 15.25 12.39 -28.72 15.00 11.49 -26.08 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 13 3 # 13 A 465 GLY C 399 GLY.? 18.04 O1 EDO B 603 A 501 ASP A 387 ASP~? 25.21 O2 GOL D 601 B 367 TYR B 418 TYR^? 11.01 C2 EDO B 603 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 22.21 18.06 -10.13 21.51 18.50 -10.08 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 25.11 -3.56 -1.18 26.67 -4.92 -0.75 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 3.01 21.54 9.44 2.74 20.74 12.09 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 14 3 # 14 A 465 GLY C 399 GLY.? 18.04 O1 EDO B 603 A 501 ASP D 357 ASP.? 12.64 O3 GOL D 601 B 367 TYR A 355 TYR^? 25.32 C1 EDO B 603 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 22.21 18.06 -10.13 21.51 18.50 -10.08 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 25.00 11.79 14.66 25.82 10.48 17.03 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 15 3 # 15 A 465 GLY C 399 GLY.? 18.04 O1 EDO B 603 A 501 ASP D 357 ASP.? 12.64 O3 GOL D 601 B 367 TYR B 326 TYR^? 30.24 C1 EDO B 603 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 22.21 18.06 -10.13 21.51 18.50 -10.08 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 34.46 17.76 14.34 35.89 17.47 16.72 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 16 3 # 16 A 465 GLY C 429 GLY.? 21.29 O2 GOL D 601 A 501 ASP A 387 ASP~? 25.21 O2 GOL D 601 B 367 TYR B 354 TYR^? 14.48 C1 EDO B 603 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 30.74 14.63 -9.51 31.39 15.13 -9.63 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 25.11 -3.56 -1.18 26.67 -4.92 -0.75 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 19.63 32.53 9.54 19.95 30.09 8.18 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 17 3 # 17 A 465 GLY C 429 GLY.? 21.29 O2 GOL D 601 A 501 ASP A 387 ASP~? 25.21 O2 GOL D 601 B 367 TYR C 326 TYR^? 22.46 O3 GOL D 601 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 30.74 14.63 -9.51 31.39 15.13 -9.63 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 25.11 -3.56 -1.18 26.67 -4.92 -0.75 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 45.91 5.03 -28.85 46.66 3.15 -30.76 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 18 3 # 18 A 465 GLY C 429 GLY.? 21.29 O2 GOL D 601 A 501 ASP B 357 ASP.? 13.04 C1 EDO B 603 B 367 TYR C 355 TYR^? 12.28 O2 EDO C 602 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 30.74 14.63 -9.51 31.39 15.13 -9.63 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 19.95 30.44 0.55 20.02 30.85 -1.53 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 28.68 24.77 -33.28 28.94 26.73 -35.28 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 19 3 # 19 A 465 GLY C 433 GLY^? 21.06 C1 EDO C 602 A 501 ASP D 440 ASP^? -5.34 O2 GOL D 601s B 367 TYR A 437 TYR^? 11.45 C1 EDO B 603 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 29.21 22.26 -18.37 28.97 21.54 -18.06 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 19.76 1.27 -26.39 17.89 0.46 -25.75 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 16.79 15.50 5.48 15.91 16.43 3.01 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 20 3 # 20 A 465 GLY D 325 GLY^? 18.19 O2 EDO C 602 A 501 ASP C 430 ASP.? 26.01 O2 GOL D 601 B 367 TYR D 421 TYR^? 13.63 C3 GOL D 601 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 35.06 26.39 -31.63 35.44 25.69 -31.89 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 33.23 18.77 -9.92 33.78 18.54 -7.88 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 30.12 -0.70 -39.30 29.82 -2.95 -37.69 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 21 3 # 21 A 465 GLY D 374 GLY.? 22.36 O3 GOL D 601 A 501 ASP D 315 ASP.? 31.69 C1 GOL D 601 B 367 TYR D 418 TYR^? 10.77 C1 GOL D 601 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 46.34 -1.28 -30.70 45.83 -1.89 -30.81 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 48.83 21.16 -21.57 48.15 21.79 -19.66 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 20.16 1.85 -35.57 20.10 2.87 -38.19 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 22 3 # 22 A 465 GLY D 374 GLY.? 22.36 O3 GOL D 601 A 501 ASP D 387 ASP~? 25.32 O3 GOL D 601 B 367 TYR C 354 TYR^? 14.37 C1 EDO C 602 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 46.34 -1.28 -30.70 45.83 -1.89 -30.81 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 33.33 -13.12 -43.54 32.71 -13.42 -45.54 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 32.76 22.10 -29.37 32.74 19.75 -30.93 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 22 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 325 GLY^? 18.29 O2 EDO B 603 D 501 ASP B 430 ASP.? 31.57 C2 EDO B 603 E 367 TYR A 421 TYR^? 19.72 O1 EDO B 603 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 21.68 36.85 7.13 22.11 36.17 7.00 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 18.19 29.66 29.51 18.36 29.43 31.62 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 20.02 8.83 1.38 20.18 6.69 3.20 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY A 374 GLY.? 31.41 C1 EDO B 603 D 501 ASP A 315 ASP.? 32.31 C1 EDO B 603 E 367 TYR A 418 TYR^? 12.62 O1 EDO B 603 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 35.36 10.25 11.54 34.84 9.63 11.39 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 35.16 33.09 19.50 33.98 34.83 19.67 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 9.59 11.03 3.92 9.74 11.89 1.25 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY A 374 GLY.? 31.41 C1 EDO B 603 D 501 ASP A 387 ASP~? 25.21 O2 GOL D 601 E 367 TYR B 354 TYR^? 14.48 C1 EDO B 603 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 35.36 10.25 11.54 34.84 9.63 11.39 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 25.11 -3.56 -1.18 26.67 -4.92 -0.75 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 19.63 32.53 9.54 19.95 30.09 8.18 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY A 374 GLY.? 31.41 C1 EDO B 603 D 501 ASP B 315 ASP.? 32.42 C1 EDO B 603 E 367 TYR A 418 TYR^? 12.62 O1 EDO B 603 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 35.36 10.25 11.54 34.84 9.63 11.39 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 37.58 31.51 9.95 39.21 32.46 10.92 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 9.59 11.03 3.92 9.74 11.89 1.25 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY A 399 GLY.? 18.69 O2 GOL D 601 D 501 ASP C 387 ASP~? 19.92 O2 EDO B 603 E 367 TYR D 418 TYR^? 10.77 C1 GOL D 601 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 24.04 14.08 -10.54 23.93 13.28 -10.73 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 12.27 32.40 -18.16 12.25 34.11 -16.91 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 20.16 1.85 -35.57 20.10 2.87 -38.19 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 6 3 # 6 D 465 GLY A 399 GLY.? 18.69 O2 GOL D 601 D 501 ASP C 387 ASP~? 19.92 O2 EDO B 603 E 367 TYR D 437 TYR^? 9.97 C1 GOL D 601 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 24.04 14.08 -10.54 23.93 13.28 -10.73 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 12.27 32.40 -18.16 12.25 34.11 -16.91 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 27.83 5.60 -34.20 26.72 6.80 -36.49 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 7 3 # 7 D 465 GLY A 429 GLY.? 20.67 O1 EDO B 603 D 501 ASP D 357 ASP.? 12.64 O3 GOL D 601 E 367 TYR A 355 TYR^? 25.32 C1 EDO B 603 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 27.23 22.60 -8.91 27.96 22.71 -8.54 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 25.00 11.79 14.66 25.82 10.48 17.03 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 8 3 # 8 D 465 GLY A 433 GLY^? 21.75 O1 EDO B 603 D 501 ASP B 315 ASP.? 32.42 C1 EDO B 603 E 367 TYR B 418 TYR^? 11.01 C2 EDO B 603 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 28.83 15.24 0.20 28.24 15.62 -0.26 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 37.58 31.51 9.95 39.21 32.46 10.92 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 3.01 21.54 9.44 2.74 20.74 12.09 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 9 3 # 9 D 465 GLY A 433 GLY^? 21.75 O1 EDO B 603 D 501 ASP C 350 ASP.? 24.48 C2 EDO C 602 E 367 TYR B 418 TYR^? 11.01 C2 EDO B 603 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 28.83 15.24 0.20 28.24 15.62 -0.26 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 3.01 21.54 9.44 2.74 20.74 12.09 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 10 3 # 10 D 465 GLY B 325 GLY^? 27.02 C1 EDO B 603 D 501 ASP A 430 ASP.? 25.41 O1 EDO B 603 E 367 TYR B 421 TYR^? 13.58 C2 EDO B 603 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 30.63 15.29 15.31 30.28 16.04 15.52 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 31.59 21.51 -7.17 32.38 22.31 -9.00 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 6.36 30.57 15.08 5.68 32.41 13.09 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 11 3 # 11 D 465 GLY B 374 GLY.? 22.43 O2 EDO B 603 D 501 ASP A 315 ASP.? 32.31 C1 EDO B 603 E 367 TYR B 418 TYR^? 11.01 C2 EDO B 603 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 18.55 43.16 11.52 17.75 43.08 11.36 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 35.16 33.09 19.50 33.98 34.83 19.67 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 3.01 21.54 9.44 2.74 20.74 12.09 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 12 3 # 12 D 465 GLY B 374 GLY.? 22.43 O2 EDO B 603 D 501 ASP B 315 ASP.? 32.42 C1 EDO B 603 E 367 TYR B 418 TYR^? 11.01 C2 EDO B 603 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 18.55 43.16 11.52 17.75 43.08 11.36 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 37.58 31.51 9.95 39.21 32.46 10.92 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 3.01 21.54 9.44 2.74 20.74 12.09 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 13 3 # 13 D 465 GLY C 374 GLY.? 22.52 O2 EDO C 602 D 501 ASP C 315 ASP.? 32.88 C1 EDO C 602 E 367 TYR C 418 TYR^? 10.50 O1 GOL D 601 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 32.81 32.80 -26.75 31.99 32.73 -26.83 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 51.14 17.66 -30.05 53.19 17.33 -29.52 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 15.25 12.39 -28.72 15.00 11.49 -26.08 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 14 3 # 14 D 465 GLY C 374 GLY.? 22.52 O2 EDO C 602 D 501 ASP C 387 ASP~? 19.92 O2 EDO B 603 E 367 TYR D 437 TYR^? 9.97 C1 GOL D 601 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 32.81 32.80 -26.75 31.99 32.73 -26.83 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 12.27 32.40 -18.16 12.25 34.11 -16.91 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 27.83 5.60 -34.20 26.72 6.80 -36.49 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 15 3 # 15 D 465 GLY C 374 GLY.? 22.52 O2 EDO C 602 D 501 ASP D 315 ASP.? 31.69 C1 GOL D 601 E 367 TYR C 418 TYR^? 10.50 O1 GOL D 601 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 32.81 32.80 -26.75 31.99 32.73 -26.83 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 48.83 21.16 -21.57 48.15 21.79 -19.66 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 15.25 12.39 -28.72 15.00 11.49 -26.08 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 16 3 # 16 D 465 GLY C 399 GLY.? 18.04 O1 EDO B 603 D 501 ASP A 387 ASP~? 25.21 O2 GOL D 601 E 367 TYR B 418 TYR^? 11.01 C2 EDO B 603 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 22.21 18.06 -10.13 21.51 18.50 -10.08 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 25.11 -3.56 -1.18 26.67 -4.92 -0.75 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 3.01 21.54 9.44 2.74 20.74 12.09 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 17 3 # 17 D 465 GLY C 399 GLY.? 18.04 O1 EDO B 603 D 501 ASP D 357 ASP.? 12.64 O3 GOL D 601 E 367 TYR A 355 TYR^? 25.32 C1 EDO B 603 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 22.21 18.06 -10.13 21.51 18.50 -10.08 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 25.00 11.79 14.66 25.82 10.48 17.03 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 18 3 # 18 D 465 GLY C 399 GLY.? 18.04 O1 EDO B 603 D 501 ASP D 357 ASP.? 12.64 O3 GOL D 601 E 367 TYR B 326 TYR^? 30.24 C1 EDO B 603 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 22.21 18.06 -10.13 21.51 18.50 -10.08 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 34.46 17.76 14.34 35.89 17.47 16.72 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 19 3 # 19 D 465 GLY C 429 GLY.? 21.29 O2 GOL D 601 D 501 ASP A 387 ASP~? 25.21 O2 GOL D 601 E 367 TYR B 354 TYR^? 14.48 C1 EDO B 603 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 30.74 14.63 -9.51 31.39 15.13 -9.63 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 25.11 -3.56 -1.18 26.67 -4.92 -0.75 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 19.63 32.53 9.54 19.95 30.09 8.18 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 20 3 # 20 D 465 GLY C 429 GLY.? 21.29 O2 GOL D 601 D 501 ASP A 387 ASP~? 25.21 O2 GOL D 601 E 367 TYR C 326 TYR^? 22.46 O3 GOL D 601 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 30.74 14.63 -9.51 31.39 15.13 -9.63 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 25.11 -3.56 -1.18 26.67 -4.92 -0.75 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 45.91 5.03 -28.85 46.66 3.15 -30.76 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 21 3 # 21 D 465 GLY C 429 GLY.? 21.29 O2 GOL D 601 D 501 ASP B 357 ASP.? 13.04 C1 EDO B 603 E 367 TYR C 355 TYR^? 12.28 O2 EDO C 602 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 30.74 14.63 -9.51 31.39 15.13 -9.63 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 19.95 30.44 0.55 20.02 30.85 -1.53 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 28.68 24.77 -33.28 28.94 26.73 -35.28 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 22 3 # 22 D 465 GLY C 433 GLY^? 21.06 C1 EDO C 602 D 501 ASP D 440 ASP^? -5.34 O2 GOL D 601s E 367 TYR A 437 TYR^? 11.45 C1 EDO B 603 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 29.21 22.26 -18.37 28.97 21.54 -18.06 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 19.76 1.27 -26.39 17.89 0.46 -25.75 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 16.79 15.50 5.48 15.91 16.43 3.01 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 23 3 # 23 D 465 GLY D 325 GLY^? 18.19 O2 EDO C 602 D 501 ASP C 430 ASP.? 26.01 O2 GOL D 601 E 367 TYR D 421 TYR^? 13.63 C3 GOL D 601 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 35.06 26.39 -31.63 35.44 25.69 -31.89 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 33.23 18.77 -9.92 33.78 18.54 -7.88 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 30.12 -0.70 -39.30 29.82 -2.95 -37.69 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 24 3 # 24 D 465 GLY D 374 GLY.? 22.36 O3 GOL D 601 D 501 ASP D 315 ASP.? 31.69 C1 GOL D 601 E 367 TYR D 418 TYR^? 10.77 C1 GOL D 601 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 46.34 -1.28 -30.70 45.83 -1.89 -30.81 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 48.83 21.16 -21.57 48.15 21.79 -19.66 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 20.16 1.85 -35.57 20.10 2.87 -38.19 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 25 3 # 25 D 465 GLY D 374 GLY.? 22.36 O3 GOL D 601 D 501 ASP D 387 ASP~? 25.32 O3 GOL D 601 E 367 TYR C 354 TYR^? 14.37 C1 EDO C 602 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 46.34 -1.28 -30.70 45.83 -1.89 -30.81 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 33.33 -13.12 -43.54 32.71 -13.42 -45.54 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 32.76 22.10 -29.37 32.74 19.75 -30.93 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 25 hits 1mro_c01 naa= 3 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 1 3 # 1 A 167 LYS A 390 LYS~? 25.88 O2 GOL D 601 A 169 LYS A 388 LYS~? 27.25 O2 GOL D 601 A 327 GLU A 378 GLU~? 27.85 O2 GOL D 601 coo 20.73 15.53 25.54 22.09 15.64 19.40 26.64 2.81 -1.98 30.91 -1.55 -0.35 coo 24.31 10.25 23.71 29.02 12.05 20.75 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 21.86 20.40 18.59 22.12 18.33 18.33 32.59 2.13 2.36 33.95 1.57 0.86 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 2 3 # 2 A 167 LYS A 390 LYS~? 25.88 O2 GOL D 601 A 169 LYS A 388 LYS~? 27.25 O2 GOL D 601 A 327 GLU A 394 GLU~? 15.90 O2 GOL D 601 coo 20.73 15.53 25.54 22.09 15.64 19.40 26.64 2.81 -1.98 30.91 -1.55 -0.35 coo 24.31 10.25 23.71 29.02 12.05 20.75 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 21.86 20.40 18.59 22.12 18.33 18.33 27.33 5.77 -8.72 27.90 4.03 -9.75 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 3 3 # 3 A 167 LYS A 415 LYS^? 20.91 C1 EDO B 603 A 169 LYS A 442 LYS~? 23.27 C1 EDO B 603 A 327 GLU A 411 GLU.? 28.28 O1 EDO B 603 coo 20.73 15.53 25.54 22.09 15.64 19.40 6.45 6.62 13.73 11.23 9.80 16.52 coo 24.31 10.25 23.71 29.02 12.05 20.75 2.76 10.16 11.03 0.96 5.43 12.32 coo 21.86 20.40 18.59 22.12 18.33 18.33 3.89 -1.22 13.75 2.15 -0.02 14.05 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 4 3 # 4 A 167 LYS A 442 LYS~? 23.27 C1 EDO B 603 A 169 LYS A 415 LYS^? 20.91 C1 EDO B 603 A 327 GLU A 446 GLU~? 20.77 C2 EDO B 603 coo 20.73 15.53 25.54 22.09 15.64 19.40 2.76 10.16 11.03 0.96 5.43 12.32 coo 24.31 10.25 23.71 29.02 12.05 20.75 6.45 6.62 13.73 11.23 9.80 16.52 coo 21.86 20.40 18.59 22.12 18.33 18.33 -3.62 12.85 13.27 -2.92 11.09 12.27 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 5 3 # 5 A 167 LYS B 390 LYS~? 27.12 C2 EDO B 603 A 169 LYS B 388 LYS~? 19.48 C2 EDO B 603 A 327 GLU B 378 GLU~? 25.07 O2 EDO B 603 coo 20.73 15.53 25.54 22.09 15.64 19.40 3.52 38.72 20.17 3.15 45.06 20.21 coo 24.31 10.25 23.71 29.02 12.05 20.75 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 21.86 20.40 18.59 22.12 18.33 18.33 7.63 44.96 15.04 7.63 45.65 17.05 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 6 3 # 6 A 167 LYS B 415 LYS^? -2.82 O2 EDO B 603s A 169 LYS B 442 LYS~? 13.00 O1 EDO B 603 A 327 GLU B 411 GLU.? 15.09 O2 EDO B 603 coo 20.73 15.53 25.54 22.09 15.64 19.40 1.57 23.62 -1.31 7.49 26.02 -1.78 coo 24.31 10.25 23.71 29.02 12.05 20.75 1.48 17.85 0.41 -2.11 18.47 -3.79 coo 21.86 20.40 18.59 22.12 18.33 18.33 -5.72 28.81 -2.48 -6.82 27.11 -1.89 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 7 3 # 7 A 167 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 169 LYS C 391 LYS~? 16.77 O1 EDO B 603 A 327 GLU C 378 GLU~? 24.96 O2 EDO B 603 coo 20.73 15.53 25.54 22.09 15.64 19.40 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 24.31 10.25 23.71 29.02 12.05 20.75 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 21.86 20.40 18.59 22.12 18.33 18.33 22.14 33.77 -19.82 21.71 34.90 -18.09 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 8 3 # 8 A 167 LYS C 390 LYS~? 21.48 O2 EDO B 603 A 169 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 327 GLU C 378 GLU~? 24.96 O2 EDO B 603 coo 20.73 15.53 25.54 22.09 15.64 19.40 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 24.31 10.25 23.71 29.02 12.05 20.75 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 21.86 20.40 18.59 22.12 18.33 18.33 22.14 33.77 -19.82 21.71 34.90 -18.09 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 9 3 # 9 A 167 LYS C 391 LYS~? 16.77 O1 EDO B 603 A 169 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 327 GLU C 378 GLU~? 24.96 O2 EDO B 603 coo 20.73 15.53 25.54 22.09 15.64 19.40 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 24.31 10.25 23.71 29.02 12.05 20.75 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 21.86 20.40 18.59 22.12 18.33 18.33 22.14 33.77 -19.82 21.71 34.90 -18.09 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 10 3 # 10 A 167 LYS C 415 LYS^? -2.71 O2 EDO C 602s A 169 LYS C 442 LYS~? 13.46 O1 EDO C 602 A 327 GLU C 411 GLU.? 15.78 O2 EDO C 602 coo 20.73 15.53 25.54 22.09 15.64 19.40 13.38 15.08 -39.34 19.41 17.19 -40.08 coo 24.31 10.25 23.71 29.02 12.05 20.75 12.96 9.36 -37.91 9.04 10.02 -41.38 coo 21.86 20.40 18.59 22.12 18.33 18.33 6.23 19.30 -42.44 5.28 17.46 -42.16 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 11 3 # 11 A 167 LYS D 390 LYS~? 25.65 O3 GOL D 601 A 169 LYS D 388 LYS~? 23.05 O3 GOL D 601 A 327 GLU D 378 GLU~? 27.27 O3 GOL D 601 coo 20.73 15.53 25.54 22.09 15.64 19.40 35.81 -6.92 -44.49 39.58 -10.95 -43.36 coo 24.31 10.25 23.71 29.02 12.05 20.75 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 21.86 20.40 18.59 22.12 18.33 18.33 43.18 -8.44 -40.40 44.74 -9.12 -41.62 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 12 3 # 12 A 167 LYS D 390 LYS~? 25.65 O3 GOL D 601 A 169 LYS D 388 LYS~? 23.05 O3 GOL D 601 A 327 GLU D 394 GLU~? 26.98 C3 GOL D 601 coo 20.73 15.53 25.54 22.09 15.64 19.40 35.81 -6.92 -44.49 39.58 -10.95 -43.36 coo 24.31 10.25 23.71 29.02 12.05 20.75 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 21.86 20.40 18.59 22.12 18.33 18.33 35.24 -3.52 -50.42 34.05 -5.26 -50.80 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 13 3 # 13 A 167 LYS D 415 LYS^? -2.91 O3 GOL D 601s A 169 LYS D 442 LYS~? 12.65 O2 GOL D 601 A 327 GLU D 411 GLU.? 16.70 O3 GOL D 601 coo 20.73 15.53 25.54 22.09 15.64 19.40 17.93 -3.17 -25.73 23.39 -0.99 -23.17 coo 24.31 10.25 23.71 29.02 12.05 20.75 14.14 0.83 -27.84 11.41 -3.18 -25.91 coo 21.86 20.40 18.59 22.12 18.33 18.33 14.38 -10.66 -25.01 13.15 -12.19 -25.81 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 14 3 # 14 A 167 LYS D 442 LYS~? 12.65 O2 GOL D 601 A 169 LYS D 415 LYS^? -2.91 O3 GOL D 601s A 327 GLU D 446 GLU~? 12.65 O1 GOL D 601 coo 20.73 15.53 25.54 22.09 15.64 19.40 14.14 0.83 -27.84 11.41 -3.18 -25.91 coo 24.31 10.25 23.71 29.02 12.05 20.75 17.93 -3.17 -25.73 23.39 -0.99 -23.17 coo 21.86 20.40 18.59 22.12 18.33 18.33 8.69 3.92 -24.74 9.85 4.42 -23.05 1muc_c00 source 1muc MUCONATE LACTONIZING ENZYME : 14 hits 1muc_c00 naa= 3 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 1 3 # 1 B 167 LYS A 390 LYS~? 25.88 O2 GOL D 601 B 169 LYS A 388 LYS~? 27.25 O2 GOL D 601 B 327 GLU A 378 GLU~? 27.85 O2 GOL D 601 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 26.64 2.81 -1.98 30.91 -1.55 -0.35 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 32.59 2.13 2.36 33.95 1.57 0.86 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 2 3 # 2 B 167 LYS A 390 LYS~? 25.88 O2 GOL D 601 B 169 LYS A 388 LYS~? 27.25 O2 GOL D 601 B 327 GLU A 394 GLU~? 15.90 O2 GOL D 601 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 26.64 2.81 -1.98 30.91 -1.55 -0.35 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 27.33 5.77 -8.72 27.90 4.03 -9.75 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 3 3 # 3 B 167 LYS A 415 LYS^? 20.91 C1 EDO B 603 B 169 LYS A 442 LYS~? 23.27 C1 EDO B 603 B 327 GLU A 411 GLU.? 28.28 O1 EDO B 603 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 6.45 6.62 13.73 11.23 9.80 16.52 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 2.76 10.16 11.03 0.96 5.43 12.32 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 3.89 -1.22 13.75 2.15 -0.02 14.05 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 4 3 # 4 B 167 LYS A 442 LYS~? 23.27 C1 EDO B 603 B 169 LYS A 415 LYS^? 20.91 C1 EDO B 603 B 327 GLU A 446 GLU~? 20.77 C2 EDO B 603 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 2.76 10.16 11.03 0.96 5.43 12.32 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 6.45 6.62 13.73 11.23 9.80 16.52 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -3.62 12.85 13.27 -2.92 11.09 12.27 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 5 3 # 5 B 167 LYS B 390 LYS~? 27.12 C2 EDO B 603 B 169 LYS B 388 LYS~? 19.48 C2 EDO B 603 B 327 GLU B 378 GLU~? 25.07 O2 EDO B 603 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 3.52 38.72 20.17 3.15 45.06 20.21 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 7.63 44.96 15.04 7.63 45.65 17.05 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 6 3 # 6 B 167 LYS B 415 LYS^? -2.82 O2 EDO B 603s B 169 LYS B 442 LYS~? 13.00 O1 EDO B 603 B 327 GLU B 411 GLU.? 15.09 O2 EDO B 603 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 1.57 23.62 -1.31 7.49 26.02 -1.78 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 1.48 17.85 0.41 -2.11 18.47 -3.79 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -5.72 28.81 -2.48 -6.82 27.11 -1.89 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 7 3 # 7 B 167 LYS C 388 LYS~? 20.15 C2 EDO C 602 B 169 LYS C 391 LYS~? 16.77 O1 EDO B 603 B 327 GLU C 378 GLU~? 24.96 O2 EDO B 603 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 22.14 33.77 -19.82 21.71 34.90 -18.09 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 8 3 # 8 B 167 LYS C 391 LYS~? 16.77 O1 EDO B 603 B 169 LYS C 388 LYS~? 20.15 C2 EDO C 602 B 327 GLU C 378 GLU~? 24.96 O2 EDO B 603 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 22.14 33.77 -19.82 21.71 34.90 -18.09 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 9 3 # 9 B 167 LYS C 415 LYS^? -2.71 O2 EDO C 602s B 169 LYS C 442 LYS~? 13.46 O1 EDO C 602 B 327 GLU C 411 GLU.? 15.78 O2 EDO C 602 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 13.38 15.08 -39.34 19.41 17.19 -40.08 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 12.96 9.36 -37.91 9.04 10.02 -41.38 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 6.23 19.30 -42.44 5.28 17.46 -42.16 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 10 3 # 10 B 167 LYS D 390 LYS~? 25.65 O3 GOL D 601 B 169 LYS D 388 LYS~? 23.05 O3 GOL D 601 B 327 GLU D 378 GLU~? 27.27 O3 GOL D 601 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 35.81 -6.92 -44.49 39.58 -10.95 -43.36 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 43.18 -8.44 -40.40 44.74 -9.12 -41.62 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 11 3 # 11 B 167 LYS D 390 LYS~? 25.65 O3 GOL D 601 B 169 LYS D 388 LYS~? 23.05 O3 GOL D 601 B 327 GLU D 394 GLU~? 26.98 C3 GOL D 601 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 35.81 -6.92 -44.49 39.58 -10.95 -43.36 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 35.24 -3.52 -50.42 34.05 -5.26 -50.80 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 12 3 # 12 B 167 LYS D 415 LYS^? -2.91 O3 GOL D 601s B 169 LYS D 442 LYS~? 12.65 O2 GOL D 601 B 327 GLU D 411 GLU.? 16.70 O3 GOL D 601 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 17.93 -3.17 -25.73 23.39 -0.99 -23.17 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 14.14 0.83 -27.84 11.41 -3.18 -25.91 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 14.38 -10.66 -25.01 13.15 -12.19 -25.81 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 13 3 # 13 B 167 LYS D 442 LYS~? 12.65 O2 GOL D 601 B 169 LYS D 415 LYS^? -2.91 O3 GOL D 601s B 327 GLU D 446 GLU~? 12.65 O1 GOL D 601 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 14.14 0.83 -27.84 11.41 -3.18 -25.91 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 17.93 -3.17 -25.73 23.39 -0.99 -23.17 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 8.69 3.92 -24.74 9.85 4.42 -23.05 1muc_c01 source 1muc MUCONATE LACTONIZING ENZYME : 13 hits 1muc_c01 naa= 3 ULMN 3 1myr_c00 MYROSINASE user 1 3 # 1 187 GLN A 400 GLN.? 13.34 O2 GOL D 601 328 ASN A 398 ASN~? 16.47 O2 GOL D 601 409 GLU A 394 GLU~? 15.90 O2 GOL D 601 coo 45.09 114.33 52.30 45.59 116.18 51.29 22.76 9.60 -12.72 23.33 7.54 -12.60 coo 41.10 116.46 52.80 42.09 116.00 54.64 26.81 10.21 -11.17 28.62 9.13 -11.03 coo 42.69 118.64 56.27 44.58 118.34 55.45 27.33 5.77 -8.72 27.90 4.03 -9.75 ULMN 3 1myr_c00 MYROSINASE user 2 3 # 2 187 GLN B 400 GLN.? 28.52 C2 EDO B 603 328 ASN B 398 ASN~? 28.43 C2 EDO B 603 409 GLU B 394 GLU~? 28.21 C2 EDO B 603 coo 45.09 114.33 52.30 45.59 116.18 51.29 2.84 29.43 29.50 2.03 31.39 29.32 coo 41.10 116.46 52.80 42.09 116.00 54.64 6.35 32.55 29.26 6.04 34.62 28.91 coo 42.69 118.64 56.27 44.58 118.34 55.45 4.47 36.77 26.38 2.63 37.63 26.96 ULMN 3 1myr_c00 MYROSINASE user 3 3 # 3 187 GLN D 400 GLN.? 25.00 O1 EDO C 602 328 ASN D 398 ASN~? 25.80 O1 EDO C 602 409 GLU D 394 GLU~? 26.98 C3 GOL D 601 coo 45.09 114.33 52.30 45.59 116.18 51.29 31.74 1.70 -54.05 32.37 -0.33 -54.30 coo 41.10 116.46 52.80 42.09 116.00 54.64 35.65 1.59 -52.48 36.44 -0.37 -52.06 coo 42.69 118.64 56.27 44.58 118.34 55.45 35.24 -3.52 -50.42 34.05 -5.26 -50.80 1myr_c00 source 1myr MYROSINASE : 3 hits 1myr_c00 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 338 HIS~? 19.64 C1 EDO B 603 A 197 ASP A 357 ASP.? 25.14 C1 EDO B 603 A 223 ALA B 428 ALA.? 31.84 C1 EDO B 603 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 16.13 23.68 19.02 16.84 23.99 20.97 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 22.54 16.74 19.72 22.05 16.00 21.61 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 20.07 24.52 30.82 20.88 25.70 31.37 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS A 338 HIS~? 19.64 C1 EDO B 603 A 197 ASP B 402 ASP.? 23.46 C2 EDO B 603 A 223 ALA B 428 ALA.? 31.84 C1 EDO B 603 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 16.13 23.68 19.02 16.84 23.99 20.97 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 8.17 23.01 23.39 8.93 22.69 25.33 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 20.07 24.52 30.82 20.88 25.70 31.37 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 197 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 223 ALA A 428 ALA.? 23.52 O1 EDO B 603 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 18.87 16.83 -6.49 16.77 17.04 -6.49 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 28.89 26.05 -8.94 30.39 25.95 -8.77 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 A 114 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 197 ASP B 357 ASP.? 13.04 C1 EDO B 603 A 223 ALA A 428 ALA.? 23.52 O1 EDO B 603 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 19.95 30.44 0.55 20.02 30.85 -1.53 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 28.89 26.05 -8.94 30.39 25.95 -8.77 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 A 114 HIS C 338 HIS~? 12.91 O1 EDO C 602 A 197 ASP C 357 ASP.? 12.50 O2 EDO C 602 A 223 ALA D 428 ALA.? 23.04 O1 EDO C 602 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 32.02 20.63 -38.57 31.77 21.72 -40.39 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 39.85 16.46 -48.84 41.33 16.15 -48.85 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 A 114 HIS C 338 HIS~? 12.91 O1 EDO C 602 A 197 ASP D 402 ASP.? 14.20 O1 EDO C 602 A 223 ALA D 428 ALA.? 23.04 O1 EDO C 602 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 28.53 7.95 -46.44 29.10 9.08 -48.14 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 39.85 16.46 -48.84 41.33 16.15 -48.85 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 A 114 HIS D 338 HIS~? 13.70 C1 GOL D 601 A 197 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 223 ALA C 428 ALA.? 24.22 O2 GOL D 601 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 29.23 12.85 -20.11 30.06 13.12 -18.20 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 22.26 13.02 -15.38 21.01 11.37 -15.92 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 34.28 13.61 -8.51 35.19 14.79 -8.24 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 A 114 HIS D 338 HIS~? 13.70 C1 GOL D 601 A 197 ASP D 357 ASP.? 12.64 O3 GOL D 601 A 223 ALA C 428 ALA.? 24.22 O2 GOL D 601 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 29.23 12.85 -20.11 30.06 13.12 -18.20 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 34.52 5.19 -20.65 34.58 3.94 -18.98 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 34.28 13.61 -8.51 35.19 14.79 -8.24 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 8 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 338 HIS~? 19.64 C1 EDO B 603 B 197 ASP A 357 ASP.? 25.14 C1 EDO B 603 B 223 ALA B 428 ALA.? 31.84 C1 EDO B 603 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 16.13 23.68 19.02 16.84 23.99 20.97 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 22.54 16.74 19.72 22.05 16.00 21.61 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 20.07 24.52 30.82 20.88 25.70 31.37 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS A 338 HIS~? 19.64 C1 EDO B 603 B 197 ASP B 402 ASP.? 23.46 C2 EDO B 603 B 223 ALA B 428 ALA.? 31.84 C1 EDO B 603 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 16.13 23.68 19.02 16.84 23.99 20.97 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 8.17 23.01 23.39 8.93 22.69 25.33 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 20.07 24.52 30.82 20.88 25.70 31.37 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS B 338 HIS.? 13.66 O1 EDO B 603 B 197 ASP A 402 ASP.? 12.59 O1 EDO B 603 B 223 ALA A 428 ALA.? 23.52 O1 EDO B 603 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 18.87 16.83 -6.49 16.77 17.04 -6.49 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 28.89 26.05 -8.94 30.39 25.95 -8.77 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 B 114 HIS B 338 HIS.? 13.66 O1 EDO B 603 B 197 ASP B 357 ASP.? 13.04 C1 EDO B 603 B 223 ALA A 428 ALA.? 23.52 O1 EDO B 603 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 19.95 30.44 0.55 20.02 30.85 -1.53 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 28.89 26.05 -8.94 30.39 25.95 -8.77 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 B 114 HIS C 338 HIS~? 12.91 O1 EDO C 602 B 197 ASP C 357 ASP.? 12.50 O2 EDO C 602 B 223 ALA D 428 ALA.? 23.04 O1 EDO C 602 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 32.02 20.63 -38.57 31.77 21.72 -40.39 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 39.85 16.46 -48.84 41.33 16.15 -48.85 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 B 114 HIS C 338 HIS~? 12.91 O1 EDO C 602 B 197 ASP D 402 ASP.? 14.20 O1 EDO C 602 B 223 ALA D 428 ALA.? 23.04 O1 EDO C 602 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 28.53 7.95 -46.44 29.10 9.08 -48.14 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 39.85 16.46 -48.84 41.33 16.15 -48.85 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 B 114 HIS D 338 HIS~? 13.70 C1 GOL D 601 B 197 ASP C 402 ASP.? 12.78 O1 GOL D 601 B 223 ALA C 428 ALA.? 24.22 O2 GOL D 601 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 29.23 12.85 -20.11 30.06 13.12 -18.20 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 22.26 13.02 -15.38 21.01 11.37 -15.92 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 34.28 13.61 -8.51 35.19 14.79 -8.24 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 B 114 HIS D 338 HIS~? 13.70 C1 GOL D 601 B 197 ASP D 357 ASP.? 12.64 O3 GOL D 601 B 223 ALA C 428 ALA.? 24.22 O2 GOL D 601 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 29.23 12.85 -20.11 30.06 13.12 -18.20 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 34.52 5.19 -20.65 34.58 3.94 -18.98 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 34.28 13.61 -8.51 35.19 14.79 -8.24 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 8 hits 1n2t_c03 naa= 3 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 1 3 # 1 A 264 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 290 LYS A 403 LYS^? 8.85 O1 EDO B 603 A 405 ARG A 397 ARG~? 24.94 O2 GOL D 601 coo 41.33 25.99 28.05 41.95 26.95 29.80 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 37.11 33.75 31.82 38.72 27.95 29.90 17.56 13.24 -3.73 14.59 17.27 -0.83 coo 42.28 27.98 41.30 43.16 28.14 38.35 31.00 11.06 -6.51 32.72 12.02 -4.11 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 2 3 # 2 A 264 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 290 LYS A 403 LYS^? 8.85 O1 EDO B 603 A 405 ARG C 425 ARG^? 21.48 O1 GOL D 601 coo 41.33 25.99 28.05 41.95 26.95 29.80 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 37.11 33.75 31.82 38.72 27.95 29.90 17.56 13.24 -3.73 14.59 17.27 -0.83 coo 42.28 27.98 41.30 43.16 28.14 38.35 27.32 15.93 -12.34 26.51 18.69 -11.26 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 3 3 # 3 A 264 HIS B 381 HIS.? 15.29 C2 EDO B 603 A 290 LYS B 367 LYS.? 8.96 O2 EDO B 603 A 405 ARG B 375 ARG.? 22.49 O2 EDO B 603 coo 41.33 25.99 28.05 41.95 26.95 29.80 4.86 38.27 11.07 6.17 36.67 11.45 coo 37.11 33.75 31.82 38.72 27.95 29.90 8.46 36.63 1.57 6.31 34.95 -1.21 coo 42.28 27.98 41.30 43.16 28.14 38.35 13.81 46.43 8.85 13.44 47.64 6.03 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 4 3 # 4 A 264 HIS D 338 HIS~? 13.70 C1 GOL D 601 A 290 LYS C 403 LYS^? 9.83 O1 GOL D 601 A 405 ARG A 425 ARG^? 21.19 O1 EDO B 603 coo 41.33 25.99 28.05 41.95 26.95 29.80 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 37.11 33.75 31.82 38.72 27.95 29.90 19.56 15.05 -18.65 18.30 10.78 -20.22 coo 42.28 27.98 41.30 43.16 28.14 38.35 25.04 18.93 -7.11 26.86 16.62 -8.01 1nhx_c00 source 1nhx PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC : 4 hits 1nhx_c00 naa= 3 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 1 3 # 1 549 LYS A 390 LYS~? 25.88 O2 GOL D 601 631 LYS C 403 LYS^? 9.83 O1 GOL D 601 708 LYS A 384 LYS~? 32.89 O2 GOL D 601 coo 8.61 33.06 11.15 10.12 29.19 8.82 26.64 2.81 -1.98 30.91 -1.55 -0.35 coo -11.99 27.40 17.14 -13.60 24.52 11.71 19.56 15.05 -18.65 18.30 10.78 -20.22 coo 18.16 32.86 9.85 16.06 28.20 13.56 23.52 -5.65 3.37 24.45 -7.36 6.79 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 2 3 # 2 549 LYS C 388 LYS~? 20.15 C2 EDO C 602 631 LYS A 403 LYS^? 8.85 O1 EDO B 603 708 LYS C 384 LYS~? 20.68 O2 EDO C 602 coo 8.61 33.06 11.15 10.12 29.19 8.82 13.46 28.58 -20.25 9.42 25.73 -22.18 coo -11.99 27.40 17.14 -13.60 24.52 11.71 17.56 13.24 -3.73 14.59 17.27 -0.83 coo 18.16 32.86 9.85 16.06 28.20 13.56 11.81 35.96 -24.38 11.26 34.03 -29.22 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 3 3 # 3 549 LYS C 390 LYS~? 21.48 O2 EDO B 603 631 LYS A 403 LYS^? 8.85 O1 EDO B 603 708 LYS C 384 LYS~? 20.68 O2 EDO C 602 coo 8.61 33.06 11.15 10.12 29.19 8.82 17.95 29.37 -17.21 18.11 35.53 -15.65 coo -11.99 27.40 17.14 -13.60 24.52 11.71 17.56 13.24 -3.73 14.59 17.27 -0.83 coo 18.16 32.86 9.85 16.06 28.20 13.56 11.81 35.96 -24.38 11.26 34.03 -29.22 1nsf_c00 source 1nsf N-ETHYLMALEIMIDE SENSITIVE FACTOR : 3 hits 1nsf_c00 naa= 3 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 401 ARG.? 15.99 O2 GOL D 601 A 101 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 132 ASP C 402 ASP.? 12.78 O1 GOL D 601 coo 11.61 22.83 17.30 14.06 21.71 15.78 17.05 9.37 -8.73 16.66 7.27 -10.98 coo 11.37 24.94 11.48 12.48 24.45 13.28 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 16.14 18.17 13.37 15.92 19.81 14.71 22.26 13.02 -15.38 21.01 11.37 -15.92 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG A 425 ARG^? 21.19 O1 EDO B 603 A 101 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 132 ASP C 430 ASP.? 26.01 O2 GOL D 601 coo 11.61 22.83 17.30 14.06 21.71 15.78 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 11.37 24.94 11.48 12.48 24.45 13.28 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 16.14 18.17 13.37 15.92 19.81 14.71 33.23 18.77 -9.92 33.78 18.54 -7.88 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG C 401 ARG.? 15.33 O1 EDO B 603 A 101 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 132 ASP A 402 ASP.? 12.59 O1 EDO B 603 coo 11.61 22.83 17.30 14.06 21.71 15.78 15.13 16.06 -14.86 13.60 17.63 -12.63 coo 11.37 24.94 11.48 12.48 24.45 13.28 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 16.14 18.17 13.37 15.92 19.81 14.71 18.87 16.83 -6.49 16.77 17.04 -6.49 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 A 99 ARG C 425 ARG^? 21.48 O1 GOL D 601 A 101 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 132 ASP A 430 ASP.? 25.41 O1 EDO B 603 coo 11.61 22.83 17.30 14.06 21.71 15.78 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 11.37 24.94 11.48 12.48 24.45 13.28 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 16.14 18.17 13.37 15.92 19.81 14.71 31.59 21.51 -7.17 32.38 22.31 -9.00 1nu3_c00 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 4 hits 1nu3_c00 naa= 3 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 401 ARG.? 15.99 O2 GOL D 601 B 101 ASP A 402 ASP.? 12.59 O1 EDO B 603 B 132 ASP C 402 ASP.? 12.78 O1 GOL D 601 coo 11.61 3.43 18.38 9.11 4.29 16.86 17.05 9.37 -8.73 16.66 7.27 -10.98 coo 11.74 0.51 12.98 10.75 1.32 14.67 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 6.93 7.52 14.08 7.18 6.08 15.65 22.26 13.02 -15.38 21.01 11.37 -15.92 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG A 425 ARG^? 21.19 O1 EDO B 603 B 101 ASP A 426 ASP.? 22.31 O1 EDO B 603 B 132 ASP C 430 ASP.? 26.01 O2 GOL D 601 coo 11.61 3.43 18.38 9.11 4.29 16.86 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 11.74 0.51 12.98 10.75 1.32 14.67 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 6.93 7.52 14.08 7.18 6.08 15.65 33.23 18.77 -9.92 33.78 18.54 -7.88 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG C 401 ARG.? 15.33 O1 EDO B 603 B 101 ASP C 402 ASP.? 12.78 O1 GOL D 601 B 132 ASP A 402 ASP.? 12.59 O1 EDO B 603 coo 11.61 3.43 18.38 9.11 4.29 16.86 15.13 16.06 -14.86 13.60 17.63 -12.63 coo 11.74 0.51 12.98 10.75 1.32 14.67 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 6.93 7.52 14.08 7.18 6.08 15.65 18.87 16.83 -6.49 16.77 17.04 -6.49 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 B 99 ARG C 425 ARG^? 21.48 O1 GOL D 601 B 101 ASP C 426 ASP.? 22.72 C2 GOL D 601 B 132 ASP A 430 ASP.? 25.41 O1 EDO B 603 coo 11.61 3.43 18.38 9.11 4.29 16.86 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 11.74 0.51 12.98 10.75 1.32 14.67 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 6.93 7.52 14.08 7.18 6.08 15.65 31.59 21.51 -7.17 32.38 22.31 -9.00 1nu3_c01 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 4 hits 1nu3_c01 naa= 3 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG C 401 ARG.? 15.33 O1 EDO B 603 A 101 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 132 ASP A 402 ASP.? 12.59 O1 EDO B 603 coo 11.50 22.77 17.24 14.00 21.62 15.86 15.13 16.06 -14.86 13.60 17.63 -12.63 coo 11.19 25.00 11.76 12.16 24.45 13.59 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 16.04 18.11 13.43 15.88 19.70 14.83 18.87 16.83 -6.49 16.77 17.04 -6.49 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG C 425 ARG^? 21.48 O1 GOL D 601 A 101 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 132 ASP A 430 ASP.? 25.41 O1 EDO B 603 coo 11.50 22.77 17.24 14.00 21.62 15.86 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 11.19 25.00 11.76 12.16 24.45 13.59 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 16.04 18.11 13.43 15.88 19.70 14.83 31.59 21.51 -7.17 32.38 22.31 -9.00 1nww_c02 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 2 hits 1nww_c02 naa= 3 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG C 401 ARG.? 15.33 O1 EDO B 603 B 101 ASP C 402 ASP.? 12.78 O1 GOL D 601 B 132 ASP A 402 ASP.? 12.59 O1 EDO B 603 coo 11.48 3.09 18.25 9.01 4.07 16.77 15.13 16.06 -14.86 13.60 17.63 -12.63 coo 11.83 0.33 13.01 10.88 1.04 14.81 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 6.85 7.33 14.07 7.10 5.88 15.60 18.87 16.83 -6.49 16.77 17.04 -6.49 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG C 425 ARG^? 21.48 O1 GOL D 601 B 101 ASP C 426 ASP.? 22.72 C2 GOL D 601 B 132 ASP A 430 ASP.? 25.41 O1 EDO B 603 coo 11.48 3.09 18.25 9.01 4.07 16.77 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 11.83 0.33 13.01 10.88 1.04 14.81 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 6.85 7.33 14.07 7.10 5.88 15.60 31.59 21.51 -7.17 32.38 22.31 -9.00 1nww_c03 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 2 hits 1nww_c03 naa= 3 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 1 3 # 1 B 1 CYH B 380 CYH~? 15.26 O2 EDO B 603 B 903 GLU A 342 GLU^? 20.93 C1 EDO B 603 B 972 LYS A 442 LYS~? 23.27 C1 EDO B 603 coo 31.47 38.87 24.90 30.94 36.98 26.93 8.08 40.31 9.00 10.50 39.00 9.22 coo 4.13 40.53 14.21 5.06 38.89 15.19 16.70 11.35 13.94 16.42 9.25 14.14 coo 4.08 30.40 21.12 1.62 33.28 16.83 2.76 10.16 11.03 0.96 5.43 12.32 1ofd_c03 source 1ofd FERREDOXIN-DEPENDENT GLUTAMATE SYNTHASE 2 : 1 hits 1ofd_c03 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP D 350 ASP.? 24.09 C3 GOL D 601 A 146 TYR D 421 TYR^? 13.63 C3 GOL D 601 A 177 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo -3.50 124.89 25.05 -2.25 124.77 23.26 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 1.87 119.38 16.45 1.41 122.11 16.84 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo -2.59 124.07 12.67 -0.91 126.17 18.42 31.25 -9.34 -42.79 29.68 -12.48 -44.35 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP D 350 ASP.? 24.09 C3 GOL D 601 B 146 TYR D 421 TYR^? 13.63 C3 GOL D 601 B 177 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo -7.43 109.06 51.23 -5.84 110.54 50.86 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 0.22 114.56 44.62 -0.76 115.18 47.18 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo -4.18 120.17 46.85 -4.02 115.31 51.00 31.25 -9.34 -42.79 29.68 -12.48 -44.35 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP D 350 ASP.? 24.09 C3 GOL D 601 C 146 TYR D 421 TYR^? 13.63 C3 GOL D 601 C 177 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo -13.49 79.65 43.90 -12.13 80.29 45.45 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo -5.65 86.78 48.49 -7.16 84.72 49.65 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo -11.22 87.18 53.49 -10.94 81.64 50.31 31.25 -9.34 -42.79 29.68 -12.48 -44.35 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP D 350 ASP.? 24.09 C3 GOL D 601 D 146 TYR D 421 TYR^? 13.63 C3 GOL D 601 D 177 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo -13.44 77.36 13.12 -12.53 75.97 14.48 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo -7.85 74.44 22.75 -9.22 72.86 20.89 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo -14.24 70.61 23.48 -12.55 71.73 17.42 31.25 -9.34 -42.79 29.68 -12.48 -44.35 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP D 350 ASP.? 24.09 C3 GOL D 601 E 146 TYR D 421 TYR^? 13.63 C3 GOL D 601 E 177 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo -7.12 105.25 1.43 -6.30 103.34 0.77 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo -3.11 94.55 3.01 -3.83 95.92 0.66 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 31.25 -9.34 -42.79 29.68 -12.48 -44.35 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP D 350 ASP.? 24.09 C3 GOL D 601 F 146 TYR D 421 TYR^? 13.63 C3 GOL D 601 F 177 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo -44.75 128.15 10.28 -45.68 129.67 11.55 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo -50.43 131.90 19.60 -49.04 133.31 17.60 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo -44.10 135.86 19.99 -45.67 134.21 14.07 31.25 -9.34 -42.79 29.68 -12.48 -44.35 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP D 350 ASP.? 24.09 C3 GOL D 601 G 146 TYR D 421 TYR^? 13.63 C3 GOL D 601 G 177 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo -44.97 128.78 41.20 -46.32 128.26 42.83 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo -52.83 122.13 46.42 -51.31 124.30 47.39 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo -47.30 122.24 51.49 -47.46 127.44 47.81 31.25 -9.34 -42.79 29.68 -12.48 -44.35 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP D 350 ASP.? 24.09 C3 GOL D 601 H 146 TYR D 421 TYR^? 13.63 C3 GOL D 601 H 177 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo -51.11 100.30 51.41 -52.67 98.82 51.12 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo -58.70 94.17 45.32 -57.76 93.82 47.92 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo -54.32 88.79 48.13 -54.61 94.04 51.74 31.25 -9.34 -42.79 29.68 -12.48 -44.35 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP D 350 ASP.? 24.09 C3 GOL D 601 I 146 TYR D 421 TYR^? 13.63 C3 GOL D 601 I 177 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo -54.65 81.97 26.87 -55.88 81.89 25.07 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo -59.92 86.62 17.74 -59.42 83.94 18.40 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo -55.38 81.61 14.50 -57.11 80.05 20.41 31.25 -9.34 -42.79 29.68 -12.48 -44.35 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP D 350 ASP.? 24.09 C3 GOL D 601 J 146 TYR D 421 TYR^? 13.63 C3 GOL D 601 J 177 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo -50.64 99.08 1.52 -51.52 100.83 0.67 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 31.25 -9.34 -42.79 29.68 -12.48 -44.35 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 350 ASP.? 26.92 O2 GOL D 601 A 96 GLU A 394 GLU~? 15.90 O2 GOL D 601 A 132 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo 31.23 12.29 16.44 30.82 11.56 18.39 33.51 7.96 1.59 32.78 7.85 -0.37 coo 26.82 3.20 24.36 27.99 4.86 24.98 27.33 5.77 -8.72 27.90 4.03 -9.75 coo 29.99 0.62 22.18 30.38 6.69 20.81 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 96 GLU C 394 GLU~? 16.86 O1 EDO B 603 A 132 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 31.23 12.29 16.44 30.82 11.56 18.39 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 26.82 3.20 24.36 27.99 4.86 24.98 19.77 27.90 -12.93 18.57 29.44 -12.10 coo 29.99 0.62 22.18 30.38 6.69 20.81 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1onr_c00 TRANSALDOLASE B user 3 3 # 3 A 17 ASP B 349 ASP.? 28.06 C2 EDO B 603 A 96 GLU B 394 GLU~? 28.21 C2 EDO B 603 A 132 LYS B 390 LYS~? 27.12 C2 EDO B 603 coo 31.23 12.29 16.44 30.82 11.56 18.39 17.36 41.29 21.17 18.85 41.14 22.68 coo 26.82 3.20 24.36 27.99 4.86 24.98 4.47 36.77 26.38 2.63 37.63 26.96 coo 29.99 0.62 22.18 30.38 6.69 20.81 3.52 38.72 20.17 3.15 45.06 20.21 ULMN 3 1onr_c00 TRANSALDOLASE B user 4 3 # 4 A 17 ASP B 350 ASP.? 23.89 C2 EDO B 603 A 96 GLU B 394 GLU~? 28.21 C2 EDO B 603 A 132 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo 31.23 12.29 16.44 30.82 11.56 18.39 12.16 40.72 19.41 11.14 39.74 20.98 coo 26.82 3.20 24.36 27.99 4.86 24.98 4.47 36.77 26.38 2.63 37.63 26.96 coo 29.99 0.62 22.18 30.38 6.69 20.81 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 1onr_c00 TRANSALDOLASE B user 5 3 # 5 A 17 ASP B 402 ASP.? 23.46 C2 EDO B 603 A 96 GLU B 394 GLU~? 28.21 C2 EDO B 603 A 132 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo 31.23 12.29 16.44 30.82 11.56 18.39 8.17 23.01 23.39 8.93 22.69 25.33 coo 26.82 3.20 24.36 27.99 4.86 24.98 4.47 36.77 26.38 2.63 37.63 26.96 coo 29.99 0.62 22.18 30.38 6.69 20.81 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 1onr_c00 TRANSALDOLASE B user 6 3 # 6 A 17 ASP C 349 ASP.? 28.09 C1 EDO C 602 A 96 GLU C 394 GLU~? 16.86 O1 EDO B 603 A 132 LYS C 390 LYS~? 21.48 O2 EDO B 603 coo 31.23 12.29 16.44 30.82 11.56 18.39 32.59 30.21 -17.31 34.23 29.55 -16.13 coo 26.82 3.20 24.36 27.99 4.86 24.98 19.77 27.90 -12.93 18.57 29.44 -12.10 coo 29.99 0.62 22.18 30.38 6.69 20.81 17.95 29.37 -17.21 18.11 35.53 -15.65 ULMN 3 1onr_c00 TRANSALDOLASE B user 7 3 # 7 A 17 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 96 GLU A 394 GLU~? 15.90 O2 GOL D 601 A 132 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo 31.23 12.29 16.44 30.82 11.56 18.39 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 26.82 3.20 24.36 27.99 4.86 24.98 27.33 5.77 -8.72 27.90 4.03 -9.75 coo 29.99 0.62 22.18 30.38 6.69 20.81 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 1onr_c00 TRANSALDOLASE B user 8 3 # 8 A 17 ASP D 350 ASP.? 24.09 C3 GOL D 601 A 96 GLU D 394 GLU~? 26.98 C3 GOL D 601 A 132 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo 31.23 12.29 16.44 30.82 11.56 18.39 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 26.82 3.20 24.36 27.99 4.86 24.98 35.24 -3.52 -50.42 34.05 -5.26 -50.80 coo 29.99 0.62 22.18 30.38 6.69 20.81 32.90 -6.30 -46.84 30.42 -11.34 -47.14 ULMN 3 1onr_c00 TRANSALDOLASE B user 9 3 # 9 A 17 ASP D 402 ASP.? 14.20 O1 EDO C 602 A 96 GLU D 394 GLU~? 26.98 C3 GOL D 601 A 132 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo 31.23 12.29 16.44 30.82 11.56 18.39 28.53 7.95 -46.44 29.10 9.08 -48.14 coo 26.82 3.20 24.36 27.99 4.86 24.98 35.24 -3.52 -50.42 34.05 -5.26 -50.80 coo 29.99 0.62 22.18 30.38 6.69 20.81 32.90 -6.30 -46.84 30.42 -11.34 -47.14 ULMN 3 1onr_c00 TRANSALDOLASE B user 10 3 # 10 A 17 ASP D 448 ASP.? 19.66 C2 EDO C 602 A 96 GLU C 446 GLU~? 12.66 O1 EDO C 602 A 132 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 31.23 12.29 16.44 30.82 11.56 18.39 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 26.82 3.20 24.36 27.99 4.86 24.98 12.37 5.19 -42.08 12.22 7.23 -42.76 coo 29.99 0.62 22.18 30.38 6.69 20.81 12.96 9.36 -37.91 9.04 10.02 -41.38 1onr_c00 source 1onr TRANSALDOLASE B : 10 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 350 ASP.? 26.92 O2 GOL D 601 B 96 GLU A 394 GLU~? 15.90 O2 GOL D 601 B 132 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo 31.16 57.31 -0.94 30.73 56.64 1.01 33.51 7.96 1.59 32.78 7.85 -0.37 coo 26.69 48.45 7.18 27.85 50.13 7.74 27.33 5.77 -8.72 27.90 4.03 -9.75 coo 29.82 45.80 5.07 30.26 51.81 3.56 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP A 402 ASP.? 12.59 O1 EDO B 603 B 96 GLU C 394 GLU~? 16.86 O1 EDO B 603 B 132 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 31.16 57.31 -0.94 30.73 56.64 1.01 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 26.69 48.45 7.18 27.85 50.13 7.74 19.77 27.90 -12.93 18.57 29.44 -12.10 coo 29.82 45.80 5.07 30.26 51.81 3.56 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1onr_c01 TRANSALDOLASE B user 3 3 # 3 B 17 ASP B 349 ASP.? 28.06 C2 EDO B 603 B 96 GLU B 394 GLU~? 28.21 C2 EDO B 603 B 132 LYS B 390 LYS~? 27.12 C2 EDO B 603 coo 31.16 57.31 -0.94 30.73 56.64 1.01 17.36 41.29 21.17 18.85 41.14 22.68 coo 26.69 48.45 7.18 27.85 50.13 7.74 4.47 36.77 26.38 2.63 37.63 26.96 coo 29.82 45.80 5.07 30.26 51.81 3.56 3.52 38.72 20.17 3.15 45.06 20.21 ULMN 3 1onr_c01 TRANSALDOLASE B user 4 3 # 4 B 17 ASP B 350 ASP.? 23.89 C2 EDO B 603 B 96 GLU B 394 GLU~? 28.21 C2 EDO B 603 B 132 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo 31.16 57.31 -0.94 30.73 56.64 1.01 12.16 40.72 19.41 11.14 39.74 20.98 coo 26.69 48.45 7.18 27.85 50.13 7.74 4.47 36.77 26.38 2.63 37.63 26.96 coo 29.82 45.80 5.07 30.26 51.81 3.56 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 1onr_c01 TRANSALDOLASE B user 5 3 # 5 B 17 ASP B 402 ASP.? 23.46 C2 EDO B 603 B 96 GLU B 394 GLU~? 28.21 C2 EDO B 603 B 132 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo 31.16 57.31 -0.94 30.73 56.64 1.01 8.17 23.01 23.39 8.93 22.69 25.33 coo 26.69 48.45 7.18 27.85 50.13 7.74 4.47 36.77 26.38 2.63 37.63 26.96 coo 29.82 45.80 5.07 30.26 51.81 3.56 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 1onr_c01 TRANSALDOLASE B user 6 3 # 6 B 17 ASP C 349 ASP.? 28.09 C1 EDO C 602 B 96 GLU C 394 GLU~? 16.86 O1 EDO B 603 B 132 LYS C 390 LYS~? 21.48 O2 EDO B 603 coo 31.16 57.31 -0.94 30.73 56.64 1.01 32.59 30.21 -17.31 34.23 29.55 -16.13 coo 26.69 48.45 7.18 27.85 50.13 7.74 19.77 27.90 -12.93 18.57 29.44 -12.10 coo 29.82 45.80 5.07 30.26 51.81 3.56 17.95 29.37 -17.21 18.11 35.53 -15.65 ULMN 3 1onr_c01 TRANSALDOLASE B user 7 3 # 7 B 17 ASP C 402 ASP.? 12.78 O1 GOL D 601 B 96 GLU A 394 GLU~? 15.90 O2 GOL D 601 B 132 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo 31.16 57.31 -0.94 30.73 56.64 1.01 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 26.69 48.45 7.18 27.85 50.13 7.74 27.33 5.77 -8.72 27.90 4.03 -9.75 coo 29.82 45.80 5.07 30.26 51.81 3.56 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 1onr_c01 TRANSALDOLASE B user 8 3 # 8 B 17 ASP D 350 ASP.? 24.09 C3 GOL D 601 B 96 GLU D 394 GLU~? 26.98 C3 GOL D 601 B 132 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo 31.16 57.31 -0.94 30.73 56.64 1.01 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 26.69 48.45 7.18 27.85 50.13 7.74 35.24 -3.52 -50.42 34.05 -5.26 -50.80 coo 29.82 45.80 5.07 30.26 51.81 3.56 32.90 -6.30 -46.84 30.42 -11.34 -47.14 ULMN 3 1onr_c01 TRANSALDOLASE B user 9 3 # 9 B 17 ASP D 402 ASP.? 14.20 O1 EDO C 602 B 96 GLU D 394 GLU~? 26.98 C3 GOL D 601 B 132 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo 31.16 57.31 -0.94 30.73 56.64 1.01 28.53 7.95 -46.44 29.10 9.08 -48.14 coo 26.69 48.45 7.18 27.85 50.13 7.74 35.24 -3.52 -50.42 34.05 -5.26 -50.80 coo 29.82 45.80 5.07 30.26 51.81 3.56 32.90 -6.30 -46.84 30.42 -11.34 -47.14 ULMN 3 1onr_c01 TRANSALDOLASE B user 10 3 # 10 B 17 ASP D 448 ASP.? 19.66 C2 EDO C 602 B 96 GLU C 446 GLU~? 12.66 O1 EDO C 602 B 132 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 31.16 57.31 -0.94 30.73 56.64 1.01 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 26.69 48.45 7.18 27.85 50.13 7.74 12.37 5.19 -42.08 12.22 7.23 -42.76 coo 29.82 45.80 5.07 30.26 51.81 3.56 12.96 9.36 -37.91 9.04 10.02 -41.38 1onr_c01 source 1onr TRANSALDOLASE B : 10 hits 1onr_c01 naa= 3 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 A 102 ASP D 387 ASP~? 25.32 O3 GOL D 601 A 167 LYS D 390 LYS~? 25.65 O3 GOL D 601 A 201 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo 26.53 8.31 20.37 28.45 8.41 19.40 33.33 -13.12 -43.54 32.71 -13.42 -45.54 coo 24.92 6.08 13.38 27.75 4.33 18.83 35.81 -6.92 -44.49 39.58 -10.95 -43.36 coo 29.08 5.53 11.69 30.46 5.61 17.93 32.90 -6.30 -46.84 30.42 -11.34 -47.14 1p1x_c00 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 1 hits 1p1x_c00 naa= 3 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 B1102 ASP A 387 ASP~? 25.21 O2 GOL D 601 B1167 LYS A 390 LYS~? 25.88 O2 GOL D 601 B1201 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo 26.10 12.11 49.61 24.19 12.48 50.51 25.11 -3.56 -1.18 26.67 -4.92 -0.75 coo 27.70 11.69 56.92 24.82 8.55 52.12 26.64 2.81 -1.98 30.91 -1.55 -0.35 coo 23.50 11.64 58.67 22.19 10.19 52.59 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 2 3 # 2 B1102 ASP D 387 ASP~? 25.32 O3 GOL D 601 B1167 LYS D 390 LYS~? 25.65 O3 GOL D 601 B1201 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo 26.10 12.11 49.61 24.19 12.48 50.51 33.33 -13.12 -43.54 32.71 -13.42 -45.54 coo 27.70 11.69 56.92 24.82 8.55 52.12 35.81 -6.92 -44.49 39.58 -10.95 -43.36 coo 23.50 11.64 58.67 22.19 10.19 52.59 32.90 -6.30 -46.84 30.42 -11.34 -47.14 1p1x_c01 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 2 hits 1p1x_c01 naa= 3 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 1 3 # 1 A 16 TYR B 418 TYR^? 11.01 C2 EDO B 603 A 38 GLU A 446 GLU~? 20.77 C2 EDO B 603 A 46 TRP B 407 TRP^? 14.83 C2 EDO B 603 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 3.01 21.54 9.44 2.74 20.74 12.09 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 -3.62 12.85 13.27 -2.92 11.09 12.27 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -3.73 22.30 9.20 -2.79 21.98 13.01 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 2 3 # 2 A 16 TYR C 418 TYR^? 10.50 O1 GOL D 601 A 38 GLU D 446 GLU~? 12.65 O1 GOL D 601 A 46 TRP C 407 TRP^? 15.00 C2 EDO C 602 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 15.25 12.39 -28.72 15.00 11.49 -26.08 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 8.69 3.92 -24.74 9.85 4.42 -23.05 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 8.62 13.87 -28.54 9.69 13.09 -24.84 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 3 3 # 3 A 16 TYR D 418 TYR^? 10.77 C1 GOL D 601 A 38 GLU C 446 GLU~? 12.66 O1 EDO C 602 A 46 TRP D 407 TRP^? 14.97 C3 GOL D 601 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 20.16 1.85 -35.57 20.10 2.87 -38.19 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 12.37 5.19 -42.08 12.22 7.23 -42.76 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 16.64 -3.51 -37.62 17.68 -1.39 -40.78 1p7m_c00 source 1p7m DNA-3-METHYLADENINE GLYCOSYLASE I : 3 hits 1p7m_c00 naa= 3 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 358 SER.? 19.71 C1 EDO B 603 A 709 ASP B 402 ASP.? 23.46 C2 EDO B 603 A 740 HIS A 338 HIS~? 19.64 C1 EDO B 603 coo -7.09 7.44 6.22 -7.53 5.14 5.59 17.92 16.03 18.01 17.94 14.38 16.23 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 8.17 23.01 23.39 8.93 22.69 25.33 coo -8.70 2.86 9.96 -8.03 3.92 8.29 16.13 23.68 19.02 16.84 23.99 20.97 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER A 358 SER.? 19.71 C1 EDO B 603 A 709 ASP B 426 ASP.? 28.68 C1 EDO B 603 A 740 HIS A 338 HIS~? 19.64 C1 EDO B 603 coo -7.09 7.44 6.22 -7.53 5.14 5.59 17.92 16.03 18.01 17.94 14.38 16.23 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 21.11 26.70 26.04 20.61 27.63 27.90 coo -8.70 2.86 9.96 -8.03 3.92 8.29 16.13 23.68 19.02 16.84 23.99 20.97 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 A 630 SER B 358 SER.? 7.25 C1 EDO B 603 A 709 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 740 HIS B 338 HIS.? 13.66 O1 EDO B 603 coo -7.09 7.44 6.22 -7.53 5.14 5.59 16.90 26.63 0.02 16.29 24.39 0.69 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 18.87 16.83 -6.49 16.77 17.04 -6.49 coo -8.70 2.86 9.96 -8.03 3.92 8.29 21.66 21.37 -0.01 22.97 22.11 -1.47 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 A 630 SER B 358 SER.? 7.25 C1 EDO B 603 A 709 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 740 HIS B 338 HIS.? 13.66 O1 EDO B 603 coo -7.09 7.44 6.22 -7.53 5.14 5.59 16.90 26.63 0.02 16.29 24.39 0.69 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 29.17 24.78 -3.72 30.40 24.16 -5.34 coo -8.70 2.86 9.96 -8.03 3.92 8.29 21.66 21.37 -0.01 22.97 22.11 -1.47 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 5 3 # 5 A 630 SER C 358 SER.? 6.66 O1 EDO C 602 A 709 ASP D 402 ASP.? 14.20 O1 EDO C 602 A 740 HIS C 338 HIS~? 12.91 O1 EDO C 602 coo -7.09 7.44 6.22 -7.53 5.14 5.59 28.49 17.26 -38.81 27.76 14.99 -38.31 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 28.53 7.95 -46.44 29.10 9.08 -48.14 coo -8.70 2.86 9.96 -8.03 3.92 8.29 32.85 11.57 -39.74 34.04 12.36 -41.28 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 6 3 # 6 A 630 SER C 358 SER.? 6.66 O1 EDO C 602 A 709 ASP D 426 ASP.? 21.84 O1 EDO C 602 A 740 HIS C 338 HIS~? 12.91 O1 EDO C 602 coo -7.09 7.44 6.22 -7.53 5.14 5.59 28.49 17.26 -38.81 27.76 14.99 -38.31 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 40.54 14.64 -43.98 41.47 13.99 -45.77 coo -8.70 2.86 9.96 -8.03 3.92 8.29 32.85 11.57 -39.74 34.04 12.36 -41.28 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 7 3 # 7 A 630 SER D 358 SER.? 6.75 C2 GOL D 601 A 709 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 740 HIS D 338 HIS~? 13.70 C1 GOL D 601 coo -7.09 7.44 6.22 -7.53 5.14 5.59 29.79 5.62 -21.71 27.82 6.72 -22.45 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 22.26 13.02 -15.38 21.01 11.37 -15.92 coo -8.70 2.86 9.96 -8.03 3.92 8.29 29.23 12.85 -20.11 30.06 13.12 -18.20 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 8 3 # 8 A 630 SER D 358 SER.? 6.75 C2 GOL D 601 A 709 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 740 HIS D 338 HIS~? 13.70 C1 GOL D 601 coo -7.09 7.44 6.22 -7.53 5.14 5.59 29.79 5.62 -21.71 27.82 6.72 -22.45 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 35.09 15.28 -13.55 34.97 16.40 -11.75 coo -8.70 2.86 9.96 -8.03 3.92 8.29 29.23 12.85 -20.11 30.06 13.12 -18.20 1pfq_c02 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 8 hits 1pfq_c02 naa= 3 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 358 SER.? 19.71 C1 EDO B 603 B 709 ASP B 402 ASP.? 23.46 C2 EDO B 603 B 740 HIS A 338 HIS~? 19.64 C1 EDO B 603 coo 4.44 13.29 37.64 6.01 11.66 38.49 17.92 16.03 18.01 17.94 14.38 16.23 coo 10.26 2.81 31.69 11.64 4.30 32.43 8.17 23.01 23.39 8.93 22.69 25.33 coo 8.57 10.09 34.47 7.10 10.73 35.82 16.13 23.68 19.02 16.84 23.99 20.97 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER A 358 SER.? 19.71 C1 EDO B 603 B 709 ASP B 426 ASP.? 28.68 C1 EDO B 603 B 740 HIS A 338 HIS~? 19.64 C1 EDO B 603 coo 4.44 13.29 37.64 6.01 11.66 38.49 17.92 16.03 18.01 17.94 14.38 16.23 coo 10.26 2.81 31.69 11.64 4.30 32.43 21.11 26.70 26.04 20.61 27.63 27.90 coo 8.57 10.09 34.47 7.10 10.73 35.82 16.13 23.68 19.02 16.84 23.99 20.97 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 B 630 SER B 358 SER.? 7.25 C1 EDO B 603 B 709 ASP A 402 ASP.? 12.59 O1 EDO B 603 B 740 HIS B 338 HIS.? 13.66 O1 EDO B 603 coo 4.44 13.29 37.64 6.01 11.66 38.49 16.90 26.63 0.02 16.29 24.39 0.69 coo 10.26 2.81 31.69 11.64 4.30 32.43 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 8.57 10.09 34.47 7.10 10.73 35.82 21.66 21.37 -0.01 22.97 22.11 -1.47 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 B 630 SER B 358 SER.? 7.25 C1 EDO B 603 B 709 ASP A 426 ASP.? 22.31 O1 EDO B 603 B 740 HIS B 338 HIS.? 13.66 O1 EDO B 603 coo 4.44 13.29 37.64 6.01 11.66 38.49 16.90 26.63 0.02 16.29 24.39 0.69 coo 10.26 2.81 31.69 11.64 4.30 32.43 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 8.57 10.09 34.47 7.10 10.73 35.82 21.66 21.37 -0.01 22.97 22.11 -1.47 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 5 3 # 5 B 630 SER C 358 SER.? 6.66 O1 EDO C 602 B 709 ASP D 402 ASP.? 14.20 O1 EDO C 602 B 740 HIS C 338 HIS~? 12.91 O1 EDO C 602 coo 4.44 13.29 37.64 6.01 11.66 38.49 28.49 17.26 -38.81 27.76 14.99 -38.31 coo 10.26 2.81 31.69 11.64 4.30 32.43 28.53 7.95 -46.44 29.10 9.08 -48.14 coo 8.57 10.09 34.47 7.10 10.73 35.82 32.85 11.57 -39.74 34.04 12.36 -41.28 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 6 3 # 6 B 630 SER C 358 SER.? 6.66 O1 EDO C 602 B 709 ASP D 426 ASP.? 21.84 O1 EDO C 602 B 740 HIS C 338 HIS~? 12.91 O1 EDO C 602 coo 4.44 13.29 37.64 6.01 11.66 38.49 28.49 17.26 -38.81 27.76 14.99 -38.31 coo 10.26 2.81 31.69 11.64 4.30 32.43 40.54 14.64 -43.98 41.47 13.99 -45.77 coo 8.57 10.09 34.47 7.10 10.73 35.82 32.85 11.57 -39.74 34.04 12.36 -41.28 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 7 3 # 7 B 630 SER D 358 SER.? 6.75 C2 GOL D 601 B 709 ASP C 402 ASP.? 12.78 O1 GOL D 601 B 740 HIS D 338 HIS~? 13.70 C1 GOL D 601 coo 4.44 13.29 37.64 6.01 11.66 38.49 29.79 5.62 -21.71 27.82 6.72 -22.45 coo 10.26 2.81 31.69 11.64 4.30 32.43 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 8.57 10.09 34.47 7.10 10.73 35.82 29.23 12.85 -20.11 30.06 13.12 -18.20 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 8 3 # 8 B 630 SER D 358 SER.? 6.75 C2 GOL D 601 B 709 ASP C 426 ASP.? 22.72 C2 GOL D 601 B 740 HIS D 338 HIS~? 13.70 C1 GOL D 601 coo 4.44 13.29 37.64 6.01 11.66 38.49 29.79 5.62 -21.71 27.82 6.72 -22.45 coo 10.26 2.81 31.69 11.64 4.30 32.43 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 8.57 10.09 34.47 7.10 10.73 35.82 29.23 12.85 -20.11 30.06 13.12 -18.20 1pfq_c03 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 8 hits 1pfq_c03 naa= 3 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 1 3 # 1 A 225 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 259 TYR A 437 TYR^? 11.45 C1 EDO B 603 A 552 ASP D 448 ASP.? 19.66 C2 EDO C 602 coo 11.34 95.90 25.54 12.13 96.42 23.67 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 14.91 97.39 18.63 13.39 95.60 20.20 16.79 15.50 5.48 15.91 16.43 3.01 coo 46.37 82.54 38.83 45.97 84.66 38.77 3.66 6.43 -31.01 2.94 8.46 -31.03 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 2 3 # 2 A 225 HIS B 381 HIS.? 15.29 C2 EDO B 603 A 259 TYR B 421 TYR^? 13.58 C2 EDO B 603 A 552 ASP C 349 ASP.? 28.09 C1 EDO C 602 coo 11.34 95.90 25.54 12.13 96.42 23.67 4.86 38.27 11.07 6.17 36.67 11.45 coo 14.91 97.39 18.63 13.39 95.60 20.20 6.36 30.57 15.08 5.68 32.41 13.09 coo 46.37 82.54 38.83 45.97 84.66 38.77 32.59 30.21 -17.31 34.23 29.55 -16.13 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 3 3 # 3 A 225 HIS B 381 HIS.? 15.29 C2 EDO B 603 A 259 TYR B 421 TYR^? 13.58 C2 EDO B 603 A 552 ASP C 350 ASP.? 24.48 C2 EDO C 602 coo 11.34 95.90 25.54 12.13 96.42 23.67 4.86 38.27 11.07 6.17 36.67 11.45 coo 14.91 97.39 18.63 13.39 95.60 20.20 6.36 30.57 15.08 5.68 32.41 13.09 coo 46.37 82.54 38.83 45.97 84.66 38.77 27.03 30.18 -18.47 26.26 29.33 -16.72 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 4 3 # 4 A 225 HIS B 381 HIS.? 15.29 C2 EDO B 603 A 259 TYR B 421 TYR^? 13.58 C2 EDO B 603 A 552 ASP C 402 ASP.? 12.78 O1 GOL D 601 coo 11.34 95.90 25.54 12.13 96.42 23.67 4.86 38.27 11.07 6.17 36.67 11.45 coo 14.91 97.39 18.63 13.39 95.60 20.20 6.36 30.57 15.08 5.68 32.41 13.09 coo 46.37 82.54 38.83 45.97 84.66 38.77 22.26 13.02 -15.38 21.01 11.37 -15.92 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 5 3 # 5 A 225 HIS B 381 HIS.? 15.29 C2 EDO B 603 A 259 TYR B 421 TYR^? 13.58 C2 EDO B 603 A 552 ASP C 430 ASP.? 26.01 O2 GOL D 601 coo 11.34 95.90 25.54 12.13 96.42 23.67 4.86 38.27 11.07 6.17 36.67 11.45 coo 14.91 97.39 18.63 13.39 95.60 20.20 6.36 30.57 15.08 5.68 32.41 13.09 coo 46.37 82.54 38.83 45.97 84.66 38.77 33.23 18.77 -9.92 33.78 18.54 -7.88 1pj5_c00 source 1pj5 N,N-DIMETHYLGLYCINE OXIDASE : 5 hits 1pj5_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 332 ALA~? 19.35 C1 EDO B 603 A 126 LEU A 334 LEU~? 21.85 C1 EDO B 603 A 158 GLU A 330 GLU~? 26.93 C1 EDO B 603 coo -2.29 37.66 144.73 -1.46 37.12 145.87 23.70 27.46 13.78 24.80 27.54 12.75 coo -4.62 32.83 147.14 -5.50 32.85 149.12 20.95 26.47 18.89 21.33 26.89 20.97 coo -0.83 29.57 149.77 -0.39 31.47 148.95 25.78 29.04 20.96 25.48 30.78 22.26 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 422 ALA^? 13.54 O1 EDO B 603 A 126 LEU A 435 LEU^? 15.09 C1 EDO B 603 A 158 GLU A 436 GLU^? 20.55 O1 EDO B 603 coo -2.29 37.66 144.73 -1.46 37.12 145.87 20.34 14.47 -0.75 19.66 15.71 -0.13 coo -4.62 32.83 147.14 -5.50 32.85 149.12 22.48 16.32 3.35 21.45 17.53 4.81 coo -0.83 29.57 149.77 -0.39 31.47 148.95 19.93 9.98 5.88 20.55 8.03 6.42 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA A 423 ALA^? 17.43 O1 EDO B 603 A 126 LEU A 435 LEU^? 15.09 C1 EDO B 603 A 158 GLU A 436 GLU^? 20.55 O1 EDO B 603 coo -2.29 37.66 144.73 -1.46 37.12 145.87 23.34 15.61 -2.79 23.45 15.65 -4.34 coo -4.62 32.83 147.14 -5.50 32.85 149.12 22.48 16.32 3.35 21.45 17.53 4.81 coo -0.83 29.57 149.77 -0.39 31.47 148.95 19.93 9.98 5.88 20.55 8.03 6.42 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA B 332 ALA~? 19.64 C1 EDO B 603 A 126 LEU B 334 LEU~? 17.92 C1 EDO B 603 A 158 GLU B 330 GLU~? 24.65 C1 EDO B 603 coo -2.29 37.66 144.73 -1.46 37.12 145.87 26.85 23.79 8.15 27.20 24.46 9.48 coo -4.62 32.83 147.14 -5.50 32.85 149.12 26.38 23.27 2.33 27.66 23.89 0.66 coo -0.83 29.57 149.77 -0.39 31.47 148.95 31.94 25.81 2.71 33.76 25.37 1.74 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA B 422 ALA^? 15.69 C2 EDO B 603 A 126 LEU B 435 LEU^? 14.13 C1 EDO B 603 A 158 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo -2.29 37.66 144.73 -1.46 37.12 145.87 9.81 26.66 18.07 10.52 25.41 17.54 coo -4.62 32.83 147.14 -5.50 32.85 149.12 13.92 27.91 15.33 14.95 26.75 13.85 coo -0.83 29.57 149.77 -0.39 31.47 148.95 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA B 423 ALA^? 20.91 C2 EDO B 603 A 126 LEU B 435 LEU^? 14.13 C1 EDO B 603 A 158 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo -2.29 37.66 144.73 -1.46 37.12 145.87 11.54 27.99 21.15 11.04 27.92 22.61 coo -4.62 32.83 147.14 -5.50 32.85 149.12 13.92 27.91 15.33 14.95 26.75 13.85 coo -0.83 29.57 149.77 -0.39 31.47 148.95 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 A 70 ALA C 332 ALA~? 19.24 C1 EDO C 602 A 126 LEU C 334 LEU~? 17.48 O1 EDO C 602 A 158 GLU C 330 GLU~? 24.03 O1 EDO C 602 coo -2.29 37.66 144.73 -1.46 37.12 145.87 38.86 12.95 -31.94 39.29 13.43 -30.53 coo -4.62 32.83 147.14 -5.50 32.85 149.12 37.93 12.93 -37.79 39.11 13.49 -39.53 coo -0.83 29.57 149.77 -0.39 31.47 148.95 43.59 14.91 -37.76 45.12 14.02 -38.99 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 A 70 ALA C 422 ALA^? 12.76 O1 GOL D 601 A 126 LEU C 435 LEU^? 14.04 C1 EDO C 602 A 158 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo -2.29 37.66 144.73 -1.46 37.12 145.87 23.09 16.73 -20.35 23.76 15.53 -20.98 coo -4.62 32.83 147.14 -5.50 32.85 149.12 27.04 17.63 -23.33 27.85 16.42 -24.95 coo -0.83 29.57 149.77 -0.39 31.47 148.95 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 A 70 ALA C 423 ALA^? 17.19 O1 GOL D 601 A 126 LEU C 435 LEU^? 14.04 C1 EDO C 602 A 158 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo -2.29 37.66 144.73 -1.46 37.12 145.87 25.18 17.70 -17.34 24.76 17.44 -15.88 coo -4.62 32.83 147.14 -5.50 32.85 149.12 27.04 17.63 -23.33 27.85 16.42 -24.95 coo -0.83 29.57 149.77 -0.39 31.47 148.95 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 A 70 ALA D 422 ALA^? 12.49 O1 EDO C 602 A 126 LEU D 435 LEU^? 13.89 C1 GOL D 601 A 158 GLU D 436 GLU^? 11.06 C3 GOL D 601 coo -2.29 37.66 144.73 -1.46 37.12 145.87 30.60 5.17 -40.84 30.09 6.36 -40.04 coo -4.62 32.83 147.14 -5.50 32.85 149.12 33.33 6.42 -36.78 32.50 7.59 -35.21 coo -0.83 29.57 149.77 -0.39 31.47 148.95 30.72 -0.04 -34.79 31.42 -2.01 -34.30 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 A 70 ALA D 423 ALA^? 16.44 O1 EDO C 602 A 126 LEU D 435 LEU^? 13.89 C1 GOL D 601 A 158 GLU D 436 GLU^? 11.06 C3 GOL D 601 coo -2.29 37.66 144.73 -1.46 37.12 145.87 33.47 6.23 -43.05 33.47 6.26 -44.59 coo -4.62 32.83 147.14 -5.50 32.85 149.12 33.33 6.42 -36.78 32.50 7.59 -35.21 coo -0.83 29.57 149.77 -0.39 31.47 148.95 30.72 -0.04 -34.79 31.42 -2.01 -34.30 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 11 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 422 ALA^? 13.54 O1 EDO B 603 B 126 LEU A 435 LEU^? 15.09 C1 EDO B 603 B 158 GLU A 436 GLU^? 20.55 O1 EDO B 603 coo -39.79 4.61 147.27 -39.61 5.56 148.47 20.34 14.47 -0.75 19.66 15.71 -0.13 coo -34.22 5.06 149.25 -33.65 4.24 151.15 22.48 16.32 3.35 21.45 17.53 4.81 coo -33.03 9.93 151.71 -34.98 9.38 151.11 19.93 9.98 5.88 20.55 8.03 6.42 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 423 ALA^? 17.43 O1 EDO B 603 B 126 LEU A 435 LEU^? 15.09 C1 EDO B 603 B 158 GLU A 436 GLU^? 20.55 O1 EDO B 603 coo -39.79 4.61 147.27 -39.61 5.56 148.47 23.34 15.61 -2.79 23.45 15.65 -4.34 coo -34.22 5.06 149.25 -33.65 4.24 151.15 22.48 16.32 3.35 21.45 17.53 4.81 coo -33.03 9.93 151.71 -34.98 9.38 151.11 19.93 9.98 5.88 20.55 8.03 6.42 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA B 332 ALA~? 19.64 C1 EDO B 603 B 126 LEU B 334 LEU~? 17.92 C1 EDO B 603 B 158 GLU B 330 GLU~? 24.65 C1 EDO B 603 coo -39.79 4.61 147.27 -39.61 5.56 148.47 26.85 23.79 8.15 27.20 24.46 9.48 coo -34.22 5.06 149.25 -33.65 4.24 151.15 26.38 23.27 2.33 27.66 23.89 0.66 coo -33.03 9.93 151.71 -34.98 9.38 151.11 31.94 25.81 2.71 33.76 25.37 1.74 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA B 422 ALA^? 15.69 C2 EDO B 603 B 126 LEU B 435 LEU^? 14.13 C1 EDO B 603 B 158 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo -39.79 4.61 147.27 -39.61 5.56 148.47 9.81 26.66 18.07 10.52 25.41 17.54 coo -34.22 5.06 149.25 -33.65 4.24 151.15 13.92 27.91 15.33 14.95 26.75 13.85 coo -33.03 9.93 151.71 -34.98 9.38 151.11 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA B 423 ALA^? 20.91 C2 EDO B 603 B 126 LEU B 435 LEU^? 14.13 C1 EDO B 603 B 158 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo -39.79 4.61 147.27 -39.61 5.56 148.47 11.54 27.99 21.15 11.04 27.92 22.61 coo -34.22 5.06 149.25 -33.65 4.24 151.15 13.92 27.91 15.33 14.95 26.75 13.85 coo -33.03 9.93 151.71 -34.98 9.38 151.11 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 B 70 ALA C 332 ALA~? 19.24 C1 EDO C 602 B 126 LEU C 334 LEU~? 17.48 O1 EDO C 602 B 158 GLU C 330 GLU~? 24.03 O1 EDO C 602 coo -39.79 4.61 147.27 -39.61 5.56 148.47 38.86 12.95 -31.94 39.29 13.43 -30.53 coo -34.22 5.06 149.25 -33.65 4.24 151.15 37.93 12.93 -37.79 39.11 13.49 -39.53 coo -33.03 9.93 151.71 -34.98 9.38 151.11 43.59 14.91 -37.76 45.12 14.02 -38.99 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 B 70 ALA C 422 ALA^? 12.76 O1 GOL D 601 B 126 LEU C 435 LEU^? 14.04 C1 EDO C 602 B 158 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo -39.79 4.61 147.27 -39.61 5.56 148.47 23.09 16.73 -20.35 23.76 15.53 -20.98 coo -34.22 5.06 149.25 -33.65 4.24 151.15 27.04 17.63 -23.33 27.85 16.42 -24.95 coo -33.03 9.93 151.71 -34.98 9.38 151.11 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 B 70 ALA C 423 ALA^? 17.19 O1 GOL D 601 B 126 LEU C 435 LEU^? 14.04 C1 EDO C 602 B 158 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo -39.79 4.61 147.27 -39.61 5.56 148.47 25.18 17.70 -17.34 24.76 17.44 -15.88 coo -34.22 5.06 149.25 -33.65 4.24 151.15 27.04 17.63 -23.33 27.85 16.42 -24.95 coo -33.03 9.93 151.71 -34.98 9.38 151.11 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 B 70 ALA D 422 ALA^? 12.49 O1 EDO C 602 B 126 LEU D 435 LEU^? 13.89 C1 GOL D 601 B 158 GLU D 436 GLU^? 11.06 C3 GOL D 601 coo -39.79 4.61 147.27 -39.61 5.56 148.47 30.60 5.17 -40.84 30.09 6.36 -40.04 coo -34.22 5.06 149.25 -33.65 4.24 151.15 33.33 6.42 -36.78 32.50 7.59 -35.21 coo -33.03 9.93 151.71 -34.98 9.38 151.11 30.72 -0.04 -34.79 31.42 -2.01 -34.30 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 B 70 ALA D 423 ALA^? 16.44 O1 EDO C 602 B 126 LEU D 435 LEU^? 13.89 C1 GOL D 601 B 158 GLU D 436 GLU^? 11.06 C3 GOL D 601 coo -39.79 4.61 147.27 -39.61 5.56 148.47 33.47 6.23 -43.05 33.47 6.26 -44.59 coo -34.22 5.06 149.25 -33.65 4.24 151.15 33.33 6.42 -36.78 32.50 7.59 -35.21 coo -33.03 9.93 151.71 -34.98 9.38 151.11 30.72 -0.04 -34.79 31.42 -2.01 -34.30 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 10 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 332 ALA~? 19.35 C1 EDO B 603 C 126 LEU A 334 LEU~? 21.85 C1 EDO B 603 C 158 GLU A 330 GLU~? 26.93 C1 EDO B 603 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 23.70 27.46 13.78 24.80 27.54 12.75 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 20.95 26.47 18.89 21.33 26.89 20.97 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 25.78 29.04 20.96 25.48 30.78 22.26 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 422 ALA^? 13.54 O1 EDO B 603 C 126 LEU A 435 LEU^? 15.09 C1 EDO B 603 C 158 GLU A 436 GLU^? 20.55 O1 EDO B 603 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 20.34 14.47 -0.75 19.66 15.71 -0.13 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 22.48 16.32 3.35 21.45 17.53 4.81 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 19.93 9.98 5.88 20.55 8.03 6.42 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA A 423 ALA^? 17.43 O1 EDO B 603 C 126 LEU A 435 LEU^? 15.09 C1 EDO B 603 C 158 GLU A 436 GLU^? 20.55 O1 EDO B 603 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 23.34 15.61 -2.79 23.45 15.65 -4.34 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 22.48 16.32 3.35 21.45 17.53 4.81 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 19.93 9.98 5.88 20.55 8.03 6.42 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA B 332 ALA~? 19.64 C1 EDO B 603 C 126 LEU B 334 LEU~? 17.92 C1 EDO B 603 C 158 GLU B 330 GLU~? 24.65 C1 EDO B 603 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 26.85 23.79 8.15 27.20 24.46 9.48 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 26.38 23.27 2.33 27.66 23.89 0.66 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 31.94 25.81 2.71 33.76 25.37 1.74 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA B 422 ALA^? 15.69 C2 EDO B 603 C 126 LEU B 435 LEU^? 14.13 C1 EDO B 603 C 158 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 9.81 26.66 18.07 10.52 25.41 17.54 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 13.92 27.91 15.33 14.95 26.75 13.85 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA B 423 ALA^? 20.91 C2 EDO B 603 C 126 LEU B 435 LEU^? 14.13 C1 EDO B 603 C 158 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 11.54 27.99 21.15 11.04 27.92 22.61 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 13.92 27.91 15.33 14.95 26.75 13.85 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 C 70 ALA C 332 ALA~? 19.24 C1 EDO C 602 C 126 LEU C 334 LEU~? 17.48 O1 EDO C 602 C 158 GLU C 330 GLU~? 24.03 O1 EDO C 602 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 38.86 12.95 -31.94 39.29 13.43 -30.53 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 37.93 12.93 -37.79 39.11 13.49 -39.53 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 43.59 14.91 -37.76 45.12 14.02 -38.99 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 C 70 ALA C 422 ALA^? 12.76 O1 GOL D 601 C 126 LEU C 435 LEU^? 14.04 C1 EDO C 602 C 158 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 23.09 16.73 -20.35 23.76 15.53 -20.98 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 27.04 17.63 -23.33 27.85 16.42 -24.95 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 C 70 ALA C 423 ALA^? 17.19 O1 GOL D 601 C 126 LEU C 435 LEU^? 14.04 C1 EDO C 602 C 158 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 25.18 17.70 -17.34 24.76 17.44 -15.88 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 27.04 17.63 -23.33 27.85 16.42 -24.95 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 C 70 ALA D 422 ALA^? 12.49 O1 EDO C 602 C 126 LEU D 435 LEU^? 13.89 C1 GOL D 601 C 158 GLU D 436 GLU^? 11.06 C3 GOL D 601 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 30.60 5.17 -40.84 30.09 6.36 -40.04 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 33.33 6.42 -36.78 32.50 7.59 -35.21 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 30.72 -0.04 -34.79 31.42 -2.01 -34.30 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 C 70 ALA D 423 ALA^? 16.44 O1 EDO C 602 C 126 LEU D 435 LEU^? 13.89 C1 GOL D 601 C 158 GLU D 436 GLU^? 11.06 C3 GOL D 601 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 33.47 6.23 -43.05 33.47 6.26 -44.59 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 33.33 6.42 -36.78 32.50 7.59 -35.21 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 30.72 -0.04 -34.79 31.42 -2.01 -34.30 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 11 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP B 387 ASP~? 25.98 C2 EDO B 603 A 270 LYS B 384 LYS~? 21.93 O2 EDO B 603 A 382 MET B 406 MET^? 13.54 C2 EDO B 603 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -2.48 41.17 18.56 -3.04 43.05 17.72 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -3.14 43.46 11.59 -5.82 40.34 10.77 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -0.25 26.20 11.96 1.65 28.79 13.56 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 2 3 # 2 A 248 ASP B 387 ASP~? 25.98 C2 EDO B 603 A 270 LYS B 390 LYS~? 27.12 C2 EDO B 603 A 382 MET B 406 MET^? 13.54 C2 EDO B 603 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -2.48 41.17 18.56 -3.04 43.05 17.72 coo -32.20 115.91 49.56 -31.37 121.03 53.12 3.52 38.72 20.17 3.15 45.06 20.21 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -0.25 26.20 11.96 1.65 28.79 13.56 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 3 3 # 3 A 248 ASP D 387 ASP~? 25.32 O3 GOL D 601 A 270 LYS D 390 LYS~? 25.65 O3 GOL D 601 A 382 MET D 406 MET^? 13.98 C3 GOL D 601 coo -27.63 121.99 45.48 -26.66 123.86 45.68 33.33 -13.12 -43.54 32.71 -13.42 -45.54 coo -32.20 115.91 49.56 -31.37 121.03 53.12 35.81 -6.92 -44.49 39.58 -10.95 -43.36 coo -23.75 127.89 58.42 -26.02 128.79 55.12 22.28 -2.96 -38.96 25.74 -3.12 -39.74 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 3 hits 1pjq_c02 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP A 387 ASP~? 25.21 O2 GOL D 601 B 270 LYS A 390 LYS~? 25.88 O2 GOL D 601 B 382 MET A 406 MET^? 19.27 O1 EDO B 603 coo -11.82 154.51 43.38 -12.86 152.74 43.79 25.11 -3.56 -1.18 26.67 -4.92 -0.75 coo -5.09 158.39 43.41 -0.74 158.80 47.15 26.64 2.81 -1.98 30.91 -1.55 -0.35 coo -2.79 145.52 50.38 -5.75 148.14 51.66 12.31 5.99 1.20 15.90 5.94 0.78 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 2 3 # 2 B 248 ASP A 387 ASP~? 25.21 O2 GOL D 601 B 270 LYS A 391 LYS~? 19.54 O2 GOL D 601 B 382 MET A 406 MET^? 19.27 O1 EDO B 603 coo -11.82 154.51 43.38 -12.86 152.74 43.79 25.11 -3.56 -1.18 26.67 -4.92 -0.75 coo -5.09 158.39 43.41 -0.74 158.80 47.15 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo -2.79 145.52 50.38 -5.75 148.14 51.66 12.31 5.99 1.20 15.90 5.94 0.78 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 3 3 # 3 B 248 ASP A 440 ASP^? 18.54 C1 EDO B 603 B 270 LYS A 442 LYS~? 23.27 C1 EDO B 603 B 382 MET A 406 MET^? 19.27 O1 EDO B 603 coo -11.82 154.51 43.38 -12.86 152.74 43.79 8.21 11.09 12.88 6.30 10.30 13.36 coo -5.09 158.39 43.41 -0.74 158.80 47.15 2.76 10.16 11.03 0.96 5.43 12.32 coo -2.79 145.52 50.38 -5.75 148.14 51.66 12.31 5.99 1.20 15.90 5.94 0.78 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 4 3 # 4 B 248 ASP D 387 ASP~? 25.32 O3 GOL D 601 B 270 LYS D 390 LYS~? 25.65 O3 GOL D 601 B 382 MET D 406 MET^? 13.98 C3 GOL D 601 coo -11.82 154.51 43.38 -12.86 152.74 43.79 33.33 -13.12 -43.54 32.71 -13.42 -45.54 coo -5.09 158.39 43.41 -0.74 158.80 47.15 35.81 -6.92 -44.49 39.58 -10.95 -43.36 coo -2.79 145.52 50.38 -5.75 148.14 51.66 22.28 -2.96 -38.96 25.74 -3.12 -39.74 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 5 3 # 5 B 248 ASP D 387 ASP~? 25.32 O3 GOL D 601 B 270 LYS D 391 LYS~? 24.88 C3 GOL D 601 B 382 MET D 406 MET^? 13.98 C3 GOL D 601 coo -11.82 154.51 43.38 -12.86 152.74 43.79 33.33 -13.12 -43.54 32.71 -13.42 -45.54 coo -5.09 158.39 43.41 -0.74 158.80 47.15 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo -2.79 145.52 50.38 -5.75 148.14 51.66 22.28 -2.96 -38.96 25.74 -3.12 -39.74 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 6 3 # 6 B 248 ASP D 440 ASP^? -5.34 O2 GOL D 601s B 270 LYS D 442 LYS~? 12.65 O2 GOL D 601 B 382 MET D 406 MET^? 13.98 C3 GOL D 601 coo -11.82 154.51 43.38 -12.86 152.74 43.79 19.76 1.27 -26.39 17.89 0.46 -25.75 coo -5.09 158.39 43.41 -0.74 158.80 47.15 14.14 0.83 -27.84 11.41 -3.18 -25.91 coo -2.79 145.52 50.38 -5.75 148.14 51.66 22.28 -2.96 -38.96 25.74 -3.12 -39.74 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 6 hits 1pjq_c03 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN A 320 GLN^? 25.36 C1 EDO B 603 294 GLU A 330 GLU~? 26.93 C1 EDO B 603 304 ARG B 316 ARG.? 22.40 C1 EDO B 603 coo 15.89 18.45 46.53 15.82 16.91 48.02 29.74 33.26 11.08 31.47 32.04 11.15 coo 22.84 13.44 52.91 20.84 13.18 52.38 25.78 29.04 20.96 25.48 30.78 22.26 coo 8.71 17.11 46.51 7.23 17.64 49.20 32.74 31.58 5.20 30.84 29.65 3.70 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 2 3 # 2 111 GLN A 427 GLN.? 20.08 O1 EDO B 603 294 GLU B 330 GLU~? 24.65 C1 EDO B 603 304 ARG C 397 ARG~? 23.93 O1 EDO B 603 coo 15.89 18.45 46.53 15.82 16.91 48.02 25.85 29.74 -6.76 26.03 31.82 -6.25 coo 22.84 13.44 52.91 20.84 13.18 52.38 31.94 25.81 2.71 33.76 25.37 1.74 coo 8.71 17.11 46.51 7.23 17.64 49.20 25.49 26.02 -11.91 27.94 26.82 -13.64 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 3 3 # 3 111 GLN B 320 GLN^? 27.80 C1 EDO B 603 294 GLU B 330 GLU~? 24.65 C1 EDO B 603 304 ARG A 316 ARG.? 27.22 C1 EDO B 603 coo 15.89 18.45 46.53 15.82 16.91 48.02 34.66 25.17 13.76 33.95 27.13 14.05 coo 22.84 13.44 52.91 20.84 13.18 52.38 31.94 25.81 2.71 33.76 25.37 1.74 coo 8.71 17.11 46.51 7.23 17.64 49.20 32.66 26.75 19.60 30.80 24.65 18.26 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 4 3 # 4 111 GLN C 320 GLN^? 25.79 C1 GOL D 601 294 GLU C 330 GLU~? 24.03 O1 EDO C 602 304 ARG D 316 ARG.? 22.70 C2 GOL D 601 coo 15.89 18.45 46.53 15.82 16.91 48.02 46.21 12.60 -26.90 46.51 14.66 -26.40 coo 22.84 13.44 52.91 20.84 13.18 52.38 43.59 14.91 -37.76 45.12 14.02 -38.99 coo 8.71 17.11 46.51 7.23 17.64 49.20 45.13 14.38 -20.32 42.13 14.31 -19.52 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 5 3 # 5 111 GLN C 400 GLN.? 12.85 O1 EDO B 603 294 GLU B 363 GLU~? 7.89 O1 EDO B 603 304 ARG C 401 ARG.? 15.33 O1 EDO B 603 coo 15.89 18.45 46.53 15.82 16.91 48.02 17.76 19.88 -9.09 16.75 21.72 -9.38 coo 22.84 13.44 52.91 20.84 13.18 52.38 8.83 27.73 -6.37 10.21 26.17 -6.89 coo 8.71 17.11 46.51 7.23 17.64 49.20 15.13 16.06 -14.86 13.60 17.63 -12.63 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 6 3 # 6 111 GLN C 427 GLN.? 21.67 C2 GOL D 601 294 GLU D 330 GLU~? 24.51 C2 GOL D 601 304 ARG A 397 ARG~? 24.94 O2 GOL D 601 coo 15.89 18.45 46.53 15.82 16.91 48.02 35.58 9.46 -10.57 37.38 8.54 -9.94 coo 22.84 13.44 52.91 20.84 13.18 52.38 39.35 17.44 -18.72 40.01 18.64 -17.10 coo 8.71 17.11 46.51 7.23 17.64 49.20 31.00 11.06 -6.51 32.72 12.02 -4.11 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 7 3 # 7 111 GLN D 320 GLN^? 25.85 C1 EDO C 602 294 GLU D 330 GLU~? 24.51 C2 GOL D 601 304 ARG C 316 ARG.? 22.36 C1 EDO C 602 coo 15.89 18.45 46.53 15.82 16.91 48.02 44.13 21.88 -28.02 45.21 20.13 -28.45 coo 22.84 13.44 52.91 20.84 13.18 52.38 39.35 17.44 -18.72 40.01 18.64 -17.10 coo 8.71 17.11 46.51 7.23 17.64 49.20 45.68 20.68 -34.53 42.70 20.67 -33.83 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 8 3 # 8 111 GLN D 372 GLN~? 15.37 O3 GOL D 601 294 GLU D 378 GLU~? 27.27 O3 GOL D 601 304 ARG D 368 ARG.? 11.23 O3 GOL D 601 coo 15.89 18.45 46.53 15.82 16.91 48.02 40.13 -6.96 -28.62 37.98 -6.85 -28.89 coo 22.84 13.44 52.91 20.84 13.18 52.38 43.18 -8.44 -40.40 44.74 -9.12 -41.62 coo 8.71 17.11 46.51 7.23 17.64 49.20 34.63 -3.42 -28.94 33.31 -3.73 -31.69 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 8 hits 1pmi_c00 naa= 3 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 A 264 ARG C 368 ARG.? 10.85 O2 EDO C 602 A 479 PHE C 366 PHE.? 8.83 C2 EDO C 602 A 483 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 17.33 52.29 2.24 18.71 54.03 0.18 24.45 26.16 -32.00 21.85 25.58 -30.53 coo 20.06 57.44 1.28 18.39 56.19 3.12 18.07 23.66 -32.15 15.84 22.39 -30.97 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 A 264 ARG D 368 ARG.? 11.23 O3 GOL D 601 A 479 PHE D 366 PHE.? 8.82 O3 GOL D 601 A 483 GLU D 436 GLU^? 11.06 C3 GOL D 601 coo 17.33 52.29 2.24 18.71 54.03 0.18 34.63 -3.42 -28.94 33.31 -3.73 -31.69 coo 20.06 57.44 1.28 18.39 56.19 3.12 29.07 -5.16 -30.73 27.19 -5.41 -32.81 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 30.72 -0.04 -34.79 31.42 -2.01 -34.30 1pow_c02 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 2 hits 1pow_c02 naa= 3 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 B 264 ARG C 368 ARG.? 10.85 O2 EDO C 602 B 479 PHE C 366 PHE.? 8.83 C2 EDO C 602 B 483 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo -26.72 93.28 20.13 -28.02 93.55 17.39 24.45 26.16 -32.00 21.85 25.58 -30.53 coo -29.34 90.48 15.69 -27.62 89.95 17.80 18.07 23.66 -32.15 15.84 22.39 -30.97 coo -26.63 95.49 14.65 -25.77 93.77 13.77 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 B 264 ARG D 368 ARG.? 11.23 O3 GOL D 601 B 479 PHE D 366 PHE.? 8.82 O3 GOL D 601 B 483 GLU D 436 GLU^? 11.06 C3 GOL D 601 coo -26.72 93.28 20.13 -28.02 93.55 17.39 34.63 -3.42 -28.94 33.31 -3.73 -31.69 coo -29.34 90.48 15.69 -27.62 89.95 17.80 29.07 -5.16 -30.73 27.19 -5.41 -32.81 coo -26.63 95.49 14.65 -25.77 93.77 13.77 30.72 -0.04 -34.79 31.42 -2.01 -34.30 1pow_c03 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 2 hits 1pow_c03 naa= 3 ULMN 3 1pyl_c00 RIBONUCLEASE user 1 3 # 1 A 56 GLU A 436 GLU^? 20.55 O1 EDO B 603 A 67 ARG A 368 ARG.? 24.16 C1 EDO B 603 A 86 HIS A 381 HIS.? 27.31 O1 EDO B 603 coo 18.15 3.28 18.56 20.10 2.92 19.20 19.93 9.98 5.88 20.55 8.03 6.42 coo 21.52 6.83 26.64 21.22 5.53 23.85 23.91 7.22 12.24 22.49 6.03 9.76 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 25.64 1.98 6.69 25.07 4.00 6.65 ULMN 3 1pyl_c00 RIBONUCLEASE user 2 3 # 2 A 56 GLU B 436 GLU^? 10.42 C2 EDO B 603 A 67 ARG B 368 ARG.? 11.04 O2 EDO B 603 A 86 HIS B 381 HIS.? 15.29 C2 EDO B 603 coo 18.15 3.28 18.56 20.10 2.92 19.20 8.55 30.19 11.17 7.66 31.90 10.29 coo 21.52 6.83 26.64 21.22 5.53 23.85 11.09 36.07 6.20 8.36 35.36 7.43 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 4.86 38.27 11.07 6.17 36.67 11.45 ULMN 3 1pyl_c00 RIBONUCLEASE user 3 3 # 3 A 56 GLU C 378 GLU~? 24.96 O2 EDO B 603 A 67 ARG C 375 ARG.? 20.99 O2 EDO C 602 A 86 HIS C 381 HIS~? 16.26 O2 EDO C 602 coo 18.15 3.28 18.56 20.10 2.92 19.20 22.14 33.77 -19.82 21.71 34.90 -18.09 coo 21.52 6.83 26.64 21.22 5.53 23.85 27.90 36.71 -28.33 26.60 36.43 -31.10 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 19.26 30.57 -26.59 20.09 28.69 -27.02 ULMN 3 1pyl_c00 RIBONUCLEASE user 4 3 # 4 A 56 GLU C 436 GLU^? 10.62 C2 EDO C 602 A 67 ARG C 368 ARG.? 10.85 O2 EDO C 602 A 86 HIS C 381 HIS~? 16.26 O2 EDO C 602 coo 18.15 3.28 18.56 20.10 2.92 19.20 21.74 20.63 -27.21 21.00 22.48 -27.90 coo 21.52 6.83 26.64 21.22 5.53 23.85 24.45 26.16 -32.00 21.85 25.58 -30.53 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 19.26 30.57 -26.59 20.09 28.69 -27.02 ULMN 3 1pyl_c00 RIBONUCLEASE user 5 3 # 5 A 56 GLU D 378 GLU~? 27.27 O3 GOL D 601 A 67 ARG D 375 ARG.? 23.45 O3 GOL D 601 A 86 HIS D 381 HIS.? 16.49 O3 GOL D 601 coo 18.15 3.28 18.56 20.10 2.92 19.20 43.18 -8.44 -40.40 44.74 -9.12 -41.62 coo 21.52 6.83 26.64 21.22 5.53 23.85 45.57 -7.61 -30.32 45.87 -9.61 -28.01 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 36.03 -8.97 -35.15 35.55 -7.12 -34.29 ULMN 3 1pyl_c00 RIBONUCLEASE user 6 3 # 6 A 56 GLU D 436 GLU^? 11.06 C3 GOL D 601 A 67 ARG D 368 ARG.? 11.23 O3 GOL D 601 A 86 HIS D 381 HIS.? 16.49 O3 GOL D 601 coo 18.15 3.28 18.56 20.10 2.92 19.20 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 21.52 6.83 26.64 21.22 5.53 23.85 34.63 -3.42 -28.94 33.31 -3.73 -31.69 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 36.03 -8.97 -35.15 35.55 -7.12 -34.29 1pyl_c00 source 1pyl RIBONUCLEASE : 6 hits 1pyl_c00 naa= 3 ULMN 3 1pyl_c01 RIBONUCLEASE user 1 3 # 1 B 56 GLU A 378 GLU~? 27.85 O2 GOL D 601 B 67 ARG A 375 ARG.? 36.99 C1 EDO B 603 B 86 HIS A 381 HIS.? 27.31 O1 EDO B 603 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 32.59 2.13 2.36 33.95 1.57 0.86 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 34.50 3.88 12.57 36.52 3.36 14.83 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 25.64 1.98 6.69 25.07 4.00 6.65 ULMN 3 1pyl_c01 RIBONUCLEASE user 2 3 # 2 B 56 GLU A 436 GLU^? 20.55 O1 EDO B 603 B 67 ARG A 368 ARG.? 24.16 C1 EDO B 603 B 86 HIS A 381 HIS.? 27.31 O1 EDO B 603 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 19.93 9.98 5.88 20.55 8.03 6.42 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 23.91 7.22 12.24 22.49 6.03 9.76 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 25.64 1.98 6.69 25.07 4.00 6.65 ULMN 3 1pyl_c01 RIBONUCLEASE user 3 3 # 3 B 56 GLU B 436 GLU^? 10.42 C2 EDO B 603 B 67 ARG B 368 ARG.? 11.04 O2 EDO B 603 B 86 HIS B 381 HIS.? 15.29 C2 EDO B 603 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 8.55 30.19 11.17 7.66 31.90 10.29 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 11.09 36.07 6.20 8.36 35.36 7.43 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 4.86 38.27 11.07 6.17 36.67 11.45 ULMN 3 1pyl_c01 RIBONUCLEASE user 4 3 # 4 B 56 GLU C 378 GLU~? 24.96 O2 EDO B 603 B 67 ARG C 375 ARG.? 20.99 O2 EDO C 602 B 86 HIS C 381 HIS~? 16.26 O2 EDO C 602 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 22.14 33.77 -19.82 21.71 34.90 -18.09 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 27.90 36.71 -28.33 26.60 36.43 -31.10 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 19.26 30.57 -26.59 20.09 28.69 -27.02 ULMN 3 1pyl_c01 RIBONUCLEASE user 5 3 # 5 B 56 GLU C 436 GLU^? 10.62 C2 EDO C 602 B 67 ARG C 368 ARG.? 10.85 O2 EDO C 602 B 86 HIS C 381 HIS~? 16.26 O2 EDO C 602 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 21.74 20.63 -27.21 21.00 22.48 -27.90 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 24.45 26.16 -32.00 21.85 25.58 -30.53 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 19.26 30.57 -26.59 20.09 28.69 -27.02 ULMN 3 1pyl_c01 RIBONUCLEASE user 6 3 # 6 B 56 GLU D 378 GLU~? 27.27 O3 GOL D 601 B 67 ARG D 375 ARG.? 23.45 O3 GOL D 601 B 86 HIS D 381 HIS.? 16.49 O3 GOL D 601 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 43.18 -8.44 -40.40 44.74 -9.12 -41.62 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 45.57 -7.61 -30.32 45.87 -9.61 -28.01 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 36.03 -8.97 -35.15 35.55 -7.12 -34.29 ULMN 3 1pyl_c01 RIBONUCLEASE user 7 3 # 7 B 56 GLU D 436 GLU^? 11.06 C3 GOL D 601 B 67 ARG D 368 ARG.? 11.23 O3 GOL D 601 B 86 HIS D 381 HIS.? 16.49 O3 GOL D 601 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 34.63 -3.42 -28.94 33.31 -3.73 -31.69 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 36.03 -8.97 -35.15 35.55 -7.12 -34.29 1pyl_c01 source 1pyl RIBONUCLEASE : 7 hits 1pyl_c01 naa= 3 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 A 48 LEU A 386 LEU~? 28.62 O2 GOL D 601 A 58 ASP A 387 ASP~? 25.21 O2 GOL D 601 A 120 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo 34.02 69.29 75.26 34.82 67.82 76.74 27.29 -1.26 3.33 29.16 -0.11 3.24 coo 34.46 72.45 78.57 32.82 72.75 77.28 25.11 -3.56 -1.18 26.67 -4.92 -0.75 coo 28.96 77.64 81.19 29.05 74.53 77.51 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 A 48 LEU B 386 LEU~? 22.37 O2 EDO B 603 A 58 ASP B 387 ASP~? 25.98 C2 EDO B 603 A 120 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo 34.02 69.29 75.26 34.82 67.82 76.74 1.45 43.13 15.24 3.53 42.84 14.65 coo 34.46 72.45 78.57 32.82 72.75 77.28 -2.48 41.17 18.56 -3.04 43.05 17.72 coo 28.96 77.64 81.19 29.05 74.53 77.51 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 A 48 LEU C 386 LEU~? 24.76 O2 EDO B 603 A 58 ASP C 387 ASP~? 19.92 O2 EDO B 603 A 120 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 34.02 69.29 75.26 34.82 67.82 76.74 16.14 34.82 -20.97 17.87 35.49 -19.78 coo 34.46 72.45 78.57 32.82 72.75 77.28 12.27 32.40 -18.16 12.25 34.11 -16.91 coo 28.96 77.64 81.19 29.05 74.53 77.51 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 4 3 # 4 A 48 LEU D 386 LEU~? 22.23 O3 GOL D 601 A 58 ASP D 387 ASP~? 25.32 O3 GOL D 601 A 120 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo 34.02 69.29 75.26 34.82 67.82 76.74 36.94 -11.45 -39.76 38.82 -10.32 -39.79 coo 34.46 72.45 78.57 32.82 72.75 77.28 33.33 -13.12 -43.54 32.71 -13.42 -45.54 coo 28.96 77.64 81.19 29.05 74.53 77.51 32.90 -6.30 -46.84 30.42 -11.34 -47.14 1pym_c00 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 4 hits 1pym_c00 naa= 3 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 B 48 LEU A 386 LEU~? 28.62 O2 GOL D 601 B 58 ASP A 387 ASP~? 25.21 O2 GOL D 601 B 120 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo 54.50 104.32 58.69 55.83 105.69 59.81 27.29 -1.26 3.33 29.16 -0.11 3.24 coo 57.63 101.19 59.83 56.60 100.89 57.99 25.11 -3.56 -1.18 26.67 -4.92 -0.75 coo 61.58 95.88 55.22 58.18 99.30 54.71 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 B 48 LEU B 386 LEU~? 22.37 O2 EDO B 603 B 58 ASP B 387 ASP~? 25.98 C2 EDO B 603 B 120 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo 54.50 104.32 58.69 55.83 105.69 59.81 1.45 43.13 15.24 3.53 42.84 14.65 coo 57.63 101.19 59.83 56.60 100.89 57.99 -2.48 41.17 18.56 -3.04 43.05 17.72 coo 61.58 95.88 55.22 58.18 99.30 54.71 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 B 48 LEU C 386 LEU~? 24.76 O2 EDO B 603 B 58 ASP C 387 ASP~? 19.92 O2 EDO B 603 B 120 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 54.50 104.32 58.69 55.83 105.69 59.81 16.14 34.82 -20.97 17.87 35.49 -19.78 coo 57.63 101.19 59.83 56.60 100.89 57.99 12.27 32.40 -18.16 12.25 34.11 -16.91 coo 61.58 95.88 55.22 58.18 99.30 54.71 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 4 3 # 4 B 48 LEU D 386 LEU~? 22.23 O3 GOL D 601 B 58 ASP D 387 ASP~? 25.32 O3 GOL D 601 B 120 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo 54.50 104.32 58.69 55.83 105.69 59.81 36.94 -11.45 -39.76 38.82 -10.32 -39.79 coo 57.63 101.19 59.83 56.60 100.89 57.99 33.33 -13.12 -43.54 32.71 -13.42 -45.54 coo 61.58 95.88 55.22 58.18 99.30 54.71 32.90 -6.30 -46.84 30.42 -11.34 -47.14 1pym_c01 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 4 hits 1pym_c01 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 68 ALA A 422 ALA^? 13.54 O1 EDO B 603 A 72 LEU A 396 LEU~? 19.04 O1 EDO B 603 coo 46.76 7.59 18.65 45.27 6.01 18.52 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 48.88 4.35 16.59 48.73 5.09 15.20 20.34 14.47 -0.75 19.66 15.71 -0.13 coo 53.89 6.25 15.09 52.88 7.92 14.14 23.61 11.57 -4.48 21.72 11.49 -3.34 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 68 ALA A 423 ALA^? 17.43 O1 EDO B 603 A 72 LEU A 396 LEU~? 19.04 O1 EDO B 603 coo 46.76 7.59 18.65 45.27 6.01 18.52 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 48.88 4.35 16.59 48.73 5.09 15.20 23.34 15.61 -2.79 23.45 15.65 -4.34 coo 53.89 6.25 15.09 52.88 7.92 14.14 23.61 11.57 -4.48 21.72 11.49 -3.34 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 3 # 3 A 67 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 68 ALA C 422 ALA^? 12.76 O1 GOL D 601 A 72 LEU C 396 LEU~? 18.49 O1 GOL D 601 coo 46.76 7.59 18.65 45.27 6.01 18.52 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 48.88 4.35 16.59 48.73 5.09 15.20 23.09 16.73 -20.35 23.76 15.53 -20.98 coo 53.89 6.25 15.09 52.88 7.92 14.14 21.93 20.60 -16.19 21.00 19.44 -17.76 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 3 # 4 A 67 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 68 ALA C 423 ALA^? 17.19 O1 GOL D 601 A 72 LEU C 396 LEU~? 18.49 O1 GOL D 601 coo 46.76 7.59 18.65 45.27 6.01 18.52 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 48.88 4.35 16.59 48.73 5.09 15.20 25.18 17.70 -17.34 24.76 17.44 -15.88 coo 53.89 6.25 15.09 52.88 7.92 14.14 21.93 20.60 -16.19 21.00 19.44 -17.76 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 5 3 # 5 A 67 ASP D 402 ASP.? 14.20 O1 EDO C 602 A 68 ALA D 423 ALA^? 16.44 O1 EDO C 602 A 72 LEU D 396 LEU~? 18.34 O1 EDO C 602 coo 46.76 7.59 18.65 45.27 6.01 18.52 28.53 7.95 -46.44 29.10 9.08 -48.14 coo 48.88 4.35 16.59 48.73 5.09 15.20 33.47 6.23 -43.05 33.47 6.26 -44.59 coo 53.89 6.25 15.09 52.88 7.92 14.14 33.65 2.40 -45.26 31.89 2.25 -43.96 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 5 hits 1q6l_c05 naa= 3 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 1 3 # 1 A 191 ASN A 356 ASN.? 18.20 C1 EDO B 603 A 239 ARG A 368 ARG.? 24.16 C1 EDO B 603 A 246 TYR A 355 TYR^? 25.32 C1 EDO B 603 coo 2.50 7.27 18.06 0.76 7.28 16.81 21.62 17.22 14.34 19.81 16.20 13.98 coo -1.16 0.95 13.41 -2.50 3.71 13.61 23.91 7.22 12.24 22.49 6.03 9.76 coo 1.59 5.18 12.30 -0.74 6.52 11.61 25.00 11.79 14.66 25.82 10.48 17.03 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 2 3 # 2 A 191 ASN B 356 ASN.? 8.23 C1 EDO B 603 A 239 ARG B 368 ARG.? 11.04 O2 EDO B 603 A 246 TYR B 355 TYR^? 12.60 O2 EDO B 603 coo 2.50 7.27 18.06 0.76 7.28 16.81 18.03 28.57 5.10 16.12 27.74 4.68 coo -1.16 0.95 13.41 -2.50 3.71 13.61 11.09 36.07 6.20 8.36 35.36 7.43 coo 1.59 5.18 12.30 -0.74 6.52 11.61 15.82 34.63 5.10 16.14 36.63 3.16 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 3 3 # 3 A 191 ASN C 356 ASN.? 8.10 C1 EDO C 602 A 239 ARG C 368 ARG.? 10.85 O2 EDO C 602 A 246 TYR C 355 TYR^? 12.28 O2 EDO C 602 coo 2.50 7.27 18.06 0.76 7.28 16.81 30.42 18.66 -33.90 28.43 18.01 -34.20 coo -1.16 0.95 13.41 -2.50 3.71 13.61 24.45 26.16 -32.00 21.85 25.58 -30.53 coo 1.59 5.18 12.30 -0.74 6.52 11.61 28.68 24.77 -33.28 28.94 26.73 -35.28 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 4 3 # 4 A 191 ASN D 356 ASN.? 8.43 C2 GOL D 601 A 239 ARG D 368 ARG.? 11.23 O3 GOL D 601 A 246 TYR D 355 TYR^? 12.42 O3 GOL D 601 coo 2.50 7.27 18.06 0.76 7.28 16.81 33.56 6.37 -25.67 31.64 5.54 -26.08 coo -1.16 0.95 13.41 -2.50 3.71 13.61 34.63 -3.42 -28.94 33.31 -3.73 -31.69 coo 1.59 5.18 12.30 -0.74 6.52 11.61 36.51 0.70 -26.17 37.53 -0.88 -24.11 1qaz_c00 source 1qaz ALGINATE LYASE A1-III : 4 hits 1qaz_c00 naa= 3 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG A 425 ARG^? 21.19 O1 EDO B 603 A 581 ARG C 425 ARG^? 21.48 O1 GOL D 601 A 713 ARG A 397 ARG~? 24.94 O2 GOL D 601 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 31.00 11.06 -6.51 32.72 12.02 -4.11 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 2 3 # 2 A 396 ARG A 425 ARG^? 21.19 O1 EDO B 603 A 581 ARG C 425 ARG^? 21.48 O1 GOL D 601 A 713 ARG C 397 ARG~? 23.93 O1 EDO B 603 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 25.49 26.02 -11.91 27.94 26.82 -13.64 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 3 3 # 3 A 396 ARG C 425 ARG^? 21.48 O1 GOL D 601 A 581 ARG A 425 ARG^? 21.19 O1 EDO B 603 A 713 ARG A 397 ARG~? 24.94 O2 GOL D 601 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 31.00 11.06 -6.51 32.72 12.02 -4.11 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 4 3 # 4 A 396 ARG C 425 ARG^? 21.48 O1 GOL D 601 A 581 ARG A 425 ARG^? 21.19 O1 EDO B 603 A 713 ARG C 397 ARG~? 23.93 O1 EDO B 603 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 25.49 26.02 -11.91 27.94 26.82 -13.64 1qb4_c01 source 1qb4 PHOSPHOENOLPYRUVATE CARBOXYLASE : 4 hits 1qb4_c01 naa= 3 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 155 HIS A 381 HIS.? 27.31 O1 EDO B 603 D 236 ASP A 402 ASP.? 12.59 O1 EDO B 603 D 261 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 25.64 1.98 6.69 25.07 4.00 6.65 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 19.56 15.05 -18.65 18.30 10.78 -20.22 1qgn_c03 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c03 naa= 3 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 155 HIS A 381 HIS.? 27.31 O1 EDO B 603 H 236 ASP A 402 ASP.? 12.59 O1 EDO B 603 H 261 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 25.64 1.98 6.69 25.07 4.00 6.65 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 19.56 15.05 -18.65 18.30 10.78 -20.22 1qgn_c07 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c07 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 354 TYR^? 20.91 C1 EDO B 603 A 236 ASP A 357 ASP.? 25.14 C1 EDO B 603 A 261 LYS A 367 LYS.? 27.79 C1 EDO B 603 coo 55.48 26.51 40.65 55.39 23.99 39.43 27.10 16.84 11.56 24.90 18.34 12.50 coo 48.87 29.19 44.63 49.10 27.34 43.63 22.54 16.74 19.72 22.05 16.00 21.61 coo 47.58 17.35 41.83 51.40 20.85 40.83 21.09 4.68 15.64 17.32 4.21 18.91 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR C 354 TYR^? 14.37 C1 EDO C 602 A 236 ASP C 357 ASP.? 12.50 O2 EDO C 602 A 261 LYS C 367 LYS.? 10.18 O2 EDO C 602 coo 55.48 26.51 40.65 55.39 23.99 39.43 32.76 22.10 -29.37 32.74 19.75 -30.93 coo 48.87 29.19 44.63 49.10 27.34 43.63 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 47.58 17.35 41.83 51.40 20.85 40.83 21.41 26.99 -36.15 19.64 26.87 -41.36 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 354 TYR^? 20.91 C1 EDO B 603 B 236 ASP A 357 ASP.? 25.14 C1 EDO B 603 B 261 LYS A 367 LYS.? 27.79 C1 EDO B 603 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 27.10 16.84 11.56 24.90 18.34 12.50 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 22.54 16.74 19.72 22.05 16.00 21.61 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 21.09 4.68 15.64 17.32 4.21 18.91 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR C 354 TYR^? 14.37 C1 EDO C 602 B 236 ASP C 357 ASP.? 12.50 O2 EDO C 602 B 261 LYS C 367 LYS.? 10.18 O2 EDO C 602 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 32.76 22.10 -29.37 32.74 19.75 -30.93 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 21.41 26.99 -36.15 19.64 26.87 -41.36 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR A 354 TYR^? 20.91 C1 EDO B 603 C 236 ASP A 357 ASP.? 25.14 C1 EDO B 603 C 261 LYS A 367 LYS.? 27.79 C1 EDO B 603 coo 39.51 34.34 13.63 37.63 32.61 14.79 27.10 16.84 11.56 24.90 18.34 12.50 coo 45.78 31.11 9.51 44.25 30.06 10.53 22.54 16.74 19.72 22.05 16.00 21.61 coo 37.54 22.37 12.10 37.83 27.55 13.24 21.09 4.68 15.64 17.32 4.21 18.91 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 163 TYR C 354 TYR^? 14.37 C1 EDO C 602 C 236 ASP C 357 ASP.? 12.50 O2 EDO C 602 C 261 LYS C 367 LYS.? 10.18 O2 EDO C 602 coo 39.51 34.34 13.63 37.63 32.61 14.79 32.76 22.10 -29.37 32.74 19.75 -30.93 coo 45.78 31.11 9.51 44.25 30.06 10.53 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 37.54 22.37 12.10 37.83 27.55 13.24 21.41 26.99 -36.15 19.64 26.87 -41.36 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR A 354 TYR^? 20.91 C1 EDO B 603 D 236 ASP A 357 ASP.? 25.14 C1 EDO B 603 D 261 LYS A 367 LYS.? 27.79 C1 EDO B 603 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 27.10 16.84 11.56 24.90 18.34 12.50 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 22.54 16.74 19.72 22.05 16.00 21.61 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 21.09 4.68 15.64 17.32 4.21 18.91 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 163 TYR C 354 TYR^? 14.37 C1 EDO C 602 D 236 ASP C 357 ASP.? 12.50 O2 EDO C 602 D 261 LYS C 367 LYS.? 10.18 O2 EDO C 602 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 32.76 22.10 -29.37 32.74 19.75 -30.93 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 21.41 26.99 -36.15 19.64 26.87 -41.36 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR C 354 TYR^? 14.37 C1 EDO C 602 E 236 ASP C 357 ASP.? 12.50 O2 EDO C 602 E 261 LYS C 367 LYS.? 10.18 O2 EDO C 602 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 32.76 22.10 -29.37 32.74 19.75 -30.93 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 21.41 26.99 -36.15 19.64 26.87 -41.36 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR A 354 TYR^? 20.91 C1 EDO B 603 G 236 ASP A 357 ASP.? 25.14 C1 EDO B 603 G 261 LYS A 367 LYS.? 27.79 C1 EDO B 603 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 27.10 16.84 11.56 24.90 18.34 12.50 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 22.54 16.74 19.72 22.05 16.00 21.61 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 21.09 4.68 15.64 17.32 4.21 18.91 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 163 TYR C 354 TYR^? 14.37 C1 EDO C 602 G 236 ASP C 357 ASP.? 12.50 O2 EDO C 602 G 261 LYS C 367 LYS.? 10.18 O2 EDO C 602 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 32.76 22.10 -29.37 32.74 19.75 -30.93 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 21.41 26.99 -36.15 19.64 26.87 -41.36 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR A 354 TYR^? 20.91 C1 EDO B 603 H 236 ASP A 357 ASP.? 25.14 C1 EDO B 603 H 261 LYS A 367 LYS.? 27.79 C1 EDO B 603 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 27.10 16.84 11.56 24.90 18.34 12.50 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 22.54 16.74 19.72 22.05 16.00 21.61 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 21.09 4.68 15.64 17.32 4.21 18.91 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 163 TYR C 354 TYR^? 14.37 C1 EDO C 602 H 236 ASP C 357 ASP.? 12.50 O2 EDO C 602 H 261 LYS C 367 LYS.? 10.18 O2 EDO C 602 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 32.76 22.10 -29.37 32.74 19.75 -30.93 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 21.41 26.99 -36.15 19.64 26.87 -41.36 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c15 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 357 ASP.? 25.14 C1 EDO B 603 A 261 ASP A 315 ASP.? 32.31 C1 EDO B 603 A 329 ASP B 426 ASP.? 28.68 C1 EDO B 603 coo 28.46 69.88 26.74 30.40 70.70 26.53 22.54 16.74 19.72 22.05 16.00 21.61 coo 34.02 79.89 42.60 34.73 78.01 41.86 35.16 33.09 19.50 33.98 34.83 19.67 coo 37.87 70.12 31.80 36.61 69.74 30.15 21.11 26.70 26.04 20.61 27.63 27.90 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 261 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 329 ASP C 402 ASP.? 12.78 O1 GOL D 601 coo 28.46 69.88 26.74 30.40 70.70 26.53 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 34.02 79.89 42.60 34.73 78.01 41.86 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 37.87 70.12 31.80 36.61 69.74 30.15 22.26 13.02 -15.38 21.01 11.37 -15.92 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 261 ASP A 350 ASP.? 26.92 O2 GOL D 601 A 329 ASP C 430 ASP.? 26.01 O2 GOL D 601 coo 28.46 69.88 26.74 30.40 70.70 26.53 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 34.02 79.89 42.60 34.73 78.01 41.86 33.51 7.96 1.59 32.78 7.85 -0.37 coo 37.87 70.12 31.80 36.61 69.74 30.15 33.23 18.77 -9.92 33.78 18.54 -7.88 ULMN 3 1qho_c05 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 261 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 329 ASP C 430 ASP.? 26.01 O2 GOL D 601 coo 28.46 69.88 26.74 30.40 70.70 26.53 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 34.02 79.89 42.60 34.73 78.01 41.86 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 37.87 70.12 31.80 36.61 69.74 30.15 33.23 18.77 -9.92 33.78 18.54 -7.88 ULMN 3 1qho_c05 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP B 357 ASP.? 13.04 C1 EDO B 603 A 261 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 329 ASP A 426 ASP.? 22.31 O1 EDO B 603 coo 28.46 69.88 26.74 30.40 70.70 26.53 19.95 30.44 0.55 20.02 30.85 -1.53 coo 34.02 79.89 42.60 34.73 78.01 41.86 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 37.87 70.12 31.80 36.61 69.74 30.15 29.17 24.78 -3.72 30.40 24.16 -5.34 ULMN 3 1qho_c05 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 261 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 329 ASP A 402 ASP.? 12.59 O1 EDO B 603 coo 28.46 69.88 26.74 30.40 70.70 26.53 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 34.02 79.89 42.60 34.73 78.01 41.86 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 37.87 70.12 31.80 36.61 69.74 30.15 18.87 16.83 -6.49 16.77 17.04 -6.49 ULMN 3 1qho_c05 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 261 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 329 ASP A 430 ASP.? 25.41 O1 EDO B 603 coo 28.46 69.88 26.74 30.40 70.70 26.53 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 34.02 79.89 42.60 34.73 78.01 41.86 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 37.87 70.12 31.80 36.61 69.74 30.15 31.59 21.51 -7.17 32.38 22.31 -9.00 ULMN 3 1qho_c05 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 261 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 329 ASP A 430 ASP.? 25.41 O1 EDO B 603 coo 28.46 69.88 26.74 30.40 70.70 26.53 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 34.02 79.89 42.60 34.73 78.01 41.86 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 37.87 70.12 31.80 36.61 69.74 30.15 31.59 21.51 -7.17 32.38 22.31 -9.00 ULMN 3 1qho_c05 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP D 357 ASP.? 12.64 O3 GOL D 601 A 261 ASP D 315 ASP.? 31.69 C1 GOL D 601 A 329 ASP C 426 ASP.? 22.72 C2 GOL D 601 coo 28.46 69.88 26.74 30.40 70.70 26.53 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 34.02 79.89 42.60 34.73 78.01 41.86 48.83 21.16 -21.57 48.15 21.79 -19.66 coo 37.87 70.12 31.80 36.61 69.74 30.15 35.09 15.28 -13.55 34.97 16.40 -11.75 1qho_c05 source 1qho ALPHA-AMYLASE : 9 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 357 ASP.? 25.14 C1 EDO B 603 A 260 ASP B 402 ASP.? 23.46 C2 EDO B 603 A 329 ASP B 426 ASP.? 28.68 C1 EDO B 603 coo 28.46 69.88 26.74 30.40 70.70 26.53 22.54 16.74 19.72 22.05 16.00 21.61 coo 30.73 81.29 37.61 31.23 82.07 35.69 8.17 23.01 23.39 8.93 22.69 25.33 coo 37.87 70.12 31.80 36.61 69.74 30.15 21.11 26.70 26.04 20.61 27.63 27.90 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 260 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 329 ASP C 402 ASP.? 12.78 O1 GOL D 601 coo 28.46 69.88 26.74 30.40 70.70 26.53 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 30.73 81.29 37.61 31.23 82.07 35.69 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 37.87 70.12 31.80 36.61 69.74 30.15 22.26 13.02 -15.38 21.01 11.37 -15.92 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 260 ASP C 430 ASP.? 26.01 O2 GOL D 601 A 329 ASP C 402 ASP.? 12.78 O1 GOL D 601 coo 28.46 69.88 26.74 30.40 70.70 26.53 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 30.73 81.29 37.61 31.23 82.07 35.69 33.23 18.77 -9.92 33.78 18.54 -7.88 coo 37.87 70.12 31.80 36.61 69.74 30.15 22.26 13.02 -15.38 21.01 11.37 -15.92 ULMN 3 1qho_c07 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 260 ASP A 349 ASP.? 30.68 C1 EDO B 603 A 329 ASP C 430 ASP.? 26.01 O2 GOL D 601 coo 28.46 69.88 26.74 30.40 70.70 26.53 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 30.73 81.29 37.61 31.23 82.07 35.69 36.99 12.23 1.79 37.88 13.87 0.83 coo 37.87 70.12 31.80 36.61 69.74 30.15 33.23 18.77 -9.92 33.78 18.54 -7.88 ULMN 3 1qho_c07 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 260 ASP C 349 ASP.? 28.09 C1 EDO C 602 A 329 ASP C 430 ASP.? 26.01 O2 GOL D 601 coo 28.46 69.88 26.74 30.40 70.70 26.53 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 30.73 81.29 37.61 31.23 82.07 35.69 32.59 30.21 -17.31 34.23 29.55 -16.13 coo 37.87 70.12 31.80 36.61 69.74 30.15 33.23 18.77 -9.92 33.78 18.54 -7.88 ULMN 3 1qho_c07 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 260 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 329 ASP C 430 ASP.? 26.01 O2 GOL D 601 coo 28.46 69.88 26.74 30.40 70.70 26.53 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 30.73 81.29 37.61 31.23 82.07 35.69 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 37.87 70.12 31.80 36.61 69.74 30.15 33.23 18.77 -9.92 33.78 18.54 -7.88 ULMN 3 1qho_c07 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP A 430 ASP.? 25.41 O1 EDO B 603 A 260 ASP A 349 ASP.? 30.68 C1 EDO B 603 A 329 ASP C 426 ASP.? 22.72 C2 GOL D 601 coo 28.46 69.88 26.74 30.40 70.70 26.53 31.59 21.51 -7.17 32.38 22.31 -9.00 coo 30.73 81.29 37.61 31.23 82.07 35.69 36.99 12.23 1.79 37.88 13.87 0.83 coo 37.87 70.12 31.80 36.61 69.74 30.15 35.09 15.28 -13.55 34.97 16.40 -11.75 ULMN 3 1qho_c07 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP A 430 ASP.? 25.41 O1 EDO B 603 A 260 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 329 ASP C 426 ASP.? 22.72 C2 GOL D 601 coo 28.46 69.88 26.74 30.40 70.70 26.53 31.59 21.51 -7.17 32.38 22.31 -9.00 coo 30.73 81.29 37.61 31.23 82.07 35.69 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 37.87 70.12 31.80 36.61 69.74 30.15 35.09 15.28 -13.55 34.97 16.40 -11.75 ULMN 3 1qho_c07 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP B 357 ASP.? 13.04 C1 EDO B 603 A 260 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 329 ASP A 426 ASP.? 22.31 O1 EDO B 603 coo 28.46 69.88 26.74 30.40 70.70 26.53 19.95 30.44 0.55 20.02 30.85 -1.53 coo 30.73 81.29 37.61 31.23 82.07 35.69 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 37.87 70.12 31.80 36.61 69.74 30.15 29.17 24.78 -3.72 30.40 24.16 -5.34 ULMN 3 1qho_c07 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP C 357 ASP.? 12.50 O2 EDO C 602 A 260 ASP D 402 ASP.? 14.20 O1 EDO C 602 A 329 ASP D 426 ASP.? 21.84 O1 EDO C 602 coo 28.46 69.88 26.74 30.40 70.70 26.53 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 30.73 81.29 37.61 31.23 82.07 35.69 28.53 7.95 -46.44 29.10 9.08 -48.14 coo 37.87 70.12 31.80 36.61 69.74 30.15 40.54 14.64 -43.98 41.47 13.99 -45.77 ULMN 3 1qho_c07 ALPHA-AMYLASE user 11 3 # 11 A 228 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 260 ASP A 430 ASP.? 25.41 O1 EDO B 603 A 329 ASP A 402 ASP.? 12.59 O1 EDO B 603 coo 28.46 69.88 26.74 30.40 70.70 26.53 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 30.73 81.29 37.61 31.23 82.07 35.69 31.59 21.51 -7.17 32.38 22.31 -9.00 coo 37.87 70.12 31.80 36.61 69.74 30.15 18.87 16.83 -6.49 16.77 17.04 -6.49 ULMN 3 1qho_c07 ALPHA-AMYLASE user 12 3 # 12 A 228 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 260 ASP A 349 ASP.? 30.68 C1 EDO B 603 A 329 ASP A 430 ASP.? 25.41 O1 EDO B 603 coo 28.46 69.88 26.74 30.40 70.70 26.53 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 30.73 81.29 37.61 31.23 82.07 35.69 36.99 12.23 1.79 37.88 13.87 0.83 coo 37.87 70.12 31.80 36.61 69.74 30.15 31.59 21.51 -7.17 32.38 22.31 -9.00 ULMN 3 1qho_c07 ALPHA-AMYLASE user 13 3 # 13 A 228 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 260 ASP A 350 ASP.? 26.92 O2 GOL D 601 A 329 ASP A 430 ASP.? 25.41 O1 EDO B 603 coo 28.46 69.88 26.74 30.40 70.70 26.53 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 30.73 81.29 37.61 31.23 82.07 35.69 33.51 7.96 1.59 32.78 7.85 -0.37 coo 37.87 70.12 31.80 36.61 69.74 30.15 31.59 21.51 -7.17 32.38 22.31 -9.00 ULMN 3 1qho_c07 ALPHA-AMYLASE user 14 3 # 14 A 228 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 260 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 329 ASP A 430 ASP.? 25.41 O1 EDO B 603 coo 28.46 69.88 26.74 30.40 70.70 26.53 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 30.73 81.29 37.61 31.23 82.07 35.69 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 37.87 70.12 31.80 36.61 69.74 30.15 31.59 21.51 -7.17 32.38 22.31 -9.00 ULMN 3 1qho_c07 ALPHA-AMYLASE user 15 3 # 15 A 228 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 260 ASP C 349 ASP.? 28.09 C1 EDO C 602 A 329 ASP A 430 ASP.? 25.41 O1 EDO B 603 coo 28.46 69.88 26.74 30.40 70.70 26.53 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 30.73 81.29 37.61 31.23 82.07 35.69 32.59 30.21 -17.31 34.23 29.55 -16.13 coo 37.87 70.12 31.80 36.61 69.74 30.15 31.59 21.51 -7.17 32.38 22.31 -9.00 ULMN 3 1qho_c07 ALPHA-AMYLASE user 16 3 # 16 A 228 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 260 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 329 ASP A 430 ASP.? 25.41 O1 EDO B 603 coo 28.46 69.88 26.74 30.40 70.70 26.53 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 30.73 81.29 37.61 31.23 82.07 35.69 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 37.87 70.12 31.80 36.61 69.74 30.15 31.59 21.51 -7.17 32.38 22.31 -9.00 ULMN 3 1qho_c07 ALPHA-AMYLASE user 17 3 # 17 A 228 ASP C 430 ASP.? 26.01 O2 GOL D 601 A 260 ASP A 349 ASP.? 30.68 C1 EDO B 603 A 329 ASP A 426 ASP.? 22.31 O1 EDO B 603 coo 28.46 69.88 26.74 30.40 70.70 26.53 33.23 18.77 -9.92 33.78 18.54 -7.88 coo 30.73 81.29 37.61 31.23 82.07 35.69 36.99 12.23 1.79 37.88 13.87 0.83 coo 37.87 70.12 31.80 36.61 69.74 30.15 29.17 24.78 -3.72 30.40 24.16 -5.34 ULMN 3 1qho_c07 ALPHA-AMYLASE user 18 3 # 18 A 228 ASP C 430 ASP.? 26.01 O2 GOL D 601 A 260 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 329 ASP A 426 ASP.? 22.31 O1 EDO B 603 coo 28.46 69.88 26.74 30.40 70.70 26.53 33.23 18.77 -9.92 33.78 18.54 -7.88 coo 30.73 81.29 37.61 31.23 82.07 35.69 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 37.87 70.12 31.80 36.61 69.74 30.15 29.17 24.78 -3.72 30.40 24.16 -5.34 ULMN 3 1qho_c07 ALPHA-AMYLASE user 19 3 # 19 A 228 ASP C 430 ASP.? 26.01 O2 GOL D 601 A 260 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 329 ASP A 426 ASP.? 22.31 O1 EDO B 603 coo 28.46 69.88 26.74 30.40 70.70 26.53 33.23 18.77 -9.92 33.78 18.54 -7.88 coo 30.73 81.29 37.61 31.23 82.07 35.69 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 37.87 70.12 31.80 36.61 69.74 30.15 29.17 24.78 -3.72 30.40 24.16 -5.34 ULMN 3 1qho_c07 ALPHA-AMYLASE user 20 3 # 20 A 228 ASP D 357 ASP.? 12.64 O3 GOL D 601 A 260 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 329 ASP C 426 ASP.? 22.72 C2 GOL D 601 coo 28.46 69.88 26.74 30.40 70.70 26.53 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 30.73 81.29 37.61 31.23 82.07 35.69 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 37.87 70.12 31.80 36.61 69.74 30.15 35.09 15.28 -13.55 34.97 16.40 -11.75 ULMN 3 1qho_c07 ALPHA-AMYLASE user 21 3 # 21 A 228 ASP D 426 ASP.? 21.84 O1 EDO C 602 A 260 ASP D 402 ASP.? 14.20 O1 EDO C 602 A 329 ASP C 357 ASP.? 12.50 O2 EDO C 602 coo 28.46 69.88 26.74 30.40 70.70 26.53 40.54 14.64 -43.98 41.47 13.99 -45.77 coo 30.73 81.29 37.61 31.23 82.07 35.69 28.53 7.95 -46.44 29.10 9.08 -48.14 coo 37.87 70.12 31.80 36.61 69.74 30.15 32.02 20.63 -38.57 31.77 21.72 -40.39 1qho_c07 source 1qho ALPHA-AMYLASE : 21 hits 1qho_c07 naa= 3 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 A 51 ALA B 422 ALA^? 15.69 C2 EDO B 603 A 148 HIS A 338 HIS~? 19.64 C1 EDO B 603 A 163 ASP B 402 ASP.? 23.46 C2 EDO B 603 coo 1.42 19.18 21.84 1.11 19.57 23.28 9.81 26.66 18.07 10.52 25.41 17.54 coo 0.71 19.67 27.92 2.43 19.16 26.83 16.13 23.68 19.02 16.84 23.99 20.97 coo 7.15 16.22 27.50 6.15 18.00 27.94 8.17 23.01 23.39 8.93 22.69 25.33 1qol_c00 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c00 naa= 3 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 B 51 ALA B 422 ALA^? 15.69 C2 EDO B 603 B 148 HIS A 338 HIS~? 19.64 C1 EDO B 603 B 163 ASP B 402 ASP.? 23.46 C2 EDO B 603 coo -33.97 19.78 54.18 -33.40 20.11 52.82 9.81 26.66 18.07 10.52 25.41 17.54 coo -33.17 20.01 48.16 -34.95 19.37 49.06 16.13 23.68 19.02 16.84 23.99 20.97 coo -39.82 16.62 48.85 -38.59 18.24 48.48 8.17 23.01 23.39 8.93 22.69 25.33 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 B 51 ALA D 422 ALA^? 12.49 O1 EDO C 602 B 148 HIS C 338 HIS~? 12.91 O1 EDO C 602 B 163 ASP D 402 ASP.? 14.20 O1 EDO C 602 coo -33.97 19.78 54.18 -33.40 20.11 52.82 30.60 5.17 -40.84 30.09 6.36 -40.04 coo -33.17 20.01 48.16 -34.95 19.37 49.06 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -39.82 16.62 48.85 -38.59 18.24 48.48 28.53 7.95 -46.44 29.10 9.08 -48.14 1qol_c01 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c01 naa= 3 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 C 51 ALA B 422 ALA^? 15.69 C2 EDO B 603 C 148 HIS A 338 HIS~? 19.64 C1 EDO B 603 C 163 ASP B 402 ASP.? 23.46 C2 EDO B 603 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 9.81 26.66 18.07 10.52 25.41 17.54 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 16.13 23.68 19.02 16.84 23.99 20.97 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 8.17 23.01 23.39 8.93 22.69 25.33 1qol_c02 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c02 naa= 3 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 D 51 ALA B 422 ALA^? 15.69 C2 EDO B 603 D 148 HIS A 338 HIS~? 19.64 C1 EDO B 603 D 163 ASP B 402 ASP.? 23.46 C2 EDO B 603 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 9.81 26.66 18.07 10.52 25.41 17.54 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 16.13 23.68 19.02 16.84 23.99 20.97 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 8.17 23.01 23.39 8.93 22.69 25.33 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 D 51 ALA D 422 ALA^? 12.49 O1 EDO C 602 D 148 HIS C 338 HIS~? 12.91 O1 EDO C 602 D 163 ASP D 402 ASP.? 14.20 O1 EDO C 602 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 30.60 5.17 -40.84 30.09 6.36 -40.04 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 28.53 7.95 -46.44 29.10 9.08 -48.14 1qol_c03 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c03 naa= 3 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 E 51 ALA A 422 ALA^? 13.54 O1 EDO B 603 E 148 HIS B 338 HIS.? 13.66 O1 EDO B 603 E 163 ASP A 402 ASP.? 12.59 O1 EDO B 603 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 20.34 14.47 -0.75 19.66 15.71 -0.13 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 18.87 16.83 -6.49 16.77 17.04 -6.49 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 E 51 ALA D 422 ALA^? 12.49 O1 EDO C 602 E 148 HIS C 338 HIS~? 12.91 O1 EDO C 602 E 163 ASP D 402 ASP.? 14.20 O1 EDO C 602 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 30.60 5.17 -40.84 30.09 6.36 -40.04 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 28.53 7.95 -46.44 29.10 9.08 -48.14 1qol_c04 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c04 naa= 3 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 F 51 ALA B 422 ALA^? 15.69 C2 EDO B 603 F 148 HIS A 338 HIS~? 19.64 C1 EDO B 603 F 163 ASP B 402 ASP.? 23.46 C2 EDO B 603 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 9.81 26.66 18.07 10.52 25.41 17.54 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 16.13 23.68 19.02 16.84 23.99 20.97 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 8.17 23.01 23.39 8.93 22.69 25.33 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 F 51 ALA D 422 ALA^? 12.49 O1 EDO C 602 F 148 HIS C 338 HIS~? 12.91 O1 EDO C 602 F 163 ASP D 402 ASP.? 14.20 O1 EDO C 602 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 30.60 5.17 -40.84 30.09 6.36 -40.04 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 28.53 7.95 -46.44 29.10 9.08 -48.14 1qol_c05 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c05 naa= 3 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 G 51 ALA A 422 ALA^? 13.54 O1 EDO B 603 G 148 HIS B 338 HIS.? 13.66 O1 EDO B 603 G 163 ASP A 402 ASP.? 12.59 O1 EDO B 603 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 20.34 14.47 -0.75 19.66 15.71 -0.13 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 18.87 16.83 -6.49 16.77 17.04 -6.49 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 G 51 ALA D 422 ALA^? 12.49 O1 EDO C 602 G 148 HIS C 338 HIS~? 12.91 O1 EDO C 602 G 163 ASP D 402 ASP.? 14.20 O1 EDO C 602 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 30.60 5.17 -40.84 30.09 6.36 -40.04 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 28.53 7.95 -46.44 29.10 9.08 -48.14 1qol_c06 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c06 naa= 3 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 3 # 1 A 145 THR A 369 THR~? 31.64 C1 EDO B 603 A 182 TYR A 355 TYR^? 25.32 C1 EDO B 603 A 186 LYS A 367 LYS.? 27.79 C1 EDO B 603 coo 69.38 87.38 24.64 71.11 88.47 25.40 27.07 6.63 18.00 27.23 4.49 18.30 coo 73.61 90.42 31.12 71.36 89.66 29.64 25.00 11.79 14.66 25.82 10.48 17.03 coo 73.54 84.00 28.64 69.01 86.68 29.71 21.09 4.68 15.64 17.32 4.21 18.91 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 2 3 # 2 A 145 THR B 369 THR~? 15.82 O2 EDO B 603 A 182 TYR B 355 TYR^? 12.60 O2 EDO B 603 A 186 LYS B 367 LYS.? 8.96 O2 EDO B 603 coo 69.38 87.38 24.64 71.11 88.47 25.40 14.08 40.07 2.07 12.56 41.55 1.60 coo 73.61 90.42 31.12 71.36 89.66 29.64 15.82 34.63 5.10 16.14 36.63 3.16 coo 73.54 84.00 28.64 69.01 86.68 29.71 8.46 36.63 1.57 6.31 34.95 -1.21 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 3 3 # 3 A 145 THR C 369 THR~? 15.84 O2 EDO C 602 A 182 TYR C 355 TYR^? 12.28 O2 EDO C 602 A 186 LYS C 367 LYS.? 10.18 O2 EDO C 602 coo 69.38 87.38 24.64 71.11 88.47 25.40 27.27 30.44 -36.03 26.03 32.19 -36.25 coo 73.61 90.42 31.12 71.36 89.66 29.64 28.68 24.77 -33.28 28.94 26.73 -35.28 coo 73.54 84.00 28.64 69.01 86.68 29.71 21.41 26.99 -36.15 19.64 26.87 -41.36 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 4 3 # 4 A 145 THR D 369 THR~? 16.21 O3 GOL D 601 A 182 TYR D 355 TYR^? 12.42 O3 GOL D 601 A 186 LYS D 367 LYS.? 8.67 O3 GOL D 601 coo 69.38 87.38 24.64 71.11 88.47 25.40 38.48 -5.77 -24.43 38.79 -7.85 -25.06 coo 73.61 90.42 31.12 71.36 89.66 29.64 36.51 0.70 -26.17 37.53 -0.88 -24.11 coo 73.54 84.00 28.64 69.01 86.68 29.71 32.17 -6.41 -25.63 28.00 -7.23 -22.20 1qrr_c01 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 4 hits 1qrr_c01 naa= 3 ULMN 3 1qrz_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 646 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 741 SER B 358 SER.? 7.25 C1 EDO B 603 coo -20.72 2.99 34.37 -21.94 1.82 35.61 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -18.83 7.68 26.86 -20.89 7.78 26.56 18.87 16.83 -6.49 16.77 17.04 -6.49 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 16.90 26.63 0.02 16.29 24.39 0.69 ULMN 3 1qrz_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 646 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 741 SER B 358 SER.? 7.25 C1 EDO B 603 coo -20.72 2.99 34.37 -21.94 1.82 35.61 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -18.83 7.68 26.86 -20.89 7.78 26.56 29.17 24.78 -3.72 30.40 24.16 -5.34 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 16.90 26.63 0.02 16.29 24.39 0.69 ULMN 3 1qrz_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS C 338 HIS~? 12.91 O1 EDO C 602 A 646 ASP D 402 ASP.? 14.20 O1 EDO C 602 A 741 SER C 358 SER.? 6.66 O1 EDO C 602 coo -20.72 2.99 34.37 -21.94 1.82 35.61 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -18.83 7.68 26.86 -20.89 7.78 26.56 28.53 7.95 -46.44 29.10 9.08 -48.14 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 28.49 17.26 -38.81 27.76 14.99 -38.31 ULMN 3 1qrz_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS D 338 HIS~? 13.70 C1 GOL D 601 A 646 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 741 SER D 358 SER.? 6.75 C2 GOL D 601 coo -20.72 2.99 34.37 -21.94 1.82 35.61 29.23 12.85 -20.11 30.06 13.12 -18.20 coo -18.83 7.68 26.86 -20.89 7.78 26.56 22.26 13.02 -15.38 21.01 11.37 -15.92 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 29.79 5.62 -21.71 27.82 6.72 -22.45 1qrz_c12 source 1qrz PLASMINOGEN : 4 hits 1qrz_c12 naa= 3 ULMN 3 1qrz_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS B 338 HIS.? 13.66 O1 EDO B 603 B 646 ASP A 402 ASP.? 12.59 O1 EDO B 603 B 741 SER B 358 SER.? 7.25 C1 EDO B 603 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 18.87 16.83 -6.49 16.77 17.04 -6.49 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 16.90 26.63 0.02 16.29 24.39 0.69 ULMN 3 1qrz_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS C 338 HIS~? 12.91 O1 EDO C 602 B 646 ASP D 402 ASP.? 14.20 O1 EDO C 602 B 741 SER C 358 SER.? 6.66 O1 EDO C 602 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 28.53 7.95 -46.44 29.10 9.08 -48.14 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 28.49 17.26 -38.81 27.76 14.99 -38.31 ULMN 3 1qrz_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS D 338 HIS~? 13.70 C1 GOL D 601 B 646 ASP C 402 ASP.? 12.78 O1 GOL D 601 B 741 SER D 358 SER.? 6.75 C2 GOL D 601 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 29.23 12.85 -20.11 30.06 13.12 -18.20 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 22.26 13.02 -15.38 21.01 11.37 -15.92 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 29.79 5.62 -21.71 27.82 6.72 -22.45 1qrz_c13 source 1qrz PLASMINOGEN : 3 hits 1qrz_c13 naa= 3 ULMN 3 1qrz_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS B 338 HIS.? 13.66 O1 EDO B 603 C 646 ASP A 402 ASP.? 12.59 O1 EDO B 603 C 741 SER B 358 SER.? 7.25 C1 EDO B 603 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 16.90 26.63 0.02 16.29 24.39 0.69 ULMN 3 1qrz_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS B 338 HIS.? 13.66 O1 EDO B 603 C 646 ASP A 426 ASP.? 22.31 O1 EDO B 603 C 741 SER B 358 SER.? 7.25 C1 EDO B 603 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 16.90 26.63 0.02 16.29 24.39 0.69 ULMN 3 1qrz_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS C 338 HIS~? 12.91 O1 EDO C 602 C 646 ASP D 402 ASP.? 14.20 O1 EDO C 602 C 741 SER C 358 SER.? 6.66 O1 EDO C 602 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 28.53 7.95 -46.44 29.10 9.08 -48.14 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 28.49 17.26 -38.81 27.76 14.99 -38.31 ULMN 3 1qrz_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS D 338 HIS~? 13.70 C1 GOL D 601 C 646 ASP C 402 ASP.? 12.78 O1 GOL D 601 C 741 SER D 358 SER.? 6.75 C2 GOL D 601 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 29.79 5.62 -21.71 27.82 6.72 -22.45 1qrz_c14 source 1qrz PLASMINOGEN : 4 hits 1qrz_c14 naa= 3 ULMN 3 1qrz_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS B 338 HIS.? 13.66 O1 EDO B 603 D 646 ASP A 402 ASP.? 12.59 O1 EDO B 603 D 741 SER B 358 SER.? 7.25 C1 EDO B 603 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 18.87 16.83 -6.49 16.77 17.04 -6.49 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 16.90 26.63 0.02 16.29 24.39 0.69 ULMN 3 1qrz_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS C 338 HIS~? 12.91 O1 EDO C 602 D 646 ASP D 402 ASP.? 14.20 O1 EDO C 602 D 741 SER C 358 SER.? 6.66 O1 EDO C 602 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 28.53 7.95 -46.44 29.10 9.08 -48.14 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 28.49 17.26 -38.81 27.76 14.99 -38.31 ULMN 3 1qrz_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS D 338 HIS~? 13.70 C1 GOL D 601 D 646 ASP C 402 ASP.? 12.78 O1 GOL D 601 D 741 SER D 358 SER.? 6.75 C2 GOL D 601 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 29.23 12.85 -20.11 30.06 13.12 -18.20 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 22.26 13.02 -15.38 21.01 11.37 -15.92 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 29.79 5.62 -21.71 27.82 6.72 -22.45 1qrz_c15 source 1qrz PLASMINOGEN : 3 hits 1qrz_c15 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 444 PHE~? 11.79 C1 EDO B 603 A 201 ASP A 448 ASP~? 19.70 O1 EDO B 603 A 227 LYS B 415 LYS^? -2.82 O2 EDO B 603s coo 23.39 49.81 32.16 21.33 51.68 32.26 2.91 15.92 8.56 5.14 17.37 9.33 coo 25.52 45.12 37.98 23.98 46.65 37.85 -6.12 13.55 5.97 -7.03 12.86 4.20 coo 12.68 46.83 36.69 18.26 48.67 34.51 1.57 23.62 -1.31 7.49 26.02 -1.78 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE B 445 PHE~? 13.78 O1 EDO B 603 A 201 ASP A 448 ASP~? 19.70 O1 EDO B 603 A 227 LYS B 415 LYS^? -2.82 O2 EDO B 603s coo 23.39 49.81 32.16 21.33 51.68 32.26 -1.25 14.50 2.62 -1.24 15.79 5.10 coo 25.52 45.12 37.98 23.98 46.65 37.85 -6.12 13.55 5.97 -7.03 12.86 4.20 coo 12.68 46.83 36.69 18.26 48.67 34.51 1.57 23.62 -1.31 7.49 26.02 -1.78 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE C 416 PHE^? 11.78 C2 EDO C 602 A 201 ASP D 448 ASP.? 19.66 C2 EDO C 602 A 227 LYS D 442 LYS~? 12.65 O2 GOL D 601 coo 23.39 49.81 32.16 21.33 51.68 32.26 10.28 12.37 -34.72 8.44 12.42 -32.58 coo 25.52 45.12 37.98 23.98 46.65 37.85 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 12.68 46.83 36.69 18.26 48.67 34.51 14.14 0.83 -27.84 11.41 -3.18 -25.91 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE C 431 PHE^? 22.21 O1 GOL D 601 A 201 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 227 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 23.39 49.81 32.16 21.33 51.68 32.26 28.24 21.80 -13.63 26.64 22.64 -15.77 coo 25.52 45.12 37.98 23.98 46.65 37.85 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 12.68 46.83 36.69 18.26 48.67 34.51 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 1qz9_c02 KYNURENINASE user 5 3 # 5 A 129 PHE C 445 PHE~? 14.33 C2 EDO C 602 A 201 ASP D 448 ASP.? 19.66 C2 EDO C 602 A 227 LYS D 442 LYS~? 12.65 O2 GOL D 601 coo 23.39 49.81 32.16 21.33 51.68 32.26 9.78 6.26 -35.53 9.91 7.07 -32.85 coo 25.52 45.12 37.98 23.98 46.65 37.85 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 12.68 46.83 36.69 18.26 48.67 34.51 14.14 0.83 -27.84 11.41 -3.18 -25.91 ULMN 3 1qz9_c02 KYNURENINASE user 6 3 # 6 A 129 PHE D 445 PHE~? 11.88 O1 GOL D 601 A 201 ASP D 448 ASP.? 19.66 C2 EDO C 602 A 227 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 23.39 49.81 32.16 21.33 51.68 32.26 10.86 1.23 -30.60 12.85 0.20 -32.29 coo 25.52 45.12 37.98 23.98 46.65 37.85 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 12.68 46.83 36.69 18.26 48.67 34.51 12.96 9.36 -37.91 9.04 10.02 -41.38 1qz9_c02 source 1qz9 KYNURENINASE : 6 hits 1qz9_c02 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 350 ASP.? 26.92 O2 GOL D 601 A 186 ASN A 347 ASN^? 27.63 C1 EDO B 603 A 260 ALA A 423 ALA^? 17.43 O1 EDO B 603 coo 11.81 33.10 11.71 13.07 31.45 11.40 33.51 7.96 1.59 32.78 7.85 -0.37 coo 11.43 26.53 7.41 13.01 27.56 8.43 32.85 15.10 3.85 34.45 13.77 4.43 coo 21.53 26.33 6.96 20.26 25.69 7.52 23.34 15.61 -2.79 23.45 15.65 -4.34 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP A 357 ASP.? 25.14 C1 EDO B 603 A 186 ASN A 333 ASN~? 23.15 C1 EDO B 603 A 260 ALA B 332 ALA~? 19.64 C1 EDO B 603 coo 11.81 33.10 11.71 13.07 31.45 11.40 22.54 16.74 19.72 22.05 16.00 21.61 coo 11.43 26.53 7.41 13.01 27.56 8.43 25.58 24.27 17.00 25.61 22.33 17.91 coo 21.53 26.33 6.96 20.26 25.69 7.52 26.85 23.79 8.15 27.20 24.46 9.48 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 3 3 # 3 A 10 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 186 ASN C 398 ASN~? 15.53 O1 EDO B 603 A 260 ALA A 428 ALA.? 23.52 O1 EDO B 603 coo 11.81 33.10 11.71 13.07 31.45 11.40 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 11.43 26.53 7.41 13.01 27.56 8.43 21.01 22.53 -8.94 21.24 24.62 -8.84 coo 21.53 26.33 6.96 20.26 25.69 7.52 28.89 26.05 -8.94 30.39 25.95 -8.77 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 4 3 # 4 A 10 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 186 ASN C 398 ASN~? 15.53 O1 EDO B 603 A 260 ALA C 423 ALA^? 17.19 O1 GOL D 601 coo 11.81 33.10 11.71 13.07 31.45 11.40 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 11.43 26.53 7.41 13.01 27.56 8.43 21.01 22.53 -8.94 21.24 24.62 -8.84 coo 21.53 26.33 6.96 20.26 25.69 7.52 25.18 17.70 -17.34 24.76 17.44 -15.88 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 5 3 # 5 A 10 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 186 ASN B 337 ASN~? 13.41 C1 EDO B 603 A 260 ALA A 423 ALA^? 17.43 O1 EDO B 603 coo 11.81 33.10 11.71 13.07 31.45 11.40 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 11.43 26.53 7.41 13.01 27.56 8.43 21.54 26.32 1.73 21.98 28.23 2.58 coo 21.53 26.33 6.96 20.26 25.69 7.52 23.34 15.61 -2.79 23.45 15.65 -4.34 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 6 3 # 6 A 10 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 186 ASN B 337 ASN~? 13.41 C1 EDO B 603 A 260 ALA B 332 ALA~? 19.64 C1 EDO B 603 coo 11.81 33.10 11.71 13.07 31.45 11.40 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 11.43 26.53 7.41 13.01 27.56 8.43 21.54 26.32 1.73 21.98 28.23 2.58 coo 21.53 26.33 6.96 20.26 25.69 7.52 26.85 23.79 8.15 27.20 24.46 9.48 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 7 3 # 7 A 10 ASP B 350 ASP.? 23.89 C2 EDO B 603 A 186 ASN B 347 ASN^? 23.37 C2 EDO B 603 A 260 ALA B 423 ALA^? 20.91 C2 EDO B 603 coo 11.81 33.10 11.71 13.07 31.45 11.40 12.16 40.72 19.41 11.14 39.74 20.98 coo 11.43 26.53 7.41 13.01 27.56 8.43 18.47 36.73 18.25 18.44 38.86 18.15 coo 21.53 26.33 6.96 20.26 25.69 7.52 11.54 27.99 21.15 11.04 27.92 22.61 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 8 3 # 8 A 10 ASP B 357 ASP.? 13.04 C1 EDO B 603 A 186 ASN B 333 ASN~? 17.11 C1 EDO B 603 A 260 ALA A 332 ALA~? 19.35 C1 EDO B 603 coo 11.81 33.10 11.71 13.07 31.45 11.40 19.95 30.44 0.55 20.02 30.85 -1.53 coo 11.43 26.53 7.41 13.01 27.56 8.43 26.50 27.72 5.31 25.42 29.17 4.18 coo 21.53 26.33 6.96 20.26 25.69 7.52 23.70 27.46 13.78 24.80 27.54 12.75 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 9 3 # 9 A 10 ASP B 426 ASP.? 28.68 C1 EDO B 603 A 186 ASN A 337 ASN~? 21.47 C1 EDO B 603 A 260 ALA A 332 ALA~? 19.35 C1 EDO B 603 coo 11.81 33.10 11.71 13.07 31.45 11.40 21.11 26.70 26.04 20.61 27.63 27.90 coo 11.43 26.53 7.41 13.01 27.56 8.43 20.37 20.71 18.22 22.41 20.05 18.06 coo 21.53 26.33 6.96 20.26 25.69 7.52 23.70 27.46 13.78 24.80 27.54 12.75 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 10 3 # 10 A 10 ASP B 426 ASP.? 28.68 C1 EDO B 603 A 186 ASN A 337 ASN~? 21.47 C1 EDO B 603 A 260 ALA B 423 ALA^? 20.91 C2 EDO B 603 coo 11.81 33.10 11.71 13.07 31.45 11.40 21.11 26.70 26.04 20.61 27.63 27.90 coo 11.43 26.53 7.41 13.01 27.56 8.43 20.37 20.71 18.22 22.41 20.05 18.06 coo 21.53 26.33 6.96 20.26 25.69 7.52 11.54 27.99 21.15 11.04 27.92 22.61 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 11 3 # 11 A 10 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 186 ASN C 347 ASN^? 23.48 C1 EDO C 602 A 260 ALA C 423 ALA^? 17.19 O1 GOL D 601 coo 11.81 33.10 11.71 13.07 31.45 11.40 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 11.43 26.53 7.41 13.01 27.56 8.43 32.68 25.81 -20.60 32.92 27.92 -20.57 coo 21.53 26.33 6.96 20.26 25.69 7.52 25.18 17.70 -17.34 24.76 17.44 -15.88 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 12 3 # 12 A 10 ASP C 357 ASP.? 12.50 O2 EDO C 602 A 186 ASN C 333 ASN~? 16.90 C1 EDO C 602 A 260 ALA D 332 ALA~? 19.27 C1 EDO C 602 coo 11.81 33.10 11.71 13.07 31.45 11.40 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 11.43 26.53 7.41 13.01 27.56 8.43 38.73 17.09 -34.48 37.68 18.68 -35.44 coo 21.53 26.33 6.96 20.26 25.69 7.52 36.62 16.28 -25.65 37.68 16.38 -26.75 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 13 3 # 13 A 10 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 186 ASN A 398 ASN~? 16.47 O2 GOL D 601 A 260 ALA A 423 ALA^? 17.43 O1 EDO B 603 coo 11.81 33.10 11.71 13.07 31.45 11.40 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 11.43 26.53 7.41 13.01 27.56 8.43 26.81 10.21 -11.17 28.62 9.13 -11.03 coo 21.53 26.33 6.96 20.26 25.69 7.52 23.34 15.61 -2.79 23.45 15.65 -4.34 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 14 3 # 14 A 10 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 186 ASN A 398 ASN~? 16.47 O2 GOL D 601 A 260 ALA C 428 ALA.? 24.22 O2 GOL D 601 coo 11.81 33.10 11.71 13.07 31.45 11.40 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 11.43 26.53 7.41 13.01 27.56 8.43 26.81 10.21 -11.17 28.62 9.13 -11.03 coo 21.53 26.33 6.96 20.26 25.69 7.52 34.28 13.61 -8.51 35.19 14.79 -8.24 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 15 3 # 15 A 10 ASP D 350 ASP.? 24.09 C3 GOL D 601 A 186 ASN D 347 ASN^? 23.69 C3 GOL D 601 A 260 ALA D 423 ALA^? 16.44 O1 EDO C 602 coo 11.81 33.10 11.71 13.07 31.45 11.40 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 11.43 26.53 7.41 13.01 27.56 8.43 43.61 4.31 -37.61 45.14 2.83 -37.46 coo 21.53 26.33 6.96 20.26 25.69 7.52 33.47 6.23 -43.05 33.47 6.26 -44.59 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 16 3 # 16 A 10 ASP D 357 ASP.? 12.64 O3 GOL D 601 A 186 ASN D 333 ASN~? 17.27 C2 GOL D 601 A 260 ALA C 332 ALA~? 19.24 C1 EDO C 602 coo 11.81 33.10 11.71 13.07 31.45 11.40 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 11.43 26.53 7.41 13.01 27.56 8.43 38.40 12.82 -22.80 38.46 10.80 -22.10 coo 21.53 26.33 6.96 20.26 25.69 7.52 38.86 12.95 -31.94 39.29 13.43 -30.53 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 17 3 # 17 A 10 ASP D 426 ASP.? 21.84 O1 EDO C 602 A 186 ASN C 337 ASN~? 13.18 C1 EDO C 602 A 260 ALA C 332 ALA~? 19.24 C1 EDO C 602 coo 11.81 33.10 11.71 13.07 31.45 11.40 40.54 14.64 -43.98 41.47 13.99 -45.77 coo 11.43 26.53 7.41 13.01 27.56 8.43 33.28 16.29 -37.60 34.03 18.13 -36.82 coo 21.53 26.33 6.96 20.26 25.69 7.52 38.86 12.95 -31.94 39.29 13.43 -30.53 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 18 3 # 18 A 10 ASP D 426 ASP.? 21.84 O1 EDO C 602 A 186 ASN C 337 ASN~? 13.18 C1 EDO C 602 A 260 ALA D 422 ALA^? 12.49 O1 EDO C 602 coo 11.81 33.10 11.71 13.07 31.45 11.40 40.54 14.64 -43.98 41.47 13.99 -45.77 coo 11.43 26.53 7.41 13.01 27.56 8.43 33.28 16.29 -37.60 34.03 18.13 -36.82 coo 21.53 26.33 6.96 20.26 25.69 7.52 30.60 5.17 -40.84 30.09 6.36 -40.04 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 19 3 # 19 A 10 ASP D 426 ASP.? 21.84 O1 EDO C 602 A 186 ASN C 337 ASN~? 13.18 C1 EDO C 602 A 260 ALA D 423 ALA^? 16.44 O1 EDO C 602 coo 11.81 33.10 11.71 13.07 31.45 11.40 40.54 14.64 -43.98 41.47 13.99 -45.77 coo 11.43 26.53 7.41 13.01 27.56 8.43 33.28 16.29 -37.60 34.03 18.13 -36.82 coo 21.53 26.33 6.96 20.26 25.69 7.52 33.47 6.23 -43.05 33.47 6.26 -44.59 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 19 hits 1r4f_c00 naa= 3 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 1 3 # 1 D 129 ARG A 425 ARG^? 21.19 O1 EDO B 603 D 156 TYR A 437 TYR^? 11.45 C1 EDO B 603 D 188 HIS B 338 HIS.? 13.66 O1 EDO B 603 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 25.04 18.93 -7.11 26.86 16.62 -8.01 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 16.79 15.50 5.48 15.91 16.43 3.01 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 21.66 21.37 -0.01 22.97 22.11 -1.47 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 2 3 # 2 D 129 ARG B 425 ARG^? 24.19 C2 EDO B 603 D 156 TYR B 437 TYR^? 10.72 C1 EDO B 603 D 188 HIS A 338 HIS~? 19.64 C1 EDO B 603 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 13.19 26.25 26.41 10.66 27.96 25.98 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 10.92 24.41 11.32 10.27 22.67 13.43 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 16.13 23.68 19.02 16.84 23.99 20.97 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 3 3 # 3 D 129 ARG D 425 ARG^? 16.89 O1 EDO C 602 D 156 TYR D 437 TYR^? 9.97 C1 GOL D 601 D 188 HIS C 338 HIS~? 12.91 O1 EDO C 602 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 35.18 9.71 -47.18 32.90 7.74 -47.72 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 27.83 5.60 -34.20 26.72 6.80 -36.49 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 32.85 11.57 -39.74 34.04 12.36 -41.28 1ro7_c03 source 1ro7 ALPHA-2,3/8-SIALYLTRANSFERASE : 3 hits 1ro7_c03 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU A 330 GLU~? 26.93 C1 EDO B 603 A 288 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 329 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 29.27 18.78 14.99 27.16 18.62 14.76 25.78 29.04 20.96 25.48 30.78 22.26 coo 49.52 10.06 10.36 50.99 9.65 8.92 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 57.80 12.92 13.83 53.77 8.42 12.15 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 A 137 GLU A 363 GLU~? 27.04 C1 EDO B 603 A 288 HIS A 381 HIS.? 27.31 O1 EDO B 603 A 329 LYS A 390 LYS~? 25.88 O2 GOL D 601 coo 29.27 18.78 14.99 27.16 18.62 14.76 14.23 7.65 22.80 13.44 9.34 23.77 coo 49.52 10.06 10.36 50.99 9.65 8.92 25.64 1.98 6.69 25.07 4.00 6.65 coo 57.80 12.92 13.83 53.77 8.42 12.15 26.64 2.81 -1.98 30.91 -1.55 -0.35 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 A 137 GLU A 411 GLU.? 28.28 O1 EDO B 603 A 288 HIS A 381 HIS.? 27.31 O1 EDO B 603 A 329 LYS A 390 LYS~? 25.88 O2 GOL D 601 coo 29.27 18.78 14.99 27.16 18.62 14.76 3.89 -1.22 13.75 2.15 -0.02 14.05 coo 49.52 10.06 10.36 50.99 9.65 8.92 25.64 1.98 6.69 25.07 4.00 6.65 coo 57.80 12.92 13.83 53.77 8.42 12.15 26.64 2.81 -1.98 30.91 -1.55 -0.35 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 A 137 GLU B 330 GLU~? 24.65 C1 EDO B 603 A 288 HIS A 338 HIS~? 19.64 C1 EDO B 603 A 329 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo 29.27 18.78 14.99 27.16 18.62 14.76 31.94 25.81 2.71 33.76 25.37 1.74 coo 49.52 10.06 10.36 50.99 9.65 8.92 16.13 23.68 19.02 16.84 23.99 20.97 coo 57.80 12.92 13.83 53.77 8.42 12.15 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 A 137 GLU B 363 GLU~? 7.89 O1 EDO B 603 A 288 HIS B 381 HIS.? 15.29 C2 EDO B 603 A 329 LYS B 388 LYS~? 19.48 C2 EDO B 603 coo 29.27 18.78 14.99 27.16 18.62 14.76 8.83 27.73 -6.37 10.21 26.17 -6.89 coo 49.52 10.06 10.36 50.99 9.65 8.92 4.86 38.27 11.07 6.17 36.67 11.45 coo 57.80 12.92 13.83 53.77 8.42 12.15 -0.92 37.13 17.34 -4.46 33.66 14.61 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 A 137 GLU B 363 GLU~? 7.89 O1 EDO B 603 A 288 HIS B 381 HIS.? 15.29 C2 EDO B 603 A 329 LYS B 390 LYS~? 27.12 C2 EDO B 603 coo 29.27 18.78 14.99 27.16 18.62 14.76 8.83 27.73 -6.37 10.21 26.17 -6.89 coo 49.52 10.06 10.36 50.99 9.65 8.92 4.86 38.27 11.07 6.17 36.67 11.45 coo 57.80 12.92 13.83 53.77 8.42 12.15 3.52 38.72 20.17 3.15 45.06 20.21 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 7 3 # 7 A 137 GLU C 330 GLU~? 24.03 O1 EDO C 602 A 288 HIS D 338 HIS~? 13.70 C1 GOL D 601 A 329 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 29.27 18.78 14.99 27.16 18.62 14.76 43.59 14.91 -37.76 45.12 14.02 -38.99 coo 49.52 10.06 10.36 50.99 9.65 8.92 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 57.80 12.92 13.83 53.77 8.42 12.15 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 8 3 # 8 A 137 GLU C 363 GLU~? 7.78 O2 EDO C 602 A 288 HIS C 381 HIS~? 16.26 O2 EDO C 602 A 329 LYS C 384 LYS~? 20.68 O2 EDO C 602 coo 29.27 18.78 14.99 27.16 18.62 14.76 20.56 19.64 -44.58 21.56 17.87 -45.23 coo 49.52 10.06 10.36 50.99 9.65 8.92 19.26 30.57 -26.59 20.09 28.69 -27.02 coo 57.80 12.92 13.83 53.77 8.42 12.15 11.81 35.96 -24.38 11.26 34.03 -29.22 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 9 3 # 9 A 137 GLU C 363 GLU~? 7.78 O2 EDO C 602 A 288 HIS C 381 HIS~? 16.26 O2 EDO C 602 A 329 LYS C 390 LYS~? 21.48 O2 EDO B 603 coo 29.27 18.78 14.99 27.16 18.62 14.76 20.56 19.64 -44.58 21.56 17.87 -45.23 coo 49.52 10.06 10.36 50.99 9.65 8.92 19.26 30.57 -26.59 20.09 28.69 -27.02 coo 57.80 12.92 13.83 53.77 8.42 12.15 17.95 29.37 -17.21 18.11 35.53 -15.65 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 10 3 # 10 A 137 GLU C 411 GLU.? 15.78 O2 EDO C 602 A 288 HIS C 381 HIS~? 16.26 O2 EDO C 602 A 329 LYS C 390 LYS~? 21.48 O2 EDO B 603 coo 29.27 18.78 14.99 27.16 18.62 14.76 6.23 19.30 -42.44 5.28 17.46 -42.16 coo 49.52 10.06 10.36 50.99 9.65 8.92 19.26 30.57 -26.59 20.09 28.69 -27.02 coo 57.80 12.92 13.83 53.77 8.42 12.15 17.95 29.37 -17.21 18.11 35.53 -15.65 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 11 3 # 11 A 137 GLU D 330 GLU~? 24.51 C2 GOL D 601 A 288 HIS C 338 HIS~? 12.91 O1 EDO C 602 A 329 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 29.27 18.78 14.99 27.16 18.62 14.76 39.35 17.44 -18.72 40.01 18.64 -17.10 coo 49.52 10.06 10.36 50.99 9.65 8.92 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 57.80 12.92 13.83 53.77 8.42 12.15 27.51 4.47 -43.69 23.30 8.13 -41.81 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 12 3 # 12 A 137 GLU D 363 GLU~? 7.90 O2 GOL D 601 A 288 HIS D 381 HIS.? 16.49 O3 GOL D 601 A 329 LYS D 390 LYS~? 25.65 O3 GOL D 601 coo 29.27 18.78 14.99 27.16 18.62 14.76 24.65 -2.66 -18.42 24.14 -0.86 -17.43 coo 49.52 10.06 10.36 50.99 9.65 8.92 36.03 -8.97 -35.15 35.55 -7.12 -34.29 coo 57.80 12.92 13.83 53.77 8.42 12.15 35.81 -6.92 -44.49 39.58 -10.95 -43.36 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 13 3 # 13 A 137 GLU D 411 GLU.? 16.70 O3 GOL D 601 A 288 HIS D 381 HIS.? 16.49 O3 GOL D 601 A 329 LYS D 390 LYS~? 25.65 O3 GOL D 601 coo 29.27 18.78 14.99 27.16 18.62 14.76 14.38 -10.66 -25.01 13.15 -12.19 -25.81 coo 49.52 10.06 10.36 50.99 9.65 8.92 36.03 -8.97 -35.15 35.55 -7.12 -34.29 coo 57.80 12.92 13.83 53.77 8.42 12.15 35.81 -6.92 -44.49 39.58 -10.95 -43.36 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 13 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU A 330 GLU~? 26.93 C1 EDO B 603 B 288 HIS B 338 HIS.? 13.66 O1 EDO B 603 B 329 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 25.78 29.04 20.96 25.48 30.78 22.26 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 B 137 GLU A 411 GLU.? 28.28 O1 EDO B 603 B 288 HIS A 381 HIS.? 27.31 O1 EDO B 603 B 329 LYS A 390 LYS~? 25.88 O2 GOL D 601 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 3.89 -1.22 13.75 2.15 -0.02 14.05 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 25.64 1.98 6.69 25.07 4.00 6.65 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 26.64 2.81 -1.98 30.91 -1.55 -0.35 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 B 137 GLU B 330 GLU~? 24.65 C1 EDO B 603 B 288 HIS A 338 HIS~? 19.64 C1 EDO B 603 B 329 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 31.94 25.81 2.71 33.76 25.37 1.74 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 16.13 23.68 19.02 16.84 23.99 20.97 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 B 137 GLU C 330 GLU~? 24.03 O1 EDO C 602 B 288 HIS D 338 HIS~? 13.70 C1 GOL D 601 B 329 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 43.59 14.91 -37.76 45.12 14.02 -38.99 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 B 137 GLU C 363 GLU~? 7.78 O2 EDO C 602 B 288 HIS C 381 HIS~? 16.26 O2 EDO C 602 B 329 LYS C 384 LYS~? 20.68 O2 EDO C 602 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 20.56 19.64 -44.58 21.56 17.87 -45.23 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 19.26 30.57 -26.59 20.09 28.69 -27.02 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 11.81 35.96 -24.38 11.26 34.03 -29.22 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 B 137 GLU C 363 GLU~? 7.78 O2 EDO C 602 B 288 HIS C 381 HIS~? 16.26 O2 EDO C 602 B 329 LYS C 390 LYS~? 21.48 O2 EDO B 603 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 20.56 19.64 -44.58 21.56 17.87 -45.23 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 19.26 30.57 -26.59 20.09 28.69 -27.02 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 17.95 29.37 -17.21 18.11 35.53 -15.65 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 7 3 # 7 B 137 GLU C 411 GLU.? 15.78 O2 EDO C 602 B 288 HIS C 381 HIS~? 16.26 O2 EDO C 602 B 329 LYS C 390 LYS~? 21.48 O2 EDO B 603 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 6.23 19.30 -42.44 5.28 17.46 -42.16 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 19.26 30.57 -26.59 20.09 28.69 -27.02 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 17.95 29.37 -17.21 18.11 35.53 -15.65 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 8 3 # 8 B 137 GLU D 330 GLU~? 24.51 C2 GOL D 601 B 288 HIS C 338 HIS~? 12.91 O1 EDO C 602 B 329 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 39.35 17.44 -18.72 40.01 18.64 -17.10 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 27.51 4.47 -43.69 23.30 8.13 -41.81 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 9 3 # 9 B 137 GLU D 363 GLU~? 7.90 O2 GOL D 601 B 288 HIS D 381 HIS.? 16.49 O3 GOL D 601 B 329 LYS D 390 LYS~? 25.65 O3 GOL D 601 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 24.65 -2.66 -18.42 24.14 -0.86 -17.43 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 36.03 -8.97 -35.15 35.55 -7.12 -34.29 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 35.81 -6.92 -44.49 39.58 -10.95 -43.36 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 10 3 # 10 B 137 GLU D 411 GLU.? 16.70 O3 GOL D 601 B 288 HIS D 381 HIS.? 16.49 O3 GOL D 601 B 329 LYS D 390 LYS~? 25.65 O3 GOL D 601 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 14.38 -10.66 -25.01 13.15 -12.19 -25.81 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 36.03 -8.97 -35.15 35.55 -7.12 -34.29 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 35.81 -6.92 -44.49 39.58 -10.95 -43.36 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 10 hits 1roz_c01 naa= 3 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 350 ASP.? 26.92 O2 GOL D 601 E 168 LYS A 348 LYS.? 29.38 O1 EDO B 603 E 171 ASN A 347 ASN^? 27.63 C1 EDO B 603 coo 5.36 16.20 22.10 3.88 17.00 23.31 33.51 7.96 1.59 32.78 7.85 -0.37 coo 5.06 22.32 18.11 1.02 22.08 22.74 33.03 14.06 -0.37 37.33 16.69 -0.99 coo 6.68 21.78 22.39 5.28 20.74 23.60 32.85 15.10 3.85 34.45 13.77 4.43 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP B 350 ASP.? 23.89 C2 EDO B 603 E 168 LYS B 348 LYS.? 28.30 C2 EDO B 603 E 171 ASN B 347 ASN^? 23.37 C2 EDO B 603 coo 5.36 16.20 22.10 3.88 17.00 23.31 12.16 40.72 19.41 11.14 39.74 20.98 coo 5.06 22.32 18.11 1.02 22.08 22.74 16.25 36.62 22.07 20.01 34.44 26.08 coo 6.68 21.78 22.39 5.28 20.74 23.60 18.47 36.73 18.25 18.44 38.86 18.15 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 3 3 # 3 E 166 ASP C 350 ASP.? 24.48 C2 EDO C 602 E 168 LYS C 348 LYS.? 28.33 O1 GOL D 601 E 171 ASN C 347 ASN^? 23.48 C1 EDO C 602 coo 5.36 16.20 22.10 3.88 17.00 23.31 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 5.06 22.32 18.11 1.02 22.08 22.74 31.02 25.73 -16.52 36.61 24.80 -13.64 coo 6.68 21.78 22.39 5.28 20.74 23.60 32.68 25.81 -20.60 32.92 27.92 -20.57 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 4 3 # 4 E 166 ASP D 350 ASP.? 24.09 C3 GOL D 601 E 168 LYS D 348 LYS.? 27.59 O1 EDO C 602 E 171 ASN D 347 ASN^? 23.69 C3 GOL D 601 coo 5.36 16.20 22.10 3.88 17.00 23.31 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 5.06 22.32 18.11 1.02 22.08 22.74 43.15 3.71 -41.93 47.18 7.62 -43.42 coo 6.68 21.78 22.39 5.28 20.74 23.60 43.61 4.31 -37.61 45.14 2.83 -37.46 1stc_c03 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 4 hits 1stc_c03 naa= 3 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 1 3 # 1 A 261 GLY A 414 GLY.? 25.12 C1 EDO B 603 B 17 GLN A 409 GLN^? 23.75 O1 EDO B 603 B 140 GLU A 411 GLU.? 28.28 O1 EDO B 603 coo 61.49 19.86 5.96 61.52 19.46 5.16 5.16 4.74 16.78 5.87 4.96 16.37 coo 63.76 11.90 7.93 65.18 13.07 6.77 3.71 1.80 8.49 2.66 2.97 9.91 coo 66.44 19.00 7.38 67.69 17.67 8.37 3.89 -1.22 13.75 2.15 -0.02 14.05 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 2 3 # 2 A 261 GLY C 414 GLY.? 10.00 O2 EDO C 602 B 17 GLN C 409 GLN^? 14.26 C2 EDO C 602 B 140 GLU C 411 GLU.? 15.78 O2 EDO C 602 coo 61.49 19.86 5.96 61.52 19.46 5.16 11.91 16.11 -42.71 12.42 16.37 -42.08 coo 63.76 11.90 7.93 65.18 13.07 6.77 7.52 15.93 -37.75 6.03 14.60 -38.53 coo 66.44 19.00 7.38 67.69 17.67 8.37 6.23 19.30 -42.44 5.28 17.46 -42.16 1t4c_c02 source 1t4c FORMYL-COENZYME A TRANSFERASE : 2 hits 1t4c_c02 naa= 3 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 A 144 HIS A 338 HIS~? 19.64 C1 EDO B 603 A 174 ASP A 357 ASP.? 25.14 C1 EDO B 603 A 404 TYR B 437 TYR^? 10.72 C1 EDO B 603 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 16.13 23.68 19.02 16.84 23.99 20.97 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 22.54 16.74 19.72 22.05 16.00 21.61 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 10.92 24.41 11.32 10.27 22.67 13.43 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 A 144 HIS A 381 HIS.? 27.31 O1 EDO B 603 A 174 ASP A 387 ASP~? 25.21 O2 GOL D 601 A 404 TYR A 421 TYR^? 19.72 O1 EDO B 603 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 25.64 1.98 6.69 25.07 4.00 6.65 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 25.11 -3.56 -1.18 26.67 -4.92 -0.75 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 20.02 8.83 1.38 20.18 6.69 3.20 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 A 144 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 174 ASP B 357 ASP.? 13.04 C1 EDO B 603 A 404 TYR A 437 TYR^? 11.45 C1 EDO B 603 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 19.95 30.44 0.55 20.02 30.85 -1.53 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 16.79 15.50 5.48 15.91 16.43 3.01 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 A 144 HIS B 381 HIS.? 15.29 C2 EDO B 603 A 174 ASP B 387 ASP~? 25.98 C2 EDO B 603 A 404 TYR B 421 TYR^? 13.58 C2 EDO B 603 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 4.86 38.27 11.07 6.17 36.67 11.45 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -2.48 41.17 18.56 -3.04 43.05 17.72 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 6.36 30.57 15.08 5.68 32.41 13.09 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 A 144 HIS C 338 HIS~? 12.91 O1 EDO C 602 A 174 ASP C 357 ASP.? 12.50 O2 EDO C 602 A 404 TYR D 437 TYR^? 9.97 C1 GOL D 601 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 27.83 5.60 -34.20 26.72 6.80 -36.49 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 A 144 HIS D 338 HIS~? 13.70 C1 GOL D 601 A 174 ASP D 357 ASP.? 12.64 O3 GOL D 601 A 404 TYR C 437 TYR^? 9.81 O1 GOL D 601 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 23.51 14.66 -27.39 22.94 13.02 -25.21 1ti6_c06 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 6 hits 1ti6_c06 naa= 3 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 C 144 HIS A 338 HIS~? 19.64 C1 EDO B 603 C 174 ASP A 357 ASP.? 25.14 C1 EDO B 603 C 404 TYR B 437 TYR^? 10.72 C1 EDO B 603 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 16.13 23.68 19.02 16.84 23.99 20.97 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 22.54 16.74 19.72 22.05 16.00 21.61 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 10.92 24.41 11.32 10.27 22.67 13.43 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 C 144 HIS A 381 HIS.? 27.31 O1 EDO B 603 C 174 ASP A 387 ASP~? 25.21 O2 GOL D 601 C 404 TYR A 421 TYR^? 19.72 O1 EDO B 603 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 25.64 1.98 6.69 25.07 4.00 6.65 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 25.11 -3.56 -1.18 26.67 -4.92 -0.75 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 20.02 8.83 1.38 20.18 6.69 3.20 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 C 144 HIS B 338 HIS.? 13.66 O1 EDO B 603 C 174 ASP B 357 ASP.? 13.04 C1 EDO B 603 C 404 TYR A 437 TYR^? 11.45 C1 EDO B 603 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 19.95 30.44 0.55 20.02 30.85 -1.53 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 16.79 15.50 5.48 15.91 16.43 3.01 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 C 144 HIS B 381 HIS.? 15.29 C2 EDO B 603 C 174 ASP B 387 ASP~? 25.98 C2 EDO B 603 C 404 TYR B 421 TYR^? 13.58 C2 EDO B 603 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 4.86 38.27 11.07 6.17 36.67 11.45 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -2.48 41.17 18.56 -3.04 43.05 17.72 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 6.36 30.57 15.08 5.68 32.41 13.09 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 C 144 HIS C 338 HIS~? 12.91 O1 EDO C 602 C 174 ASP C 357 ASP.? 12.50 O2 EDO C 602 C 404 TYR D 437 TYR^? 9.97 C1 GOL D 601 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 32.02 20.63 -38.57 31.77 21.72 -40.39 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 27.83 5.60 -34.20 26.72 6.80 -36.49 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 C 144 HIS D 338 HIS~? 13.70 C1 GOL D 601 C 174 ASP D 357 ASP.? 12.64 O3 GOL D 601 C 404 TYR C 437 TYR^? 9.81 O1 GOL D 601 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 29.23 12.85 -20.11 30.06 13.12 -18.20 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 34.52 5.19 -20.65 34.58 3.94 -18.98 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 23.51 14.66 -27.39 22.94 13.02 -25.21 1ti6_c07 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 6 hits 1ti6_c07 naa= 3 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 E 144 HIS A 338 HIS~? 19.64 C1 EDO B 603 E 174 ASP A 357 ASP.? 25.14 C1 EDO B 603 E 404 TYR B 437 TYR^? 10.72 C1 EDO B 603 coo -7.53-107.59 75.19 -8.14-106.04 76.47 16.13 23.68 19.02 16.84 23.99 20.97 coo -3.55-105.39 83.13 -5.21-106.24 82.09 22.54 16.74 19.72 22.05 16.00 21.61 coo -16.31-108.78 75.35 -14.20-107.14 76.16 10.92 24.41 11.32 10.27 22.67 13.43 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 E 144 HIS A 381 HIS.? 27.31 O1 EDO B 603 E 174 ASP A 387 ASP~? 25.21 O2 GOL D 601 E 404 TYR A 421 TYR^? 19.72 O1 EDO B 603 coo -7.53-107.59 75.19 -8.14-106.04 76.47 25.64 1.98 6.69 25.07 4.00 6.65 coo -3.55-105.39 83.13 -5.21-106.24 82.09 25.11 -3.56 -1.18 26.67 -4.92 -0.75 coo -16.31-108.78 75.35 -14.20-107.14 76.16 20.02 8.83 1.38 20.18 6.69 3.20 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 E 144 HIS B 338 HIS.? 13.66 O1 EDO B 603 E 174 ASP B 357 ASP.? 13.04 C1 EDO B 603 E 404 TYR A 437 TYR^? 11.45 C1 EDO B 603 coo -7.53-107.59 75.19 -8.14-106.04 76.47 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -3.55-105.39 83.13 -5.21-106.24 82.09 19.95 30.44 0.55 20.02 30.85 -1.53 coo -16.31-108.78 75.35 -14.20-107.14 76.16 16.79 15.50 5.48 15.91 16.43 3.01 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 E 144 HIS B 381 HIS.? 15.29 C2 EDO B 603 E 174 ASP B 387 ASP~? 25.98 C2 EDO B 603 E 404 TYR B 421 TYR^? 13.58 C2 EDO B 603 coo -7.53-107.59 75.19 -8.14-106.04 76.47 4.86 38.27 11.07 6.17 36.67 11.45 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -2.48 41.17 18.56 -3.04 43.05 17.72 coo -16.31-108.78 75.35 -14.20-107.14 76.16 6.36 30.57 15.08 5.68 32.41 13.09 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 E 144 HIS C 338 HIS~? 12.91 O1 EDO C 602 E 174 ASP C 357 ASP.? 12.50 O2 EDO C 602 E 404 TYR D 437 TYR^? 9.97 C1 GOL D 601 coo -7.53-107.59 75.19 -8.14-106.04 76.47 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -3.55-105.39 83.13 -5.21-106.24 82.09 32.02 20.63 -38.57 31.77 21.72 -40.39 coo -16.31-108.78 75.35 -14.20-107.14 76.16 27.83 5.60 -34.20 26.72 6.80 -36.49 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 E 144 HIS D 338 HIS~? 13.70 C1 GOL D 601 E 174 ASP D 357 ASP.? 12.64 O3 GOL D 601 E 404 TYR C 437 TYR^? 9.81 O1 GOL D 601 coo -7.53-107.59 75.19 -8.14-106.04 76.47 29.23 12.85 -20.11 30.06 13.12 -18.20 coo -3.55-105.39 83.13 -5.21-106.24 82.09 34.52 5.19 -20.65 34.58 3.94 -18.98 coo -16.31-108.78 75.35 -14.20-107.14 76.16 23.51 14.66 -27.39 22.94 13.02 -25.21 1ti6_c08 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 6 hits 1ti6_c08 naa= 3 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 G 144 HIS A 338 HIS~? 19.64 C1 EDO B 603 G 174 ASP A 357 ASP.? 25.14 C1 EDO B 603 G 404 TYR B 437 TYR^? 10.72 C1 EDO B 603 coo 60.48-101.16 45.95 60.56-101.20 43.85 16.13 23.68 19.02 16.84 23.99 20.97 coo 58.10-108.15 40.62 59.57-106.86 41.51 22.54 16.74 19.72 22.05 16.00 21.61 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 10.92 24.41 11.32 10.27 22.67 13.43 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 G 144 HIS A 381 HIS.? 27.31 O1 EDO B 603 G 174 ASP A 387 ASP~? 25.21 O2 GOL D 601 G 404 TYR A 421 TYR^? 19.72 O1 EDO B 603 coo 60.48-101.16 45.95 60.56-101.20 43.85 25.64 1.98 6.69 25.07 4.00 6.65 coo 58.10-108.15 40.62 59.57-106.86 41.51 25.11 -3.56 -1.18 26.67 -4.92 -0.75 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 20.02 8.83 1.38 20.18 6.69 3.20 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 G 144 HIS B 338 HIS.? 13.66 O1 EDO B 603 G 174 ASP B 357 ASP.? 13.04 C1 EDO B 603 G 404 TYR A 437 TYR^? 11.45 C1 EDO B 603 coo 60.48-101.16 45.95 60.56-101.20 43.85 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 58.10-108.15 40.62 59.57-106.86 41.51 19.95 30.44 0.55 20.02 30.85 -1.53 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 16.79 15.50 5.48 15.91 16.43 3.01 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 G 144 HIS B 381 HIS.? 15.29 C2 EDO B 603 G 174 ASP B 387 ASP~? 25.98 C2 EDO B 603 G 404 TYR B 421 TYR^? 13.58 C2 EDO B 603 coo 60.48-101.16 45.95 60.56-101.20 43.85 4.86 38.27 11.07 6.17 36.67 11.45 coo 58.10-108.15 40.62 59.57-106.86 41.51 -2.48 41.17 18.56 -3.04 43.05 17.72 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 6.36 30.57 15.08 5.68 32.41 13.09 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 G 144 HIS C 338 HIS~? 12.91 O1 EDO C 602 G 174 ASP C 357 ASP.? 12.50 O2 EDO C 602 G 404 TYR D 437 TYR^? 9.97 C1 GOL D 601 coo 60.48-101.16 45.95 60.56-101.20 43.85 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 58.10-108.15 40.62 59.57-106.86 41.51 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 27.83 5.60 -34.20 26.72 6.80 -36.49 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 G 144 HIS D 338 HIS~? 13.70 C1 GOL D 601 G 174 ASP D 357 ASP.? 12.64 O3 GOL D 601 G 404 TYR C 437 TYR^? 9.81 O1 GOL D 601 coo 60.48-101.16 45.95 60.56-101.20 43.85 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 58.10-108.15 40.62 59.57-106.86 41.51 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 23.51 14.66 -27.39 22.94 13.02 -25.21 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 G 144 HIS D 381 HIS.? 16.49 O3 GOL D 601 G 174 ASP D 387 ASP~? 25.32 O3 GOL D 601 G 404 TYR D 421 TYR^? 13.63 C3 GOL D 601 coo 60.48-101.16 45.95 60.56-101.20 43.85 36.03 -8.97 -35.15 35.55 -7.12 -34.29 coo 58.10-108.15 40.62 59.57-106.86 41.51 33.33 -13.12 -43.54 32.71 -13.42 -45.54 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 30.12 -0.70 -39.30 29.82 -2.95 -37.69 1ti6_c09 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 7 hits 1ti6_c09 naa= 3 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 I 144 HIS A 338 HIS~? 19.64 C1 EDO B 603 I 174 ASP A 357 ASP.? 25.14 C1 EDO B 603 I 404 TYR B 437 TYR^? 10.72 C1 EDO B 603 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 16.13 23.68 19.02 16.84 23.99 20.97 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 22.54 16.74 19.72 22.05 16.00 21.61 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 10.92 24.41 11.32 10.27 22.67 13.43 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 I 144 HIS A 381 HIS.? 27.31 O1 EDO B 603 I 174 ASP A 387 ASP~? 25.21 O2 GOL D 601 I 404 TYR A 421 TYR^? 19.72 O1 EDO B 603 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 25.64 1.98 6.69 25.07 4.00 6.65 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 25.11 -3.56 -1.18 26.67 -4.92 -0.75 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 20.02 8.83 1.38 20.18 6.69 3.20 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 I 144 HIS B 338 HIS.? 13.66 O1 EDO B 603 I 174 ASP B 357 ASP.? 13.04 C1 EDO B 603 I 404 TYR A 437 TYR^? 11.45 C1 EDO B 603 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 21.66 21.37 -0.01 22.97 22.11 -1.47 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 19.95 30.44 0.55 20.02 30.85 -1.53 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 16.79 15.50 5.48 15.91 16.43 3.01 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 I 144 HIS B 381 HIS.? 15.29 C2 EDO B 603 I 174 ASP B 387 ASP~? 25.98 C2 EDO B 603 I 404 TYR B 421 TYR^? 13.58 C2 EDO B 603 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 4.86 38.27 11.07 6.17 36.67 11.45 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -2.48 41.17 18.56 -3.04 43.05 17.72 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 6.36 30.57 15.08 5.68 32.41 13.09 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 I 144 HIS C 338 HIS~? 12.91 O1 EDO C 602 I 174 ASP C 357 ASP.? 12.50 O2 EDO C 602 I 404 TYR D 437 TYR^? 9.97 C1 GOL D 601 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 32.02 20.63 -38.57 31.77 21.72 -40.39 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 27.83 5.60 -34.20 26.72 6.80 -36.49 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 I 144 HIS D 338 HIS~? 13.70 C1 GOL D 601 I 174 ASP D 357 ASP.? 12.64 O3 GOL D 601 I 404 TYR C 437 TYR^? 9.81 O1 GOL D 601 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 29.23 12.85 -20.11 30.06 13.12 -18.20 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 34.52 5.19 -20.65 34.58 3.94 -18.98 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 23.51 14.66 -27.39 22.94 13.02 -25.21 1ti6_c10 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 6 hits 1ti6_c10 naa= 3 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 K 144 HIS A 338 HIS~? 19.64 C1 EDO B 603 K 174 ASP A 357 ASP.? 25.14 C1 EDO B 603 K 404 TYR B 437 TYR^? 10.72 C1 EDO B 603 coo 100.18 26.45 -1.32 99.24 26.12 0.53 16.13 23.68 19.02 16.84 23.99 20.97 coo 102.36 30.86 6.31 102.45 29.08 5.12 22.54 16.74 19.72 22.05 16.00 21.61 coo 99.93 17.48 -0.85 99.14 19.86 0.39 10.92 24.41 11.32 10.27 22.67 13.43 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 K 144 HIS A 381 HIS.? 27.31 O1 EDO B 603 K 174 ASP A 387 ASP~? 25.21 O2 GOL D 601 K 404 TYR A 421 TYR^? 19.72 O1 EDO B 603 coo 100.18 26.45 -1.32 99.24 26.12 0.53 25.64 1.98 6.69 25.07 4.00 6.65 coo 102.36 30.86 6.31 102.45 29.08 5.12 25.11 -3.56 -1.18 26.67 -4.92 -0.75 coo 99.93 17.48 -0.85 99.14 19.86 0.39 20.02 8.83 1.38 20.18 6.69 3.20 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 K 144 HIS B 338 HIS.? 13.66 O1 EDO B 603 K 174 ASP B 357 ASP.? 13.04 C1 EDO B 603 K 404 TYR A 437 TYR^? 11.45 C1 EDO B 603 coo 100.18 26.45 -1.32 99.24 26.12 0.53 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 102.36 30.86 6.31 102.45 29.08 5.12 19.95 30.44 0.55 20.02 30.85 -1.53 coo 99.93 17.48 -0.85 99.14 19.86 0.39 16.79 15.50 5.48 15.91 16.43 3.01 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 K 144 HIS B 381 HIS.? 15.29 C2 EDO B 603 K 174 ASP B 387 ASP~? 25.98 C2 EDO B 603 K 404 TYR B 421 TYR^? 13.58 C2 EDO B 603 coo 100.18 26.45 -1.32 99.24 26.12 0.53 4.86 38.27 11.07 6.17 36.67 11.45 coo 102.36 30.86 6.31 102.45 29.08 5.12 -2.48 41.17 18.56 -3.04 43.05 17.72 coo 99.93 17.48 -0.85 99.14 19.86 0.39 6.36 30.57 15.08 5.68 32.41 13.09 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 K 144 HIS C 338 HIS~? 12.91 O1 EDO C 602 K 174 ASP C 357 ASP.? 12.50 O2 EDO C 602 K 404 TYR D 437 TYR^? 9.97 C1 GOL D 601 coo 100.18 26.45 -1.32 99.24 26.12 0.53 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 102.36 30.86 6.31 102.45 29.08 5.12 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 99.93 17.48 -0.85 99.14 19.86 0.39 27.83 5.60 -34.20 26.72 6.80 -36.49 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 K 144 HIS D 338 HIS~? 13.70 C1 GOL D 601 K 174 ASP D 357 ASP.? 12.64 O3 GOL D 601 K 404 TYR C 437 TYR^? 9.81 O1 GOL D 601 coo 100.18 26.45 -1.32 99.24 26.12 0.53 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 102.36 30.86 6.31 102.45 29.08 5.12 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 99.93 17.48 -0.85 99.14 19.86 0.39 23.51 14.66 -27.39 22.94 13.02 -25.21 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 K 144 HIS D 381 HIS.? 16.49 O3 GOL D 601 K 174 ASP D 387 ASP~? 25.32 O3 GOL D 601 K 404 TYR D 421 TYR^? 13.63 C3 GOL D 601 coo 100.18 26.45 -1.32 99.24 26.12 0.53 36.03 -8.97 -35.15 35.55 -7.12 -34.29 coo 102.36 30.86 6.31 102.45 29.08 5.12 33.33 -13.12 -43.54 32.71 -13.42 -45.54 coo 99.93 17.48 -0.85 99.14 19.86 0.39 30.12 -0.70 -39.30 29.82 -2.95 -37.69 1ti6_c11 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 7 hits 1ti6_c11 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA A 428 ALA.? 23.52 O1 EDO B 603 A 251 GLY A 429 GLY.? 20.67 O1 EDO B 603 A 252 ASP A 426 ASP.? 22.31 O1 EDO B 603 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 28.89 26.05 -8.94 30.39 25.95 -8.77 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 27.23 22.60 -8.91 27.96 22.71 -8.54 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 29.17 24.78 -3.72 30.40 24.16 -5.34 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 2 3 # 2 A 250 ALA A 428 ALA.? 23.52 O1 EDO B 603 A 251 GLY A 429 GLY.? 20.67 O1 EDO B 603 A 252 ASP A 430 ASP.? 25.41 O1 EDO B 603 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 28.89 26.05 -8.94 30.39 25.95 -8.77 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 27.23 22.60 -8.91 27.96 22.71 -8.54 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 31.59 21.51 -7.17 32.38 22.31 -9.00 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 3 3 # 3 A 250 ALA B 428 ALA.? 31.84 C1 EDO B 603 A 251 GLY B 429 GLY.? 28.53 C1 EDO B 603 A 252 ASP B 426 ASP.? 28.68 C1 EDO B 603 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 20.07 24.52 30.82 20.88 25.70 31.37 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 16.61 25.09 29.33 17.13 25.70 29.37 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 21.11 26.70 26.04 20.61 27.63 27.90 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 4 3 # 4 A 250 ALA B 428 ALA.? 31.84 C1 EDO B 603 A 251 GLY B 429 GLY.? 28.53 C1 EDO B 603 A 252 ASP B 430 ASP.? 31.57 C2 EDO B 603 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 20.07 24.52 30.82 20.88 25.70 31.37 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 16.61 25.09 29.33 17.13 25.70 29.37 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 18.19 29.66 29.51 18.36 29.43 31.62 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 5 3 # 5 A 250 ALA C 428 ALA.? 24.22 O2 GOL D 601 A 251 GLY C 429 GLY.? 21.29 O2 GOL D 601 A 252 ASP C 426 ASP.? 22.72 C2 GOL D 601 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 34.28 13.61 -8.51 35.19 14.79 -8.24 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 30.74 14.63 -9.51 31.39 15.13 -9.63 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 35.09 15.28 -13.55 34.97 16.40 -11.75 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 6 3 # 6 A 250 ALA C 428 ALA.? 24.22 O2 GOL D 601 A 251 GLY C 429 GLY.? 21.29 O2 GOL D 601 A 252 ASP C 430 ASP.? 26.01 O2 GOL D 601 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 34.28 13.61 -8.51 35.19 14.79 -8.24 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 30.74 14.63 -9.51 31.39 15.13 -9.63 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 33.23 18.77 -9.92 33.78 18.54 -7.88 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 7 3 # 7 A 250 ALA D 428 ALA.? 23.04 O1 EDO C 602 A 251 GLY D 429 GLY.? 19.97 O1 EDO C 602 A 252 ASP D 426 ASP.? 21.84 O1 EDO C 602 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 39.85 16.46 -48.84 41.33 16.15 -48.85 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 37.64 13.34 -48.99 38.39 13.31 -48.67 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 40.54 14.64 -43.98 41.47 13.99 -45.77 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 8 3 # 8 A 250 ALA D 428 ALA.? 23.04 O1 EDO C 602 A 251 GLY D 429 GLY.? 19.97 O1 EDO C 602 A 252 ASP D 430 ASP.? 24.82 O1 EDO C 602 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 39.85 16.46 -48.84 41.33 16.15 -48.85 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 37.64 13.34 -48.99 38.39 13.31 -48.67 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 41.96 11.40 -47.93 42.69 12.01 -49.83 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 8 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA A 428 ALA.? 23.52 O1 EDO B 603 B 251 GLY A 429 GLY.? 20.67 O1 EDO B 603 B 252 ASP A 426 ASP.? 22.31 O1 EDO B 603 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 28.89 26.05 -8.94 30.39 25.95 -8.77 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 27.23 22.60 -8.91 27.96 22.71 -8.54 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 29.17 24.78 -3.72 30.40 24.16 -5.34 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 2 3 # 2 B 250 ALA A 428 ALA.? 23.52 O1 EDO B 603 B 251 GLY A 429 GLY.? 20.67 O1 EDO B 603 B 252 ASP A 430 ASP.? 25.41 O1 EDO B 603 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 28.89 26.05 -8.94 30.39 25.95 -8.77 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 27.23 22.60 -8.91 27.96 22.71 -8.54 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 31.59 21.51 -7.17 32.38 22.31 -9.00 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 3 3 # 3 B 250 ALA B 428 ALA.? 31.84 C1 EDO B 603 B 251 GLY B 429 GLY.? 28.53 C1 EDO B 603 B 252 ASP B 426 ASP.? 28.68 C1 EDO B 603 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 20.07 24.52 30.82 20.88 25.70 31.37 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 16.61 25.09 29.33 17.13 25.70 29.37 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 21.11 26.70 26.04 20.61 27.63 27.90 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 4 3 # 4 B 250 ALA B 428 ALA.? 31.84 C1 EDO B 603 B 251 GLY B 429 GLY.? 28.53 C1 EDO B 603 B 252 ASP B 430 ASP.? 31.57 C2 EDO B 603 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 20.07 24.52 30.82 20.88 25.70 31.37 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 16.61 25.09 29.33 17.13 25.70 29.37 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 18.19 29.66 29.51 18.36 29.43 31.62 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 5 3 # 5 B 250 ALA C 428 ALA.? 24.22 O2 GOL D 601 B 251 GLY C 429 GLY.? 21.29 O2 GOL D 601 B 252 ASP C 426 ASP.? 22.72 C2 GOL D 601 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 34.28 13.61 -8.51 35.19 14.79 -8.24 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 30.74 14.63 -9.51 31.39 15.13 -9.63 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 35.09 15.28 -13.55 34.97 16.40 -11.75 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 6 3 # 6 B 250 ALA C 428 ALA.? 24.22 O2 GOL D 601 B 251 GLY C 429 GLY.? 21.29 O2 GOL D 601 B 252 ASP C 430 ASP.? 26.01 O2 GOL D 601 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 34.28 13.61 -8.51 35.19 14.79 -8.24 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 30.74 14.63 -9.51 31.39 15.13 -9.63 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 33.23 18.77 -9.92 33.78 18.54 -7.88 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 7 3 # 7 B 250 ALA D 428 ALA.? 23.04 O1 EDO C 602 B 251 GLY D 429 GLY.? 19.97 O1 EDO C 602 B 252 ASP D 426 ASP.? 21.84 O1 EDO C 602 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 39.85 16.46 -48.84 41.33 16.15 -48.85 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 37.64 13.34 -48.99 38.39 13.31 -48.67 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 40.54 14.64 -43.98 41.47 13.99 -45.77 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 8 3 # 8 B 250 ALA D 428 ALA.? 23.04 O1 EDO C 602 B 251 GLY D 429 GLY.? 19.97 O1 EDO C 602 B 252 ASP D 430 ASP.? 24.82 O1 EDO C 602 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 39.85 16.46 -48.84 41.33 16.15 -48.85 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 37.64 13.34 -48.99 38.39 13.31 -48.67 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 41.96 11.40 -47.93 42.69 12.01 -49.83 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 8 hits 1tz3_c03 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU A 363 GLU~? 27.04 C1 EDO B 603 B 126 LYS A 367 LYS.? 27.79 C1 EDO B 603 B 171 ALA A 361 ALA~? 29.16 C1 EDO B 603 coo 20.47 87.42 16.54 20.16 87.17 14.45 14.23 7.65 22.80 13.44 9.34 23.77 coo 24.73 94.37 14.59 21.08 89.84 11.98 21.09 4.68 15.64 17.32 4.21 18.91 coo 24.38 86.32 12.71 22.88 86.54 12.71 20.58 8.39 21.62 21.97 8.14 22.23 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 B 46 GLU A 363 GLU~? 27.04 C1 EDO B 603 B 126 LYS A 367 LYS.? 27.79 C1 EDO B 603 B 171 ALA A 362 ALA~? 30.81 C1 EDO B 603 coo 20.47 87.42 16.54 20.16 87.17 14.45 14.23 7.65 22.80 13.44 9.34 23.77 coo 24.73 94.37 14.59 21.08 89.84 11.98 21.09 4.68 15.64 17.32 4.21 18.91 coo 24.38 86.32 12.71 22.88 86.54 12.71 18.29 5.50 22.58 17.98 5.11 24.04 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 2 hits 1uf7_c01 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 315 ASP.? 32.31 C1 EDO B 603 218 GLU A 436 GLU^? 20.55 O1 EDO B 603 329 ASP B 315 ASP.? 32.42 C1 EDO B 603 coo 49.16 35.16 15.19 51.08 34.43 15.65 35.16 33.09 19.50 33.98 34.83 19.67 coo 70.09 11.71 8.46 70.56 12.89 6.77 19.93 9.98 5.88 20.55 8.03 6.42 coo 59.16 37.82 13.95 57.63 37.03 15.12 37.58 31.51 9.95 39.21 32.46 10.92 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 315 ASP.? 32.31 C1 EDO B 603 218 GLU B 342 GLU^? -3.54 O2 EDO B 603s 329 ASP B 315 ASP.? 32.42 C1 EDO B 603 coo 49.16 35.16 15.19 51.08 34.43 15.65 35.16 33.09 19.50 33.98 34.83 19.67 coo 70.09 11.71 8.46 70.56 12.89 6.77 10.25 28.44 3.00 8.52 29.59 2.44 coo 59.16 37.82 13.95 57.63 37.03 15.12 37.58 31.51 9.95 39.21 32.46 10.92 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 426 ASP.? 22.31 O1 EDO B 603 218 GLU C 342 GLU^? -3.52 O2 EDO C 602s 329 ASP C 430 ASP.? 26.01 O2 GOL D 601 coo 49.16 35.16 15.19 51.08 34.43 15.65 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 70.09 11.71 8.46 70.56 12.89 6.77 22.61 19.18 -35.41 20.92 20.43 -35.77 coo 59.16 37.82 13.95 57.63 37.03 15.12 33.23 18.77 -9.92 33.78 18.54 -7.88 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP B 315 ASP.? 32.42 C1 EDO B 603 218 GLU B 378 GLU~? 25.07 O2 EDO B 603 329 ASP A 315 ASP.? 32.31 C1 EDO B 603 coo 49.16 35.16 15.19 51.08 34.43 15.65 37.58 31.51 9.95 39.21 32.46 10.92 coo 70.09 11.71 8.46 70.56 12.89 6.77 7.63 44.96 15.04 7.63 45.65 17.05 coo 59.16 37.82 13.95 57.63 37.03 15.12 35.16 33.09 19.50 33.98 34.83 19.67 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 426 ASP.? 28.68 C1 EDO B 603 218 GLU A 446 GLU~? 20.77 C2 EDO B 603 329 ASP A 357 ASP.? 25.14 C1 EDO B 603 coo 49.16 35.16 15.19 51.08 34.43 15.65 21.11 26.70 26.04 20.61 27.63 27.90 coo 70.09 11.71 8.46 70.56 12.89 6.77 -3.62 12.85 13.27 -2.92 11.09 12.27 coo 59.16 37.82 13.95 57.63 37.03 15.12 22.54 16.74 19.72 22.05 16.00 21.61 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP C 426 ASP.? 22.72 C2 GOL D 601 218 GLU A 342 GLU^? 20.93 C1 EDO B 603 329 ASP A 430 ASP.? 25.41 O1 EDO B 603 coo 49.16 35.16 15.19 51.08 34.43 15.65 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 70.09 11.71 8.46 70.56 12.89 6.77 16.70 11.35 13.94 16.42 9.25 14.14 coo 59.16 37.82 13.95 57.63 37.03 15.12 31.59 21.51 -7.17 32.38 22.31 -9.00 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP D 315 ASP.? 31.69 C1 GOL D 601 218 GLU D 436 GLU^? 11.06 C3 GOL D 601 329 ASP C 315 ASP.? 32.88 C1 EDO C 602 coo 49.16 35.16 15.19 51.08 34.43 15.65 48.83 21.16 -21.57 48.15 21.79 -19.66 coo 70.09 11.71 8.46 70.56 12.89 6.77 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 59.16 37.82 13.95 57.63 37.03 15.12 51.14 17.66 -30.05 53.19 17.33 -29.52 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 7 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 402 ASP.? 12.59 O1 EDO B 603 242 GLU A 342 GLU^? 20.93 C1 EDO B 603 329 ASP C 402 ASP.? 12.78 O1 GOL D 601 coo 49.16 35.16 15.19 51.08 34.43 15.65 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 30.42 34.74 5.00 29.09 35.09 3.38 16.70 11.35 13.94 16.42 9.25 14.14 coo 59.16 37.82 13.95 57.63 37.03 15.12 22.26 13.02 -15.38 21.01 11.37 -15.92 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 426 ASP.? 22.31 O1 EDO B 603 242 GLU D 330 GLU~? 24.51 C2 GOL D 601 329 ASP B 357 ASP.? 13.04 C1 EDO B 603 coo 49.16 35.16 15.19 51.08 34.43 15.65 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 30.42 34.74 5.00 29.09 35.09 3.38 39.35 17.44 -18.72 40.01 18.64 -17.10 coo 59.16 37.82 13.95 57.63 37.03 15.12 19.95 30.44 0.55 20.02 30.85 -1.53 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP C 402 ASP.? 12.78 O1 GOL D 601 242 GLU C 342 GLU^? -3.52 O2 EDO C 602s 329 ASP A 402 ASP.? 12.59 O1 EDO B 603 coo 49.16 35.16 15.19 51.08 34.43 15.65 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 30.42 34.74 5.00 29.09 35.09 3.38 22.61 19.18 -35.41 20.92 20.43 -35.77 coo 59.16 37.82 13.95 57.63 37.03 15.12 18.87 16.83 -6.49 16.77 17.04 -6.49 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP C 426 ASP.? 22.72 C2 GOL D 601 242 GLU B 330 GLU~? 24.65 C1 EDO B 603 329 ASP D 357 ASP.? 12.64 O3 GOL D 601 coo 49.16 35.16 15.19 51.08 34.43 15.65 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 30.42 34.74 5.00 29.09 35.09 3.38 31.94 25.81 2.71 33.76 25.37 1.74 coo 59.16 37.82 13.95 57.63 37.03 15.12 34.52 5.19 -20.65 34.58 3.94 -18.98 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP C 426 ASP.? 22.72 C2 GOL D 601 242 GLU D 342 GLU^? -3.57 O3 GOL D 601s 329 ASP A 430 ASP.? 25.41 O1 EDO B 603 coo 49.16 35.16 15.19 51.08 34.43 15.65 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 30.42 34.74 5.00 29.09 35.09 3.38 28.06 0.59 -26.56 27.66 -1.50 -26.76 coo 59.16 37.82 13.95 57.63 37.03 15.12 31.59 21.51 -7.17 32.38 22.31 -9.00 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 5 hits 1uok_c05 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU A 394 GLU~? 15.90 O2 GOL D 601 A 596 ARG A 397 ARG~? 24.94 O2 GOL D 601 A 647 ARG C 425 ARG^? 21.48 O1 GOL D 601 coo 69.13 32.20 28.58 68.39 32.96 30.44 27.33 5.77 -8.72 27.90 4.03 -9.75 coo 70.89 37.31 29.70 69.54 36.29 32.39 31.00 11.06 -6.51 32.72 12.02 -4.11 coo 66.09 40.54 34.70 66.92 37.69 35.49 27.32 15.93 -12.34 26.51 18.69 -11.26 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 2 3 # 2 A 581 GLU C 394 GLU~? 16.86 O1 EDO B 603 A 596 ARG C 397 ARG~? 23.93 O1 EDO B 603 A 647 ARG A 425 ARG^? 21.19 O1 EDO B 603 coo 69.13 32.20 28.58 68.39 32.96 30.44 19.77 27.90 -12.93 18.57 29.44 -12.10 coo 70.89 37.31 29.70 69.54 36.29 32.39 25.49 26.02 -11.91 27.94 26.82 -13.64 coo 66.09 40.54 34.70 66.92 37.69 35.49 25.04 18.93 -7.11 26.86 16.62 -8.01 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU A 394 GLU~? 15.90 O2 GOL D 601 B 596 ARG A 397 ARG~? 24.94 O2 GOL D 601 B 647 ARG C 425 ARG^? 21.48 O1 GOL D 601 coo 38.22 57.83 70.36 36.82 56.74 69.18 27.33 5.77 -8.72 27.90 4.03 -9.75 coo 34.24 60.89 68.08 33.31 57.93 67.63 31.00 11.06 -6.51 32.72 12.02 -4.11 coo 31.43 57.38 61.97 31.90 55.58 64.41 27.32 15.93 -12.34 26.51 18.69 -11.26 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 2 3 # 2 B 581 GLU C 394 GLU~? 16.86 O1 EDO B 603 B 596 ARG C 397 ARG~? 23.93 O1 EDO B 603 B 647 ARG A 425 ARG^? 21.19 O1 EDO B 603 coo 38.22 57.83 70.36 36.82 56.74 69.18 19.77 27.90 -12.93 18.57 29.44 -12.10 coo 34.24 60.89 68.08 33.31 57.93 67.63 25.49 26.02 -11.91 27.94 26.82 -13.64 coo 31.43 57.38 61.97 31.90 55.58 64.41 25.04 18.93 -7.11 26.86 16.62 -8.01 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU A 394 GLU~? 15.90 O2 GOL D 601 C 596 ARG A 397 ARG~? 24.94 O2 GOL D 601 C 647 ARG C 425 ARG^? 21.48 O1 GOL D 601 coo 11.31 31.26 27.00 13.31 30.71 26.58 27.33 5.77 -8.72 27.90 4.03 -9.75 coo 13.44 32.78 22.07 15.56 30.91 23.37 31.00 11.06 -6.51 32.72 12.02 -4.11 coo 21.00 33.35 22.82 19.83 30.82 24.09 27.32 15.93 -12.34 26.51 18.69 -11.26 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 2 3 # 2 C 581 GLU C 394 GLU~? 16.86 O1 EDO B 603 C 596 ARG C 397 ARG~? 23.93 O1 EDO B 603 C 647 ARG A 425 ARG^? 21.19 O1 EDO B 603 coo 11.31 31.26 27.00 13.31 30.71 26.58 19.77 27.90 -12.93 18.57 29.44 -12.10 coo 13.44 32.78 22.07 15.56 30.91 23.37 25.49 26.02 -11.91 27.94 26.82 -13.64 coo 21.00 33.35 22.82 19.83 30.82 24.09 25.04 18.93 -7.11 26.86 16.62 -8.01 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU A 394 GLU~? 15.90 O2 GOL D 601 D 596 ARG A 397 ARG~? 24.94 O2 GOL D 601 D 647 ARG C 425 ARG^? 21.48 O1 GOL D 601 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 27.33 5.77 -8.72 27.90 4.03 -9.75 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 31.00 11.06 -6.51 32.72 12.02 -4.11 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 27.32 15.93 -12.34 26.51 18.69 -11.26 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 2 3 # 2 D 581 GLU C 394 GLU~? 16.86 O1 EDO B 603 D 596 ARG C 397 ARG~? 23.93 O1 EDO B 603 D 647 ARG A 425 ARG^? 21.19 O1 EDO B 603 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 19.77 27.90 -12.93 18.57 29.44 -12.10 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 25.49 26.02 -11.91 27.94 26.82 -13.64 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 25.04 18.93 -7.11 26.86 16.62 -8.01 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU A 394 GLU~? 15.90 O2 GOL D 601 E 596 ARG A 397 ARG~? 24.94 O2 GOL D 601 E 647 ARG C 425 ARG^? 21.48 O1 GOL D 601 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 27.33 5.77 -8.72 27.90 4.03 -9.75 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 31.00 11.06 -6.51 32.72 12.02 -4.11 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 27.32 15.93 -12.34 26.51 18.69 -11.26 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 2 3 # 2 E 581 GLU C 394 GLU~? 16.86 O1 EDO B 603 E 596 ARG C 397 ARG~? 23.93 O1 EDO B 603 E 647 ARG A 425 ARG^? 21.19 O1 EDO B 603 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 19.77 27.90 -12.93 18.57 29.44 -12.10 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 25.49 26.02 -11.91 27.94 26.82 -13.64 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 25.04 18.93 -7.11 26.86 16.62 -8.01 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU A 394 GLU~? 15.90 O2 GOL D 601 F 596 ARG A 397 ARG~? 24.94 O2 GOL D 601 F 647 ARG C 425 ARG^? 21.48 O1 GOL D 601 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 27.33 5.77 -8.72 27.90 4.03 -9.75 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 31.00 11.06 -6.51 32.72 12.02 -4.11 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 27.32 15.93 -12.34 26.51 18.69 -11.26 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 2 3 # 2 F 581 GLU C 394 GLU~? 16.86 O1 EDO B 603 F 596 ARG C 397 ARG~? 23.93 O1 EDO B 603 F 647 ARG A 425 ARG^? 21.19 O1 EDO B 603 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 19.77 27.90 -12.93 18.57 29.44 -12.10 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 25.49 26.02 -11.91 27.94 26.82 -13.64 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 25.04 18.93 -7.11 26.86 16.62 -8.01 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c05 naa= 3 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 A 100 PHE A 352 PHE^? 25.89 C1 EDO B 603 A 197 ASN B 324 ASN.? 26.30 C1 EDO B 603 A 198 PRO A 370 PRO~? 31.09 C1 EDO B 603 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 29.09 9.19 9.94 27.10 9.67 11.86 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 26.83 13.52 17.81 25.43 13.66 19.36 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 29.03 9.43 20.75 29.44 8.57 18.71 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 A 100 PHE B 352 PHE^? 15.29 O2 EDO B 603 A 197 ASN A 324 ASN.? 13.71 O2 EDO B 603 A 198 PRO B 370 PRO~? 17.37 O2 EDO B 603 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 14.23 38.41 10.43 14.31 36.78 8.15 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 19.23 35.37 3.15 19.16 34.35 1.29 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 18.17 40.76 0.71 17.03 40.97 2.63 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 A 100 PHE C 352 PHE^? 15.48 O2 EDO C 602 A 197 ASN D 324 ASN.? 13.50 O2 EDO C 602 A 198 PRO C 370 PRO~? 16.74 O2 EDO C 602 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 27.97 28.62 -27.76 27.73 27.28 -30.22 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 32.08 25.49 -35.40 31.73 24.73 -37.32 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 31.34 30.17 -37.58 30.37 30.78 -35.67 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 3 # 4 A 100 PHE D 352 PHE^? 15.53 O3 GOL D 601 A 197 ASN C 324 ASN.? 13.62 O3 GOL D 601 A 198 PRO D 370 PRO~? 16.78 O3 GOL D 601 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 40.13 -1.84 -31.50 38.47 -1.47 -29.25 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 38.59 2.13 -22.95 37.27 2.55 -21.34 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 40.43 -3.44 -21.32 40.85 -4.02 -23.42 1vq1_c00 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 4 hits 1vq1_c00 naa= 3 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 B 100 PHE A 352 PHE^? 25.89 C1 EDO B 603 B 197 ASN B 324 ASN.? 26.30 C1 EDO B 603 B 198 PRO A 370 PRO~? 31.09 C1 EDO B 603 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 29.09 9.19 9.94 27.10 9.67 11.86 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 26.83 13.52 17.81 25.43 13.66 19.36 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 29.03 9.43 20.75 29.44 8.57 18.71 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 B 100 PHE B 352 PHE^? 15.29 O2 EDO B 603 B 197 ASN A 324 ASN.? 13.71 O2 EDO B 603 B 198 PRO B 370 PRO~? 17.37 O2 EDO B 603 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 14.23 38.41 10.43 14.31 36.78 8.15 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 19.23 35.37 3.15 19.16 34.35 1.29 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 18.17 40.76 0.71 17.03 40.97 2.63 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 B 100 PHE C 352 PHE^? 15.48 O2 EDO C 602 B 197 ASN D 324 ASN.? 13.50 O2 EDO C 602 B 198 PRO C 370 PRO~? 16.74 O2 EDO C 602 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 27.97 28.62 -27.76 27.73 27.28 -30.22 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 32.08 25.49 -35.40 31.73 24.73 -37.32 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 31.34 30.17 -37.58 30.37 30.78 -35.67 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 3 # 4 B 100 PHE D 352 PHE^? 15.53 O3 GOL D 601 B 197 ASN C 324 ASN.? 13.62 O3 GOL D 601 B 198 PRO D 370 PRO~? 16.78 O3 GOL D 601 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 40.13 -1.84 -31.50 38.47 -1.47 -29.25 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 38.59 2.13 -22.95 37.27 2.55 -21.34 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 40.43 -3.44 -21.32 40.85 -4.02 -23.42 1vq1_c01 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 4 hits 1vq1_c01 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR A 421 TYR^? 19.72 O1 EDO B 603 A 317 GLU A 436 GLU^? 20.55 O1 EDO B 603 A 365 ARG A 425 ARG^? 21.19 O1 EDO B 603 coo 1.77 6.56 57.05 3.05 7.44 59.37 20.02 8.83 1.38 20.18 6.69 3.20 coo 3.06 2.85 52.79 4.83 3.89 53.24 19.93 9.98 5.88 20.55 8.03 6.42 coo 3.82 17.09 49.56 4.09 14.32 50.84 25.04 18.93 -7.11 26.86 16.62 -8.01 ULMN 3 1vzx_c02 2.04.01.0087 user 2 3 # 2 A 314 TYR B 421 TYR^? 13.58 C2 EDO B 603 A 317 GLU B 436 GLU^? 10.42 C2 EDO B 603 A 365 ARG B 397 ARG~? 26.01 C2 EDO B 603 coo 1.77 6.56 57.05 3.05 7.44 59.37 6.36 30.57 15.08 5.68 32.41 13.09 coo 3.06 2.85 52.79 4.83 3.89 53.24 8.55 30.19 11.17 7.66 31.90 10.29 coo 3.82 17.09 49.56 4.09 14.32 50.84 10.79 36.41 26.32 12.94 37.68 24.51 ULMN 3 1vzx_c02 2.04.01.0087 user 3 3 # 3 A 314 TYR B 421 TYR^? 13.58 C2 EDO B 603 A 317 GLU B 436 GLU^? 10.42 C2 EDO B 603 A 365 ARG B 425 ARG^? 24.19 C2 EDO B 603 coo 1.77 6.56 57.05 3.05 7.44 59.37 6.36 30.57 15.08 5.68 32.41 13.09 coo 3.06 2.85 52.79 4.83 3.89 53.24 8.55 30.19 11.17 7.66 31.90 10.29 coo 3.82 17.09 49.56 4.09 14.32 50.84 13.19 26.25 26.41 10.66 27.96 25.98 ULMN 3 1vzx_c02 2.04.01.0087 user 4 3 # 4 A 314 TYR C 421 TYR^? 13.35 C2 EDO C 602 A 317 GLU C 436 GLU^? 10.62 C2 EDO C 602 A 365 ARG C 425 ARG^? 21.48 O1 GOL D 601 coo 1.77 6.56 57.05 3.05 7.44 59.37 19.38 20.76 -23.26 18.18 22.24 -25.31 coo 3.06 2.85 52.79 4.83 3.89 53.24 21.74 20.63 -27.21 21.00 22.48 -27.90 coo 3.82 17.09 49.56 4.09 14.32 50.84 27.32 15.93 -12.34 26.51 18.69 -11.26 ULMN 3 1vzx_c02 2.04.01.0087 user 5 3 # 5 A 314 TYR D 421 TYR^? 13.63 C3 GOL D 601 A 317 GLU D 436 GLU^? 11.06 C3 GOL D 601 A 365 ARG D 397 ARG~? 26.17 C3 GOL D 601 coo 1.77 6.56 57.05 3.05 7.44 59.37 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo 3.06 2.85 52.79 4.83 3.89 53.24 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 3.82 17.09 49.56 4.09 14.32 50.84 40.54 0.77 -47.66 42.41 1.45 -45.29 ULMN 3 1vzx_c02 2.04.01.0087 user 6 3 # 6 A 314 TYR D 421 TYR^? 13.63 C3 GOL D 601 A 317 GLU D 436 GLU^? 11.06 C3 GOL D 601 A 365 ARG D 401 ARG.? 17.46 O1 EDO C 602 coo 1.77 6.56 57.05 3.05 7.44 59.37 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo 3.06 2.85 52.79 4.83 3.89 53.24 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 3.82 17.09 49.56 4.09 14.32 50.84 26.50 1.94 -49.52 24.85 0.58 -47.31 ULMN 3 1vzx_c02 2.04.01.0087 user 7 3 # 7 A 314 TYR D 421 TYR^? 13.63 C3 GOL D 601 A 317 GLU D 436 GLU^? 11.06 C3 GOL D 601 A 365 ARG D 425 ARG^? 16.89 O1 EDO C 602 coo 1.77 6.56 57.05 3.05 7.44 59.37 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo 3.06 2.85 52.79 4.83 3.89 53.24 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 3.82 17.09 49.56 4.09 14.32 50.84 35.18 9.71 -47.18 32.90 7.74 -47.72 1vzx_c02 source 1vzx 2.04.01.0087 : 7 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR A 421 TYR^? 19.72 O1 EDO B 603 B1317 GLU A 436 GLU^? 20.55 O1 EDO B 603 B1365 ARG A 397 ARG~? 24.94 O2 GOL D 601 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 20.02 8.83 1.38 20.18 6.69 3.20 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 19.93 9.98 5.88 20.55 8.03 6.42 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 31.00 11.06 -6.51 32.72 12.02 -4.11 ULMN 3 1vzx_c03 2.04.01.0087 user 2 3 # 2 B1314 TYR A 421 TYR^? 19.72 O1 EDO B 603 B1317 GLU A 436 GLU^? 20.55 O1 EDO B 603 B1365 ARG A 425 ARG^? 21.19 O1 EDO B 603 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 20.02 8.83 1.38 20.18 6.69 3.20 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 19.93 9.98 5.88 20.55 8.03 6.42 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 25.04 18.93 -7.11 26.86 16.62 -8.01 ULMN 3 1vzx_c03 2.04.01.0087 user 3 3 # 3 B1314 TYR B 421 TYR^? 13.58 C2 EDO B 603 B1317 GLU B 436 GLU^? 10.42 C2 EDO B 603 B1365 ARG B 397 ARG~? 26.01 C2 EDO B 603 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 6.36 30.57 15.08 5.68 32.41 13.09 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 8.55 30.19 11.17 7.66 31.90 10.29 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 10.79 36.41 26.32 12.94 37.68 24.51 ULMN 3 1vzx_c03 2.04.01.0087 user 4 3 # 4 B1314 TYR B 421 TYR^? 13.58 C2 EDO B 603 B1317 GLU B 436 GLU^? 10.42 C2 EDO B 603 B1365 ARG B 425 ARG^? 24.19 C2 EDO B 603 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 6.36 30.57 15.08 5.68 32.41 13.09 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 8.55 30.19 11.17 7.66 31.90 10.29 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 13.19 26.25 26.41 10.66 27.96 25.98 ULMN 3 1vzx_c03 2.04.01.0087 user 5 3 # 5 B1314 TYR C 421 TYR^? 13.35 C2 EDO C 602 B1317 GLU C 436 GLU^? 10.62 C2 EDO C 602 B1365 ARG C 397 ARG~? 23.93 O1 EDO B 603 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 19.38 20.76 -23.26 18.18 22.24 -25.31 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 21.74 20.63 -27.21 21.00 22.48 -27.90 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 25.49 26.02 -11.91 27.94 26.82 -13.64 ULMN 3 1vzx_c03 2.04.01.0087 user 6 3 # 6 B1314 TYR C 421 TYR^? 13.35 C2 EDO C 602 B1317 GLU C 436 GLU^? 10.62 C2 EDO C 602 B1365 ARG C 425 ARG^? 21.48 O1 GOL D 601 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 19.38 20.76 -23.26 18.18 22.24 -25.31 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 21.74 20.63 -27.21 21.00 22.48 -27.90 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 27.32 15.93 -12.34 26.51 18.69 -11.26 ULMN 3 1vzx_c03 2.04.01.0087 user 7 3 # 7 B1314 TYR D 421 TYR^? 13.63 C3 GOL D 601 B1317 GLU D 436 GLU^? 11.06 C3 GOL D 601 B1365 ARG D 397 ARG~? 26.17 C3 GOL D 601 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 40.54 0.77 -47.66 42.41 1.45 -45.29 ULMN 3 1vzx_c03 2.04.01.0087 user 8 3 # 8 B1314 TYR D 421 TYR^? 13.63 C3 GOL D 601 B1317 GLU D 436 GLU^? 11.06 C3 GOL D 601 B1365 ARG D 401 ARG.? 17.46 O1 EDO C 602 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 26.50 1.94 -49.52 24.85 0.58 -47.31 ULMN 3 1vzx_c03 2.04.01.0087 user 9 3 # 9 B1314 TYR D 421 TYR^? 13.63 C3 GOL D 601 B1317 GLU D 436 GLU^? 11.06 C3 GOL D 601 B1365 ARG D 425 ARG^? 16.89 O1 EDO C 602 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 35.18 9.71 -47.18 32.90 7.74 -47.72 1vzx_c03 source 1vzx 2.04.01.0087 : 9 hits 1vzx_c03 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 354 TYR^? 20.91 C1 EDO B 603 A 40 ASP A 357 ASP.? 25.14 C1 EDO B 603 A 103 LEU A 336 LEU~? 17.01 C1 EDO B 603 coo 12.09 16.13 10.57 11.28 18.80 10.73 27.10 16.84 11.56 24.90 18.34 12.50 coo 7.55 25.51 14.34 9.65 25.73 14.24 22.54 16.74 19.72 22.05 16.00 21.61 coo 11.83 18.73 16.99 10.99 19.71 15.26 21.86 21.77 13.22 22.80 22.14 11.24 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 421 TYR^? 19.72 O1 EDO B 603 A 40 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 103 LEU A 396 LEU~? 19.04 O1 EDO B 603 coo 12.09 16.13 10.57 11.28 18.80 10.73 20.02 8.83 1.38 20.18 6.69 3.20 coo 7.55 25.51 14.34 9.65 25.73 14.24 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 11.83 18.73 16.99 10.99 19.71 15.26 23.61 11.57 -4.48 21.72 11.49 -3.34 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR A 421 TYR^? 19.72 O1 EDO B 603 A 40 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 103 LEU A 435 LEU^? 15.09 C1 EDO B 603 coo 12.09 16.13 10.57 11.28 18.80 10.73 20.02 8.83 1.38 20.18 6.69 3.20 coo 7.55 25.51 14.34 9.65 25.73 14.24 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 11.83 18.73 16.99 10.99 19.71 15.26 22.48 16.32 3.35 21.45 17.53 4.81 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR A 437 TYR^? 11.45 C1 EDO B 603 A 40 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 103 LEU A 435 LEU^? 15.09 C1 EDO B 603 coo 12.09 16.13 10.57 11.28 18.80 10.73 16.79 15.50 5.48 15.91 16.43 3.01 coo 7.55 25.51 14.34 9.65 25.73 14.24 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 11.83 18.73 16.99 10.99 19.71 15.26 22.48 16.32 3.35 21.45 17.53 4.81 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR A 437 TYR^? 11.45 C1 EDO B 603 A 40 ASP A 440 ASP^? 18.54 C1 EDO B 603 A 103 LEU A 341 LEU.? 12.32 C1 EDO B 603 coo 12.09 16.13 10.57 11.28 18.80 10.73 16.79 15.50 5.48 15.91 16.43 3.01 coo 7.55 25.51 14.34 9.65 25.73 14.24 8.21 11.09 12.88 6.30 10.30 13.36 coo 11.83 18.73 16.99 10.99 19.71 15.26 15.39 16.50 10.50 14.22 17.33 8.84 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 6 3 # 6 A 16 TYR B 354 TYR^? 14.48 C1 EDO B 603 A 40 ASP B 357 ASP.? 13.04 C1 EDO B 603 A 103 LEU B 336 LEU~? 13.75 C1 EDO B 603 coo 12.09 16.13 10.57 11.28 18.80 10.73 19.63 32.53 9.54 19.95 30.09 8.18 coo 7.55 25.51 14.34 9.65 25.73 14.24 19.95 30.44 0.55 20.02 30.85 -1.53 coo 11.83 18.73 16.99 10.99 19.71 15.26 21.21 25.82 7.03 21.30 25.84 9.24 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 7 3 # 7 A 16 TYR B 421 TYR^? 13.58 C2 EDO B 603 A 40 ASP B 402 ASP.? 23.46 C2 EDO B 603 A 103 LEU B 396 LEU~? 19.84 C2 EDO B 603 coo 12.09 16.13 10.57 11.28 18.80 10.73 6.36 30.57 15.08 5.68 32.41 13.09 coo 7.55 25.51 14.34 9.65 25.73 14.24 8.17 23.01 23.39 8.93 22.69 25.33 coo 11.83 18.73 16.99 10.99 19.71 15.26 8.14 30.55 22.24 7.48 29.36 20.54 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 8 3 # 8 A 16 TYR B 437 TYR^? 10.72 C1 EDO B 603 A 40 ASP B 440 ASP^? 5.62 O1 EDO B 603 A 103 LEU B 341 LEU.? 6.12 C1 EDO B 603 coo 12.09 16.13 10.57 11.28 18.80 10.73 10.92 24.41 11.32 10.27 22.67 13.43 coo 7.55 25.51 14.34 9.65 25.73 14.24 5.66 21.79 0.79 4.10 21.14 -0.54 coo 11.83 18.73 16.99 10.99 19.71 15.26 12.64 23.79 6.14 12.06 22.08 7.37 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 9 3 # 9 A 16 TYR C 354 TYR^? 14.37 C1 EDO C 602 A 40 ASP C 357 ASP.? 12.50 O2 EDO C 602 A 103 LEU C 336 LEU~? 13.53 C1 EDO C 602 coo 12.09 16.13 10.57 11.28 18.80 10.73 32.76 22.10 -29.37 32.74 19.75 -30.93 coo 7.55 25.51 14.34 9.65 25.73 14.24 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 11.83 18.73 16.99 10.99 19.71 15.26 33.45 15.44 -32.37 33.71 15.35 -30.19 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 10 3 # 10 A 16 TYR C 421 TYR^? 13.35 C2 EDO C 602 A 40 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 103 LEU C 396 LEU~? 18.49 O1 GOL D 601 coo 12.09 16.13 10.57 11.28 18.80 10.73 19.38 20.76 -23.26 18.18 22.24 -25.31 coo 7.55 25.51 14.34 9.65 25.73 14.24 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 11.83 18.73 16.99 10.99 19.71 15.26 21.93 20.60 -16.19 21.00 19.44 -17.76 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 11 3 # 11 A 16 TYR C 421 TYR^? 13.35 C2 EDO C 602 A 40 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 103 LEU C 435 LEU^? 14.04 C1 EDO C 602 coo 12.09 16.13 10.57 11.28 18.80 10.73 19.38 20.76 -23.26 18.18 22.24 -25.31 coo 7.55 25.51 14.34 9.65 25.73 14.24 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 11.83 18.73 16.99 10.99 19.71 15.26 27.04 17.63 -23.33 27.85 16.42 -24.95 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 12 3 # 12 A 16 TYR C 437 TYR^? 9.81 O1 GOL D 601 A 40 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 103 LEU C 435 LEU^? 14.04 C1 EDO C 602 coo 12.09 16.13 10.57 11.28 18.80 10.73 23.51 14.66 -27.39 22.94 13.02 -25.21 coo 7.55 25.51 14.34 9.65 25.73 14.24 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 11.83 18.73 16.99 10.99 19.71 15.26 27.04 17.63 -23.33 27.85 16.42 -24.95 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 13 3 # 13 A 16 TYR C 437 TYR^? 9.81 O1 GOL D 601 A 40 ASP C 440 ASP^? 5.97 O1 EDO C 602 A 103 LEU C 341 LEU.? 6.12 C1 EDO C 602 coo 12.09 16.13 10.57 11.28 18.80 10.73 23.51 14.66 -27.39 22.94 13.02 -25.21 coo 7.55 25.51 14.34 9.65 25.73 14.24 17.33 13.03 -37.56 15.74 12.38 -38.82 coo 11.83 18.73 16.99 10.99 19.71 15.26 24.86 14.23 -32.54 24.31 12.49 -31.36 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 14 3 # 14 A 16 TYR D 354 TYR^? 14.76 C3 GOL D 601 A 40 ASP D 357 ASP.? 12.64 O3 GOL D 601 A 103 LEU D 336 LEU~? 13.69 C1 GOL D 601 coo 12.09 16.13 10.57 11.28 18.80 10.73 38.74 5.77 -29.00 36.83 7.38 -27.74 coo 7.55 25.51 14.34 9.65 25.73 14.24 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 11.83 18.73 16.99 10.99 19.71 15.26 34.18 10.94 -26.45 34.89 11.44 -28.47 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 15 3 # 15 A 16 TYR D 421 TYR^? 13.63 C3 GOL D 601 A 40 ASP D 402 ASP.? 14.20 O1 EDO C 602 A 103 LEU D 396 LEU~? 18.34 O1 EDO C 602 coo 12.09 16.13 10.57 11.28 18.80 10.73 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo 7.55 25.51 14.34 9.65 25.73 14.24 28.53 7.95 -46.44 29.10 9.08 -48.14 coo 11.83 18.73 16.99 10.99 19.71 15.26 33.65 2.40 -45.26 31.89 2.25 -43.96 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 16 3 # 16 A 16 TYR D 437 TYR^? 9.97 C1 GOL D 601 A 40 ASP D 440 ASP^? -5.34 O2 GOL D 601s A 103 LEU D 341 LEU.? 5.42 C1 GOL D 601 coo 12.09 16.13 10.57 11.28 18.80 10.73 27.83 5.60 -34.20 26.72 6.80 -36.49 coo 7.55 25.51 14.34 9.65 25.73 14.24 19.76 1.27 -26.39 17.89 0.46 -25.75 coo 11.83 18.73 16.99 10.99 19.71 15.26 26.97 6.29 -28.91 25.74 7.22 -30.34 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 16 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 354 TYR^? 20.91 C1 EDO B 603 B 40 ASP A 357 ASP.? 25.14 C1 EDO B 603 B 103 LEU A 336 LEU~? 17.01 C1 EDO B 603 coo 14.25 20.09 37.35 13.48 17.40 37.38 27.10 16.84 11.56 24.90 18.34 12.50 coo 9.39 10.77 34.53 11.50 10.63 34.41 22.54 16.74 19.72 22.05 16.00 21.61 coo 12.89 17.60 31.13 12.34 16.51 32.90 21.86 21.77 13.22 22.80 22.14 11.24 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 421 TYR^? 19.72 O1 EDO B 603 B 40 ASP A 402 ASP.? 12.59 O1 EDO B 603 B 103 LEU A 396 LEU~? 19.04 O1 EDO B 603 coo 14.25 20.09 37.35 13.48 17.40 37.38 20.02 8.83 1.38 20.18 6.69 3.20 coo 9.39 10.77 34.53 11.50 10.63 34.41 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 12.89 17.60 31.13 12.34 16.51 32.90 23.61 11.57 -4.48 21.72 11.49 -3.34 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR A 437 TYR^? 11.45 C1 EDO B 603 B 40 ASP A 440 ASP^? 18.54 C1 EDO B 603 B 103 LEU A 341 LEU.? 12.32 C1 EDO B 603 coo 14.25 20.09 37.35 13.48 17.40 37.38 16.79 15.50 5.48 15.91 16.43 3.01 coo 9.39 10.77 34.53 11.50 10.63 34.41 8.21 11.09 12.88 6.30 10.30 13.36 coo 12.89 17.60 31.13 12.34 16.51 32.90 15.39 16.50 10.50 14.22 17.33 8.84 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR B 354 TYR^? 14.48 C1 EDO B 603 B 40 ASP B 357 ASP.? 13.04 C1 EDO B 603 B 103 LEU B 336 LEU~? 13.75 C1 EDO B 603 coo 14.25 20.09 37.35 13.48 17.40 37.38 19.63 32.53 9.54 19.95 30.09 8.18 coo 9.39 10.77 34.53 11.50 10.63 34.41 19.95 30.44 0.55 20.02 30.85 -1.53 coo 12.89 17.60 31.13 12.34 16.51 32.90 21.21 25.82 7.03 21.30 25.84 9.24 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR B 421 TYR^? 13.58 C2 EDO B 603 B 40 ASP B 402 ASP.? 23.46 C2 EDO B 603 B 103 LEU B 396 LEU~? 19.84 C2 EDO B 603 coo 14.25 20.09 37.35 13.48 17.40 37.38 6.36 30.57 15.08 5.68 32.41 13.09 coo 9.39 10.77 34.53 11.50 10.63 34.41 8.17 23.01 23.39 8.93 22.69 25.33 coo 12.89 17.60 31.13 12.34 16.51 32.90 8.14 30.55 22.24 7.48 29.36 20.54 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 6 3 # 6 B 16 TYR B 437 TYR^? 10.72 C1 EDO B 603 B 40 ASP B 440 ASP^? 5.62 O1 EDO B 603 B 103 LEU B 341 LEU.? 6.12 C1 EDO B 603 coo 14.25 20.09 37.35 13.48 17.40 37.38 10.92 24.41 11.32 10.27 22.67 13.43 coo 9.39 10.77 34.53 11.50 10.63 34.41 5.66 21.79 0.79 4.10 21.14 -0.54 coo 12.89 17.60 31.13 12.34 16.51 32.90 12.64 23.79 6.14 12.06 22.08 7.37 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 7 3 # 7 B 16 TYR C 354 TYR^? 14.37 C1 EDO C 602 B 40 ASP C 357 ASP.? 12.50 O2 EDO C 602 B 103 LEU C 336 LEU~? 13.53 C1 EDO C 602 coo 14.25 20.09 37.35 13.48 17.40 37.38 32.76 22.10 -29.37 32.74 19.75 -30.93 coo 9.39 10.77 34.53 11.50 10.63 34.41 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 12.89 17.60 31.13 12.34 16.51 32.90 33.45 15.44 -32.37 33.71 15.35 -30.19 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 8 3 # 8 B 16 TYR C 421 TYR^? 13.35 C2 EDO C 602 B 40 ASP C 402 ASP.? 12.78 O1 GOL D 601 B 103 LEU C 396 LEU~? 18.49 O1 GOL D 601 coo 14.25 20.09 37.35 13.48 17.40 37.38 19.38 20.76 -23.26 18.18 22.24 -25.31 coo 9.39 10.77 34.53 11.50 10.63 34.41 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 12.89 17.60 31.13 12.34 16.51 32.90 21.93 20.60 -16.19 21.00 19.44 -17.76 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 9 3 # 9 B 16 TYR C 421 TYR^? 13.35 C2 EDO C 602 B 40 ASP C 402 ASP.? 12.78 O1 GOL D 601 B 103 LEU C 435 LEU^? 14.04 C1 EDO C 602 coo 14.25 20.09 37.35 13.48 17.40 37.38 19.38 20.76 -23.26 18.18 22.24 -25.31 coo 9.39 10.77 34.53 11.50 10.63 34.41 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 12.89 17.60 31.13 12.34 16.51 32.90 27.04 17.63 -23.33 27.85 16.42 -24.95 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 10 3 # 10 B 16 TYR C 437 TYR^? 9.81 O1 GOL D 601 B 40 ASP C 402 ASP.? 12.78 O1 GOL D 601 B 103 LEU C 435 LEU^? 14.04 C1 EDO C 602 coo 14.25 20.09 37.35 13.48 17.40 37.38 23.51 14.66 -27.39 22.94 13.02 -25.21 coo 9.39 10.77 34.53 11.50 10.63 34.41 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 12.89 17.60 31.13 12.34 16.51 32.90 27.04 17.63 -23.33 27.85 16.42 -24.95 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 11 3 # 11 B 16 TYR C 437 TYR^? 9.81 O1 GOL D 601 B 40 ASP C 440 ASP^? 5.97 O1 EDO C 602 B 103 LEU C 341 LEU.? 6.12 C1 EDO C 602 coo 14.25 20.09 37.35 13.48 17.40 37.38 23.51 14.66 -27.39 22.94 13.02 -25.21 coo 9.39 10.77 34.53 11.50 10.63 34.41 17.33 13.03 -37.56 15.74 12.38 -38.82 coo 12.89 17.60 31.13 12.34 16.51 32.90 24.86 14.23 -32.54 24.31 12.49 -31.36 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 12 3 # 12 B 16 TYR D 354 TYR^? 14.76 C3 GOL D 601 B 40 ASP D 357 ASP.? 12.64 O3 GOL D 601 B 103 LEU D 336 LEU~? 13.69 C1 GOL D 601 coo 14.25 20.09 37.35 13.48 17.40 37.38 38.74 5.77 -29.00 36.83 7.38 -27.74 coo 9.39 10.77 34.53 11.50 10.63 34.41 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 12.89 17.60 31.13 12.34 16.51 32.90 34.18 10.94 -26.45 34.89 11.44 -28.47 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 13 3 # 13 B 16 TYR D 421 TYR^? 13.63 C3 GOL D 601 B 40 ASP D 402 ASP.? 14.20 O1 EDO C 602 B 103 LEU D 396 LEU~? 18.34 O1 EDO C 602 coo 14.25 20.09 37.35 13.48 17.40 37.38 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo 9.39 10.77 34.53 11.50 10.63 34.41 28.53 7.95 -46.44 29.10 9.08 -48.14 coo 12.89 17.60 31.13 12.34 16.51 32.90 33.65 2.40 -45.26 31.89 2.25 -43.96 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 14 3 # 14 B 16 TYR D 437 TYR^? 9.97 C1 GOL D 601 B 40 ASP D 440 ASP^? -5.34 O2 GOL D 601s B 103 LEU D 341 LEU.? 5.42 C1 GOL D 601 coo 14.25 20.09 37.35 13.48 17.40 37.38 27.83 5.60 -34.20 26.72 6.80 -36.49 coo 9.39 10.77 34.53 11.50 10.63 34.41 19.76 1.27 -26.39 17.89 0.46 -25.75 coo 12.89 17.60 31.13 12.34 16.51 32.90 26.97 6.29 -28.91 25.74 7.22 -30.34 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 14 hits 1vzz_c01 naa= 3 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 420 ALA A 423 ALA^? 17.43 O1 EDO B 603 B 182 GLY A 399 GLY.? 18.69 O2 GOL D 601 B 183 GLY C 399 GLY.? 18.04 O1 EDO B 603 coo 38.36-101.47-135.52 39.62-101.29-136.35 23.34 15.61 -2.79 23.45 15.65 -4.34 coo 41.93-102.35-126.87 41.52-101.89-126.30 24.04 14.08 -10.54 23.93 13.28 -10.73 coo 38.37-101.99-128.11 38.63-102.24-127.37 22.21 18.06 -10.13 21.51 18.50 -10.08 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 420 ALA A 423 ALA^? 17.43 O1 EDO B 603 B 182 GLY C 399 GLY.? 18.04 O1 EDO B 603 B 183 GLY A 399 GLY.? 18.69 O2 GOL D 601 coo 38.36-101.47-135.52 39.62-101.29-136.35 23.34 15.61 -2.79 23.45 15.65 -4.34 coo 41.93-102.35-126.87 41.52-101.89-126.30 22.21 18.06 -10.13 21.51 18.50 -10.08 coo 38.37-101.99-128.11 38.63-102.24-127.37 24.04 14.08 -10.54 23.93 13.28 -10.73 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 420 ALA C 423 ALA^? 17.19 O1 GOL D 601 B 182 GLY A 399 GLY.? 18.69 O2 GOL D 601 B 183 GLY C 399 GLY.? 18.04 O1 EDO B 603 coo 38.36-101.47-135.52 39.62-101.29-136.35 25.18 17.70 -17.34 24.76 17.44 -15.88 coo 41.93-102.35-126.87 41.52-101.89-126.30 24.04 14.08 -10.54 23.93 13.28 -10.73 coo 38.37-101.99-128.11 38.63-102.24-127.37 22.21 18.06 -10.13 21.51 18.50 -10.08 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 420 ALA C 423 ALA^? 17.19 O1 GOL D 601 B 182 GLY C 399 GLY.? 18.04 O1 EDO B 603 B 183 GLY A 399 GLY.? 18.69 O2 GOL D 601 coo 38.36-101.47-135.52 39.62-101.29-136.35 25.18 17.70 -17.34 24.76 17.44 -15.88 coo 41.93-102.35-126.87 41.52-101.89-126.30 22.21 18.06 -10.13 21.51 18.50 -10.08 coo 38.37-101.99-128.11 38.63-102.24-127.37 24.04 14.08 -10.54 23.93 13.28 -10.73 1xny_c01 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 4 hits 1xny_c01 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 361 ALA~? 29.16 C1 EDO B 603 B 126 ARG A 368 ARG.? 24.16 C1 EDO B 603 B 138 GLU A 363 GLU~? 27.04 C1 EDO B 603 coo 2.11 4.00 19.31 3.14 4.86 19.99 20.58 8.39 21.62 21.97 8.14 22.23 coo 2.45 5.53 11.28 3.59 7.56 13.29 23.91 7.22 12.24 22.49 6.03 9.76 coo 6.10 2.00 25.24 6.12 1.84 23.13 14.23 7.65 22.80 13.44 9.34 23.77 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 B 124 ALA A 422 ALA^? 13.54 O1 EDO B 603 B 126 ARG A 401 ARG.? 15.99 O2 GOL D 601 B 138 GLU A 436 GLU^? 20.55 O1 EDO B 603 coo 2.11 4.00 19.31 3.14 4.86 19.99 20.34 14.47 -0.75 19.66 15.71 -0.13 coo 2.45 5.53 11.28 3.59 7.56 13.29 17.05 9.37 -8.73 16.66 7.27 -10.98 coo 6.10 2.00 25.24 6.12 1.84 23.13 19.93 9.98 5.88 20.55 8.03 6.42 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 B 124 ALA A 422 ALA^? 13.54 O1 EDO B 603 B 126 ARG A 425 ARG^? 21.19 O1 EDO B 603 B 138 GLU A 436 GLU^? 20.55 O1 EDO B 603 coo 2.11 4.00 19.31 3.14 4.86 19.99 20.34 14.47 -0.75 19.66 15.71 -0.13 coo 2.45 5.53 11.28 3.59 7.56 13.29 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 6.10 2.00 25.24 6.12 1.84 23.13 19.93 9.98 5.88 20.55 8.03 6.42 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 B 124 ALA B 422 ALA^? 15.69 C2 EDO B 603 B 126 ARG B 401 ARG.? 20.08 C2 EDO B 603 B 138 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo 2.11 4.00 19.31 3.14 4.86 19.99 9.81 26.66 18.07 10.52 25.41 17.54 coo 2.45 5.53 11.28 3.59 7.56 13.29 1.75 25.80 23.58 1.16 24.37 20.91 coo 6.10 2.00 25.24 6.12 1.84 23.13 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 B 124 ALA B 422 ALA^? 15.69 C2 EDO B 603 B 126 ARG B 425 ARG^? 24.19 C2 EDO B 603 B 138 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo 2.11 4.00 19.31 3.14 4.86 19.99 9.81 26.66 18.07 10.52 25.41 17.54 coo 2.45 5.53 11.28 3.59 7.56 13.29 13.19 26.25 26.41 10.66 27.96 25.98 coo 6.10 2.00 25.24 6.12 1.84 23.13 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 B 124 ALA C 361 ALA~? 10.66 O2 EDO C 602 B 126 ARG C 368 ARG.? 10.85 O2 EDO C 602 B 138 GLU C 363 GLU~? 7.78 O2 EDO C 602 coo 2.11 4.00 19.31 3.14 4.86 19.99 24.11 24.72 -41.81 24.86 26.05 -41.98 coo 2.45 5.53 11.28 3.59 7.56 13.29 24.45 26.16 -32.00 21.85 25.58 -30.53 coo 6.10 2.00 25.24 6.12 1.84 23.13 20.56 19.64 -44.58 21.56 17.87 -45.23 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 B 124 ALA C 422 ALA^? 12.76 O1 GOL D 601 B 126 ARG C 401 ARG.? 15.33 O1 EDO B 603 B 138 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 2.11 4.00 19.31 3.14 4.86 19.99 23.09 16.73 -20.35 23.76 15.53 -20.98 coo 2.45 5.53 11.28 3.59 7.56 13.29 15.13 16.06 -14.86 13.60 17.63 -12.63 coo 6.10 2.00 25.24 6.12 1.84 23.13 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 B 124 ALA C 422 ALA^? 12.76 O1 GOL D 601 B 126 ARG C 425 ARG^? 21.48 O1 GOL D 601 B 138 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 2.11 4.00 19.31 3.14 4.86 19.99 23.09 16.73 -20.35 23.76 15.53 -20.98 coo 2.45 5.53 11.28 3.59 7.56 13.29 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 6.10 2.00 25.24 6.12 1.84 23.13 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 B 124 ALA D 361 ALA~? 11.04 O3 GOL D 601 B 126 ARG D 368 ARG.? 11.23 O3 GOL D 601 B 138 GLU D 363 GLU~? 7.90 O2 GOL D 601 coo 2.11 4.00 19.31 3.14 4.86 19.99 31.17 -3.31 -19.50 32.51 -3.83 -18.93 coo 2.45 5.53 11.28 3.59 7.56 13.29 34.63 -3.42 -28.94 33.31 -3.73 -31.69 coo 6.10 2.00 25.24 6.12 1.84 23.13 24.65 -2.66 -18.42 24.14 -0.86 -17.43 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 B 124 ALA D 422 ALA^? 12.49 O1 EDO C 602 B 126 ARG D 401 ARG.? 17.46 O1 EDO C 602 B 138 GLU D 436 GLU^? 11.06 C3 GOL D 601 coo 2.11 4.00 19.31 3.14 4.86 19.99 30.60 5.17 -40.84 30.09 6.36 -40.04 coo 2.45 5.53 11.28 3.59 7.56 13.29 26.50 1.94 -49.52 24.85 0.58 -47.31 coo 6.10 2.00 25.24 6.12 1.84 23.13 30.72 -0.04 -34.79 31.42 -2.01 -34.30 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 B 124 ALA D 422 ALA^? 12.49 O1 EDO C 602 B 126 ARG D 425 ARG^? 16.89 O1 EDO C 602 B 138 GLU D 436 GLU^? 11.06 C3 GOL D 601 coo 2.11 4.00 19.31 3.14 4.86 19.99 30.60 5.17 -40.84 30.09 6.36 -40.04 coo 2.45 5.53 11.28 3.59 7.56 13.29 35.18 9.71 -47.18 32.90 7.74 -47.72 coo 6.10 2.00 25.24 6.12 1.84 23.13 30.72 -0.04 -34.79 31.42 -2.01 -34.30 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 11 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA A 361 ALA~? 29.16 C1 EDO B 603 C 126 ARG A 368 ARG.? 24.16 C1 EDO B 603 C 138 GLU A 363 GLU~? 27.04 C1 EDO B 603 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 20.58 8.39 21.62 21.97 8.14 22.23 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 23.91 7.22 12.24 22.49 6.03 9.76 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 14.23 7.65 22.80 13.44 9.34 23.77 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA A 422 ALA^? 13.54 O1 EDO B 603 C 126 ARG A 401 ARG.? 15.99 O2 GOL D 601 C 138 GLU A 436 GLU^? 20.55 O1 EDO B 603 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 20.34 14.47 -0.75 19.66 15.71 -0.13 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 17.05 9.37 -8.73 16.66 7.27 -10.98 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 19.93 9.98 5.88 20.55 8.03 6.42 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 C 124 ALA A 422 ALA^? 13.54 O1 EDO B 603 C 126 ARG A 425 ARG^? 21.19 O1 EDO B 603 C 138 GLU A 436 GLU^? 20.55 O1 EDO B 603 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 20.34 14.47 -0.75 19.66 15.71 -0.13 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 25.04 18.93 -7.11 26.86 16.62 -8.01 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 19.93 9.98 5.88 20.55 8.03 6.42 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 C 124 ALA B 422 ALA^? 15.69 C2 EDO B 603 C 126 ARG B 401 ARG.? 20.08 C2 EDO B 603 C 138 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 9.81 26.66 18.07 10.52 25.41 17.54 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 1.75 25.80 23.58 1.16 24.37 20.91 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 C 124 ALA B 422 ALA^? 15.69 C2 EDO B 603 C 126 ARG B 425 ARG^? 24.19 C2 EDO B 603 C 138 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 9.81 26.66 18.07 10.52 25.41 17.54 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 13.19 26.25 26.41 10.66 27.96 25.98 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 C 124 ALA C 361 ALA~? 10.66 O2 EDO C 602 C 126 ARG C 368 ARG.? 10.85 O2 EDO C 602 C 138 GLU C 363 GLU~? 7.78 O2 EDO C 602 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 24.11 24.72 -41.81 24.86 26.05 -41.98 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 24.45 26.16 -32.00 21.85 25.58 -30.53 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 20.56 19.64 -44.58 21.56 17.87 -45.23 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 C 124 ALA C 422 ALA^? 12.76 O1 GOL D 601 C 126 ARG C 401 ARG.? 15.33 O1 EDO B 603 C 138 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 23.09 16.73 -20.35 23.76 15.53 -20.98 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 15.13 16.06 -14.86 13.60 17.63 -12.63 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 C 124 ALA C 422 ALA^? 12.76 O1 GOL D 601 C 126 ARG C 425 ARG^? 21.48 O1 GOL D 601 C 138 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 23.09 16.73 -20.35 23.76 15.53 -20.98 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 27.32 15.93 -12.34 26.51 18.69 -11.26 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 C 124 ALA D 361 ALA~? 11.04 O3 GOL D 601 C 126 ARG D 368 ARG.? 11.23 O3 GOL D 601 C 138 GLU D 363 GLU~? 7.90 O2 GOL D 601 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 31.17 -3.31 -19.50 32.51 -3.83 -18.93 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 34.63 -3.42 -28.94 33.31 -3.73 -31.69 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 24.65 -2.66 -18.42 24.14 -0.86 -17.43 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 C 124 ALA D 422 ALA^? 12.49 O1 EDO C 602 C 126 ARG D 401 ARG.? 17.46 O1 EDO C 602 C 138 GLU D 436 GLU^? 11.06 C3 GOL D 601 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 30.60 5.17 -40.84 30.09 6.36 -40.04 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 26.50 1.94 -49.52 24.85 0.58 -47.31 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 30.72 -0.04 -34.79 31.42 -2.01 -34.30 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 C 124 ALA D 422 ALA^? 12.49 O1 EDO C 602 C 126 ARG D 425 ARG^? 16.89 O1 EDO C 602 C 138 GLU D 436 GLU^? 11.06 C3 GOL D 601 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 30.60 5.17 -40.84 30.09 6.36 -40.04 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 35.18 9.71 -47.18 32.90 7.74 -47.72 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 30.72 -0.04 -34.79 31.42 -2.01 -34.30 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 11 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 361 ALA~? 29.16 C1 EDO B 603 D 126 ARG A 368 ARG.? 24.16 C1 EDO B 603 D 138 GLU A 363 GLU~? 27.04 C1 EDO B 603 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 20.58 8.39 21.62 21.97 8.14 22.23 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 23.91 7.22 12.24 22.49 6.03 9.76 coo 6.23 0.50 57.10 5.93 0.72 59.19 14.23 7.65 22.80 13.44 9.34 23.77 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA A 422 ALA^? 13.54 O1 EDO B 603 D 126 ARG A 401 ARG.? 15.99 O2 GOL D 601 D 138 GLU A 436 GLU^? 20.55 O1 EDO B 603 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 20.34 14.47 -0.75 19.66 15.71 -0.13 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 17.05 9.37 -8.73 16.66 7.27 -10.98 coo 6.23 0.50 57.10 5.93 0.72 59.19 19.93 9.98 5.88 20.55 8.03 6.42 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 D 124 ALA A 422 ALA^? 13.54 O1 EDO B 603 D 126 ARG A 425 ARG^? 21.19 O1 EDO B 603 D 138 GLU A 436 GLU^? 20.55 O1 EDO B 603 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 20.34 14.47 -0.75 19.66 15.71 -0.13 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 6.23 0.50 57.10 5.93 0.72 59.19 19.93 9.98 5.88 20.55 8.03 6.42 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 D 124 ALA B 422 ALA^? 15.69 C2 EDO B 603 D 126 ARG B 401 ARG.? 20.08 C2 EDO B 603 D 138 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 9.81 26.66 18.07 10.52 25.41 17.54 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 1.75 25.80 23.58 1.16 24.37 20.91 coo 6.23 0.50 57.10 5.93 0.72 59.19 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 D 124 ALA B 422 ALA^? 15.69 C2 EDO B 603 D 126 ARG B 425 ARG^? 24.19 C2 EDO B 603 D 138 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 9.81 26.66 18.07 10.52 25.41 17.54 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 13.19 26.25 26.41 10.66 27.96 25.98 coo 6.23 0.50 57.10 5.93 0.72 59.19 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 D 124 ALA C 361 ALA~? 10.66 O2 EDO C 602 D 126 ARG C 368 ARG.? 10.85 O2 EDO C 602 D 138 GLU C 363 GLU~? 7.78 O2 EDO C 602 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 24.11 24.72 -41.81 24.86 26.05 -41.98 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 24.45 26.16 -32.00 21.85 25.58 -30.53 coo 6.23 0.50 57.10 5.93 0.72 59.19 20.56 19.64 -44.58 21.56 17.87 -45.23 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 D 124 ALA C 422 ALA^? 12.76 O1 GOL D 601 D 126 ARG C 401 ARG.? 15.33 O1 EDO B 603 D 138 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 23.09 16.73 -20.35 23.76 15.53 -20.98 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 15.13 16.06 -14.86 13.60 17.63 -12.63 coo 6.23 0.50 57.10 5.93 0.72 59.19 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 D 124 ALA C 422 ALA^? 12.76 O1 GOL D 601 D 126 ARG C 425 ARG^? 21.48 O1 GOL D 601 D 138 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 23.09 16.73 -20.35 23.76 15.53 -20.98 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 6.23 0.50 57.10 5.93 0.72 59.19 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 D 124 ALA D 361 ALA~? 11.04 O3 GOL D 601 D 126 ARG D 368 ARG.? 11.23 O3 GOL D 601 D 138 GLU D 363 GLU~? 7.90 O2 GOL D 601 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 31.17 -3.31 -19.50 32.51 -3.83 -18.93 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 34.63 -3.42 -28.94 33.31 -3.73 -31.69 coo 6.23 0.50 57.10 5.93 0.72 59.19 24.65 -2.66 -18.42 24.14 -0.86 -17.43 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 D 124 ALA D 422 ALA^? 12.49 O1 EDO C 602 D 126 ARG D 425 ARG^? 16.89 O1 EDO C 602 D 138 GLU D 436 GLU^? 11.06 C3 GOL D 601 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 30.60 5.17 -40.84 30.09 6.36 -40.04 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 35.18 9.71 -47.18 32.90 7.74 -47.72 coo 6.23 0.50 57.10 5.93 0.72 59.19 30.72 -0.04 -34.79 31.42 -2.01 -34.30 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 10 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 361 ALA~? 29.16 C1 EDO B 603 E 126 ARG A 368 ARG.? 24.16 C1 EDO B 603 E 138 GLU A 363 GLU~? 27.04 C1 EDO B 603 coo -4.56 10.03 62.36 -4.38 11.31 61.55 20.58 8.39 21.62 21.97 8.14 22.23 coo -3.02 12.00 70.07 -1.94 13.84 67.82 23.91 7.22 12.24 22.49 6.03 9.76 coo -8.67 12.22 56.54 -8.68 12.09 58.65 14.23 7.65 22.80 13.44 9.34 23.77 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA A 422 ALA^? 13.54 O1 EDO B 603 E 126 ARG A 401 ARG.? 15.99 O2 GOL D 601 E 138 GLU A 436 GLU^? 20.55 O1 EDO B 603 coo -4.56 10.03 62.36 -4.38 11.31 61.55 20.34 14.47 -0.75 19.66 15.71 -0.13 coo -3.02 12.00 70.07 -1.94 13.84 67.82 17.05 9.37 -8.73 16.66 7.27 -10.98 coo -8.67 12.22 56.54 -8.68 12.09 58.65 19.93 9.98 5.88 20.55 8.03 6.42 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 E 124 ALA A 422 ALA^? 13.54 O1 EDO B 603 E 126 ARG A 425 ARG^? 21.19 O1 EDO B 603 E 138 GLU A 436 GLU^? 20.55 O1 EDO B 603 coo -4.56 10.03 62.36 -4.38 11.31 61.55 20.34 14.47 -0.75 19.66 15.71 -0.13 coo -3.02 12.00 70.07 -1.94 13.84 67.82 25.04 18.93 -7.11 26.86 16.62 -8.01 coo -8.67 12.22 56.54 -8.68 12.09 58.65 19.93 9.98 5.88 20.55 8.03 6.42 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 E 124 ALA B 422 ALA^? 15.69 C2 EDO B 603 E 126 ARG B 401 ARG.? 20.08 C2 EDO B 603 E 138 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo -4.56 10.03 62.36 -4.38 11.31 61.55 9.81 26.66 18.07 10.52 25.41 17.54 coo -3.02 12.00 70.07 -1.94 13.84 67.82 1.75 25.80 23.58 1.16 24.37 20.91 coo -8.67 12.22 56.54 -8.68 12.09 58.65 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 E 124 ALA B 422 ALA^? 15.69 C2 EDO B 603 E 126 ARG B 425 ARG^? 24.19 C2 EDO B 603 E 138 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo -4.56 10.03 62.36 -4.38 11.31 61.55 9.81 26.66 18.07 10.52 25.41 17.54 coo -3.02 12.00 70.07 -1.94 13.84 67.82 13.19 26.25 26.41 10.66 27.96 25.98 coo -8.67 12.22 56.54 -8.68 12.09 58.65 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 E 124 ALA C 361 ALA~? 10.66 O2 EDO C 602 E 126 ARG C 368 ARG.? 10.85 O2 EDO C 602 E 138 GLU C 363 GLU~? 7.78 O2 EDO C 602 coo -4.56 10.03 62.36 -4.38 11.31 61.55 24.11 24.72 -41.81 24.86 26.05 -41.98 coo -3.02 12.00 70.07 -1.94 13.84 67.82 24.45 26.16 -32.00 21.85 25.58 -30.53 coo -8.67 12.22 56.54 -8.68 12.09 58.65 20.56 19.64 -44.58 21.56 17.87 -45.23 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 E 124 ALA C 422 ALA^? 12.76 O1 GOL D 601 E 126 ARG C 401 ARG.? 15.33 O1 EDO B 603 E 138 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo -4.56 10.03 62.36 -4.38 11.31 61.55 23.09 16.73 -20.35 23.76 15.53 -20.98 coo -3.02 12.00 70.07 -1.94 13.84 67.82 15.13 16.06 -14.86 13.60 17.63 -12.63 coo -8.67 12.22 56.54 -8.68 12.09 58.65 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 E 124 ALA C 422 ALA^? 12.76 O1 GOL D 601 E 126 ARG C 425 ARG^? 21.48 O1 GOL D 601 E 138 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo -4.56 10.03 62.36 -4.38 11.31 61.55 23.09 16.73 -20.35 23.76 15.53 -20.98 coo -3.02 12.00 70.07 -1.94 13.84 67.82 27.32 15.93 -12.34 26.51 18.69 -11.26 coo -8.67 12.22 56.54 -8.68 12.09 58.65 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 E 124 ALA D 361 ALA~? 11.04 O3 GOL D 601 E 126 ARG D 368 ARG.? 11.23 O3 GOL D 601 E 138 GLU D 363 GLU~? 7.90 O2 GOL D 601 coo -4.56 10.03 62.36 -4.38 11.31 61.55 31.17 -3.31 -19.50 32.51 -3.83 -18.93 coo -3.02 12.00 70.07 -1.94 13.84 67.82 34.63 -3.42 -28.94 33.31 -3.73 -31.69 coo -8.67 12.22 56.54 -8.68 12.09 58.65 24.65 -2.66 -18.42 24.14 -0.86 -17.43 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 E 124 ALA D 422 ALA^? 12.49 O1 EDO C 602 E 126 ARG D 425 ARG^? 16.89 O1 EDO C 602 E 138 GLU D 436 GLU^? 11.06 C3 GOL D 601 coo -4.56 10.03 62.36 -4.38 11.31 61.55 30.60 5.17 -40.84 30.09 6.36 -40.04 coo -3.02 12.00 70.07 -1.94 13.84 67.82 35.18 9.71 -47.18 32.90 7.74 -47.72 coo -8.67 12.22 56.54 -8.68 12.09 58.65 30.72 -0.04 -34.79 31.42 -2.01 -34.30 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 10 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA A 361 ALA~? 29.16 C1 EDO B 603 F 126 ARG A 368 ARG.? 24.16 C1 EDO B 603 F 138 GLU A 363 GLU~? 27.04 C1 EDO B 603 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 20.58 8.39 21.62 21.97 8.14 22.23 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 23.91 7.22 12.24 22.49 6.03 9.76 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 14.23 7.65 22.80 13.44 9.34 23.77 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA A 422 ALA^? 13.54 O1 EDO B 603 F 126 ARG A 401 ARG.? 15.99 O2 GOL D 601 F 138 GLU A 436 GLU^? 20.55 O1 EDO B 603 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 20.34 14.47 -0.75 19.66 15.71 -0.13 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 17.05 9.37 -8.73 16.66 7.27 -10.98 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 19.93 9.98 5.88 20.55 8.03 6.42 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 F 124 ALA A 422 ALA^? 13.54 O1 EDO B 603 F 126 ARG A 425 ARG^? 21.19 O1 EDO B 603 F 138 GLU A 436 GLU^? 20.55 O1 EDO B 603 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 20.34 14.47 -0.75 19.66 15.71 -0.13 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 25.04 18.93 -7.11 26.86 16.62 -8.01 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 19.93 9.98 5.88 20.55 8.03 6.42 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 F 124 ALA B 422 ALA^? 15.69 C2 EDO B 603 F 126 ARG B 401 ARG.? 20.08 C2 EDO B 603 F 138 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 9.81 26.66 18.07 10.52 25.41 17.54 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 1.75 25.80 23.58 1.16 24.37 20.91 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 F 124 ALA B 422 ALA^? 15.69 C2 EDO B 603 F 126 ARG B 425 ARG^? 24.19 C2 EDO B 603 F 138 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 9.81 26.66 18.07 10.52 25.41 17.54 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 13.19 26.25 26.41 10.66 27.96 25.98 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 F 124 ALA C 361 ALA~? 10.66 O2 EDO C 602 F 126 ARG C 368 ARG.? 10.85 O2 EDO C 602 F 138 GLU C 363 GLU~? 7.78 O2 EDO C 602 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 24.11 24.72 -41.81 24.86 26.05 -41.98 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 24.45 26.16 -32.00 21.85 25.58 -30.53 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 20.56 19.64 -44.58 21.56 17.87 -45.23 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 F 124 ALA C 422 ALA^? 12.76 O1 GOL D 601 F 126 ARG C 401 ARG.? 15.33 O1 EDO B 603 F 138 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 23.09 16.73 -20.35 23.76 15.53 -20.98 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 15.13 16.06 -14.86 13.60 17.63 -12.63 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 F 124 ALA C 422 ALA^? 12.76 O1 GOL D 601 F 126 ARG C 425 ARG^? 21.48 O1 GOL D 601 F 138 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 23.09 16.73 -20.35 23.76 15.53 -20.98 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 27.32 15.93 -12.34 26.51 18.69 -11.26 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 F 124 ALA D 361 ALA~? 11.04 O3 GOL D 601 F 126 ARG D 368 ARG.? 11.23 O3 GOL D 601 F 138 GLU D 363 GLU~? 7.90 O2 GOL D 601 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 31.17 -3.31 -19.50 32.51 -3.83 -18.93 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 34.63 -3.42 -28.94 33.31 -3.73 -31.69 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 24.65 -2.66 -18.42 24.14 -0.86 -17.43 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 F 124 ALA D 422 ALA^? 12.49 O1 EDO C 602 F 126 ARG D 401 ARG.? 17.46 O1 EDO C 602 F 138 GLU D 436 GLU^? 11.06 C3 GOL D 601 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 30.60 5.17 -40.84 30.09 6.36 -40.04 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 26.50 1.94 -49.52 24.85 0.58 -47.31 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 30.72 -0.04 -34.79 31.42 -2.01 -34.30 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 F 124 ALA D 422 ALA^? 12.49 O1 EDO C 602 F 126 ARG D 425 ARG^? 16.89 O1 EDO C 602 F 138 GLU D 436 GLU^? 11.06 C3 GOL D 601 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 30.60 5.17 -40.84 30.09 6.36 -40.04 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 35.18 9.71 -47.18 32.90 7.74 -47.72 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 30.72 -0.04 -34.79 31.42 -2.01 -34.30 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 11 hits 1xs1_c11 naa= 3 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS B 391 LYS~? 27.06 C2 EDO B 603 A 74 LYS B 388 LYS~? 19.48 C2 EDO B 603 A 165 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo 18.28 7.83 36.39 22.82 8.75 39.52 1.34 36.06 21.83 0.02 35.49 25.91 coo 14.16 13.09 37.03 20.00 12.44 37.49 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 22.22 16.06 48.76 23.94 15.33 49.78 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS B 415 LYS^? -2.82 O2 EDO B 603s A 74 LYS B 442 LYS~? 13.00 O1 EDO B 603 A 165 GLU A 450 GLU~? 18.15 C2 EDO B 603 coo 18.28 7.83 36.39 22.82 8.75 39.52 1.57 23.62 -1.31 7.49 26.02 -1.78 coo 14.16 13.09 37.03 20.00 12.44 37.49 1.48 17.85 0.41 -2.11 18.47 -3.79 coo 22.22 16.06 48.76 23.94 15.33 49.78 -8.36 20.71 9.57 -7.00 20.85 11.17 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS B 442 LYS~? 13.00 O1 EDO B 603 A 74 LYS B 415 LYS^? -2.82 O2 EDO B 603s A 165 GLU A 450 GLU~? 18.15 C2 EDO B 603 coo 18.28 7.83 36.39 22.82 8.75 39.52 1.48 17.85 0.41 -2.11 18.47 -3.79 coo 14.16 13.09 37.03 20.00 12.44 37.49 1.57 23.62 -1.31 7.49 26.02 -1.78 coo 22.22 16.06 48.76 23.94 15.33 49.78 -8.36 20.71 9.57 -7.00 20.85 11.17 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 74 LYS C 390 LYS~? 21.48 O2 EDO B 603 A 165 GLU B 363 GLU~? 7.89 O1 EDO B 603 coo 18.28 7.83 36.39 22.82 8.75 39.52 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 14.16 13.09 37.03 20.00 12.44 37.49 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 22.22 16.06 48.76 23.94 15.33 49.78 8.83 27.73 -6.37 10.21 26.17 -6.89 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 74 LYS C 390 LYS~? 21.48 O2 EDO B 603 A 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 18.28 7.83 36.39 22.82 8.75 39.52 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 14.16 13.09 37.03 20.00 12.44 37.49 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 22.22 16.06 48.76 23.94 15.33 49.78 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 74 LYS C 391 LYS~? 16.77 O1 EDO B 603 A 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 18.28 7.83 36.39 22.82 8.75 39.52 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 14.16 13.09 37.03 20.00 12.44 37.49 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 22.22 16.06 48.76 23.94 15.33 49.78 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS C 390 LYS~? 21.48 O2 EDO B 603 A 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 165 GLU B 363 GLU~? 7.89 O1 EDO B 603 coo 18.28 7.83 36.39 22.82 8.75 39.52 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 14.16 13.09 37.03 20.00 12.44 37.49 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 22.22 16.06 48.76 23.94 15.33 49.78 8.83 27.73 -6.37 10.21 26.17 -6.89 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS C 390 LYS~? 21.48 O2 EDO B 603 A 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 18.28 7.83 36.39 22.82 8.75 39.52 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 14.16 13.09 37.03 20.00 12.44 37.49 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 22.22 16.06 48.76 23.94 15.33 49.78 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS C 391 LYS~? 16.77 O1 EDO B 603 A 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 18.28 7.83 36.39 22.82 8.75 39.52 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 14.16 13.09 37.03 20.00 12.44 37.49 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 22.22 16.06 48.76 23.94 15.33 49.78 21.74 20.63 -27.21 21.00 22.48 -27.90 1ylu_c00 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 9 hits 1ylu_c00 naa= 3 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS B 390 LYS~? 27.12 C2 EDO B 603 B 74 LYS B 388 LYS~? 19.48 C2 EDO B 603 B 165 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo 13.51 0.92 76.10 12.98 6.13 74.68 3.52 38.72 20.17 3.15 45.06 20.21 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 21.39 11.56 68.52 20.24 13.13 67.73 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS B 391 LYS~? 27.06 C2 EDO B 603 B 74 LYS B 388 LYS~? 19.48 C2 EDO B 603 B 165 GLU B 436 GLU^? 10.42 C2 EDO B 603 coo 13.51 0.92 76.10 12.98 6.13 74.68 1.34 36.06 21.83 0.02 35.49 25.91 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 21.39 11.56 68.52 20.24 13.13 67.73 8.55 30.19 11.17 7.66 31.90 10.29 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS B 415 LYS^? -2.82 O2 EDO B 603s B 74 LYS B 442 LYS~? 13.00 O1 EDO B 603 B 165 GLU A 450 GLU~? 18.15 C2 EDO B 603 coo 13.51 0.92 76.10 12.98 6.13 74.68 1.57 23.62 -1.31 7.49 26.02 -1.78 coo 19.89 -0.55 76.51 17.10 4.32 77.43 1.48 17.85 0.41 -2.11 18.47 -3.79 coo 21.39 11.56 68.52 20.24 13.13 67.73 -8.36 20.71 9.57 -7.00 20.85 11.17 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS B 442 LYS~? 13.00 O1 EDO B 603 B 74 LYS B 415 LYS^? -2.82 O2 EDO B 603s B 165 GLU A 450 GLU~? 18.15 C2 EDO B 603 coo 13.51 0.92 76.10 12.98 6.13 74.68 1.48 17.85 0.41 -2.11 18.47 -3.79 coo 19.89 -0.55 76.51 17.10 4.32 77.43 1.57 23.62 -1.31 7.49 26.02 -1.78 coo 21.39 11.56 68.52 20.24 13.13 67.73 -8.36 20.71 9.57 -7.00 20.85 11.17 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS C 388 LYS~? 20.15 C2 EDO C 602 B 74 LYS C 390 LYS~? 21.48 O2 EDO B 603 B 165 GLU B 363 GLU~? 7.89 O1 EDO B 603 coo 13.51 0.92 76.10 12.98 6.13 74.68 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 19.89 -0.55 76.51 17.10 4.32 77.43 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 21.39 11.56 68.52 20.24 13.13 67.73 8.83 27.73 -6.37 10.21 26.17 -6.89 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS C 388 LYS~? 20.15 C2 EDO C 602 B 74 LYS C 390 LYS~? 21.48 O2 EDO B 603 B 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 13.51 0.92 76.10 12.98 6.13 74.68 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 19.89 -0.55 76.51 17.10 4.32 77.43 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 21.39 11.56 68.52 20.24 13.13 67.73 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS C 388 LYS~? 20.15 C2 EDO C 602 B 74 LYS C 391 LYS~? 16.77 O1 EDO B 603 B 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 13.51 0.92 76.10 12.98 6.13 74.68 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 19.89 -0.55 76.51 17.10 4.32 77.43 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 21.39 11.56 68.52 20.24 13.13 67.73 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS C 390 LYS~? 21.48 O2 EDO B 603 B 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 B 165 GLU B 363 GLU~? 7.89 O1 EDO B 603 coo 13.51 0.92 76.10 12.98 6.13 74.68 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 19.89 -0.55 76.51 17.10 4.32 77.43 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 21.39 11.56 68.52 20.24 13.13 67.73 8.83 27.73 -6.37 10.21 26.17 -6.89 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 B 14 LYS C 390 LYS~? 21.48 O2 EDO B 603 B 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 B 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 13.51 0.92 76.10 12.98 6.13 74.68 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 19.89 -0.55 76.51 17.10 4.32 77.43 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 21.39 11.56 68.52 20.24 13.13 67.73 21.74 20.63 -27.21 21.00 22.48 -27.90 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 B 14 LYS C 391 LYS~? 16.77 O1 EDO B 603 B 74 LYS C 388 LYS~? 20.15 C2 EDO C 602 B 165 GLU C 436 GLU^? 10.62 C2 EDO C 602 coo 13.51 0.92 76.10 12.98 6.13 74.68 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 19.89 -0.55 76.51 17.10 4.32 77.43 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 21.39 11.56 68.52 20.24 13.13 67.73 21.74 20.63 -27.21 21.00 22.48 -27.90 1ylu_c01 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 10 hits 1ylu_c01 naa= 3 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 350 ASP.? 26.92 O2 GOL D 601 A 371 LYS A 348 LYS.? 29.38 O1 EDO B 603 A 374 ASN A 347 ASN^? 27.63 C1 EDO B 603 coo -5.17 31.09 15.73 -7.07 31.12 16.73 33.51 7.96 1.59 32.78 7.85 -0.37 coo -4.43 30.92 22.89 -6.61 31.91 19.71 33.03 14.06 -0.37 37.33 16.69 -0.99 coo -4.84 27.04 20.49 -6.40 27.76 19.26 32.85 15.10 3.85 34.45 13.77 4.43 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP B 350 ASP.? 23.89 C2 EDO B 603 A 371 LYS B 348 LYS.? 28.30 C2 EDO B 603 A 374 ASN B 347 ASN^? 23.37 C2 EDO B 603 coo -5.17 31.09 15.73 -7.07 31.12 16.73 12.16 40.72 19.41 11.14 39.74 20.98 coo -4.43 30.92 22.89 -6.61 31.91 19.71 16.25 36.62 22.07 20.01 34.44 26.08 coo -4.84 27.04 20.49 -6.40 27.76 19.26 18.47 36.73 18.25 18.44 38.86 18.15 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 3 3 # 3 A 369 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 371 LYS C 348 LYS.? 28.33 O1 GOL D 601 A 374 ASN C 347 ASN^? 23.48 C1 EDO C 602 coo -5.17 31.09 15.73 -7.07 31.12 16.73 27.03 30.18 -18.47 26.26 29.33 -16.72 coo -4.43 30.92 22.89 -6.61 31.91 19.71 31.02 25.73 -16.52 36.61 24.80 -13.64 coo -4.84 27.04 20.49 -6.40 27.76 19.26 32.68 25.81 -20.60 32.92 27.92 -20.57 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 4 3 # 4 A 369 ASP D 350 ASP.? 24.09 C3 GOL D 601 A 371 LYS D 348 LYS.? 27.59 O1 EDO C 602 A 374 ASN D 347 ASN^? 23.69 C3 GOL D 601 coo -5.17 31.09 15.73 -7.07 31.12 16.73 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo -4.43 30.92 22.89 -6.61 31.91 19.71 43.15 3.71 -41.93 47.18 7.62 -43.42 coo -4.84 27.04 20.49 -6.40 27.76 19.26 43.61 4.31 -37.61 45.14 2.83 -37.46 1zrz_c03 source 1zrz PROTEIN KINASE C, IOTA : 4 hits 1zrz_c03 naa= 3 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS D 381 HIS.? 16.49 O3 GOL D 601 B 50 GLU D 436 GLU^? 11.06 C3 GOL D 601 B 113 GLN D 372 GLN~? 15.37 O3 GOL D 601 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 36.03 -8.97 -35.15 35.55 -7.12 -34.29 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 40.13 -6.96 -28.62 37.98 -6.85 -28.89 2ag0_c04 source 2ag0 BENZALDEHYDE LYASE : 1 hits 2ag0_c04 naa= 3 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS D 381 HIS.? 16.49 O3 GOL D 601 B 50 GLU D 436 GLU^? 11.06 C3 GOL D 601 B 113 GLN D 372 GLN~? 15.37 O3 GOL D 601 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 36.03 -8.97 -35.15 35.55 -7.12 -34.29 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 40.13 -6.96 -28.62 37.98 -6.85 -28.89 2ag0_c08 source 2ag0 BENZALDEHYDE LYASE : 1 hits 2ag0_c08 naa= 3 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 1 3 # 1 A 29 HIS D 381 HIS.? 16.49 O3 GOL D 601 A 50 GLU D 436 GLU^? 11.06 C3 GOL D 601 A 113 GLN D 372 GLN~? 15.37 O3 GOL D 601 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 36.03 -8.97 -35.15 35.55 -7.12 -34.29 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 40.13 -6.96 -28.62 37.98 -6.85 -28.89 2ag0_c09 source 2ag0 BENZALDEHYDE LYASE : 1 hits 2ag0_c09 naa= 3 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 1 3 # 1 C 29 HIS D 381 HIS.? 16.49 O3 GOL D 601 C 50 GLU D 436 GLU^? 11.06 C3 GOL D 601 C 113 GLN D 372 GLN~? 15.37 O3 GOL D 601 coo 74.92 8.52 28.42 74.88 6.86 29.70 36.03 -8.97 -35.15 35.55 -7.12 -34.29 coo 65.25 15.95 28.73 65.73 15.63 30.78 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 70.80 6.73 32.72 71.88 8.55 32.53 40.13 -6.96 -28.62 37.98 -6.85 -28.89 2ag0_c10 source 2ag0 BENZALDEHYDE LYASE : 1 hits 2ag0_c10 naa= 3 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 1 3 # 1 D 29 HIS D 381 HIS.? 16.49 O3 GOL D 601 D 50 GLU D 436 GLU^? 11.06 C3 GOL D 601 D 113 GLN D 372 GLN~? 15.37 O3 GOL D 601 coo 38.66 11.31 27.15 38.67 12.13 25.22 36.03 -8.97 -35.15 35.55 -7.12 -34.29 coo 48.72 12.85 33.83 48.36 14.77 32.95 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 42.85 14.77 24.15 41.85 15.11 26.02 40.13 -6.96 -28.62 37.98 -6.85 -28.89 2ag0_c11 source 2ag0 BENZALDEHYDE LYASE : 1 hits 2ag0_c11 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 357 ASP.? 25.14 C1 EDO B 603 231 ASP B 315 ASP.? 32.42 C1 EDO B 603 294 ASP B 426 ASP.? 28.68 C1 EDO B 603 coo 27.89 102.52 14.98 29.35 101.92 13.57 22.54 16.74 19.72 22.05 16.00 21.61 coo 14.74 93.05 -1.00 14.30 94.22 0.73 37.58 31.51 9.95 39.21 32.46 10.92 coo 33.16 106.80 7.72 33.34 104.87 6.92 21.11 26.70 26.04 20.61 27.63 27.90 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 357 ASP.? 25.14 C1 EDO B 603 231 ASP B 357 ASP.? 13.04 C1 EDO B 603 294 ASP B 426 ASP.? 28.68 C1 EDO B 603 coo 27.89 102.52 14.98 29.35 101.92 13.57 22.54 16.74 19.72 22.05 16.00 21.61 coo 14.74 93.05 -1.00 14.30 94.22 0.73 19.95 30.44 0.55 20.02 30.85 -1.53 coo 33.16 106.80 7.72 33.34 104.87 6.92 21.11 26.70 26.04 20.61 27.63 27.90 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP A 426 ASP.? 22.31 O1 EDO B 603 231 ASP C 387 ASP~? 19.92 O2 EDO B 603 294 ASP C 430 ASP.? 26.01 O2 GOL D 601 coo 27.89 102.52 14.98 29.35 101.92 13.57 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 14.74 93.05 -1.00 14.30 94.22 0.73 12.27 32.40 -18.16 12.25 34.11 -16.91 coo 33.16 106.80 7.72 33.34 104.87 6.92 33.23 18.77 -9.92 33.78 18.54 -7.88 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP B 357 ASP.? 13.04 C1 EDO B 603 231 ASP A 315 ASP.? 32.31 C1 EDO B 603 294 ASP A 426 ASP.? 22.31 O1 EDO B 603 coo 27.89 102.52 14.98 29.35 101.92 13.57 19.95 30.44 0.55 20.02 30.85 -1.53 coo 14.74 93.05 -1.00 14.30 94.22 0.73 35.16 33.09 19.50 33.98 34.83 19.67 coo 33.16 106.80 7.72 33.34 104.87 6.92 29.17 24.78 -3.72 30.40 24.16 -5.34 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP B 357 ASP.? 13.04 C1 EDO B 603 231 ASP A 357 ASP.? 25.14 C1 EDO B 603 294 ASP A 426 ASP.? 22.31 O1 EDO B 603 coo 27.89 102.52 14.98 29.35 101.92 13.57 19.95 30.44 0.55 20.02 30.85 -1.53 coo 14.74 93.05 -1.00 14.30 94.22 0.73 22.54 16.74 19.72 22.05 16.00 21.61 coo 33.16 106.80 7.72 33.34 104.87 6.92 29.17 24.78 -3.72 30.40 24.16 -5.34 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP B 426 ASP.? 28.68 C1 EDO B 603 231 ASP B 315 ASP.? 32.42 C1 EDO B 603 294 ASP A 357 ASP.? 25.14 C1 EDO B 603 coo 27.89 102.52 14.98 29.35 101.92 13.57 21.11 26.70 26.04 20.61 27.63 27.90 coo 14.74 93.05 -1.00 14.30 94.22 0.73 37.58 31.51 9.95 39.21 32.46 10.92 coo 33.16 106.80 7.72 33.34 104.87 6.92 22.54 16.74 19.72 22.05 16.00 21.61 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP C 315 ASP.? 32.88 C1 EDO C 602 231 ASP C 357 ASP.? 12.50 O2 EDO C 602 294 ASP D 315 ASP.? 31.69 C1 GOL D 601 coo 27.89 102.52 14.98 29.35 101.92 13.57 51.14 17.66 -30.05 53.19 17.33 -29.52 coo 14.74 93.05 -1.00 14.30 94.22 0.73 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 33.16 106.80 7.72 33.34 104.87 6.92 48.83 21.16 -21.57 48.15 21.79 -19.66 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP C 357 ASP.? 12.50 O2 EDO C 602 231 ASP D 315 ASP.? 31.69 C1 GOL D 601 294 ASP D 426 ASP.? 21.84 O1 EDO C 602 coo 27.89 102.52 14.98 29.35 101.92 13.57 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 14.74 93.05 -1.00 14.30 94.22 0.73 48.83 21.16 -21.57 48.15 21.79 -19.66 coo 33.16 106.80 7.72 33.34 104.87 6.92 40.54 14.64 -43.98 41.47 13.99 -45.77 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 3 # 9 193 ASP C 357 ASP.? 12.50 O2 EDO C 602 231 ASP D 357 ASP.? 12.64 O3 GOL D 601 294 ASP D 426 ASP.? 21.84 O1 EDO C 602 coo 27.89 102.52 14.98 29.35 101.92 13.57 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 14.74 93.05 -1.00 14.30 94.22 0.73 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 33.16 106.80 7.72 33.34 104.87 6.92 40.54 14.64 -43.98 41.47 13.99 -45.77 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 3 # 10 193 ASP C 426 ASP.? 22.72 C2 GOL D 601 231 ASP A 387 ASP~? 25.21 O2 GOL D 601 294 ASP A 430 ASP.? 25.41 O1 EDO B 603 coo 27.89 102.52 14.98 29.35 101.92 13.57 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 14.74 93.05 -1.00 14.30 94.22 0.73 25.11 -3.56 -1.18 26.67 -4.92 -0.75 coo 33.16 106.80 7.72 33.34 104.87 6.92 31.59 21.51 -7.17 32.38 22.31 -9.00 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 11 3 # 11 193 ASP D 315 ASP.? 31.69 C1 GOL D 601 231 ASP D 357 ASP.? 12.64 O3 GOL D 601 294 ASP C 315 ASP.? 32.88 C1 EDO C 602 coo 27.89 102.52 14.98 29.35 101.92 13.57 48.83 21.16 -21.57 48.15 21.79 -19.66 coo 14.74 93.05 -1.00 14.30 94.22 0.73 34.52 5.19 -20.65 34.58 3.94 -18.98 coo 33.16 106.80 7.72 33.34 104.87 6.92 51.14 17.66 -30.05 53.19 17.33 -29.52 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 12 3 # 12 193 ASP D 426 ASP.? 21.84 O1 EDO C 602 231 ASP D 315 ASP.? 31.69 C1 GOL D 601 294 ASP C 357 ASP.? 12.50 O2 EDO C 602 coo 27.89 102.52 14.98 29.35 101.92 13.57 40.54 14.64 -43.98 41.47 13.99 -45.77 coo 14.74 93.05 -1.00 14.30 94.22 0.73 48.83 21.16 -21.57 48.15 21.79 -19.66 coo 33.16 106.80 7.72 33.34 104.87 6.92 32.02 20.63 -38.57 31.77 21.72 -40.39 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 12 hits 2amg_c06 naa= 3 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 1 3 # 1 65 THR C 369 THR~? 15.84 O2 EDO C 602 242 CYH C 380 CYH~? 18.52 O2 EDO C 602 270 PHE C 352 PHE^? 15.48 O2 EDO C 602 coo 12.97 28.35 3.84 11.81 28.07 2.09 27.27 30.44 -36.03 26.03 32.19 -36.25 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 22.88 33.08 -27.72 25.47 32.05 -27.37 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 27.97 28.62 -27.76 27.73 27.28 -30.22 2cnd_c01 source 2cnd NADH-DEPENDENT NITRATE REDUCTASE (CYTOCHROME B: 1 hits 2cnd_c01 naa= 3 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 1 3 # 1 A 197 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 233 GLU B 330 GLU~? 24.65 C1 EDO B 603 A 300 ASN B 333 ASN~? 17.11 C1 EDO B 603 coo 12.51 17.07 49.46 12.44 16.89 47.35 29.17 24.78 -3.72 30.40 24.16 -5.34 coo 6.52 19.14 48.16 7.77 18.42 46.61 31.94 25.81 2.71 33.76 25.37 1.74 coo 9.30 22.40 41.76 10.10 20.96 40.36 26.50 27.72 5.31 25.42 29.17 4.18 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 2 3 # 2 A 197 ASP B 426 ASP.? 28.68 C1 EDO B 603 A 233 GLU A 330 GLU~? 26.93 C1 EDO B 603 A 300 ASN A 333 ASN~? 23.15 C1 EDO B 603 coo 12.51 17.07 49.46 12.44 16.89 47.35 21.11 26.70 26.04 20.61 27.63 27.90 coo 6.52 19.14 48.16 7.77 18.42 46.61 25.78 29.04 20.96 25.48 30.78 22.26 coo 9.30 22.40 41.76 10.10 20.96 40.36 25.58 24.27 17.00 25.61 22.33 17.91 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 3 3 # 3 A 197 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 233 GLU D 330 GLU~? 24.51 C2 GOL D 601 A 300 ASN D 333 ASN~? 17.27 C2 GOL D 601 coo 12.51 17.07 49.46 12.44 16.89 47.35 35.09 15.28 -13.55 34.97 16.40 -11.75 coo 6.52 19.14 48.16 7.77 18.42 46.61 39.35 17.44 -18.72 40.01 18.64 -17.10 coo 9.30 22.40 41.76 10.10 20.96 40.36 38.40 12.82 -22.80 38.46 10.80 -22.10 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 4 3 # 4 A 197 ASP D 426 ASP.? 21.84 O1 EDO C 602 A 233 GLU C 330 GLU~? 24.03 O1 EDO C 602 A 300 ASN C 333 ASN~? 16.90 C1 EDO C 602 coo 12.51 17.07 49.46 12.44 16.89 47.35 40.54 14.64 -43.98 41.47 13.99 -45.77 coo 6.52 19.14 48.16 7.77 18.42 46.61 43.59 14.91 -37.76 45.12 14.02 -38.99 coo 9.30 22.40 41.76 10.10 20.96 40.36 38.73 17.09 -34.48 37.68 18.68 -35.44 2cpu_c01 source 2cpu ALPHA-AMYLASE : 4 hits 2cpu_c01 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 342 GLU^? 20.93 C1 EDO B 603 A 156 GLU A 363 GLU~? 27.04 C1 EDO B 603 A 194 ASN A 337 ASN~? 21.47 C1 EDO B 603 coo 74.14 15.91 8.55 72.08 15.36 8.63 16.70 11.35 13.94 16.42 9.25 14.14 coo 67.47 20.07 1.34 65.99 20.06 2.88 14.23 7.65 22.80 13.44 9.34 23.77 coo 67.44 25.26 13.91 67.54 23.65 15.28 20.37 20.71 18.22 22.41 20.05 18.06 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU A 342 GLU^? 20.93 C1 EDO B 603 A 156 GLU A 363 GLU~? 27.04 C1 EDO B 603 A 194 ASN B 324 ASN.? 26.30 C1 EDO B 603 coo 74.14 15.91 8.55 72.08 15.36 8.63 16.70 11.35 13.94 16.42 9.25 14.14 coo 67.47 20.07 1.34 65.99 20.06 2.88 14.23 7.65 22.80 13.44 9.34 23.77 coo 67.44 25.26 13.91 67.54 23.65 15.28 26.83 13.52 17.81 25.43 13.66 19.36 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU A 342 GLU^? 20.93 C1 EDO B 603 A 156 GLU A 436 GLU^? 20.55 O1 EDO B 603 A 194 ASN B 324 ASN.? 26.30 C1 EDO B 603 coo 74.14 15.91 8.55 72.08 15.36 8.63 16.70 11.35 13.94 16.42 9.25 14.14 coo 67.47 20.07 1.34 65.99 20.06 2.88 19.93 9.98 5.88 20.55 8.03 6.42 coo 67.44 25.26 13.91 67.54 23.65 15.28 26.83 13.52 17.81 25.43 13.66 19.36 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU A 446 GLU~? 20.77 C2 EDO B 603 A 156 GLU A 450 GLU~? 18.15 C2 EDO B 603 A 194 ASN B 405 ASN^? 14.52 C2 EDO B 603 coo 74.14 15.91 8.55 72.08 15.36 8.63 -3.62 12.85 13.27 -2.92 11.09 12.27 coo 67.47 20.07 1.34 65.99 20.06 2.88 -8.36 20.71 9.57 -7.00 20.85 11.17 coo 67.44 25.26 13.91 67.54 23.65 15.28 1.99 23.48 14.63 3.63 22.52 15.58 ULMN 3 2dbt_c00 CHITINASE C user 5 3 # 5 A 147 GLU A 450 GLU~? 18.15 C2 EDO B 603 A 156 GLU A 446 GLU~? 20.77 C2 EDO B 603 A 194 ASN B 405 ASN^? 14.52 C2 EDO B 603 coo 74.14 15.91 8.55 72.08 15.36 8.63 -8.36 20.71 9.57 -7.00 20.85 11.17 coo 67.47 20.07 1.34 65.99 20.06 2.88 -3.62 12.85 13.27 -2.92 11.09 12.27 coo 67.44 25.26 13.91 67.54 23.65 15.28 1.99 23.48 14.63 3.63 22.52 15.58 ULMN 3 2dbt_c00 CHITINASE C user 6 3 # 6 A 147 GLU B 342 GLU^? -3.54 O2 EDO B 603s A 156 GLU B 363 GLU~? 7.89 O1 EDO B 603 A 194 ASN B 337 ASN~? 13.41 C1 EDO B 603 coo 74.14 15.91 8.55 72.08 15.36 8.63 10.25 28.44 3.00 8.52 29.59 2.44 coo 67.47 20.07 1.34 65.99 20.06 2.88 8.83 27.73 -6.37 10.21 26.17 -6.89 coo 67.44 25.26 13.91 67.54 23.65 15.28 21.54 26.32 1.73 21.98 28.23 2.58 ULMN 3 2dbt_c00 CHITINASE C user 7 3 # 7 A 147 GLU C 342 GLU^? -3.52 O2 EDO C 602s A 156 GLU C 363 GLU~? 7.78 O2 EDO C 602 A 194 ASN C 337 ASN~? 13.18 C1 EDO C 602 coo 74.14 15.91 8.55 72.08 15.36 8.63 22.61 19.18 -35.41 20.92 20.43 -35.77 coo 67.47 20.07 1.34 65.99 20.06 2.88 20.56 19.64 -44.58 21.56 17.87 -45.23 coo 67.44 25.26 13.91 67.54 23.65 15.28 33.28 16.29 -37.60 34.03 18.13 -36.82 ULMN 3 2dbt_c00 CHITINASE C user 8 3 # 8 A 147 GLU C 378 GLU~? 24.96 O2 EDO B 603 A 156 GLU C 394 GLU~? 16.86 O1 EDO B 603 A 194 ASN C 347 ASN^? 23.48 C1 EDO C 602 coo 74.14 15.91 8.55 72.08 15.36 8.63 22.14 33.77 -19.82 21.71 34.90 -18.09 coo 67.47 20.07 1.34 65.99 20.06 2.88 19.77 27.90 -12.93 18.57 29.44 -12.10 coo 67.44 25.26 13.91 67.54 23.65 15.28 32.68 25.81 -20.60 32.92 27.92 -20.57 ULMN 3 2dbt_c00 CHITINASE C user 9 3 # 9 A 147 GLU D 342 GLU^? -3.57 O3 GOL D 601s A 156 GLU D 363 GLU~? 7.90 O2 GOL D 601 A 194 ASN C 324 ASN.? 13.62 O3 GOL D 601 coo 74.14 15.91 8.55 72.08 15.36 8.63 28.06 0.59 -26.56 27.66 -1.50 -26.76 coo 67.47 20.07 1.34 65.99 20.06 2.88 24.65 -2.66 -18.42 24.14 -0.86 -17.43 coo 67.44 25.26 13.91 67.54 23.65 15.28 38.59 2.13 -22.95 37.27 2.55 -21.34 ULMN 3 2dbt_c00 CHITINASE C user 10 3 # 10 A 147 GLU D 342 GLU^? -3.57 O3 GOL D 601s A 156 GLU D 363 GLU~? 7.90 O2 GOL D 601 A 194 ASN D 337 ASN~? 13.43 C2 GOL D 601 coo 74.14 15.91 8.55 72.08 15.36 8.63 28.06 0.59 -26.56 27.66 -1.50 -26.76 coo 67.47 20.07 1.34 65.99 20.06 2.88 24.65 -2.66 -18.42 24.14 -0.86 -17.43 coo 67.44 25.26 13.91 67.54 23.65 15.28 33.20 9.44 -21.47 35.12 8.58 -21.91 2dbt_c00 source 2dbt CHITINASE C : 10 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 342 GLU^? 20.93 C1 EDO B 603 B 156 GLU A 363 GLU~? 27.04 C1 EDO B 603 B 194 ASN A 337 ASN~? 21.47 C1 EDO B 603 coo 45.64 63.11 17.20 47.48 62.43 16.45 16.70 11.35 13.94 16.42 9.25 14.14 coo 54.43 67.89 19.82 55.62 67.90 18.07 14.23 7.65 22.80 13.44 9.34 23.77 coo 49.79 70.75 7.78 50.10 68.90 6.86 20.37 20.71 18.22 22.41 20.05 18.06 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU A 342 GLU^? 20.93 C1 EDO B 603 B 156 GLU A 363 GLU~? 27.04 C1 EDO B 603 B 194 ASN B 324 ASN.? 26.30 C1 EDO B 603 coo 45.64 63.11 17.20 47.48 62.43 16.45 16.70 11.35 13.94 16.42 9.25 14.14 coo 54.43 67.89 19.82 55.62 67.90 18.07 14.23 7.65 22.80 13.44 9.34 23.77 coo 49.79 70.75 7.78 50.10 68.90 6.86 26.83 13.52 17.81 25.43 13.66 19.36 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU A 342 GLU^? 20.93 C1 EDO B 603 B 156 GLU A 436 GLU^? 20.55 O1 EDO B 603 B 194 ASN B 324 ASN.? 26.30 C1 EDO B 603 coo 45.64 63.11 17.20 47.48 62.43 16.45 16.70 11.35 13.94 16.42 9.25 14.14 coo 54.43 67.89 19.82 55.62 67.90 18.07 19.93 9.98 5.88 20.55 8.03 6.42 coo 49.79 70.75 7.78 50.10 68.90 6.86 26.83 13.52 17.81 25.43 13.66 19.36 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU A 446 GLU~? 20.77 C2 EDO B 603 B 156 GLU A 450 GLU~? 18.15 C2 EDO B 603 B 194 ASN B 405 ASN^? 14.52 C2 EDO B 603 coo 45.64 63.11 17.20 47.48 62.43 16.45 -3.62 12.85 13.27 -2.92 11.09 12.27 coo 54.43 67.89 19.82 55.62 67.90 18.07 -8.36 20.71 9.57 -7.00 20.85 11.17 coo 49.79 70.75 7.78 50.10 68.90 6.86 1.99 23.48 14.63 3.63 22.52 15.58 ULMN 3 2dbt_c01 CHITINASE C user 5 3 # 5 B 147 GLU A 450 GLU~? 18.15 C2 EDO B 603 B 156 GLU A 446 GLU~? 20.77 C2 EDO B 603 B 194 ASN B 405 ASN^? 14.52 C2 EDO B 603 coo 45.64 63.11 17.20 47.48 62.43 16.45 -8.36 20.71 9.57 -7.00 20.85 11.17 coo 54.43 67.89 19.82 55.62 67.90 18.07 -3.62 12.85 13.27 -2.92 11.09 12.27 coo 49.79 70.75 7.78 50.10 68.90 6.86 1.99 23.48 14.63 3.63 22.52 15.58 ULMN 3 2dbt_c01 CHITINASE C user 6 3 # 6 B 147 GLU B 342 GLU^? -3.54 O2 EDO B 603s B 156 GLU B 363 GLU~? 7.89 O1 EDO B 603 B 194 ASN B 337 ASN~? 13.41 C1 EDO B 603 coo 45.64 63.11 17.20 47.48 62.43 16.45 10.25 28.44 3.00 8.52 29.59 2.44 coo 54.43 67.89 19.82 55.62 67.90 18.07 8.83 27.73 -6.37 10.21 26.17 -6.89 coo 49.79 70.75 7.78 50.10 68.90 6.86 21.54 26.32 1.73 21.98 28.23 2.58 ULMN 3 2dbt_c01 CHITINASE C user 7 3 # 7 B 147 GLU B 342 GLU^? -3.54 O2 EDO B 603s B 156 GLU B 436 GLU^? 10.42 C2 EDO B 603 B 194 ASN A 324 ASN.? 13.71 O2 EDO B 603 coo 45.64 63.11 17.20 47.48 62.43 16.45 10.25 28.44 3.00 8.52 29.59 2.44 coo 54.43 67.89 19.82 55.62 67.90 18.07 8.55 30.19 11.17 7.66 31.90 10.29 coo 49.79 70.75 7.78 50.10 68.90 6.86 19.23 35.37 3.15 19.16 34.35 1.29 ULMN 3 2dbt_c01 CHITINASE C user 8 3 # 8 B 147 GLU B 436 GLU^? 10.42 C2 EDO B 603 B 156 GLU B 342 GLU^? -3.54 O2 EDO B 603s B 194 ASN A 324 ASN.? 13.71 O2 EDO B 603 coo 45.64 63.11 17.20 47.48 62.43 16.45 8.55 30.19 11.17 7.66 31.90 10.29 coo 54.43 67.89 19.82 55.62 67.90 18.07 10.25 28.44 3.00 8.52 29.59 2.44 coo 49.79 70.75 7.78 50.10 68.90 6.86 19.23 35.37 3.15 19.16 34.35 1.29 ULMN 3 2dbt_c01 CHITINASE C user 9 3 # 9 B 147 GLU C 342 GLU^? -3.52 O2 EDO C 602s B 156 GLU C 363 GLU~? 7.78 O2 EDO C 602 B 194 ASN C 337 ASN~? 13.18 C1 EDO C 602 coo 45.64 63.11 17.20 47.48 62.43 16.45 22.61 19.18 -35.41 20.92 20.43 -35.77 coo 54.43 67.89 19.82 55.62 67.90 18.07 20.56 19.64 -44.58 21.56 17.87 -45.23 coo 49.79 70.75 7.78 50.10 68.90 6.86 33.28 16.29 -37.60 34.03 18.13 -36.82 ULMN 3 2dbt_c01 CHITINASE C user 10 3 # 10 B 147 GLU C 342 GLU^? -3.52 O2 EDO C 602s B 156 GLU C 436 GLU^? 10.62 C2 EDO C 602 B 194 ASN D 324 ASN.? 13.50 O2 EDO C 602 coo 45.64 63.11 17.20 47.48 62.43 16.45 22.61 19.18 -35.41 20.92 20.43 -35.77 coo 54.43 67.89 19.82 55.62 67.90 18.07 21.74 20.63 -27.21 21.00 22.48 -27.90 coo 49.79 70.75 7.78 50.10 68.90 6.86 32.08 25.49 -35.40 31.73 24.73 -37.32 ULMN 3 2dbt_c01 CHITINASE C user 11 3 # 11 B 147 GLU C 378 GLU~? 24.96 O2 EDO B 603 B 156 GLU C 394 GLU~? 16.86 O1 EDO B 603 B 194 ASN C 347 ASN^? 23.48 C1 EDO C 602 coo 45.64 63.11 17.20 47.48 62.43 16.45 22.14 33.77 -19.82 21.71 34.90 -18.09 coo 54.43 67.89 19.82 55.62 67.90 18.07 19.77 27.90 -12.93 18.57 29.44 -12.10 coo 49.79 70.75 7.78 50.10 68.90 6.86 32.68 25.81 -20.60 32.92 27.92 -20.57 ULMN 3 2dbt_c01 CHITINASE C user 12 3 # 12 B 147 GLU C 436 GLU^? 10.62 C2 EDO C 602 B 156 GLU C 342 GLU^? -3.52 O2 EDO C 602s B 194 ASN D 324 ASN.? 13.50 O2 EDO C 602 coo 45.64 63.11 17.20 47.48 62.43 16.45 21.74 20.63 -27.21 21.00 22.48 -27.90 coo 54.43 67.89 19.82 55.62 67.90 18.07 22.61 19.18 -35.41 20.92 20.43 -35.77 coo 49.79 70.75 7.78 50.10 68.90 6.86 32.08 25.49 -35.40 31.73 24.73 -37.32 ULMN 3 2dbt_c01 CHITINASE C user 13 3 # 13 B 147 GLU D 342 GLU^? -3.57 O3 GOL D 601s B 156 GLU D 363 GLU~? 7.90 O2 GOL D 601 B 194 ASN D 337 ASN~? 13.43 C2 GOL D 601 coo 45.64 63.11 17.20 47.48 62.43 16.45 28.06 0.59 -26.56 27.66 -1.50 -26.76 coo 54.43 67.89 19.82 55.62 67.90 18.07 24.65 -2.66 -18.42 24.14 -0.86 -17.43 coo 49.79 70.75 7.78 50.10 68.90 6.86 33.20 9.44 -21.47 35.12 8.58 -21.91 ULMN 3 2dbt_c01 CHITINASE C user 14 3 # 14 B 147 GLU D 342 GLU^? -3.57 O3 GOL D 601s B 156 GLU D 436 GLU^? 11.06 C3 GOL D 601 B 194 ASN C 324 ASN.? 13.62 O3 GOL D 601 coo 45.64 63.11 17.20 47.48 62.43 16.45 28.06 0.59 -26.56 27.66 -1.50 -26.76 coo 54.43 67.89 19.82 55.62 67.90 18.07 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 49.79 70.75 7.78 50.10 68.90 6.86 38.59 2.13 -22.95 37.27 2.55 -21.34 ULMN 3 2dbt_c01 CHITINASE C user 15 3 # 15 B 147 GLU D 436 GLU^? 11.06 C3 GOL D 601 B 156 GLU D 342 GLU^? -3.57 O3 GOL D 601s B 194 ASN C 324 ASN.? 13.62 O3 GOL D 601 coo 45.64 63.11 17.20 47.48 62.43 16.45 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 54.43 67.89 19.82 55.62 67.90 18.07 28.06 0.59 -26.56 27.66 -1.50 -26.76 coo 49.79 70.75 7.78 50.10 68.90 6.86 38.59 2.13 -22.95 37.27 2.55 -21.34 2dbt_c01 source 2dbt CHITINASE C : 15 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 342 GLU^? 20.93 C1 EDO B 603 C 156 GLU A 363 GLU~? 27.04 C1 EDO B 603 C 194 ASN A 337 ASN~? 21.47 C1 EDO B 603 coo 41.23 29.31 13.28 43.03 29.85 12.29 16.70 11.35 13.94 16.42 9.25 14.14 coo 44.75 23.09 5.51 46.77 22.91 6.12 14.23 7.65 22.80 13.44 9.34 23.77 coo 49.75 21.00 18.12 50.45 23.02 18.26 20.37 20.71 18.22 22.41 20.05 18.06 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU A 342 GLU^? 20.93 C1 EDO B 603 C 156 GLU A 363 GLU~? 27.04 C1 EDO B 603 C 194 ASN B 324 ASN.? 26.30 C1 EDO B 603 coo 41.23 29.31 13.28 43.03 29.85 12.29 16.70 11.35 13.94 16.42 9.25 14.14 coo 44.75 23.09 5.51 46.77 22.91 6.12 14.23 7.65 22.80 13.44 9.34 23.77 coo 49.75 21.00 18.12 50.45 23.02 18.26 26.83 13.52 17.81 25.43 13.66 19.36 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU A 342 GLU^? 20.93 C1 EDO B 603 C 156 GLU A 436 GLU^? 20.55 O1 EDO B 603 C 194 ASN B 324 ASN.? 26.30 C1 EDO B 603 coo 41.23 29.31 13.28 43.03 29.85 12.29 16.70 11.35 13.94 16.42 9.25 14.14 coo 44.75 23.09 5.51 46.77 22.91 6.12 19.93 9.98 5.88 20.55 8.03 6.42 coo 49.75 21.00 18.12 50.45 23.02 18.26 26.83 13.52 17.81 25.43 13.66 19.36 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU A 446 GLU~? 20.77 C2 EDO B 603 C 156 GLU A 450 GLU~? 18.15 C2 EDO B 603 C 194 ASN B 405 ASN^? 14.52 C2 EDO B 603 coo 41.23 29.31 13.28 43.03 29.85 12.29 -3.62 12.85 13.27 -2.92 11.09 12.27 coo 44.75 23.09 5.51 46.77 22.91 6.12 -8.36 20.71 9.57 -7.00 20.85 11.17 coo 49.75 21.00 18.12 50.45 23.02 18.26 1.99 23.48 14.63 3.63 22.52 15.58 ULMN 3 2dbt_c02 CHITINASE C user 5 3 # 5 C 147 GLU A 450 GLU~? 18.15 C2 EDO B 603 C 156 GLU A 446 GLU~? 20.77 C2 EDO B 603 C 194 ASN B 405 ASN^? 14.52 C2 EDO B 603 coo 41.23 29.31 13.28 43.03 29.85 12.29 -8.36 20.71 9.57 -7.00 20.85 11.17 coo 44.75 23.09 5.51 46.77 22.91 6.12 -3.62 12.85 13.27 -2.92 11.09 12.27 coo 49.75 21.00 18.12 50.45 23.02 18.26 1.99 23.48 14.63 3.63 22.52 15.58 ULMN 3 2dbt_c02 CHITINASE C user 6 3 # 6 C 147 GLU B 342 GLU^? -3.54 O2 EDO B 603s C 156 GLU B 363 GLU~? 7.89 O1 EDO B 603 C 194 ASN B 337 ASN~? 13.41 C1 EDO B 603 coo 41.23 29.31 13.28 43.03 29.85 12.29 10.25 28.44 3.00 8.52 29.59 2.44 coo 44.75 23.09 5.51 46.77 22.91 6.12 8.83 27.73 -6.37 10.21 26.17 -6.89 coo 49.75 21.00 18.12 50.45 23.02 18.26 21.54 26.32 1.73 21.98 28.23 2.58 ULMN 3 2dbt_c02 CHITINASE C user 7 3 # 7 C 147 GLU C 342 GLU^? -3.52 O2 EDO C 602s C 156 GLU C 363 GLU~? 7.78 O2 EDO C 602 C 194 ASN C 337 ASN~? 13.18 C1 EDO C 602 coo 41.23 29.31 13.28 43.03 29.85 12.29 22.61 19.18 -35.41 20.92 20.43 -35.77 coo 44.75 23.09 5.51 46.77 22.91 6.12 20.56 19.64 -44.58 21.56 17.87 -45.23 coo 49.75 21.00 18.12 50.45 23.02 18.26 33.28 16.29 -37.60 34.03 18.13 -36.82 ULMN 3 2dbt_c02 CHITINASE C user 8 3 # 8 C 147 GLU C 378 GLU~? 24.96 O2 EDO B 603 C 156 GLU C 394 GLU~? 16.86 O1 EDO B 603 C 194 ASN C 347 ASN^? 23.48 C1 EDO C 602 coo 41.23 29.31 13.28 43.03 29.85 12.29 22.14 33.77 -19.82 21.71 34.90 -18.09 coo 44.75 23.09 5.51 46.77 22.91 6.12 19.77 27.90 -12.93 18.57 29.44 -12.10 coo 49.75 21.00 18.12 50.45 23.02 18.26 32.68 25.81 -20.60 32.92 27.92 -20.57 ULMN 3 2dbt_c02 CHITINASE C user 9 3 # 9 C 147 GLU D 342 GLU^? -3.57 O3 GOL D 601s C 156 GLU D 363 GLU~? 7.90 O2 GOL D 601 C 194 ASN C 324 ASN.? 13.62 O3 GOL D 601 coo 41.23 29.31 13.28 43.03 29.85 12.29 28.06 0.59 -26.56 27.66 -1.50 -26.76 coo 44.75 23.09 5.51 46.77 22.91 6.12 24.65 -2.66 -18.42 24.14 -0.86 -17.43 coo 49.75 21.00 18.12 50.45 23.02 18.26 38.59 2.13 -22.95 37.27 2.55 -21.34 ULMN 3 2dbt_c02 CHITINASE C user 10 3 # 10 C 147 GLU D 342 GLU^? -3.57 O3 GOL D 601s C 156 GLU D 363 GLU~? 7.90 O2 GOL D 601 C 194 ASN D 337 ASN~? 13.43 C2 GOL D 601 coo 41.23 29.31 13.28 43.03 29.85 12.29 28.06 0.59 -26.56 27.66 -1.50 -26.76 coo 44.75 23.09 5.51 46.77 22.91 6.12 24.65 -2.66 -18.42 24.14 -0.86 -17.43 coo 49.75 21.00 18.12 50.45 23.02 18.26 33.20 9.44 -21.47 35.12 8.58 -21.91 ULMN 3 2dbt_c02 CHITINASE C user 11 3 # 11 C 147 GLU D 342 GLU^? -3.57 O3 GOL D 601s C 156 GLU D 436 GLU^? 11.06 C3 GOL D 601 C 194 ASN C 324 ASN.? 13.62 O3 GOL D 601 coo 41.23 29.31 13.28 43.03 29.85 12.29 28.06 0.59 -26.56 27.66 -1.50 -26.76 coo 44.75 23.09 5.51 46.77 22.91 6.12 30.72 -0.04 -34.79 31.42 -2.01 -34.30 coo 49.75 21.00 18.12 50.45 23.02 18.26 38.59 2.13 -22.95 37.27 2.55 -21.34 2dbt_c02 source 2dbt CHITINASE C : 11 hits 2dbt_c02 naa= 3 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 1 3 # 1 A 182 LYS A 388 LYS~? 27.25 O2 GOL D 601 A 184 LYS A 391 LYS~? 19.54 O2 GOL D 601 A 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo 5.98 42.76 7.73 10.19 38.62 9.02 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 2.77 37.17 4.99 6.33 34.76 8.06 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 0.07 40.30 18.65 -0.21 42.34 18.18 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 2 3 # 2 A 182 LYS A 391 LYS~? 19.54 O2 GOL D 601 A 184 LYS A 388 LYS~? 27.25 O2 GOL D 601 A 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo 5.98 42.76 7.73 10.19 38.62 9.02 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 2.77 37.17 4.99 6.33 34.76 8.06 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 0.07 40.30 18.65 -0.21 42.34 18.18 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 3 3 # 3 A 182 LYS B 391 LYS~? 27.06 C2 EDO B 603 A 184 LYS B 388 LYS~? 19.48 C2 EDO B 603 A 345 ASP B 350 ASP.? 23.89 C2 EDO B 603 coo 5.98 42.76 7.73 10.19 38.62 9.02 1.34 36.06 21.83 0.02 35.49 25.91 coo 2.77 37.17 4.99 6.33 34.76 8.06 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 0.07 40.30 18.65 -0.21 42.34 18.18 12.16 40.72 19.41 11.14 39.74 20.98 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 4 3 # 4 A 182 LYS C 391 LYS~? 16.77 O1 EDO B 603 A 184 LYS C 388 LYS~? 20.15 C2 EDO C 602 A 345 ASP C 350 ASP.? 24.48 C2 EDO C 602 coo 5.98 42.76 7.73 10.19 38.62 9.02 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 2.77 37.17 4.99 6.33 34.76 8.06 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 0.07 40.30 18.65 -0.21 42.34 18.18 27.03 30.18 -18.47 26.26 29.33 -16.72 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 5 3 # 5 A 182 LYS C 442 LYS~? 13.46 O1 EDO C 602 A 184 LYS C 415 LYS^? -2.71 O2 EDO C 602s A 345 ASP D 448 ASP.? 19.66 C2 EDO C 602 coo 5.98 42.76 7.73 10.19 38.62 9.02 12.96 9.36 -37.91 9.04 10.02 -41.38 coo 2.77 37.17 4.99 6.33 34.76 8.06 13.38 15.08 -39.34 19.41 17.19 -40.08 coo 0.07 40.30 18.65 -0.21 42.34 18.18 3.66 6.43 -31.01 2.94 8.46 -31.03 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 6 3 # 6 A 182 LYS D 388 LYS~? 23.05 O3 GOL D 601 A 184 LYS D 391 LYS~? 24.88 C3 GOL D 601 A 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 5.98 42.76 7.73 10.19 38.62 9.02 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 2.77 37.17 4.99 6.33 34.76 8.06 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo 0.07 40.30 18.65 -0.21 42.34 18.18 42.88 -2.45 -40.67 41.90 -2.09 -42.54 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 7 3 # 7 A 182 LYS D 391 LYS~? 24.88 C3 GOL D 601 A 184 LYS D 388 LYS~? 23.05 O3 GOL D 601 A 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 5.98 42.76 7.73 10.19 38.62 9.02 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo 2.77 37.17 4.99 6.33 34.76 8.06 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 0.07 40.30 18.65 -0.21 42.34 18.18 42.88 -2.45 -40.67 41.90 -2.09 -42.54 2dw7_c32 source 2dw7 BLL6730 PROTEIN : 7 hits 2dw7_c32 naa= 3 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 1 3 # 1 B 182 LYS A 388 LYS~? 27.25 O2 GOL D 601 B 184 LYS A 384 LYS~? 32.89 O2 GOL D 601 B 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo 38.76 2.27 4.00 34.00 5.99 4.37 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 40.63 7.13 9.06 35.85 7.36 8.95 23.52 -5.65 3.37 24.45 -7.36 6.79 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 2 3 # 2 B 182 LYS A 442 LYS~? 23.27 C1 EDO B 603 B 184 LYS A 415 LYS^? 20.91 C1 EDO B 603 B 345 ASP B 448 ASP.? 21.29 O1 EDO B 603 coo 38.76 2.27 4.00 34.00 5.99 4.37 2.76 10.16 11.03 0.96 5.43 12.32 coo 40.63 7.13 9.06 35.85 7.36 8.95 6.45 6.62 13.73 11.23 9.80 16.52 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -0.19 5.34 -1.92 0.46 4.35 -0.12 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 3 3 # 3 B 182 LYS B 388 LYS~? 19.48 C2 EDO B 603 B 184 LYS B 384 LYS~? 21.93 O2 EDO B 603 B 345 ASP B 350 ASP.? 23.89 C2 EDO B 603 coo 38.76 2.27 4.00 34.00 5.99 4.37 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 40.63 7.13 9.06 35.85 7.36 8.95 -3.14 43.46 11.59 -5.82 40.34 10.77 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 12.16 40.72 19.41 11.14 39.74 20.98 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 4 3 # 4 B 182 LYS C 388 LYS~? 20.15 C2 EDO C 602 B 184 LYS C 384 LYS~? 20.68 O2 EDO C 602 B 345 ASP C 350 ASP.? 24.48 C2 EDO C 602 coo 38.76 2.27 4.00 34.00 5.99 4.37 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 40.63 7.13 9.06 35.85 7.36 8.95 11.81 35.96 -24.38 11.26 34.03 -29.22 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 27.03 30.18 -18.47 26.26 29.33 -16.72 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 5 3 # 5 B 182 LYS C 442 LYS~? 13.46 O1 EDO C 602 B 184 LYS C 415 LYS^? -2.71 O2 EDO C 602s B 345 ASP D 448 ASP.? 19.66 C2 EDO C 602 coo 38.76 2.27 4.00 34.00 5.99 4.37 12.96 9.36 -37.91 9.04 10.02 -41.38 coo 40.63 7.13 9.06 35.85 7.36 8.95 13.38 15.08 -39.34 19.41 17.19 -40.08 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 3.66 6.43 -31.01 2.94 8.46 -31.03 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 6 3 # 6 B 182 LYS D 388 LYS~? 23.05 O3 GOL D 601 B 184 LYS D 384 LYS~? 21.94 O3 GOL D 601 B 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 38.76 2.27 4.00 34.00 5.99 4.37 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 40.63 7.13 9.06 35.85 7.36 8.95 32.39 -15.23 -40.24 32.53 -17.53 -36.22 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 42.88 -2.45 -40.67 41.90 -2.09 -42.54 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 7 3 # 7 B 182 LYS D 391 LYS~? 24.88 C3 GOL D 601 B 184 LYS D 388 LYS~? 23.05 O3 GOL D 601 B 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 38.76 2.27 4.00 34.00 5.99 4.37 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo 40.63 7.13 9.06 35.85 7.36 8.95 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 42.88 -2.45 -40.67 41.90 -2.09 -42.54 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 8 3 # 8 B 182 LYS D 442 LYS~? 12.65 O2 GOL D 601 B 184 LYS D 415 LYS^? -2.91 O3 GOL D 601s B 345 ASP C 448 ASP.? 19.32 O1 GOL D 601 coo 38.76 2.27 4.00 34.00 5.99 4.37 14.14 0.83 -27.84 11.41 -3.18 -25.91 coo 40.63 7.13 9.06 35.85 7.36 8.95 17.93 -3.17 -25.73 23.39 -0.99 -23.17 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 9.52 -2.93 -40.85 10.47 -4.20 -39.42 2dw7_c33 source 2dw7 BLL6730 PROTEIN : 8 hits 2dw7_c33 naa= 3 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 1 3 # 1 C 182 LYS A 391 LYS~? 19.54 O2 GOL D 601 C 184 LYS A 388 LYS~? 27.25 O2 GOL D 601 C 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo -5.66 12.40 71.13 -2.66 9.98 66.50 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 0.95 12.72 73.51 1.58 12.72 68.31 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo -4.59 24.28 66.67 -6.26 24.34 67.99 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 2 3 # 2 C 182 LYS A 442 LYS~? 23.27 C1 EDO B 603 C 184 LYS A 415 LYS^? 20.91 C1 EDO B 603 C 345 ASP A 448 ASP~? 19.70 O1 EDO B 603 coo -5.66 12.40 71.13 -2.66 9.98 66.50 2.76 10.16 11.03 0.96 5.43 12.32 coo 0.95 12.72 73.51 1.58 12.72 68.31 6.45 6.62 13.73 11.23 9.80 16.52 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -6.12 13.55 5.97 -7.03 12.86 4.20 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 3 3 # 3 C 182 LYS B 391 LYS~? 27.06 C2 EDO B 603 C 184 LYS B 388 LYS~? 19.48 C2 EDO B 603 C 345 ASP B 350 ASP.? 23.89 C2 EDO B 603 coo -5.66 12.40 71.13 -2.66 9.98 66.50 1.34 36.06 21.83 0.02 35.49 25.91 coo 0.95 12.72 73.51 1.58 12.72 68.31 -0.92 37.13 17.34 -4.46 33.66 14.61 coo -4.59 24.28 66.67 -6.26 24.34 67.99 12.16 40.72 19.41 11.14 39.74 20.98 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 4 3 # 4 C 182 LYS C 391 LYS~? 16.77 O1 EDO B 603 C 184 LYS C 388 LYS~? 20.15 C2 EDO C 602 C 345 ASP C 350 ASP.? 24.48 C2 EDO C 602 coo -5.66 12.40 71.13 -2.66 9.98 66.50 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 0.95 12.72 73.51 1.58 12.72 68.31 13.46 28.58 -20.25 9.42 25.73 -22.18 coo -4.59 24.28 66.67 -6.26 24.34 67.99 27.03 30.18 -18.47 26.26 29.33 -16.72 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 5 3 # 5 C 182 LYS C 442 LYS~? 13.46 O1 EDO C 602 C 184 LYS C 415 LYS^? -2.71 O2 EDO C 602s C 345 ASP D 448 ASP.? 19.66 C2 EDO C 602 coo -5.66 12.40 71.13 -2.66 9.98 66.50 12.96 9.36 -37.91 9.04 10.02 -41.38 coo 0.95 12.72 73.51 1.58 12.72 68.31 13.38 15.08 -39.34 19.41 17.19 -40.08 coo -4.59 24.28 66.67 -6.26 24.34 67.99 3.66 6.43 -31.01 2.94 8.46 -31.03 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 6 3 # 6 C 182 LYS D 391 LYS~? 24.88 C3 GOL D 601 C 184 LYS D 388 LYS~? 23.05 O3 GOL D 601 C 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo -5.66 12.40 71.13 -2.66 9.98 66.50 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo 0.95 12.72 73.51 1.58 12.72 68.31 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo -4.59 24.28 66.67 -6.26 24.34 67.99 42.88 -2.45 -40.67 41.90 -2.09 -42.54 2dw7_c34 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c34 naa= 3 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 1 3 # 1 D 182 LYS A 391 LYS~? 19.54 O2 GOL D 601 D 184 LYS A 388 LYS~? 27.25 O2 GOL D 601 D 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 2 3 # 2 D 182 LYS A 442 LYS~? 23.27 C1 EDO B 603 D 184 LYS A 415 LYS^? 20.91 C1 EDO B 603 D 345 ASP A 448 ASP~? 19.70 O1 EDO B 603 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 2.76 10.16 11.03 0.96 5.43 12.32 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 6.45 6.62 13.73 11.23 9.80 16.52 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -6.12 13.55 5.97 -7.03 12.86 4.20 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 3 3 # 3 D 182 LYS B 391 LYS~? 27.06 C2 EDO B 603 D 184 LYS B 388 LYS~? 19.48 C2 EDO B 603 D 345 ASP B 350 ASP.? 23.89 C2 EDO B 603 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 1.34 36.06 21.83 0.02 35.49 25.91 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 12.16 40.72 19.41 11.14 39.74 20.98 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 4 3 # 4 D 182 LYS C 391 LYS~? 16.77 O1 EDO B 603 D 184 LYS C 388 LYS~? 20.15 C2 EDO C 602 D 345 ASP C 350 ASP.? 24.48 C2 EDO C 602 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 27.03 30.18 -18.47 26.26 29.33 -16.72 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 5 3 # 5 D 182 LYS C 442 LYS~? 13.46 O1 EDO C 602 D 184 LYS C 415 LYS^? -2.71 O2 EDO C 602s D 345 ASP D 448 ASP.? 19.66 C2 EDO C 602 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 12.96 9.36 -37.91 9.04 10.02 -41.38 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 13.38 15.08 -39.34 19.41 17.19 -40.08 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 3.66 6.43 -31.01 2.94 8.46 -31.03 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 6 3 # 6 D 182 LYS D 391 LYS~? 24.88 C3 GOL D 601 D 184 LYS D 388 LYS~? 23.05 O3 GOL D 601 D 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 42.88 -2.45 -40.67 41.90 -2.09 -42.54 2dw7_c35 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c35 naa= 3 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 1 3 # 1 E 182 LYS A 391 LYS~? 19.54 O2 GOL D 601 E 184 LYS A 388 LYS~? 27.25 O2 GOL D 601 E 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo -21.16 62.58 121.86 -16.35 60.33 119.23 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo -23.22 55.98 120.74 -18.11 55.31 120.43 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo -17.15 59.71 133.33 -17.96 61.54 134.01 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 2 3 # 2 E 182 LYS A 442 LYS~? 23.27 C1 EDO B 603 E 184 LYS A 415 LYS^? 20.91 C1 EDO B 603 E 345 ASP A 448 ASP~? 19.70 O1 EDO B 603 coo -21.16 62.58 121.86 -16.35 60.33 119.23 2.76 10.16 11.03 0.96 5.43 12.32 coo -23.22 55.98 120.74 -18.11 55.31 120.43 6.45 6.62 13.73 11.23 9.80 16.52 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -6.12 13.55 5.97 -7.03 12.86 4.20 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 3 3 # 3 E 182 LYS B 391 LYS~? 27.06 C2 EDO B 603 E 184 LYS B 388 LYS~? 19.48 C2 EDO B 603 E 345 ASP B 350 ASP.? 23.89 C2 EDO B 603 coo -21.16 62.58 121.86 -16.35 60.33 119.23 1.34 36.06 21.83 0.02 35.49 25.91 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -0.92 37.13 17.34 -4.46 33.66 14.61 coo -17.15 59.71 133.33 -17.96 61.54 134.01 12.16 40.72 19.41 11.14 39.74 20.98 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 4 3 # 4 E 182 LYS C 391 LYS~? 16.77 O1 EDO B 603 E 184 LYS C 388 LYS~? 20.15 C2 EDO C 602 E 345 ASP C 350 ASP.? 24.48 C2 EDO C 602 coo -21.16 62.58 121.86 -16.35 60.33 119.23 15.56 26.67 -15.99 9.90 23.87 -16.19 coo -23.22 55.98 120.74 -18.11 55.31 120.43 13.46 28.58 -20.25 9.42 25.73 -22.18 coo -17.15 59.71 133.33 -17.96 61.54 134.01 27.03 30.18 -18.47 26.26 29.33 -16.72 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 5 3 # 5 E 182 LYS C 442 LYS~? 13.46 O1 EDO C 602 E 184 LYS C 415 LYS^? -2.71 O2 EDO C 602s E 345 ASP D 448 ASP.? 19.66 C2 EDO C 602 coo -21.16 62.58 121.86 -16.35 60.33 119.23 12.96 9.36 -37.91 9.04 10.02 -41.38 coo -23.22 55.98 120.74 -18.11 55.31 120.43 13.38 15.08 -39.34 19.41 17.19 -40.08 coo -17.15 59.71 133.33 -17.96 61.54 134.01 3.66 6.43 -31.01 2.94 8.46 -31.03 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 6 3 # 6 E 182 LYS D 391 LYS~? 24.88 C3 GOL D 601 E 184 LYS D 388 LYS~? 23.05 O3 GOL D 601 E 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo -21.16 62.58 121.86 -16.35 60.33 119.23 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo -23.22 55.98 120.74 -18.11 55.31 120.43 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo -17.15 59.71 133.33 -17.96 61.54 134.01 42.88 -2.45 -40.67 41.90 -2.09 -42.54 2dw7_c36 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c36 naa= 3 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 1 3 # 1 F 182 LYS A 388 LYS~? 27.25 O2 GOL D 601 F 184 LYS A 391 LYS~? 19.54 O2 GOL D 601 F 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo 10.64 34.02 91.30 6.30 35.60 95.11 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 13.75 39.76 94.12 11.42 37.23 97.89 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 16.35 26.90 99.56 16.81 25.90 97.75 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 2 3 # 2 F 182 LYS A 391 LYS~? 19.54 O2 GOL D 601 F 184 LYS A 388 LYS~? 27.25 O2 GOL D 601 F 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo 10.64 34.02 91.30 6.30 35.60 95.11 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 13.75 39.76 94.12 11.42 37.23 97.89 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 16.35 26.90 99.56 16.81 25.90 97.75 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 3 3 # 3 F 182 LYS B 391 LYS~? 27.06 C2 EDO B 603 F 184 LYS B 388 LYS~? 19.48 C2 EDO B 603 F 345 ASP B 350 ASP.? 23.89 C2 EDO B 603 coo 10.64 34.02 91.30 6.30 35.60 95.11 1.34 36.06 21.83 0.02 35.49 25.91 coo 13.75 39.76 94.12 11.42 37.23 97.89 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 16.35 26.90 99.56 16.81 25.90 97.75 12.16 40.72 19.41 11.14 39.74 20.98 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 4 3 # 4 F 182 LYS B 442 LYS~? 13.00 O1 EDO B 603 F 184 LYS B 415 LYS^? -2.82 O2 EDO B 603s F 345 ASP A 448 ASP~? 19.70 O1 EDO B 603 coo 10.64 34.02 91.30 6.30 35.60 95.11 1.48 17.85 0.41 -2.11 18.47 -3.79 coo 13.75 39.76 94.12 11.42 37.23 97.89 1.57 23.62 -1.31 7.49 26.02 -1.78 coo 16.35 26.90 99.56 16.81 25.90 97.75 -6.12 13.55 5.97 -7.03 12.86 4.20 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 5 3 # 5 F 182 LYS C 388 LYS~? 20.15 C2 EDO C 602 F 184 LYS C 391 LYS~? 16.77 O1 EDO B 603 F 345 ASP C 350 ASP.? 24.48 C2 EDO C 602 coo 10.64 34.02 91.30 6.30 35.60 95.11 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 13.75 39.76 94.12 11.42 37.23 97.89 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 16.35 26.90 99.56 16.81 25.90 97.75 27.03 30.18 -18.47 26.26 29.33 -16.72 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 6 3 # 6 F 182 LYS C 391 LYS~? 16.77 O1 EDO B 603 F 184 LYS C 388 LYS~? 20.15 C2 EDO C 602 F 345 ASP C 350 ASP.? 24.48 C2 EDO C 602 coo 10.64 34.02 91.30 6.30 35.60 95.11 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 13.75 39.76 94.12 11.42 37.23 97.89 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 16.35 26.90 99.56 16.81 25.90 97.75 27.03 30.18 -18.47 26.26 29.33 -16.72 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 7 3 # 7 F 182 LYS C 442 LYS~? 13.46 O1 EDO C 602 F 184 LYS C 415 LYS^? -2.71 O2 EDO C 602s F 345 ASP D 448 ASP.? 19.66 C2 EDO C 602 coo 10.64 34.02 91.30 6.30 35.60 95.11 12.96 9.36 -37.91 9.04 10.02 -41.38 coo 13.75 39.76 94.12 11.42 37.23 97.89 13.38 15.08 -39.34 19.41 17.19 -40.08 coo 16.35 26.90 99.56 16.81 25.90 97.75 3.66 6.43 -31.01 2.94 8.46 -31.03 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 8 3 # 8 F 182 LYS D 388 LYS~? 23.05 O3 GOL D 601 F 184 LYS D 391 LYS~? 24.88 C3 GOL D 601 F 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 10.64 34.02 91.30 6.30 35.60 95.11 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 13.75 39.76 94.12 11.42 37.23 97.89 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo 16.35 26.90 99.56 16.81 25.90 97.75 42.88 -2.45 -40.67 41.90 -2.09 -42.54 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 9 3 # 9 F 182 LYS D 391 LYS~? 24.88 C3 GOL D 601 F 184 LYS D 388 LYS~? 23.05 O3 GOL D 601 F 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 10.64 34.02 91.30 6.30 35.60 95.11 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo 13.75 39.76 94.12 11.42 37.23 97.89 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 16.35 26.90 99.56 16.81 25.90 97.75 42.88 -2.45 -40.67 41.90 -2.09 -42.54 2dw7_c37 source 2dw7 BLL6730 PROTEIN : 9 hits 2dw7_c37 naa= 3 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 1 3 # 1 G 182 LYS A 388 LYS~? 27.25 O2 GOL D 601 G 184 LYS A 391 LYS~? 19.54 O2 GOL D 601 G 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo 39.68 42.04 76.11 43.42 46.43 74.96 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 36.69 47.69 78.93 39.38 50.40 75.35 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 33.43 44.37 65.47 33.10 42.30 65.37 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 2 3 # 2 G 182 LYS A 391 LYS~? 19.54 O2 GOL D 601 G 184 LYS A 388 LYS~? 27.25 O2 GOL D 601 G 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo 39.68 42.04 76.11 43.42 46.43 74.96 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 36.69 47.69 78.93 39.38 50.40 75.35 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 33.43 44.37 65.47 33.10 42.30 65.37 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 3 3 # 3 G 182 LYS B 391 LYS~? 27.06 C2 EDO B 603 G 184 LYS B 388 LYS~? 19.48 C2 EDO B 603 G 345 ASP B 350 ASP.? 23.89 C2 EDO B 603 coo 39.68 42.04 76.11 43.42 46.43 74.96 1.34 36.06 21.83 0.02 35.49 25.91 coo 36.69 47.69 78.93 39.38 50.40 75.35 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 33.43 44.37 65.47 33.10 42.30 65.37 12.16 40.72 19.41 11.14 39.74 20.98 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 4 3 # 4 G 182 LYS C 388 LYS~? 20.15 C2 EDO C 602 G 184 LYS C 391 LYS~? 16.77 O1 EDO B 603 G 345 ASP C 350 ASP.? 24.48 C2 EDO C 602 coo 39.68 42.04 76.11 43.42 46.43 74.96 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 36.69 47.69 78.93 39.38 50.40 75.35 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 33.43 44.37 65.47 33.10 42.30 65.37 27.03 30.18 -18.47 26.26 29.33 -16.72 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 5 3 # 5 G 182 LYS C 391 LYS~? 16.77 O1 EDO B 603 G 184 LYS C 388 LYS~? 20.15 C2 EDO C 602 G 345 ASP C 350 ASP.? 24.48 C2 EDO C 602 coo 39.68 42.04 76.11 43.42 46.43 74.96 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 36.69 47.69 78.93 39.38 50.40 75.35 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 33.43 44.37 65.47 33.10 42.30 65.37 27.03 30.18 -18.47 26.26 29.33 -16.72 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 6 3 # 6 G 182 LYS C 442 LYS~? 13.46 O1 EDO C 602 G 184 LYS C 415 LYS^? -2.71 O2 EDO C 602s G 345 ASP D 448 ASP.? 19.66 C2 EDO C 602 coo 39.68 42.04 76.11 43.42 46.43 74.96 12.96 9.36 -37.91 9.04 10.02 -41.38 coo 36.69 47.69 78.93 39.38 50.40 75.35 13.38 15.08 -39.34 19.41 17.19 -40.08 coo 33.43 44.37 65.47 33.10 42.30 65.37 3.66 6.43 -31.01 2.94 8.46 -31.03 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 7 3 # 7 G 182 LYS D 388 LYS~? 23.05 O3 GOL D 601 G 184 LYS D 391 LYS~? 24.88 C3 GOL D 601 G 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 39.68 42.04 76.11 43.42 46.43 74.96 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 36.69 47.69 78.93 39.38 50.40 75.35 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo 33.43 44.37 65.47 33.10 42.30 65.37 42.88 -2.45 -40.67 41.90 -2.09 -42.54 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 8 3 # 8 G 182 LYS D 391 LYS~? 24.88 C3 GOL D 601 G 184 LYS D 388 LYS~? 23.05 O3 GOL D 601 G 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 39.68 42.04 76.11 43.42 46.43 74.96 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo 36.69 47.69 78.93 39.38 50.40 75.35 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 33.43 44.37 65.47 33.10 42.30 65.37 42.88 -2.45 -40.67 41.90 -2.09 -42.54 2dw7_c38 source 2dw7 BLL6730 PROTEIN : 8 hits 2dw7_c38 naa= 3 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 1 3 # 1 H 182 LYS A 388 LYS~? 27.25 O2 GOL D 601 H 184 LYS A 391 LYS~? 19.54 O2 GOL D 601 H 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo 71.58 83.18 80.51 66.88 79.77 79.84 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 73.65 78.64 75.66 68.14 79.07 75.04 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 67.43 90.73 71.39 68.27 92.30 72.52 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 2 3 # 2 H 182 LYS A 391 LYS~? 19.54 O2 GOL D 601 H 184 LYS A 388 LYS~? 27.25 O2 GOL D 601 H 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo 71.58 83.18 80.51 66.88 79.77 79.84 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 73.65 78.64 75.66 68.14 79.07 75.04 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 67.43 90.73 71.39 68.27 92.30 72.52 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 3 3 # 3 H 182 LYS B 391 LYS~? 27.06 C2 EDO B 603 H 184 LYS B 388 LYS~? 19.48 C2 EDO B 603 H 345 ASP B 350 ASP.? 23.89 C2 EDO B 603 coo 71.58 83.18 80.51 66.88 79.77 79.84 1.34 36.06 21.83 0.02 35.49 25.91 coo 73.65 78.64 75.66 68.14 79.07 75.04 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 67.43 90.73 71.39 68.27 92.30 72.52 12.16 40.72 19.41 11.14 39.74 20.98 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 4 3 # 4 H 182 LYS C 391 LYS~? 16.77 O1 EDO B 603 H 184 LYS C 388 LYS~? 20.15 C2 EDO C 602 H 345 ASP C 350 ASP.? 24.48 C2 EDO C 602 coo 71.58 83.18 80.51 66.88 79.77 79.84 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 73.65 78.64 75.66 68.14 79.07 75.04 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 67.43 90.73 71.39 68.27 92.30 72.52 27.03 30.18 -18.47 26.26 29.33 -16.72 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 5 3 # 5 H 182 LYS C 442 LYS~? 13.46 O1 EDO C 602 H 184 LYS C 415 LYS^? -2.71 O2 EDO C 602s H 345 ASP D 448 ASP.? 19.66 C2 EDO C 602 coo 71.58 83.18 80.51 66.88 79.77 79.84 12.96 9.36 -37.91 9.04 10.02 -41.38 coo 73.65 78.64 75.66 68.14 79.07 75.04 13.38 15.08 -39.34 19.41 17.19 -40.08 coo 67.43 90.73 71.39 68.27 92.30 72.52 3.66 6.43 -31.01 2.94 8.46 -31.03 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 6 3 # 6 H 182 LYS D 388 LYS~? 23.05 O3 GOL D 601 H 184 LYS D 391 LYS~? 24.88 C3 GOL D 601 H 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 71.58 83.18 80.51 66.88 79.77 79.84 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 73.65 78.64 75.66 68.14 79.07 75.04 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo 67.43 90.73 71.39 68.27 92.30 72.52 42.88 -2.45 -40.67 41.90 -2.09 -42.54 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 7 3 # 7 H 182 LYS D 391 LYS~? 24.88 C3 GOL D 601 H 184 LYS D 388 LYS~? 23.05 O3 GOL D 601 H 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 71.58 83.18 80.51 66.88 79.77 79.84 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo 73.65 78.64 75.66 68.14 79.07 75.04 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 67.43 90.73 71.39 68.27 92.30 72.52 42.88 -2.45 -40.67 41.90 -2.09 -42.54 2dw7_c39 source 2dw7 BLL6730 PROTEIN : 7 hits 2dw7_c39 naa= 3 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 1 3 # 1 I 182 LYS A 391 LYS~? 19.54 O2 GOL D 601 I 184 LYS A 388 LYS~? 27.25 O2 GOL D 601 I 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo 60.20 96.92 42.53 57.60 93.13 38.67 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 54.31 95.46 46.01 55.34 91.59 42.65 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 66.35 87.81 48.53 68.10 89.01 48.77 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 2 3 # 2 I 182 LYS A 442 LYS~? 23.27 C1 EDO B 603 I 184 LYS A 415 LYS^? 20.91 C1 EDO B 603 I 345 ASP A 448 ASP~? 19.70 O1 EDO B 603 coo 60.20 96.92 42.53 57.60 93.13 38.67 2.76 10.16 11.03 0.96 5.43 12.32 coo 54.31 95.46 46.01 55.34 91.59 42.65 6.45 6.62 13.73 11.23 9.80 16.52 coo 66.35 87.81 48.53 68.10 89.01 48.77 -6.12 13.55 5.97 -7.03 12.86 4.20 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 3 3 # 3 I 182 LYS B 391 LYS~? 27.06 C2 EDO B 603 I 184 LYS B 388 LYS~? 19.48 C2 EDO B 603 I 345 ASP B 350 ASP.? 23.89 C2 EDO B 603 coo 60.20 96.92 42.53 57.60 93.13 38.67 1.34 36.06 21.83 0.02 35.49 25.91 coo 54.31 95.46 46.01 55.34 91.59 42.65 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 66.35 87.81 48.53 68.10 89.01 48.77 12.16 40.72 19.41 11.14 39.74 20.98 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 4 3 # 4 I 182 LYS C 391 LYS~? 16.77 O1 EDO B 603 I 184 LYS C 388 LYS~? 20.15 C2 EDO C 602 I 345 ASP C 350 ASP.? 24.48 C2 EDO C 602 coo 60.20 96.92 42.53 57.60 93.13 38.67 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 54.31 95.46 46.01 55.34 91.59 42.65 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 66.35 87.81 48.53 68.10 89.01 48.77 27.03 30.18 -18.47 26.26 29.33 -16.72 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 5 3 # 5 I 182 LYS C 442 LYS~? 13.46 O1 EDO C 602 I 184 LYS C 415 LYS^? -2.71 O2 EDO C 602s I 345 ASP D 448 ASP.? 19.66 C2 EDO C 602 coo 60.20 96.92 42.53 57.60 93.13 38.67 12.96 9.36 -37.91 9.04 10.02 -41.38 coo 54.31 95.46 46.01 55.34 91.59 42.65 13.38 15.08 -39.34 19.41 17.19 -40.08 coo 66.35 87.81 48.53 68.10 89.01 48.77 3.66 6.43 -31.01 2.94 8.46 -31.03 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 6 3 # 6 I 182 LYS D 391 LYS~? 24.88 C3 GOL D 601 I 184 LYS D 388 LYS~? 23.05 O3 GOL D 601 I 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 60.20 96.92 42.53 57.60 93.13 38.67 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo 54.31 95.46 46.01 55.34 91.59 42.65 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 66.35 87.81 48.53 68.10 89.01 48.77 42.88 -2.45 -40.67 41.90 -2.09 -42.54 2dw7_c40 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c40 naa= 3 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 1 3 # 1 J 182 LYS A 391 LYS~? 19.54 O2 GOL D 601 J 184 LYS A 388 LYS~? 27.25 O2 GOL D 601 J 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo 25.22 70.55 14.03 27.64 73.07 18.65 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 31.73 69.87 11.50 32.73 70.19 16.40 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 25.87 58.42 18.79 23.95 58.54 17.90 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 2 3 # 2 J 182 LYS B 391 LYS~? 27.06 C2 EDO B 603 J 184 LYS B 388 LYS~? 19.48 C2 EDO B 603 J 345 ASP B 350 ASP.? 23.89 C2 EDO B 603 coo 25.22 70.55 14.03 27.64 73.07 18.65 1.34 36.06 21.83 0.02 35.49 25.91 coo 31.73 69.87 11.50 32.73 70.19 16.40 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 25.87 58.42 18.79 23.95 58.54 17.90 12.16 40.72 19.41 11.14 39.74 20.98 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 3 3 # 3 J 182 LYS C 391 LYS~? 16.77 O1 EDO B 603 J 184 LYS C 388 LYS~? 20.15 C2 EDO C 602 J 345 ASP C 350 ASP.? 24.48 C2 EDO C 602 coo 25.22 70.55 14.03 27.64 73.07 18.65 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 31.73 69.87 11.50 32.73 70.19 16.40 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 25.87 58.42 18.79 23.95 58.54 17.90 27.03 30.18 -18.47 26.26 29.33 -16.72 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 4 3 # 4 J 182 LYS C 442 LYS~? 13.46 O1 EDO C 602 J 184 LYS C 415 LYS^? -2.71 O2 EDO C 602s J 345 ASP D 448 ASP.? 19.66 C2 EDO C 602 coo 25.22 70.55 14.03 27.64 73.07 18.65 12.96 9.36 -37.91 9.04 10.02 -41.38 coo 31.73 69.87 11.50 32.73 70.19 16.40 13.38 15.08 -39.34 19.41 17.19 -40.08 coo 25.87 58.42 18.79 23.95 58.54 17.90 3.66 6.43 -31.01 2.94 8.46 -31.03 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 5 3 # 5 J 182 LYS D 388 LYS~? 23.05 O3 GOL D 601 J 184 LYS D 384 LYS~? 21.94 O3 GOL D 601 J 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 25.22 70.55 14.03 27.64 73.07 18.65 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 31.73 69.87 11.50 32.73 70.19 16.40 32.39 -15.23 -40.24 32.53 -17.53 -36.22 coo 25.87 58.42 18.79 23.95 58.54 17.90 42.88 -2.45 -40.67 41.90 -2.09 -42.54 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 6 3 # 6 J 182 LYS D 391 LYS~? 24.88 C3 GOL D 601 J 184 LYS D 388 LYS~? 23.05 O3 GOL D 601 J 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 25.22 70.55 14.03 27.64 73.07 18.65 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo 31.73 69.87 11.50 32.73 70.19 16.40 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 25.87 58.42 18.79 23.95 58.54 17.90 42.88 -2.45 -40.67 41.90 -2.09 -42.54 2dw7_c41 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c41 naa= 3 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 1 3 # 1 K 182 LYS A 391 LYS~? 19.54 O2 GOL D 601 K 184 LYS A 388 LYS~? 27.25 O2 GOL D 601 K 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 2 3 # 2 K 182 LYS A 442 LYS~? 23.27 C1 EDO B 603 K 184 LYS A 415 LYS^? 20.91 C1 EDO B 603 K 345 ASP A 448 ASP~? 19.70 O1 EDO B 603 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 2.76 10.16 11.03 0.96 5.43 12.32 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 6.45 6.62 13.73 11.23 9.80 16.52 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -6.12 13.55 5.97 -7.03 12.86 4.20 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 3 3 # 3 K 182 LYS B 391 LYS~? 27.06 C2 EDO B 603 K 184 LYS B 388 LYS~? 19.48 C2 EDO B 603 K 345 ASP B 350 ASP.? 23.89 C2 EDO B 603 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 1.34 36.06 21.83 0.02 35.49 25.91 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 12.16 40.72 19.41 11.14 39.74 20.98 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 4 3 # 4 K 182 LYS C 391 LYS~? 16.77 O1 EDO B 603 K 184 LYS C 388 LYS~? 20.15 C2 EDO C 602 K 345 ASP C 350 ASP.? 24.48 C2 EDO C 602 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 27.03 30.18 -18.47 26.26 29.33 -16.72 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 5 3 # 5 K 182 LYS C 442 LYS~? 13.46 O1 EDO C 602 K 184 LYS C 415 LYS^? -2.71 O2 EDO C 602s K 345 ASP D 448 ASP.? 19.66 C2 EDO C 602 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 12.96 9.36 -37.91 9.04 10.02 -41.38 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 13.38 15.08 -39.34 19.41 17.19 -40.08 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 3.66 6.43 -31.01 2.94 8.46 -31.03 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 6 3 # 6 K 182 LYS D 388 LYS~? 23.05 O3 GOL D 601 K 184 LYS D 384 LYS~? 21.94 O3 GOL D 601 K 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 32.39 -15.23 -40.24 32.53 -17.53 -36.22 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 42.88 -2.45 -40.67 41.90 -2.09 -42.54 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 7 3 # 7 K 182 LYS D 391 LYS~? 24.88 C3 GOL D 601 K 184 LYS D 388 LYS~? 23.05 O3 GOL D 601 K 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 42.88 -2.45 -40.67 41.90 -2.09 -42.54 2dw7_c42 source 2dw7 BLL6730 PROTEIN : 7 hits 2dw7_c42 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS A 388 LYS~? 27.25 O2 GOL D 601 L 184 LYS A 384 LYS~? 32.89 O2 GOL D 601 L 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 23.52 -5.65 3.37 24.45 -7.36 6.79 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 2 3 # 2 L 182 LYS A 391 LYS~? 19.54 O2 GOL D 601 L 184 LYS A 388 LYS~? 27.25 O2 GOL D 601 L 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 3 3 # 3 L 182 LYS A 442 LYS~? 23.27 C1 EDO B 603 L 184 LYS A 415 LYS^? 20.91 C1 EDO B 603 L 345 ASP B 448 ASP.? 21.29 O1 EDO B 603 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 2.76 10.16 11.03 0.96 5.43 12.32 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 6.45 6.62 13.73 11.23 9.80 16.52 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -0.19 5.34 -1.92 0.46 4.35 -0.12 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 4 3 # 4 L 182 LYS B 388 LYS~? 19.48 C2 EDO B 603 L 184 LYS B 384 LYS~? 21.93 O2 EDO B 603 L 345 ASP B 350 ASP.? 23.89 C2 EDO B 603 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -3.14 43.46 11.59 -5.82 40.34 10.77 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 12.16 40.72 19.41 11.14 39.74 20.98 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 5 3 # 5 L 182 LYS B 391 LYS~? 27.06 C2 EDO B 603 L 184 LYS B 388 LYS~? 19.48 C2 EDO B 603 L 345 ASP B 402 ASP.? 23.46 C2 EDO B 603 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 1.34 36.06 21.83 0.02 35.49 25.91 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 8.17 23.01 23.39 8.93 22.69 25.33 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 6 3 # 6 L 182 LYS C 388 LYS~? 20.15 C2 EDO C 602 L 184 LYS C 384 LYS~? 20.68 O2 EDO C 602 L 345 ASP C 350 ASP.? 24.48 C2 EDO C 602 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 11.81 35.96 -24.38 11.26 34.03 -29.22 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 27.03 30.18 -18.47 26.26 29.33 -16.72 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 7 3 # 7 L 182 LYS C 442 LYS~? 13.46 O1 EDO C 602 L 184 LYS C 415 LYS^? -2.71 O2 EDO C 602s L 345 ASP D 448 ASP.? 19.66 C2 EDO C 602 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 12.96 9.36 -37.91 9.04 10.02 -41.38 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 13.38 15.08 -39.34 19.41 17.19 -40.08 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 3.66 6.43 -31.01 2.94 8.46 -31.03 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 8 3 # 8 L 182 LYS D 388 LYS~? 23.05 O3 GOL D 601 L 184 LYS D 384 LYS~? 21.94 O3 GOL D 601 L 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 32.39 -15.23 -40.24 32.53 -17.53 -36.22 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 42.88 -2.45 -40.67 41.90 -2.09 -42.54 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 9 3 # 9 L 182 LYS D 391 LYS~? 24.88 C3 GOL D 601 L 184 LYS D 388 LYS~? 23.05 O3 GOL D 601 L 345 ASP D 402 ASP.? 14.20 O1 EDO C 602 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 28.53 7.95 -46.44 29.10 9.08 -48.14 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 10 3 # 10 L 182 LYS D 442 LYS~? 12.65 O2 GOL D 601 L 184 LYS D 415 LYS^? -2.91 O3 GOL D 601s L 345 ASP C 448 ASP.? 19.32 O1 GOL D 601 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 14.14 0.83 -27.84 11.41 -3.18 -25.91 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 17.93 -3.17 -25.73 23.39 -0.99 -23.17 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 9.52 -2.93 -40.85 10.47 -4.20 -39.42 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 10 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS A 388 LYS~? 27.25 O2 GOL D 601 M 184 LYS A 384 LYS~? 32.89 O2 GOL D 601 M 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 23.52 -5.65 3.37 24.45 -7.36 6.79 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 2 3 # 2 M 182 LYS A 391 LYS~? 19.54 O2 GOL D 601 M 184 LYS A 388 LYS~? 27.25 O2 GOL D 601 M 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 3 3 # 3 M 182 LYS A 442 LYS~? 23.27 C1 EDO B 603 M 184 LYS A 415 LYS^? 20.91 C1 EDO B 603 M 345 ASP B 448 ASP.? 21.29 O1 EDO B 603 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 2.76 10.16 11.03 0.96 5.43 12.32 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 6.45 6.62 13.73 11.23 9.80 16.52 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -0.19 5.34 -1.92 0.46 4.35 -0.12 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 4 3 # 4 M 182 LYS B 388 LYS~? 19.48 C2 EDO B 603 M 184 LYS B 384 LYS~? 21.93 O2 EDO B 603 M 345 ASP B 350 ASP.? 23.89 C2 EDO B 603 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -0.92 37.13 17.34 -4.46 33.66 14.61 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -3.14 43.46 11.59 -5.82 40.34 10.77 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 12.16 40.72 19.41 11.14 39.74 20.98 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 5 3 # 5 M 182 LYS B 391 LYS~? 27.06 C2 EDO B 603 M 184 LYS B 388 LYS~? 19.48 C2 EDO B 603 M 345 ASP B 402 ASP.? 23.46 C2 EDO B 603 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 1.34 36.06 21.83 0.02 35.49 25.91 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -0.92 37.13 17.34 -4.46 33.66 14.61 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 8.17 23.01 23.39 8.93 22.69 25.33 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 6 3 # 6 M 182 LYS C 388 LYS~? 20.15 C2 EDO C 602 M 184 LYS C 384 LYS~? 20.68 O2 EDO C 602 M 345 ASP C 350 ASP.? 24.48 C2 EDO C 602 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 13.46 28.58 -20.25 9.42 25.73 -22.18 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 11.81 35.96 -24.38 11.26 34.03 -29.22 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 27.03 30.18 -18.47 26.26 29.33 -16.72 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 7 3 # 7 M 182 LYS C 442 LYS~? 13.46 O1 EDO C 602 M 184 LYS C 415 LYS^? -2.71 O2 EDO C 602s M 345 ASP D 448 ASP.? 19.66 C2 EDO C 602 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 12.96 9.36 -37.91 9.04 10.02 -41.38 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 13.38 15.08 -39.34 19.41 17.19 -40.08 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 3.66 6.43 -31.01 2.94 8.46 -31.03 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 8 3 # 8 M 182 LYS D 388 LYS~? 23.05 O3 GOL D 601 M 184 LYS D 384 LYS~? 21.94 O3 GOL D 601 M 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 32.39 -15.23 -40.24 32.53 -17.53 -36.22 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 42.88 -2.45 -40.67 41.90 -2.09 -42.54 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 9 3 # 9 M 182 LYS D 391 LYS~? 24.88 C3 GOL D 601 M 184 LYS D 388 LYS~? 23.05 O3 GOL D 601 M 345 ASP D 402 ASP.? 14.20 O1 EDO C 602 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 28.53 7.95 -46.44 29.10 9.08 -48.14 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 10 3 # 10 M 182 LYS D 442 LYS~? 12.65 O2 GOL D 601 M 184 LYS D 415 LYS^? -2.91 O3 GOL D 601s M 345 ASP C 448 ASP.? 19.32 O1 GOL D 601 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 14.14 0.83 -27.84 11.41 -3.18 -25.91 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 17.93 -3.17 -25.73 23.39 -0.99 -23.17 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 9.52 -2.93 -40.85 10.47 -4.20 -39.42 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 11 3 # 11 M 182 LYS D 442 LYS~? 12.65 O2 GOL D 601 M 184 LYS D 415 LYS^? -2.91 O3 GOL D 601s M 345 ASP D 448 ASP.? 19.66 C2 EDO C 602 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 14.14 0.83 -27.84 11.41 -3.18 -25.91 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 17.93 -3.17 -25.73 23.39 -0.99 -23.17 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 3.66 6.43 -31.01 2.94 8.46 -31.03 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 11 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 1 3 # 1 N 182 LYS A 388 LYS~? 27.25 O2 GOL D 601 N 184 LYS A 391 LYS~? 19.54 O2 GOL D 601 N 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 2 3 # 2 N 182 LYS A 391 LYS~? 19.54 O2 GOL D 601 N 184 LYS A 388 LYS~? 27.25 O2 GOL D 601 N 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 3 3 # 3 N 182 LYS B 391 LYS~? 27.06 C2 EDO B 603 N 184 LYS B 388 LYS~? 19.48 C2 EDO B 603 N 345 ASP B 350 ASP.? 23.89 C2 EDO B 603 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 1.34 36.06 21.83 0.02 35.49 25.91 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 12.16 40.72 19.41 11.14 39.74 20.98 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 4 3 # 4 N 182 LYS B 442 LYS~? 13.00 O1 EDO B 603 N 184 LYS B 415 LYS^? -2.82 O2 EDO B 603s N 345 ASP A 448 ASP~? 19.70 O1 EDO B 603 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 1.48 17.85 0.41 -2.11 18.47 -3.79 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 1.57 23.62 -1.31 7.49 26.02 -1.78 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -6.12 13.55 5.97 -7.03 12.86 4.20 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 5 3 # 5 N 182 LYS C 388 LYS~? 20.15 C2 EDO C 602 N 184 LYS C 391 LYS~? 16.77 O1 EDO B 603 N 345 ASP C 350 ASP.? 24.48 C2 EDO C 602 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 27.03 30.18 -18.47 26.26 29.33 -16.72 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 6 3 # 6 N 182 LYS C 391 LYS~? 16.77 O1 EDO B 603 N 184 LYS C 388 LYS~? 20.15 C2 EDO C 602 N 345 ASP C 350 ASP.? 24.48 C2 EDO C 602 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 27.03 30.18 -18.47 26.26 29.33 -16.72 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 7 3 # 7 N 182 LYS C 442 LYS~? 13.46 O1 EDO C 602 N 184 LYS C 415 LYS^? -2.71 O2 EDO C 602s N 345 ASP D 448 ASP.? 19.66 C2 EDO C 602 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 12.96 9.36 -37.91 9.04 10.02 -41.38 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 13.38 15.08 -39.34 19.41 17.19 -40.08 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 3.66 6.43 -31.01 2.94 8.46 -31.03 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 8 3 # 8 N 182 LYS D 388 LYS~? 23.05 O3 GOL D 601 N 184 LYS D 391 LYS~? 24.88 C3 GOL D 601 N 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 42.88 -2.45 -40.67 41.90 -2.09 -42.54 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 9 3 # 9 N 182 LYS D 391 LYS~? 24.88 C3 GOL D 601 N 184 LYS D 388 LYS~? 23.05 O3 GOL D 601 N 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 42.88 -2.45 -40.67 41.90 -2.09 -42.54 2dw7_c45 source 2dw7 BLL6730 PROTEIN : 9 hits 2dw7_c45 naa= 3 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 1 3 # 1 O 182 LYS A 391 LYS~? 19.54 O2 GOL D 601 O 184 LYS A 388 LYS~? 27.25 O2 GOL D 601 O 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 2 3 # 2 O 182 LYS A 442 LYS~? 23.27 C1 EDO B 603 O 184 LYS A 415 LYS^? 20.91 C1 EDO B 603 O 345 ASP A 448 ASP~? 19.70 O1 EDO B 603 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 2.76 10.16 11.03 0.96 5.43 12.32 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 6.45 6.62 13.73 11.23 9.80 16.52 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -6.12 13.55 5.97 -7.03 12.86 4.20 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 3 3 # 3 O 182 LYS B 391 LYS~? 27.06 C2 EDO B 603 O 184 LYS B 388 LYS~? 19.48 C2 EDO B 603 O 345 ASP B 350 ASP.? 23.89 C2 EDO B 603 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 1.34 36.06 21.83 0.02 35.49 25.91 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 12.16 40.72 19.41 11.14 39.74 20.98 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 4 3 # 4 O 182 LYS C 391 LYS~? 16.77 O1 EDO B 603 O 184 LYS C 388 LYS~? 20.15 C2 EDO C 602 O 345 ASP C 350 ASP.? 24.48 C2 EDO C 602 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 15.56 26.67 -15.99 9.90 23.87 -16.19 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 27.03 30.18 -18.47 26.26 29.33 -16.72 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 5 3 # 5 O 182 LYS C 442 LYS~? 13.46 O1 EDO C 602 O 184 LYS C 415 LYS^? -2.71 O2 EDO C 602s O 345 ASP D 448 ASP.? 19.66 C2 EDO C 602 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 12.96 9.36 -37.91 9.04 10.02 -41.38 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 13.38 15.08 -39.34 19.41 17.19 -40.08 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 3.66 6.43 -31.01 2.94 8.46 -31.03 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 6 3 # 6 O 182 LYS D 388 LYS~? 23.05 O3 GOL D 601 O 184 LYS D 384 LYS~? 21.94 O3 GOL D 601 O 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 32.39 -15.23 -40.24 32.53 -17.53 -36.22 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 42.88 -2.45 -40.67 41.90 -2.09 -42.54 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 7 3 # 7 O 182 LYS D 391 LYS~? 24.88 C3 GOL D 601 O 184 LYS D 388 LYS~? 23.05 O3 GOL D 601 O 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 42.88 -2.45 -40.67 41.90 -2.09 -42.54 2dw7_c46 source 2dw7 BLL6730 PROTEIN : 7 hits 2dw7_c46 naa= 3 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 1 3 # 1 P 182 LYS A 388 LYS~? 27.25 O2 GOL D 601 P 184 LYS A 384 LYS~? 32.89 O2 GOL D 601 P 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 23.52 -5.65 3.37 24.45 -7.36 6.79 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 2 3 # 2 P 182 LYS A 391 LYS~? 19.54 O2 GOL D 601 P 184 LYS A 388 LYS~? 27.25 O2 GOL D 601 P 345 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 24.25 2.80 -4.96 21.44 -2.66 -5.78 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 22.21 -0.11 -1.07 17.85 -4.01 1.39 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 3 3 # 3 P 182 LYS A 442 LYS~? 23.27 C1 EDO B 603 P 184 LYS A 415 LYS^? 20.91 C1 EDO B 603 P 345 ASP B 448 ASP.? 21.29 O1 EDO B 603 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 2.76 10.16 11.03 0.96 5.43 12.32 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 6.45 6.62 13.73 11.23 9.80 16.52 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -0.19 5.34 -1.92 0.46 4.35 -0.12 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 4 3 # 4 P 182 LYS B 388 LYS~? 19.48 C2 EDO B 603 P 184 LYS B 384 LYS~? 21.93 O2 EDO B 603 P 345 ASP B 350 ASP.? 23.89 C2 EDO B 603 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -3.14 43.46 11.59 -5.82 40.34 10.77 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 12.16 40.72 19.41 11.14 39.74 20.98 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 5 3 # 5 P 182 LYS B 391 LYS~? 27.06 C2 EDO B 603 P 184 LYS B 388 LYS~? 19.48 C2 EDO B 603 P 345 ASP B 402 ASP.? 23.46 C2 EDO B 603 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 1.34 36.06 21.83 0.02 35.49 25.91 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -0.92 37.13 17.34 -4.46 33.66 14.61 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 8.17 23.01 23.39 8.93 22.69 25.33 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 6 3 # 6 P 182 LYS C 388 LYS~? 20.15 C2 EDO C 602 P 184 LYS C 384 LYS~? 20.68 O2 EDO C 602 P 345 ASP C 350 ASP.? 24.48 C2 EDO C 602 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 13.46 28.58 -20.25 9.42 25.73 -22.18 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 11.81 35.96 -24.38 11.26 34.03 -29.22 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 27.03 30.18 -18.47 26.26 29.33 -16.72 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 7 3 # 7 P 182 LYS C 442 LYS~? 13.46 O1 EDO C 602 P 184 LYS C 415 LYS^? -2.71 O2 EDO C 602s P 345 ASP D 448 ASP.? 19.66 C2 EDO C 602 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 12.96 9.36 -37.91 9.04 10.02 -41.38 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 13.38 15.08 -39.34 19.41 17.19 -40.08 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 3.66 6.43 -31.01 2.94 8.46 -31.03 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 8 3 # 8 P 182 LYS D 388 LYS~? 23.05 O3 GOL D 601 P 184 LYS D 384 LYS~? 21.94 O3 GOL D 601 P 345 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 32.39 -15.23 -40.24 32.53 -17.53 -36.22 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 42.88 -2.45 -40.67 41.90 -2.09 -42.54 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 9 3 # 9 P 182 LYS D 391 LYS~? 24.88 C3 GOL D 601 P 184 LYS D 388 LYS~? 23.05 O3 GOL D 601 P 345 ASP D 402 ASP.? 14.20 O1 EDO C 602 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 32.90 -6.30 -46.84 30.42 -11.34 -47.14 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 31.25 -9.34 -42.79 29.68 -12.48 -44.35 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 28.53 7.95 -46.44 29.10 9.08 -48.14 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 10 3 # 10 P 182 LYS D 442 LYS~? 12.65 O2 GOL D 601 P 184 LYS D 415 LYS^? -2.91 O3 GOL D 601s P 345 ASP C 448 ASP.? 19.32 O1 GOL D 601 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 14.14 0.83 -27.84 11.41 -3.18 -25.91 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 17.93 -3.17 -25.73 23.39 -0.99 -23.17 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 9.52 -2.93 -40.85 10.47 -4.20 -39.42 2dw7_c47 source 2dw7 BLL6730 PROTEIN : 10 hits 2dw7_c47 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR A 354 TYR^? 20.91 C1 EDO B 603 A 245 ASP A 357 ASP.? 25.14 C1 EDO B 603 A 273 LYS A 367 LYS.? 27.79 C1 EDO B 603 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 27.10 16.84 11.56 24.90 18.34 12.50 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 22.54 16.74 19.72 22.05 16.00 21.61 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 21.09 4.68 15.64 17.32 4.21 18.91 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 150 TYR B 354 TYR^? 14.48 C1 EDO B 603 A 245 ASP B 357 ASP.? 13.04 C1 EDO B 603 A 273 LYS B 367 LYS.? 8.96 O2 EDO B 603 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 19.63 32.53 9.54 19.95 30.09 8.18 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 19.95 30.44 0.55 20.02 30.85 -1.53 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 8.46 36.63 1.57 6.31 34.95 -1.21 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 150 TYR C 354 TYR^? 14.37 C1 EDO C 602 A 245 ASP C 357 ASP.? 12.50 O2 EDO C 602 A 273 LYS C 367 LYS.? 10.18 O2 EDO C 602 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 32.76 22.10 -29.37 32.74 19.75 -30.93 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 32.02 20.63 -38.57 31.77 21.72 -40.39 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 21.41 26.99 -36.15 19.64 26.87 -41.36 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 150 TYR D 354 TYR^? 14.76 C3 GOL D 601 A 245 ASP D 357 ASP.? 12.64 O3 GOL D 601 A 273 LYS D 367 LYS.? 8.67 O3 GOL D 601 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 38.74 5.77 -29.00 36.83 7.38 -27.74 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 34.52 5.19 -20.65 34.58 3.94 -18.98 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 32.17 -6.41 -25.63 28.00 -7.23 -22.20 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 4 hits 2gsa_c02 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE A 352 PHE^? 25.89 C1 EDO B 603 A 245 ASP A 350 ASP.? 26.92 O2 GOL D 601 A 273 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 29.09 9.19 9.94 27.10 9.67 11.86 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 33.51 7.96 1.59 32.78 7.85 -0.37 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 157 PHE A 431 PHE^? 22.59 O1 EDO B 603 A 245 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 273 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 29.40 15.33 -4.65 28.40 13.37 -2.94 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 18.87 16.83 -6.49 16.77 17.04 -6.49 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 157 PHE A 431 PHE^? 22.59 O1 EDO B 603 A 245 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 273 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 29.40 15.33 -4.65 28.40 13.37 -2.94 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 29.17 24.78 -3.72 30.40 24.16 -5.34 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 31.02 25.73 -16.52 36.61 24.80 -13.64 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 157 PHE A 431 PHE^? 22.59 O1 EDO B 603 A 245 ASP A 430 ASP.? 25.41 O1 EDO B 603 A 273 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 29.40 15.33 -4.65 28.40 13.37 -2.94 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 31.59 21.51 -7.17 32.38 22.31 -9.00 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 31.02 25.73 -16.52 36.61 24.80 -13.64 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 157 PHE A 431 PHE^? 22.59 O1 EDO B 603 A 245 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 273 LYS C 348 LYS.? 28.33 O1 GOL D 601 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 29.40 15.33 -4.65 28.40 13.37 -2.94 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 35.09 15.28 -13.55 34.97 16.40 -11.75 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 31.02 25.73 -16.52 36.61 24.80 -13.64 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 6 3 # 6 A 157 PHE B 352 PHE^? 15.29 O2 EDO B 603 A 245 ASP B 350 ASP.? 23.89 C2 EDO B 603 A 273 LYS B 388 LYS~? 19.48 C2 EDO B 603 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 14.23 38.41 10.43 14.31 36.78 8.15 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 12.16 40.72 19.41 11.14 39.74 20.98 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -0.92 37.13 17.34 -4.46 33.66 14.61 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 7 3 # 7 A 157 PHE B 352 PHE^? 15.29 O2 EDO B 603 A 245 ASP B 350 ASP.? 23.89 C2 EDO B 603 A 273 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 14.23 38.41 10.43 14.31 36.78 8.15 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 12.16 40.72 19.41 11.14 39.74 20.98 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 8 3 # 8 A 157 PHE B 431 PHE^? 23.47 C2 EDO B 603 A 245 ASP B 350 ASP.? 23.89 C2 EDO B 603 A 273 LYS B 388 LYS~? 19.48 C2 EDO B 603 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 13.65 32.28 24.99 12.40 33.20 22.64 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 12.16 40.72 19.41 11.14 39.74 20.98 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -0.92 37.13 17.34 -4.46 33.66 14.61 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 9 3 # 9 A 157 PHE C 352 PHE^? 15.48 O2 EDO C 602 A 245 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 273 LYS C 388 LYS~? 20.15 C2 EDO C 602 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 27.97 28.62 -27.76 27.73 27.28 -30.22 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 27.03 30.18 -18.47 26.26 29.33 -16.72 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 13.46 28.58 -20.25 9.42 25.73 -22.18 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 10 3 # 10 A 157 PHE C 352 PHE^? 15.48 O2 EDO C 602 A 245 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 273 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 27.97 28.62 -27.76 27.73 27.28 -30.22 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 27.03 30.18 -18.47 26.26 29.33 -16.72 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 11 3 # 11 A 157 PHE C 431 PHE^? 22.21 O1 GOL D 601 A 245 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 273 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 28.24 21.80 -13.63 26.64 22.64 -15.77 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 29.17 24.78 -3.72 30.40 24.16 -5.34 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 12 3 # 12 A 157 PHE C 431 PHE^? 22.21 O1 GOL D 601 A 245 ASP A 430 ASP.? 25.41 O1 EDO B 603 A 273 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 28.24 21.80 -13.63 26.64 22.64 -15.77 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 31.59 21.51 -7.17 32.38 22.31 -9.00 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 13 3 # 13 A 157 PHE C 431 PHE^? 22.21 O1 GOL D 601 A 245 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 273 LYS C 388 LYS~? 20.15 C2 EDO C 602 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 28.24 21.80 -13.63 26.64 22.64 -15.77 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 27.03 30.18 -18.47 26.26 29.33 -16.72 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 13.46 28.58 -20.25 9.42 25.73 -22.18 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 14 3 # 14 A 157 PHE C 431 PHE^? 22.21 O1 GOL D 601 A 245 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 273 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 28.24 21.80 -13.63 26.64 22.64 -15.77 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 22.26 13.02 -15.38 21.01 11.37 -15.92 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 15 3 # 15 A 157 PHE C 431 PHE^? 22.21 O1 GOL D 601 A 245 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 273 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 28.24 21.80 -13.63 26.64 22.64 -15.77 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 35.09 15.28 -13.55 34.97 16.40 -11.75 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 16 3 # 16 A 157 PHE C 431 PHE^? 22.21 O1 GOL D 601 A 245 ASP C 430 ASP.? 26.01 O2 GOL D 601 A 273 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 28.24 21.80 -13.63 26.64 22.64 -15.77 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 33.23 18.77 -9.92 33.78 18.54 -7.88 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 17 3 # 17 A 157 PHE D 352 PHE^? 15.53 O3 GOL D 601 A 245 ASP D 350 ASP.? 24.09 C3 GOL D 601 A 273 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 40.13 -1.84 -31.50 38.47 -1.47 -29.25 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 31.25 -9.34 -42.79 29.68 -12.48 -44.35 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 18 3 # 18 A 157 PHE D 352 PHE^? 15.53 O3 GOL D 601 A 245 ASP D 350 ASP.? 24.09 C3 GOL D 601 A 273 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 40.13 -1.84 -31.50 38.47 -1.47 -29.25 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 32.90 -6.30 -46.84 30.42 -11.34 -47.14 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 19 3 # 19 A 157 PHE D 431 PHE^? 21.51 O1 EDO C 602 A 245 ASP D 350 ASP.? 24.09 C3 GOL D 601 A 273 LYS D 388 LYS~? 23.05 O3 GOL D 601 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 39.18 5.51 -45.56 38.23 3.44 -43.92 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 31.25 -9.34 -42.79 29.68 -12.48 -44.35 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 19 hits 2gsa_c04 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 416 PHE^? 19.67 O1 EDO B 603 A 263 ASP B 448 ASP.? 21.29 O1 EDO B 603 A 292 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 51.51 50.32 16.39 52.13 49.68 13.75 4.63 6.30 7.93 4.64 5.09 5.42 coo 54.43 44.82 23.74 55.21 45.06 21.80 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo 63.95 45.30 16.71 59.11 49.15 16.05 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE A 431 PHE^? 22.59 O1 EDO B 603 A 263 ASP A 350 ASP.? 26.92 O2 GOL D 601 A 292 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo 51.51 50.32 16.39 52.13 49.68 13.75 29.40 15.33 -4.65 28.40 13.37 -2.94 coo 54.43 44.82 23.74 55.21 45.06 21.80 33.51 7.96 1.59 32.78 7.85 -0.37 coo 63.95 45.30 16.71 59.11 49.15 16.05 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE B 416 PHE^? 11.67 C2 EDO B 603 A 263 ASP A 448 ASP~? 19.70 O1 EDO B 603 A 292 LYS A 442 LYS~? 23.27 C1 EDO B 603 coo 51.51 50.32 16.39 52.13 49.68 13.75 -1.62 21.04 3.18 -3.66 21.32 5.09 coo 54.43 44.82 23.74 55.21 45.06 21.80 -6.12 13.55 5.97 -7.03 12.86 4.20 coo 63.95 45.30 16.71 59.11 49.15 16.05 2.76 10.16 11.03 0.96 5.43 12.32 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 177 PHE B 431 PHE^? 23.47 C2 EDO B 603 A 263 ASP B 350 ASP.? 23.89 C2 EDO B 603 A 292 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo 51.51 50.32 16.39 52.13 49.68 13.75 13.65 32.28 24.99 12.40 33.20 22.64 coo 54.43 44.82 23.74 55.21 45.06 21.80 12.16 40.72 19.41 11.14 39.74 20.98 coo 63.95 45.30 16.71 59.11 49.15 16.05 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 A 177 PHE C 416 PHE^? 11.78 C2 EDO C 602 A 263 ASP D 448 ASP.? 19.66 C2 EDO C 602 A 292 LYS D 442 LYS~? 12.65 O2 GOL D 601 coo 51.51 50.32 16.39 52.13 49.68 13.75 10.28 12.37 -34.72 8.44 12.42 -32.58 coo 54.43 44.82 23.74 55.21 45.06 21.80 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 63.95 45.30 16.71 59.11 49.15 16.05 14.14 0.83 -27.84 11.41 -3.18 -25.91 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 A 177 PHE C 431 PHE^? 22.21 O1 GOL D 601 A 263 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 292 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 51.51 50.32 16.39 52.13 49.68 13.75 28.24 21.80 -13.63 26.64 22.64 -15.77 coo 54.43 44.82 23.74 55.21 45.06 21.80 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 63.95 45.30 16.71 59.11 49.15 16.05 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 A 177 PHE D 416 PHE^? 11.70 C3 GOL D 601 A 263 ASP C 448 ASP.? 19.32 O1 GOL D 601 A 292 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 51.51 50.32 16.39 52.13 49.68 13.75 15.40 -2.83 -31.27 15.07 -3.80 -33.86 coo 54.43 44.82 23.74 55.21 45.06 21.80 9.52 -2.93 -40.85 10.47 -4.20 -39.42 coo 63.95 45.30 16.71 59.11 49.15 16.05 12.96 9.36 -37.91 9.04 10.02 -41.38 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 A 177 PHE D 431 PHE^? 21.51 O1 EDO C 602 A 263 ASP D 350 ASP.? 24.09 C3 GOL D 601 A 292 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo 51.51 50.32 16.39 52.13 49.68 13.75 39.18 5.51 -45.56 38.23 3.44 -43.92 coo 54.43 44.82 23.74 55.21 45.06 21.80 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 63.95 45.30 16.71 59.11 49.15 16.05 32.90 -6.30 -46.84 30.42 -11.34 -47.14 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 8 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 416 PHE^? 19.67 O1 EDO B 603 B 263 ASP B 448 ASP.? 21.29 O1 EDO B 603 B 292 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 49.99 26.05 6.28 51.46 26.87 8.49 4.63 6.30 7.93 4.64 5.09 5.42 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo 60.53 31.67 0.97 57.79 27.51 3.63 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE A 431 PHE^? 22.59 O1 EDO B 603 B 263 ASP A 350 ASP.? 26.92 O2 GOL D 601 B 292 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo 49.99 26.05 6.28 51.46 26.87 8.49 29.40 15.33 -4.65 28.40 13.37 -2.94 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 33.51 7.96 1.59 32.78 7.85 -0.37 coo 60.53 31.67 0.97 57.79 27.51 3.63 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE B 416 PHE^? 11.67 C2 EDO B 603 B 263 ASP A 448 ASP~? 19.70 O1 EDO B 603 B 292 LYS A 442 LYS~? 23.27 C1 EDO B 603 coo 49.99 26.05 6.28 51.46 26.87 8.49 -1.62 21.04 3.18 -3.66 21.32 5.09 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -6.12 13.55 5.97 -7.03 12.86 4.20 coo 60.53 31.67 0.97 57.79 27.51 3.63 2.76 10.16 11.03 0.96 5.43 12.32 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 177 PHE B 431 PHE^? 23.47 C2 EDO B 603 B 263 ASP B 350 ASP.? 23.89 C2 EDO B 603 B 292 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo 49.99 26.05 6.28 51.46 26.87 8.49 13.65 32.28 24.99 12.40 33.20 22.64 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 12.16 40.72 19.41 11.14 39.74 20.98 coo 60.53 31.67 0.97 57.79 27.51 3.63 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 B 177 PHE C 416 PHE^? 11.78 C2 EDO C 602 B 263 ASP D 448 ASP.? 19.66 C2 EDO C 602 B 292 LYS D 442 LYS~? 12.65 O2 GOL D 601 coo 49.99 26.05 6.28 51.46 26.87 8.49 10.28 12.37 -34.72 8.44 12.42 -32.58 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 60.53 31.67 0.97 57.79 27.51 3.63 14.14 0.83 -27.84 11.41 -3.18 -25.91 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 B 177 PHE C 431 PHE^? 22.21 O1 GOL D 601 B 263 ASP C 350 ASP.? 24.48 C2 EDO C 602 B 292 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 49.99 26.05 6.28 51.46 26.87 8.49 28.24 21.80 -13.63 26.64 22.64 -15.77 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 60.53 31.67 0.97 57.79 27.51 3.63 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 B 177 PHE D 416 PHE^? 11.70 C3 GOL D 601 B 263 ASP C 448 ASP.? 19.32 O1 GOL D 601 B 292 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 49.99 26.05 6.28 51.46 26.87 8.49 15.40 -2.83 -31.27 15.07 -3.80 -33.86 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 9.52 -2.93 -40.85 10.47 -4.20 -39.42 coo 60.53 31.67 0.97 57.79 27.51 3.63 12.96 9.36 -37.91 9.04 10.02 -41.38 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 B 177 PHE D 431 PHE^? 21.51 O1 EDO C 602 B 263 ASP D 350 ASP.? 24.09 C3 GOL D 601 B 292 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo 49.99 26.05 6.28 51.46 26.87 8.49 39.18 5.51 -45.56 38.23 3.44 -43.92 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 60.53 31.67 0.97 57.79 27.51 3.63 32.90 -6.30 -46.84 30.42 -11.34 -47.14 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 B 177 PHE D 445 PHE~? 11.88 O1 GOL D 601 B 263 ASP C 448 ASP.? 19.32 O1 GOL D 601 B 292 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 49.99 26.05 6.28 51.46 26.87 8.49 10.86 1.23 -30.60 12.85 0.20 -32.29 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 9.52 -2.93 -40.85 10.47 -4.20 -39.42 coo 60.53 31.67 0.97 57.79 27.51 3.63 12.96 9.36 -37.91 9.04 10.02 -41.38 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 B 177 PHE D 445 PHE~? 11.88 O1 GOL D 601 B 263 ASP D 448 ASP.? 19.66 C2 EDO C 602 B 292 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 49.99 26.05 6.28 51.46 26.87 8.49 10.86 1.23 -30.60 12.85 0.20 -32.29 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 60.53 31.67 0.97 57.79 27.51 3.63 12.96 9.36 -37.91 9.04 10.02 -41.38 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 10 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 416 PHE^? 19.67 O1 EDO B 603 C 263 ASP B 448 ASP.? 21.29 O1 EDO B 603 C 292 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 4.63 6.30 7.93 4.64 5.09 5.42 coo 19.84 12.02 9.33 18.68 11.23 7.75 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo 12.82 3.49 4.98 17.80 5.59 1.90 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE A 431 PHE^? 22.59 O1 EDO B 603 C 263 ASP A 350 ASP.? 26.92 O2 GOL D 601 C 292 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 29.40 15.33 -4.65 28.40 13.37 -2.94 coo 19.84 12.02 9.33 18.68 11.23 7.75 33.51 7.96 1.59 32.78 7.85 -0.37 coo 12.82 3.49 4.98 17.80 5.59 1.90 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE B 416 PHE^? 11.67 C2 EDO B 603 C 263 ASP A 448 ASP~? 19.70 O1 EDO B 603 C 292 LYS A 442 LYS~? 23.27 C1 EDO B 603 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -1.62 21.04 3.18 -3.66 21.32 5.09 coo 19.84 12.02 9.33 18.68 11.23 7.75 -6.12 13.55 5.97 -7.03 12.86 4.20 coo 12.82 3.49 4.98 17.80 5.59 1.90 2.76 10.16 11.03 0.96 5.43 12.32 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 177 PHE B 431 PHE^? 23.47 C2 EDO B 603 C 263 ASP B 350 ASP.? 23.89 C2 EDO B 603 C 292 LYS B 391 LYS~? 27.06 C2 EDO B 603 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 13.65 32.28 24.99 12.40 33.20 22.64 coo 19.84 12.02 9.33 18.68 11.23 7.75 12.16 40.72 19.41 11.14 39.74 20.98 coo 12.82 3.49 4.98 17.80 5.59 1.90 1.34 36.06 21.83 0.02 35.49 25.91 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 177 PHE C 416 PHE^? 11.78 C2 EDO C 602 C 263 ASP D 448 ASP.? 19.66 C2 EDO C 602 C 292 LYS D 442 LYS~? 12.65 O2 GOL D 601 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 10.28 12.37 -34.72 8.44 12.42 -32.58 coo 19.84 12.02 9.33 18.68 11.23 7.75 3.66 6.43 -31.01 2.94 8.46 -31.03 coo 12.82 3.49 4.98 17.80 5.59 1.90 14.14 0.83 -27.84 11.41 -3.18 -25.91 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 C 177 PHE C 431 PHE^? 22.21 O1 GOL D 601 C 263 ASP C 350 ASP.? 24.48 C2 EDO C 602 C 292 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 28.24 21.80 -13.63 26.64 22.64 -15.77 coo 19.84 12.02 9.33 18.68 11.23 7.75 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 12.82 3.49 4.98 17.80 5.59 1.90 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 C 177 PHE D 416 PHE^? 11.70 C3 GOL D 601 C 263 ASP C 448 ASP.? 19.32 O1 GOL D 601 C 292 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 15.40 -2.83 -31.27 15.07 -3.80 -33.86 coo 19.84 12.02 9.33 18.68 11.23 7.75 9.52 -2.93 -40.85 10.47 -4.20 -39.42 coo 12.82 3.49 4.98 17.80 5.59 1.90 12.96 9.36 -37.91 9.04 10.02 -41.38 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 C 177 PHE D 431 PHE^? 21.51 O1 EDO C 602 C 263 ASP D 350 ASP.? 24.09 C3 GOL D 601 C 292 LYS D 391 LYS~? 24.88 C3 GOL D 601 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 39.18 5.51 -45.56 38.23 3.44 -43.92 coo 19.84 12.02 9.33 18.68 11.23 7.75 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 12.82 3.49 4.98 17.80 5.59 1.90 32.90 -6.30 -46.84 30.42 -11.34 -47.14 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 8 hits 2oat_c05 naa= 3 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 178 TRP A 407 TRP^? 17.84 O1 EDO B 603 A 263 ASP B 448 ASP.? 21.29 O1 EDO B 603 A 292 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 48.96 45.07 19.49 48.62 41.39 18.16 6.49 5.24 2.04 7.76 7.03 -1.22 coo 54.43 44.82 23.74 55.21 45.06 21.80 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo 63.95 45.30 16.71 59.11 49.15 16.05 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 178 TRP D 407 TRP^? 14.97 C3 GOL D 601 A 263 ASP C 448 ASP.? 19.32 O1 GOL D 601 A 292 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 48.96 45.07 19.49 48.62 41.39 18.16 16.64 -3.51 -37.62 17.68 -1.39 -40.78 coo 54.43 44.82 23.74 55.21 45.06 21.80 9.52 -2.93 -40.85 10.47 -4.20 -39.42 coo 63.95 45.30 16.71 59.11 49.15 16.05 12.96 9.36 -37.91 9.04 10.02 -41.38 2oat_c06 source 2oat ORNITHINE AMINOTRANSFERASE : 2 hits 2oat_c06 naa= 3 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 178 TRP A 407 TRP^? 17.84 O1 EDO B 603 B 263 ASP B 448 ASP.? 21.29 O1 EDO B 603 B 292 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 45.83 31.15 4.65 45.88 34.74 6.24 6.49 5.24 2.04 7.76 7.03 -1.22 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo 60.53 31.67 0.97 57.79 27.51 3.63 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 178 TRP D 407 TRP^? 14.97 C3 GOL D 601 B 263 ASP C 448 ASP.? 19.32 O1 GOL D 601 B 292 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 45.83 31.15 4.65 45.88 34.74 6.24 16.64 -3.51 -37.62 17.68 -1.39 -40.78 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 9.52 -2.93 -40.85 10.47 -4.20 -39.42 coo 60.53 31.67 0.97 57.79 27.51 3.63 12.96 9.36 -37.91 9.04 10.02 -41.38 2oat_c07 source 2oat ORNITHINE AMINOTRANSFERASE : 2 hits 2oat_c07 naa= 3 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 178 TRP A 407 TRP^? 17.84 O1 EDO B 603 C 263 ASP B 448 ASP.? 21.29 O1 EDO B 603 C 292 LYS B 442 LYS~? 13.00 O1 EDO B 603 coo 20.52 16.65 4.15 17.32 18.91 4.39 6.49 5.24 2.04 7.76 7.03 -1.22 coo 19.84 12.02 9.33 18.68 11.23 7.75 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo 12.82 3.49 4.98 17.80 5.59 1.90 1.48 17.85 0.41 -2.11 18.47 -3.79 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 178 TRP D 407 TRP^? 14.97 C3 GOL D 601 C 263 ASP C 448 ASP.? 19.32 O1 GOL D 601 C 292 LYS C 442 LYS~? 13.46 O1 EDO C 602 coo 20.52 16.65 4.15 17.32 18.91 4.39 16.64 -3.51 -37.62 17.68 -1.39 -40.78 coo 19.84 12.02 9.33 18.68 11.23 7.75 9.52 -2.93 -40.85 10.47 -4.20 -39.42 coo 12.82 3.49 4.98 17.80 5.59 1.90 12.96 9.36 -37.91 9.04 10.02 -41.38 2oat_c08 source 2oat ORNITHINE AMINOTRANSFERASE : 2 hits 2oat_c08 naa= 3 ULMN 3 2phk_c03 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 350 ASP.? 26.92 O2 GOL D 601 A 151 LYS A 348 LYS.? 29.38 O1 EDO B 603 A 154 ASN A 347 ASN^? 27.63 C1 EDO B 603 coo 41.42 17.90 44.98 43.39 18.36 45.61 33.51 7.96 1.59 32.78 7.85 -0.37 coo 45.75 16.58 39.61 47.43 18.26 45.54 33.03 14.06 -0.37 37.33 16.69 -0.99 coo 44.77 13.10 43.25 45.01 14.21 45.03 32.85 15.10 3.85 34.45 13.77 4.43 ULMN 3 2phk_c03 MC-PEPTIDE user 2 3 # 2 A 149 ASP B 350 ASP.? 23.89 C2 EDO B 603 A 151 LYS B 348 LYS.? 28.30 C2 EDO B 603 A 154 ASN B 347 ASN^? 23.37 C2 EDO B 603 coo 41.42 17.90 44.98 43.39 18.36 45.61 12.16 40.72 19.41 11.14 39.74 20.98 coo 45.75 16.58 39.61 47.43 18.26 45.54 16.25 36.62 22.07 20.01 34.44 26.08 coo 44.77 13.10 43.25 45.01 14.21 45.03 18.47 36.73 18.25 18.44 38.86 18.15 ULMN 3 2phk_c03 MC-PEPTIDE user 3 3 # 3 A 149 ASP C 350 ASP.? 24.48 C2 EDO C 602 A 151 LYS C 348 LYS.? 28.33 O1 GOL D 601 A 154 ASN C 347 ASN^? 23.48 C1 EDO C 602 coo 41.42 17.90 44.98 43.39 18.36 45.61 27.03 30.18 -18.47 26.26 29.33 -16.72 coo 45.75 16.58 39.61 47.43 18.26 45.54 31.02 25.73 -16.52 36.61 24.80 -13.64 coo 44.77 13.10 43.25 45.01 14.21 45.03 32.68 25.81 -20.60 32.92 27.92 -20.57 ULMN 3 2phk_c03 MC-PEPTIDE user 4 3 # 4 A 149 ASP D 350 ASP.? 24.09 C3 GOL D 601 A 151 LYS D 348 LYS.? 27.59 O1 EDO C 602 A 154 ASN D 347 ASN^? 23.69 C3 GOL D 601 coo 41.42 17.90 44.98 43.39 18.36 45.61 42.88 -2.45 -40.67 41.90 -2.09 -42.54 coo 45.75 16.58 39.61 47.43 18.26 45.54 43.15 3.71 -41.93 47.18 7.62 -43.42 coo 44.77 13.10 43.25 45.01 14.21 45.03 43.61 4.31 -37.61 45.14 2.83 -37.46 2phk_c03 source 2phk MC-PEPTIDE : 4 hits 2phk_c03 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 402 ASP.? 12.59 O1 EDO B 603 166 GLY C 433 GLY^? 21.06 C1 EDO C 602 169 GLU D 330 GLU~? 24.51 C2 GOL D 601 coo 8.28 6.87 1.62 10.08 5.77 1.34 18.87 16.83 -6.49 16.77 17.04 -6.49 coo -8.58 13.22 3.21 -8.90 13.15 4.05 29.21 22.26 -18.37 28.97 21.54 -18.06 coo -16.67 7.89 2.78 -17.65 6.56 1.49 39.35 17.44 -18.72 40.01 18.64 -17.10 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 440 ASP^? 18.54 C1 EDO B 603 166 GLY B 323 GLY.? 23.84 C1 EDO B 603 169 GLU A 330 GLU~? 26.93 C1 EDO B 603 coo 8.28 6.87 1.62 10.08 5.77 1.34 8.21 11.09 12.88 6.30 10.30 13.36 coo -8.58 13.22 3.21 -8.90 13.15 4.05 26.13 18.22 17.28 26.94 18.27 17.39 coo -16.67 7.89 2.78 -17.65 6.56 1.49 25.78 29.04 20.96 25.48 30.78 22.26 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 448 ASP~? 19.70 O1 EDO B 603 166 GLY B 414 GLY.? 9.96 O2 EDO B 603 169 GLU B 363 GLU~? 7.89 O1 EDO B 603 coo 8.28 6.87 1.62 10.08 5.77 1.34 -6.12 13.55 5.97 -7.03 12.86 4.20 coo -8.58 13.22 3.21 -8.90 13.15 4.05 0.04 24.42 -4.70 0.60 24.73 -4.14 coo -16.67 7.89 2.78 -17.65 6.56 1.49 8.83 27.73 -6.37 10.21 26.17 -6.89 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP B 357 ASP.? 13.04 C1 EDO B 603 166 GLY B 374 GLY.? 22.43 O2 EDO B 603 169 GLU B 378 GLU~? 25.07 O2 EDO B 603 coo 8.28 6.87 1.62 10.08 5.77 1.34 19.95 30.44 0.55 20.02 30.85 -1.53 coo -8.58 13.22 3.21 -8.90 13.15 4.05 18.55 43.16 11.52 17.75 43.08 11.36 coo -16.67 7.89 2.78 -17.65 6.56 1.49 7.63 44.96 15.04 7.63 45.65 17.05 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP B 440 ASP^? 5.62 O1 EDO B 603 166 GLY A 323 GLY.? 15.38 C1 EDO B 603 169 GLU B 330 GLU~? 24.65 C1 EDO B 603 coo 8.28 6.87 1.62 10.08 5.77 1.34 5.66 21.79 0.79 4.10 21.14 -0.54 coo -8.58 13.22 3.21 -8.90 13.15 4.05 22.31 31.99 4.41 22.84 32.64 4.56 coo -16.67 7.89 2.78 -17.65 6.56 1.49 31.94 25.81 2.71 33.76 25.37 1.74 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP B 448 ASP.? 21.29 O1 EDO B 603 166 GLY B 414 GLY.? 9.96 O2 EDO B 603 169 GLU B 363 GLU~? 7.89 O1 EDO B 603 coo 8.28 6.87 1.62 10.08 5.77 1.34 -0.19 5.34 -1.92 0.46 4.35 -0.12 coo -8.58 13.22 3.21 -8.90 13.15 4.05 0.04 24.42 -4.70 0.60 24.73 -4.14 coo -16.67 7.89 2.78 -17.65 6.56 1.49 8.83 27.73 -6.37 10.21 26.17 -6.89 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP C 349 ASP.? 28.09 C1 EDO C 602 166 GLY A 399 GLY.? 18.69 O2 GOL D 601 169 GLU A 394 GLU~? 15.90 O2 GOL D 601 coo 8.28 6.87 1.62 10.08 5.77 1.34 32.59 30.21 -17.31 34.23 29.55 -16.13 coo -8.58 13.22 3.21 -8.90 13.15 4.05 24.04 14.08 -10.54 23.93 13.28 -10.73 coo -16.67 7.89 2.78 -17.65 6.56 1.49 27.33 5.77 -8.72 27.90 4.03 -9.75 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP C 349 ASP.? 28.09 C1 EDO C 602 166 GLY C 429 GLY.? 21.29 O2 GOL D 601 169 GLU A 394 GLU~? 15.90 O2 GOL D 601 coo 8.28 6.87 1.62 10.08 5.77 1.34 32.59 30.21 -17.31 34.23 29.55 -16.13 coo -8.58 13.22 3.21 -8.90 13.15 4.05 30.74 14.63 -9.51 31.39 15.13 -9.63 coo -16.67 7.89 2.78 -17.65 6.56 1.49 27.33 5.77 -8.72 27.90 4.03 -9.75 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP C 350 ASP.? 24.48 C2 EDO C 602 166 GLY A 399 GLY.? 18.69 O2 GOL D 601 169 GLU A 394 GLU~? 15.90 O2 GOL D 601 coo 8.28 6.87 1.62 10.08 5.77 1.34 27.03 30.18 -18.47 26.26 29.33 -16.72 coo -8.58 13.22 3.21 -8.90 13.15 4.05 24.04 14.08 -10.54 23.93 13.28 -10.73 coo -16.67 7.89 2.78 -17.65 6.56 1.49 27.33 5.77 -8.72 27.90 4.03 -9.75 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP C 350 ASP.? 24.48 C2 EDO C 602 166 GLY C 429 GLY.? 21.29 O2 GOL D 601 169 GLU A 394 GLU~? 15.90 O2 GOL D 601 coo 8.28 6.87 1.62 10.08 5.77 1.34 27.03 30.18 -18.47 26.26 29.33 -16.72 coo -8.58 13.22 3.21 -8.90 13.15 4.05 30.74 14.63 -9.51 31.39 15.13 -9.63 coo -16.67 7.89 2.78 -17.65 6.56 1.49 27.33 5.77 -8.72 27.90 4.03 -9.75 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP C 387 ASP~? 19.92 O2 EDO B 603 166 GLY B 414 GLY.? 9.96 O2 EDO B 603 169 GLU B 446 GLU~? 12.80 O1 EDO B 603 coo 8.28 6.87 1.62 10.08 5.77 1.34 12.27 32.40 -18.16 12.25 34.11 -16.91 coo -8.58 13.22 3.21 -8.90 13.15 4.05 0.04 24.42 -4.70 0.60 24.73 -4.14 coo -16.67 7.89 2.78 -17.65 6.56 1.49 0.25 13.76 -3.23 0.76 15.38 -4.51 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP C 402 ASP.? 12.78 O1 GOL D 601 166 GLY A 433 GLY^? 21.75 O1 EDO B 603 169 GLU B 330 GLU~? 24.65 C1 EDO B 603 coo 8.28 6.87 1.62 10.08 5.77 1.34 22.26 13.02 -15.38 21.01 11.37 -15.92 coo -8.58 13.22 3.21 -8.90 13.15 4.05 28.83 15.24 0.20 28.24 15.62 -0.26 coo -16.67 7.89 2.78 -17.65 6.56 1.49 31.94 25.81 2.71 33.76 25.37 1.74 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP C 440 ASP^? 5.97 O1 EDO C 602 166 GLY D 323 GLY.? 15.22 C1 EDO C 602 169 GLU C 330 GLU~? 24.03 O1 EDO C 602 coo 8.28 6.87 1.62 10.08 5.77 1.34 17.33 13.03 -37.56 15.74 12.38 -38.82 coo -8.58 13.22 3.21 -8.90 13.15 4.05 34.88 21.72 -34.87 35.47 22.28 -34.67 coo -16.67 7.89 2.78 -17.65 6.56 1.49 43.59 14.91 -37.76 45.12 14.02 -38.99 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 14 3 # 14 141 ASP C 448 ASP.? 19.32 O1 GOL D 601 166 GLY C 414 GLY.? 10.00 O2 EDO C 602 169 GLU C 363 GLU~? 7.78 O2 EDO C 602 coo 8.28 6.87 1.62 10.08 5.77 1.34 9.52 -2.93 -40.85 10.47 -4.20 -39.42 coo -8.58 13.22 3.21 -8.90 13.15 4.05 11.91 16.11 -42.71 12.42 16.37 -42.08 coo -16.67 7.89 2.78 -17.65 6.56 1.49 20.56 19.64 -44.58 21.56 17.87 -45.23 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 15 3 # 15 141 ASP D 440 ASP^? -5.34 O2 GOL D 601s 166 GLY C 323 GLY.? 15.53 C2 GOL D 601 169 GLU D 330 GLU~? 24.51 C2 GOL D 601 coo 8.28 6.87 1.62 10.08 5.77 1.34 19.76 1.27 -26.39 17.89 0.46 -25.75 coo -8.58 13.22 3.21 -8.90 13.15 4.05 38.52 6.83 -23.34 39.38 6.77 -23.23 coo -16.67 7.89 2.78 -17.65 6.56 1.49 39.35 17.44 -18.72 40.01 18.64 -17.10 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 16 3 # 16 141 ASP D 448 ASP.? 19.66 C2 EDO C 602 166 GLY C 414 GLY.? 10.00 O2 EDO C 602 169 GLU C 363 GLU~? 7.78 O2 EDO C 602 coo 8.28 6.87 1.62 10.08 5.77 1.34 3.66 6.43 -31.01 2.94 8.46 -31.03 coo -8.58 13.22 3.21 -8.90 13.15 4.05 11.91 16.11 -42.71 12.42 16.37 -42.08 coo -16.67 7.89 2.78 -17.65 6.56 1.49 20.56 19.64 -44.58 21.56 17.87 -45.23 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 17 3 # 17 141 ASP D 448 ASP.? 19.66 C2 EDO C 602 166 GLY D 414 GLY.? 9.76 O2 GOL D 601 169 GLU D 363 GLU~? 7.90 O2 GOL D 601 coo 8.28 6.87 1.62 10.08 5.77 1.34 3.66 6.43 -31.01 2.94 8.46 -31.03 coo -8.58 13.22 3.21 -8.90 13.15 4.05 16.70 -5.33 -22.82 17.39 -5.12 -23.25 coo -16.67 7.89 2.78 -17.65 6.56 1.49 24.65 -2.66 -18.42 24.14 -0.86 -17.43 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 17 hits 2tdt_c00 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR A 418 TYR^? 12.62 O1 EDO B 603 A 214 ASP A 440 ASP^? 18.54 C1 EDO B 603 A 256 LYS A 367 LYS.? 27.79 C1 EDO B 603 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 9.59 11.03 3.92 9.74 11.89 1.25 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 8.21 11.09 12.88 6.30 10.30 13.36 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 21.09 4.68 15.64 17.32 4.21 18.91 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 2 3 # 2 A 122 TYR A 418 TYR^? 12.62 O1 EDO B 603 A 214 ASP A 440 ASP^? 18.54 C1 EDO B 603 A 256 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 9.59 11.03 3.92 9.74 11.89 1.25 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 8.21 11.09 12.88 6.30 10.30 13.36 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 3 3 # 3 A 122 TYR A 421 TYR^? 19.72 O1 EDO B 603 A 214 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 256 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 20.02 8.83 1.38 20.18 6.69 3.20 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 18.87 16.83 -6.49 16.77 17.04 -6.49 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 4 3 # 4 A 122 TYR A 437 TYR^? 11.45 C1 EDO B 603 A 214 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 256 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 16.79 15.50 5.48 15.91 16.43 3.01 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 18.87 16.83 -6.49 16.77 17.04 -6.49 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 5 3 # 5 A 122 TYR A 437 TYR^? 11.45 C1 EDO B 603 A 214 ASP A 440 ASP^? 18.54 C1 EDO B 603 A 256 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 16.79 15.50 5.48 15.91 16.43 3.01 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 8.21 11.09 12.88 6.30 10.30 13.36 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 6 3 # 6 A 122 TYR B 418 TYR^? 11.01 C2 EDO B 603 A 214 ASP B 440 ASP^? 5.62 O1 EDO B 603 A 256 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 3.01 21.54 9.44 2.74 20.74 12.09 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 5.66 21.79 0.79 4.10 21.14 -0.54 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 7 3 # 7 A 122 TYR B 418 TYR^? 11.01 C2 EDO B 603 A 214 ASP B 440 ASP^? 5.62 O1 EDO B 603 A 256 LYS B 367 LYS.? 8.96 O2 EDO B 603 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 3.01 21.54 9.44 2.74 20.74 12.09 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 5.66 21.79 0.79 4.10 21.14 -0.54 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 8.46 36.63 1.57 6.31 34.95 -1.21 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 8 3 # 8 A 122 TYR B 437 TYR^? 10.72 C1 EDO B 603 A 214 ASP B 440 ASP^? 5.62 O1 EDO B 603 A 256 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 10.92 24.41 11.32 10.27 22.67 13.43 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 5.66 21.79 0.79 4.10 21.14 -0.54 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 9 3 # 9 A 122 TYR C 418 TYR^? 10.50 O1 GOL D 601 A 214 ASP C 440 ASP^? 5.97 O1 EDO C 602 A 256 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 15.25 12.39 -28.72 15.00 11.49 -26.08 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 17.33 13.03 -37.56 15.74 12.38 -38.82 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 27.51 4.47 -43.69 23.30 8.13 -41.81 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 10 3 # 10 A 122 TYR C 421 TYR^? 13.35 C2 EDO C 602 A 214 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 256 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 19.38 20.76 -23.26 18.18 22.24 -25.31 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 22.26 13.02 -15.38 21.01 11.37 -15.92 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 11 3 # 11 A 122 TYR C 437 TYR^? 9.81 O1 GOL D 601 A 214 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 256 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 23.51 14.66 -27.39 22.94 13.02 -25.21 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 22.26 13.02 -15.38 21.01 11.37 -15.92 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 12 3 # 12 A 122 TYR C 437 TYR^? 9.81 O1 GOL D 601 A 214 ASP C 440 ASP^? 5.97 O1 EDO C 602 A 256 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 23.51 14.66 -27.39 22.94 13.02 -25.21 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 17.33 13.03 -37.56 15.74 12.38 -38.82 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 27.51 4.47 -43.69 23.30 8.13 -41.81 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 13 3 # 13 A 122 TYR D 418 TYR^? 10.77 C1 GOL D 601 A 214 ASP D 440 ASP^? -5.34 O2 GOL D 601s A 256 LYS D 367 LYS.? 8.67 O3 GOL D 601 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 20.16 1.85 -35.57 20.10 2.87 -38.19 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 19.76 1.27 -26.39 17.89 0.46 -25.75 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 32.17 -6.41 -25.63 28.00 -7.23 -22.20 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 13 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR A 418 TYR^? 12.62 O1 EDO B 603 B 214 ASP A 440 ASP^? 18.54 C1 EDO B 603 B 256 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo -32.67 22.74 10.17 -32.85 23.98 7.70 9.59 11.03 3.92 9.74 11.89 1.25 coo -26.88 17.61 16.89 -26.08 17.11 15.00 8.21 11.09 12.88 6.30 10.30 13.36 coo -16.04 12.06 11.09 -17.97 10.54 5.71 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 2 3 # 2 B 122 TYR A 421 TYR^? 19.72 O1 EDO B 603 B 214 ASP A 402 ASP.? 12.59 O1 EDO B 603 B 256 LYS C 403 LYS^? 9.83 O1 GOL D 601 coo -32.67 22.74 10.17 -32.85 23.98 7.70 20.02 8.83 1.38 20.18 6.69 3.20 coo -26.88 17.61 16.89 -26.08 17.11 15.00 18.87 16.83 -6.49 16.77 17.04 -6.49 coo -16.04 12.06 11.09 -17.97 10.54 5.71 19.56 15.05 -18.65 18.30 10.78 -20.22 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 3 3 # 3 B 122 TYR A 437 TYR^? 11.45 C1 EDO B 603 B 214 ASP A 402 ASP.? 12.59 O1 EDO B 603 B 256 LYS A 391 LYS~? 19.54 O2 GOL D 601 coo -32.67 22.74 10.17 -32.85 23.98 7.70 16.79 15.50 5.48 15.91 16.43 3.01 coo -26.88 17.61 16.89 -26.08 17.11 15.00 18.87 16.83 -6.49 16.77 17.04 -6.49 coo -16.04 12.06 11.09 -17.97 10.54 5.71 24.25 2.80 -4.96 21.44 -2.66 -5.78 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 4 3 # 4 B 122 TYR A 437 TYR^? 11.45 C1 EDO B 603 B 214 ASP A 440 ASP^? 18.54 C1 EDO B 603 B 256 LYS B 403 LYS^? 16.64 C2 EDO B 603 coo -32.67 22.74 10.17 -32.85 23.98 7.70 16.79 15.50 5.48 15.91 16.43 3.01 coo -26.88 17.61 16.89 -26.08 17.11 15.00 8.21 11.09 12.88 6.30 10.30 13.36 coo -16.04 12.06 11.09 -17.97 10.54 5.71 6.24 24.71 19.66 5.62 19.48 17.38 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 5 3 # 5 B 122 TYR B 418 TYR^? 11.01 C2 EDO B 603 B 214 ASP B 440 ASP^? 5.62 O1 EDO B 603 B 256 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo -32.67 22.74 10.17 -32.85 23.98 7.70 3.01 21.54 9.44 2.74 20.74 12.09 coo -26.88 17.61 16.89 -26.08 17.11 15.00 5.66 21.79 0.79 4.10 21.14 -0.54 coo -16.04 12.06 11.09 -17.97 10.54 5.71 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 6 3 # 6 B 122 TYR B 418 TYR^? 11.01 C2 EDO B 603 B 214 ASP B 440 ASP^? 5.62 O1 EDO B 603 B 256 LYS B 367 LYS.? 8.96 O2 EDO B 603 coo -32.67 22.74 10.17 -32.85 23.98 7.70 3.01 21.54 9.44 2.74 20.74 12.09 coo -26.88 17.61 16.89 -26.08 17.11 15.00 5.66 21.79 0.79 4.10 21.14 -0.54 coo -16.04 12.06 11.09 -17.97 10.54 5.71 8.46 36.63 1.57 6.31 34.95 -1.21 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 7 3 # 7 B 122 TYR B 437 TYR^? 10.72 C1 EDO B 603 B 214 ASP B 440 ASP^? 5.62 O1 EDO B 603 B 256 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo -32.67 22.74 10.17 -32.85 23.98 7.70 10.92 24.41 11.32 10.27 22.67 13.43 coo -26.88 17.61 16.89 -26.08 17.11 15.00 5.66 21.79 0.79 4.10 21.14 -0.54 coo -16.04 12.06 11.09 -17.97 10.54 5.71 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 8 3 # 8 B 122 TYR C 418 TYR^? 10.50 O1 GOL D 601 B 214 ASP C 440 ASP^? 5.97 O1 EDO C 602 B 256 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo -32.67 22.74 10.17 -32.85 23.98 7.70 15.25 12.39 -28.72 15.00 11.49 -26.08 coo -26.88 17.61 16.89 -26.08 17.11 15.00 17.33 13.03 -37.56 15.74 12.38 -38.82 coo -16.04 12.06 11.09 -17.97 10.54 5.71 27.51 4.47 -43.69 23.30 8.13 -41.81 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 9 3 # 9 B 122 TYR C 421 TYR^? 13.35 C2 EDO C 602 B 214 ASP C 402 ASP.? 12.78 O1 GOL D 601 B 256 LYS A 403 LYS^? 8.85 O1 EDO B 603 coo -32.67 22.74 10.17 -32.85 23.98 7.70 19.38 20.76 -23.26 18.18 22.24 -25.31 coo -26.88 17.61 16.89 -26.08 17.11 15.00 22.26 13.02 -15.38 21.01 11.37 -15.92 coo -16.04 12.06 11.09 -17.97 10.54 5.71 17.56 13.24 -3.73 14.59 17.27 -0.83 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 10 3 # 10 B 122 TYR C 437 TYR^? 9.81 O1 GOL D 601 B 214 ASP C 402 ASP.? 12.78 O1 GOL D 601 B 256 LYS C 391 LYS~? 16.77 O1 EDO B 603 coo -32.67 22.74 10.17 -32.85 23.98 7.70 23.51 14.66 -27.39 22.94 13.02 -25.21 coo -26.88 17.61 16.89 -26.08 17.11 15.00 22.26 13.02 -15.38 21.01 11.37 -15.92 coo -16.04 12.06 11.09 -17.97 10.54 5.71 15.56 26.67 -15.99 9.90 23.87 -16.19 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 11 3 # 11 B 122 TYR C 437 TYR^? 9.81 O1 GOL D 601 B 214 ASP C 440 ASP^? 5.97 O1 EDO C 602 B 256 LYS D 403 LYS^? 8.04 O1 EDO C 602 coo -32.67 22.74 10.17 -32.85 23.98 7.70 23.51 14.66 -27.39 22.94 13.02 -25.21 coo -26.88 17.61 16.89 -26.08 17.11 15.00 17.33 13.03 -37.56 15.74 12.38 -38.82 coo -16.04 12.06 11.09 -17.97 10.54 5.71 27.51 4.47 -43.69 23.30 8.13 -41.81 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 11 hits 2tpl_c05 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG B 368 ARG.? 11.04 O2 EDO B 603 B 130 SER B 358 SER.? 7.25 C1 EDO B 603 B 159 LYS B 367 LYS.? 8.96 O2 EDO B 603 coo 58.72 31.58 20.45 60.80 29.39 20.94 11.09 36.07 6.20 8.36 35.36 7.43 coo 61.66 35.17 10.39 61.29 34.14 12.56 16.90 26.63 0.02 16.29 24.39 0.69 coo 65.38 28.77 21.17 63.49 28.03 16.12 8.46 36.63 1.57 6.31 34.95 -1.21 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 B 59 ARG B 368 ARG.? 11.04 O2 EDO B 603 B 130 SER B 371 SER~? 20.39 O2 EDO B 603 B 159 LYS B 367 LYS.? 8.96 O2 EDO B 603 coo 58.72 31.58 20.45 60.80 29.39 20.94 11.09 36.07 6.20 8.36 35.36 7.43 coo 61.66 35.17 10.39 61.29 34.14 12.56 16.10 44.50 4.20 15.46 45.36 2.02 coo 65.38 28.77 21.17 63.49 28.03 16.12 8.46 36.63 1.57 6.31 34.95 -1.21 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 2 hits 2tps_c01 naa= 3 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 3 # 1 71 ARG A 425 ARG^? 21.19 O1 EDO B 603 127 ARG C 425 ARG^? 21.48 O1 GOL D 601 270 GLU A 394 GLU~? 15.90 O2 GOL D 601 coo -1.14 25.72 1.64 0.76 28.10 1.50 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 27.32 15.93 -12.34 26.51 18.69 -11.26 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 27.33 5.77 -8.72 27.90 4.03 -9.75 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 3 # 2 71 ARG A 425 ARG^? 21.19 O1 EDO B 603 127 ARG C 425 ARG^? 21.48 O1 GOL D 601 270 GLU C 394 GLU~? 16.86 O1 EDO B 603 coo -1.14 25.72 1.64 0.76 28.10 1.50 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 27.32 15.93 -12.34 26.51 18.69 -11.26 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 19.77 27.90 -12.93 18.57 29.44 -12.10 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 3 3 # 3 71 ARG C 425 ARG^? 21.48 O1 GOL D 601 127 ARG A 425 ARG^? 21.19 O1 EDO B 603 270 GLU A 394 GLU~? 15.90 O2 GOL D 601 coo -1.14 25.72 1.64 0.76 28.10 1.50 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 25.04 18.93 -7.11 26.86 16.62 -8.01 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 27.33 5.77 -8.72 27.90 4.03 -9.75 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 4 3 # 4 71 ARG C 425 ARG^? 21.48 O1 GOL D 601 127 ARG A 425 ARG^? 21.19 O1 EDO B 603 270 GLU C 394 GLU~? 16.86 O1 EDO B 603 coo -1.14 25.72 1.64 0.76 28.10 1.50 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 25.04 18.93 -7.11 26.86 16.62 -8.01 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 19.77 27.90 -12.93 18.57 29.44 -12.10 5cpa_c01 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 4 hits 5cpa_c01 naa= 3 ULMN 3 9pap_c01 PAPAIN user 1 3 # 1 19 GLN A 372 GLN~? 29.79 C1 EDO B 603 25 CYH A 380 CYH~? 29.74 C1 EDO B 603 159 HIS A 381 HIS.? 27.31 O1 EDO B 603 coo 32.31 73.73 23.96 30.81 72.30 23.25 29.22 4.55 14.43 27.23 4.14 13.82 coo 28.80 72.58 20.00 27.22 70.79 21.44 29.01 2.63 9.50 30.23 5.08 9.65 coo 29.11 66.58 21.75 30.70 67.95 21.84 25.64 1.98 6.69 25.07 4.00 6.65 ULMN 3 9pap_c01 PAPAIN user 2 3 # 2 19 GLN B 372 GLN~? 15.06 O2 EDO B 603 25 CYH B 380 CYH~? 15.26 O2 EDO B 603 159 HIS B 381 HIS.? 15.29 C2 EDO B 603 coo 32.31 73.73 23.96 30.81 72.30 23.25 11.94 42.08 6.13 10.66 40.49 5.62 coo 28.80 72.58 20.00 27.22 70.79 21.44 8.08 40.31 9.00 10.50 39.00 9.22 coo 29.11 66.58 21.75 30.70 67.95 21.84 4.86 38.27 11.07 6.17 36.67 11.45 ULMN 3 9pap_c01 PAPAIN user 3 3 # 3 19 GLN C 372 GLN~? 15.13 O2 EDO C 602 25 CYH C 380 CYH~? 18.52 O2 EDO C 602 159 HIS C 381 HIS~? 16.26 O2 EDO C 602 coo 32.31 73.73 23.96 30.81 72.30 23.25 25.94 32.46 -32.01 24.35 31.02 -32.18 coo 28.80 72.58 20.00 27.22 70.79 21.44 22.88 33.08 -27.72 25.47 32.05 -27.37 coo 29.11 66.58 21.75 30.70 67.95 21.84 19.26 30.57 -26.59 20.09 28.69 -27.02 ULMN 3 9pap_c01 PAPAIN user 4 3 # 4 19 GLN D 372 GLN~? 15.37 O3 GOL D 601 25 CYH D 380 CYH~? 19.05 O3 GOL D 601 159 HIS D 381 HIS.? 16.49 O3 GOL D 601 coo 32.31 73.73 23.96 30.81 72.30 23.25 40.13 -6.96 -28.62 37.98 -6.85 -28.89 coo 28.80 72.58 20.00 27.22 70.79 21.44 39.90 -9.16 -33.04 41.11 -6.65 -32.46 coo 29.11 66.58 21.75 30.70 67.95 21.84 36.03 -8.97 -35.15 35.55 -7.12 -34.29 9pap_c01 source 9pap PAPAIN : 4 hits 9pap_c01 naa= 3 ULMN 4 1bqp_p00 PROTEIN (LECTIN) user 1 4 # 1 A 80 ALA A 423 ALA^? 17.43 O1 EDO B 603 A 81 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 99 GLY C 399 GLY.? 18.04 O1 EDO B 603 A 125 ASN C 398 ASN~? 15.53 O1 EDO B 603 coo 19.43 1.05 36.35 20.96 1.11 36.31 23.34 15.61 -2.79 23.45 15.65 -4.34 coo 19.96 4.58 34.44 21.97 4.19 34.87 18.87 16.83 -6.49 16.77 17.04 -6.49 coo 22.98 7.95 34.76 23.00 8.20 34.02 22.21 18.06 -10.13 21.51 18.50 -10.08 coo 24.48 8.71 39.91 23.90 7.42 38.32 21.01 22.53 -8.94 21.24 24.62 -8.84 ULMN 4 1bqp_p00 PROTEIN (LECTIN) user 2 4 # 2 A 80 ALA C 423 ALA^? 17.19 O1 GOL D 601 A 81 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 99 GLY A 399 GLY.? 18.69 O2 GOL D 601 A 125 ASN A 398 ASN~? 16.47 O2 GOL D 601 coo 19.43 1.05 36.35 20.96 1.11 36.31 25.18 17.70 -17.34 24.76 17.44 -15.88 coo 19.96 4.58 34.44 21.97 4.19 34.87 22.26 13.02 -15.38 21.01 11.37 -15.92 coo 22.98 7.95 34.76 23.00 8.20 34.02 24.04 14.08 -10.54 23.93 13.28 -10.73 coo 24.48 8.71 39.91 23.90 7.42 38.32 26.81 10.21 -11.17 28.62 9.13 -11.03 1bqp_p00 source 1bqp PROTEIN (LECTIN) : 2 hits 1bqp_p00 naa= 4 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 1 3 # 1 A 81 ASP A 357 ASP.? 25.14 C1 EDO B 603 A 99 GLY B 323 GLY.? 23.84 C1 EDO B 603 A 125 ASN A 333 ASN~? 23.15 C1 EDO B 603 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 22.54 16.74 19.72 22.05 16.00 21.61 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 26.13 18.22 17.28 26.94 18.27 17.39 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 25.58 24.27 17.00 25.61 22.33 17.91 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 2 3 # 2 A 81 ASP A 402 ASP.? 12.59 O1 EDO B 603 A 99 GLY C 399 GLY.? 18.04 O1 EDO B 603 A 125 ASN C 398 ASN~? 15.53 O1 EDO B 603 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 18.87 16.83 -6.49 16.77 17.04 -6.49 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 22.21 18.06 -10.13 21.51 18.50 -10.08 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 21.01 22.53 -8.94 21.24 24.62 -8.84 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 3 3 # 3 A 81 ASP A 426 ASP.? 22.31 O1 EDO B 603 A 99 GLY A 429 GLY.? 20.67 O1 EDO B 603 A 125 ASN C 398 ASN~? 15.53 O1 EDO B 603 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 29.17 24.78 -3.72 30.40 24.16 -5.34 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 27.23 22.60 -8.91 27.96 22.71 -8.54 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 21.01 22.53 -8.94 21.24 24.62 -8.84 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 4 3 # 4 A 81 ASP B 357 ASP.? 13.04 C1 EDO B 603 A 99 GLY A 323 GLY.? 15.38 C1 EDO B 603 A 125 ASN B 333 ASN~? 17.11 C1 EDO B 603 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 19.95 30.44 0.55 20.02 30.85 -1.53 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 22.31 31.99 4.41 22.84 32.64 4.56 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 26.50 27.72 5.31 25.42 29.17 4.18 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 5 3 # 5 A 81 ASP C 357 ASP.? 12.50 O2 EDO C 602 A 99 GLY D 323 GLY.? 15.22 C1 EDO C 602 A 125 ASN C 333 ASN~? 16.90 C1 EDO C 602 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 32.02 20.63 -38.57 31.77 21.72 -40.39 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 34.88 21.72 -34.87 35.47 22.28 -34.67 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 38.73 17.09 -34.48 37.68 18.68 -35.44 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 6 3 # 6 A 81 ASP C 402 ASP.? 12.78 O1 GOL D 601 A 99 GLY A 399 GLY.? 18.69 O2 GOL D 601 A 125 ASN A 398 ASN~? 16.47 O2 GOL D 601 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 22.26 13.02 -15.38 21.01 11.37 -15.92 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 24.04 14.08 -10.54 23.93 13.28 -10.73 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 26.81 10.21 -11.17 28.62 9.13 -11.03 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 7 3 # 7 A 81 ASP C 426 ASP.? 22.72 C2 GOL D 601 A 99 GLY C 429 GLY.? 21.29 O2 GOL D 601 A 125 ASN A 398 ASN~? 16.47 O2 GOL D 601 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 35.09 15.28 -13.55 34.97 16.40 -11.75 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 30.74 14.63 -9.51 31.39 15.13 -9.63 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 26.81 10.21 -11.17 28.62 9.13 -11.03 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 8 3 # 8 A 81 ASP D 357 ASP.? 12.64 O3 GOL D 601 A 99 GLY C 323 GLY.? 15.53 C2 GOL D 601 A 125 ASN D 333 ASN~? 17.27 C2 GOL D 601 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 34.52 5.19 -20.65 34.58 3.94 -18.98 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 38.52 6.83 -23.34 39.38 6.77 -23.23 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 38.40 12.82 -22.80 38.46 10.80 -22.10 1hkd_p00 source 1hkd PEA LECTIN ALPHA CHAIN : 8 hits 1hkd_p00 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 324 ASN.? 13.71 O2 EDO B 603 coo 5.80 63.03 55.85 5.52 65.03 56.45 19.23 35.37 3.15 19.16 34.35 1.29 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 333 ASN~? 23.15 C1 EDO B 603 coo 5.80 63.03 55.85 5.52 65.03 56.45 25.58 24.27 17.00 25.61 22.33 17.91 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 337 ASN~? 21.47 C1 EDO B 603 coo 5.80 63.03 55.85 5.52 65.03 56.45 20.37 20.71 18.22 22.41 20.05 18.06 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 347 ASN^? 27.63 C1 EDO B 603 coo 5.80 63.03 55.85 5.52 65.03 56.45 32.85 15.10 3.85 34.45 13.77 4.43 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 356 ASN.? 18.20 C1 EDO B 603 coo 5.80 63.03 55.85 5.52 65.03 56.45 21.62 17.22 14.34 19.81 16.20 13.98 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN A 376 ASN~? 30.77 O2 GOL D 601 coo 5.80 63.03 55.85 5.52 65.03 56.45 35.45 5.09 5.49 35.04 5.15 3.39 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN A 398 ASN~? 16.47 O2 GOL D 601 coo 5.80 63.03 55.85 5.52 65.03 56.45 26.81 10.21 -11.17 28.62 9.13 -11.03 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN A 405 ASN^? 12.74 O1 EDO B 603 coo 5.80 63.03 55.85 5.52 65.03 56.45 12.33 9.89 -0.90 12.81 11.91 -1.36 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN B 324 ASN.? 26.30 C1 EDO B 603 coo 5.80 63.03 55.85 5.52 65.03 56.45 26.83 13.52 17.81 25.43 13.66 19.36 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN B 333 ASN~? 17.11 C1 EDO B 603 coo 5.80 63.03 55.85 5.52 65.03 56.45 26.50 27.72 5.31 25.42 29.17 4.18 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN B 337 ASN~? 13.41 C1 EDO B 603 coo 5.80 63.03 55.85 5.52 65.03 56.45 21.54 26.32 1.73 21.98 28.23 2.58 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN B 347 ASN^? 23.37 C2 EDO B 603 coo 5.80 63.03 55.85 5.52 65.03 56.45 18.47 36.73 18.25 18.44 38.86 18.15 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN B 356 ASN.? 8.23 C1 EDO B 603 coo 5.80 63.03 55.85 5.52 65.03 56.45 18.03 28.57 5.10 16.12 27.74 4.68 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN B 376 ASN~? 24.05 C2 EDO B 603 coo 5.80 63.03 55.85 5.52 65.03 56.45 11.86 44.76 15.81 10.83 43.80 17.41 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 15 1 # 15 A 461 ASN B 398 ASN~? 28.43 C2 EDO B 603 coo 5.80 63.03 55.85 5.52 65.03 56.45 6.35 32.55 29.26 6.04 34.62 28.91 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 16 1 # 16 A 461 ASN B 405 ASN^? 14.52 C2 EDO B 603 coo 5.80 63.03 55.85 5.52 65.03 56.45 1.99 23.48 14.63 3.63 22.52 15.58 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 17 1 # 17 A 461 ASN C 324 ASN.? 13.62 O3 GOL D 601 coo 5.80 63.03 55.85 5.52 65.03 56.45 38.59 2.13 -22.95 37.27 2.55 -21.34 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 18 1 # 18 A 461 ASN C 333 ASN~? 16.90 C1 EDO C 602 coo 5.80 63.03 55.85 5.52 65.03 56.45 38.73 17.09 -34.48 37.68 18.68 -35.44 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 19 1 # 19 A 461 ASN C 337 ASN~? 13.18 C1 EDO C 602 coo 5.80 63.03 55.85 5.52 65.03 56.45 33.28 16.29 -37.60 34.03 18.13 -36.82 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 20 1 # 20 A 461 ASN C 347 ASN^? 23.48 C1 EDO C 602 coo 5.80 63.03 55.85 5.52 65.03 56.45 32.68 25.81 -20.60 32.92 27.92 -20.57 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 21 1 # 21 A 461 ASN C 356 ASN.? 8.10 C1 EDO C 602 coo 5.80 63.03 55.85 5.52 65.03 56.45 30.42 18.66 -33.90 28.43 18.01 -34.20 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 22 1 # 22 A 461 ASN C 376 ASN~? 24.86 O2 EDO C 602 coo 5.80 63.03 55.85 5.52 65.03 56.45 27.15 34.69 -21.55 26.19 33.87 -19.83 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 23 1 # 23 A 461 ASN C 398 ASN~? 15.53 O1 EDO B 603 coo 5.80 63.03 55.85 5.52 65.03 56.45 21.01 22.53 -8.94 21.24 24.62 -8.84 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 24 1 # 24 A 461 ASN C 405 ASN^? 11.21 O1 GOL D 601 coo 5.80 63.03 55.85 5.52 65.03 56.45 14.76 14.23 -23.45 16.38 13.06 -22.71 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 25 1 # 25 A 461 ASN D 324 ASN.? 13.50 O2 EDO C 602 coo 5.80 63.03 55.85 5.52 65.03 56.45 32.08 25.49 -35.40 31.73 24.73 -37.32 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 26 1 # 26 A 461 ASN D 333 ASN~? 17.27 C2 GOL D 601 coo 5.80 63.03 55.85 5.52 65.03 56.45 38.40 12.82 -22.80 38.46 10.80 -22.10 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 27 1 # 27 A 461 ASN D 337 ASN~? 13.43 C2 GOL D 601 coo 5.80 63.03 55.85 5.52 65.03 56.45 33.20 9.44 -21.47 35.12 8.58 -21.91 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 28 1 # 28 A 461 ASN D 347 ASN^? 23.69 C3 GOL D 601 coo 5.80 63.03 55.85 5.52 65.03 56.45 43.61 4.31 -37.61 45.14 2.83 -37.46 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 29 1 # 29 A 461 ASN D 356 ASN.? 8.43 C2 GOL D 601 coo 5.80 63.03 55.85 5.52 65.03 56.45 33.56 6.37 -25.67 31.64 5.54 -26.08 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 30 1 # 30 A 461 ASN D 376 ASN~? 25.04 O3 GOL D 601 coo 5.80 63.03 55.85 5.52 65.03 56.45 45.52 -5.82 -37.17 44.96 -5.40 -39.18 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 31 1 # 31 A 461 ASN D 398 ASN~? 25.80 O1 EDO C 602 coo 5.80 63.03 55.85 5.52 65.03 56.45 35.65 1.59 -52.48 36.44 -0.37 -52.06 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 32 1 # 32 A 461 ASN D 405 ASN^? 12.21 O1 EDO C 602 coo 5.80 63.03 55.85 5.52 65.03 56.45 22.38 1.13 -40.71 22.97 3.13 -41.03 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 32 hits 1kbk_p00 naa= 1 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 1 3 # 1 A 56 TYR C 326 TYR^? 22.46 O3 GOL D 601 A 112 PHE D 345 PHE^? 18.57 C3 GOL D 601 A 140 ASN D 347 ASN^? 23.69 C3 GOL D 601 coo -6.29 44.15 17.65 -9.00 44.92 17.68 45.91 5.03 -28.85 46.66 3.15 -30.76 coo -7.38 52.77 16.75 -5.54 52.71 18.82 38.63 5.82 -34.75 40.11 6.86 -36.92 coo -4.46 50.64 12.29 -5.69 49.89 13.85 43.61 4.31 -37.61 45.14 2.83 -37.46 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 2 3 # 2 A 56 TYR D 326 TYR^? 23.09 O2 EDO C 602 A 112 PHE C 345 PHE^? 18.39 C1 EDO C 602 A 140 ASN C 347 ASN^? 23.48 C1 EDO C 602 coo -6.29 44.15 17.65 -9.00 44.92 17.68 38.71 27.20 -29.06 40.04 28.98 -30.75 coo -7.38 52.77 16.75 -5.54 52.71 18.82 30.97 21.80 -24.09 32.10 21.77 -21.54 coo -4.46 50.64 12.29 -5.69 49.89 13.85 32.68 25.81 -20.60 32.92 27.92 -20.57 1o8s_p00 source 1o8s PUTATIVE ENDO-XYLANASE : 2 hits 1o8s_p00 naa= 3 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 1 4 # 1 A 25 ILE A 351 ILE.? 30.07 C1 EDO B 603 A 52 ASN C 333 ASN~? 16.90 C1 EDO C 602 A 53 VAL C 329 VAL~? 23.05 C1 EDO C 602 A 78 ASN A 376 ASN~? 30.77 O2 GOL D 601 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 34.91 11.09 6.39 35.77 10.15 7.02 coo 81.20 29.47 37.49 79.47 28.44 38.24 38.73 17.09 -34.48 37.68 18.68 -35.44 coo 82.17 24.86 36.27 81.03 23.67 37.80 43.30 15.47 -31.48 43.67 17.44 -30.57 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 35.45 5.09 5.49 35.04 5.15 3.39 1qfw_p00 source 1qfw GONADOTROPIN ALPHA SUBUNIT : 1 hits 1qfw_p00 naa= 4 ULMN 5 1u4j_p00 PHOSPHOLIPASE A2 ISOFORM 2 user 1 5 # 1 A 2 LEU A 341 LEU.? 12.32 C1 EDO B 603 A 31 TYR A 354 TYR^? 20.91 C1 EDO B 603 A 32 GLY B 323 GLY.? 23.84 C1 EDO B 603 A 49 ASP A 357 ASP.? 25.14 C1 EDO B 603 A 64 LEU A 339 LEU~? 12.32 C1 EDO B 603 coo 17.65 19.60 -6.47 17.30 21.43 -5.38 15.39 16.50 10.50 14.22 17.33 8.84 coo 14.61 30.95 -3.62 14.67 31.99 -6.22 27.10 16.84 11.56 24.90 18.34 12.50 coo 18.00 33.20 -2.62 17.94 32.79 -1.95 26.13 18.22 17.28 26.94 18.27 17.39 coo 23.82 30.85 -3.15 21.80 30.70 -2.93 22.54 16.74 19.72 22.05 16.00 21.61 coo 17.75 22.71 -10.33 17.59 24.38 -8.98 15.71 20.93 12.39 16.05 22.67 11.09 ULMN 5 1u4j_p00 PHOSPHOLIPASE A2 ISOFORM 2 user 2 5 # 2 A 2 LEU B 341 LEU.? 6.12 C1 EDO B 603 A 31 TYR B 354 TYR^? 14.48 C1 EDO B 603 A 32 GLY A 323 GLY.? 15.38 C1 EDO B 603 A 49 ASP B 357 ASP.? 13.04 C1 EDO B 603 A 64 LEU B 339 LEU.? 10.03 C1 EDO B 603 coo 17.65 19.60 -6.47 17.30 21.43 -5.38 12.64 23.79 6.14 12.06 22.08 7.37 coo 14.61 30.95 -3.62 14.67 31.99 -6.22 19.63 32.53 9.54 19.95 30.09 8.18 coo 18.00 33.20 -2.62 17.94 32.79 -1.95 22.31 31.99 4.41 22.84 32.64 4.56 coo 23.82 30.85 -3.15 21.80 30.70 -2.93 19.95 30.44 0.55 20.02 30.85 -1.53 coo 17.75 22.71 -10.33 17.59 24.38 -8.98 16.90 21.51 5.38 17.99 20.40 6.89 ULMN 5 1u4j_p00 PHOSPHOLIPASE A2 ISOFORM 2 user 3 5 # 3 A 2 LEU C 341 LEU.? 6.12 C1 EDO C 602 A 31 TYR C 354 TYR^? 14.37 C1 EDO C 602 A 32 GLY D 323 GLY.? 15.22 C1 EDO C 602 A 49 ASP C 357 ASP.? 12.50 O2 EDO C 602 A 64 LEU C 339 LEU~? 9.90 C1 EDO C 602 coo 17.65 19.60 -6.47 17.30 21.43 -5.38 24.86 14.23 -32.54 24.31 12.49 -31.36 coo 14.61 30.95 -3.62 14.67 31.99 -6.22 32.76 22.10 -29.37 32.74 19.75 -30.93 coo 18.00 33.20 -2.62 17.94 32.79 -1.95 34.88 21.72 -34.87 35.47 22.28 -34.67 coo 23.82 30.85 -3.15 21.80 30.70 -2.93 32.02 20.63 -38.57 31.77 21.72 -40.39 coo 17.75 22.71 -10.33 17.59 24.38 -8.98 28.74 11.58 -33.79 29.79 10.33 -32.40 1u4j_p00 source 1u4j PHOSPHOLIPASE A2 ISOFORM 2 : 3 hits 1u4j_p00 naa= 5 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 326 TYR^? 23.02 O2 EDO B 603 A 108 ASN B 337 ASN~? 13.41 C1 EDO B 603 A 135 ASN A 324 ASN.? 13.71 O2 EDO B 603 coo 17.59 4.66 17.88 15.38 5.96 18.97 24.84 38.31 9.87 26.02 39.99 8.01 coo 12.36 16.24 15.27 12.06 14.29 16.05 21.54 26.32 1.73 21.98 28.23 2.58 coo 18.05 11.56 12.71 17.57 10.75 14.60 19.23 35.37 3.15 19.16 34.35 1.29 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 2 3 # 2 A 51 TYR A 326 TYR^? 23.02 O2 EDO B 603 A 108 ASN B 356 ASN.? 8.23 C1 EDO B 603 A 135 ASN A 324 ASN.? 13.71 O2 EDO B 603 coo 17.59 4.66 17.88 15.38 5.96 18.97 24.84 38.31 9.87 26.02 39.99 8.01 coo 12.36 16.24 15.27 12.06 14.29 16.05 18.03 28.57 5.10 16.12 27.74 4.68 coo 18.05 11.56 12.71 17.57 10.75 14.60 19.23 35.37 3.15 19.16 34.35 1.29 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 3 3 # 3 A 51 TYR B 326 TYR^? 30.24 C1 EDO B 603 A 108 ASN A 337 ASN~? 21.47 C1 EDO B 603 A 135 ASN B 324 ASN.? 26.30 C1 EDO B 603 coo 17.59 4.66 17.88 15.38 5.96 18.97 34.46 17.76 14.34 35.89 17.47 16.72 coo 12.36 16.24 15.27 12.06 14.29 16.05 20.37 20.71 18.22 22.41 20.05 18.06 coo 18.05 11.56 12.71 17.57 10.75 14.60 26.83 13.52 17.81 25.43 13.66 19.36 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 4 3 # 4 A 51 TYR B 326 TYR^? 30.24 C1 EDO B 603 A 108 ASN A 356 ASN.? 18.20 C1 EDO B 603 A 135 ASN B 324 ASN.? 26.30 C1 EDO B 603 coo 17.59 4.66 17.88 15.38 5.96 18.97 34.46 17.76 14.34 35.89 17.47 16.72 coo 12.36 16.24 15.27 12.06 14.29 16.05 21.62 17.22 14.34 19.81 16.20 13.98 coo 18.05 11.56 12.71 17.57 10.75 14.60 26.83 13.52 17.81 25.43 13.66 19.36 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 5 3 # 5 A 51 TYR C 326 TYR^? 22.46 O3 GOL D 601 A 108 ASN D 356 ASN.? 8.43 C2 GOL D 601 A 135 ASN C 324 ASN.? 13.62 O3 GOL D 601 coo 17.59 4.66 17.88 15.38 5.96 18.97 45.91 5.03 -28.85 46.66 3.15 -30.76 coo 12.36 16.24 15.27 12.06 14.29 16.05 33.56 6.37 -25.67 31.64 5.54 -26.08 coo 18.05 11.56 12.71 17.57 10.75 14.60 38.59 2.13 -22.95 37.27 2.55 -21.34 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 6 3 # 6 A 51 TYR C 355 TYR^? 12.28 O2 EDO C 602 A 108 ASN C 333 ASN~? 16.90 C1 EDO C 602 A 135 ASN C 337 ASN~? 13.18 C1 EDO C 602 coo 17.59 4.66 17.88 15.38 5.96 18.97 28.68 24.77 -33.28 28.94 26.73 -35.28 coo 12.36 16.24 15.27 12.06 14.29 16.05 38.73 17.09 -34.48 37.68 18.68 -35.44 coo 18.05 11.56 12.71 17.57 10.75 14.60 33.28 16.29 -37.60 34.03 18.13 -36.82 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 7 3 # 7 A 51 TYR D 326 TYR^? 23.09 O2 EDO C 602 A 108 ASN C 337 ASN~? 13.18 C1 EDO C 602 A 135 ASN D 324 ASN.? 13.50 O2 EDO C 602 coo 17.59 4.66 17.88 15.38 5.96 18.97 38.71 27.20 -29.06 40.04 28.98 -30.75 coo 12.36 16.24 15.27 12.06 14.29 16.05 33.28 16.29 -37.60 34.03 18.13 -36.82 coo 18.05 11.56 12.71 17.57 10.75 14.60 32.08 25.49 -35.40 31.73 24.73 -37.32 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 8 3 # 8 A 51 TYR D 326 TYR^? 23.09 O2 EDO C 602 A 108 ASN C 356 ASN.? 8.10 C1 EDO C 602 A 135 ASN D 324 ASN.? 13.50 O2 EDO C 602 coo 17.59 4.66 17.88 15.38 5.96 18.97 38.71 27.20 -29.06 40.04 28.98 -30.75 coo 12.36 16.24 15.27 12.06 14.29 16.05 30.42 18.66 -33.90 28.43 18.01 -34.20 coo 18.05 11.56 12.71 17.57 10.75 14.60 32.08 25.49 -35.40 31.73 24.73 -37.32 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 9 3 # 9 A 51 TYR D 355 TYR^? 12.42 O3 GOL D 601 A 108 ASN D 333 ASN~? 17.27 C2 GOL D 601 A 135 ASN D 337 ASN~? 13.43 C2 GOL D 601 coo 17.59 4.66 17.88 15.38 5.96 18.97 36.51 0.70 -26.17 37.53 -0.88 -24.11 coo 12.36 16.24 15.27 12.06 14.29 16.05 38.40 12.82 -22.80 38.46 10.80 -22.10 coo 18.05 11.56 12.71 17.57 10.75 14.60 33.20 9.44 -21.47 35.12 8.58 -21.91 1uy2_p00 source 1uy2 ENDO-1,4-BETA-XYLANASE A : 9 hits 1uy2_p00 naa= 3 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 326 TYR^? 23.02 O2 EDO B 603 A 108 ASN B 356 ASN.? 8.23 C1 EDO B 603 A 135 ASN A 324 ASN.? 13.71 O2 EDO B 603 coo 17.50 4.57 17.85 15.28 5.88 18.97 24.84 38.31 9.87 26.02 39.99 8.01 coo 12.22 15.98 15.24 11.94 14.05 16.09 18.03 28.57 5.10 16.12 27.74 4.68 coo 17.94 11.43 12.65 17.42 10.61 14.53 19.23 35.37 3.15 19.16 34.35 1.29 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 2 3 # 2 A 51 TYR B 326 TYR^? 30.24 C1 EDO B 603 A 108 ASN A 356 ASN.? 18.20 C1 EDO B 603 A 135 ASN B 324 ASN.? 26.30 C1 EDO B 603 coo 17.50 4.57 17.85 15.28 5.88 18.97 34.46 17.76 14.34 35.89 17.47 16.72 coo 12.22 15.98 15.24 11.94 14.05 16.09 21.62 17.22 14.34 19.81 16.20 13.98 coo 17.94 11.43 12.65 17.42 10.61 14.53 26.83 13.52 17.81 25.43 13.66 19.36 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 3 3 # 3 A 51 TYR C 326 TYR^? 22.46 O3 GOL D 601 A 108 ASN D 356 ASN.? 8.43 C2 GOL D 601 A 135 ASN C 324 ASN.? 13.62 O3 GOL D 601 coo 17.50 4.57 17.85 15.28 5.88 18.97 45.91 5.03 -28.85 46.66 3.15 -30.76 coo 12.22 15.98 15.24 11.94 14.05 16.09 33.56 6.37 -25.67 31.64 5.54 -26.08 coo 17.94 11.43 12.65 17.42 10.61 14.53 38.59 2.13 -22.95 37.27 2.55 -21.34 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 4 3 # 4 A 51 TYR C 355 TYR^? 12.28 O2 EDO C 602 A 108 ASN C 333 ASN~? 16.90 C1 EDO C 602 A 135 ASN C 337 ASN~? 13.18 C1 EDO C 602 coo 17.50 4.57 17.85 15.28 5.88 18.97 28.68 24.77 -33.28 28.94 26.73 -35.28 coo 12.22 15.98 15.24 11.94 14.05 16.09 38.73 17.09 -34.48 37.68 18.68 -35.44 coo 17.94 11.43 12.65 17.42 10.61 14.53 33.28 16.29 -37.60 34.03 18.13 -36.82 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 5 3 # 5 A 51 TYR D 326 TYR^? 23.09 O2 EDO C 602 A 108 ASN C 356 ASN.? 8.10 C1 EDO C 602 A 135 ASN D 324 ASN.? 13.50 O2 EDO C 602 coo 17.50 4.57 17.85 15.28 5.88 18.97 38.71 27.20 -29.06 40.04 28.98 -30.75 coo 12.22 15.98 15.24 11.94 14.05 16.09 30.42 18.66 -33.90 28.43 18.01 -34.20 coo 17.94 11.43 12.65 17.42 10.61 14.53 32.08 25.49 -35.40 31.73 24.73 -37.32 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 6 3 # 6 A 51 TYR D 355 TYR^? 12.42 O3 GOL D 601 A 108 ASN D 333 ASN~? 17.27 C2 GOL D 601 A 135 ASN D 337 ASN~? 13.43 C2 GOL D 601 coo 17.50 4.57 17.85 15.28 5.88 18.97 36.51 0.70 -26.17 37.53 -0.88 -24.11 coo 12.22 15.98 15.24 11.94 14.05 16.09 38.40 12.82 -22.80 38.46 10.80 -22.10 coo 17.94 11.43 12.65 17.42 10.61 14.53 33.20 9.44 -21.47 35.12 8.58 -21.91 1uy4_p00 source 1uy4 ENDO-1,4-BETA-XYLANASE A : 6 hits 1uy4_p00 naa= 3 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 1 3 # 1 A 44 ASN D 324 ASN.? 13.50 O2 EDO C 602 A 213 PRO C 370 PRO~? 16.74 O2 EDO C 602 A 219 ASN C 333 ASN~? 16.90 C1 EDO C 602 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 32.08 25.49 -35.40 31.73 24.73 -37.32 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 31.34 30.17 -37.58 30.37 30.78 -35.67 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 38.73 17.09 -34.48 37.68 18.68 -35.44 1wbf_p00 source 1wbf PROTEIN (AGGLUTININ) : 1 hits 1wbf_p00 naa= 3 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 1 3 # 1 A 26 HIS A 338 HIS~? 19.64 C1 EDO B 603 A 76 ASN A 356 ASN.? 18.20 C1 EDO B 603 A 81 ASP A 357 ASP.? 25.14 C1 EDO B 603 coo 4.09 43.69 67.89 2.45 42.40 68.10 16.13 23.68 19.02 16.84 23.99 20.97 coo 4.75 48.17 75.81 4.99 47.30 77.74 21.62 17.22 14.34 19.81 16.20 13.98 coo 0.57 50.41 73.18 0.46 48.28 73.56 22.54 16.74 19.72 22.05 16.00 21.61 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 2 3 # 2 A 26 HIS A 381 HIS.? 27.31 O1 EDO B 603 A 76 ASN A 376 ASN~? 30.77 O2 GOL D 601 A 81 ASP A 350 ASP.? 26.92 O2 GOL D 601 coo 4.09 43.69 67.89 2.45 42.40 68.10 25.64 1.98 6.69 25.07 4.00 6.65 coo 4.75 48.17 75.81 4.99 47.30 77.74 35.45 5.09 5.49 35.04 5.15 3.39 coo 0.57 50.41 73.18 0.46 48.28 73.56 33.51 7.96 1.59 32.78 7.85 -0.37 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 3 3 # 3 A 26 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 76 ASN B 356 ASN.? 8.23 C1 EDO B 603 A 81 ASP B 357 ASP.? 13.04 C1 EDO B 603 coo 4.09 43.69 67.89 2.45 42.40 68.10 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 4.75 48.17 75.81 4.99 47.30 77.74 18.03 28.57 5.10 16.12 27.74 4.68 coo 0.57 50.41 73.18 0.46 48.28 73.56 19.95 30.44 0.55 20.02 30.85 -1.53 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 4 3 # 4 A 26 HIS B 338 HIS.? 13.66 O1 EDO B 603 A 76 ASN C 398 ASN~? 15.53 O1 EDO B 603 A 81 ASP A 402 ASP.? 12.59 O1 EDO B 603 coo 4.09 43.69 67.89 2.45 42.40 68.10 21.66 21.37 -0.01 22.97 22.11 -1.47 coo 4.75 48.17 75.81 4.99 47.30 77.74 21.01 22.53 -8.94 21.24 24.62 -8.84 coo 0.57 50.41 73.18 0.46 48.28 73.56 18.87 16.83 -6.49 16.77 17.04 -6.49 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 5 3 # 5 A 26 HIS C 338 HIS~? 12.91 O1 EDO C 602 A 76 ASN C 356 ASN.? 8.10 C1 EDO C 602 A 81 ASP C 357 ASP.? 12.50 O2 EDO C 602 coo 4.09 43.69 67.89 2.45 42.40 68.10 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 4.75 48.17 75.81 4.99 47.30 77.74 30.42 18.66 -33.90 28.43 18.01 -34.20 coo 0.57 50.41 73.18 0.46 48.28 73.56 32.02 20.63 -38.57 31.77 21.72 -40.39 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 6 3 # 6 A 26 HIS D 338 HIS~? 13.70 C1 GOL D 601 A 76 ASN A 398 ASN~? 16.47 O2 GOL D 601 A 81 ASP C 402 ASP.? 12.78 O1 GOL D 601 coo 4.09 43.69 67.89 2.45 42.40 68.10 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 4.75 48.17 75.81 4.99 47.30 77.74 26.81 10.21 -11.17 28.62 9.13 -11.03 coo 0.57 50.41 73.18 0.46 48.28 73.56 22.26 13.02 -15.38 21.01 11.37 -15.92 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 7 3 # 7 A 26 HIS D 338 HIS~? 13.70 C1 GOL D 601 A 76 ASN D 356 ASN.? 8.43 C2 GOL D 601 A 81 ASP D 357 ASP.? 12.64 O3 GOL D 601 coo 4.09 43.69 67.89 2.45 42.40 68.10 29.23 12.85 -20.11 30.06 13.12 -18.20 coo 4.75 48.17 75.81 4.99 47.30 77.74 33.56 6.37 -25.67 31.64 5.54 -26.08 coo 0.57 50.41 73.18 0.46 48.28 73.56 34.52 5.19 -20.65 34.58 3.94 -18.98 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 8 3 # 8 A 26 HIS D 381 HIS.? 16.49 O3 GOL D 601 A 76 ASN D 376 ASN~? 25.04 O3 GOL D 601 A 81 ASP D 350 ASP.? 24.09 C3 GOL D 601 coo 4.09 43.69 67.89 2.45 42.40 68.10 36.03 -8.97 -35.15 35.55 -7.12 -34.29 coo 4.75 48.17 75.81 4.99 47.30 77.74 45.52 -5.82 -37.17 44.96 -5.40 -39.18 coo 0.57 50.41 73.18 0.46 48.28 73.56 42.88 -2.45 -40.67 41.90 -2.09 -42.54 2c3x_p00 source 2c3x ALPHA-AMYLASE G-6 : 8 hits 2c3x_p00 naa= 3 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 1 3 # 1 A 459 ASN A 324 ASN.? 13.71 O2 EDO B 603 A 460 GLY A 323 GLY.? 15.38 C1 EDO B 603 A 461 ASN B 356 ASN.? 8.23 C1 EDO B 603 coo 15.00 94.38 6.97 13.00 93.59 6.99 19.23 35.37 3.15 19.16 34.35 1.29 coo 19.48 94.04 5.03 19.26 94.00 5.78 22.31 31.99 4.41 22.84 32.64 4.56 coo 20.23 95.69 9.16 21.55 97.37 9.20 18.03 28.57 5.10 16.12 27.74 4.68 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 2 3 # 2 A 459 ASN A 333 ASN~? 23.15 C1 EDO B 603 A 460 GLY B 323 GLY.? 23.84 C1 EDO B 603 A 461 ASN A 337 ASN~? 21.47 C1 EDO B 603 coo 15.00 94.38 6.97 13.00 93.59 6.99 25.58 24.27 17.00 25.61 22.33 17.91 coo 19.48 94.04 5.03 19.26 94.00 5.78 26.13 18.22 17.28 26.94 18.27 17.39 coo 20.23 95.69 9.16 21.55 97.37 9.20 20.37 20.71 18.22 22.41 20.05 18.06 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 3 3 # 3 A 459 ASN A 337 ASN~? 21.47 C1 EDO B 603 A 460 GLY B 323 GLY.? 23.84 C1 EDO B 603 A 461 ASN A 333 ASN~? 23.15 C1 EDO B 603 coo 15.00 94.38 6.97 13.00 93.59 6.99 20.37 20.71 18.22 22.41 20.05 18.06 coo 19.48 94.04 5.03 19.26 94.00 5.78 26.13 18.22 17.28 26.94 18.27 17.39 coo 20.23 95.69 9.16 21.55 97.37 9.20 25.58 24.27 17.00 25.61 22.33 17.91 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 4 3 # 4 A 459 ASN A 337 ASN~? 21.47 C1 EDO B 603 A 460 GLY B 323 GLY.? 23.84 C1 EDO B 603 A 461 ASN A 356 ASN.? 18.20 C1 EDO B 603 coo 15.00 94.38 6.97 13.00 93.59 6.99 20.37 20.71 18.22 22.41 20.05 18.06 coo 19.48 94.04 5.03 19.26 94.00 5.78 26.13 18.22 17.28 26.94 18.27 17.39 coo 20.23 95.69 9.16 21.55 97.37 9.20 21.62 17.22 14.34 19.81 16.20 13.98 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 5 3 # 5 A 459 ASN A 356 ASN.? 18.20 C1 EDO B 603 A 460 GLY B 323 GLY.? 23.84 C1 EDO B 603 A 461 ASN A 337 ASN~? 21.47 C1 EDO B 603 coo 15.00 94.38 6.97 13.00 93.59 6.99 21.62 17.22 14.34 19.81 16.20 13.98 coo 19.48 94.04 5.03 19.26 94.00 5.78 26.13 18.22 17.28 26.94 18.27 17.39 coo 20.23 95.69 9.16 21.55 97.37 9.20 20.37 20.71 18.22 22.41 20.05 18.06 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 6 3 # 6 A 459 ASN A 356 ASN.? 18.20 C1 EDO B 603 A 460 GLY B 323 GLY.? 23.84 C1 EDO B 603 A 461 ASN B 324 ASN.? 26.30 C1 EDO B 603 coo 15.00 94.38 6.97 13.00 93.59 6.99 21.62 17.22 14.34 19.81 16.20 13.98 coo 19.48 94.04 5.03 19.26 94.00 5.78 26.13 18.22 17.28 26.94 18.27 17.39 coo 20.23 95.69 9.16 21.55 97.37 9.20 26.83 13.52 17.81 25.43 13.66 19.36 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 7 3 # 7 A 459 ASN B 324 ASN.? 26.30 C1 EDO B 603 A 460 GLY B 323 GLY.? 23.84 C1 EDO B 603 A 461 ASN A 356 ASN.? 18.20 C1 EDO B 603 coo 15.00 94.38 6.97 13.00 93.59 6.99 26.83 13.52 17.81 25.43 13.66 19.36 coo 19.48 94.04 5.03 19.26 94.00 5.78 26.13 18.22 17.28 26.94 18.27 17.39 coo 20.23 95.69 9.16 21.55 97.37 9.20 21.62 17.22 14.34 19.81 16.20 13.98 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 8 3 # 8 A 459 ASN B 333 ASN~? 17.11 C1 EDO B 603 A 460 GLY A 323 GLY.? 15.38 C1 EDO B 603 A 461 ASN B 337 ASN~? 13.41 C1 EDO B 603 coo 15.00 94.38 6.97 13.00 93.59 6.99 26.50 27.72 5.31 25.42 29.17 4.18 coo 19.48 94.04 5.03 19.26 94.00 5.78 22.31 31.99 4.41 22.84 32.64 4.56 coo 20.23 95.69 9.16 21.55 97.37 9.20 21.54 26.32 1.73 21.98 28.23 2.58 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 9 3 # 9 A 459 ASN B 337 ASN~? 13.41 C1 EDO B 603 A 460 GLY A 323 GLY.? 15.38 C1 EDO B 603 A 461 ASN B 333 ASN~? 17.11 C1 EDO B 603 coo 15.00 94.38 6.97 13.00 93.59 6.99 21.54 26.32 1.73 21.98 28.23 2.58 coo 19.48 94.04 5.03 19.26 94.00 5.78 22.31 31.99 4.41 22.84 32.64 4.56 coo 20.23 95.69 9.16 21.55 97.37 9.20 26.50 27.72 5.31 25.42 29.17 4.18 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 10 3 # 10 A 459 ASN B 337 ASN~? 13.41 C1 EDO B 603 A 460 GLY A 323 GLY.? 15.38 C1 EDO B 603 A 461 ASN B 356 ASN.? 8.23 C1 EDO B 603 coo 15.00 94.38 6.97 13.00 93.59 6.99 21.54 26.32 1.73 21.98 28.23 2.58 coo 19.48 94.04 5.03 19.26 94.00 5.78 22.31 31.99 4.41 22.84 32.64 4.56 coo 20.23 95.69 9.16 21.55 97.37 9.20 18.03 28.57 5.10 16.12 27.74 4.68 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 11 3 # 11 A 459 ASN B 356 ASN.? 8.23 C1 EDO B 603 A 460 GLY A 323 GLY.? 15.38 C1 EDO B 603 A 461 ASN A 324 ASN.? 13.71 O2 EDO B 603 coo 15.00 94.38 6.97 13.00 93.59 6.99 18.03 28.57 5.10 16.12 27.74 4.68 coo 19.48 94.04 5.03 19.26 94.00 5.78 22.31 31.99 4.41 22.84 32.64 4.56 coo 20.23 95.69 9.16 21.55 97.37 9.20 19.23 35.37 3.15 19.16 34.35 1.29 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 12 3 # 12 A 459 ASN B 356 ASN.? 8.23 C1 EDO B 603 A 460 GLY A 323 GLY.? 15.38 C1 EDO B 603 A 461 ASN B 337 ASN~? 13.41 C1 EDO B 603 coo 15.00 94.38 6.97 13.00 93.59 6.99 18.03 28.57 5.10 16.12 27.74 4.68 coo 19.48 94.04 5.03 19.26 94.00 5.78 22.31 31.99 4.41 22.84 32.64 4.56 coo 20.23 95.69 9.16 21.55 97.37 9.20 21.54 26.32 1.73 21.98 28.23 2.58 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 13 3 # 13 A 459 ASN C 324 ASN.? 13.62 O3 GOL D 601 A 460 GLY C 323 GLY.? 15.53 C2 GOL D 601 A 461 ASN D 356 ASN.? 8.43 C2 GOL D 601 coo 15.00 94.38 6.97 13.00 93.59 6.99 38.59 2.13 -22.95 37.27 2.55 -21.34 coo 19.48 94.04 5.03 19.26 94.00 5.78 38.52 6.83 -23.34 39.38 6.77 -23.23 coo 20.23 95.69 9.16 21.55 97.37 9.20 33.56 6.37 -25.67 31.64 5.54 -26.08 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 14 3 # 14 A 459 ASN C 333 ASN~? 16.90 C1 EDO C 602 A 460 GLY D 323 GLY.? 15.22 C1 EDO C 602 A 461 ASN C 337 ASN~? 13.18 C1 EDO C 602 coo 15.00 94.38 6.97 13.00 93.59 6.99 38.73 17.09 -34.48 37.68 18.68 -35.44 coo 19.48 94.04 5.03 19.26 94.00 5.78 34.88 21.72 -34.87 35.47 22.28 -34.67 coo 20.23 95.69 9.16 21.55 97.37 9.20 33.28 16.29 -37.60 34.03 18.13 -36.82 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 15 3 # 15 A 459 ASN C 337 ASN~? 13.18 C1 EDO C 602 A 460 GLY D 323 GLY.? 15.22 C1 EDO C 602 A 461 ASN C 333 ASN~? 16.90 C1 EDO C 602 coo 15.00 94.38 6.97 13.00 93.59 6.99 33.28 16.29 -37.60 34.03 18.13 -36.82 coo 19.48 94.04 5.03 19.26 94.00 5.78 34.88 21.72 -34.87 35.47 22.28 -34.67 coo 20.23 95.69 9.16 21.55 97.37 9.20 38.73 17.09 -34.48 37.68 18.68 -35.44 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 16 3 # 16 A 459 ASN C 337 ASN~? 13.18 C1 EDO C 602 A 460 GLY D 323 GLY.? 15.22 C1 EDO C 602 A 461 ASN C 356 ASN.? 8.10 C1 EDO C 602 coo 15.00 94.38 6.97 13.00 93.59 6.99 33.28 16.29 -37.60 34.03 18.13 -36.82 coo 19.48 94.04 5.03 19.26 94.00 5.78 34.88 21.72 -34.87 35.47 22.28 -34.67 coo 20.23 95.69 9.16 21.55 97.37 9.20 30.42 18.66 -33.90 28.43 18.01 -34.20 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 17 3 # 17 A 459 ASN C 356 ASN.? 8.10 C1 EDO C 602 A 460 GLY D 323 GLY.? 15.22 C1 EDO C 602 A 461 ASN C 337 ASN~? 13.18 C1 EDO C 602 coo 15.00 94.38 6.97 13.00 93.59 6.99 30.42 18.66 -33.90 28.43 18.01 -34.20 coo 19.48 94.04 5.03 19.26 94.00 5.78 34.88 21.72 -34.87 35.47 22.28 -34.67 coo 20.23 95.69 9.16 21.55 97.37 9.20 33.28 16.29 -37.60 34.03 18.13 -36.82 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 18 3 # 18 A 459 ASN C 356 ASN.? 8.10 C1 EDO C 602 A 460 GLY D 323 GLY.? 15.22 C1 EDO C 602 A 461 ASN D 324 ASN.? 13.50 O2 EDO C 602 coo 15.00 94.38 6.97 13.00 93.59 6.99 30.42 18.66 -33.90 28.43 18.01 -34.20 coo 19.48 94.04 5.03 19.26 94.00 5.78 34.88 21.72 -34.87 35.47 22.28 -34.67 coo 20.23 95.69 9.16 21.55 97.37 9.20 32.08 25.49 -35.40 31.73 24.73 -37.32 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 19 3 # 19 A 459 ASN D 324 ASN.? 13.50 O2 EDO C 602 A 460 GLY D 323 GLY.? 15.22 C1 EDO C 602 A 461 ASN C 356 ASN.? 8.10 C1 EDO C 602 coo 15.00 94.38 6.97 13.00 93.59 6.99 32.08 25.49 -35.40 31.73 24.73 -37.32 coo 19.48 94.04 5.03 19.26 94.00 5.78 34.88 21.72 -34.87 35.47 22.28 -34.67 coo 20.23 95.69 9.16 21.55 97.37 9.20 30.42 18.66 -33.90 28.43 18.01 -34.20 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 20 3 # 20 A 459 ASN D 333 ASN~? 17.27 C2 GOL D 601 A 460 GLY C 323 GLY.? 15.53 C2 GOL D 601 A 461 ASN D 337 ASN~? 13.43 C2 GOL D 601 coo 15.00 94.38 6.97 13.00 93.59 6.99 38.40 12.82 -22.80 38.46 10.80 -22.10 coo 19.48 94.04 5.03 19.26 94.00 5.78 38.52 6.83 -23.34 39.38 6.77 -23.23 coo 20.23 95.69 9.16 21.55 97.37 9.20 33.20 9.44 -21.47 35.12 8.58 -21.91 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 21 3 # 21 A 459 ASN D 337 ASN~? 13.43 C2 GOL D 601 A 460 GLY C 323 GLY.? 15.53 C2 GOL D 601 A 461 ASN D 333 ASN~? 17.27 C2 GOL D 601 coo 15.00 94.38 6.97 13.00 93.59 6.99 33.20 9.44 -21.47 35.12 8.58 -21.91 coo 19.48 94.04 5.03 19.26 94.00 5.78 38.52 6.83 -23.34 39.38 6.77 -23.23 coo 20.23 95.69 9.16 21.55 97.37 9.20 38.40 12.82 -22.80 38.46 10.80 -22.10 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 22 3 # 22 A 459 ASN D 337 ASN~? 13.43 C2 GOL D 601 A 460 GLY C 323 GLY.? 15.53 C2 GOL D 601 A 461 ASN D 356 ASN.? 8.43 C2 GOL D 601 coo 15.00 94.38 6.97 13.00 93.59 6.99 33.20 9.44 -21.47 35.12 8.58 -21.91 coo 19.48 94.04 5.03 19.26 94.00 5.78 38.52 6.83 -23.34 39.38 6.77 -23.23 coo 20.23 95.69 9.16 21.55 97.37 9.20 33.56 6.37 -25.67 31.64 5.54 -26.08 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 23 3 # 23 A 459 ASN D 356 ASN.? 8.43 C2 GOL D 601 A 460 GLY C 323 GLY.? 15.53 C2 GOL D 601 A 461 ASN C 324 ASN.? 13.62 O3 GOL D 601 coo 15.00 94.38 6.97 13.00 93.59 6.99 33.56 6.37 -25.67 31.64 5.54 -26.08 coo 19.48 94.04 5.03 19.26 94.00 5.78 38.52 6.83 -23.34 39.38 6.77 -23.23 coo 20.23 95.69 9.16 21.55 97.37 9.20 38.59 2.13 -22.95 37.27 2.55 -21.34 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 24 3 # 24 A 459 ASN D 356 ASN.? 8.43 C2 GOL D 601 A 460 GLY C 323 GLY.? 15.53 C2 GOL D 601 A 461 ASN D 337 ASN~? 13.43 C2 GOL D 601 coo 15.00 94.38 6.97 13.00 93.59 6.99 33.56 6.37 -25.67 31.64 5.54 -26.08 coo 19.48 94.04 5.03 19.26 94.00 5.78 38.52 6.83 -23.34 39.38 6.77 -23.23 coo 20.23 95.69 9.16 21.55 97.37 9.20 33.20 9.44 -21.47 35.12 8.58 -21.91 2qv4_p00 source 2qv4 PANCREATIC ALPHA-AMYLASE : 24 hits 2qv4_p00 naa= 3 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 376 ASN~? 30.77 O2 GOL D 601 A 384 ASN B 333 ASN~? 17.11 C1 EDO B 603 A 385 GLU B 330 GLU~? 24.65 C1 EDO B 603 coo 22.28 63.17 110.61 22.47 65.06 111.53 35.45 5.09 5.49 35.04 5.15 3.39 coo 7.06 50.07 96.17 8.50 48.54 96.31 26.50 27.72 5.31 25.42 29.17 4.18 coo 11.59 49.83 99.41 10.92 47.97 100.16 31.94 25.81 2.71 33.76 25.37 1.74 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN A 398 ASN~? 16.47 O2 GOL D 601 A 384 ASN B 333 ASN~? 17.11 C1 EDO B 603 A 385 GLU B 330 GLU~? 24.65 C1 EDO B 603 coo 22.28 63.17 110.61 22.47 65.06 111.53 26.81 10.21 -11.17 28.62 9.13 -11.03 coo 7.06 50.07 96.17 8.50 48.54 96.31 26.50 27.72 5.31 25.42 29.17 4.18 coo 11.59 49.83 99.41 10.92 47.97 100.16 31.94 25.81 2.71 33.76 25.37 1.74 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 3 3 # 3 A 270 ASN A 405 ASN^? 12.74 O1 EDO B 603 A 384 ASN A 376 ASN~? 30.77 O2 GOL D 601 A 385 GLU A 378 GLU~? 27.85 O2 GOL D 601 coo 22.28 63.17 110.61 22.47 65.06 111.53 12.33 9.89 -0.90 12.81 11.91 -1.36 coo 7.06 50.07 96.17 8.50 48.54 96.31 35.45 5.09 5.49 35.04 5.15 3.39 coo 11.59 49.83 99.41 10.92 47.97 100.16 32.59 2.13 2.36 33.95 1.57 0.86 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 4 3 # 4 A 270 ASN B 376 ASN~? 24.05 C2 EDO B 603 A 384 ASN A 333 ASN~? 23.15 C1 EDO B 603 A 385 GLU A 330 GLU~? 26.93 C1 EDO B 603 coo 22.28 63.17 110.61 22.47 65.06 111.53 11.86 44.76 15.81 10.83 43.80 17.41 coo 7.06 50.07 96.17 8.50 48.54 96.31 25.58 24.27 17.00 25.61 22.33 17.91 coo 11.59 49.83 99.41 10.92 47.97 100.16 25.78 29.04 20.96 25.48 30.78 22.26 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 5 3 # 5 A 270 ASN B 398 ASN~? 28.43 C2 EDO B 603 A 384 ASN A 333 ASN~? 23.15 C1 EDO B 603 A 385 GLU A 330 GLU~? 26.93 C1 EDO B 603 coo 22.28 63.17 110.61 22.47 65.06 111.53 6.35 32.55 29.26 6.04 34.62 28.91 coo 7.06 50.07 96.17 8.50 48.54 96.31 25.58 24.27 17.00 25.61 22.33 17.91 coo 11.59 49.83 99.41 10.92 47.97 100.16 25.78 29.04 20.96 25.48 30.78 22.26 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 6 3 # 6 A 270 ASN B 405 ASN^? 14.52 C2 EDO B 603 A 384 ASN B 376 ASN~? 24.05 C2 EDO B 603 A 385 GLU B 378 GLU~? 25.07 O2 EDO B 603 coo 22.28 63.17 110.61 22.47 65.06 111.53 1.99 23.48 14.63 3.63 22.52 15.58 coo 7.06 50.07 96.17 8.50 48.54 96.31 11.86 44.76 15.81 10.83 43.80 17.41 coo 11.59 49.83 99.41 10.92 47.97 100.16 7.63 44.96 15.04 7.63 45.65 17.05 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 7 3 # 7 A 270 ASN C 376 ASN~? 24.86 O2 EDO C 602 A 384 ASN D 333 ASN~? 17.27 C2 GOL D 601 A 385 GLU D 330 GLU~? 24.51 C2 GOL D 601 coo 22.28 63.17 110.61 22.47 65.06 111.53 27.15 34.69 -21.55 26.19 33.87 -19.83 coo 7.06 50.07 96.17 8.50 48.54 96.31 38.40 12.82 -22.80 38.46 10.80 -22.10 coo 11.59 49.83 99.41 10.92 47.97 100.16 39.35 17.44 -18.72 40.01 18.64 -17.10 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 8 3 # 8 A 270 ASN C 398 ASN~? 15.53 O1 EDO B 603 A 384 ASN D 333 ASN~? 17.27 C2 GOL D 601 A 385 GLU D 330 GLU~? 24.51 C2 GOL D 601 coo 22.28 63.17 110.61 22.47 65.06 111.53 21.01 22.53 -8.94 21.24 24.62 -8.84 coo 7.06 50.07 96.17 8.50 48.54 96.31 38.40 12.82 -22.80 38.46 10.80 -22.10 coo 11.59 49.83 99.41 10.92 47.97 100.16 39.35 17.44 -18.72 40.01 18.64 -17.10 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 9 3 # 9 A 270 ASN C 405 ASN^? 11.21 O1 GOL D 601 A 384 ASN C 376 ASN~? 24.86 O2 EDO C 602 A 385 GLU C 378 GLU~? 24.96 O2 EDO B 603 coo 22.28 63.17 110.61 22.47 65.06 111.53 14.76 14.23 -23.45 16.38 13.06 -22.71 coo 7.06 50.07 96.17 8.50 48.54 96.31 27.15 34.69 -21.55 26.19 33.87 -19.83 coo 11.59 49.83 99.41 10.92 47.97 100.16 22.14 33.77 -19.82 21.71 34.90 -18.09 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 10 3 # 10 A 270 ASN D 376 ASN~? 25.04 O3 GOL D 601 A 384 ASN C 333 ASN~? 16.90 C1 EDO C 602 A 385 GLU C 330 GLU~? 24.03 O1 EDO C 602 coo 22.28 63.17 110.61 22.47 65.06 111.53 45.52 -5.82 -37.17 44.96 -5.40 -39.18 coo 7.06 50.07 96.17 8.50 48.54 96.31 38.73 17.09 -34.48 37.68 18.68 -35.44 coo 11.59 49.83 99.41 10.92 47.97 100.16 43.59 14.91 -37.76 45.12 14.02 -38.99 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 11 3 # 11 A 270 ASN D 398 ASN~? 25.80 O1 EDO C 602 A 384 ASN C 333 ASN~? 16.90 C1 EDO C 602 A 385 GLU C 330 GLU~? 24.03 O1 EDO C 602 coo 22.28 63.17 110.61 22.47 65.06 111.53 35.65 1.59 -52.48 36.44 -0.37 -52.06 coo 7.06 50.07 96.17 8.50 48.54 96.31 38.73 17.09 -34.48 37.68 18.68 -35.44 coo 11.59 49.83 99.41 10.92 47.97 100.16 43.59 14.91 -37.76 45.12 14.02 -38.99 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 11 hits 2v3r_p00 naa= 3 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 1 3 # 1 A 9 GLN A 331 GLN~? 22.54 C1 EDO B 603 A 11 ASN A 333 ASN~? 23.15 C1 EDO B 603 A 13 ARG A 316 ARG.? 27.22 C1 EDO B 603 coo 33.45 2.10 7.21 34.51 1.09 5.67 22.78 31.90 17.78 22.64 33.92 17.20 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 25.58 24.27 17.00 25.61 22.33 17.91 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 32.66 26.75 19.60 30.80 24.65 18.26 1bdv_d00 source 1bdv GENE REGULATION/DNA : 1 hits 1bdv_d00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 354 TYR^? 20.91 C1 EDO B 603 I 306 VAL A 346 VAL^? 24.05 C1 EDO B 603 I 308 VAL A 434 VAL^? 19.93 O1 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 27.10 16.84 11.56 24.90 18.34 12.50 coo 23.55 29.53 9.81 23.15 27.39 10.24 29.01 12.29 4.94 28.88 10.14 4.54 coo 16.43 30.18 9.35 15.05 30.67 11.01 25.58 13.52 1.08 24.99 11.62 0.22 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 418 TYR^? 12.62 O1 EDO B 603 I 306 VAL A 417 VAL^? 19.17 O1 EDO B 603 I 308 VAL A 365 VAL.? 22.32 C1 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 9.59 11.03 3.92 9.74 11.89 1.25 coo 23.55 29.53 9.81 23.15 27.39 10.24 9.44 7.34 8.80 11.20 6.49 9.86 coo 16.43 30.18 9.35 15.05 30.67 11.01 15.27 5.80 14.06 13.79 6.53 12.57 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 418 TYR^? 12.62 O1 EDO B 603 I 306 VAL A 438 VAL^? 16.91 C1 EDO B 603 I 308 VAL A 365 VAL.? 22.32 C1 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 9.59 11.03 3.92 9.74 11.89 1.25 coo 23.55 29.53 9.81 23.15 27.39 10.24 14.88 11.45 8.65 15.44 9.44 9.33 coo 16.43 30.18 9.35 15.05 30.67 11.01 15.27 5.80 14.06 13.79 6.53 12.57 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR A 421 TYR^? 19.72 O1 EDO B 603 I 306 VAL A 389 VAL~? 25.61 O1 EDO B 603 I 308 VAL A 377 VAL~? 28.44 O1 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 20.02 8.83 1.38 20.18 6.69 3.20 coo 23.55 29.53 9.81 23.15 27.39 10.24 23.80 2.96 0.58 24.25 3.58 2.66 coo 16.43 30.18 9.35 15.05 30.67 11.01 30.83 5.28 5.61 29.42 5.64 3.91 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR A 421 TYR^? 19.72 O1 EDO B 603 I 306 VAL A 389 VAL~? 25.61 O1 EDO B 603 I 308 VAL A 385 VAL~? 29.09 O1 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 20.02 8.83 1.38 20.18 6.69 3.20 coo 23.55 29.53 9.81 23.15 27.39 10.24 23.80 2.96 0.58 24.25 3.58 2.66 coo 16.43 30.18 9.35 15.05 30.67 11.01 22.54 -2.06 4.23 21.74 -1.13 6.06 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR A 421 TYR^? 19.72 O1 EDO B 603 I 306 VAL A 419 VAL^? 17.14 O1 EDO B 603 I 308 VAL A 417 VAL^? 19.17 O1 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 20.02 8.83 1.38 20.18 6.69 3.20 coo 23.55 29.53 9.81 23.15 27.39 10.24 14.02 9.25 4.72 15.24 7.52 5.36 coo 16.43 30.18 9.35 15.05 30.67 11.01 9.44 7.34 8.80 11.20 6.49 9.86 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR A 421 TYR^? 19.72 O1 EDO B 603 I 306 VAL A 434 VAL^? 19.93 O1 EDO B 603 I 308 VAL A 346 VAL^? 24.05 C1 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 20.02 8.83 1.38 20.18 6.69 3.20 coo 23.55 29.53 9.81 23.15 27.39 10.24 25.58 13.52 1.08 24.99 11.62 0.22 coo 16.43 30.18 9.35 15.05 30.67 11.01 29.01 12.29 4.94 28.88 10.14 4.54 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR A 421 TYR^? 19.72 O1 EDO B 603 I 306 VAL A 434 VAL^? 19.93 O1 EDO B 603 I 308 VAL A 424 VAL^? 17.06 O1 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 20.02 8.83 1.38 20.18 6.69 3.20 coo 23.55 29.53 9.81 23.15 27.39 10.24 25.58 13.52 1.08 24.99 11.62 0.22 coo 16.43 30.18 9.35 15.05 30.67 11.01 24.97 18.63 -1.16 25.35 19.02 0.96 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR A 437 TYR^? 11.45 C1 EDO B 603 I 306 VAL A 419 VAL^? 17.14 O1 EDO B 603 I 308 VAL A 404 VAL^? 17.61 O1 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 16.79 15.50 5.48 15.91 16.43 3.01 coo 23.55 29.53 9.81 23.15 27.39 10.24 14.02 9.25 4.72 15.24 7.52 5.36 coo 16.43 30.18 9.35 15.05 30.67 11.01 16.49 9.66 -3.07 17.67 7.94 -3.69 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 10 3 # 10 I 303 TYR A 437 TYR^? 11.45 C1 EDO B 603 I 306 VAL A 419 VAL^? 17.14 O1 EDO B 603 I 308 VAL A 417 VAL^? 19.17 O1 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 16.79 15.50 5.48 15.91 16.43 3.01 coo 23.55 29.53 9.81 23.15 27.39 10.24 14.02 9.25 4.72 15.24 7.52 5.36 coo 16.43 30.18 9.35 15.05 30.67 11.01 9.44 7.34 8.80 11.20 6.49 9.86 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 11 3 # 11 I 303 TYR A 437 TYR^? 11.45 C1 EDO B 603 I 306 VAL A 438 VAL^? 16.91 C1 EDO B 603 I 308 VAL A 365 VAL.? 22.32 C1 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 16.79 15.50 5.48 15.91 16.43 3.01 coo 23.55 29.53 9.81 23.15 27.39 10.24 14.88 11.45 8.65 15.44 9.44 9.33 coo 16.43 30.18 9.35 15.05 30.67 11.01 15.27 5.80 14.06 13.79 6.53 12.57 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 12 3 # 12 I 303 TYR A 437 TYR^? 11.45 C1 EDO B 603 I 306 VAL A 438 VAL^? 16.91 C1 EDO B 603 I 308 VAL A 417 VAL^? 19.17 O1 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 16.79 15.50 5.48 15.91 16.43 3.01 coo 23.55 29.53 9.81 23.15 27.39 10.24 14.88 11.45 8.65 15.44 9.44 9.33 coo 16.43 30.18 9.35 15.05 30.67 11.01 9.44 7.34 8.80 11.20 6.49 9.86 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 13 3 # 13 I 303 TYR B 354 TYR^? 14.48 C1 EDO B 603 I 306 VAL B 346 VAL^? 18.03 C2 EDO B 603 I 308 VAL B 377 VAL~? 19.22 C2 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 19.63 32.53 9.54 19.95 30.09 8.18 coo 23.55 29.53 9.81 23.15 27.39 10.24 14.71 35.57 15.47 12.76 36.63 15.46 coo 16.43 30.18 9.35 15.05 30.67 11.01 10.43 40.77 13.96 9.57 39.13 15.19 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 14 3 # 14 I 303 TYR B 354 TYR^? 14.48 C1 EDO B 603 I 306 VAL B 346 VAL^? 18.03 C2 EDO B 603 I 308 VAL B 434 VAL^? 17.71 C2 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 19.63 32.53 9.54 19.95 30.09 8.18 coo 23.55 29.53 9.81 23.15 27.39 10.24 14.71 35.57 15.47 12.76 36.63 15.46 coo 16.43 30.18 9.35 15.05 30.67 11.01 12.63 31.58 18.08 10.52 32.18 18.31 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 15 3 # 15 I 303 TYR B 355 TYR^? 12.60 O2 EDO B 603 I 306 VAL B 373 VAL~? 18.76 O2 EDO B 603 I 308 VAL B 377 VAL~? 19.22 C2 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 15.82 34.63 5.10 16.14 36.63 3.16 coo 23.55 29.53 9.81 23.15 27.39 10.24 17.47 41.24 8.39 18.88 39.68 7.76 coo 16.43 30.18 9.35 15.05 30.67 11.01 10.43 40.77 13.96 9.57 39.13 15.19 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 16 3 # 16 I 303 TYR B 418 TYR^? 11.01 C2 EDO B 603 I 306 VAL B 417 VAL^? 6.29 C2 EDO B 603 I 308 VAL B 365 VAL.? 4.92 O2 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 3.01 21.54 9.44 2.74 20.74 12.09 coo 23.55 29.53 9.81 23.15 27.39 10.24 1.81 24.58 4.33 2.30 26.66 3.83 coo 16.43 30.18 9.35 15.05 30.67 11.01 5.32 30.91 1.06 4.26 29.31 2.09 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 17 3 # 17 I 303 TYR B 418 TYR^? 11.01 C2 EDO B 603 I 306 VAL B 438 VAL^? -4.95 C2 EDO B 603s I 308 VAL B 365 VAL.? 4.92 O2 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 3.01 21.54 9.44 2.74 20.74 12.09 coo 23.55 29.53 9.81 23.15 27.39 10.24 7.87 26.09 7.07 6.82 27.89 6.41 coo 16.43 30.18 9.35 15.05 30.67 11.01 5.32 30.91 1.06 4.26 29.31 2.09 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 18 3 # 18 I 303 TYR B 421 TYR^? 13.58 C2 EDO B 603 I 306 VAL B 389 VAL~? 18.95 C2 EDO B 603 I 308 VAL B 377 VAL~? 19.22 C2 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 6.36 30.57 15.08 5.68 32.41 13.09 coo 23.55 29.53 9.81 23.15 27.39 10.24 2.86 37.26 16.70 4.03 38.09 15.03 coo 16.43 30.18 9.35 15.05 30.67 11.01 10.43 40.77 13.96 9.57 39.13 15.19 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 19 3 # 19 I 303 TYR B 421 TYR^? 13.58 C2 EDO B 603 I 306 VAL B 389 VAL~? 18.95 C2 EDO B 603 I 308 VAL B 385 VAL~? 19.41 O2 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 6.36 30.57 15.08 5.68 32.41 13.09 coo 23.55 29.53 9.81 23.15 27.39 10.24 2.86 37.26 16.70 4.03 38.09 15.03 coo 16.43 30.18 9.35 15.05 30.67 11.01 -1.53 40.22 12.75 -0.78 38.51 11.57 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 20 3 # 20 I 303 TYR B 421 TYR^? 13.58 C2 EDO B 603 I 306 VAL B 419 VAL^? 8.77 C2 EDO B 603 I 308 VAL B 417 VAL^? 6.29 C2 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 6.36 30.57 15.08 5.68 32.41 13.09 coo 23.55 29.53 9.81 23.15 27.39 10.24 4.38 26.18 9.96 3.95 28.34 9.54 coo 16.43 30.18 9.35 15.05 30.67 11.01 1.81 24.58 4.33 2.30 26.66 3.83 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 21 3 # 21 I 303 TYR B 421 TYR^? 13.58 C2 EDO B 603 I 306 VAL B 434 VAL^? 17.71 C2 EDO B 603 I 308 VAL B 346 VAL^? 18.03 C2 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 6.36 30.57 15.08 5.68 32.41 13.09 coo 23.55 29.53 9.81 23.15 27.39 10.24 12.63 31.58 18.08 10.52 32.18 18.31 coo 16.43 30.18 9.35 15.05 30.67 11.01 14.71 35.57 15.47 12.76 36.63 15.46 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 22 3 # 22 I 303 TYR B 421 TYR^? 13.58 C2 EDO B 603 I 306 VAL B 434 VAL^? 17.71 C2 EDO B 603 I 308 VAL B 424 VAL^? 19.75 C1 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 6.36 30.57 15.08 5.68 32.41 13.09 coo 23.55 29.53 9.81 23.15 27.39 10.24 12.63 31.58 18.08 10.52 32.18 18.31 coo 16.43 30.18 9.35 15.05 30.67 11.01 15.29 27.52 20.89 16.63 28.05 19.20 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 23 3 # 23 I 303 TYR B 437 TYR^? 10.72 C1 EDO B 603 I 306 VAL B 419 VAL^? 8.77 C2 EDO B 603 I 308 VAL B 404 VAL^? 17.30 C2 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 10.92 24.41 11.32 10.27 22.67 13.43 coo 23.55 29.53 9.81 23.15 27.39 10.24 4.38 26.18 9.96 3.95 28.34 9.54 coo 16.43 30.18 9.35 15.05 30.67 11.01 3.26 26.44 18.10 2.38 28.35 18.80 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 24 3 # 24 I 303 TYR B 437 TYR^? 10.72 C1 EDO B 603 I 306 VAL B 419 VAL^? 8.77 C2 EDO B 603 I 308 VAL B 417 VAL^? 6.29 C2 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 10.92 24.41 11.32 10.27 22.67 13.43 coo 23.55 29.53 9.81 23.15 27.39 10.24 4.38 26.18 9.96 3.95 28.34 9.54 coo 16.43 30.18 9.35 15.05 30.67 11.01 1.81 24.58 4.33 2.30 26.66 3.83 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 25 3 # 25 I 303 TYR B 437 TYR^? 10.72 C1 EDO B 603 I 306 VAL B 438 VAL^? -4.95 C2 EDO B 603s I 308 VAL B 417 VAL^? 6.29 C2 EDO B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 10.92 24.41 11.32 10.27 22.67 13.43 coo 23.55 29.53 9.81 23.15 27.39 10.24 7.87 26.09 7.07 6.82 27.89 6.41 coo 16.43 30.18 9.35 15.05 30.67 11.01 1.81 24.58 4.33 2.30 26.66 3.83 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 26 3 # 26 I 303 TYR C 354 TYR^? 14.37 C1 EDO C 602 I 306 VAL C 346 VAL^? 18.34 C2 EDO C 602 I 308 VAL C 434 VAL^? 17.86 C2 EDO C 602 coo 26.18 35.24 6.87 24.33 35.18 8.97 32.76 22.10 -29.37 32.74 19.75 -30.93 coo 23.55 29.53 9.81 23.15 27.39 10.24 28.57 25.36 -22.99 26.75 26.57 -22.80 coo 16.43 30.18 9.35 15.05 30.67 11.01 26.19 21.35 -20.48 24.16 22.12 -20.14 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 27 3 # 27 I 303 TYR C 418 TYR^? 10.50 O1 GOL D 601 I 306 VAL C 417 VAL^? 6.39 C2 EDO C 602 I 308 VAL C 365 VAL.? 5.09 O2 EDO C 602 coo 26.18 35.24 6.87 24.33 35.18 8.97 15.25 12.39 -28.72 15.00 11.49 -26.08 coo 23.55 29.53 9.81 23.15 27.39 10.24 14.01 15.75 -33.67 14.54 17.84 -34.00 coo 16.43 30.18 9.35 15.05 30.67 11.01 17.70 21.96 -36.53 16.68 20.28 -35.54 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 28 3 # 28 I 303 TYR C 418 TYR^? 10.50 O1 GOL D 601 I 306 VAL C 438 VAL^? -5.14 C2 EDO C 602s I 308 VAL C 365 VAL.? 5.09 O2 EDO C 602 coo 26.18 35.24 6.87 24.33 35.18 8.97 15.25 12.39 -28.72 15.00 11.49 -26.08 coo 23.55 29.53 9.81 23.15 27.39 10.24 20.26 16.82 -31.29 19.35 18.72 -31.94 coo 16.43 30.18 9.35 15.05 30.67 11.01 17.70 21.96 -36.53 16.68 20.28 -35.54 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 29 3 # 29 I 303 TYR C 421 TYR^? 13.35 C2 EDO C 602 I 306 VAL C 389 VAL~? 19.67 C2 EDO C 602 I 308 VAL C 377 VAL~? 19.90 O2 EDO C 602 coo 26.18 35.24 6.87 24.33 35.18 8.97 19.38 20.76 -23.26 18.18 22.24 -25.31 coo 23.55 29.53 9.81 23.15 27.39 10.24 17.26 28.56 -20.86 18.61 29.49 -22.34 coo 16.43 30.18 9.35 15.05 30.67 11.01 24.75 31.16 -23.41 23.83 29.45 -22.34 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 30 3 # 30 I 303 TYR C 421 TYR^? 13.35 C2 EDO C 602 I 306 VAL C 389 VAL~? 19.67 C2 EDO C 602 I 308 VAL C 385 VAL~? 20.30 O2 EDO C 602 coo 26.18 35.24 6.87 24.33 35.18 8.97 19.38 20.76 -23.26 18.18 22.24 -25.31 coo 23.55 29.53 9.81 23.15 27.39 10.24 17.26 28.56 -20.86 18.61 29.49 -22.34 coo 16.43 30.18 9.35 15.05 30.67 11.01 13.23 32.44 -24.06 13.71 31.02 -25.72 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 31 3 # 31 I 303 TYR C 421 TYR^? 13.35 C2 EDO C 602 I 306 VAL C 419 VAL^? 8.98 C2 EDO C 602 I 308 VAL C 417 VAL^? 6.39 C2 EDO C 602 coo 26.18 35.24 6.87 24.33 35.18 8.97 19.38 20.76 -23.26 18.18 22.24 -25.31 coo 23.55 29.53 9.81 23.15 27.39 10.24 17.04 16.88 -28.14 16.79 19.05 -28.45 coo 16.43 30.18 9.35 15.05 30.67 11.01 14.01 15.75 -33.67 14.54 17.84 -34.00 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 32 3 # 32 I 303 TYR C 421 TYR^? 13.35 C2 EDO C 602 I 306 VAL C 434 VAL^? 17.86 C2 EDO C 602 I 308 VAL C 346 VAL^? 18.34 C2 EDO C 602 coo 26.18 35.24 6.87 24.33 35.18 8.97 19.38 20.76 -23.26 18.18 22.24 -25.31 coo 23.55 29.53 9.81 23.15 27.39 10.24 26.19 21.35 -20.48 24.16 22.12 -20.14 coo 16.43 30.18 9.35 15.05 30.67 11.01 28.57 25.36 -22.99 26.75 26.57 -22.80 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 33 3 # 33 I 303 TYR C 421 TYR^? 13.35 C2 EDO C 602 I 306 VAL C 434 VAL^? 17.86 C2 EDO C 602 I 308 VAL C 424 VAL^? 16.76 O1 GOL D 601 coo 26.18 35.24 6.87 24.33 35.18 8.97 19.38 20.76 -23.26 18.18 22.24 -25.31 coo 23.55 29.53 9.81 23.15 27.39 10.24 26.19 21.35 -20.48 24.16 22.12 -20.14 coo 16.43 30.18 9.35 15.05 30.67 11.01 28.86 16.99 -18.02 30.08 17.32 -19.82 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 34 3 # 34 I 303 TYR C 437 TYR^? 9.81 O1 GOL D 601 I 306 VAL C 419 VAL^? 8.98 C2 EDO C 602 I 308 VAL C 404 VAL^? 16.48 O1 GOL D 601 coo 26.18 35.24 6.87 24.33 35.18 8.97 23.51 14.66 -27.39 22.94 13.02 -25.21 coo 23.55 29.53 9.81 23.15 27.39 10.24 17.04 16.88 -28.14 16.79 19.05 -28.45 coo 16.43 30.18 9.35 15.05 30.67 11.01 16.52 16.94 -19.97 15.92 18.97 -19.27 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 35 3 # 35 I 303 TYR C 437 TYR^? 9.81 O1 GOL D 601 I 306 VAL C 419 VAL^? 8.98 C2 EDO C 602 I 308 VAL C 417 VAL^? 6.39 C2 EDO C 602 coo 26.18 35.24 6.87 24.33 35.18 8.97 23.51 14.66 -27.39 22.94 13.02 -25.21 coo 23.55 29.53 9.81 23.15 27.39 10.24 17.04 16.88 -28.14 16.79 19.05 -28.45 coo 16.43 30.18 9.35 15.05 30.67 11.01 14.01 15.75 -33.67 14.54 17.84 -34.00 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 36 3 # 36 I 303 TYR C 437 TYR^? 9.81 O1 GOL D 601 I 306 VAL C 438 VAL^? -5.14 C2 EDO C 602s I 308 VAL C 365 VAL.? 5.09 O2 EDO C 602 coo 26.18 35.24 6.87 24.33 35.18 8.97 23.51 14.66 -27.39 22.94 13.02 -25.21 coo 23.55 29.53 9.81 23.15 27.39 10.24 20.26 16.82 -31.29 19.35 18.72 -31.94 coo 16.43 30.18 9.35 15.05 30.67 11.01 17.70 21.96 -36.53 16.68 20.28 -35.54 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 37 3 # 37 I 303 TYR C 437 TYR^? 9.81 O1 GOL D 601 I 306 VAL C 438 VAL^? -5.14 C2 EDO C 602s I 308 VAL C 417 VAL^? 6.39 C2 EDO C 602 coo 26.18 35.24 6.87 24.33 35.18 8.97 23.51 14.66 -27.39 22.94 13.02 -25.21 coo 23.55 29.53 9.81 23.15 27.39 10.24 20.26 16.82 -31.29 19.35 18.72 -31.94 coo 16.43 30.18 9.35 15.05 30.67 11.01 14.01 15.75 -33.67 14.54 17.84 -34.00 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 38 3 # 38 I 303 TYR D 418 TYR^? 10.77 C1 GOL D 601 I 306 VAL D 417 VAL^? 6.52 C3 GOL D 601 I 308 VAL D 365 VAL.? 4.92 O3 GOL D 601 coo 26.18 35.24 6.87 24.33 35.18 8.97 20.16 1.85 -35.57 20.10 2.87 -38.19 coo 23.55 29.53 9.81 23.15 27.39 10.24 20.30 -2.25 -31.05 22.02 -3.42 -30.38 coo 16.43 30.18 9.35 15.05 30.67 11.01 26.22 -4.90 -26.75 24.58 -4.20 -28.03 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 39 3 # 39 I 303 TYR D 418 TYR^? 10.77 C1 GOL D 601 I 306 VAL D 419 VAL^? 8.98 C3 GOL D 601 I 308 VAL D 404 VAL^? 16.89 O1 EDO C 602 coo 26.18 35.24 6.87 24.33 35.18 8.97 20.16 1.85 -35.57 20.10 2.87 -38.19 coo 23.55 29.53 9.81 23.15 27.39 10.24 24.60 -0.22 -35.30 25.78 -2.06 -34.95 coo 16.43 30.18 9.35 15.05 30.67 11.01 26.33 0.89 -43.26 27.25 -0.88 -44.23 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 40 3 # 40 I 303 TYR D 418 TYR^? 10.77 C1 GOL D 601 I 306 VAL D 438 VAL^? -5.06 C3 GOL D 601s I 308 VAL D 365 VAL.? 4.92 O3 GOL D 601 coo 26.18 35.24 6.87 24.33 35.18 8.97 20.16 1.85 -35.57 20.10 2.87 -38.19 coo 23.55 29.53 9.81 23.15 27.39 10.24 25.98 1.45 -31.30 26.35 -0.69 -30.91 coo 16.43 30.18 9.35 15.05 30.67 11.01 26.22 -4.90 -26.75 24.58 -4.20 -28.03 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 41 3 # 41 I 303 TYR D 421 TYR^? 13.63 C3 GOL D 601 I 306 VAL D 389 VAL~? 18.63 C3 GOL D 601 I 308 VAL D 377 VAL~? 19.72 O3 GOL D 601 coo 26.18 35.24 6.87 24.33 35.18 8.97 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo 23.55 29.53 9.81 23.15 27.39 10.24 33.58 -6.60 -41.42 34.52 -6.13 -39.49 coo 16.43 30.18 9.35 15.05 30.67 11.01 40.93 -5.69 -36.53 39.14 -4.56 -37.10 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 42 3 # 42 I 303 TYR D 421 TYR^? 13.63 C3 GOL D 601 I 306 VAL D 389 VAL~? 18.63 C3 GOL D 601 I 308 VAL D 385 VAL~? 18.11 O3 GOL D 601 coo 26.18 35.24 6.87 24.33 35.18 8.97 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo 23.55 29.53 9.81 23.15 27.39 10.24 33.58 -6.60 -41.42 34.52 -6.13 -39.49 coo 16.43 30.18 9.35 15.05 30.67 11.01 32.37 -11.96 -38.26 32.15 -11.38 -36.14 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 43 3 # 43 I 303 TYR D 421 TYR^? 13.63 C3 GOL D 601 I 306 VAL D 419 VAL^? 8.98 C3 GOL D 601 I 308 VAL D 417 VAL^? 6.52 C3 GOL D 601 coo 26.18 35.24 6.87 24.33 35.18 8.97 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo 23.55 29.53 9.81 23.15 27.39 10.24 24.60 -0.22 -35.30 25.78 -2.06 -34.95 coo 16.43 30.18 9.35 15.05 30.67 11.01 20.30 -2.25 -31.05 22.02 -3.42 -30.38 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 44 3 # 44 I 303 TYR D 421 TYR^? 13.63 C3 GOL D 601 I 306 VAL D 434 VAL^? 17.75 C3 GOL D 601 I 308 VAL D 424 VAL^? 16.11 O1 EDO C 602 coo 26.18 35.24 6.87 24.33 35.18 8.97 30.12 -0.70 -39.30 29.82 -2.95 -37.69 coo 23.55 29.53 9.81 23.15 27.39 10.24 35.97 3.58 -39.60 35.23 1.68 -40.44 coo 16.43 30.18 9.35 15.05 30.67 11.01 35.65 8.91 -41.46 36.26 9.12 -39.36 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 45 3 # 45 I 303 TYR D 437 TYR^? 9.97 C1 GOL D 601 I 306 VAL D 419 VAL^? 8.98 C3 GOL D 601 I 308 VAL D 404 VAL^? 16.89 O1 EDO C 602 coo 26.18 35.24 6.87 24.33 35.18 8.97 27.83 5.60 -34.20 26.72 6.80 -36.49 coo 23.55 29.53 9.81 23.15 27.39 10.24 24.60 -0.22 -35.30 25.78 -2.06 -34.95 coo 16.43 30.18 9.35 15.05 30.67 11.01 26.33 0.89 -43.26 27.25 -0.88 -44.23 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 46 3 # 46 I 303 TYR D 437 TYR^? 9.97 C1 GOL D 601 I 306 VAL D 419 VAL^? 8.98 C3 GOL D 601 I 308 VAL D 417 VAL^? 6.52 C3 GOL D 601 coo 26.18 35.24 6.87 24.33 35.18 8.97 27.83 5.60 -34.20 26.72 6.80 -36.49 coo 23.55 29.53 9.81 23.15 27.39 10.24 24.60 -0.22 -35.30 25.78 -2.06 -34.95 coo 16.43 30.18 9.35 15.05 30.67 11.01 20.30 -2.25 -31.05 22.02 -3.42 -30.38 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 47 3 # 47 I 303 TYR D 437 TYR^? 9.97 C1 GOL D 601 I 306 VAL D 438 VAL^? -5.06 C3 GOL D 601s I 308 VAL D 365 VAL.? 4.92 O3 GOL D 601 coo 26.18 35.24 6.87 24.33 35.18 8.97 27.83 5.60 -34.20 26.72 6.80 -36.49 coo 23.55 29.53 9.81 23.15 27.39 10.24 25.98 1.45 -31.30 26.35 -0.69 -30.91 coo 16.43 30.18 9.35 15.05 30.67 11.01 26.22 -4.90 -26.75 24.58 -4.20 -28.03 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 48 3 # 48 I 303 TYR D 437 TYR^? 9.97 C1 GOL D 601 I 306 VAL D 438 VAL^? -5.06 C3 GOL D 601s I 308 VAL D 417 VAL^? 6.52 C3 GOL D 601 coo 26.18 35.24 6.87 24.33 35.18 8.97 27.83 5.60 -34.20 26.72 6.80 -36.49 coo 23.55 29.53 9.81 23.15 27.39 10.24 25.98 1.45 -31.30 26.35 -0.69 -30.91 coo 16.43 30.18 9.35 15.05 30.67 11.01 20.30 -2.25 -31.05 22.02 -3.42 -30.38 1cqt_d00 source 1cqt GENE REGULATION/DNA : 48 hits 1cqt_d00 naa= 3 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 1 3 # 1 C 70 ARG A 401 ARG.? 15.99 O2 GOL D 601 C 71 LYS A 403 LYS^? 8.85 O1 EDO B 603 C 72 VAL A 404 VAL^? 17.61 O1 EDO B 603 coo 23.89 33.54 29.21 26.59 34.86 28.68 17.05 9.37 -8.73 16.66 7.27 -10.98 coo 25.82 26.89 29.68 23.33 22.98 25.84 17.56 13.24 -3.73 14.59 17.27 -0.83 coo 28.86 29.08 30.37 28.04 31.02 29.93 16.49 9.66 -3.07 17.67 7.94 -3.69 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 2 3 # 2 C 70 ARG B 401 ARG.? 20.08 C2 EDO B 603 C 71 LYS B 403 LYS^? 16.64 C2 EDO B 603 C 72 VAL B 404 VAL^? 17.30 C2 EDO B 603 coo 23.89 33.54 29.21 26.59 34.86 28.68 1.75 25.80 23.58 1.16 24.37 20.91 coo 25.82 26.89 29.68 23.33 22.98 25.84 6.24 24.71 19.66 5.62 19.48 17.38 coo 28.86 29.08 30.37 28.04 31.02 29.93 3.26 26.44 18.10 2.38 28.35 18.80 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 3 3 # 3 C 70 ARG C 401 ARG.? 15.33 O1 EDO B 603 C 71 LYS C 403 LYS^? 9.83 O1 GOL D 601 C 72 VAL C 404 VAL^? 16.48 O1 GOL D 601 coo 23.89 33.54 29.21 26.59 34.86 28.68 15.13 16.06 -14.86 13.60 17.63 -12.63 coo 25.82 26.89 29.68 23.33 22.98 25.84 19.56 15.05 -18.65 18.30 10.78 -20.22 coo 28.86 29.08 30.37 28.04 31.02 29.93 16.52 16.94 -19.97 15.92 18.97 -19.27 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 4 3 # 4 C 70 ARG D 401 ARG.? 17.46 O1 EDO C 602 C 71 LYS D 403 LYS^? 8.04 O1 EDO C 602 C 72 VAL D 404 VAL^? 16.89 O1 EDO C 602 coo 23.89 33.54 29.21 26.59 34.86 28.68 26.50 1.94 -49.52 24.85 0.58 -47.31 coo 25.82 26.89 29.68 23.33 22.98 25.84 27.51 4.47 -43.69 23.30 8.13 -41.81 coo 28.86 29.08 30.37 28.04 31.02 29.93 26.33 0.89 -43.26 27.25 -0.88 -44.23 1hwt_d00 source 1hwt GENE REGULATION/DNA : 4 hits 1hwt_d00 naa= 3 ULMN 4 1kqq_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 92 THR A 317 THR.? 30.13 C1 EDO B 603 A 93 SER A 328 SER~? 24.32 C1 EDO B 603 A 96 LEU A 327 LEU^? 18.69 C1 EDO B 603 A 131 ARG B 316 ARG.? 22.40 C1 EDO B 603 coo 3.35 5.93 10.54 2.79 5.49 12.55 29.57 32.99 19.64 30.09 32.97 21.72 coo 3.53 2.76 8.43 3.13 1.02 10.05 27.10 32.44 15.23 26.15 32.07 17.43 coo 5.64 -0.49 6.46 5.57 -2.53 7.21 23.89 31.95 12.46 21.87 31.23 12.13 coo 12.62 -3.51 13.26 13.87 -0.97 14.34 32.74 31.58 5.20 30.84 29.65 3.70 ULMN 4 1kqq_d00 TRANSCRIPTION/DNA user 2 4 # 2 A 92 THR A 318 THR.? 30.43 C1 EDO B 603 A 93 SER A 328 SER~? 24.32 C1 EDO B 603 A 96 LEU A 327 LEU^? 18.69 C1 EDO B 603 A 131 ARG B 316 ARG.? 22.40 C1 EDO B 603 coo 3.35 5.93 10.54 2.79 5.49 12.55 30.31 35.91 17.26 32.03 37.29 17.23 coo 3.53 2.76 8.43 3.13 1.02 10.05 27.10 32.44 15.23 26.15 32.07 17.43 coo 5.64 -0.49 6.46 5.57 -2.53 7.21 23.89 31.95 12.46 21.87 31.23 12.13 coo 12.62 -3.51 13.26 13.87 -0.97 14.34 32.74 31.58 5.20 30.84 29.65 3.70 ULMN 4 1kqq_d00 TRANSCRIPTION/DNA user 3 4 # 3 A 92 THR B 317 THR.? 28.99 C1 EDO B 603 A 93 SER B 328 SER~? 24.34 C1 EDO B 603 A 96 LEU B 327 LEU^? 21.89 C1 EDO B 603 A 131 ARG A 316 ARG.? 27.22 C1 EDO B 603 coo 3.35 5.93 10.54 2.79 5.49 12.55 36.64 25.71 6.15 37.93 26.34 4.55 coo 3.53 2.76 8.43 3.13 1.02 10.05 32.93 23.60 9.01 32.97 23.42 6.61 coo 5.64 -0.49 6.46 5.57 -2.53 7.21 29.86 20.93 10.32 28.09 19.79 9.77 coo 12.62 -3.51 13.26 13.87 -0.97 14.34 32.66 26.75 19.60 30.80 24.65 18.26 ULMN 4 1kqq_d00 TRANSCRIPTION/DNA user 4 4 # 4 A 92 THR B 318 THR.? 31.71 C1 EDO B 603 A 93 SER B 328 SER~? 24.34 C1 EDO B 603 A 96 LEU B 327 LEU^? 21.89 C1 EDO B 603 A 131 ARG A 316 ARG.? 27.22 C1 EDO B 603 coo 3.35 5.93 10.54 2.79 5.49 12.55 38.06 24.71 9.55 39.51 25.67 10.82 coo 3.53 2.76 8.43 3.13 1.02 10.05 32.93 23.60 9.01 32.97 23.42 6.61 coo 5.64 -0.49 6.46 5.57 -2.53 7.21 29.86 20.93 10.32 28.09 19.79 9.77 coo 12.62 -3.51 13.26 13.87 -0.97 14.34 32.66 26.75 19.60 30.80 24.65 18.26 ULMN 4 1kqq_d00 TRANSCRIPTION/DNA user 5 4 # 5 A 92 THR C 317 THR.? 28.45 C1 EDO C 602 A 93 SER C 328 SER~? 23.98 C1 EDO C 602 A 96 LEU C 327 LEU^? 18.96 C1 GOL D 601 A 131 ARG D 316 ARG.? 22.70 C2 GOL D 601 coo 3.35 5.93 10.54 2.79 5.49 12.55 48.45 14.16 -34.83 49.57 14.57 -36.66 coo 3.53 2.76 8.43 3.13 1.02 10.05 45.06 12.12 -31.74 44.78 12.22 -34.15 coo 5.64 -0.49 6.46 5.57 -2.53 7.21 41.90 9.61 -30.25 40.02 8.65 -30.71 coo 12.62 -3.51 13.26 13.87 -0.97 14.34 45.13 14.38 -20.32 42.13 14.31 -19.52 ULMN 4 1kqq_d00 TRANSCRIPTION/DNA user 6 4 # 6 A 92 THR C 318 THR.? 30.49 C2 GOL D 601 A 93 SER C 328 SER~? 23.98 C1 EDO C 602 A 96 LEU C 327 LEU^? 18.96 C1 GOL D 601 A 131 ARG D 316 ARG.? 22.70 C2 GOL D 601 coo 3.35 5.93 10.54 2.79 5.49 12.55 50.21 12.77 -31.72 51.79 13.54 -30.47 coo 3.53 2.76 8.43 3.13 1.02 10.05 45.06 12.12 -31.74 44.78 12.22 -34.15 coo 5.64 -0.49 6.46 5.57 -2.53 7.21 41.90 9.61 -30.25 40.02 8.65 -30.71 coo 12.62 -3.51 13.26 13.87 -0.97 14.34 45.13 14.38 -20.32 42.13 14.31 -19.52 ULMN 4 1kqq_d00 TRANSCRIPTION/DNA user 7 4 # 7 A 92 THR D 317 THR.? 28.79 C1 GOL D 601 A 93 SER D 328 SER~? 24.00 C1 EDO C 602 A 96 LEU D 327 LEU^? 18.43 C1 EDO C 602 A 131 ARG C 316 ARG.? 22.36 C1 EDO C 602 coo 3.35 5.93 10.54 2.79 5.49 12.55 43.40 21.29 -20.10 44.08 21.40 -18.06 coo 3.53 2.76 8.43 3.13 1.02 10.05 40.49 20.83 -24.30 39.56 20.57 -22.09 coo 5.64 -0.49 6.46 5.57 -2.53 7.21 37.08 20.81 -26.92 35.00 20.28 -27.12 coo 12.62 -3.51 13.26 13.87 -0.97 14.34 45.68 20.68 -34.53 42.70 20.67 -33.83 ULMN 4 1kqq_d00 TRANSCRIPTION/DNA user 8 4 # 8 A 92 THR D 318 THR.? 30.09 C1 EDO C 602 A 93 SER D 328 SER~? 24.00 C1 EDO C 602 A 96 LEU D 327 LEU^? 18.43 C1 EDO C 602 A 131 ARG C 316 ARG.? 22.36 C1 EDO C 602 coo 3.35 5.93 10.54 2.79 5.49 12.55 44.56 23.70 -22.81 46.55 24.41 -23.21 coo 3.53 2.76 8.43 3.13 1.02 10.05 40.49 20.83 -24.30 39.56 20.57 -22.09 coo 5.64 -0.49 6.46 5.57 -2.53 7.21 37.08 20.81 -26.92 35.00 20.28 -27.12 coo 12.62 -3.51 13.26 13.87 -0.97 14.34 45.68 20.68 -34.53 42.70 20.67 -33.83 1kqq_d00 source 1kqq TRANSCRIPTION/DNA : 8 hits 1kqq_d00 naa= 4 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 1 3 # 1 D 23 LYS A 367 LYS.? 27.79 C1 EDO B 603 D 25 THR A 369 THR~? 31.64 C1 EDO B 603 D 27 SER A 371 SER~? 34.73 C1 EDO B 603 coo 86.60 33.38 44.00 87.05 39.52 42.71 21.09 4.68 15.64 17.32 4.21 18.91 coo 81.20 31.58 48.03 79.23 32.24 47.54 27.07 6.63 18.00 27.23 4.49 18.30 coo 79.09 29.82 54.20 77.17 28.90 53.05 32.36 6.06 17.83 31.41 4.72 19.63 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 2 3 # 2 D 23 LYS B 367 LYS.? 8.96 O2 EDO B 603 D 25 THR B 369 THR~? 15.82 O2 EDO B 603 D 27 SER B 371 SER~? 20.39 O2 EDO B 603 coo 86.60 33.38 44.00 87.05 39.52 42.71 8.46 36.63 1.57 6.31 34.95 -1.21 coo 81.20 31.58 48.03 79.23 32.24 47.54 14.08 40.07 2.07 12.56 41.55 1.60 coo 79.09 29.82 54.20 77.17 28.90 53.05 16.10 44.50 4.20 15.46 45.36 2.02 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 3 3 # 3 D 23 LYS C 367 LYS.? 10.18 O2 EDO C 602 D 25 THR C 369 THR~? 15.84 O2 EDO C 602 D 27 SER C 371 SER~? 19.63 O2 EDO C 602 coo 86.60 33.38 44.00 87.05 39.52 42.71 21.41 26.99 -36.15 19.64 26.87 -41.36 coo 81.20 31.58 48.03 79.23 32.24 47.54 27.27 30.44 -36.03 26.03 32.19 -36.25 coo 79.09 29.82 54.20 77.17 28.90 53.05 30.17 34.40 -34.13 29.04 35.01 -36.23 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 4 3 # 4 D 23 LYS D 367 LYS.? 8.67 O3 GOL D 601 D 25 THR D 369 THR~? 16.21 O3 GOL D 601 D 27 SER D 371 SER~? 20.50 O3 GOL D 601 coo 86.60 33.38 44.00 87.05 39.52 42.71 32.17 -6.41 -25.63 28.00 -7.23 -22.20 coo 81.20 31.58 48.03 79.23 32.24 47.54 38.48 -5.77 -24.43 38.79 -7.85 -25.06 coo 79.09 29.82 54.20 77.17 28.90 53.05 43.73 -6.40 -24.93 43.24 -8.29 -23.45 1mjo_d00 source 1mjo TRANSCRIPTION/DNA : 4 hits 1mjo_d00 naa= 3 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 19 ARG A 425 ARG^? 21.19 O1 EDO B 603 A 30 THR A 344 THR^? 21.00 C1 EDO B 603 A 34 VAL A 346 VAL^? 24.05 C1 EDO B 603 A 38 LYS A 348 LYS.? 29.38 O1 EDO B 603 coo 30.09 31.19 5.41 30.53 28.24 4.72 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 23.70 12.96 9.21 23.27 10.80 9.07 coo 18.16 36.88 2.14 19.60 35.97 0.73 29.01 12.29 4.94 28.88 10.14 4.54 coo 16.75 32.35 6.21 21.42 30.93 2.22 33.03 14.06 -0.37 37.33 16.69 -0.99 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 2 4 # 2 A 19 ARG B 425 ARG^? 24.19 C2 EDO B 603 A 30 THR B 344 THR^? 10.89 C2 EDO B 603 A 34 VAL B 346 VAL^? 18.03 C2 EDO B 603 A 38 LYS B 348 LYS.? 28.30 C2 EDO B 603 coo 30.09 31.19 5.41 30.53 28.24 4.72 13.19 26.25 26.41 10.66 27.96 25.98 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 14.01 31.82 9.85 12.08 32.62 9.23 coo 18.16 36.88 2.14 19.60 35.97 0.73 14.71 35.57 15.47 12.76 36.63 15.46 coo 16.75 32.35 6.21 21.42 30.93 2.22 16.25 36.62 22.07 20.01 34.44 26.08 1mnm_d00 source 1mnm TRANSCRIPTION/DNA : 2 hits 1mnm_d00 naa= 4 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 1 3 # 1 C 43 GLN B 372 GLN~? 15.06 O2 EDO B 603 C 44 LYS B 367 LYS.? 8.96 O2 EDO B 603 C 75 ARG B 368 ARG.? 11.04 O2 EDO B 603 coo 34.33 34.01 1.06 32.24 34.35 1.22 11.94 42.08 6.13 10.66 40.49 5.62 coo 36.27 30.15 5.40 32.93 24.83 5.96 8.46 36.63 1.57 6.31 34.95 -1.21 coo 30.88 29.31 6.12 29.39 29.02 3.47 11.09 36.07 6.20 8.36 35.36 7.43 2er8_d00 source 2er8 TRANSCRIPTION ACTIVATOR/DNA : 1 hits 2er8_d00 naa= 3 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 24 ARG A 368 ARG.? 24.16 C1 EDO B 603 A 32 LYS A 367 LYS.? 27.79 C1 EDO B 603 A 46 ARG A 375 ARG.? 36.99 C1 EDO B 603 coo -8.00 4.27 27.74 -7.09 2.66 30.09 23.91 7.22 12.24 22.49 6.03 9.76 coo -5.15 8.65 26.69 -4.26 5.48 32.02 21.09 4.68 15.64 17.32 4.21 18.91 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 34.50 3.88 12.57 36.52 3.36 14.83 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 24 ARG A 401 ARG.? 15.99 O2 GOL D 601 A 32 LYS A 403 LYS^? 8.85 O1 EDO B 603 A 46 ARG A 397 ARG~? 24.94 O2 GOL D 601 coo -8.00 4.27 27.74 -7.09 2.66 30.09 17.05 9.37 -8.73 16.66 7.27 -10.98 coo -5.15 8.65 26.69 -4.26 5.48 32.02 17.56 13.24 -3.73 14.59 17.27 -0.83 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 31.00 11.06 -6.51 32.72 12.02 -4.11 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 24 ARG A 401 ARG.? 15.99 O2 GOL D 601 A 32 LYS A 403 LYS^? 8.85 O1 EDO B 603 A 46 ARG C 425 ARG^? 21.48 O1 GOL D 601 coo -8.00 4.27 27.74 -7.09 2.66 30.09 17.05 9.37 -8.73 16.66 7.27 -10.98 coo -5.15 8.65 26.69 -4.26 5.48 32.02 17.56 13.24 -3.73 14.59 17.27 -0.83 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 27.32 15.93 -12.34 26.51 18.69 -11.26 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 4 3 # 4 A 24 ARG B 368 ARG.? 11.04 O2 EDO B 603 A 32 LYS B 367 LYS.? 8.96 O2 EDO B 603 A 46 ARG B 375 ARG.? 22.49 O2 EDO B 603 coo -8.00 4.27 27.74 -7.09 2.66 30.09 11.09 36.07 6.20 8.36 35.36 7.43 coo -5.15 8.65 26.69 -4.26 5.48 32.02 8.46 36.63 1.57 6.31 34.95 -1.21 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 13.81 46.43 8.85 13.44 47.64 6.03 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 5 3 # 5 A 24 ARG B 401 ARG.? 20.08 C2 EDO B 603 A 32 LYS B 403 LYS^? 16.64 C2 EDO B 603 A 46 ARG B 397 ARG~? 26.01 C2 EDO B 603 coo -8.00 4.27 27.74 -7.09 2.66 30.09 1.75 25.80 23.58 1.16 24.37 20.91 coo -5.15 8.65 26.69 -4.26 5.48 32.02 6.24 24.71 19.66 5.62 19.48 17.38 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 10.79 36.41 26.32 12.94 37.68 24.51 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 6 3 # 6 A 24 ARG C 368 ARG.? 10.85 O2 EDO C 602 A 32 LYS C 367 LYS.? 10.18 O2 EDO C 602 A 46 ARG C 375 ARG.? 20.99 O2 EDO C 602 coo -8.00 4.27 27.74 -7.09 2.66 30.09 24.45 26.16 -32.00 21.85 25.58 -30.53 coo -5.15 8.65 26.69 -4.26 5.48 32.02 21.41 26.99 -36.15 19.64 26.87 -41.36 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 27.90 36.71 -28.33 26.60 36.43 -31.10 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 7 3 # 7 A 24 ARG C 401 ARG.? 15.33 O1 EDO B 603 A 32 LYS C 403 LYS^? 9.83 O1 GOL D 601 A 46 ARG A 425 ARG^? 21.19 O1 EDO B 603 coo -8.00 4.27 27.74 -7.09 2.66 30.09 15.13 16.06 -14.86 13.60 17.63 -12.63 coo -5.15 8.65 26.69 -4.26 5.48 32.02 19.56 15.05 -18.65 18.30 10.78 -20.22 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 25.04 18.93 -7.11 26.86 16.62 -8.01 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 8 3 # 8 A 24 ARG D 368 ARG.? 11.23 O3 GOL D 601 A 32 LYS D 367 LYS.? 8.67 O3 GOL D 601 A 46 ARG D 375 ARG.? 23.45 O3 GOL D 601 coo -8.00 4.27 27.74 -7.09 2.66 30.09 34.63 -3.42 -28.94 33.31 -3.73 -31.69 coo -5.15 8.65 26.69 -4.26 5.48 32.02 32.17 -6.41 -25.63 28.00 -7.23 -22.20 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 45.57 -7.61 -30.32 45.87 -9.61 -28.01 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 9 3 # 9 A 24 ARG D 401 ARG.? 17.46 O1 EDO C 602 A 32 LYS D 403 LYS^? 8.04 O1 EDO C 602 A 46 ARG D 397 ARG~? 26.17 C3 GOL D 601 coo -8.00 4.27 27.74 -7.09 2.66 30.09 26.50 1.94 -49.52 24.85 0.58 -47.31 coo -5.15 8.65 26.69 -4.26 5.48 32.02 27.51 4.47 -43.69 23.30 8.13 -41.81 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 40.54 0.77 -47.66 42.41 1.45 -45.29 2ky8_d00 source 2ky8 TRANSCRIPTION/DNA : 9 hits 2ky8_d00 naa= 3 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 358 SER.? 19.71 C1 EDO B 603 B 37 ASN A 337 ASN~? 21.47 C1 EDO B 603 B 45 THR B 344 THR^? 10.89 C2 EDO B 603 coo -19.49 41.97 71.08 -17.37 40.80 71.17 17.92 16.03 18.01 17.94 14.38 16.23 coo -23.05 39.62 69.74 -22.86 39.59 67.61 20.37 20.71 18.22 22.41 20.05 18.06 coo -30.87 34.84 80.57 -28.94 34.51 81.49 14.01 31.82 9.85 12.08 32.62 9.23 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER A 358 SER.? 19.71 C1 EDO B 603 B 37 ASN A 337 ASN~? 21.47 C1 EDO B 603 B 45 THR B 420 THR^? 12.07 C2 EDO B 603 coo -19.49 41.97 71.08 -17.37 40.80 71.17 17.92 16.03 18.01 17.94 14.38 16.23 coo -23.05 39.62 69.74 -22.86 39.59 67.61 20.37 20.71 18.22 22.41 20.05 18.06 coo -30.87 34.84 80.57 -28.94 34.51 81.49 6.28 25.69 13.21 6.93 23.74 13.95 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 B 34 SER A 358 SER.? 19.71 C1 EDO B 603 B 37 ASN A 356 ASN.? 18.20 C1 EDO B 603 B 45 THR A 420 THR^? 12.22 O1 EDO B 603 coo -19.49 41.97 71.08 -17.37 40.80 71.17 17.92 16.03 18.01 17.94 14.38 16.23 coo -23.05 39.62 69.74 -22.86 39.59 67.61 21.62 17.22 14.34 19.81 16.20 13.98 coo -30.87 34.84 80.57 -28.94 34.51 81.49 15.83 11.51 2.31 14.98 13.34 1.54 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 B 34 SER B 358 SER.? 7.25 C1 EDO B 603 B 37 ASN B 337 ASN~? 13.41 C1 EDO B 603 B 45 THR A 344 THR^? 21.00 C1 EDO B 603 coo -19.49 41.97 71.08 -17.37 40.80 71.17 16.90 26.63 0.02 16.29 24.39 0.69 coo -23.05 39.62 69.74 -22.86 39.59 67.61 21.54 26.32 1.73 21.98 28.23 2.58 coo -30.87 34.84 80.57 -28.94 34.51 81.49 23.70 12.96 9.21 23.27 10.80 9.07 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 B 34 SER B 358 SER.? 7.25 C1 EDO B 603 B 37 ASN B 337 ASN~? 13.41 C1 EDO B 603 B 45 THR A 420 THR^? 12.22 O1 EDO B 603 coo -19.49 41.97 71.08 -17.37 40.80 71.17 16.90 26.63 0.02 16.29 24.39 0.69 coo -23.05 39.62 69.74 -22.86 39.59 67.61 21.54 26.32 1.73 21.98 28.23 2.58 coo -30.87 34.84 80.57 -28.94 34.51 81.49 15.83 11.51 2.31 14.98 13.34 1.54 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 B 34 SER B 358 SER.? 7.25 C1 EDO B 603 B 37 ASN B 356 ASN.? 8.23 C1 EDO B 603 B 45 THR B 420 THR^? 12.07 C2 EDO B 603 coo -19.49 41.97 71.08 -17.37 40.80 71.17 16.90 26.63 0.02 16.29 24.39 0.69 coo -23.05 39.62 69.74 -22.86 39.59 67.61 18.03 28.57 5.10 16.12 27.74 4.68 coo -30.87 34.84 80.57 -28.94 34.51 81.49 6.28 25.69 13.21 6.93 23.74 13.95 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 7 3 # 7 B 34 SER C 358 SER.? 6.66 O1 EDO C 602 B 37 ASN C 337 ASN~? 13.18 C1 EDO C 602 B 45 THR D 344 THR^? 11.84 C3 GOL D 601 coo -19.49 41.97 71.08 -17.37 40.80 71.17 28.49 17.26 -38.81 27.76 14.99 -38.31 coo -23.05 39.62 69.74 -22.86 39.59 67.61 33.28 16.29 -37.60 34.03 18.13 -36.82 coo -30.87 34.84 80.57 -28.94 34.51 81.49 34.76 2.40 -31.44 34.92 0.24 -31.49 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 8 3 # 8 B 34 SER C 358 SER.? 6.66 O1 EDO C 602 B 37 ASN C 337 ASN~? 13.18 C1 EDO C 602 B 45 THR D 420 THR^? 11.62 O1 EDO C 602 coo -19.49 41.97 71.08 -17.37 40.80 71.17 28.49 17.26 -38.81 27.76 14.99 -38.31 coo -23.05 39.62 69.74 -22.86 39.59 67.61 33.28 16.29 -37.60 34.03 18.13 -36.82 coo -30.87 34.84 80.57 -28.94 34.51 81.49 26.36 2.12 -37.74 25.52 4.03 -38.26 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 9 3 # 9 B 34 SER C 358 SER.? 6.66 O1 EDO C 602 B 37 ASN C 356 ASN.? 8.10 C1 EDO C 602 B 45 THR C 420 THR^? 10.46 O1 GOL D 601 coo -19.49 41.97 71.08 -17.37 40.80 71.17 28.49 17.26 -38.81 27.76 14.99 -38.31 coo -23.05 39.62 69.74 -22.86 39.59 67.61 30.42 18.66 -33.90 28.43 18.01 -34.20 coo -30.87 34.84 80.57 -28.94 34.51 81.49 19.08 16.16 -25.00 19.73 14.12 -24.43 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 10 3 # 10 B 34 SER D 358 SER.? 6.75 C2 GOL D 601 B 37 ASN D 337 ASN~? 13.43 C2 GOL D 601 B 45 THR C 344 THR^? 11.72 O2 EDO C 602 coo -19.49 41.97 71.08 -17.37 40.80 71.17 29.79 5.62 -21.71 27.82 6.72 -22.45 coo -23.05 39.62 69.74 -22.86 39.59 67.61 33.20 9.44 -21.47 35.12 8.58 -21.91 coo -30.87 34.84 80.57 -28.94 34.51 81.49 26.88 22.01 -28.65 25.52 23.63 -29.04 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 11 3 # 11 B 34 SER D 358 SER.? 6.75 C2 GOL D 601 B 37 ASN D 337 ASN~? 13.43 C2 GOL D 601 B 45 THR C 420 THR^? 10.46 O1 GOL D 601 coo -19.49 41.97 71.08 -17.37 40.80 71.17 29.79 5.62 -21.71 27.82 6.72 -22.45 coo -23.05 39.62 69.74 -22.86 39.59 67.61 33.20 9.44 -21.47 35.12 8.58 -21.91 coo -30.87 34.84 80.57 -28.94 34.51 81.49 19.08 16.16 -25.00 19.73 14.12 -24.43 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 12 3 # 12 B 34 SER D 358 SER.? 6.75 C2 GOL D 601 B 37 ASN D 356 ASN.? 8.43 C2 GOL D 601 B 45 THR D 369 THR~? 16.21 O3 GOL D 601 coo -19.49 41.97 71.08 -17.37 40.80 71.17 29.79 5.62 -21.71 27.82 6.72 -22.45 coo -23.05 39.62 69.74 -22.86 39.59 67.61 33.56 6.37 -25.67 31.64 5.54 -26.08 coo -30.87 34.84 80.57 -28.94 34.51 81.49 38.48 -5.77 -24.43 38.79 -7.85 -25.06 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 13 3 # 13 B 34 SER D 358 SER.? 6.75 C2 GOL D 601 B 37 ASN D 356 ASN.? 8.43 C2 GOL D 601 B 45 THR D 420 THR^? 11.62 O1 EDO C 602 coo -19.49 41.97 71.08 -17.37 40.80 71.17 29.79 5.62 -21.71 27.82 6.72 -22.45 coo -23.05 39.62 69.74 -22.86 39.59 67.61 33.56 6.37 -25.67 31.64 5.54 -26.08 coo -30.87 34.84 80.57 -28.94 34.51 81.49 26.36 2.12 -37.74 25.52 4.03 -38.26 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 13 hits 2z3x_d00 naa= 3 ULMN 4 3cvu_d00 LYASE/DNA user 1 4 # 1 A 417 HIS D 381 HIS.? 16.49 O3 GOL D 601 A 418 GLN D 372 GLN~? 15.37 O3 GOL D 601 A 420 PHE D 352 PHE^? 15.53 O3 GOL D 601 A 421 ARG D 375 ARG.? 23.45 O3 GOL D 601 coo 91.76 18.33 -7.08 90.96 16.67 -8.08 36.03 -8.97 -35.15 35.55 -7.12 -34.29 coo 91.93 22.94 -2.41 90.60 24.03 -1.13 40.13 -6.96 -28.62 37.98 -6.85 -28.89 coo 98.17 24.89 -2.53 97.47 24.93 -5.21 40.13 -1.84 -31.50 38.47 -1.47 -29.25 coo 93.36 23.14 2.71 90.44 24.03 2.50 45.57 -7.61 -30.32 45.87 -9.61 -28.01 3cvu_d00 source 3cvu LYASE/DNA : 1 hits 3cvu_d00 naa= 4 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 18 SER A 358 SER.? 19.71 C1 EDO B 603 A 20 HIS A 338 HIS~? 19.64 C1 EDO B 603 A 22 LEU B 435 LEU^? 14.13 C1 EDO B 603 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 17.92 16.03 18.01 17.94 14.38 16.23 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 16.13 23.68 19.02 16.84 23.99 20.97 coo -14.55 2.62 13.63 -14.94 2.66 11.50 13.92 27.91 15.33 14.95 26.75 13.85 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 18 SER D 358 SER.? 6.75 C2 GOL D 601 A 20 HIS D 338 HIS~? 13.70 C1 GOL D 601 A 22 LEU C 435 LEU^? 14.04 C1 EDO C 602 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 29.79 5.62 -21.71 27.82 6.72 -22.45 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 29.23 12.85 -20.11 30.06 13.12 -18.20 coo -14.55 2.62 13.63 -14.94 2.66 11.50 27.04 17.63 -23.33 27.85 16.42 -24.95 3gxq_d00 source 3gxq DNA BINDING PROTEIN/DNA : 2 hits 3gxq_d00 naa= 3 ULMN 3 3pta_d00 TRANSFERASE/DNA user 1 3 # 1 A 682 SER B 410 SER^? 8.36 O2 EDO B 603 A 683 LYS B 415 LYS^? -2.82 O2 EDO B 603s A 684 GLN B 409 GLN^? 12.48 O2 EDO B 603 coo -8.24 -20.23 36.50 -7.44 -18.27 37.68 -1.48 27.73 -0.43 0.38 29.00 -1.36 coo -5.30 -22.52 37.30 -6.47 -26.26 32.30 1.57 23.62 -1.31 7.49 26.02 -1.78 coo -3.80 -18.22 38.13 -1.93 -17.88 37.17 -4.42 24.87 -0.50 -3.78 23.19 -1.67 ULMN 3 3pta_d00 TRANSFERASE/DNA user 2 3 # 2 A 682 SER C 410 SER^? 8.67 O2 EDO C 602 A 683 LYS C 415 LYS^? -2.71 O2 EDO C 602s A 684 GLN C 409 GLN^? 14.26 C2 EDO C 602 coo -8.24 -20.23 36.50 -7.44 -18.27 37.68 10.49 19.19 -38.07 12.37 20.48 -39.01 coo -5.30 -22.52 37.30 -6.47 -26.26 32.30 13.38 15.08 -39.34 19.41 17.19 -40.08 coo -3.80 -18.22 38.13 -1.93 -17.88 37.17 7.52 15.93 -37.75 6.03 14.60 -38.53 3pta_d00 source 3pta TRANSFERASE/DNA : 2 hits 3pta_d00 naa= 3 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 1 3 # 1 A 101 VAL A 346 VAL^? 24.05 C1 EDO B 603 A 102 PHE A 345 PHE^? 20.97 C1 EDO B 603 A 169 CYH A 380 CYH~? 29.74 C1 EDO B 603 coo -0.48 2.03 12.21 0.64 0.32 12.97 29.01 12.29 4.94 28.88 10.14 4.54 coo 0.51 5.20 15.97 0.26 4.09 18.50 27.58 16.29 6.01 29.18 17.39 3.97 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 29.01 2.63 9.50 30.23 5.08 9.65 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 2 3 # 2 A 101 VAL A 389 VAL~? 25.61 O1 EDO B 603 A 102 PHE A 393 PHE~? 23.82 O1 EDO B 603 A 169 CYH A 380 CYH~? 29.74 C1 EDO B 603 coo -0.48 2.03 12.21 0.64 0.32 12.97 23.80 2.96 0.58 24.25 3.58 2.66 coo 0.51 5.20 15.97 0.26 4.09 18.50 26.74 7.64 -0.70 26.45 8.27 2.03 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 29.01 2.63 9.50 30.23 5.08 9.65 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 3 3 # 3 A 101 VAL B 346 VAL^? 18.03 C2 EDO B 603 A 102 PHE B 345 PHE^? 18.52 C2 EDO B 603 A 169 CYH B 380 CYH~? 15.26 O2 EDO B 603 coo -0.48 2.03 12.21 0.64 0.32 12.97 14.71 35.57 15.47 12.76 36.63 15.46 coo 0.51 5.20 15.97 0.26 4.09 18.50 17.53 32.29 14.73 18.42 32.57 17.36 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 8.08 40.31 9.00 10.50 39.00 9.22 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 4 3 # 4 A 101 VAL B 434 VAL^? 17.71 C2 EDO B 603 A 102 PHE B 345 PHE^? 18.52 C2 EDO B 603 A 169 CYH B 380 CYH~? 15.26 O2 EDO B 603 coo -0.48 2.03 12.21 0.64 0.32 12.97 12.63 31.58 18.08 10.52 32.18 18.31 coo 0.51 5.20 15.97 0.26 4.09 18.50 17.53 32.29 14.73 18.42 32.57 17.36 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 8.08 40.31 9.00 10.50 39.00 9.22 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 5 3 # 5 A 101 VAL C 346 VAL^? 18.34 C2 EDO C 602 A 102 PHE C 345 PHE^? 18.39 C1 EDO C 602 A 169 CYH C 380 CYH~? 18.52 O2 EDO C 602 coo -0.48 2.03 12.21 0.64 0.32 12.97 28.57 25.36 -22.99 26.75 26.57 -22.80 coo 0.51 5.20 15.97 0.26 4.09 18.50 30.97 21.80 -24.09 32.10 21.77 -21.54 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 22.88 33.08 -27.72 25.47 32.05 -27.37 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 6 3 # 6 A 101 VAL D 389 VAL~? 18.63 C3 GOL D 601 A 102 PHE D 393 PHE~? 18.95 C3 GOL D 601 A 169 CYH D 380 CYH~? 19.05 O3 GOL D 601 coo -0.48 2.03 12.21 0.64 0.32 12.97 33.58 -6.60 -41.42 34.52 -6.13 -39.49 coo 0.51 5.20 15.97 0.26 4.09 18.50 36.24 -2.17 -42.24 36.19 -1.76 -39.45 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 39.90 -9.16 -33.04 41.11 -6.65 -32.46 3s57_d00 source 3s57 OXIDOREDUCTASE/DNA : 6 hits 3s57_d00 naa= 3 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 21 GLN A 331 GLN~? 22.54 C1 EDO B 603 A 41 TYR B 354 TYR^? 14.48 C1 EDO B 603 A 43 ASN B 347 ASN^? 23.37 C2 EDO B 603 coo 22.03 6.35 12.16 20.71 6.08 10.54 22.78 31.90 17.78 22.64 33.92 17.20 coo 18.67 0.21 9.03 16.70 -1.66 8.55 19.63 32.53 9.54 19.95 30.09 8.18 coo 14.90 7.30 8.78 14.25 8.14 6.97 18.47 36.73 18.25 18.44 38.86 18.15 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 21 GLN B 331 GLN~? 24.19 C1 EDO B 603 A 41 TYR A 354 TYR^? 20.91 C1 EDO B 603 A 43 ASN A 347 ASN^? 27.63 C1 EDO B 603 coo 22.03 6.35 12.16 20.71 6.08 10.54 31.22 21.08 5.08 32.44 19.62 5.97 coo 18.67 0.21 9.03 16.70 -1.66 8.55 27.10 16.84 11.56 24.90 18.34 12.50 coo 14.90 7.30 8.78 14.25 8.14 6.97 32.85 15.10 3.85 34.45 13.77 4.43 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 21 GLN C 331 GLN~? 22.65 C3 GOL D 601 A 41 TYR C 326 TYR^? 22.46 O3 GOL D 601 A 43 ASN D 347 ASN^? 23.69 C3 GOL D 601 coo 22.03 6.35 12.16 20.71 6.08 10.54 42.71 10.11 -35.60 43.90 8.50 -34.90 coo 18.67 0.21 9.03 16.70 -1.66 8.55 45.91 5.03 -28.85 46.66 3.15 -30.76 coo 14.90 7.30 8.78 14.25 8.14 6.97 43.61 4.31 -37.61 45.14 2.83 -37.46 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 A 21 GLN C 331 GLN~? 22.65 C3 GOL D 601 A 41 TYR D 354 TYR^? 14.76 C3 GOL D 601 A 43 ASN D 347 ASN^? 23.69 C3 GOL D 601 coo 22.03 6.35 12.16 20.71 6.08 10.54 42.71 10.11 -35.60 43.90 8.50 -34.90 coo 18.67 0.21 9.03 16.70 -1.66 8.55 38.74 5.77 -29.00 36.83 7.38 -27.74 coo 14.90 7.30 8.78 14.25 8.14 6.97 43.61 4.31 -37.61 45.14 2.83 -37.46 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 A 21 GLN D 331 GLN~? 22.40 C1 EDO C 602 A 41 TYR C 354 TYR^? 14.37 C1 EDO C 602 A 43 ASN C 347 ASN^? 23.48 C1 EDO C 602 coo 22.03 6.35 12.16 20.71 6.08 10.54 36.40 20.60 -21.50 36.46 22.66 -21.93 coo 18.67 0.21 9.03 16.70 -1.66 8.55 32.76 22.10 -29.37 32.74 19.75 -30.93 coo 14.90 7.30 8.78 14.25 8.14 6.97 32.68 25.81 -20.60 32.92 27.92 -20.57 3ssc_d00 source 3ssc DNA BINDING PROTEIN/DNA : 5 hits 3ssc_d00 naa= 3 ULMN 4 4ail_d00 TRANSFERASE user 1 4 # 1 C 495 TYR A 355 TYR^? 25.32 C1 EDO B 603 C 593 LYS A 403 LYS^? 8.85 O1 EDO B 603 C 613 ARG A 425 ARG^? 21.19 O1 EDO B 603 C 615 ASP C 430 ASP.? 26.01 O2 GOL D 601 coo 15.47 67.10 68.66 15.00 68.14 71.20 25.00 11.79 14.66 25.82 10.48 17.03 coo -0.58 65.96 78.57 4.36 67.40 76.38 17.56 13.24 -3.73 14.59 17.27 -0.83 coo -0.42 56.97 83.23 2.13 57.80 84.74 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 1.55 52.45 87.75 1.51 54.41 86.94 33.23 18.77 -9.92 33.78 18.54 -7.88 ULMN 4 4ail_d00 TRANSFERASE user 2 4 # 2 C 495 TYR A 437 TYR^? 11.45 C1 EDO B 603 C 593 LYS B 403 LYS^? 16.64 C2 EDO B 603 C 613 ARG B 425 ARG^? 24.19 C2 EDO B 603 C 615 ASP B 430 ASP.? 31.57 C2 EDO B 603 coo 15.47 67.10 68.66 15.00 68.14 71.20 16.79 15.50 5.48 15.91 16.43 3.01 coo -0.58 65.96 78.57 4.36 67.40 76.38 6.24 24.71 19.66 5.62 19.48 17.38 coo -0.42 56.97 83.23 2.13 57.80 84.74 13.19 26.25 26.41 10.66 27.96 25.98 coo 1.55 52.45 87.75 1.51 54.41 86.94 18.19 29.66 29.51 18.36 29.43 31.62 ULMN 4 4ail_d00 TRANSFERASE user 3 4 # 3 C 495 TYR B 437 TYR^? 10.72 C1 EDO B 603 C 593 LYS A 403 LYS^? 8.85 O1 EDO B 603 C 613 ARG A 425 ARG^? 21.19 O1 EDO B 603 C 615 ASP A 430 ASP.? 25.41 O1 EDO B 603 coo 15.47 67.10 68.66 15.00 68.14 71.20 10.92 24.41 11.32 10.27 22.67 13.43 coo -0.58 65.96 78.57 4.36 67.40 76.38 17.56 13.24 -3.73 14.59 17.27 -0.83 coo -0.42 56.97 83.23 2.13 57.80 84.74 25.04 18.93 -7.11 26.86 16.62 -8.01 coo 1.55 52.45 87.75 1.51 54.41 86.94 31.59 21.51 -7.17 32.38 22.31 -9.00 ULMN 4 4ail_d00 TRANSFERASE user 4 4 # 4 C 495 TYR C 437 TYR^? 9.81 O1 GOL D 601 C 593 LYS D 403 LYS^? 8.04 O1 EDO C 602 C 613 ARG D 425 ARG^? 16.89 O1 EDO C 602 C 615 ASP D 430 ASP.? 24.82 O1 EDO C 602 coo 15.47 67.10 68.66 15.00 68.14 71.20 23.51 14.66 -27.39 22.94 13.02 -25.21 coo -0.58 65.96 78.57 4.36 67.40 76.38 27.51 4.47 -43.69 23.30 8.13 -41.81 coo -0.42 56.97 83.23 2.13 57.80 84.74 35.18 9.71 -47.18 32.90 7.74 -47.72 coo 1.55 52.45 87.75 1.51 54.41 86.94 41.96 11.40 -47.93 42.69 12.01 -49.83 ULMN 4 4ail_d00 TRANSFERASE user 5 4 # 5 C 495 TYR D 437 TYR^? 9.97 C1 GOL D 601 C 593 LYS C 403 LYS^? 9.83 O1 GOL D 601 C 613 ARG C 425 ARG^? 21.48 O1 GOL D 601 C 615 ASP C 430 ASP.? 26.01 O2 GOL D 601 coo 15.47 67.10 68.66 15.00 68.14 71.20 27.83 5.60 -34.20 26.72 6.80 -36.49 coo -0.58 65.96 78.57 4.36 67.40 76.38 19.56 15.05 -18.65 18.30 10.78 -20.22 coo -0.42 56.97 83.23 2.13 57.80 84.74 27.32 15.93 -12.34 26.51 18.69 -11.26 coo 1.55 52.45 87.75 1.51 54.41 86.94 33.23 18.77 -9.92 33.78 18.54 -7.88 4ail_d00 source 4ail TRANSFERASE : 5 hits 4ail_d00 naa= 4 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 78 ARG A 368 ARG.? 24.16 C1 EDO B 603 A 82 LYS A 367 LYS.? 27.79 C1 EDO B 603 A 97 ARG A 375 ARG.? 36.99 C1 EDO B 603 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 23.91 7.22 12.24 22.49 6.03 9.76 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 21.09 4.68 15.64 17.32 4.21 18.91 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 34.50 3.88 12.57 36.52 3.36 14.83 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 78 ARG A 401 ARG.? 15.99 O2 GOL D 601 A 82 LYS A 403 LYS^? 8.85 O1 EDO B 603 A 97 ARG C 425 ARG^? 21.48 O1 GOL D 601 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 17.05 9.37 -8.73 16.66 7.27 -10.98 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 17.56 13.24 -3.73 14.59 17.27 -0.83 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 27.32 15.93 -12.34 26.51 18.69 -11.26 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 78 ARG B 368 ARG.? 11.04 O2 EDO B 603 A 82 LYS B 367 LYS.? 8.96 O2 EDO B 603 A 97 ARG B 375 ARG.? 22.49 O2 EDO B 603 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 11.09 36.07 6.20 8.36 35.36 7.43 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 8.46 36.63 1.57 6.31 34.95 -1.21 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 13.81 46.43 8.85 13.44 47.64 6.03 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 A 78 ARG C 368 ARG.? 10.85 O2 EDO C 602 A 82 LYS C 367 LYS.? 10.18 O2 EDO C 602 A 97 ARG C 375 ARG.? 20.99 O2 EDO C 602 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 24.45 26.16 -32.00 21.85 25.58 -30.53 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 21.41 26.99 -36.15 19.64 26.87 -41.36 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 27.90 36.71 -28.33 26.60 36.43 -31.10 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 A 78 ARG C 401 ARG.? 15.33 O1 EDO B 603 A 82 LYS C 403 LYS^? 9.83 O1 GOL D 601 A 97 ARG A 425 ARG^? 21.19 O1 EDO B 603 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 15.13 16.06 -14.86 13.60 17.63 -12.63 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 19.56 15.05 -18.65 18.30 10.78 -20.22 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 25.04 18.93 -7.11 26.86 16.62 -8.01 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 A 78 ARG D 368 ARG.? 11.23 O3 GOL D 601 A 82 LYS D 367 LYS.? 8.67 O3 GOL D 601 A 97 ARG D 375 ARG.? 23.45 O3 GOL D 601 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 34.63 -3.42 -28.94 33.31 -3.73 -31.69 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 32.17 -6.41 -25.63 28.00 -7.23 -22.20 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 45.57 -7.61 -30.32 45.87 -9.61 -28.01 4er8_d00 source 4er8 DNA BINDING PROTEIN/DNA : 6 hits 4er8_d00 naa= 3 ULMN 3 1hq0_o00 CYTOTOXIC NECROTIZING FACTOR 1 user 1 3 # 1 A 833 VAL A 389 VAL~? 25.61 O1 EDO B 603 A 866 CYH A 380 CYH~? 29.74 C1 EDO B 603 A 881 HIS A 381 HIS.? 27.31 O1 EDO B 603 coo 14.42 17.43 18.29 12.57 16.27 18.27 23.80 2.96 0.58 24.25 3.58 2.66 coo 12.88 23.75 28.18 13.64 25.11 25.83 29.01 2.63 9.50 30.23 5.08 9.65 coo 12.85 19.92 23.16 14.49 20.89 24.04 25.64 1.98 6.69 25.07 4.00 6.65 ULMN 3 1hq0_o00 CYTOTOXIC NECROTIZING FACTOR 1 user 2 3 # 2 A 833 VAL B 385 VAL~? 19.41 O2 EDO B 603 A 866 CYH B 380 CYH~? 15.26 O2 EDO B 603 A 881 HIS B 381 HIS.? 15.29 C2 EDO B 603 coo 14.42 17.43 18.29 12.57 16.27 18.27 -1.53 40.22 12.75 -0.78 38.51 11.57 coo 12.88 23.75 28.18 13.64 25.11 25.83 8.08 40.31 9.00 10.50 39.00 9.22 coo 12.85 19.92 23.16 14.49 20.89 24.04 4.86 38.27 11.07 6.17 36.67 11.45 ULMN 3 1hq0_o00 CYTOTOXIC NECROTIZING FACTOR 1 user 3 3 # 3 A 833 VAL C 385 VAL~? 20.30 O2 EDO C 602 A 866 CYH C 380 CYH~? 18.52 O2 EDO C 602 A 881 HIS C 381 HIS~? 16.26 O2 EDO C 602 coo 14.42 17.43 18.29 12.57 16.27 18.27 13.23 32.44 -24.06 13.71 31.02 -25.72 coo 12.88 23.75 28.18 13.64 25.11 25.83 22.88 33.08 -27.72 25.47 32.05 -27.37 coo 12.85 19.92 23.16 14.49 20.89 24.04 19.26 30.57 -26.59 20.09 28.69 -27.02 ULMN 3 1hq0_o00 CYTOTOXIC NECROTIZING FACTOR 1 user 4 3 # 4 A 833 VAL C 389 VAL~? 19.67 C2 EDO C 602 A 866 CYH C 380 CYH~? 18.52 O2 EDO C 602 A 881 HIS C 381 HIS~? 16.26 O2 EDO C 602 coo 14.42 17.43 18.29 12.57 16.27 18.27 17.26 28.56 -20.86 18.61 29.49 -22.34 coo 12.88 23.75 28.18 13.64 25.11 25.83 22.88 33.08 -27.72 25.47 32.05 -27.37 coo 12.85 19.92 23.16 14.49 20.89 24.04 19.26 30.57 -26.59 20.09 28.69 -27.02 ULMN 3 1hq0_o00 CYTOTOXIC NECROTIZING FACTOR 1 user 5 3 # 5 A 833 VAL D 389 VAL~? 18.63 C3 GOL D 601 A 866 CYH D 380 CYH~? 19.05 O3 GOL D 601 A 881 HIS D 381 HIS.? 16.49 O3 GOL D 601 coo 14.42 17.43 18.29 12.57 16.27 18.27 33.58 -6.60 -41.42 34.52 -6.13 -39.49 coo 12.88 23.75 28.18 13.64 25.11 25.83 39.90 -9.16 -33.04 41.11 -6.65 -32.46 coo 12.85 19.92 23.16 14.49 20.89 24.04 36.03 -8.97 -35.15 35.55 -7.12 -34.29 1hq0_o00 source 1Hq0 CYTOTOXIC NECROTIZING FACTOR 1 : 5 hits 1hq0_o00 naa= 3 ULMN 3 2io8_o00 BIFUNCTIONAL GLUTATHIONYLSPERMIDINE user 1 3 # 1 A 59 CYH A 380 CYH~? 29.74 C1 EDO B 603 A 131 HIS A 381 HIS.? 27.31 O1 EDO B 603 A 147 GLU A 378 GLU~? 27.85 O2 GOL D 601 coo 4.62 -21.76 1.74 6.07 -20.80 -0.50 29.01 2.63 9.50 30.23 5.08 9.65 coo 9.76 -23.46 -1.15 9.10 -24.76 0.37 25.64 1.98 6.69 25.07 4.00 6.65 coo 8.38 -27.41 3.38 10.22 -28.03 2.51 32.59 2.13 2.36 33.95 1.57 0.86 ULMN 3 2io8_o00 BIFUNCTIONAL GLUTATHIONYLSPERMIDINE user 2 3 # 2 A 59 CYH C 380 CYH~? 18.52 O2 EDO C 602 A 131 HIS C 381 HIS~? 16.26 O2 EDO C 602 A 147 GLU C 378 GLU~? 24.96 O2 EDO B 603 coo 4.62 -21.76 1.74 6.07 -20.80 -0.50 22.88 33.08 -27.72 25.47 32.05 -27.37 coo 9.76 -23.46 -1.15 9.10 -24.76 0.37 19.26 30.57 -26.59 20.09 28.69 -27.02 coo 8.38 -27.41 3.38 10.22 -28.03 2.51 22.14 33.77 -19.82 21.71 34.90 -18.09 2io8_o00 source 2IO8 BIFUNCTIONAL GLUTATHIONYLSPERMIDINE : 2 hits 2io8_o00 naa= 3 ULMN 3 2io9_o00 BIFUNCTIONAL GLUTATHIONYLSPERMIDINE user 1 3 # 1 A 59 CYH C 380 CYH~? 18.52 O2 EDO C 602 A 131 HIS C 381 HIS~? 16.26 O2 EDO C 602 A 147 GLU C 378 GLU~? 24.96 O2 EDO B 603 coo 4.78 -21.63 1.72 5.87 -20.70 -0.68 22.88 33.08 -27.72 25.47 32.05 -27.37 coo 9.63 -23.30 -1.07 9.01 -24.56 0.49 19.26 30.57 -26.59 20.09 28.69 -27.02 coo 8.17 -27.22 3.40 10.11 -27.89 2.67 22.14 33.77 -19.82 21.71 34.90 -18.09 2io9_o00 source 2IO9 BIFUNCTIONAL GLUTATHIONYLSPERMIDINE : 1 hits 2io9_o00 naa= 3 ULMN 3 2io9_o01 BIFUNCTIONAL GLUTATHIONYLSPERMIDINE user 1 3 # 1 B 59 CYH C 380 CYH~? 18.52 O2 EDO C 602 B 131 HIS C 381 HIS~? 16.26 O2 EDO C 602 B 147 GLU C 378 GLU~? 24.96 O2 EDO B 603 coo -23.64 8.52 37.93 -23.29 8.46 40.73 22.88 33.08 -27.72 25.47 32.05 -27.37 coo -24.27 12.78 41.98 -24.92 13.24 40.03 19.26 30.57 -26.59 20.09 28.69 -27.02 coo -26.15 14.67 36.54 -26.29 16.45 37.81 22.14 33.77 -19.82 21.71 34.90 -18.09 2io9_o01 source 2IO9 BIFUNCTIONAL GLUTATHIONYLSPERMIDINE : 1 hits 2io9_o01 naa= 3 ULMN 3 2odj_o00 PORIN D user 1 3 # 1 A 156 HIS C 338 HIS~? 12.91 O1 EDO C 602 A 208 ASP C 440 ASP^? 5.97 O1 EDO C 602 A 296 SER C 371 SER~? 19.63 O2 EDO C 602 coo 12.72 17.48 24.71 12.80 19.37 23.81 32.85 11.57 -39.74 34.04 12.36 -41.28 coo 18.47 29.19 29.68 19.30 29.17 27.75 17.33 13.03 -37.56 15.74 12.38 -38.82 coo 6.89 17.22 46.63 5.08 16.21 47.91 30.17 34.40 -34.13 29.04 35.01 -36.23 2odj_o00 source 2ODJ PORIN D : 1 hits 2odj_o00 naa= 3 ULMN 3 2odj_o01 PORIN D user 1 3 # 1 B 156 HIS C 338 HIS~? 12.91 O1 EDO C 602 B 208 ASP C 440 ASP^? 5.97 O1 EDO C 602 B 296 SER C 371 SER~? 19.63 O2 EDO C 602 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 32.85 11.57 -39.74 34.04 12.36 -41.28 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 17.33 13.03 -37.56 15.74 12.38 -38.82 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 30.17 34.40 -34.13 29.04 35.01 -36.23 2odj_o01 source 2ODJ PORIN D : 1 hits 2odj_o01 naa= 3 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER A 328 SER~? 24.32 C1 EDO B 603 A 166 PHE B 345 PHE^? 18.52 C2 EDO B 603 A 182 PHE B 352 PHE^? 15.29 O2 EDO B 603 coo -46.28 37.24 81.97 -44.96 39.32 82.40 27.10 32.44 15.23 26.15 32.07 17.43 coo -36.62 39.62 84.60 -38.76 41.24 85.25 17.53 32.29 14.73 18.42 32.57 17.36 coo -36.55 45.66 79.22 -38.34 43.94 80.53 14.23 38.41 10.43 14.31 36.78 8.15 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 2 3 # 2 A 130 SER A 449 SER~? 20.83 C2 EDO B 603 A 166 PHE A 445 PHE~? 17.72 O1 EDO B 603 A 182 PHE A 444 PHE~? 11.79 C1 EDO B 603 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -0.28 10.05 7.85 1.97 9.05 6.47 coo -36.55 45.66 79.22 -38.34 43.94 80.53 2.91 15.92 8.56 5.14 17.37 9.33 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 3 3 # 3 A 130 SER A 449 SER~? 20.83 C2 EDO B 603 A 166 PHE A 445 PHE~? 17.72 O1 EDO B 603 A 182 PHE B 444 PHE~? 10.27 O1 EDO B 603 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -0.28 10.05 7.85 1.97 9.05 6.47 coo -36.55 45.66 79.22 -38.34 43.94 80.53 5.02 14.17 3.93 7.63 15.10 4.40 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 4 3 # 4 A 130 SER A 449 SER~? 20.83 C2 EDO B 603 A 166 PHE B 416 PHE^? 11.67 C2 EDO B 603 A 182 PHE A 444 PHE~? 11.79 C1 EDO B 603 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -1.62 21.04 3.18 -3.66 21.32 5.09 coo -36.55 45.66 79.22 -38.34 43.94 80.53 2.91 15.92 8.56 5.14 17.37 9.33 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 5 3 # 5 A 130 SER A 449 SER~? 20.83 C2 EDO B 603 A 166 PHE B 416 PHE^? 11.67 C2 EDO B 603 A 182 PHE B 408 PHE^? 9.99 C2 EDO B 603 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -1.62 21.04 3.18 -3.66 21.32 5.09 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -2.06 28.13 5.41 0.32 29.58 4.96 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 6 3 # 6 A 130 SER A 449 SER~? 20.83 C2 EDO B 603 A 166 PHE B 416 PHE^? 11.67 C2 EDO B 603 A 182 PHE B 444 PHE~? 10.27 O1 EDO B 603 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -1.62 21.04 3.18 -3.66 21.32 5.09 coo -36.55 45.66 79.22 -38.34 43.94 80.53 5.02 14.17 3.93 7.63 15.10 4.40 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 7 3 # 7 A 130 SER A 449 SER~? 20.83 C2 EDO B 603 A 166 PHE B 445 PHE~? 13.78 O1 EDO B 603 A 182 PHE A 444 PHE~? 11.79 C1 EDO B 603 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -1.25 14.50 2.62 -1.24 15.79 5.10 coo -36.55 45.66 79.22 -38.34 43.94 80.53 2.91 15.92 8.56 5.14 17.37 9.33 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 8 3 # 8 A 130 SER A 449 SER~? 20.83 C2 EDO B 603 A 166 PHE B 445 PHE~? 13.78 O1 EDO B 603 A 182 PHE B 444 PHE~? 10.27 O1 EDO B 603 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -1.25 14.50 2.62 -1.24 15.79 5.10 coo -36.55 45.66 79.22 -38.34 43.94 80.53 5.02 14.17 3.93 7.63 15.10 4.40 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 9 3 # 9 A 130 SER B 328 SER~? 24.34 C1 EDO B 603 A 166 PHE A 345 PHE^? 20.97 C1 EDO B 603 A 182 PHE A 352 PHE^? 25.89 C1 EDO B 603 coo -46.28 37.24 81.97 -44.96 39.32 82.40 32.93 23.60 9.01 32.97 23.42 6.61 coo -36.62 39.62 84.60 -38.76 41.24 85.25 27.58 16.29 6.01 29.18 17.39 3.97 coo -36.55 45.66 79.22 -38.34 43.94 80.53 29.09 9.19 9.94 27.10 9.67 11.86 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 10 3 # 10 A 130 SER B 449 SER.? 19.37 O1 EDO B 603 A 166 PHE B 445 PHE~? 13.78 O1 EDO B 603 A 182 PHE A 445 PHE~? 17.72 O1 EDO B 603 coo -46.28 37.24 81.97 -44.96 39.32 82.40 1.07 6.55 -6.47 1.69 8.16 -8.19 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -1.25 14.50 2.62 -1.24 15.79 5.10 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -0.28 10.05 7.85 1.97 9.05 6.47 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 11 3 # 11 A 130 SER B 449 SER.? 19.37 O1 EDO B 603 A 166 PHE B 445 PHE~? 13.78 O1 EDO B 603 A 182 PHE B 444 PHE~? 10.27 O1 EDO B 603 coo -46.28 37.24 81.97 -44.96 39.32 82.40 1.07 6.55 -6.47 1.69 8.16 -8.19 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -1.25 14.50 2.62 -1.24 15.79 5.10 coo -36.55 45.66 79.22 -38.34 43.94 80.53 5.02 14.17 3.93 7.63 15.10 4.40 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 12 3 # 12 A 130 SER C 328 SER~? 23.98 C1 EDO C 602 A 166 PHE D 345 PHE^? 18.57 C3 GOL D 601 A 182 PHE D 352 PHE^? 15.53 O3 GOL D 601 coo -46.28 37.24 81.97 -44.96 39.32 82.40 45.06 12.12 -31.74 44.78 12.22 -34.15 coo -36.62 39.62 84.60 -38.76 41.24 85.25 38.63 5.82 -34.75 40.11 6.86 -36.92 coo -36.55 45.66 79.22 -38.34 43.94 80.53 40.13 -1.84 -31.50 38.47 -1.47 -29.25 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 13 3 # 13 A 130 SER C 449 SER.? 18.20 O1 EDO C 602 A 166 PHE C 445 PHE~? 14.33 C2 EDO C 602 A 182 PHE C 444 PHE~? 9.55 O1 GOL D 601 coo -46.28 37.24 81.97 -44.96 39.32 82.40 9.18 0.49 -44.18 10.65 1.97 -45.43 coo -36.62 39.62 84.60 -38.76 41.24 85.25 9.78 6.26 -35.53 9.91 7.07 -32.85 coo -36.55 45.66 79.22 -38.34 43.94 80.53 16.05 5.22 -34.74 18.74 5.99 -34.45 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 14 3 # 14 A 130 SER C 449 SER.? 18.20 O1 EDO C 602 A 166 PHE C 445 PHE~? 14.33 C2 EDO C 602 A 182 PHE D 445 PHE~? 11.88 O1 GOL D 601 coo -46.28 37.24 81.97 -44.96 39.32 82.40 9.18 0.49 -44.18 10.65 1.97 -45.43 coo -36.62 39.62 84.60 -38.76 41.24 85.25 9.78 6.26 -35.53 9.91 7.07 -32.85 coo -36.55 45.66 79.22 -38.34 43.94 80.53 10.86 1.23 -30.60 12.85 0.20 -32.29 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 15 3 # 15 A 130 SER D 328 SER~? 24.00 C1 EDO C 602 A 166 PHE C 345 PHE^? 18.39 C1 EDO C 602 A 182 PHE C 352 PHE^? 15.48 O2 EDO C 602 coo -46.28 37.24 81.97 -44.96 39.32 82.40 40.49 20.83 -24.30 39.56 20.57 -22.09 coo -36.62 39.62 84.60 -38.76 41.24 85.25 30.97 21.80 -24.09 32.10 21.77 -21.54 coo -36.55 45.66 79.22 -38.34 43.94 80.53 27.97 28.62 -27.76 27.73 27.28 -30.22 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 15 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER A 328 SER~? 24.32 C1 EDO B 603 B 166 PHE B 345 PHE^? 18.52 C2 EDO B 603 B 182 PHE B 352 PHE^? 15.29 O2 EDO B 603 coo -19.94 46.29 97.83 -22.38 46.56 97.60 27.10 32.44 15.23 26.15 32.07 17.43 coo -29.59 43.40 95.66 -28.22 45.54 94.50 17.53 32.29 14.73 18.42 32.57 17.36 coo -32.72 50.15 98.46 -30.32 48.85 97.77 14.23 38.41 10.43 14.31 36.78 8.15 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 2 3 # 2 B 130 SER A 449 SER~? 20.83 C2 EDO B 603 B 166 PHE A 445 PHE~? 17.72 O1 EDO B 603 B 182 PHE A 444 PHE~? 11.79 C1 EDO B 603 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -0.28 10.05 7.85 1.97 9.05 6.47 coo -32.72 50.15 98.46 -30.32 48.85 97.77 2.91 15.92 8.56 5.14 17.37 9.33 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 3 3 # 3 B 130 SER A 449 SER~? 20.83 C2 EDO B 603 B 166 PHE A 445 PHE~? 17.72 O1 EDO B 603 B 182 PHE B 444 PHE~? 10.27 O1 EDO B 603 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -0.28 10.05 7.85 1.97 9.05 6.47 coo -32.72 50.15 98.46 -30.32 48.85 97.77 5.02 14.17 3.93 7.63 15.10 4.40 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 4 3 # 4 B 130 SER A 449 SER~? 20.83 C2 EDO B 603 B 166 PHE B 416 PHE^? 11.67 C2 EDO B 603 B 182 PHE A 444 PHE~? 11.79 C1 EDO B 603 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -1.62 21.04 3.18 -3.66 21.32 5.09 coo -32.72 50.15 98.46 -30.32 48.85 97.77 2.91 15.92 8.56 5.14 17.37 9.33 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 5 3 # 5 B 130 SER A 449 SER~? 20.83 C2 EDO B 603 B 166 PHE B 416 PHE^? 11.67 C2 EDO B 603 B 182 PHE B 408 PHE^? 9.99 C2 EDO B 603 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -1.62 21.04 3.18 -3.66 21.32 5.09 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -2.06 28.13 5.41 0.32 29.58 4.96 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 6 3 # 6 B 130 SER A 449 SER~? 20.83 C2 EDO B 603 B 166 PHE B 416 PHE^? 11.67 C2 EDO B 603 B 182 PHE B 444 PHE~? 10.27 O1 EDO B 603 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -1.62 21.04 3.18 -3.66 21.32 5.09 coo -32.72 50.15 98.46 -30.32 48.85 97.77 5.02 14.17 3.93 7.63 15.10 4.40 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 7 3 # 7 B 130 SER A 449 SER~? 20.83 C2 EDO B 603 B 166 PHE B 445 PHE~? 13.78 O1 EDO B 603 B 182 PHE A 444 PHE~? 11.79 C1 EDO B 603 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -1.25 14.50 2.62 -1.24 15.79 5.10 coo -32.72 50.15 98.46 -30.32 48.85 97.77 2.91 15.92 8.56 5.14 17.37 9.33 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 8 3 # 8 B 130 SER A 449 SER~? 20.83 C2 EDO B 603 B 166 PHE B 445 PHE~? 13.78 O1 EDO B 603 B 182 PHE B 444 PHE~? 10.27 O1 EDO B 603 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -1.25 14.50 2.62 -1.24 15.79 5.10 coo -32.72 50.15 98.46 -30.32 48.85 97.77 5.02 14.17 3.93 7.63 15.10 4.40 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 9 3 # 9 B 130 SER B 328 SER~? 24.34 C1 EDO B 603 B 166 PHE A 345 PHE^? 20.97 C1 EDO B 603 B 182 PHE A 352 PHE^? 25.89 C1 EDO B 603 coo -19.94 46.29 97.83 -22.38 46.56 97.60 32.93 23.60 9.01 32.97 23.42 6.61 coo -29.59 43.40 95.66 -28.22 45.54 94.50 27.58 16.29 6.01 29.18 17.39 3.97 coo -32.72 50.15 98.46 -30.32 48.85 97.77 29.09 9.19 9.94 27.10 9.67 11.86 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 10 3 # 10 B 130 SER B 449 SER.? 19.37 O1 EDO B 603 B 166 PHE B 445 PHE~? 13.78 O1 EDO B 603 B 182 PHE A 445 PHE~? 17.72 O1 EDO B 603 coo -19.94 46.29 97.83 -22.38 46.56 97.60 1.07 6.55 -6.47 1.69 8.16 -8.19 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -1.25 14.50 2.62 -1.24 15.79 5.10 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -0.28 10.05 7.85 1.97 9.05 6.47 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 11 3 # 11 B 130 SER B 449 SER.? 19.37 O1 EDO B 603 B 166 PHE B 445 PHE~? 13.78 O1 EDO B 603 B 182 PHE B 444 PHE~? 10.27 O1 EDO B 603 coo -19.94 46.29 97.83 -22.38 46.56 97.60 1.07 6.55 -6.47 1.69 8.16 -8.19 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -1.25 14.50 2.62 -1.24 15.79 5.10 coo -32.72 50.15 98.46 -30.32 48.85 97.77 5.02 14.17 3.93 7.63 15.10 4.40 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 12 3 # 12 B 130 SER C 328 SER~? 23.98 C1 EDO C 602 B 166 PHE D 345 PHE^? 18.57 C3 GOL D 601 B 182 PHE D 352 PHE^? 15.53 O3 GOL D 601 coo -19.94 46.29 97.83 -22.38 46.56 97.60 45.06 12.12 -31.74 44.78 12.22 -34.15 coo -29.59 43.40 95.66 -28.22 45.54 94.50 38.63 5.82 -34.75 40.11 6.86 -36.92 coo -32.72 50.15 98.46 -30.32 48.85 97.77 40.13 -1.84 -31.50 38.47 -1.47 -29.25 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 13 3 # 13 B 130 SER C 449 SER.? 18.20 O1 EDO C 602 B 166 PHE C 445 PHE~? 14.33 C2 EDO C 602 B 182 PHE C 416 PHE^? 11.78 C2 EDO C 602 coo -19.94 46.29 97.83 -22.38 46.56 97.60 9.18 0.49 -44.18 10.65 1.97 -45.43 coo -29.59 43.40 95.66 -28.22 45.54 94.50 9.78 6.26 -35.53 9.91 7.07 -32.85 coo -32.72 50.15 98.46 -30.32 48.85 97.77 10.28 12.37 -34.72 8.44 12.42 -32.58 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 14 3 # 14 B 130 SER C 449 SER.? 18.20 O1 EDO C 602 B 166 PHE C 445 PHE~? 14.33 C2 EDO C 602 B 182 PHE C 444 PHE~? 9.55 O1 GOL D 601 coo -19.94 46.29 97.83 -22.38 46.56 97.60 9.18 0.49 -44.18 10.65 1.97 -45.43 coo -29.59 43.40 95.66 -28.22 45.54 94.50 9.78 6.26 -35.53 9.91 7.07 -32.85 coo -32.72 50.15 98.46 -30.32 48.85 97.77 16.05 5.22 -34.74 18.74 5.99 -34.45 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 15 3 # 15 B 130 SER C 449 SER.? 18.20 O1 EDO C 602 B 166 PHE C 445 PHE~? 14.33 C2 EDO C 602 B 182 PHE D 445 PHE~? 11.88 O1 GOL D 601 coo -19.94 46.29 97.83 -22.38 46.56 97.60 9.18 0.49 -44.18 10.65 1.97 -45.43 coo -29.59 43.40 95.66 -28.22 45.54 94.50 9.78 6.26 -35.53 9.91 7.07 -32.85 coo -32.72 50.15 98.46 -30.32 48.85 97.77 10.86 1.23 -30.60 12.85 0.20 -32.29 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 16 3 # 16 B 130 SER D 328 SER~? 24.00 C1 EDO C 602 B 166 PHE C 345 PHE^? 18.39 C1 EDO C 602 B 182 PHE C 352 PHE^? 15.48 O2 EDO C 602 coo -19.94 46.29 97.83 -22.38 46.56 97.60 40.49 20.83 -24.30 39.56 20.57 -22.09 coo -29.59 43.40 95.66 -28.22 45.54 94.50 30.97 21.80 -24.09 32.10 21.77 -21.54 coo -32.72 50.15 98.46 -30.32 48.85 97.77 27.97 28.62 -27.76 27.73 27.28 -30.22 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 16 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER A 328 SER~? 24.32 C1 EDO B 603 C 166 PHE B 345 PHE^? 18.52 C2 EDO B 603 C 182 PHE B 352 PHE^? 15.29 O2 EDO B 603 coo -2.19 64.27 51.12 -3.34 62.10 50.60 27.10 32.44 15.23 26.15 32.07 17.43 coo -11.14 61.91 46.89 -9.88 60.30 48.76 17.53 32.29 14.73 18.42 32.57 17.36 coo -7.71 55.92 42.70 -7.18 57.60 44.85 14.23 38.41 10.43 14.31 36.78 8.15 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 2 3 # 2 C 130 SER A 449 SER~? 20.83 C2 EDO B 603 C 166 PHE A 445 PHE~? 17.72 O1 EDO B 603 C 182 PHE A 444 PHE~? 11.79 C1 EDO B 603 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -0.28 10.05 7.85 1.97 9.05 6.47 coo -7.71 55.92 42.70 -7.18 57.60 44.85 2.91 15.92 8.56 5.14 17.37 9.33 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 3 3 # 3 C 130 SER A 449 SER~? 20.83 C2 EDO B 603 C 166 PHE A 445 PHE~? 17.72 O1 EDO B 603 C 182 PHE B 444 PHE~? 10.27 O1 EDO B 603 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -0.28 10.05 7.85 1.97 9.05 6.47 coo -7.71 55.92 42.70 -7.18 57.60 44.85 5.02 14.17 3.93 7.63 15.10 4.40 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 4 3 # 4 C 130 SER A 449 SER~? 20.83 C2 EDO B 603 C 166 PHE B 416 PHE^? 11.67 C2 EDO B 603 C 182 PHE A 444 PHE~? 11.79 C1 EDO B 603 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -1.62 21.04 3.18 -3.66 21.32 5.09 coo -7.71 55.92 42.70 -7.18 57.60 44.85 2.91 15.92 8.56 5.14 17.37 9.33 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 5 3 # 5 C 130 SER A 449 SER~? 20.83 C2 EDO B 603 C 166 PHE B 416 PHE^? 11.67 C2 EDO B 603 C 182 PHE B 408 PHE^? 9.99 C2 EDO B 603 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -1.62 21.04 3.18 -3.66 21.32 5.09 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -2.06 28.13 5.41 0.32 29.58 4.96 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 6 3 # 6 C 130 SER A 449 SER~? 20.83 C2 EDO B 603 C 166 PHE B 416 PHE^? 11.67 C2 EDO B 603 C 182 PHE B 444 PHE~? 10.27 O1 EDO B 603 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -1.62 21.04 3.18 -3.66 21.32 5.09 coo -7.71 55.92 42.70 -7.18 57.60 44.85 5.02 14.17 3.93 7.63 15.10 4.40 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 7 3 # 7 C 130 SER A 449 SER~? 20.83 C2 EDO B 603 C 166 PHE B 445 PHE~? 13.78 O1 EDO B 603 C 182 PHE A 444 PHE~? 11.79 C1 EDO B 603 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -1.25 14.50 2.62 -1.24 15.79 5.10 coo -7.71 55.92 42.70 -7.18 57.60 44.85 2.91 15.92 8.56 5.14 17.37 9.33 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 8 3 # 8 C 130 SER A 449 SER~? 20.83 C2 EDO B 603 C 166 PHE B 445 PHE~? 13.78 O1 EDO B 603 C 182 PHE B 444 PHE~? 10.27 O1 EDO B 603 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -1.25 14.50 2.62 -1.24 15.79 5.10 coo -7.71 55.92 42.70 -7.18 57.60 44.85 5.02 14.17 3.93 7.63 15.10 4.40 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 9 3 # 9 C 130 SER B 328 SER~? 24.34 C1 EDO B 603 C 166 PHE A 345 PHE^? 20.97 C1 EDO B 603 C 182 PHE A 352 PHE^? 25.89 C1 EDO B 603 coo -2.19 64.27 51.12 -3.34 62.10 50.60 32.93 23.60 9.01 32.97 23.42 6.61 coo -11.14 61.91 46.89 -9.88 60.30 48.76 27.58 16.29 6.01 29.18 17.39 3.97 coo -7.71 55.92 42.70 -7.18 57.60 44.85 29.09 9.19 9.94 27.10 9.67 11.86 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 10 3 # 10 C 130 SER C 328 SER~? 23.98 C1 EDO C 602 C 166 PHE D 345 PHE^? 18.57 C3 GOL D 601 C 182 PHE D 352 PHE^? 15.53 O3 GOL D 601 coo -2.19 64.27 51.12 -3.34 62.10 50.60 45.06 12.12 -31.74 44.78 12.22 -34.15 coo -11.14 61.91 46.89 -9.88 60.30 48.76 38.63 5.82 -34.75 40.11 6.86 -36.92 coo -7.71 55.92 42.70 -7.18 57.60 44.85 40.13 -1.84 -31.50 38.47 -1.47 -29.25 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 11 3 # 11 C 130 SER C 449 SER.? 18.20 O1 EDO C 602 C 166 PHE C 445 PHE~? 14.33 C2 EDO C 602 C 182 PHE C 444 PHE~? 9.55 O1 GOL D 601 coo -2.19 64.27 51.12 -3.34 62.10 50.60 9.18 0.49 -44.18 10.65 1.97 -45.43 coo -11.14 61.91 46.89 -9.88 60.30 48.76 9.78 6.26 -35.53 9.91 7.07 -32.85 coo -7.71 55.92 42.70 -7.18 57.60 44.85 16.05 5.22 -34.74 18.74 5.99 -34.45 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 12 3 # 12 C 130 SER C 449 SER.? 18.20 O1 EDO C 602 C 166 PHE C 445 PHE~? 14.33 C2 EDO C 602 C 182 PHE D 445 PHE~? 11.88 O1 GOL D 601 coo -2.19 64.27 51.12 -3.34 62.10 50.60 9.18 0.49 -44.18 10.65 1.97 -45.43 coo -11.14 61.91 46.89 -9.88 60.30 48.76 9.78 6.26 -35.53 9.91 7.07 -32.85 coo -7.71 55.92 42.70 -7.18 57.60 44.85 10.86 1.23 -30.60 12.85 0.20 -32.29 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 12 hits 2r11_o02 naa= 3 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 1 3 # 1 D 130 SER A 328 SER~? 24.32 C1 EDO B 603 D 166 PHE B 345 PHE^? 18.52 C2 EDO B 603 D 182 PHE B 352 PHE^? 15.29 O2 EDO B 603 coo -32.42 55.27 46.18 -30.51 54.94 47.67 27.10 32.44 15.23 26.15 32.07 17.43 coo -23.62 58.20 50.84 -23.76 56.14 48.96 17.53 32.29 14.73 18.42 32.57 17.36 coo -23.08 51.44 54.96 -24.43 52.71 52.88 14.23 38.41 10.43 14.31 36.78 8.15 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 2 3 # 2 D 130 SER A 449 SER~? 20.83 C2 EDO B 603 D 166 PHE A 445 PHE~? 17.72 O1 EDO B 603 D 182 PHE A 444 PHE~? 11.79 C1 EDO B 603 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -0.28 10.05 7.85 1.97 9.05 6.47 coo -23.08 51.44 54.96 -24.43 52.71 52.88 2.91 15.92 8.56 5.14 17.37 9.33 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 3 3 # 3 D 130 SER A 449 SER~? 20.83 C2 EDO B 603 D 166 PHE A 445 PHE~? 17.72 O1 EDO B 603 D 182 PHE B 444 PHE~? 10.27 O1 EDO B 603 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -0.28 10.05 7.85 1.97 9.05 6.47 coo -23.08 51.44 54.96 -24.43 52.71 52.88 5.02 14.17 3.93 7.63 15.10 4.40 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 4 3 # 4 D 130 SER A 449 SER~? 20.83 C2 EDO B 603 D 166 PHE B 416 PHE^? 11.67 C2 EDO B 603 D 182 PHE A 444 PHE~? 11.79 C1 EDO B 603 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -1.62 21.04 3.18 -3.66 21.32 5.09 coo -23.08 51.44 54.96 -24.43 52.71 52.88 2.91 15.92 8.56 5.14 17.37 9.33 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 5 3 # 5 D 130 SER A 449 SER~? 20.83 C2 EDO B 603 D 166 PHE B 416 PHE^? 11.67 C2 EDO B 603 D 182 PHE B 408 PHE^? 9.99 C2 EDO B 603 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -1.62 21.04 3.18 -3.66 21.32 5.09 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -2.06 28.13 5.41 0.32 29.58 4.96 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 6 3 # 6 D 130 SER A 449 SER~? 20.83 C2 EDO B 603 D 166 PHE B 416 PHE^? 11.67 C2 EDO B 603 D 182 PHE B 444 PHE~? 10.27 O1 EDO B 603 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -1.62 21.04 3.18 -3.66 21.32 5.09 coo -23.08 51.44 54.96 -24.43 52.71 52.88 5.02 14.17 3.93 7.63 15.10 4.40 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 7 3 # 7 D 130 SER A 449 SER~? 20.83 C2 EDO B 603 D 166 PHE B 445 PHE~? 13.78 O1 EDO B 603 D 182 PHE A 444 PHE~? 11.79 C1 EDO B 603 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -1.25 14.50 2.62 -1.24 15.79 5.10 coo -23.08 51.44 54.96 -24.43 52.71 52.88 2.91 15.92 8.56 5.14 17.37 9.33 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 8 3 # 8 D 130 SER A 449 SER~? 20.83 C2 EDO B 603 D 166 PHE B 445 PHE~? 13.78 O1 EDO B 603 D 182 PHE B 444 PHE~? 10.27 O1 EDO B 603 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -9.34 16.33 7.24 -8.94 16.06 9.64 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -1.25 14.50 2.62 -1.24 15.79 5.10 coo -23.08 51.44 54.96 -24.43 52.71 52.88 5.02 14.17 3.93 7.63 15.10 4.40 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 9 3 # 9 D 130 SER B 328 SER~? 24.34 C1 EDO B 603 D 166 PHE A 345 PHE^? 20.97 C1 EDO B 603 D 182 PHE A 352 PHE^? 25.89 C1 EDO B 603 coo -32.42 55.27 46.18 -30.51 54.94 47.67 32.93 23.60 9.01 32.97 23.42 6.61 coo -23.62 58.20 50.84 -23.76 56.14 48.96 27.58 16.29 6.01 29.18 17.39 3.97 coo -23.08 51.44 54.96 -24.43 52.71 52.88 29.09 9.19 9.94 27.10 9.67 11.86 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 10 3 # 10 D 130 SER B 449 SER.? 19.37 O1 EDO B 603 D 166 PHE B 445 PHE~? 13.78 O1 EDO B 603 D 182 PHE A 445 PHE~? 17.72 O1 EDO B 603 coo -32.42 55.27 46.18 -30.51 54.94 47.67 1.07 6.55 -6.47 1.69 8.16 -8.19 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -1.25 14.50 2.62 -1.24 15.79 5.10 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -0.28 10.05 7.85 1.97 9.05 6.47 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 11 3 # 11 D 130 SER B 449 SER.? 19.37 O1 EDO B 603 D 166 PHE B 445 PHE~? 13.78 O1 EDO B 603 D 182 PHE B 444 PHE~? 10.27 O1 EDO B 603 coo -32.42 55.27 46.18 -30.51 54.94 47.67 1.07 6.55 -6.47 1.69 8.16 -8.19 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -1.25 14.50 2.62 -1.24 15.79 5.10 coo -23.08 51.44 54.96 -24.43 52.71 52.88 5.02 14.17 3.93 7.63 15.10 4.40 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 12 3 # 12 D 130 SER C 328 SER~? 23.98 C1 EDO C 602 D 166 PHE D 345 PHE^? 18.57 C3 GOL D 601 D 182 PHE D 352 PHE^? 15.53 O3 GOL D 601 coo -32.42 55.27 46.18 -30.51 54.94 47.67 45.06 12.12 -31.74 44.78 12.22 -34.15 coo -23.62 58.20 50.84 -23.76 56.14 48.96 38.63 5.82 -34.75 40.11 6.86 -36.92 coo -23.08 51.44 54.96 -24.43 52.71 52.88 40.13 -1.84 -31.50 38.47 -1.47 -29.25 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 13 3 # 13 D 130 SER C 449 SER.? 18.20 O1 EDO C 602 D 166 PHE C 445 PHE~? 14.33 C2 EDO C 602 D 182 PHE C 416 PHE^? 11.78 C2 EDO C 602 coo -32.42 55.27 46.18 -30.51 54.94 47.67 9.18 0.49 -44.18 10.65 1.97 -45.43 coo -23.62 58.20 50.84 -23.76 56.14 48.96 9.78 6.26 -35.53 9.91 7.07 -32.85 coo -23.08 51.44 54.96 -24.43 52.71 52.88 10.28 12.37 -34.72 8.44 12.42 -32.58 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 14 3 # 14 D 130 SER C 449 SER.? 18.20 O1 EDO C 602 D 166 PHE C 445 PHE~? 14.33 C2 EDO C 602 D 182 PHE C 444 PHE~? 9.55 O1 GOL D 601 coo -32.42 55.27 46.18 -30.51 54.94 47.67 9.18 0.49 -44.18 10.65 1.97 -45.43 coo -23.62 58.20 50.84 -23.76 56.14 48.96 9.78 6.26 -35.53 9.91 7.07 -32.85 coo -23.08 51.44 54.96 -24.43 52.71 52.88 16.05 5.22 -34.74 18.74 5.99 -34.45 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 15 3 # 15 D 130 SER C 449 SER.? 18.20 O1 EDO C 602 D 166 PHE C 445 PHE~? 14.33 C2 EDO C 602 D 182 PHE D 445 PHE~? 11.88 O1 GOL D 601 coo -32.42 55.27 46.18 -30.51 54.94 47.67 9.18 0.49 -44.18 10.65 1.97 -45.43 coo -23.62 58.20 50.84 -23.76 56.14 48.96 9.78 6.26 -35.53 9.91 7.07 -32.85 coo -23.08 51.44 54.96 -24.43 52.71 52.88 10.86 1.23 -30.60 12.85 0.20 -32.29 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 16 3 # 16 D 130 SER D 328 SER~? 24.00 C1 EDO C 602 D 166 PHE C 345 PHE^? 18.39 C1 EDO C 602 D 182 PHE C 352 PHE^? 15.48 O2 EDO C 602 coo -32.42 55.27 46.18 -30.51 54.94 47.67 40.49 20.83 -24.30 39.56 20.57 -22.09 coo -23.62 58.20 50.84 -23.76 56.14 48.96 30.97 21.80 -24.09 32.10 21.77 -21.54 coo -23.08 51.44 54.96 -24.43 52.71 52.88 27.97 28.62 -27.76 27.73 27.28 -30.22 2r11_o03 source 2R11 CARBOXYLESTERASE NP : 16 hits 2r11_o03 naa= 3 ULMN 3 3hde_o00 LYSOZYME user 1 3 # 1 A 35 GLU A 330 GLU~? 26.93 C1 EDO B 603 A 44 ASP A 315 ASP.? 32.31 C1 EDO B 603 A 50 THR A 318 THR.? 30.43 C1 EDO B 603 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 25.78 29.04 20.96 25.48 30.78 22.26 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 35.16 33.09 19.50 33.98 34.83 19.67 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 30.31 35.91 17.26 32.03 37.29 17.23 ULMN 3 3hde_o00 LYSOZYME user 2 3 # 2 A 35 GLU B 330 GLU~? 24.65 C1 EDO B 603 A 44 ASP B 315 ASP.? 32.42 C1 EDO B 603 A 50 THR B 318 THR.? 31.71 C1 EDO B 603 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 31.94 25.81 2.71 33.76 25.37 1.74 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 37.58 31.51 9.95 39.21 32.46 10.92 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 38.06 24.71 9.55 39.51 25.67 10.82 ULMN 3 3hde_o00 LYSOZYME user 3 3 # 3 A 35 GLU C 330 GLU~? 24.03 O1 EDO C 602 A 44 ASP C 315 ASP.? 32.88 C1 EDO C 602 A 50 THR C 318 THR.? 30.49 C2 GOL D 601 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 43.59 14.91 -37.76 45.12 14.02 -38.99 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 51.14 17.66 -30.05 53.19 17.33 -29.52 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 50.21 12.77 -31.72 51.79 13.54 -30.47 ULMN 3 3hde_o00 LYSOZYME user 4 3 # 4 A 35 GLU D 330 GLU~? 24.51 C2 GOL D 601 A 44 ASP D 315 ASP.? 31.69 C1 GOL D 601 A 50 THR D 318 THR.? 30.09 C1 EDO C 602 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 39.35 17.44 -18.72 40.01 18.64 -17.10 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 48.83 21.16 -21.57 48.15 21.79 -19.66 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 44.56 23.70 -22.81 46.55 24.41 -23.21 3hde_o00 source 3HDE LYSOZYME : 4 hits 3hde_o00 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU B 330 GLU~? 24.65 C1 EDO B 603 B 44 ASP B 315 ASP.? 32.42 C1 EDO B 603 B 50 THR B 318 THR.? 31.71 C1 EDO B 603 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 31.94 25.81 2.71 33.76 25.37 1.74 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 37.58 31.51 9.95 39.21 32.46 10.92 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 38.06 24.71 9.55 39.51 25.67 10.82 ULMN 3 3hde_o01 LYSOZYME user 2 3 # 2 B 35 GLU C 330 GLU~? 24.03 O1 EDO C 602 B 44 ASP C 315 ASP.? 32.88 C1 EDO C 602 B 50 THR C 318 THR.? 30.49 C2 GOL D 601 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 43.59 14.91 -37.76 45.12 14.02 -38.99 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 51.14 17.66 -30.05 53.19 17.33 -29.52 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 50.21 12.77 -31.72 51.79 13.54 -30.47 ULMN 3 3hde_o01 LYSOZYME user 3 3 # 3 B 35 GLU D 330 GLU~? 24.51 C2 GOL D 601 B 44 ASP D 315 ASP.? 31.69 C1 GOL D 601 B 50 THR D 318 THR.? 30.09 C1 EDO C 602 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 39.35 17.44 -18.72 40.01 18.64 -17.10 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 48.83 21.16 -21.57 48.15 21.79 -19.66 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 44.56 23.70 -22.81 46.55 24.41 -23.21 3hde_o01 source 3HDE LYSOZYME : 3 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 330 GLU~? 26.93 C1 EDO B 603 C 44 ASP A 315 ASP.? 32.31 C1 EDO B 603 C 50 THR A 318 THR.? 30.43 C1 EDO B 603 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 25.78 29.04 20.96 25.48 30.78 22.26 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 35.16 33.09 19.50 33.98 34.83 19.67 coo 25.48 4.87 1.60 23.90 4.95 0.15 30.31 35.91 17.26 32.03 37.29 17.23 ULMN 3 3hde_o02 LYSOZYME user 2 3 # 2 C 35 GLU B 330 GLU~? 24.65 C1 EDO B 603 C 44 ASP B 315 ASP.? 32.42 C1 EDO B 603 C 50 THR B 318 THR.? 31.71 C1 EDO B 603 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 31.94 25.81 2.71 33.76 25.37 1.74 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 37.58 31.51 9.95 39.21 32.46 10.92 coo 25.48 4.87 1.60 23.90 4.95 0.15 38.06 24.71 9.55 39.51 25.67 10.82 ULMN 3 3hde_o02 LYSOZYME user 3 3 # 3 C 35 GLU C 330 GLU~? 24.03 O1 EDO C 602 C 44 ASP C 315 ASP.? 32.88 C1 EDO C 602 C 50 THR C 318 THR.? 30.49 C2 GOL D 601 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 43.59 14.91 -37.76 45.12 14.02 -38.99 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 51.14 17.66 -30.05 53.19 17.33 -29.52 coo 25.48 4.87 1.60 23.90 4.95 0.15 50.21 12.77 -31.72 51.79 13.54 -30.47 ULMN 3 3hde_o02 LYSOZYME user 4 3 # 4 C 35 GLU D 330 GLU~? 24.51 C2 GOL D 601 C 44 ASP D 315 ASP.? 31.69 C1 GOL D 601 C 50 THR D 318 THR.? 30.09 C1 EDO C 602 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 39.35 17.44 -18.72 40.01 18.64 -17.10 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 48.83 21.16 -21.57 48.15 21.79 -19.66 coo 25.48 4.87 1.60 23.90 4.95 0.15 44.56 23.70 -22.81 46.55 24.41 -23.21 3hde_o02 source 3HDE LYSOZYME : 4 hits 3hde_o02 naa= 3 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 1 3 # 1 H 28 VAL A 377 VAL~? 28.44 O1 EDO B 603 H 117 LYS A 390 LYS~? 25.88 O2 GOL D 601 H 150 CYH A 380 CYH~? 29.74 C1 EDO B 603 coo 45.82 27.58 23.40 45.30 28.87 21.66 30.83 5.28 5.61 29.42 5.64 3.91 coo 38.01 32.08 28.20 39.46 29.85 23.57 26.64 2.81 -1.98 30.91 -1.55 -0.35 coo 41.19 29.62 18.76 39.21 28.51 20.32 29.01 2.63 9.50 30.23 5.08 9.65 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 2 3 # 2 H 28 VAL B 377 VAL~? 19.22 C2 EDO B 603 H 117 LYS B 390 LYS~? 27.12 C2 EDO B 603 H 150 CYH B 380 CYH~? 15.26 O2 EDO B 603 coo 45.82 27.58 23.40 45.30 28.87 21.66 10.43 40.77 13.96 9.57 39.13 15.19 coo 38.01 32.08 28.20 39.46 29.85 23.57 3.52 38.72 20.17 3.15 45.06 20.21 coo 41.19 29.62 18.76 39.21 28.51 20.32 8.08 40.31 9.00 10.50 39.00 9.22 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 3 3 # 3 H 28 VAL C 377 VAL~? 19.90 O2 EDO C 602 H 117 LYS C 390 LYS~? 21.48 O2 EDO B 603 H 150 CYH C 380 CYH~? 18.52 O2 EDO C 602 coo 45.82 27.58 23.40 45.30 28.87 21.66 24.75 31.16 -23.41 23.83 29.45 -22.34 coo 38.01 32.08 28.20 39.46 29.85 23.57 17.95 29.37 -17.21 18.11 35.53 -15.65 coo 41.19 29.62 18.76 39.21 28.51 20.32 22.88 33.08 -27.72 25.47 32.05 -27.37 3uao_o07 source 3UAO PUTATIVE ISOCHORISMATASE : 3 hits 3uao_o07 naa= 3